BLE eh He M08 red Footie os od ohare
eo = eieet
ty ? + ~ ck
s ie ae : : bis Nee tir wrt ee = Hehe tae Mae ha = Te Ne Tey Mea ahs Fea
og te Or are tetee ; a * > ES tt IE Ae eet eer
Feat Ton ie Heh tetts
recone
bee fe Gathesa Sa mts Ma He 3 - : cee ; : : as = * > ied ee Sas oe eee Be Fee Tae Mar ne Sas Rete Narn Ne Ke teteRe — a ae ay (Bote he Wee Rt the eee
—_ rather eters A eer e S = See at a i 3 Fee : haat em Peay
ced
a ee ed . Tirta a wa ee ee ye eel - oS a . A ? -' - . = oe ; rare ihe, & . = g 2 ¥ ‘ rae cade Rettig aha iat i ya te Tear Pp Rs as Be tin ete : i ace arte et : = Spoke oye es S “2, rin, Bag Pon Poet ag Ma Be rutin “ p - F Tstimciat 7 sf : = a r < c , Sa “ Ee te
ots eae
FS
seh Mo Seyh = Me AAR Ee Fe iad wm A a BT keF ettas Mn PeteW a) x ena Ria aTotted
———,
oper ange dh phere Ke
Saw Fro Mer’ Sits th
ete Prete
Sa sh i bad debt hee Lista PTe Tee ot eae 2 atone? ~ : Sr Ste a Tey BT Ly ARG ay ret hh ee Oe me seiko! : . eT as = to ee ne ait
Co ee gee meas ha esta louie txt patel Nabe teste Meta ee MACE OES POO ae oe tanec athe too tin yng Pastime aha Naa Ea
a the a tas Bee Fate Tate Meh reas 4 ere vt 3 3 : é Tee Tey ca as Py te Ne Toes Fim ay he Fe =e Eats Pas eS Pts Sopot Ga brag re ats PEIN Ra Din ew hs Map RS ate Oe Ne la TET IIS Sete EAH os a : pel % Po Be Ain Role Bee 2 Fe te 15 Tate Malate ieee rr - 3 0 oe at a es zs 6 Pete aee ‘ Sieh hl Yin PP he Te rath cone s aos al Fer tenant eneene re sls ee te Ree Fa Qa P> Ms" » Ah a Cat BEI EN LEAD LOO A ar FIO Mo Sw . So Pa TINE en er in gn ig ‘ a Pairard > ee eaten. ea at atin rn 0 Tart ot ihe pe ~tr-ar easter ~ de. . ieee ae ee Pieters eee Se - aia - A asa a os Cenonebaie stare’ wie’ sectetrrers ieee - “ saat : sae poe a Site ie pat r cout ’ - oh ed Asient gin tate bre Pres * 3 - ; Pap ee OR Ren AS EE a Beet ate hus tone 7 ‘ ” mts ia ae Maren ees aorta ~ eu rolerete tate berate Pee
Te go ONE LE eR A Po pion SE aire . Eder ge arrest hl Fe eh Cate te ate = Po
Treats ee Serta: danas
Hw dc
ig. ott 5. ee 3 Fea the Map SS Pepe Nom z fs 4 4 an oat . Fea ages ea ee Teeter eS * ard 5 - ' ate aT in gta
SEF aaa ain tg ta he
ne tara et
ote Tene
Pfs Od a
Digitized by the Internet Archive in 2022 with funding from Maryland Pharmacists Association Foundation
httos://archive.org/details/marylandpharmaci47mary
Volume 47
the maryland
ASSOCIATION
= Dharmacist
Editorial:
State Legislation 1971 Board of Pharmacy Changes Commission on Pharmacy Discipline Relicensure on Continuing Education
Pharmacy Power
by Nathan I. Gruz
Discounting and Pharmacy Management
by Richard Schott
JANUARY 1971
Number 1
Compliments of
oxell
CORPORATION
NOXZEMA SKIN CREAMS
Makers of
NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
r each prescription
a test of your professional
knowledge
Even the simplest-appearing prescription requires the exercise of your professional skill and judgment. Is it the proper strength? Is the dosage within usual or
accepted limits? Is it compatible with other medication your
prescription patient may be taking?
This same judgment also tells you . . . when it comes to your prescription patient’s health (and your reputation), you
want to dispense the finest-quality pharmaceuticals available.
There are no finer-quality products than those from Lilly.
100215
Eli Lilly and Company - Indianapolis, Indiana 46206 Lilly
IN COLD COUNTRY DON’T FOOL AROUND WITH SALES AND PROFITS
Now that winter's here, and temperatures have dropped, everywhere is Cold Country.
So don't fool around...stick with the leader. For an avalanche of sales, and a blizzard of profits, stock, display, and promote the fastest moving, most popular brand of cold products in Cold Country —Contac!
— — Country
Deal up to 44% profit thru February 19
Menley & James Laboratories, Philadelphia, Pa. 19101
The Maryland Pharmacist
NATHAN 1. GRUZ, Editor 650 WEST LOMBARD STREET
NORMAND A. PELISSIER, Assistant Editor BALTIMORE, MARYLAND 21201
ASSOCIATION VoLUME 47 JANUARY 1971 NuMBER 1 OFFICERS 1970-71 Honorary President MORRIS L. COOPER—Baltimore President TABLE OF CONTENTS DONALD O. FEDDER—Dundalk Page President Elect Editorial— i i oes Sebel Gare wore 1G IS LALERLESISIALION aL Ol Limit siakee tetas cn cer ooae rs eat tac cee ss basa cearsesant 6 mriretriaiion: | PharmacveCalendarierceerc te ee ee ae ee eee tere et tad ee cee ee. 6 SYDNEY eRe eS R.—Baltimore University of Maryland School of Pharmacy 8 ea rk EE | I ne sis te ek Ne ee BERNARD B. LACHMAN—Baltimore MarvyiandeDOalc@olmlbarinacveN CW Smee emer e cate tn eee 10 Vice President ; :
MELVIN J. SOLLOD— Adelphi TLOSpltalePharmacve SOCtlON mers meats ceaeu ie cece enin on ire eee ere, sas 12 Mrecutivercecretary PNarmacveLOwere Dy Nat nae Lee GLU siete cesses eres reed evens es 14 NATHAN I. GRUZ : : :
650) Wi Lombard’Strest.-Baltimore 21201 Washing tones pOGlentelO bee Nabiac] Sts meer emeree create ee ene ee ee, 16 Treasurer Discounting and Pharmacy Management by Richard Schott.........000........ 18 MORRIS LINDENBAUM A ih Ee Main Strestl Reisterstown Allegany-Garrett County Pharmaceutical Association ..00.......0..ccccceeeseeerees 22 ODItUAaTiCs ee ee ee eS 7 ee ee NA ee eee 26 Executive Committee Chairman I. EARL KERPELMAN—Salisbury District 1—Eastern Shore PHILIP D. LINDEMAN—Berlin JAMES W. TRUITT, JR.—Federalsburg INDEX TO ADVERTISERS District 2—Central MORRIS ape Segre cre Page JOSEPH U. DORSCH—Baltimore ; PAUL FREIMAN Baltimore geey TA DOLTACOTICS Men nee ne Cem ere cane et cat hts so) ee BOE ok. Vent 28 IRVIN KAMENETZ—Baltimore American Hygienic Company ...................00.... 21 ret eee paltin see AENEAN COLTS ORE Cath oo SPS NE Nato roam eC ANTHONY G. PADUSSIS—Baltimore iBarre- Nationale Proce COMPANY ms LDC ee eee eee 21 ae Tre SC Pee 131k irs ON nem | Oe se Re ih ee eS H. NELSON WARFIELD—Baltimore ‘Borden-HendleralcerCream pee i ie ee 23 District 3—Southern Berke yerilm eer OCCSSING merece ae coer eee we Ns gene eee ee iv! PAUL R. BERGERON, II—Bethesda SAUL B. FRIEDM AN—Potomac CalvVerteDruceCOMDAan VamLIiG saree ree eens ee eee Oe ete eee 23 EDWARD NUSSBAUM—Rockville The Dru DOMINIC J. VICINO—Mt. Rainier e PAELOUSC He LIC seer teseterere reese cerns ene oie te es I Oe ke 20 RICHARD D. PARKER—Silver Spring Henrye bs Gilpin COMPA Varese eee hace 9 District 4—Northern ELVNISON MEW CSLCOLGEACEE UDITNIN) Om 111 Cte reer 27 ARNOLD L. AMASS—Taneytown : ROBERT K. MOLER—Brunswick Eli Lilly and Company POSIT TTI ITEP E ETT TT TEL TTTTTTTTTrT eee riiiririerriririreeererirreererriereeriee 3 District 5—_Western TEOC WV DTU SE COMI DANY eerrr eran ee eee nce eee Cen Pe eee tee ea 7 HARRY G. EISENTROUT, JR. ManzinigandeASSOCIALCS aln Camere ener nee ees 15 Fe RISO SHINS Cp 01 NG Bags Papen tt renee sie i te or Ones mae Cana an Sree STEPHEN HOSPODAVIS—Cumberland Marvyland@ News COMDan Vig ee ee ee en ae. 25 Committeemen at Large Menlevaandsd aMeSeLADOLALOLICS mererte ee eteer tere terete re erenr cee see ee 4 JOHN R. McHUGH ; ROBERT E. SNYDER INOXE]IRCOLDOL ACL ON er eee aa ee ener Tene ee eee ee 2 ML Officigs Menihers PATAMOUNESEPNOTORSCLV ICC werner her eee cree: 19 FRANCIS 8. BALASSONE Pension and Investment Association of America, Inc.............00cc... 22 WILLIAM J. KINNARD, JR. iat aOR Te CS DMStuarte W EDDRAGVELLISING ESET VICES i eeerrreree eee eerees ree aee ene 20
Honorary Life Member of the : j
Executive Committee LY. OUN Se DTIC mELOCUCtSmCOXDOTALION me meerttere rertere te erase ene 11
SIMON SOLOMON
MARYLAND BOARD OF PHARMACY Honorary President SIMON SOLOMON President NORMAN J. LEVIN—Pikesville
Secretary Fr. S. BALASSONE—Baltimore
FRANK BLOCK—Baltimore HOWARD L. GORDY—Salisbury MORRIS R. YAFFE—Potomac
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
Editorial ...
State Legislation 1971 Board of Pharmacy Changes Commission on Pharmacy Discipline Relicensure on Continuing Education
There are several legislative proposals which have been endorsed by the Maryland Pharmaceutical Associa- tion. First, we will again propose that the Maryland Board of Pharmacy be expanded from five to seven members. The present geographical restrictions requiring two mem- bers to reside in the counties, two in Baltimore City, with one from either area, will be eliminated.
The declining number of pharmacists residing in Baltimore City unduly restrict the eligibility of qualified pharmacists to serve on the Board of Pharmacy. It is im- portant that vacancies be filled using the entire state as the basis for selection, although it would certainly be advisable to have representation from as many areas as possible. Enlargement of the Board will enable more facets of pharmacy to be represented. Every attempt should be made to include pharmacists from community, hospital and other kinds of practice. Ideally, proprietor, managerial and salaried pharmacists should be included.
The second bill is a “Commission on Pharmacy Dis- cipline,” modelled after the “Commission on Medical Dis- cipline”’ initiated by the State Medical Society and enacted in 1969. It would provide for greater participation by the profession of pharmacy in disciplinary procedures. The Commission would be made up of representatives of the Maryland Pharmaceutical Association, the Maryland Board of Pharmacy and pharmacists appointed by the
Governor.
The Maryland Pharmaceutical Association would have a role in the disciplinary process by referral of cases by the Commission for investigation and report, by initiat- ing action and by recommending actions to the Commis- sion.
The Commission would be able to act on violations of a code of unprofessional conduct. Its actions would be guided by the legal safeguards afforded all persons under the Administrative Procedures Act, with the right of ap- peal. Such a commission by involving the entire profes- sion, through the state professional society, with the au- thority required to act would be a giant step in curbing the “bad apples” present in every group.
Certainly every pharmacist would prefer to be judged by his own peers who are expert in the unique problems of the practice of pharmacy, rather than find himself sud- denly before a judge and jury unfamiliar with his pro- fession. In other words, by setting and maintaining high ethical and professional standards, pharmacy can truly serve the public interest and the health needs of all real self-policing is the mark of a profession.
The third proposal involves the need for every prac- titioner to constantly maintain a current state of knowl- edge. Changes, innovations and scientific and professional breakthroughs require each health professional to par- ticipate in meaningful organized and supervised continu- ing education.
6
The proposal of the Maryland Pharmaceutical Asso- ciation is to require that relicensure (reregistration) be contingent upon reexamination by the Board of Pharmacy periodically or by presentation of proof of completion of suitable continuing education. The criteria for this con- tinuing education would be developed by a tripartite com- mittee composed of representatives of the University of Maryland School of Pharmacy, Board of Pharmacy and
Maryland Pharmaceutical Association.
Surely, there will be differences of opinion about these proposals. As the details become available, we hope that thorough discussion will convince the large majority of the soundness of these legislative remedies.
If the profession of pharmacy does not take the initi- ative in developing the legislative framework to assure the public of the best possible pharmaceutical service, others will. Let us act before others act for us.
Nathan I. Gruz
Baltimore Veteran Druggists’ Association
Installs New Officers
The Baltimore Veteran Druggists’ Association held its 355th meeting on January 20, 1971 at the University of Maryland Hospital. Installed as officers for the com- ing year were: Carl Caplan, President; Paul Gaver, Ist Vice-President; Albert Rosenfeld, 2nd Vice-President and Dr. Benjamin F. Allen, Secretary-Treasurer.
The Association was first organized in 1926 and has been meeting regularly since that time.
PHARMACY CALENDAR
March 7—AZO Fraternity, Joint Dinner Meeting with Auxiliary, Martin’s West.
March 11—School of Pharmacy Alumni Association Din- ner Meeting, Eudowood Gardens.
March 21-27—Poison Prevention Week. March 27-April 2—APhA Annual Meeting, San Francis-
co, California.
May 16-17—MPhA Annual Convention, Hunt Valley Inn.
May 26—School of Pharmacy Alumni Association An- nual Meeting.
June 2—School of Pharmacy Annual Alumni Banquet in - Honor of Graduates.
June 5—School of Pharmacy Commencement Exercises.
June 11-13—6th Annual MSHP Hospital Pharmacy Sem- inar, Ocean City, Md.
THE MARYLAND PHARMACIST
There’s alot more going for you at LOEwy
Sfectre PERSONALIZED SERVICE PLUS
provides you with the flawless backing of 100% computerization— along with the specia! personal follow-through of people who care
Drug wholesaling divisions of Spectro were among the first in the industry to know the unprecedented advantages of fully computerized warehousing and delivery service. But as a retailing-oriented distributor, we know, too, that nothing can take the place of personalized understanding and service follow- through. That’s why every one of us at the management, sales and service levels is vitally concerned about any phase of service that is of special concern to you. This happy combination of automation and personalization adds up to a quality and completeness of service that just isn’t likely to be matched through any other source.
Got a special supply, financial or service problem? Why not give us a ring during any working hour any day of the week. That’s one way you'll really know what we mean by personalized service. See why more and more retailers throughout the eastern seaboard are saying right outloud...
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
After hours, 485-8105 for order taking. (301) 485-8100 for office and daytime order taking. aT,
LOEWY DRUG COMPANY 3S! Yoctr Srchustoiis, Ine
a) S 6801 Quad Avenue, Baltimore, Md. 21237 Tel.: (301) 485-8100 2 ino?
DIVISION OF
University of Maryland School of Pharmacy
Alumni Association Nominations open for Honored Alumnus
All alumni of the University of Maryland School of Pharmacy are invited to submit nominees for considera- tion for the Alumni Association Honored Alumnus Award for 1971. Most recent honorees are: Frank Block, Dean Warren Weaver, H. Nelson Warfield, Alexander J. Ogrinz, Jr., Dean George P. Hager, and Francis S. Balassone.
Please submit names and supporting information by March 15 to Nathan I. Gruz, Chairman, 650 W. Lom- bard St., Baltimore, Maryland 21201. The Annual Alum- ni Dinner Meeting will be held March 11, 1971 at Eudo-
wood Gardens.
Handbook of Non-Prescription Drugs (APhA) 1969-1970 Edition
A limited number of the 1969-1970 APhA Hand- book of Non-Prescription Drugs are available at a special price of $2.50 (regular price $5.00) from Mr. Henry Seidman, Office of Continuing Education, Room 104, University of Maryland School of Pharmacy, 636 W. Lombard St., Baltimore, Maryland 21201.
Vitamin C and the Common Cold
The claims made recently by Dr. Linus Pauling on the benefits of vitamin C in preventing and relieving the common cold must be questioned for the time being until a large scale, controlled trial is conducted. This study must be conducted over a long period and include many hundreds of persons to give meaningful resuits. No such study has been performed.
According to the December 25 issue of The Medical Letter, (Vol. 12, No. 26), vitamin C in large doses can have adverse effects, Professor Pauling recommends doses as high as 15 Gm. daily for the treatment of colds. When 4 to 12 Gm. of vitamin C are taken daily for acidifica- tion of the urine, however, as in the management of some chronic urinary tract infections, precipitation of urate and cystine stones in the urinary tract can occur. Very large doses of vitamin C, therefore, should be avoided in patients with a tendency to gout, to formation of urate stones, or to cystinuria. Nor can the possibility of other adverse effects of very large doses be excluded.
It should also be noted that the ingestion of large amounts of vitamin C and its excretion in the urine make
8
the results obtained with “dip” and Testape tests for
sugar in the urine unreliable.
The article goes on to conclude “in the absence of ©
convincing evidence of its effectiveness and safety, The
Medical Letter does not recommend the use of large ©
doses of vitamin C for the prevention or treatment of the common cold.”
University of Maryland to Conduct Test on Vitamin C Effectiveness
The University of Maryland will soon begin one of the first definitive tests in this country on whether vita- min C is effective in preventing the common cold. The test will be conducted by the school’s infectious disease re- search unit at the Maryland House of Corrections in Jessup. A total of 40 prisoner-volunteers will participate in the test. Twenty men will receive 4 Gm. of ascorbic acid daily for one month while a control group will re- ceive placebos for the one-month period. At the end of the second week all of the subjects will be injected with live cold viruses. Their conditions will be monitored closely during the final two weeks.
Results of the double-blind study will not be known for three or four months as additional tests will be con- ducted after the four-week period. The test is being spon- sored by the Hoffman-LaRoche Pharmaceutical Company.
Morgenroth to Participate in ACA Management Conference
The Third Annual American College of Apothe- caries Management Conference will be held February 19 to 21 in Fort Worth, Texas. Victor H. Morgenroth, Jr., FACA, and past-president of MPhA, will moderate a workshop session along with M. Donald Pritchard, FACA, Buffalo, N.Y., Joseph G. King, FACA, Chattanooga, Tenn., and Casimir H. Srutwa, FACA, Scottsdale Arizona.
Included among the other sessions will be the fol- lowing presentations: “The Pharmacist and The Com- puter in the 70’s, Robert E. Abrams, FACA, President PAID Prescriptions and “The Formulary and Pharmacist Legal Liability,” Robert F. Steeves, Attorney at Law.
Other presentations include: “Think Before You
Sign,” Dr. M. M. Wolfred, FACA, Beverly Hills, Cali- —
fornia and “Profitable Physician Communication: Work- shop and Action Plan,” John T. Fay, V.P. and Director of Professional Relations of McKesson and Robbins Drug Company.
THE MARYLAND PHARMACIST
=_
let’s get down to “brass tacks”
We ve got a long story to tell .. . but it would take 125 years to tell it.
y
KS
BN TNs Aa,
The beginning would be in 1845, the year the Henry B. Gilpin Company was founded. Over the years, our primary concern has been to provide the most modern and complete services to you and to your business operation.
At the outset, our services were comparatively simple but complete. Today our services are not quite so simple but
are stili complete in every detail.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
BALTIMORE + DOVER + NORFOLK +» WASHINGTON
7. 8.
10.
11
TS
L.
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January
=. featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
Sirs: | am interested in the following programs. Please have your representative contact me in this regard.
Name
Name of Pharmacy ___Phone Slate 21D
Address City
IN a We.
“=
tees et
Maryland Board of Pharmacy News
Pharmacy Changes...
The following are the pharmacy changes of the
month of December:
New Pharmacies
Drug Fair No. 132, Milton L. Elsberg, President, Route 2 and 402, P.O. Box 356, Prince Frederick, Mary- land 20678.
Peoples Service Drug Store, Inc. No. 277, W. E. Pannill, President, 7050 Allentown Road, Camp Springs, Maryland 20031.
Peoples Service Drug Store, Inc. No. 296, W. E. Pannill, President, 5560 Norbeck Road, Rockville, Mary- land 20853.
Sentry Drug Center, Philip Bogash, President, 140 Village Shopping Center, Westminster, Maryland 21157.
Pride Pharmacy, Samuel Adams, President, 2305 East Chase Street, Baltimore, Maryland 21213.
No Longer Operating As Pharmacies
William Rossberg Pharmacy, John T. Meeth, Presi- dent, 3255 Frederick Avenue, Baltimore, Maryland 21229.
Model Drug Store, Nathan Cohen, 1828 East Balti- more Street, Baltimore, Maryland 21231.
Waldorf Drug Company, Inc., Harry B. Rosenstein, President, P.O. Box 65, Waldorf, Maryland 20601.
Changes Of Address, Ownership, Ete.
Eakles Pharmacy, Leon R. Catlett, President, Holi- day Acres, Route 2, Smithsburg, Maryland 21783.
Patterson Park Pharmacy, Inc., Bernard F. Macek, President, 2245 Eastern Avenue, Baltimore, Maryland 2123 Lb;
Provident Hospital—Pharmacy, George L. Russell, Jr., President, 2600 Liberty Heights Avenue, Baltimore, Maryland 21215.
Sale of Needles and Syringes
Mr. F. S. Balassone, Chief of the Division of Drug Control, Maryland Department of Health and Mental Hy- giene, has announced the following regulation governing the sale of needles and syringes.
REGULATION 43C08 GOVERNING THE SALE OF NEEDLES AND SYRINGES OR OTHER PARA- PHERNALIA.
The following regulation adopted December 11, 1970 became effective December 21, 1970.
The sale of needles and syringes or other parapher- nalia shall be made by the pharmacist only in good faith to patients showing proper identification and indication of need. Such record of sales shall be recorded in a Regis- try to be established for this purpose which shall contain the purchaser’s name and address, date of sale, item and quantity sold and the signature of the pharmacist.
10
Milton L. Elsberg Named Chairman of D.C. Savings Bond Committee
Mliton L. Elsberg, President of Drug Fair, was ap- pointed volunteer Chairman of the District of Columbia Savings Bonds Committee by Secretary of the Treasury David M. Kennedy.
Mr. Elsberg will head a committee of District busi- ness, financial, labor, and governmental leaders which— working with the U. S. Savings Bonds Division—assists in promoting the sale of Savings Bonds. He also con- tinues as a member of the U. S. Industrial Payroll Sav- | ings Committee.
The Baltimore native came to Washington in 1935, working as a pharmacist. In 1938 he and a partner, Rob- ert Gerber opened the first Drug Fair. The drug depart- ment store chain has since grown to more than 120 out- lets.
He is a member of the Executive Committee of the Board of Directors, Riggs National Bank; the Washing- ton Board of Trade, Washington Board of Realtors, Inc.; National Association of Real Estate Boards, and member of the Boards of Directors, Brand Names Foundation, Inc., and of the National Association of Chain Drug Stores.
Mr. Elsberg, also serves as trustee, Boys’ Club of Greater Washington; member of the Board of Trustees, United Jewish Appeal of Greater Washington; and mem- ber, Board of Directors, United Givers Fund. He is a member of the President’s Council of Brandeis Univer- sity, Waltham, Massachusetts.
He has received the Washington Advertising Club Award of Achievement and the Brand Name Retailers of the Year Award for Chains in the United States and Canada and was named “American Marketing Man of the Year” by the American Marketing Association.
Mr. Elsberg graduated from the University of Mary- land, School of Pharmacy in 1932 and is a member of the Maryland Pharmaceutical Association.
He and his wife, the former Rita Kahn of New York City, have one son and one grandchild. The Els- bergs reside in Washington.
Cigarette Packs Carry New Warning
By Act of Congress, the following statement must be placed on all cigarettes manufactured for sale in the United States on or after November 1, 1970. Warning: The Surgeon General Has Determined That Cigarette Smoking is Dangerous to Your Health. The American Pharmaceutical Association as well as several state asso- ciations have urged their members to discontinue the sale | of cigarettes.
While this action is an important factor in controll- ing cigarette-caused diseases, pharmacists have a positive contribution to offer in the form of public education re- garding the hazards of smoking.
THE MARYLAND PHARMACIST
Sell him Guardian
Extie | VYenslive
Prick
: TWELVE ROLLED LATEX OS :
L oe Ga NV. f en, Mite
og oS ~ ORIEN.
aes ROLLED LATEX PROPHYLACTICS de i a
go Sf Cli Sensitive
< Ppicnr® TWELVE ROLLED LATEX PROPHYLACTICS
OLLED LATEX #)
TWELVE FR
and he’ll never ask for just prophylactics again
Once a customer uses Guardian, the chances are he'll ask for them every time. Lubricated prophylactics are becoming increasingly more popular every day, and Guardian prophylactics are by far the finest truly lubricated rubber prophylactics made. They’re extra sensitive, thin, and sealed in foil—an excellent product for your customer. Plus, the extra profit makes Guardian a
great product for you to sell.
So the next time he asks for just prophylactics, sell him Guardian,
the Trojan brand premium lubricated product from Youngs, the company tuned to today’s pharmacy customers.
he Youngs Drug Products Corporation, . Piscataway, New Jersey 08854
Hospital Pharmacy Section
Maryland Society of Hospital Pharmacists Meeting of January 14, 1971
The January 14th meeting was held at Mercy Hos- pital in Baltimore. A dinner was served at 6 P.M. Dr. Joseph A. Mead, Chief of Ambulatory Services and Act- ing Chief of Medicine at Mercy Hospital, presented a talk entitled “Hospital Based Group Practice.” Dr. Mead described a program of health care in which private phy- sicians devote part of their time in seeing service patients in a hospital clinic.
Robert Snyder noted that the Society was proceed- ing with the printing of the “Suggested Guidelines and Principles for the Practice of Pharmacy in Hospitals” and that the Maryland Pharmaceutical Association had voted to contribute $100.00 towards the expense involved in the printing and distribution.
Mr. Snyder announced that the recipient of the W. Arthur Purdum Award will be selected by the Board of Directors this year but hereafter the recipient will be chosen by a committee consisting of former award win- ners.
A statement on drug dispensing and drug adminis- tration drafted by Pat Birmingham and the Nursing Liai- son Committee is under review by the Board of Directors.
Robert Snyder reported for June Shaw on upcoming programs. Sam Lichter described the program for the Swain Pharmacy Seminar. The February meeting of the MSHP will be held following the Swain Seminar at Good Samaritan Hospital on February 11th.
The March meeting, sponsored by Roerig, will be held at the North Arundel Hospital. David Nurco, Com- missioner of the State of Maryland Drug Abuse Au- thority, will be our speaker. This meeting will also be the Annual meeting as prescribed in the MSHP By-Laws. The April meeting will be a joint meeting with the D.C. Society at the Schraft’s Colony Motor Lodge. The pro- gram for this meeting is still being planned.
Mary Connelly reported on the Medicaid meeting of the MPhA. The MPhA wants the state to accept Red Book cost of ingredients on Medicaid prescriptions. The Committee anticipates an increase on July Ist of the Medi- caid Fee from $1.75 to $1.85 and a minimum reimburse- ment of $1.00 for OTC prescriptions.
Robert Snyder announced that he was going to sub- mit Dr. Peter P. Lamy’s name in nomination to the Board of Directors of the American Society of Hospital Pharmacists. A motion was made and seconded that the nomination of Dr. Lamy, which will be submitted by
Robert Snyder to the ASHP, has the endorsement of the MSHP.
The following names were approved for member-
ship in the Society: Ronald C. Telak, Pharmacist at Maryland General; Cal Myer with Beecham Laboratories;
12
Clay Sisk, Chief of Pharmacy at National Institute of Health; and Douglas Campbell, student at the Phila- delphia College of Pharmacy and Science, Class of ’73.
Robert Snyder announced the following committee appointments. Howard Sherman and Alan Jaskulski will be co-chairmen of the membership committee. Steven Cohen will replace Murray Ginsberg as representative to the Health Careers Committee of the Maryland Hospital Association Council on Research and Education. Dr. Peter P. Lamy will be chairman of the nominating committee. Also serving on the committee will be Harry Hamet and
Frank Kratz.
Kent Johnson reported that there had not yet been any final decision on the threatened closing of the USPHS Hospital at Wyman Park but a decision would probably be made before February Ist. He asked that the Society send an official letter to the Department of Health, Edu- cation and Welfare stating that it recognizes the many accomplishments of this hospital over the past years and that it strongly recommends not closing this hospital. A motion to this effect was made and seconded.
Mary Connelly introduced her Associate Adminis- trator, Mr. Albert Gilbert and her pharmacy staff. Robert Snyder thanked Mary Connelly for hosting the meeting and thanked The Upjohn Company for sponsoring the meeting. The meeting adjourned at 8:30 P.M.
Three New Systems Introduced For Hospitals
Under a new program aimed at developing products and services for hospitals, Bristol Laboratories has re- cently introduced three new systems for hospital use. The first, the “Bristol Emergency Medication System” (BEMS) features a pre-filled disposable syringe and needle which speeds the administration of various emer- gency medications. The second, the “Aspirite System” provides a completely disposable collection system which can replace glass bottles now used for body fluids in aspirating procedures,
Bac-Data, a third new system, supplies participating hospitals with computerized data on disease-causing or- ganisms and on the antibiotics to which they are suscepti-
ble.
Bristol Laboratories, a division of Bristol-Myers Com- pany, since 1943 has pioneered in the development of antibiotics and other prescription products, particularly the semisynthetic penicillins.
In explaining the move into a new area of business, Frank Kilpatrick, Executive Vice President, said that “although we have long been identified with the develop- ment of pharmaceutical specialties, we now see a great need for many new non-pharmaceutical products, serv-
THE MARYLAND PHARMACIST
ices, and devices to improve health care and reduce hos- pital costs. With the introduction of these three new sys- tems and in view of our past experience in hospitals, we feel we can make a major contribution to the future health care delivery system in hospitals.”
Mr. Kilpatrick went on to say that in test-marketing the Bristoject disposable syringe, the company has found that nurses almost universally applaud the saving in time it provides in medical emergencies.
Bristol sales representatives are presently giving 24- hour-in-service advance training to operating and emer- gency room nurses in all hospitals where BEMS is being adopted. This program insures that all nurses will be thoroughly familiar with the procedure of quickly as- sembling the simple two-part syringe in emergency situa- tions.
Until now, the filing off the tops of ampules and drawing of solutions into syringes was a time-consuming and sometimes frustrating experience. In emergencies phy- sicians seek to minimize time loss. Administering injec- tions immediately to avoid possible brain damage or other medical problems that can worsen with each passing sec- ond. With the Bristoject syringe, several injectable solu- tions can be prepared in 10 to 15 seconds. The nurse, re- lieved of that job, can then better utilize her time in helping the physician care for the patient.
Mr. Kilpatrick pointed out that the medications used in the pre-filled Bristoject syringes have been available for many years. The advantage of the system is not in the medications, but in the device which can deliver them so much faster, and in larger pre-filled sizes. For instance, aminophylline has a well established use in treating acute asthma attacks; the cardiac stimulants calcium chloride and epinephrine are injected directly into the heart with Bristoject’s long needle; and sodium bicarbonate is in- jected in large amounts to overcome acidosis in cardiac arrest. Other drugs presently available in the Bristoject syringe include licodaine HCL and dextrose.
Accurate Penicillin Allergy Test Developed
New York University scientists have developed an inexpensive, simple 15-minute skin test that is virtually 100 per cent accurate in the detection of penicillin allergy. Routine use of the test in the United States—once ap- proved by the FDA—could prevent at least 600 deaths a year from anaphylaxis, an immediate allergic reaction to penicillin involving shock, cardiac arrest and convulsions.
The test, known as the BPL-MDM test (benzyl- penialloylpolylsine and minor determinant mixture) in- volves injecting a small amount of allergen under the skin of the arm. If the test is positive, the patient’s skin develops the characteristic “wheal and flare’”—a swollen, reddened area. According to Dr. Bernard Levine, associ- ate professor of medicine at New York University, peni- cillin skin tests in current use are not 100 per cent re- liable and in some cases the use of even small amounts of penicillin to perform the skin test caused either a bad reaction in the patients or sensitized them to a_ subse- quent, potentially dangerous dose. Instead of using peni- cillin for testing, Dr. Levine uses products of the break- down of penicillin or “artificial” allergens.
JANUARY 1971
Paul LeSage to Receive W. Arthur Purdum Award
Paul LeSage, Chief of Pharmacy at the United States Public Health Service Hospital in San Francisco, has been named recipient of the second annual W. Arthur Purdum Award. The announcement was made by Sam- uel Lichter, Chairman of the Board of Directors of the Maryland Society of Hospital Pharmacists. The award is named in honor of Maryland’s pioneer in the develop- ment of hospital pharmacy practice, and an early leader and Past-President in the American Society of Hospital Pharmacists. The W. Arthur Purdum Award is presented on an annual basis to the person who has made the most significant or sustained contribution to hospital pharmacy
in Maryland.
Mr. LeSage received his Bachelor of Science degree from the Massachusetts College of Pharmacy in 1954. He completed his residency in hospital pharmacy at the United States Public Health Service Hospital in New Orleans in 1955. Since that time he has served as Chief of Pharmacy at USPHS hospitals in Savannah, Georgia; Seattle, Washington; Perry Point, Md.; and more recent- ly in Baltimore from 1965 to 1970. He is a former Lec- turer in Hospital Pharmacy at the University of Mary- land School of Pharmacy where he was appointed Clini- cal Assistant Professor of Pharmacy in 1969. Mr. LeSage holds membership in the American Pharmaceutical As- sociation, American Society of Hospital Pharmacists, the Clinical Society of the United States Public Health Serv- ice, the United States Public Health Service Commis- sioned Officer’s Association and is a Past-President of the Maryland Society of Hospital Pharmacists.
The award will be made at the 6th Annual Hospital Pharmacy Seminar of the Maryland Society of Hospital Pharmacists, June 11-13, 1970 in Ocean City, Maryland.
13
“PHARMACY POWER”
by NATHAN I. GRUZ, Executive Director Maryland Pharmaceutical Association
Presented at the Student American Pharmaceutical Association — Region II Convention, Pittsburgh, Pennsylvania, November 7, 1970
Of all the varied aspects of the vocation of state pharmaceutical association executive, the most rewarding and personally gratifying, for me has always been work- ing with the young people preparing for the profession— the pharmacy students.
When pharmacists gather together, or as they pro- ceed in their individual practice or employment, they are not permitted to forget the many problems and frustra- tions that seem to be inherent in pursuing the profession of pharmacy. I, too, am sometimes depressed by some of the problems which appear to be insolvable.
But I am, basically, an optimist and hopefully try to be a realistic pragmatist. In fact, I believe it is impos- sible to pursue a career in pharmaceutical association man- agement, and in the leadership of a profession without an essentially optimistic, idealistic and positive outlook. After all, pharmacy is an integral part of life—an essential ele- ment of service to society.
Problems are a part of life and are the challenges we must address ourselves to if life is to be stimulating and satisfying. Problems then, are of course, really opportuni- ties for us to exercise our initiative imagination and inno- vative talents in the process of life which characteristi- cally differentiates us from other species as Homo Sapiens.
Your program indicates that you are addressing your- selves to some of the vital issues facing pharmacy today, such as:
Collective Bargaining; National Health Insurance; Recruitment; Drug Abuse Education; Affiliation; State Boards; Anti-Substitution Laws; and Education
Many more could be added, including third-party pre- scription plans, supportive personnel (or technicians, )
APhA-NARD Relations and so forth.
I could speak of the crucial role pharmacy students can and should play in pharmaceutical association pro- grams. In fact, we in the Maryland Pharmaceutical Asso- ciation have appointed students to our committees; they have participated in our annual meetings and they have voting representation in our House of Delegates, just established two weeks ago. The students’ input has been welcomed and has been valuable and constructive.
We earnestly hope students will be able to extend their participation in association activities. For example, we feel they can be an unequalled factor in membership recruitment which will be expanded in the coming weeks following the final vote of MPhA on affiliation with the APhA. A preliminary mail ballot now in progress shows 173 for affiliation and 33 against. This is one of the most encouraging developments for pharmacy in Maryland. We hope that adoption and implementation of affiliation as the sixteenth state, will launch Maryland pharmacists into
14
a strong posture for progress which will benefit not only — pharmacy but the public health and welfare as well.
But, what I see as most critical for pharmacy today — is to look at both the broad picture of pharmacy at pres- ent and its long range prospects. What can be done about current trends? Where is pharmacy going? How can phar- macists influence the nature of the emerging new pro- fession of pharmacy which will result? How can phar- macists play a significant role in the control of the pro- fession of pharmacy and of the varied systems of deliver- ing pharmaceutical services? What should the responsi- bilities of a pharmacist encompass as to pharmaceutical products and services in the areas of research, develop- ment, distribution, dispensing, clinical pharmacy _prac- tice, public health, drug abuse, poison control, health edu- cation and information? What are their responsibilities in governmental, legislative, political, civic and cultural levels of our society? All these facets must be considered as they impinge on both the private and public sectors of our country.
And finally, we come to what is to me the key issue which explodes out of all my preceding remarks this eve- ning.
The body of students who are in the pharmacy schools of America today can go a long way toward creat- ing the kind of profession that they believe is best for the profession and the public, within a period of three to five years!
Let me repeat this statement:
The body of students who are in the pharmacy schools of America today can go a long way toward creating the kind of profession that they believe is best for the profes- sion and the public, within a period of three to five years! How? Not by the wave of a magic wand or wishful think- ing.
It can be done by commitment to certain goals and by a measure of selflessness and temporary sacrifice. The desire for immediate temporary financial gain, greed and short-sighted self-interest are the enemies of what I will present for your consideration.
My premise is that the young pharmacist today has the rare opportunity for choosing the kind of pharma- ceutical career he prefers.
If a pharmacist is really committed to working as a full time health professional in a health oriented environ- ment, he can do so today. At times this may require some additional formal academic education or training, which can be achieved with little sacrifice by the pharmacist truly anxious and motivated to be part of the “health team.”
Employment as a pharmacy student, intern or phar- macist on the basis of “temporary” expediency or because
THE MARYLAND PHARMACIST
of any unprofessional considerations, in an establishment exploiting the profession, places the pharmacist in an untenable position in seeking a place in the sun along side the physician, dentist and other health professionals.
On what tenable basis can such pharmacists con- tinue to complain about the difference in law and in status between the pharmacist and these other profes- sionals?
In other words, if you accept a position in an estab- lishment that is using pharmacy merely as an umbrella of respectability to trade on the health-associated public interest image of pharmacy, or to serve as bait for the sale of merchandise, you are selling your pharmacist’s license to be exploited.
Some pharmacists have rationalized this action on the basis of temporary employment to get experience and learn how the commercially successful entrepeneur or firm operates. Many in confessions to me have lived to
regret the effects of the monster they have helped to create.
A three to five year period of commitment, such as I suggest, by pharmacy students, interns, and pharma-
cists as they graduate beginning in 1971 can transform pharmacy.
Yes, it may mean that some would have to turn down alluring offers and some might have to turn tem- porarily to other fields. Some would have to alter the time- tables they have set up for themselves.
In summary, you can begin today to make decisions and to be involved in the kind of pharmacy practice which either:
1) Furthers pharmacy as a health profession de- voted to more effectively bringing pharmaceutical services and health care of the highest possible standards to all our citizens, as an integral part of the delivery of health service: or the kind that
2) facilitates the survival or expansion of a mini- mal kind of a “count and pour” prescription dis- pensing in which the pharmacist is an impersonal computer, an easily replaceable technician, avail- able to any investor desiring to use the pharma- cist as a tool for loss leader promotions.
The decision is yours. You and your colleagues in the colleges of pharmacy can be the vanguard influencing many pharmacists already in practice.
The alternative will be the domination of pharma- cists (outside of hospitals) by a concentration of power in the hands of a few faceless conglomerate entities who are dedicated first and foremost to the interest and demands of their stockholders.
Whether I have indulged in a useless, time-wasting fantasy is up to you. You can dismiss these thoughts as many of your predecessors have relegated similar ideas to the garbage dump of impractical dreams.
On the other hand, you have it within your power to be the vanguard—the leaders—for pharmacist power in retrieving pharmacy from subordination, by the out- side forces of the “Big’”—“Big Government,” “Big In- dustry,” “Big Labor,” “Big Medicine,” and now “Big Consumerism.” “Pharmacist Power,” coordinated and
JANUARY 1971
strengthened to forge a unified organizational structure of federated local and state pharmaceutical societies linked to the American Pharmaceutical Association, can only re- sult in a golden age of pharmacy in America, an era of a profession of pharmacy universally recognized as superbly educated and trained to serve the public in the com- munity, the hospital, the health center and in every facility organized to deliver health care.
Our goal of all pharmaceutical services and products provided only under the control and supervision of phar- macists would then be achieved. No private or govern- mental agency would then be involved in any activity or decision-making, pertaining to pharmacy or drugs, with- out the input and significant participation by the profes- sion of pharmacy in services, health planning information, education, legislation or law enforcement.
You can be the creative catalysts and the innovators for a new era to retrieve and advance pharmacy—or you can add yourselves to a legion of pharmacists, much too large, who have and are now debasing and destroying a free profession.
Your actions in the days ahead—not your words— will spell out the picture of pharmacy we will see in the year 1975.
The man who rolls up his sleeves rarely looses his shirt.
We still count! But now we back our crack inventory teams with computers that give you selective comparisons, de- tailed cost factors and more customized information—faster! Error-free, too! Mangini’s still the most requested phar- maceutical inventory service. It figures, doesn't it?
Mangini & Associates, Inc. INVENTORY SPECIALISTS
4850 W. Belmont Ave., Chicago, Ill. Tig22estudt St. St. Louis, Mo; 2760 W. Market St., Akron, Ohio
Our new computer does more for you than count.
Lak
[= JHOtG Gate. wut =
—————
f LD 2
Washington Spotlight For Pharmacists by APhA
Legal Division
Physician Held Liable for Patients Amphetamine Addiction
Three men who allegedly suffered complete loss of earning capacity as a result of becoming addicted to amphetamines have been awarded a total of $435,000 by a California jury.
The patients were treated for tension, arising from business pressures over a five year period, with injections of what they said were described to them as vitamins plus a relaxant. They contended that the injections were actually amphetamines of various kinds. The patients claimed that as a result of this treatment, they became addicted to the amphetamines to the extent that they could no longer carry on their business.
Complaint to Grievance Committee of Professional Association is Privileged
A complaint to a bar association grievance com- mittee containing libelous statements was held to be a privileged communication. A suit against the complain- ing party was dismissed by the court on the basis that the privileged status of communications made during the course of a judicial proceeding applies with equal force in proceedings before a grievance committee. The court pointed out that the professional conduct of attorneys is a matter of great importance to the public and that the power of the bar association to discipline members of the bar for misconduct is necessary. The court held that members of the public have a right to make complaints against attorneys and that such complaints cannot con- stitute the basis for a civil action in libel or slander.
It would appear from this decision that a pharma- cist who files a complaint with a disciplinary board at the local, state or national level would not be vulnerable to potential liability for libel or slander, provided that the complaint is made in good faith and in accordance with the procedures established by the disciplinary body involved.
Thalidomide Settlement—$30 Million
The principal thalidomide damage suit has finally ended after a trial of 244 years. The compromise settle- ment calls for a payment of $27 million plus interest to the 2,000 surviving West German children with thalido- mide deformities. $1.1 million will be paid to 800 adults who suffered nervous disorders because of the drug and an additional $1.6 million was assessed against the drug manufacturer for court costs.
The West German court declined to hand down any formal verdict against five employees of the firm charged with causing bodily harm through neglect and intent, negligent homicide and violation of West Germany’s drug law.
16
Personal Financial Planning For The Pharmacist
Personal financial planning should take into account the years after retirement. The community pharmacist must consider his personal financial planning needs as well as the need to hire and retain qualified professional pharmacists. The employed pharmacist must consider his personal need to build a sound retirement plan. In many cases, these needs are intertwined and should be con- sidered as one.
For the past three years, the Maryland Pharmaceuti- cal Association has made available to its members a pen- sion/retirement plan implemented through the facilities of Pension and Investment Associates of America, Inc. (P.I.A.A.).
P.I.A.A. has advised us that recent changes in In-— ternal Revenue Regulations have greatly increased the flexibility of design available in the establishment of tax-— qualified pension plans. These changes reflect IRS aware- ness that the small businessman and self-employed pro- fessional have been the “forgotten man” in previous pen-— sion regulations.
The new regulations make available the use of : “Master prototypes.” This permits an organization such as Bankers National Life Insurance Company, which im-— plements our program through its affiliate, Pension and — Investment Associates of America, Inc., to file basic prototype plans with IRS. The filing of these plans makes : available to you as an individual member greater flexi- bility in the design and installation of your own pension program. These prototypes are especially suited for mem- : bers who operate as sole proprietors . . . partnerships . . . | or corporations. They greatly reduce the burden of initial costs involved in the establishment of a tax-qualified pen- sion plan.
In our endeavor to offer you sound association pro- gramming, we are providing the services of Pension and Investment Associates of America, Inc. (P.I.A.A.). P.L.- A.A. representatives shortly will be contacting you to ex- plain the impact of these new Internal Revenue Regula- tions. Regardless of whether you are self-employed .. . a_ sole proprietor . . . a partnership . . . or a corporation, these new regulatory changes can be important to you. When you are contacted by a P.I.A.A. representative, we suggest that you give him an opportunity to explain the benefits which are available, and to discuss your needs and design a plan for your consideration.
If you require further information or an immediate appointment, contact Mr. David S. Rosenberg, Pension and Investment Associates of America, 2000 Spruce
Street, Trenton, New Jersey 08639 (609-883-0696 ).
Illegal Sale of Amphetamines by Osteopaths
A federal appellate court upheld the conviction of two osteopaths who sold 5,000 amphetamines to former patients. The tablets were purchased by former patients engaged in horse racing, for use in treating the horses.
The court noted that while osteopaths can legally prescribe stimulant drugs to their patients, it was absurd to argue that the sale of the tablets for use as “horse medication” was within the authorized handling of stim- ulant drugs for an osteopath.
THE MARYLAND PHARMACIST
amiliar service or strange film
Are customers bringing in “strange” film brands lately? Have these mysterious “unknowns” been confusing your people?
They don’t have to. Big, small, foreign or domestic, just drop them into the Berkey bag and leave the rest to us.
Who makes the film or where it comes from doesn’t matter. Whether it’s branded or unbranded, Berkey will process it. Our custom quality and custom service means satisfied customers for you. Customers who come back. Again and again. Berkey can do things for you that nobody else does, because nobody else can. Trust all your D and P work to Berkey. It’s good business. You uncomplicate life for your staff. And with one bill from one supplier, your bookkeeper will love you.
Berkey Film Processing of Washington, D.C. 3701 Mt. Vernon Avenue Berkey Io) Alexandria, Virginia 22305 (703) 549-7500
Photo Inc.
Discounting and Pharmacy
Management
by RICHARD SCHOTT, M.B:S., Executive Vice-President, Merchants Buying Syndicate, Inc., New York
Presented on November 19, 1970 at the Simon Solomon Pharmacy Eco- nomics Seminar, Warren House, Pikes-
ville, Maryland.
The discounters today are actually the largest retail force in America. In footage alone in 1970, the discount industry is projected to have 276 million square feet of selling space. This footage is a gain of over 13% over 1969. In 1970, the discount industry will be represented by over 4,000 retail units which is actually almost 400 retail units more than in 1969. The approximate annual sales of the discount industry, projected for 1970, are a staggering 22 billion dollars.
In the area of drugs and cosmetics, the discounter has managed to make tremendous inroads. As an example, 82% of the drug and cosmetics departments are operated by stores themselves with only 12% leased.
In the area of pharmacy operations, roughly 12% of the discounters have pharmacy departments. It is inter- esting to note that the index of incidence of the drugs and cosmetics departments is 82% while the pharmacies index is only 12%.
This type of statistic may be encouraging to some of you as it shows that the one area that the discounter has found difficult to capture is the pharmacy depart- ment.
You should know your competitor better. The aver- age drug and toiletry department in the discount store today is approximately 2,000 square feet. It has an annual turnover of 4.7 times, an initial mark up of 28% and a maintained margin of 24%.
Just what are the discounters doing this year in their drug, health and beauty aids department? Their first concern this year, the year of consolidation, is focus- ing their efforts on tighter and more profitable depart- ments by eliminating slower moving categories and add- ing hot new categories, such as feminine hygiene lines, hair coloring lines, men’s personal grooming aids, as well as ladies’ personal care products such as hair curlers, cosmetic mirrors, etc.
Their next approach in 1970 has been in the mer- chandising swing to larger and professional sizes to com- pete with the supermarkets, as well as the addition of franchise cosmetics which up until now were unavail- able to the chains, but slowly are being opened and ac- cepted by the chains because of the additional prestige and dollars that they contribute.
The discounter will continue to be a formidable com- petitor to your daily business and the time has come for you, the independent, to take cognizance of this fact and begin, if you have not done so as yet, to take action for survival. I think that I should also bring into focus the competitive role that is played by the chain drug
18
operators today. It is the prediction of many experts that the large drug chains with their know-how could well control better than 85% of the drug store business in the next five years. Personally, it is my feeling that your greatest competition in the next few years will not come out of the discount chain, but out of the drug, super- market and variety store units that have been developed by the discounter.
The merchandising job that has been done by the independent in the non-drug categories, has been a poor one. It has been a haphazard approach. A stop gap measure, and at times a ridiculous mish mash of mer: chandise that has ruined your professional standing in the community. The fault does not lie with you alone. It lies with those who have given misguided guidance, some of the wholesalers, some of the opportunists who simply stated that all you have to do to compete with the discounter or the supermarketeer, or the large drug operator, is to be cheaper in your product and carry the most important sundry items.
By now many of you realize, | am sure, that price alone is not going to bring the consumer to your doors. The modern store, well fixtured, well merchandised in the various important drug and health and beauty aids as well as in the non-drug items, has a far better chance of surviving the competitive onslaught from both sides, than one that has decided to ignore the competition.
Those of you who have followed the growth of some of the drug chains, will notice that stores that are being put up are no longer in the 3 to 5,000 square feet cate- gory, but run into the 15,000 and 20,000 and sometimes even 30,000 square feet size and handle merchandise in tremendous assortments—housewares, toys, sporting goods, luggage, china, glass, gifts, notions, stationery, electronics, and who knows what else. In essence they have become variety store oriented and have used variety store tech- niques of merchandising. These chains have developed not only in major cities but in smaller communities, with
the cluster of stores strategically located and utilizing the ~ same newspaper media, in doing so reducing their ad-—
vertising costs.
It is true that their purchasing power is tremendous, and it is also true that in many instances they are cap-
able of buying better. Now, buying better does not neces-
sarily mean that they buy cheaper all the time. It does however mean that the timing and coverage of the vari- ous markets is such that it may give them a far greater advantage over the independent who has to depend solely on the distributor who may not at all times be pro-
gressive or aggressive, to be able to act the supporting
role that is so necessary for the independent.
I have come up with certain observations which I feel must be acted upon by the independent if he is to survive the changes in our industry. First he must no longer think in terms of small stores. The days of the
THE MARYLAND PHARMACIST
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue Baltimore, Maryland 21218
ANUARY 1971 19
1500 or 2500 square feet drug store, even on a local neighborhood basis, are slowly disappearing. Business has doubled, tripled and quadrupled at the neighborhood local store level. Now, how do you merchandise a store in that space? Obviously you do it with better fixturing, and a far broader merchandising mix than ever before. As we, in the discount industry have learned from you 15 years ago when we copied some of your excellent merchan- dising techniques, you now should learn from us, the dis- counters, and that is, that in order for you to merchan- dise the size of the stores that are today acceptable to the American public, you will have to combine your purchas- ing power by getting together either in cooperatives, or call them guilds, or call them whatever you want to call them, by developing central warehousing on a cooperative basis and by developing central buying, central advertis- ing, central store planning and central electronic data processing.
This I believe is the only way an independent will survive the giants of today who are spreading through- out the United States. And who incidentally, in spite of what you may think, are performing an excellent func- tion in servicing a local community.
I realize that it is very nice to put your name on a big sign outside of your store, but I am also aware of the fact that as a one or two store operation, your cost of ad- vertising can become tremendously costly.
I visualize 20 or 30 independent drug operators within a geographic area, getting together, forming a co- operative, developing their own advertising program, ware- housing programs, store planning programs, and even electronic data processing. And at the same time, doing
cn {cr (cs (cn (cs (cn (cms (cr (cree (coe ( coe (cee, (cm (cee
customers.
For information, call or write:
1011 West Butler Street Philadelphia, Pa. 19101 (215) 223-9000
A Service of The Drug House, Inc.
LET OUR COMPUTER WORK FOR YOU With WAP ee
TIP TOP is a computerized procedure by which you are automatically supplied with a monthly statement of purchases for each of your charge account
PLUS
An immediate monthly (and annual) breakdown of their pharmacy purchases of deductible items for income tax purposes.
THE DRUG HOUSE, INC.
1880 Princeton Avenue Trenton, New Jersey 08638 (609) 396-5586
one very important thing in order to present to their customers a strong and cohesive image, and that is, to operate under one name.
I don’t know how startling this suggestion might be to you, but I as an individual, who has seen over the last 15 years the strength and potential capabilities of the chains, as they have developed, feel that the power of per- haps quasi chain operators, even if in name only, can give the customer the image that the national chains have been able to establish over a period of years. I realize that my suggestion to give up your name can be a hard pill to swallow, but as pharmacists you also know, that while some pills do not taste well at first, they manage to cure the illness.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
en (een (er (ees (ce (en (cm (we (cr (en (sn (cen (come (com (cen (eon (ome (ce (es (en ee (n(n (ws (ee (ee (a (es os (s(n (ce (cs (ee (nen (en
— — = ——
I 3069 Newcastle Avenue
| Newcastle, Del. 17920
H (302) 655-7401
by I I EI IIS 20 THE MARYLAND PHARMACIST
Loyalty is a love affair!
In Maryland you are first and foremost in our hearts and mind, Why? Because Barre-National is the last broad-range pharmaceutical manufacturer owned by Marylanders.
We’re “home folks” with a great sense of loyalty. And we love to promptly service your needs of OTC SPECIALTIES, TABLETS & CAPSULES, SUP- POSITORIES, WET PACK, DRY PACK, LIQUID
PHARMACEUTICALS, OINTMENTS, INJECT- ABLES, OPHTHALMIC SOLUTIONS. Give us a try.
BARRE - NATIONAL DRUG CO., INC.
4128 HAYWARD AVENUE @ BALTIMORE, MARYLAND 21215 @ PHONE: 542-5272
)
ANUARY 1971
Be Smart!
Stock the One and Only— Original “SAFETY TIPS”
Think Smart!
Always Sell Them
Smart Users Ask For Them By Name
AMERICAN HYGIENIC CO.
111 S. Paca Street, Baltimore, Md. 21201
727-8328 Represented by IRV NORWITZ Phone 727-8328 SSS I I SS SS SSS SSAA SAA)
>)
21
Allegany-Garrett County Pharmaceutical Association
Retired Pharmacists are Honored
The Allegany-Garrett County Pharmaceutical Asso- ciation honored six retired pharmacists at a testimonial dinner at Clarysville Inn recently.
Honored guests were Francis C. Knepper, Harry C. Lewis, Raymond J. Lowry, Virginia S. Radcliffe, the late James E. McMichael, who died in May, 1970 and W. D. Timmons. The six pharmacists have been practicing for a total of almost three centuries. Their years of health care service to residents of the Cumberland area collec- tively number 270.
At the dinner, C. Murray Allen was master of cere- monies and presented each retired guest with a cup bear- ing his name and years of service. Mrs. Leta McMichael accepted the memorial award for her husband _post- humously.
Presenting remarks were: Henry J. Glick, pharma- cist at Sacred Heart Hospital; Harry Sellers, from Me- morial Hospital; George B. Harmon, from Keyser Drug; Samuel Wertheimer, pharmacist at Memorial Hospital; M. Joseph Eshelman from Peoples Drug Store and Mr. Allen.
The dinner was arranged by officers of the Allegany- Garrett County Pharmaceutical Association: Stephen Hospodavis, president; James L. Ritchie, vice-president; and Robert F. Tomsko, secretary-treasurer.
Free Management Service
The Lilly Analysis Service has evaluated individual financial statements submitted by community pharmacist owners throughout the United States for 39 consecutive years. Each year, about 2,500 pharmacists request a finan- cial review by Lilly staff analysts and receive a complete report of their operation. The service is offered again this year.
The report is free and strictly confidential. Anony- mous statements are also processed and mailed if an ade- quate address is provided. To receive a free analysis, send your financial statements and prescription data to the Lilly Analysis Service, Department M-501, P.O. Box 814, Indianapolis, Indiana 46206.
New Interaction Handbook
The Handbook of Drug Interactions by Edward A. Hartshorn, Ph.D., has recently been published by Donald E. Francke. The Handbook consists of 18 chapters and discusses drug interactions according to the pharmacologi- cal and therapeutic index of the American Hospital For- mulary Service. The material originally appeared in Drug Intelligence and Clinical Pharmacy. The 88-page Hand- eee contains a helpful index which includes drug names only.
The Handbook of Drug Interactions may be ordered from Drug Intelligence and Clinical Pharmacy, College of Pharmacy, University of Cincinnati, Cincinnati, Ohio 45221, at a cost of $3.50 each; $4.00 will be charged if
payment is not enclosed with an order.
cM:
FDA Is Developing A 9-Digit ‘“‘Code” For Non-Drug Health Products
A National Health Related Products Code, corre- sponding to the existing National Drug Code, is now be- ing developed by the Food & Drug Administration, in cooperation with health field organizations, manufac- turers, and other government agencies.
The new code will cover medical and surgical equip- ment used in the treatment of institutionalized patients, as well as a wide range of non-drug health products sold in retail pharmacies. Among these will be thermometers, wheelchairs, bandages, hot water bottles, vaporizers, and bed pans.
The same 9-digit alpha-numerical sequence employed — in the National Drug Code will be used in the Health Products Code. Like the drug code, it is intended to make possible automated electronic ordering, dispensing, cost accounting, inventory control, and third-party claims processing for the covered products.
Hot is Better Than Cold—For Teeth
A group of scientists from the University of Utah, following an extensive two-year study of the thermal stresses on human teeth caused by the constant tempera- ture changes inside the mouth, report that hot drinks and food may be better for teeth than cold ones.
When tooth surface is subjected to sudden tempera- ture drops caused by drinking or eating something cold, the enamel tends to contract and is more susceptible to cracking.
One of the worse things a person can do to his teeth, the researchers warn, is to chew on ice. They also state that breathing through your teeth on a cold winter day may also be inviting a visit to the dentist.
Pension €& Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships)
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
THE MARYLAND PHARMACIST
Congratulations and Best Wishes to the newly elected officers of the Baltimore Metropolitan Pharmaceutical Association
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218 Phone 467-2780
<5 AS SR Q d ! Z 0; CHS First name in ice cream
ICE CRE AM for over a half-century
675-6000
NUARY 1971 23
re
National Health Insurance
The Committee for National Health Insurance, at a press conference on July 7, 1970, described its plan to establish a “Health Security Program.” Senator Edward M. Kennedy (D) Massachusetts announced that he plans to introduce legislation to implement the program some- time before the end of July. He said he hopes to get broad sponsorship of the measure and anticipates hearings will be held in August or early September. The Senator indi- cated the bill will be considered first by the Senate Labor and Public Welfare Committee because of its health aspects but will also go before the Senate Finance Committee which considers legislation involving Federal tax revenues. In response to questioning, Leonard Woodcock, President of the United Auto Workers and Chairman of the Com- mittee for National Health Insurance, advised they were in agreement with George Meany, President, AFL-CIO, and the legislation they are endorsing which has been intro- duced by U.S. Representative Martha W. Griffiths (D) Michigan, the National Health Insurance Act (H.R. 15779) , with only some technical disparities to be resolved.
The Program was described as providing for com- prehensive health care for everyone living in the United States, which would include physicians’ services, institu- tional services, psychiatric services, dental services for children up to age fifteen, certain drugs provided by hos- pitals and group practice plans, and supporting services such as professional services of optometrists and podiatrists, and ambulance and other emergency transportation, among others. “Health Security” would be administered by a five-member Board appointed by the President serving under the Secretary of Department HEW, assisted by an advisory council with consumers holding majority mem- bership.
The plan would absorb Medicare and most other ma- jor health care programs and replace private insurance for services which are covered under the program. It would be financed by taxes which would go into a Health Securi- ty Trust Fund, similar to the Social Security Trust Fund. Funds would be raised from three sources:
Forty percent from Federal general tax revenues
Thirty-five percent from a 2.8% tax on employer payroll
Twenty-five percent from a 1.8% tax on individual adjusted gross income up to $15,000.
Money from the Trust Fund would be distributed to the ten Department HEW regions throughout the country, primarily on the basis of population within the region. From the regional office, the funds would be distributed to local areas for each covered category of health care. Institutions would receive payment on the basis of pros- pective budgets. From the physicians’ services allotment, first priority would be given to group health programs which undertake total physicians’ care on a per person payment basis, for salaried doctors in institutions and for physicians receiving stipends. The remaining funds would be available to pay individual physicians on the basis of negotiated fee schedules.
A percentage of the Trust Fund, two percent in the first year and increasing amounts to a maximum of five percent, would be earmarked as a Resources Development Fund to increase health personnel and facilities and strengthen the health care system. Priority would be given
24
to stimulating the development and growth of group prac-_
tice programs and other innovative and productive health care alternatives and to help to enhance the practice of
medicine in rural and undermanned urban areas. The Pro-:
gram would provide incentives for more efficient use of
existing manpower, and educational and training funds to
supplement programs for the production of new physicians nurses, dentists and other health personnel.
—From COTH Report No. 36, July 29,1970
Council on Teaching Hospitals, Washington, D.C.
Methotrexate Dispensing:
Two physicians reported at the recent AMA annual
meeting that Methotrexate may have been responsible fo
the development of tuberculosis in two patients receiving
the drug for treatment of psoriasis. While it has not been
proven that these two patients developed tuberculosis as”
a direct result of the Methotrexate therapy, case reports and cited animal work led the physicians to suspect that Methotrexate may have been a factor, due to its effect o suppressing the patient’s immune competency. This ef- fect would tend to render a patient more susceptible to infection.
In another case, a suit is pending against a physi- cian and the drug’s manufacturer for the death of a young father of three who died of heptocellular necrosis allegedly induced by methotrexate during treatment for psoriasis. Attention is again directed to the fact that psoriasis is not an FDA approved use of this drug.
The apparent increased non-approved use of Metho- trexate for treatment of psoriasis has re-opened the long standing question as to whether a pharmacist should dispense this drug directly to a patient in contravention of the warning placed on the label by the manufacturer. The warning states that the drug should be dispensec only to physicians.
It is the opinion of the APhA Legal Division that a pharmacist who dispenses this drug directly to a patient, increases his risk of civil liability in the event of an ad- verse reaction. The practical effect of this warning could be to shift the burden of proof required in a negligence action. Instead of requiring the patient to prove the phar- macist negligent, the presence of the warning could re- quire the pharmacist to prove that he was not negligent in dispensing it contrary to the stated warning. The saf- est course for pharmacists is to dispense the drug in the manner specified by the manufacturer.
CHANGE OF ADDRESS
When you move— Please inform this office four weeks in advance to avoid undelivered issues. "The Maryland Pharmacist" is not forwarded by the Post Office when you move.
To insure delivery of "The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move and state the effective date.
Thank you for your cooperation.
Nathan I. Gruz, Editor Maryland Pharmacist
650 West Lombard Street Baltimore, Maryland 21201
THE MARYLAND PHARMACIS
brain.
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regu'arly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
Readin
iS Still the fastest Way to program the
human
et /] At
C2246 Ps
SN
P—<(\km Ea
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
FTC Consent Order Forbids 13 Drug Firms Knowingly To Induce Preferential Prices:
A consent order provisionally accepted by the Fed- eral Trade Commission prohibits 13 affiliated drug re- tailers in North Dakota, South Dakota and Minnesota, from knowingly inducing and receiving discriminatory prices from pharmaceutical suppliers.
The group also is forbidden to maintain any ar- rangement which results in a diversion of prescription drugs to it from a nonprofit institution, or which passes on or makes available to it a preferential price offered by pharmaceutical manufacturers only to nonprofit in- stitutions.
The FTC complaint had alleged that although the major part of the group’s pharmaceutical supplies and equipment purchases are made directly for its own ac- count, substantial quantities of prescription drugs are purchased via the account of a nonprofit hospital. This concerted action between the group and hospital was be- gun approximately nine years ago and has evolved, in part, into a means of obtaining discriminatory prices for the group.
In practice and effect, the complaint continues, the hospital serves as the medium through which the group has exerted influence on suppliers by knowingly demand- ing and receiving on its purchases discriminatory prices, discounts, allowances, rebates and terms and conditions of sale. Suppliers not agreeing to its demands allegedly were usually replaced by others who did.
The complaint also charges that this knowing in- ducement or receipt of the discriminatory prices has sub- stantially lessened competition between acceding and non- acceding suppliers, and also between the group and its unfavored independent competitors.
The consent agreement is for settlement purposes only and does not constitute an admission by respondents that they have violated the law.
Drugstore Sales in 1970—A New High
Sales in the nation’s 50,000 drugstores skyrocketed to a new peak of $13,501,000,000 during 1970, up 5% from the year previous, Drug Topics reports. Sales were divided in the ratio of 63% for independents and 37% for chain drugstores (one of a group of 4 or more drugstores ). Independents accounted for $8,510,000,000 of the sales, and chain drugstores for $4,991,000,000. The average increase per store comes to over $20,000 a year—a gain in gross sales of $385 per week. Total aver- age gross per store was $274,420 for the year.
“1971 should prove to be another record-breaking year for consumer expenditures in drugstores,” said Harrison S. Fraker, Publisher of Drug Topics. “The num- ber of prescriptions filled is well past the one billion mark. New and improved pharmaceuticals, as well as over-the-counter health products, toiletries and cosmetics, should boost customer visits in drugstores from 180,000,- 000 a week to over 200,000,000 with a corresponding in-
crease in the pharmacist’s receipts.”
26
Obituaries...
DR. GAYLORD B. ESTABROOK
Dr. Gaylord B. Estabrook, retired physics professo at the University of Maryland professional schools i Baltimore, died December 4, 1970 after a three-mon illness.
Dr. Estabrook, who taught at the university for 2 years, first came to the university in 1937 as a physics i structor. In 1939, he was made an assistant professor, i 1947 an associate professor and three years later he w appointed a full professor. He retired in 1966.
He was a popular figure at the University. The gra uating classes of 1953 and 1957 of the School of Pha macy dedicated their yearbooks to him. He is survived b his wife, the former Marylyn Way; his mother, Mr. Catherine B. Estabrook, and his sister, Ruth Schoepfle.
DR. CHESTER A. DUNCAN
Dr. Chester A. Duncan, 88, former dean of Baylo University’s School of Pharmacy, in Dallas, died on De cember 2, 1970 after a short illness. Dr. Duncan was bor in Lancaster, Pa., and received his doctorate from th Philadelphia College of Pharmacy in 1906. He then wen to Dallas, where he was dean at Baylor until 1928.
He than came to Baltimore where he managed sev eral pharmacies including the old Tenant’s Pharmacy. H retired in 1965.
L. REX SPRINGER
R. Rex Springer, 68, of Morrel Park, died recentl at his home after suffering a heart attack. Mr. Springe operated the Superior Pharmacy at Washington Boul vard and DeSoto Road from 1928 to 1945. He was a 192 graduate of the University of Maryland School of Phar
macy.
CLARENCE HENRY PIERSON
Clarence Henry Pierson, 70, former member of th firm of Armentrout and Pierson, which in the 1920’s and 1930’s owned pharmacies at Park Heights and Belveder Avenues and Poplar Grove Street and Riggs Avenue, died December 28 after a long illness. Mr. Pierson grad- uated from the Milton College of Pharmacy and became registered in December, 1939. He retired in 1961. |
.
|
JOHN KAIRIS |
John Kairis, 65, died on December 9 after a short illness. He graduated in 1927 from the University of Maryland School of Pharmacy. Mr. Kairis was associated with the Aero Pharmacy for 25 years and with the Ser- pick Pharmacy for 4 years. He was the husband of the late Catherine C. Matthews and is survived by a daughter and son. He is also survived by 2 sisters, Nancy Luck: hardt and Eleanor Bannerman, both graduates of the University of Maryland School of Pharmacy.
THE MARYLAND PHARMACIST
Thantis, the reliable throat lozenge.
The THANTIS DISPENSER, containing a roll of 25 individually foil-wrapped lozenges, is attractively packaged — 6 dispensers in a fold-up counter display. The packaging is right! The profit is good! The time to purchase Thantis is now!
(#740/171)
HYNSON, WESTCOTT & DUNNING, INC. Baltimore, Maryland 21201
INEW ANTI-DANDRU LOTION | SHAMPOO
SELS
BLUE
Helps contro§ symptoms wi use—leaves | tomanage
No. 6620 Contains Selenium Sulfide, 1%
Net Conte
NEW
| ANTI-DANDRUFF LOTION SHAMPOO
SELSUN BLUE”
Helps control dandruff symptoms with regular use. Leaves hair
easy to manage.
No. 6620 Contains Selenium Sulfide, 1%
$1.98 Net Contents 4 fl.oz.
ABBOTT
Finally
It isn’t often that a product combines the best of two possible worlds—the effectiveness of a professional product with the elegance of a cosmetic specialty.
New SELSUN BLUE is a refreshing exception.
In double-blind clinical studies, it was shown to have greater overall effectiveness than
two leading anti-dandruff preparations.*
Yet in every important way SELSUN BLUE re- sembles a superior cosmetic shampoo. It lath- ers beautifully. It has a delightful fragrance. It leaves the hair soft, easy-to-manage.
Isn’t this what a lot of your customers have
been waiting for? 007296
*Tested were a zine pyrithione preparation and a product containing hexachlorophene, sulfur and salicylic acid.
the maryland
w—~" oharmacist
Children Are Frequent Victims of Poisoning by Ordinary D Woachild Products
PARTICIPATE IN NATIONAL POISON PREVENTION WEEK MARCH 21 to MARCH 27
Volume 47 FEBRUARY 1971 Number 2
Compliments of
oxell
CORPORATION
N
NOXZEMA SKIN CREAMS
Makers of
NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your prescription patients may not know the difference ... but you do.
As a pharmacist, you Know that neither brand name nor generic drugs are any better than the demon- strated reliability of their manufacturers. The im- portant thing to you and your prescription patients is not what the product is called but how expertly it is made.
Four generations’ experience in producing fine pharmaceuticals is one of the many reasons you can have confidence in Lilly products.
Eli Lilly and Company « Indianapolis, Indiana 46206 EZ
100218
THE MARYLAND PHARMACEUTICAL ASSOC.
Play
cation and ONLY 100
ANE neee RESERVATIONS
MAY 18 THRU MAY 23, 1971
MAY 18
MONTEGO BAY, JAMAICA
MAY 18 TO MAY 23
MAY 23
LEFT ... MAKE YOURS NOW!
Depart 9 A.M. from Friendship Airport in Baltimore via Eastern Airlines non-stop charter flight to your place in the sun. Relax in the gaiety of the party-like atmosphere, enjoying a leisurely Brunch — Free Open Bar — soaring over the ocean at nearly the speed of sound.
Arrive at the Montego Bay Airport. After clearing Customs, you will be whisked, with your luggage, to the HOLIDAY INN, the glamorous, new exciting tropical island resort. Here you will “live it up” in a breathtaking succession of six sun-splashed days and balmy starlit nights of sheer pleasure at Jamaica’s liveliest and loveliest resort hotel.
Glow in a sunshine world of complete vacation activities . .. revel in a magnificent pool, bask in the sun, plunge in the crystal-clear surf, sail, snorkel, water ski, skuba dive, deep sea fish . ... enjoy golf, play shuffle- board, explore the charming Island, shop for exotic things in an international bazaar or “drive” your cares away on the hotel’s sporty putting green. Freeport prices on Perfumes, Linen, Cashmere Sweaters, Bone China and Porcelain, Watches, Crystal, Silver, Diamonds, Pearls, Cameras, Equipment.
When the sun goes down the magic of Jamaica nightlife takes over with gourmet dining, dancing to the Calypso beat of native drums or to rhythmic Latin and American music.
Just let your mood set the pace from “dawn to yawn” for an unforgettable vacation that dreams are made of.
In addition to the many, many resort activities available, we have included: Multi-course English breakfast each morning in the hotel.
Romantic candlelight dinner each evening in the elegant dining room, offering a wide selection of taste-tingling delights.
All good things must come to an end. . . and so must your delightful “playcation” in Jamaica. On checking out . . . before leaving you will be responsible only for gratuities and personal charges.
Transportation will be provided from the hotel to the airport for your homeward journey via non-stop charter flight, enjoying a delightful Dinner and continuous complimentary bar en route.
You will alight from the plane relaxed and refreshed after six wonderful days in the sun enjoying the best that Jamaica has to offer.
FOR INFORMATION AND RESERVATIONS
CALL MPHA - 727-0746
or NATHAN 269-0212
SCHWARTZ, Chairman § PER 1-956-3300 4EQ® ee
or ALDER SIMON 747-3400 (Day or Nite)
he Maryland Pharmacist
NATHAN |. GRUZ, Editor '650 WEST LOMBARD STREET
VoLUME 47
| OFFICERS 1970-71
Honorary President MORRIS L. COOPER—Baltimore
President DONALD O. FEDDER—Dundalk President Elect NATHAN SCHWARTZ—Annapolis Vice President SYDNEY L. BURGEE, JR.—Baltimore Vice President BERNARD a LACHMAN—Baltimore ce President MELVIN y. SOLLOD—A delphi Executive Director NATHAN I. GRUZ 650 W. Lombard Street, Baltimore 21201 Treasurer
MORRIS LINDENBAUM 5 Main Street, Reisterstown
Executive Committee Chairman I EARL KERPELMAN—Salisbury
District 1—Eastern Shore PHILIP D. LINDEMAN—Berlin JAMES W. TRUITT, JR.—Federalsburg
District 2—Central
MORRIS BOOKOFF—Baltimore JOSEPH U. DORSCH—Baltimore PAUL FREIMAN—Baltimore IRVIN KAMENETZ—Baltimore JEROME MASK—Baltimore ANTHONY G. PADUSSIS—Baitimore DAVID I. SCOTT—Baltimore H. NELSON WARFIELD—Baltimore
District 3—Southern PAUL R. BERGERON, II—Bethesda SAUL B. FRIEDMAN—Potomac EDWARD NUSSBAUM—Rockville DOMINIC J. VICINO—Mt. Rainier RICHARD D. PARKER—Silver Spring
District 4—Northern
ARNOLD L. AMASS—Taneytown ROBERT K. MOLER—Brunswick
District 5—Western
HARRY G. EISENTROUT, JR. Cumberland STEPHEN HOSPODAVIS—Cumberland
Committeemen at Large
JOHN R. McHUGH ROBERT E. SNYDER
Ex-Officio Members
FRANCIS S. BALASSONE WILLIAM J. KINNARD, JR.
Honorary Life Member of the f Executive Committee
SIMON SOLOMON
MARYLAND BOARD OF PHARMACY ] Honorary President SIMON SOLOMON President NORMAN J. LEVIN—Pikesville Secretary I eS BALASSONE Baltimore
FRANK BLOCK—Baltimore HOWARD L. GORDY—Salisbury MORRIS R. YAFFE—Potomac
NORMAND A. PELISSIER, Assistant Editor BALTIMORE, MARYLAND 21201
ASSOCIATION
FEBRUARY 1971 NUMBER 2
TABLE OF CONTENTS
Page
Editorial—Non-Prescription Medication—A Responsibility LOTMENATINACIStS sear 2A meee le eek I ee oe 6 PNarMaAcy Calendarg ccs yt ee Nees Cen ee me yee Pineal La iT. 6 BME AG a cscsestctt sarees st Stone eek AEN, Se OOM aM na or teen ee We we 2g Oe 8 AMD A tis sassaasrssrtogeetane nile ores tee, abi ve diye meryes Rene PUNE he recreate Piece bate 10 SS WHITE LIeLT De CUy SCLILINIAT NA rn sk Oi en ee te eet HOR DLC OR. ily: FOspitalg Pharniacy. Section (ase re te ee se el Re 14 Drug Interactions—Levodopa by David A. Blake.o.........ccccccccccecscesscesseceeeees 16 Thise Month's (News Drugsymers pectin 2 oe iene Mer Pee ee ee 20 CODICUAT IOS ameter te eee ne atria ecel en at eee rie ee 22
INDEX TO ADVERTISERS
Page AINGCTICANSLITLC PIStS a NSULaNCey CU. nee ee ed ee Ae ce 17 ATMICT CANMELY SICHICE COLD AT) Vame ame teen sra aaa ann eee rt ae ee ee 13 Barre Naonale Drom ONDA yan ll a een ee en een eee 9 BEY RCVERIINE PIOCCSSING ernie tertie ten oad ee ee eee 23 BOrden-Hendlerml Cem Crear eccrine de nate ee ae ey ore 24 @CalverteDruce Compan yam LC aires ean eee ree ee ee ee 24 AT hemDruee HOUSER INC ieee ee mere et een a ene eee ee ee eee es we, oe. 17 Hentve bs Gilping Com pariy cee eee ee eee tee ee ee, 21 ElighillyZand sCOmpany gress nce macs eee een aes oe Rene ca S| 3 Loewy: Drugs Company tr. cammrrie neers eee ren et an ss eens eastern Ss: 7 Mangini ands ASSOCIAteS ah INC ar esc eee ee re ees ae ee 22 Marylande NOW Ss COMPANY irr ccceces ce teten reine tere ee meen ee Se 19 INOXel]E COTDPOTAtION creer cree etree oe ede ea eee ee aL, eee 2 PAT ATO UN Gebel OCOMSCIEV ICC meermerecrem ter tac tem crrnece tenn ere ee ee mn eon 15 De StUarteweDDBAGCVeLLISINS A OCLVICES meee eee ee ee es 9 Moungss Drug serpauet= Corporations... ee eee 11
a a a
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
Editorial ...
Non-Prescription Medication— A Responsibility for Pharmacists
Traditionally, when the pharmacist thought of his professional role, he thought only of compounding and dispensing physicians’ prescriptions. But today the prac- tice of pharmacy is emerging as a health care profession concerned with the patient, not just with various aspects of producing and distributing drug products.
Some of the responsibilities that more and more pharmacists are assuming are in the areas of patient medication records, clinical pharmacy practices, drug interactions and intravenous solutions, to mention just a few.
A much neglected area for assumption of full pro- fessional responsibility by pharmacists is that of profes- sional attention to protecting the public in their choice of and self-medication with non-prescription medicines or
over-the-counter drugs (OTC).
Certainly, at the very least, OTC preparations con- taining drugs, which in larger amounts per dosage unit, are restricted to prescriptions, should be available only under a pharmacist’s supervision. Certainly these prepa- rations and all those containing warnings and contraindi- cations should be under the pharmacist’s control. The warnings, among others, include the dangers of use by those who have heart, diabetes or thyroid disease. One wonders about the percentage among purchasers of such medicines who unknowingly are suffering from some of these contraindicated conditions.
Certainly mass display, open display and sale by self-service of potent medication is incompatible with the nature of these preparations and with the public health responsibilities of pharmacists.
Certainly the participation of pharmacists in the promotion of the promiscuous use of patent medicines is in conflict with pharmacists’ professional education, re- sponsibilities and our Code of Ethics.
How about the contribution of advertising and pro- motion techniques to the attitude of people toward the use of drugs and their consequent misuse and abuse?
Is it not time for pharmacists to clearly dissociate themselves from hucksterism in health?
Pharmacists are the only qualified licensed cus- todians of drugs—prescription and non-prescription. Pharmacists, if they wish to be recognized as responsible members of the health care team, with the patient’s wel- fare always foremost, must not give any appearance of abetting those proprietary manufacturers who mislead the public with distortions that the lay public is not qualified to recognize.
Is it not time that all physiologically active ingredi- ents and their quantities be revealed on the labels of all medication and cosmetics?
Many pharmacists have and are assuming full re- sponsibility for advising their patrons about OTC drugs and their use. It is time for every pharmacist to join his
6
colleagues who are sensitive to the ethical and moral issues involved. The pharmacist can perform a truly clinical pharmacy function in both the community and in the institutional setting by asserting professional judg- ment and discretion in the OTC drugs he stocks, how he displays and recommends them, in refusing to stock or sell some, and in the advice he gives those who rely and trust in him.
There is a growing awareness by responsible persons in and out of government who understand that the cus- tomary approach of the market place to ordinary articles of trade does not apply to drugs. This attitude is demon- strated by Charles C. Edwards, M.D., the Commissioner of the Food and Drug Administration, who stated before the NARD in October: “We must also give serious thought to how drugs are being sold in this country. The sale of drugs has tended to move away from the pharmacy as distribution increases through wholesale outlets and supermarkets. There may well be a case, in this area of drug abuse and overuse, to ensure that all sales are under supervision of the pharmacist who is the trained person in the field.”
3
We believe the public expects and deserves from pharmacists straight, medically sound guidance about health products. The basis must be facts, not advertising claims, promotions, advertising allowances, merchandis- ing deals or the demand artificially created by electronic or printed media.
It is time for eliminating all aspects of the patent medicine side-show from pharmacy.
Will you accept this responsibility?
Nathan I. Gruz | |
PHARMACY CALENDAR
March 21-27—Poison Prevention Week.
March 24—MPhA Spring Regional Meeting, Colony 7 Motor Inn.
March 27-April 2—APhA Annual Meeting, San Francis-
co, California. | |
May 16-17—MPhA Annual Convention, Hunt Valley
Inn.
May 26—School of Pharmacy Alumni Association An- nual Meeting.
April 16—Meeting of Maryland Graduate Chapter of Kappa Psi.
June 2—School of Pharmacy Annual Alumni Banquet ine Honor of Graduates.
June 5—School of Pharmacy Commencement Exercises.
June 11-13—6th Annual MSHP Hospital Pharmacy Sem- inar, Ocean City, Md.
THE MARYLAND PHARMACIST
There’s a lot more going for you at LOEwy*
VOM
COMPUTERIZED SERVICE
puts America’s most advanced warehouse facility behind your store
How much is it worth to you to know that the most advanced computerized distribution system in existence isin motion to process your every order ...instantly, efficiently, completely? That you needn't ever stock more than a minimum of a far greater variety of merchandise than you could ever show before... and without investment in excessive inventory? That your wholesaler is never likely to be out-of stock on any desirable item? That every invoice and statement is assured of up-to-the-minute accuracy? And that there is never a lapse of more than 60 minutes from receipt of your order to the time itis on the loading platform, ready to roll?
How much? You'll be able to measure its worth by the number of customers attracted to your store. Old customers and new, it’s the kind of service they aren’t likely to have known before.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
: _ , <A Shectvo ==
j lustrtes,
wisn carci niente et
~~ DIVISION OF OY) 9 ies E Spectre SIniusteies, Ine. % noe
6801 Quad Avenue Baltimore, Md. 21206 Telephone: (301) 485-8100
Baltimore Metropolitan Pharmaceutical Association
55th Annual Installation Dinner-Dance
Irving Kamenetz, installed as president of the Balti- more Metropolitan Pharmaceutical Association for 1971, called for pharmacists to emphasize the personal service they provide to their patrons. He asserted that the public is being mislead about the cost of prescriptions and is ig- noring the vital role that pharmacists perform in their communities. President Kamenetz stressed the importance of every pharmacy maintaining patient medication rec- ords and urged all pharmacists to establish an effective system.
Featured speaker at the function, which was at- tended by 400 members, the allied drug industry and guests, was Senator Rosalie Silber Abrams of the 5th District of Baltimore City. Senator Abrams, a registered nurse who has served a term with distinction in the House of Delegates, reviewed some of the problems in the area of health confronting the state. The need for cost-containment in health care, analysis of hospital and
SENATOR ROSALIE ABRAMS
BMPA Officers 1971
Irvin Kamentz, center, President. Left to right: Charles E. Spigelmire, Treasurer; Anthony G. Padussis, Chairman of Executive Committee; Joseph U. Dorsch, Presi-
dent-elect; Byron Millenson, Honorary President;
Paul Freiman, Vice-President;
Nathan I. Gruz, Secretary and Executive Director. Absent from photo: Vice-Presi-
dents Harold P. Levin and Harry R. Wille.
THE MARYLAND PHARMACIST
nursing home operations and the government health programs in the state budget were reviewed.
A special citation was presented to Byron (Bernie) Millenson, Vice President and General Manager of Radio Station WCAO, by Executive Director Nathan I. Gruz. Mr. Millenson was installed as Honorary President and cited for his cooperation in providing public service time to both state and local pharmaceutical associations in various public health programs such as Poison Preven- tion, Diabetes Detection and Pharmacy Week. The MPhA Sunday evening program on WCAO, “Your Best Neigh- bor,” has set a record for public service time with more than 600 consecutive programs under MPhA and BMPA Public Relations Chairman, Charles E. Spigelmire.
The other officers and Executives installed at Blue Crest North, Pikesville, on January 31, 1971, were: President Elect: Joseph U. Dorsch
Vice Presidents: Paul Freiman Harry R. Wille Harold P. Lewis
Secretary and Executive Director: Nathan I. Gruz Treasurer: Charles E. Spigelmire
Executive Committee Anthony G. Padussis, Chairman Robert W. Henderson Charles H. Wagner Henry Seidman John E. Padussis
William I. Lottier, Jr. Melvin Rubin David I. Scott Ronald Lubman
Loyalty is a
Ex-Officio William J. Kinnard, Jr.
Francis S. Balassone The Banquet Committee consisted of Joseph U. Dorsch, Chairman, Paul Freiman, Co-Chairman, George J. Stiffman, Ticket Chairman, Sam A. Goldstein, Co- Ordinator, Gerald F reedenberg, Ronald A. Lubman, John E. Padussis, Charles E. Spigelmire and Charles H. Wag-
ner.
He who wakes up rich has not been sleeping.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
love affair!
In Maryland you are first and foremost in our
hearts and mind, Why? Because Barre-National is the last broad-range pharmaceutical manufacturer owned by Marylanders.
We’re “home folks” with a great sense of loyalty. And we love to promptly service your needs of OTC SPECIALTIES, TABLETS & CAPSULES, SUP- POSITORIES, WET PACK, DRY PACK, LIQUID
PHARMACEUTICALS, OINTMENTS, INJECT- ABLES, OPHTHALMIC SOLUTIONS. Give us a try.
BARRE - NATIONAL DRUG CO., INC.
4128 HAYWARD AVENUE @ BALTIMORE, MARYLAND 21215 @ PHONE: 542-5272
-EBRUARY 1971
TAMPA Activities
Highlights of recent activities of the Traveler’s Aux- iliary of the Maryland Pharmaceutical Association (TAM- PA) were reported by William A. Pokorny, Secretary- Treasurer and Herman Bloom, Chairman of the Com- mittee on The Maryland Pharmacist.
The TAMPA Ladies’ Night was held at the Lime- stone Dinner Theatre on Thursday, November 5, 1970. The affair was an outstanding social success with an at- tendance of 300. A Cocktail Hour and Buffet Dinner preceded a most enjoyable comedy, “Fool’s Paradise.” Arrangements for the affair were handled hy TAMPA President, William L. Nelson. The guests included MPhA President, Donald O. Fedder and Mrs. Fedder and MPhA and BMPA Executive Director, Nathan I. Gruz and Mrs.
Gruz.
The December meeting was held at The Tail of the Fox, Timonium, on December 5, 1970. The Baltimore Colts 1959 Championship Film was presented. Plans again were announced to make a Christmas Contribu- tion for the Children’s Southwestern Christian Parish.
The annual Goodwill Meeting was held at Ordelle Braase’s Flaming Pit on January 14. There was a good attendance of membership present including the wives of some of the members. The meeting was opened with a prayer and Pledge of Allegiance to the Flag. Following dinner, President William Nelson, announced that all business would be dispensed with except the voting on the new member, Mr. Fred C. Brandau, of Abbott Lab- oratories, which was approved unanimously. The guest speaker was Miss Roberta Poulton, a registered nurse from the S. S. Hope. A very interesting talk about the trips of this ship, the functions of the project and beauti- ful slides were presented and discussed. This project is privately sponsored without governmental support. The contribution to S. S. Hope was approved.
it XILIARY®
ORGANIZED 1916
NT
MACEUT’ J
‘Soc Ce Nesinge cre
t
Left to right: TAMPA President William L. Nelson, guest speaker Roberta Poulton, R.N., Secretary-Treasurer William A.
Pokorny.
APhA Annual Meeting to be Held in
San Francisco
Luxury hotels with lofty skyrooms, the up-turned roofs of Chinatown, the Golden Gate Bridge, a sparkling bay and much, much more await pharmacists and their guests who will be in San Francisco March 27-April 2, 1971, for the APhA Annual Meeting.
More than 4,000 APhA members, their families and friends are expected to attend this 118th annual gathering of the profession, which will officially start with the Opening Session Sunday evening, March 28, and conclude Thursday evening, April 1, with the APhA Annual Banquet at the San Francisco Hilton. Exhibits, registration and meetings will be held at the Civic Audi- torium, with meetings also scheduled in other hotels.
Hotel reservation forms are now being accepted by
the APhA Housing Bureau.
Child Center Opened at Bon Secours Hospital
A new child health center has been opened by the Baltimore City Health Department in the Bon Secours Hospital, 2025 West Fayette Street, for residents in the Steuart Hill and Model Cities “G” areas. Located on the second floor of the east wing of the hospital, the center will be open Mondays and Thursdays and will offer families health services and guidance for their children through the preschool years. The center location at Bon Secours also provides the advantages of hospital facilities if clinic evaluations determine that such services are needed.
Appointments may be made by calling 837-2710 or by contacting the neighborhood public health nurse.
The gavel of officers goes from Francis J. Watkins (right), outgoing President to President William L. Nelson.
THE MARYLAND PHARMACIST
Sell her Bidette...
ELE MORE PIER LEE LL ALE LOE LOPS OLE ELBA LB ER. OX $e LOLS OR ROE PE LRP PE PP BE HE
it means peace of mind to her and repeat profit to you
_ Now from the makers of Bidette
_ Towelette comes Bidette Mist, the
_ most modern convenient answer to
_ the odor problem men don’t have.
_ New Bidette Mist is a gentle, pleasant-to-use vaginal deodorant that is available in aerosol form.
It offers the same reliable deodorant rotection to your customer as
he Bidette Towelette you helped us pioneer. Because of our broad national advertising campaign appearing in over 24 of the nation’s leading women’s magazines with combined circulations reaching over 00 million, more women will be asking and looking for Bidette products in your pharmacy. ae Why. not give premium products ©
premium display... and watch your profits cim>
mew (ntimat
Youngs one Products Corporation, - iscataway, New Jersey 08854
INTIMATE MININE HYGIENE
@odorant Mist
INTIBA ATE FEMININE
| HYGIENE Deodorant : Mist Younge _ NETWr. 5 02. :
NET wr. 3/4 OL
Swain Pharmacy Seminar
The Eleventh Annual Swain Pharmacy Seminar was held on Thursday, February 11, at the Good Samaritan Hospital in Baltimore. The theme of this year’s seminar was “Pharmacy in the Seventies” and to explore this theme, the Swain Seminar Committee chose the follow- ing speakers and topics: Mary Lou Andersen, Communi- ty Pharmacist, Wilmington, Delaware—‘Clinical Phar- macy in Community Practice”; Joseph A. Higgins, Di- rector, Drug Task Force, Social Security Administration —‘‘Factors in the Administration of an Out of Hospital Medicare Drug Program”; Panel Discussion—‘‘Effective Communications Within the Profession and With Other Professions,” Winifred Sewell, Co-ordinator Drug Infor- mation Services, Health Sciences Library, Panel Modera- tor; Sydney L. Burgee, Jr., Hospital Pharmacist; Noel David List, M.D.; Frederick Magaziner, D.D.S.; and Mel-
vin N. Rubin, Community Pharmacist.
The first speaker, Mrs. Andersen, described a phar- macy group-practice known as “Pharmacy Associates, Inc.” This incorporated group of 22 pharmacists was formed for the purpose of providing “‘a mechanism where- by community and hospital pharmacists can play a role in making health care available to residents of depressed areas.” The group presently services 2 health centers located in communities where there is no other phar- macy service available. Each members of the group serves at one of the centers on a rotation basis.
The Northeast Service Center serves as a well-baby center and youth health center during the day until 4 p.m. After 4 p.m. the building becomes a “primary care” health center, operated by a group practice of physicians and pharmacists. Payment for prescriptions at this cen- ter is $1.75 per prescription plus medication cost. The same 60-drug formulary is also used at the Southbridge Center, the second center serviced by the group.
At the centers, patients are seen first by a nurse who records personal data and takes his blood pressure, then the patient sees the pharmacist, who prepares a medica- tion profile and drug history. The patient then takes his chart to the physician who examines him and enters the diagnosis and suggested treatment. The patient then re- turns to the pharmacist who fills his prescription directly from the chart and explains to the patient how to take the product. Prescriptions are labeled with all information necessary to enable the patient to have his prescription refilled elsewhere if necessary when the clinic is closed. The success of this system demonstrates that clinical pharmacy can be practiced in an ambulatory setting, as well as in a hospital.
The second speaker, Joseph Higgins, explained how the Social Security Administration might process pre- scription claims under a National Health Insurance Pro- gram. An estimated 300 to 400 million prescriptions per year are anticipated to be involved. The reimbursements to the pharmacists would have to be done through an electronic process. The administration is aiming at a processing cost of 20 cents per prescription. If the 300 to 100 million prescriptions per year figure is accurate, the
12
MRS. MARY LOUISE ANDERSON
government would be reimbursing pharmacists approxi- mately 1.5 billion dollars per year for prescriptions.
One idea in the planning stages is an “‘auto-input”’ system. A pencil-size scanning device which the pharma- cist would pass over a series of numbers on a card, i.e. social security identifying number and NDC number, would relay information into a magnetic tape set-up located in the pharmacy. Once a day the information con- tained on the tape would be relayed over telephone wires to a central claims processing station. A computer would analyze the information and reject any incomplete claims to be returned to the pharmacist for correction. A check would be sent to the pharmacist for the properly processed claims.
After a short intermission, the program resumed with a panel discussion on “Effective Communications Within The Profession and with Other Professions.” Dr. Noel List indicated areas where he thought pharmacists could do more to improve communications. He pointed out the importance of patient drug profiles. Forty per cent of all patients have their prescriptions filled at the same pharmacy all of the time. This percentage is much higher if we leave out those patients who have prescrip- tions filled at both hospital pharmacies and community pharmacies. Studies also show that 90 per cent of patients will have a second prescription filled at the same phar- macy they have used before.
He thought pharmacists could do more in the area of instructing patients on taking drugs, could be instru- mental in health planning and should act as a referral service to the physician. As far as improving communica- |
THE MARYLAND PHARMACIST |
is with physicians, he thought that pharmacists must e the initiative; they must make their capabilities ywn to the physician.
Melvin Rubin stressed the importance of the phar- sist-patient relationship. At his pharmacy, Mr. Rubin ributes a periodic “letter” to his patients. A recent le gave helpful instructions on the general frequency t certain categories of drugs should be taken for opti- | effect. Mr. Rubin believes in educating the public ut the drugs that they take. He labels all prescrip- is with the name of the drug unless specifically re- sted not to by the prescriber. One of the means phar- sists can develop professional confidence in themselves yy regularly attending continuing education courses.
Dr. Magaziner noted that 83% of dentists now have 1arcotic registration number and that 200 million tal prescriptions were written in 1969. He recognized t dentists in general are weak in their knowledge of g law and this is one area where more direct contact ween dentists and pharmacists would be valuable. The cational role that pharmacists can play in dental care ybvious when statistics show that less than 50% of public regularly see a dentist.
Mr. Burgee pointed out that pharmacists who want mprove their position must make their abilities known ther people. To develop closer ties with the physician, pharmacist must demonstrate to him that he is knowl- eable about drugs. Means available to do this in the pital setting are teaching and publication of Pharmacy letins. He stressed the importance of a good drug in- nation library.
The dinner speaker was Dr. Zsolt H. Koppanyi, Di- rector, Comprehensive Children’s and Youth Clinic, Bal- timore City Hospitals. Dr. Koppanyi described the pre- ventitive medical program at Baltimore City Hospitals. He spoke highly in favor of safety closures on prescrip- tion vials. One of the roles he saw for pharmacists of the future was that of a “triage” specialist. The pharmacist, with the proper training, could make minor diagnoses and refer the more serious patient to a physician.
Shirkey to Receive APhA Hugo H. Schaefer Medal
Harry C. Shirkey, internationally recognized phar- macist-physician, will receive the Hugh H. Schaefer Medal of the American Pharmaceutical Association, ac- cording to an announcement by George Denmark, Chair- man of the APhA Board of Trustees.
Presentation of the Medal, one of the Association’s highest awards for outstanding service, will be made April 1 in San Francisco during the APhA Annual Meet- ing. Dr. Shirkey will be honored for his “heroic dedica- tion to rational drug therapy for children.”
Author of APhA’s “1971 Pediatric Dosage Hand- book,” Dr. Shirkey is internationally recognized as an authority in the field of pediatrics, particularly pediatric therapy. He has practiced pharmacy and medicine in hospitals and the community setting and has served on several university faculties, teaching pharmacology to medical students, pharmacy students and nursing stu- dents.
Be Smart!
Stock the One and Only— Original “SAFETY TIPS”
Think Smart!
Smart Users Ask For Them By Name
AMERICAN HYGIENIC CO.
111 S. Paca Street, Baltimore, Md. 21201
727-8328 Represented by
IRV NORWITZ
Always Sell Them |
Phone 727-8328
RUARY 1971
Hospital Pharmacy Section
Service!
by Robert E. Snyder, President, Maryland Society of Hospital Pharmacists
Service! Pharmaceutical Service! Delivery of Phar- maceutical Service! These terms have been appearing in the pharmacy literature more and more frequently in re- cent years. They are not new. Pharmacy has always been a service profession. The advent of Medicare, how- ever, brought with it a re-examination of these terms as they relate to patient care. Pharmacists in all areas of practice are beginning to take a serious look at the ‘service’ they have been providing. Many community pharmacists have initiated family prescription record systems and pharmacist-patient consultations in an effort to improve service. Hospital pharmacists have developed and are implementing such services as: unit dose drug distribution, patient medication profiles, and 1.V. admix- tures. More recently hospital pharmacists are exploring their contribution to patient care in the clinical setting as part of the health care team.
Since service is our primary function, I believe it is important for each hospital pharmacy to develop a state- ment setting forth in writing it’s “philosophy of service.” An example of such a statement might be as follows:
“The Pharmacy Department of ..................000s-. Hospital is dedicated to the ideal of providing the finest pharmacy service to all persons seek- ing medical care in this institution. We shall endeavor to make the services of the department always available to the patient, the physician, and the nurse. And we shall constantly strive to improve the quality of our professional prac- tice.”
Pharmacists should be proud of their contribution to the medical profession. Service is not a “bad” word. We all need to take a long hard look at our practice in terms of the service we are providing.
Maryland Society of Hospital Pharmacists Meeting of February 11, 1971
The February 11th meeting was held at the Good Samaritan Hospital. The secretary read the minutes of the previous meeting which were approved as read. Mary Connelly reported that she had been contacted by Eli Lilly concerning a joint meeting of the D.C. and Mary- land Society of Hospital Pharmacists. Eli Lilly is plan- ning on sponsoring this meeting which would be held on Saturday, October 23rd, 1971.
Robert Snyder reported for Henry Derewicz and the Liaison Committee with the Maryland Hospital Associa-
14
tion’s Professional Practices Committee. He also : ported that Clarence Fortner had reconfirmed the me ing dates and arrangements for the Sixth Annual H pital Pharmacy Seminar. The Membership Commit will soon be starting on a new membership survey of hospitals in Maryland.
June Shaw reported for the Program Committ The date of the March meeting, to be held at the No1 Arunde! Hospital, was uncertain because of a conflict dates with the annual dinner meeting of the alun association. The D.C. Society requested to postpone 1 April joint D.C. Maryland meeting to May because the elaborate program planned by the D.C. Society : this Organon sponsored meeting. In the event that 1 joint meeting is postponed to May, the April meeti would be sponsored by H. B. Gilpin and Dr. Earl Mase of the FDA would be the speaker. His topic will be ¢ titled “Disposable Medical Appliances.”
The following new members were approved: Pam Brown, pharmacist at Maryland General; Kendal Melt pharmacist at V.A. Hospital at Perry Point; John © Ebrite, with Merck Sharp and Dohme; and Dorothy Le
pharmacist at Lutheran Hospital.
Robert Snyder announced that the recipient of 1 1971 W. Arthur Purdum Award is Paul LeSage. T meeting adjourned at 9:45 P.M.
Ineffective Drugs
Just-completed government studies show that or about one out of five prescription drugs totally live to their claimed effectiveness and that one out of sev fails to meet manufacturers’ claims at all. The stu showed that only 41.7 per cent of 2,752 drugs tested 1 questionably work as advertised to relieve symptoms cure diseases.
These figures, representing the final compilation drug effectiveness studies begun in 1966, were repor'
to a special Senate subcommittee by Dr. Charles C. ] wards, head of the Food and Drug Administration. said the misuse of prescription drugs—especially | taking of too much of too many kinds of medications is a “serious problem and threatens to become more : unless “vigorous steps” are taken to stop it.
Dr. Edwards told the subcommittee, headed by S ator Gaylord Nelson, D-Wis., that the FDA is moving clear 245 ineffective drugs from the market and to- quire drug advertisements to carry government effecti ness ratings. But he conceded that the toughtest probl will be in persuading the nation’s doctors, who last y wrote more than two billion prescriptions, to change tk prescribing habits. |
THE MARYLAND PHARMAC.
f
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439 PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue Baltimore, Maryland 21218
BRUARY 1971
Drug Interactions
LEVODOPA by DAVID A. BLAKE, Ph.D.
Associate Professor and Chairman Department of Pharmacology and Toxicology School of Pharmacy University of Maryland
Levodopa (1-DOPA, Dopar®, Larodopa®) offers a new and effective treatment for Parkinson’s Disease (See August, 1970 edition of this Journal). Its mechanism of action is believed to be conversion to dopamine in the basal ganglia after passage into this area of the brain. Since 1-DOPA and DOPAmine are plentiful in nervous tissue in other parts of the body as well, proper dosage adjustment is critical if the patient is to realize improve- ment with minimal side effects.
There are few confirmed clinical cases of drug inter- actions involving levodopa although the potential for in- teraction is high and particular concern in this regard should be exercised. (1)
Reserpine (Serpasil) :
This antihypertensive drug causes a loss of serotonin, norepinephrine and dopamine from neural storage sites and thus aggrevates the symptoms of Parkinson’s Disease. Actually, the ability of reserpine to cause tremors and rigidity was a clue to the biochemical defect of this disease. Reserpine should be regarded as an absolute con- traindication in patients with Parkinson’s disease and also as therapeutically incompatible (2) with levodopa.
Guanethidine (Ismelin) :
This is also an antihypertensive drug but exerts its effect on blood pressure by causing release of catechola- mines (dopamine and norepinephrine) in peripheral sympathetic nerves. Although guanethidine does not read- ily enter the brain, the concomitant presence of the ele- vated amounts of dopamine that are formed during ther- apy with levodopa might interfere with the uptake of the antihypertensive into sympathetic nerve endings. Thus the addition of levodopa to the therapy of a hypertensive patient being treated with guanethidine would be ex- pected to result in a rise in blood pressure back to hyper- tensive levels.
Methyldopa (Aldomet) :
The antihypertensive action of methyldopa is the result of its metabolic conversion to alpha-methyl norepi- nephrine which replaces norepinephrine in central and peripheral “adrenergic” nerves but is a false transmitter. In addition, methyldopa inhibits dopa decarboxylase, the enzyme responsible for the conversion of levodopa to dopamine, a requirement for anti-Parkinsonian effects. Thus the combination of methyldopa with levodopa would be expected to interfere with the latter drug’s ability to relieve the symptoms of Parkinson’s disease.
(1) Morgan, J. P. and Bianchine, J. R.: “The Clinical Phar- macology of Levodopa.” Rational Drug Therapy. 5: 1-8, 1971.
(2) Lamy, P. P. and Blake, D. A.: “Therapeutic Incompati- bilities,” J. Amer. Pharmaceutical Assn. Vol. NS10, No. 2, February, 1970.
Phenothiazines (Thorazine, Compazine, Mellaril, etc.) :
The phenothiazines are valuable drugs in the tre: ment of certain psychoses and also nausea and vomitin apparently by virtue of their ability to alter the sen tivity of receptors in the brain. Diskinesias similar Parkinson’s disease are caused by an action of the drugs on the extrapyramidal system and can be severe some patients. Thus not only do phenothiazines aggreva the symptoms of Parkinson’s disease, they also blo dopamine receptors in the basal ganglia and like reserpir should be considered absolutely contraindicated in_ tk disease even if the patient is not receiving levodopa.
Pyridoxine (Vitamin B,):
As previously mentioned, before levodopa can exe its anti-Parkinson’s effect it must be converied to dop mine, this reaction requires the catalytic intervention — dopa decarboxylase, an enzyme which requires pyridoxi1 as a cofactor. Hence it would appear that this vitam: would enhance the therapeutic effect of levodopa by i creasing its conversion to dopamine. Such is not the cas Even maintenance doses of pyridoxine (0.3 to 1 mg—tl usual range found in multiple vitamins) can complete inhibit the therapeutic action of levodopa. The mechnis of this antagonism has been attributed to an increase metabolism of levodopa to dopamine in peripheral tissu and consequently less drug is available to the bas ganglia. For Parkinson’s patients, being treated wit levodopa, who must take multiple vitamins, a preparatic without pyridoxine (Larobec ) is available.
Monoamine Oxidase Inhibitors (Parnate, Eutony
Furoxone, Marplan, etc.) :
These drugs have been previously used in the tree ment of Parkinson’s disease with some success. Whe combined with levodopa, hypertensive crisis may resu presumably because of prolonged sojourn of dopamit which is a pressor substance.
Tricyclic Antidepressants (Tofranil, Elavil, Norpramin, etc.): These valuable antidepressant drugs potentiate tl pressor activity of dopamine and norepinephrine. Hence
when a “tricyclic” is combined with levodopa, a hype tensive reaction may be produced.
Summary
The growing popularity of levodopa as the treatme1 of choice for Parkinson’s disease makes it necessary fc the pharmacist to be vigilant for unintentional hazardov or antagonistic combinations with other drugs. Becaus this disease usually strikes middle aged or older person it is likely that antihypertensive, antidepressant and vit min therapy may also be indicated. Many of the popule drugs for treating these conditions have a potential fc interaction with levodopa and may negate its therapeuti effects or even aggrevate the symptoms of Parkinson disease. The pharmacist who is mentally prepared 1 recognize these interactions and who maintains an ind vidual prescription record system for his patients is i a position to be of particular value in the successful trea ment of Parkinson’s disease.
THE MARYLAND PHARMACIS
MAYER & STEINBERG Maryland State Agents 1101 N. CALVERT STREET BALTIMORE, MD. 21202 752-7311
AMERICAN
DRUGGISTS’ INSURANCE CO,
700 American Building Cincinnati, Ohio 45202
WITH AMERICAN DRUGGISTS’ INSURANCE
When you must file a claim for a disaster... fire...theft... liability... you want prompt assistance from someone with the genuine concern and wide expe- rience to settle the claim promptly. American Druggists’ Insurance Co. ‘‘cuts the red tape’’. ADI was created by druggists in 1906 to serve the needs of fellow drug- gists. They know and appreciate what loss means to a druggist and make every effort to provide 100% recovery.
Don't wait till you’re in need to ask about our full coverage plans. Contact your ADI agent, NOW.
A Service of The Drug House, Inc. LET OUR COMPUTER WORK FOR YOU With iithee Abe TIP TOP is a computerized procedure by which you are automatically supplied with a monthly statement of purchases for each of your charge account customers. PLUS An immediate monthly (and annual) breakdown of their pharmacy purchases HM of deductible items for income tax purposes. 1 For information, call or write: THE DRUG HOUSE, INC. 1011 West Butler Street Philadelphia, Pa. 19101 l (215) 223-9000 nt 1880 Princeton Avenue fl Trenton, New Jersey 08638 i (609) 396-5586 i 3069 Newcastle Avenue Newcastle, Del. 17920 i] (302) 655-7401 i
-BRUARY 1971
Dr. Reed Commends MPhA For Its Diabetes Detection Efforts
Doctor Julian W. Reed, Public Education and Dia- betes Detection Chairman of the Maryland Diabetes Asso- ciation, recently reported that a large percentage of the 700 pharmacists who belong to the Maryland Pharma- ceutical Association throughout the city and state have been rendering an extremely useful public service for the past several years in the area of diabetes detection. He reported that in 1969-70, 2,024 mail-in urine tests ( Drey- paks) purchased by the Maryland Pharmaceutical Asso- ciation and distributed without charge through the drug stores, were returned and analyzed in the Maryland State Department of Health laboratory. Of this number, 338 (16.7% ) were positive.
Where geographically feasible, those who screened pos- itive were retested at the Western Health District Head- quarters at 700 W. Lombard Street in Baliimore. The retest consisted of a capillary blood sugar determination two hours after ingesting 75 grams of glucose in a dexcola. Those whose retests were positive were sent to their family physicians for a definitive diagnosis. Of the 338 individuals whose screening test was positive. 272 were referred for a definitive diagnosis. Of this number, 60 newly discovered cases of diabetes were identified. This constituted a yield of 29 per 1000 screened which was extremely high, and compared quite favorably with the yield from initial blood screening at several armories dur- ing diabetes detection week, November 15 through No- vember 22, 1969. The yield of newly discovered diabetics from the blood screening was 23 per 1000.
Doctor Reed attributes this high yield from the Drey- paks to the fact that large numbers of individuals in the “high risk” group—i.e., those individuals with blood relatives with diabetes, those over 40 years of age and those individuals more than 10 percent overweight—are availing themselves of the tests, which is commendable.
It was additionally reported that this year to date 1,031 Drey-paks have been returned, of which 143 (13.8% ) were positive. More Drey-paks are still available in most pharmacies. Those individuals who are in the “high risk” group who have not been tested for diabetes within the past year are strongly urged to pick up a Drey-pak and take the test according to the directions.
Whereas most investigators agree that blood screen- ing is Superior to urine screening, the yield of newly dis- covered diabetics in Maryland over the past three years, as a result of Drey-pak screening with blood retesting of the positives is quite satisfactory, particularly for those individuals who are unable to get to the blood testing sites.
Doctor Reed commended the Maryland Pharma- ceutical Association for its efforts in this endeavor and encouraged them to make Drey-paks available in drug stores throughout the year. He stated that an active pub- licity campaign by the organization would result in a significant increase in utilization of the Drey-paks.
18
Wholesale Drug Companies Offer Service To Pharmacie
: THE ASTRO PROGRAM
This is the first of a series of articles describing some of the services that the full-line, full-service dru wholesalers can offer to assist the pharmacist in establish ing and maintaining a successful operation in the face 0 rising competition.
The ASTRO program is an advertisirig-merchandi ing program aimed through the wholesaler, through th retailer, directly to the consumer. The purpose of th program, offered by the Calvert Drug Company, is to le the consumer know that their neighborhood independen retail pharmacy is also a good place to buy their healtl and beauty aids at competitive prices in addition to “thi place” to obtain their medicines.
The ASTRO program utilizes the journal type cit cular as the principal media for its advertising program Under the ASTRO plan, a participating pharmacy in thi Baltimore marketing area would have its location liste along with all other participants in the same area in th ASTRO Journal of Health and Beauty. This journa would be distributed as a supplement to the News Ameri can and Evening Sun publications. In addition to carry ing promotional ads, the journal also features severa pages of health-related articles of general interest to th consumer.
There are also alternate plans available for phat macies beyond the range of Baltimore city newspape coverage. Stores participating in the plan display an iden tifying emblem or insignia showing that they are ASTR¢
members.
The costs of joining the program involve an initia membership fee plus a monthly fee to help support th program and cover the member’s share of advertisin commitments. The member agrees to participate in al ASTRO promotions during the year and to carry and pul chase if necessary (in the required quantities) all healt and Beauty items advertised in the Astro Journal o
Health and Beauty.
The wholesaler furnishes seven or eight majo Journal promotions during the year and 15 to 18 weekl special promotions supplemented by frequent newspape and radio advertisements. ASTRO membership is avail able to all Calvert members in good standing.
CHANGE OF ADDRESS
When you move— Please inform this office four weeks in advance to avoid undelivered issues. “The Maryland Pharmacist" is not forwarded by the Post Office when you move.
To insure delivery of "The Maryland Pharmacist" and all — mail, kindly notify the office when you plan to move and state the effective date.
Thank you for your cooperation.
Nathan |. Gruz, Editor Maryland Pharmacist
650 West Lombard Street Baltimore, Maryland 21201
THE MARYLAND PHARMACIS
|
—_—
on
IN
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- uage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
_ __ Reading iS Still the fa
to progr human. brain. -
stest way
mi the
\
ro °oo
‘ ee
4 iE “ "4 39 Sn — |
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
This Month’s New Drugs
DRUG NAME: KEFLEX (cephalexin monohydrate ) MANUFACTURER: Eli Lilly and Co. DESCRIPTION: A semisynthetic cephalosporin anti-
biotic intended for oral administration.
HOW SUPPLIED: Capsules equivalent to 250 mg. cepha- lexin, are supplied in bottles of 24. Oral suspension equivalent to 125 mg. cephalexin per 5 ml. is sup- plied in 100 ml. size.
DRUG NAME: VERSAPEN-K (potassium hetacillin), VERSAPEN (hetacillin )
MANUFACTURER: Bristol Laboratories DESCRIPTION: A semisynthetic antibiotic derived from
the penicillin nucleus, 6-amino penicillanic acid. Its antibiotic activity results from the rapid conversion of the hetacillin moiety to ampicillin.
HOW SUPPLIED: Capsules of potassium hetacillin equivalent to 225 or 450 mg. ampicillin per capsule. Chewable tablets equivalent to 112.5 mg. ampicillin per tablet. Oral suspension equivalent to 112.5 mg. ampicillin per 5 ml. Pediatric drops equivalent to 112.5 mg. ampicillin per ml. For intravenous use— 225 mg. and 450 mg. equivalent of ampicillin per vial. For intramuscular use—225 and 450 mg. equivalent of ampicillin per vial.
DRUG NAME: CLEOCIN HC1 (clindamycin HC1 hy- drate )
MANUFACTURER: UPJOHN
DESCRIPTION: A new semisynthetic antibiotic pro- duced by 7-chloro-substitution of the 7(R)-hydroxyl group of the parent compound lincomycin. This chemical alteration gives clindamycin more in vitro potency, better oral absorption and fewer gastroin- testinal side effects than the parent compound.
HOW SUPPLIED: Capsules containing equivalent of 75 mg. clindamycin base in bottles of 16’s and 100’s. Capsules containing equivalent of 150 mg. clindamycin base in bottles of 16’s and 100’s.
Cost of New Drug Development
Did you know that it takes approximately six years from the time a drug is discovered to when it actually becomes available—and this under favorable circum- stances?
Dr. George deStevens, executive vice-president and director of research of CIBA Corporation, who reported this recently, estimated also that average development costs of a single new drug are $7-million. If the drug does not prove out, this large investment in time and money can be completely wiped out, according to the drug industry executive.
Research on a life-saving or life-prolonging drug is expensive and filled with risks, he explained, but such risks must be accepted as part of the necessary process of ‘bee new drugs for the improvement of human realth.
20
Wonder Drugs of the 70s?
Prostaglandins, a group of body chemicals found i various human tissues and fluids, now being researche by various U.S. drug companies, have been found to effective against a wide range of medical problems. P tential application of prostaglandins include their use i aborting pregnancies, inducing labor in pregnant wome lowering blood pressure, and controlling peptic ulcer Eventually, they also may be used as a once-a-mont birth-control pill.
To date, 14 prostaglandins have been found, an ar cle in a recent issue of Chemical Week reports. Larg scale production is difficult because the molecules are s complex.
According to the article, research programs hav been underway in the U.S. for as long as 10 years. It i expected that after the U.S. Food and Drug Administr tion requirements are met, and production problems hav been solved, prostaglandin drugs should be available i the U.S. about 1975-78.
The possibility is noted that the first prostaglandi product may be on the market in Europe by the end o 1971, “probably to induce labor.”
Ih f}iwsrat
A SWAIN Se WORTH BROADCASTING
THE MARYLAND PHARMACIS
box D SAY IS)
y/
For 126 years, the Henry B. Gilpin Company has offered a wide range of services to pharmacists and pharmacies. Once these services were simple. Today they are complex. But the Gilpin service is still complete. Completely modern. Com- pletely attuned to your needs. Like the Gilpin sundries plan. We provide a complete sundries department with inventory specially designed for your store, and a built-in provision for economical and reliable restocking of your shelves. Gilpin also maintains an expanding stock of promotional sundries and programs that build traffic and make sales for you. In addi- tion, Gilpin offers 10 other services to help you in your practice of pharmacy. One or more of them may just fit your need.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
BALTIMORE + DOVER » NORFOLK + WASHINGTON
tie 8.
11.
ee I ‘ E i i
L.
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
eee ee ee eee Sirs:
| am interested in the following programs. Please have your representative contact me in this regard.
Name
Name of Pharmacy
Address Phone.
ys orale
2
“4 :
: 7 d
I
al
GP Academy Plans First Annual Lunch
The Academy of General Practice of Pharmacy of the American Pharmaceutical Association will hold its first Annual Luncheon on Thursday, April 1, in Conti- nental Ballroom No. 5 of the San Francisco Hilton Hotel, during the APhA Annual Meeting, March 27-April 2.
Describing the Luncheon as a “fitting conclusion for the Academy programs,’ ’ AGP President C. Albert Olson noted that “the Luncheon will provide Academy members with the opportunity to honor the Daniel B. Smith Award recipient and the incoming Academy Ex- ecutive Committee.”
The featured speaker will be Milton Silverman, Ph.D., member of the faculty of the School of Medicine and the School of Pharmacy and Special Assistant to the Chancellor at the University of California at San Fran- cisco. “Now It’s Their Turn!” is the title of his address regarding the consumer movement. Dr. Silverman was Executive Secretary of the HEW Task Force on Pre-
scription Drugs.
Tickets for the event will be limited. They will be available at the special Academy booth and the regular APhA Ticket Booth, both located in the Registration area of the Civic Auditorium. The Executive Committee and Academy Delegates also will have tickets available for purchase.
The United States of Mangini
Now, Mangini counts in 41 States! And we're counting with computers that deliver selective com- parisons, detailed cost factors and more customized information than ever before! Our experienced in- ventory teams are now covering more pharmacists in more areas across the country and doing it faster with the same, careful, guaranteed Mangini accu- racy. If your inventory service is not giving you the answers you need, you need Mangini. Write/call/wire for DESCRIPTIVE BROCHURE
MANGINI & ASSOCIATES, INC 4850 W. Belmont Ave., Chicago, III. (312) 282-8181
11722 Studt St., St. Louis, Mo. 2760 W. Market St., Akron, Ohio 575 Savin Ave.,West Haven, Conn. 5501 Cherokee Ave., Alexandria, Va.
22
Francis J. FitzGerald New General Manage of Gilpin Subsidiary
Claiborne B. Morton, Jr., Vice President of Point o Purchase Service Merchandisers, Inc., announced tha Francis J. FitzGerald has joined the firm as Gener Manager.
Mr. FitzGerald is experienced in the rack jobbin business, having been a former Vice President of Rich ray Distributors from 1954 to 1968, and more recently Vice President of Clayton Sales, an Arlington base manufacturers representative firm. Born in Washington, D.C., he attended Gonzaga High School and Mount Sain Mary’s College in Emmitsburg, Maryland.
Point of Purchase Service Merchandisers, known “POPS” to its customers, is a subsidiary of The Henry B. Gilpin Company whose executives offices are in Wash. ington, D.C. POPS offers a comprehensive merchandis ing program in sundries to pharmacies and other outlets in the mid-Atlantic area.
40,000 Covered for Drugs under Maryland Blue Cross :
More than 40,000 Marylanders currently are pra tected against the cost of out-of-hospital drugs by the two-year-old Blue Cross Prescription Drug Program. Blue Cross is processing some 3,000 claims per week from Maryland pharmacies for prescriptions obtained by eligi: ble members. Covered under the program are legend drugs and insulin obtained by a non-hospitalized mem- ber. There is no limit to the number of prescriptions or refills a member or dependent may obtain while covered.
Obituaries...
Samuel Wolfovitz Samuel Wolfovitz, 61, proprietor of Sussman’s Phar- macy, Baltimore, died December 22, 1970. He was a 1931 graduate of the University of Maryland, School of Pharmacy.
Bernard B. Hackett
Bernard B. Hackett, 60, of Baltimore, died January 1. He was a 1934 graduate of the University of Mary- land, School of Pharmacy.
Harold J. Hocking
Harold J. Hocking, 77, Chillum, died January 15. He graduated from Northwestern University, School of Pharmacy in 1917.
Frank M. Noll Frank M. Noll, 79, Baltimore pharmacist, died on January 31 after a long ‘illness. A native of Waynesboro, Pa., Mr. Noll was associated with Read’s, Shuster’s and Weltner’s Pharmacies during his career. He retired in
1966. He is survived by his wife, the former Frieda Freund.
THE MARYLAND PHARMACIS1
odd orders processed, ~ naturally
The oddball customer who insists he wants a print cropped “just this way.”
The man who wants cut film developed, or some positive film strips. The guy who hands your clerk an unheard-of cartridge of film.
Welcome them. They all mean good business.
Just drop the oddball order into the Berkey bag. We'll process it with the same professional skill, care, and dispatch we apply to all our D and P work.
Berkey’s special facilities and broad experience gives us a distinct edge in processing every kind of film. From unfamiliar foreign films to Ultra-miniatures in color and black-and-white, right up to 16 x 20 black-and-white blowups.
We’re ready to service all your needs. Berkey does things for you that no one else does . . . because no one else can.
Berkey
Film Processing
of Washington, D.C.
3701 Mt. Vernon Avenue Alexandria, Virginia 22305
& CIVISION OF (= (703) 549-7500 sealed I |
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up
to making your best source of supply,
THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
KORDEN. First name in ice cream
for over a half-century
675-6000
24 THE MARYLAND PHARMACI:
the maryland
(2. §69pharmacist
Editorial:
Maryland Pharmaceutical Association Serves Every Pharmacist and the Public Interest
Annual Report of the Maryland Board of Pharmacy
An Invitation to All to Attend the 89th Annual Convention Maryland Pharmaceutical Association May 16-17, 1971 Hunt Valley Inn Cockeysville, Maryland
olume 47 MARCH 1971 Number 3
in, —
Compliments of
\oxell
CORPORATION
Makers of NOXZEMA SKIN CREAMS NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your written guarantee of quality
Each prescription you fill is an exercise of your pro- fessional judgment. The drug you dispense may be vital to your prescription patient’s health and well- being. Minor differences in dosage form, particle size, solubility, rate of absorption, or hardness of tab- let can make major differences in therapeutic effi- cacy. When the choice is yours, you want to dispense the best.
Lilly
Eli Lilly and Company : Indianapolis, Indiana 46206
Roche is concerned with the professional needs of all practicing phar- macists along with the best health-care delivery. The needs of all pharma- cists start with a drug source that is fairly priced, equitably distributed and easily available.
Our pricing policy results from our commitment not only to develop new drugs but also to help the pharmacist better serve his community, his pro- fession and himself. That’s why pharmacists with broad firsthand pharmacy experience are in management positions at Roche. Programs, policies and
services are conceived and implemented by pharmacists for :
pharmacists...to help you participate more fully in the ex- ae
panding contribution of health sciences. Rah ae AA AN Base TAL Nutley, New Jersey 07110
When it comes to pricing you're both. the same oRoche
he Maryland Pharmacist
ATHAN I. GRUZ, Editor NORMAND A. PELISSIER, Assistant Editor
O WEST LOMBARD STREET BALTIMORE, MARYLAND 21201
MARCH 1971
OFFICERS 1970-71
Honorary President MORRIS L. COOPER—Baltimore
President TABLE OF CONTENTS DONALD O. FEDDER—Dundalk Pa ge President Elect A F ‘ - NATHAN SCHWARTZ—Annapolis Editorial—MPhA Serves Every Pharmacist and the Public Interest... 6 Vice President Pharmacy) Calendar te. 5. er eee es ee a 6 SYDNEY L. BURGEE, JR.—Baltimore Annual Revor Wise oresidant po Y of the etal Boardgorseharmacya eee en 8 BERN ARD B. LACHMAN—Baltimore MEAs ExecutiverCommittee Meetings satin a ee ee 14 Vice President | MELVINGS SOLLOD-_ Adelphi UAMPAINGWS fee unre cete ke uicn Mee metre een ees ee tats crane: Aton 16 Meee Ditector JIOSDILAlE ENarmacye SOCLON cee Geeta Weer a tami eae ae, ie. 18 NATHAN I. GRUZ Nursing and Pharmacy—Towards Better Patient Care 660 W. Lombard Street, Baltimore 21201 Dy2 Jean ele Macy icar tae cr nil te a ene ok ve eet OP 18 | Treasurer MORRIS LINDENBAUM pee and Board7oie Pharmacy eNows i ee ee ee ee 22 5 Main Street, Reisterstown Washineton= spotiieht. ror + Pharmacists..2..0..40. one 26 : : Obituaries ........... Executive Committee 1es OPP eee POPES S TIES ier rr err err rer ererrrere rer Tr rreree rire rere rerereee rire a Oeeerescceesesesese 30 Chairman I. EARL KERPELMAN—Salisbury District 1—Eastern Shore INDEX TO ADVERTISERS . PHILIP D. LINDEMAN—Berlin P JAMES W. TRUITT, JR.—Federalsburg ) vache AGU CADOTALOTICS ae teed hd aes ee ee ee ls ee 21 District 2—Central K ; a ety. ped te teed ek eS IS aa rae MORRIS BOOKOFF—Baltimore TNOTICHITE LLy geOaCs COMDATIV gic nue scntrtecas ce) teactt a fate e een eae ee 19 JOSEPH U. DORSCH—Baltimore el i rea FREIMAN—Baltimore Batre-NationalsurucsCOmpanve nome ao ar, |e ee nee: 28 IRVIN KAMBNETZ—Baltimore Ber i ; JEROME MASK~—Baltimore erkeys Rilmag Processing mneerrs ete ce eee) ee en ee 17 ANTHONY G. PADUSSIS—Baltimore Borden-Hend lermices Creamer teen ee ee 29 Pe Eee ary et sd me |i) 2 CLGCD TRON OL ECON CLOARIN a areeghetansccncneenihnnrSdtesntoosdepsnnontecceucannttteosversenteraoch H. NELSON WARFIELD—Baltimore Calverte Drugs COMpPany = LC weet ae eee ee ee ee ee 29 District 3—Southern New DIU Set OUSCME LNG tre ens eertnre tere rr eens en eee 0 eS ee 13 PAUL R. BERGERON, II—Bethesda pats 3 AUL B. FRIEDM ANP otomac Hen Lye MGLOl Ti aC OMPAl vers cca ne seen aie erect tise cnet: cons at Reese 7 DWARD NUSSBAUM—Rockville : OOMINIGUT. VICINO_-Mt_ Hatnier Lvnson mW eSsCoOttecza DUNNING 6:1 NC areenrtee ern en ee SL RICHARD D. PARKER—Silver Spring LederlembaboratOries merce rence er ee re ner teen be 15 District 4—Northern Bis lilly sands COMpPAan Veet: ce cere ape eenrel eee hate oe eacee 3 ARNOLD L. AMASS—Taneytown ROBERT K. MOLER—Brunswick Loewy Drug Company Sossesdseosacsdesbesedeabshesadeduvcsedeusnsenveuens seaeeseeeuede ses seecccccesccccecees 23 Districts Western Mangini sands ASSOCIALOS SIN Gains stress weer cstta ase tas ceskecnshcaraeacatspananerspetvssasencost os 22 HARRY G. EISENTROUT, JR. Marylanda News aCOMpany tects ween eee eee ee ee ae 25 Cumberland é STEPHEN HOSPODAVIS—Cumberland NOXC]IS COTDOTACION were cee ae Lee ene ae 2 Committeemen at Large PATAMOUNtS PROLORSEIVICE merc c recente eee Re AA ap Pension and Investment Association of America, INC. oo.ccccccccccccccccssseseses 22 Ee Otticie Members AH RODINS ECOMPAN Via caer tr eee ee oe ee 11 FRANCIS S. BALASSONE ROCHE= Lia DOLAtOTICS wwe eteeee reece oar ree Tes Meese neon 4 WILLIAM J. KINNARD, JR. Poe F DeStUarTtaW CDDEAGVeErLiSIngs SCrviCeS mee ee eee ee ee 28 Honorary Life Member of the ‘ Executive Committee VOUNSSH DTI CmeTOCUCESE CONDOL2G]O lime meron tee erent nn enna eee 32 SIMON SOLOMON MARYLAND BOARD OF PHARMACY Honorary President Change of address may be made by sending old address (as it appears on SIMON SOLOMON your journal) and new address with zip code number. Allow four weeks for President changeover NORMAN J. LEVIN—Pikesville x F. Ss. ay a ete Baltimore The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a FRANK BLOCK—Baltimore year. Entered as second class matter December 10, 1925, at the Post Office at Balti-
H ARD L. GORDY—Salisbur onnis R. Stan bears ait more, Maryland, under the Act of March 8, 1879.
Editorial...
Maryland Pharmaceutical Association Serves Every Pharmacist And The Public Interest
Through the years MPhA has sought to advance the legitimate interests of pharmacy and pharmacists, always keeping in mind the over-riding interests of the general
public.
We have participated in developing guidelines for providing pharmaceutical services to hospitals so that pharmacists will assure professional pharmaceutical prac- tices and safeguards for the benefit of patients.
We want the public assured that they can obtain pharmaceutical services in community pharmacies, with all maintaining high standards of professional practice.
Today comprehensive pharmaceutical practice in community and hospital pharmacies certainly must in- clude a capability for maintaining, retrieving, and utiliz- ing patient medication histories for all drugs used by patients.
Prescription prepayment plans — governmental and private sector—must provide equitable, adequate com- pensation sufficient to reimburse pharmacists for both professional and administrative functions.
As pharmacists move into situations where all or most of their time is spent functioning as health profes- sionals, their time must be properly considered and they must be justly remunerated.
Practicing as a pharmacist necessitates patient-in- volvement. The pharmacist serves as a first line of medi- cal contact for many people. He is called upon for advice. We are approaching the time when health delivering systems must consider payment for this service. Perhaps this would be feasible with capitation payment systems where a flat charge per person or per family will cover the cost of service.
We urge every pharmacist to give attention to these issues in pharmacy and participate in developing the ideas and programs which will serve both pharmacy and the public.
Nathan |. Gruz
PHARMACY CALENDAR April 16—Meeting of Maryland Graduate Chapter of
Kappa Psi. May 16-17—MPhA Annual Convention, Hunt Valley nn.
May 26—School of Pharmacy Alumni Association An- nual Meeting.
June 2—School of Pharmacy Annual Alumni Banquet in Honor of Graduates.
June 5—School of Pharmacy Commencement Exercises.
June 11-13—6th Annual MSHP Hospital Pharmacy Sem- inar, Ocean City, Md.
The National Formulary XIII
The new National Formulary XIII, published in January 1970, became official September 1, 1970. It rep- resents the results of a five-year revision program by the American Pharmaceutical Association, involving more than 500 persons from the fields of medicine, pharmacy, and chemistry.
Of the 992 officially recognized drugs in NF XIII, 411 are newly admitted. Two hundred twenty-one drugs, recognized in NF XII, have been dropped in going to
the new edition.
A new dosage form, aerosols, will be recognized officially for the first time in NF XIII through inclusion of monographs for several therapeutically important aero- sol preparations. Leak testing, delivery rate, and pres- sure testing are among the procedures used to establish standards for aerosol products. In addition to mono- graphs for six individual aerosol dosage forms, NF XIII provides standards and specifications for four aerosol pro- pellants.
In pursuit of its fundamental purpose—to provide standards and specifications which can be used to evalu- ate the quality of pharmaceuticals—NF XIII has drawn upon and utilized the many recent developments in drug analysis and methodology. The X-ray Diffraction specifi- cations and the Dissolution Test constitute two important. examples of the effort made to provide objective means of assessing drug quality with respect to drug forms and formulations, as these attributes may influence the bio- logical performance of the article. :
An admissions policy based on the therapeutic value’ of the drug again serves as the sole criterion for articles admitted to the NF for medicinal purposes, with combi- nation drugs gaining admittance only if the combination offered a “distinct therapeutic advantage” over the sepa- rate components.
The National Formulary XIII is available from the Mack Publishing Co., Easton, Pessylvania 18042 at a cost of $15.00.
Maryland Graduate Chapter Kappa Psi
The Maryland Graduate Chapter of Kappa Psi Phar- maceutical Fraternity is sponsoring a dance to be held on Friday, April 16, 1971 at the Famous Ballroom, 1717 N. Charles Street, Baltimore, from 9 p.m. to 1 a.m. The dance, entitled “The Spring Tonic” will feature “A. J. and the Essentials.” Tickets are available at $7.00 per couple from Larry Hogue, Mike Luzuriaga or Jim Culp. —
THE MARYLAND PHARMACIST
pia
eZ
0
y KIT
e-
pA
For 126 years, the Henry B. Gilpin Company has been aiding pharmacists in the practice of their profession. At the outset, our services were comparatively simple but complete. Today they are more complex but still complete. One of these services—so vita! to a profitable pharmacy—is promotion and advertising. When it comes to selling, come to Gilpin. We are prepared to provide you with an on-going advertising and promotional program. We also maintain the necessary stocks of promotional merchandise and in-store merchandising aids required for a successful program. Now is the time to nail down your profits with a “brass tacks” advertising plan tailored for you by the specialists at Gilpin.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. in addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now. A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department. = | A complete sundries program providing sundries *) departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves, Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales. A professional planning and remodeling service = within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store * development and in lease acquisition for desirable sites.
= Computerized inventory and billing systems. This | modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
BALTIMORE + DOVER + NORFOLK + WASHINGTON
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
>) Two giant product shows each year: in January *) featuring summer goods; in July featuring selections
of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance.
>. Our specialists in this area now provide on-going
[jets ese
advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business,
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange tor Gilpin specialists to tailor the services which your particular interest or situation requires.
ee ee eee Sirs:
! am interested in the following programs. Please have your i representative contact me in this regard. 5
Name
Name of Pharmacy
Address Phone.
City Sisles ee i
Annual Report of the Maryland Board of Pharmacy
1969 1970
In compliance with the provisions as set forth in Section 258 of Article 43 of the Annotated Code of Mary- land, this report is submitted to the Honorable Marvin Mandel, Governor of Maryland, and to the Maryland Pharmaceutical Association. This is the sixty-seventh re- port to the Governor of the State and the fifty-seventh to the Association. The report covers the activities of the Maryland Board of Pharmacy for the fiscal year ending June 30, 1970. For the first time, this report is being submitted to the Secretary of the Department of Health and Mental Hygiene.
Personnel
During the year the Board held fourteen meetings, six of which were held at the School of Pharmacy of the University of Maryland, for the purpose of conducting examinations for registration of pharmacists.
At its first meeting the Board reorganized and elected Mr. A. J. Ogrinz, Jr., President and Mr. F. S. Balassone, Secretary-Treasurer. The other members of the Board were: Messrs. Norman J. Levin, Howard L.
Gordy and Morris R. Yaffe.
At the annual meeting of the Maryland Pharma- ceutical Association held at the Tamiment-in-the-Poconos, Tamiment, Pennsylvania on July 13-17, 1969, the Nomi- nating Committee submitted the following names which were later submitted to the Governor as possible succes- sors for Alexander J. Ogrinz, Jr. whose term would ex-
pire on April 30, 1970:
Alexander J. Ogrinz, Jr. Frank Block Harry Wille
Governor Mandel appointed Frank Block a member of the Board for a term of five years, beginning May 1, 1970.
Since Mr. Ogrinz was not reappointed, the Board re- organized and Mr. Norman J. Levin was elected Presi- dent by unanimous vote.
On June 24th a letter signed by all the Board mem- bers was given to Mr. Ogrinz, which reads thusly:
“Mr. Alexander J. Ogrinz, President 3200 Parkside Drive Baltimore, Maryland 21214
Dear Al:
This is to acknowledge your long, dedicated period of service to the Board of Pharmacy and the people of the State of Maryland.
The dedication, interest and application to Board matters shall remain a symbol for all succes- sive members to emulate.
The cheerful manner and the wealth of pleas-
antries we have shared is a memory we shall always treasure.
In your personal and professional activities we wish you great success and happiness, and with ev- ery hope that you will continue to maintain interest in our activities, we remain
Cordially,”
Examination
The Board conducted two examinations for regis- tration of pharmacists during the fiscal year. They were held at the School of Pharmacy of the University of Maryland on October 27, 28 and 29, 1969 and on June 22, 23 and 24, 1970.
There were twenty-three applicants for the full Board in October. Twenty passed both the theoretical and prac- tical portions of the examination and were subsequently registered. Three failed the examination.
Having previously passed the theoretical portion of the examination, fifty-four candidates took the practical examination in October. All of these candidates passed and were subsequently registered.
One applicant took only the theoretical portion of the examination. This applicant passed and will take the practical examination upon completion of his practical experience.
One applicant took only the practical portion of the examination, as he did not have the required experience for reciprocity. This applicant passed and was subse- quently licensed by reciprocity in Maryland. |
There were seven candidates who were eligible to take the full Board. Of these, six passed and were subse- quently licensed and one failed this examination.
Ninety-one candidates were eligible to take the theo- retical portion of the examination. Of these, eighty-two passed and eight failed this portion of the examination. One student was not able to take the theoretical portion of the examination due to illness.
Two applicants having previously passed the theo- retical portion of the examination took the practical ex- amination. Both of these applicants passed and were sub- sequently registered with the Board.
Four applicants took only the practical portion of the examination as they did not have the required ex- perience for reciprocity. All of these applicants passed and were subsequently licensed by reciprocity in Mary- land.
The subjects assigned at both the October, 1969 and
the June, 1970 examinations were as follows: Chemistry ge eee Alexander J. Ogrinz, Jr. Frank Block Pharmacy and Jurisprudence..Norman J. Levin Materia Medica and Pharmacognosy
Morris R. Yaffe
Chemical and Pharmaceutical Mathematics F. S. Balassone
Practical Pharmacy ................ Howard L. Gordy
THE MARYLAND PHARMACIS1
Record of Examinations Held
ctober 27, 28 and 29, 1969
pplicants Passed Withheld Failed 85 0 3 une 22, 23 and 24, 1970 pplicants Passed Withheld Failed 99 8 82 9 otal Number Examined for Registration as Pharmacists pplicants Passed Withheld Failed 187 93 82 12
The following table shows the number of pharma- ists who were registered by examination during the past en years:
YEAR NUMBER OF PHARMACISTS 1960-1961 63 1961-1962 62 1962-1963 74 1963-1964 100 1964-1965 11 1965-1966 64 1966-1967 58 1967-1968 41 1968-1969 60 1969-1970 93
As in the past many pharmacists applied for re- ciprocal registration in Maryland in order to accept posi- tions with their employers who are opening stores in Maryland.
Those applicants who did not meet cur require- ments concerning practical experience prior to or after registration were advised that they must take our practi- cal examination in order to verify their qualifications.
In all cases an applicant for reciprocal registration must appear for a personal interview. The entire Board
ust act on whether or not to grant registration to such applicants, who must sign an agreement to comply with Maryland’s laws pertaining to drugs and pharmacy.
The following table shows those granted registration by reciprocity during the 1970 Fiscal Year:
Registered By Reciprocity
Certificate
Name Number Dated State Richard L. Marden 7103 Sept. 26, 1969 New Hampshire Peter A. Moulton 7104 Sept, 26, 1969 New Hampshire Harry Collins 7105 Oct. 30, 1969 Pennsylvania Anthony J. Farny 7106 Oct. 30, 1969 Indiana Audrey R, Liffring 7107 Oct. 30, 1969 Alabama George S. Buckner, Jr. 7108 Nov. 14, 1969 Nebraska James R. Guerin 7109 Nov. 14, 1969 Louisiana Haskel D. McAnear 7110 Nov, 14, 1969 Oklahoma Suzanne S. Penzotti 7111 Nov. 14, 1969 North Carolina Richard E. Rumrill 7112 Noy. 14, 1969 Connecticut Janet T. Carriuolo 7146 Nov. 14, 1969 Massachusetts Charles R. Perakis 7147 Nov. 20, 1969 Massachusetts Ronald G. Cohen 7173 Dec 3, 1969 Virginia Maurice Kooba 7174 Dec 3, 1969 New York Norman Moritz 7175 Dec 3, 1969 Pennsylvania Ralph D. Pittle 7176 Dec. 3, 1969 New Jersey Stephen J. Sweeney 7177 Dec. 3, 1969 Minnesota Sammy T, Herrod, Jr. 7178 Dec 3, 1969 Louisiana Troy D. Ballew 7180 Dec. 11, 1969 Oklahoma John P. Corless 7185 Dec. 23, 1969 Pennsylvania Joseph L. Pedulla 7186 Dec, 23, 1969 New York Nathan Weston 7187 Dec. 23, 1969 New York Jule K. Deloye 7193 Jan. 20, 1970 Wisconsin Carolyn M. Bowles 7195 Jan. 26, 1970 Oregon Leroy Bradley 7196 Jan. 26, 1970 Dist. of Columbia Leon L, Cohen 7197 Jan. 26, 1970 Dist. of Columbia Thomas D. Langston 7198 Jan. 26, 1970 Dist. of Columbia Herbert S. Lebowitz 7199 Jan, 26, 1970 Pennsylvania Kendall W. Lok 7200 Jan. 26, 1970 Utah Harold D. Thornton 7201 Jan. 26, 1970 Dist, of Columbia B. Elliot Cohen 7205 Feb. 2, 1970 New York Mattie T, Simmons 7206 Feb. 2, 1970 Dist, of Columbia Man Ko Yim 7207 Feb. 2, 1970 North Carolina Gerald A. Sievers 7209 Feb. 19, 1970 Nebraska Herbert Gerstenzang 7210 Mar. 6, 1970 New York Alfred S. Jackson 7211 Mar. 6, 1970 Louisiana James W. Menzie 7212 Mar. 6, 1970 Oklahoma William S. Padgett 7213 Mar. 6, 1970 Kansas Anthony C. Jung 7214 Mar. 19, 1970 Texas Carol L, Knoth 7215. Mar. 19, 1970 Indiana Susan J. H. Barnes 7216 April 3, 1970 Iowa Charles R. Burt 7217 April 28, 1970 Ohio Robert G. Leventhal 7218 April 28, 1970 New York Nelden C. McCort, Jr, 7219 April 28, 1970 West Virginia Jackie R. Simmons 7220 April 28, 1970 Texas Zulma C. Reaux 7221 May 19, 1970 Texas Joanne G. Denkevitz 7222 May 13,1970 Michigan Robert J. McAuley 7223 May 13, 1970 Pennsylvania Steven C, Shaw 7224 May 13, 1970 New Jersey Ronald C. Punch 7225 June 11, 1970 Texas Lawrence H. Levin 7226 June 12, 1970 Pennsylvania Luigi DeBoni 7227 June 16, 1970 West Virginia Donald A. Shaw 7228 June 16,
Massachusetts
Certificate Name Number
James A. Harris 7072 July Michael A, Krun 7073 July Brian P. Martin 7074 July Sidney M. Miller 7075 July James R. Weitzel 7076 July Priestly J. Mance 7077 July Dawn B. Henderson 7078 July Henry J, Levin 7079 July Karen M. Pahoresky 7080 July Gary L. Fox 7081 Aug. Irving Goldman 7082 Aug, Catherine S. Putz 7083 Aug, Henry W. Theis, Jr 7084 Aug. James C. Cradock 7094 Aug. Alfred E. Friendman 7095 Aug. Renard R. Monti 7096 Aug. Gerson T. Serody 7097 Aug. Susan C. Wolf 7098 Aug, James S. Burks 7099 Aug.
avid A, Dodge 7100 Aug. Lance W. Berkowitz 7101 Sept. Raymond M. Stewart 7102 Sept.
Dated
10, 10, 10, 10, 10, 16, 31, 31, 31,
6,
1969 1969 1969 1969 1969 1969 1969 1969 1969 1969
6, 1969
1969 1969 1969 1969 1969 1969 1969 1969 1969 1969 1969
State
Oklahoma Pennsylvania Rhode Island Massachusetts Dist. of Columbia Dist. of Columbia Michigan Pennsylvania Nebraska
New Hampshire West Virginia Minnesota
New Jersey Missouri
New Jersey Minnesota Pennsylvania Rhode Island West Virginia Michigan
Dist. of Columbia Georgia
Pharmacy Permits
The following table shows the number of pharma- cists granted registration by reciprocity and the number who were certified to register by reciprocity in other states during the past ten years:
Certified for
Fiscal Year Reciprocity Registration in
Other States 1960-1961 aa 18 1961-1962 Do 20 1962-1963 54 18 1963-1964 46 23 1964-1965 63 20 1965-1966 44 25 1966-1967 61 27 1967-1968 64 20 1968-1969 84 27 1969-1970 75 40 Total 5959 238
The table shows Maryland gained 321 pharmacists by reciprocity during the past ten years.
Counties:
Location 1968-1969 1969-1970 Allegany 23 22 Anne Arundel ae ead Baltimore 138 144 Calvert 1 Ll Caroline 3 3 Carroll 12 11 Cecil 9 10 Charles 1 7 Dorchester 3 3 Frederick 14 14 Garrett 3 3 Harford 2h 21 Howard 9 10 Kent 3 3 Montgomery 86 86 Prince George’s 87 98 Queen Anne’s 4 4 Saint Mary’s 4 4 Somerset 5 5 Talbot 8 9 Washington 18 16 Wicomico 13 13 Worcester 7 #
County Totals 530 547 Baltimore City 257 238
State-wide Totals
787 785
The above figures include permits issued to hos- pitals in the counties as follows:
Allegany 2 Montgomery 3
Anne Arundel 2 Prince George’s *
Baltimore 3 Washington 1
Cecil 1 Wicomico 1
Frederick 1 oa
Harford 1 Total 20 1
Howard
In Baltimore City, 15 hospitals received a permit to operate a pharmacy. Thus, a total of 35 hospitals have a licensed pharmacy. Six nursing homes have received a “limited” pharmacy permit, and one State Penal Institu- tion was also licensed.
From July 1, 1969 through June 30, 1970 permits have been issued to 20 new pharmacies. A total of 19 pharmacies have closed and have not, as yet, been re- opened as pharmacies.
The following table shows the number of pharma- cies opened, changes in ownership, and closed during the year:
Changes in Ownership
Opened Corporation, and/or Closed rit the Address Counties 16 15 6 Baltimore City 4 6 I; Total 20 21 19
The following table shows the number of pharma- cies opened, changes in ownership, etc. and closed in the past ten years:
Fiscal Year Opened Changes Closed 1960-1961 Al 41 25 1961-1962 34 od is 1962-1963 39 45 ig? 1963-1964 20 38 20 1964-1965 2p 34 20 1965-1966 27 46 44, 1966-1967 41 26 25 1967-1968 24 5a oo : 1968-1969 34 19 51 1969-1870 20 21 19
:
Certificate of Registration Renewals There are some who are still not aware of the bi- ennial registration renewal which became effective in June 1961. The following shows the renewal periods, the number of new renewals during the past year, and the total renewals to date:
: : |
Renewals During
Renewal Period Fiscal Year Total Renewals 1961-1962 6 2,341 1963-1964 6 2,397 1965-1966 9 2,632 1967-1968 8 2D 1969-1970 13 2.861
Manufacturer’s Permits
Permits to manufacture drugs, medicines, toilet arti- cles, dentifrices or cosmetics during 1970 were issued te 50 firms, 40 of which were “limited” permits. An appli- cant applying for a permit for newly established company is required to appear before the Board and to furnish all information the Board considers pertinent to the con-
ducting of such operation.
Dangerous Drug Distributors’ Permits The Board issued 140 permits to sell, distribute, give or in any way dispose of dangerous drugs during 1970. It is not necessary for a subsidiary or subsidiaries of a company to have a separate permit, as they are covered under the permit held by the parent company.
Prescription Survey The following table shows a survey of prescriptions filled in 1969:
PRESCRIPTION SURVEY — 1969
Baltimore City Average Number New Prescriptions Filled in
03 *out of) 229) Pharmaciesse ices eee 13,506 Average Number Prescriptions Refilled in
O35 Sout, Ole Om be harmaciesmies: aslctct erent 7,356 20,862 Average Price of Prescriptions
in 93 out of 229 Pharmacies $3.37 Estimated New Prescriptions Filled in
299 ~Pharmactes ) mecca tse siete ieee ane erate 3,092,874 Estimated Prescriptions Refilled in
29 - Pharmaciesies sence aot oes ree oer 1,684,524 4,777,391)
Counties |
Average Number New Prescriptions Filled in |
21 Gtouteotmo0 let narmacles marries cate cherie iaterstons 16,691 ! Average Number Prescriptions Refilled in
D16so0utoteo0 met barmaciesn ean. aee seer aes 13,190 29,88
Average Price of Prescriptions in 216 out of 507 Pharmacies $3.56 Estimated New Prescriptions Filled in 507: Pharmaciesiisrn sees eee ere oe etle ec ciee 8,462,337
THE MARYLAND PHARMACIS
A-H ROBINS
Donnagel”
it's profit
plantin time!
$
fd + ” s
Allbee with C i MULTIVITAMING :
Each capsule contains: % MOE Thiamine 4 J _mononitrate (8B) 15mg 1500% § Riboflavin (B:) 10 mg -834° { Pyridoxine hydrochloride (B.) 5 mg Niacinamide 50 mg Calcium pantothenate 10 mg Ascorbic acid (Vitamin C) 300 mg 1000®
100 CAPSULES
A++ROBINS:
#
“ae
i AlibeewithC
MULTIVITAMINS
30 CAPSULES = AH ROBINS
ANNOUNCING |
z be 3 bs % ic ie 3 %,%, tP- “ “ : bd ; a j en” , J i ; if : te : ao ed Sa ae eS $ % £
‘buy now for bigger summer and fall profits
A. H. Robins announces money-saving deals on Allbee® with C and Donnagel®. Allbee with C is the number one vitamin in its Suen, class in drug store sales, and it also leads in drug store pur- Se or cl chases with over 25% of the market. This isn’t surprising when you consider that it’s the B-complex with C most often pre- “ss scribed by the medical and dental professions. Almost one
‘million scripts are filled annually, and this doesn’t even “include professional recommendations or over-the- counter sales. More than one half of all Allbee with C )
Oe
‘sales are OTC. You purchase and sell far more Allbee with C. ae Isn’t it good business to also give it more facings and shelf space? The Spring Deals run from April 1-May 28. Your Robins representative will be around soon to discuss the deals and facings with you. With Allbee with C and Donnagel you've got Deal Power!
A. H. Robins Company, Richmond, Va. A-H-)20B | NS Put your facings where your profits arel
Estimated Prescriptions Refilled in
507m bharmactes mnie ntti cents seiteiisieie ler dear. 6,687,330 15,149,667 State Estimated New Prescriptions Filled in 136 ME NALINACLES te) se rtres eiele cine tor vics taeterer penta apo. Estimated Prescriptions Refilled in (30m Pharmacleseuen aise ces cioteeite oe eee tche ake sts 8,371,854 19,927,065 Legislation
There were many Bills introduced in the 1970 ses- sion of the legislature. However, three Bills are of im- mediate interest to pharmacists and to the Board.
House Bill 1421
This Bill sought to increase membership of the Board members from five to seven members, and remove the geographical limitations to membership on the Board and to have the per diem established by the Secretary of Health and Mental Hygiene.
This Bill was not enacted.
Senate Bill 89
A pharmacist shall affix to the container in which the medication is dispensed, when indicated by the pre- scriber, a label showing the name and strength of medi- cation prescribed, in addition to all other information re- quired by law.
This Bill was enacted into law. S.B. 89
AN ACT to add new Section 254A to Article 43 of the Annotated Code of Maryland (1965 Replacement Volume and 1969 Supplement), title “Health,” sub- title “Commissioners of Pharmacy,” to follow im- mediately after Section 254 thereof, to provide that a label with the name and strength of medication prescribed may be affixed to the container of any medication sold or dispensed by a pharmacist on a prescription issued by a doctor or dentist at the re- quest of the doctor or dentist and to provide further for a penalty for violation of the provisions of this Section.
SECTION 1. Be it enacted by the General Assembly of Maryland, That new Section 254A be and it is hereby added to Article 43 of the Annotated Code of Maryland (1965 Replacement Volume and 1969 Supplement), title “Health,” subtitle “Commissioners of Pharmacy,” to fol- low immediately after Section 254 thereof, and to read as follows:
254A.
Whenever a pharmacist sells or dispenses any medi- cations on prescription issued by a physician or a dentist, he shall affix to the container in which the medication is sold or dispensed, when indicated or requested by the prescriber, a label showing the name and the strength of medication prescribed, in addition to all other informa- tion required by law. In listing the established or trade name, the label shall conform to the name used by the practitioner in his prescription. No person shall alter, de- face, or remove any label so affixed so long as any of the original contents remain. Any person failing to ob- serve the provisions of this section is guilty of a mis- demeanor, and upon conviction thereof, shall be fined fifty dollars ($50.00). Pharmacists violating this section shall be subject to disciplinary action by the Board of Pharmacy.
12
SEC. 2. And be it further enacted, That this Act shall take effect July 1, 1970.
Senate Bill 883 |
This Bill repealed several of our present statutes; namely, the Narcotic Drug Act, Drug Abuse Control Act, Unsolicited Mailing of Drugs, Possession of Barbiturates and Amphetamines and in lieu thereof, a new sub-head- ing known as Controlled Dangerous Substances.
This Bill was enacted into law.
In resume, this Bill provides for Definitions of drugs covered therein; provides for four schedules of drugs, registration of persons dispensing or handling drugs; pub- lishing of schedules; record and inventory keeping; ad- ministrating inspections; penalties, etc.
Because this Bill comprises some 31 pages and be- cause some portions are vague and ambiguous, several Attorney General opinions have already been requested in order to seek clarification and guidance in the imple- mentation of the Act. As soon as we receive clarification of the interpretations, we shall proceed with dispatch to make this information available to all persons concerned
or affected by the Act. | Senate Bill 15, which was passed in the 1970 Ses-
sion of the Legislature, removes the special fund pro- vision. This Board will function as a general fund agency as of July 1, 1970.
The Board maintained membership in the National Association of Boards of Pharmacy. The annual meeting of the Association which was held in conjunction with the American Pharmaceutical Association was held in Washington, D.C. on April 12-17, 1970. The Board was represented by Secretary F. S. Balassone and Morris R. Yaffe.
The Board also maintained membership in the Con- ference of Boards and Colleges of Pharmacy of the Na- tional Association of Boards of Pharmacy, District Num- ber Two, comprising the States of New York, New Jersey, Pennsylvania, Delaware, Maryland, the District of Co- lumbia, Virginia, and West Virginia. The annual meet- ing was held in Wilmington, Delaware on October 2-4, 1969. Secretary Balassone was the official delegate of the Board at the meeting.
Secretary-Treasurer F. S. Balassone was made _ the official delegate of the National Association of Boards of Pharmacy to the annual meeting of the Association of Food and Drug Officials of the United States which was held in San Francisco, California on June 14-19, 1970, and also served as a member of the Committee on Drugs, Devices, Cosmetics and Hazardous Substances.
Secretary Balassone served as a member of the Awards Committee of the Central Atlantic States Associa- tion of Food and Drug Officials of the United States and attended the annual meeting in Ocean City, Maryland on May 25-27, 1970.
Secretary Balassone attended the Decennial Conven: tion of the United States Pharmacopoeial Convention which met in Washington, D.C., April 8-10, 1970, repre: senting the Association of Food and Drug Officials of the United States.
A Tri Partite Committee was established to study review and make recommendations regarding internship which would make this experience more meaningful t students. The Committee is composed of Mr. Frank
Block and Secretary F. S. Balassone representing the Board, Dean William J. Kinnard and Dr. R. Shangray
THE MARYLAND PHARMACIS’
epresenting the School of Pharmacy, and Mr. Nathan Gruz, Executive Director and Paul Freiman representing the Maryland Pharmaceutical Association.
The Board maintained cooperative activities with the State Department of Health and Mental Hygiene, the School of Pharmacy—University of Maryland, the Mary- land Pharmaceutical Association, the Baltimore Metro-
litan Pharmaceutical Association, Federal Bureau of Narcotics and Dangerous Drugs, Food and Drug Admin- istration, City, County and State Police.
Mind-Body Phrases Acknowledge
Psychosomatic Hlness
Psychosomatic illness has its origin in a patient’s mind. However, such illness is very real, and according to information from the Duke University Medical Center division of psychosomatic medicine, patients have been known to die as a result.
Many patients are unwilling to accept the fact that emotions and stressful situations can play a part in bring- ing on physical disability, the Center has found, and ask the physician for a “cure,” rather than for the help they really need.
Such “mind-body phrases” as “you make me sick” or “he gives me a pain” are indicative that unconsciously people recognize strong emotions can be reflected in physi- cal illness.
Spm comm (cm ( cen ( con ( cs (cr (cms (cm (crn ( ce (cee (cee (cee (ome eee oon (rom (ee (oe ( ce (em lees eee lee (es (ean (een (ee (ee len (ee (ee (en (em
A Service of The Drug House, Inc. , i
MARCH 1971
The Drug House Reports Sales Increase
The Drug House, Inc., drug wholesaler with loca- tions in Philadelphia, Trenton, and Newcastle, Delaware, reports net sales of $33,957,676 for 1970, a gain of 2.8 per cent over 1969, and net income of $539,893, an in- crease of 17.8 per cent.
TDH Chairman J. Mahlon Buck, Jr. attributes the improvement “to more agressive merchandising and data processing activity, together with increasing efficiency and cost control throughout every phase of the company’s operations.” Directors of TDH have voted to establish a 1214 cent semi-annual dividend, payable April 12 to stock of record March 26.
Red Cross Rejects Marihuana Users
A recent blood drive at the University of Maryland campus at College Park fell short of its goal, apparently because it refused donors who smoked marijuana. The drive wound up 136 pints short of its 900 pint goal after Red Cross officials refused to take the blood of students who had smoked even one marijuana cigarette.
Dr. Evan Stone, the district Red Cross director, said the ruling was made because not enough is known about the effects of marijuana. “If we’re going to have the safest blood possible, then let’s live up to it,” he said. A guard was stationed at the door to inform donors of the rule. It was not known how many students were turned away. A drive last November without restriction was successful,
LET OUR COMPUTER WORK FOR YOU With WI be
1
L
U
1
U
i
U
Hl
U
U
i TIP TOP is a computerized procedure by which you are automatically supplied
J with a monthly statement of purchases for each of your charge account
! customers.
PLUS
! An immediate monthly (and annual) breakdown of their pharmacy purchases
of deductible items for income tax purposes.
For information, call or write:
THE DRUG HOUSE, INC.
1011 West Butler Street
i Philadelphia, Pa. 19101
i (215) 223-9000
i 1880 Princeton Avenue
I Trenton, New Jersey 08638
: (609) 396-5586
! 3069 Newcastle Avenue
Newcastle, Del. 17920
it (302) 655-7401
il
1 |) Sn) Sn) a) en) oe) ee) ee) ee) ) ee) Se) SS) en) SO) SO) SO) ) ) ) ) ) ) ) =) =) — ==) =) =) |) =) 3) 5) 3])3])3])35)3)2])=>)=>)=)=)=)=)—=) 3
MPhA. Executive Committee
Meetings
The MPhA Executive Committee meetings run
about 3 to 4 hours, sometimes longer. The following are highlights from the 1971 meetings.
10.
ik Fe
January 7, 1971
Communications included acknowledgement for fur- nishing speakers on “Drug Abuse” and for assistance to the Baltimore City Public Schools. Receipt of regulation by State Department of Health and Men- tal Hygiene placing sales of needles and syringes by pharmacists only.
Report on Testimonial Dinner for John Crozier, re- tiring general manager of Calvert Drug Company.
Review of 1970 financial statement by the Treasurer, indicating deficit and need for more effort particu- larly in the areas of dues and sustaining member-
ship.
Executive Director reported on efforts resulting in completion of MPhA affiliation with APhA. Serv- ices by APhA to affiliated states were detailed.
A report of two-day meeting at APhA of affiliated state association executives in Washington was made. Major problems facing pharmacy were reviewed in depth. Mr. Gruz reported he emphasized to APhA the critical need for pharmacy to develop ideas and programs for pharmaceutical service for incorpora- tion in the national health insurance plans that are
being proposed.
Executive Director reported on his other activities, including: Medicaid, convention planning, legisla- tive conferences with medical society and other health professions, Maryland Pharmaceutical Foun- dation, legislator contacts, BMPA Banquet.
The Membership Committee report indicates an in- crease in total membership to 766 versus 745 for 1969. There was an increase in the salaried pharma- cist category and a decrease in the owner-managers.
A report was made on the Simon Solomon Pharmacy Economics Seminar’s excellent program, but a defi- cit was entailed.
Reports on the Diabetes Detention and Children’s Dental Health Week were made.
The referral of patients by physicians to certain pharmacies was discussed and referred to Joint Phar- macy Liaison Committee with the Medical Society.
“The Principles and Guidelines for Hospital Phar- macy,” prepared with representatives of MPhA, Board of Pharmacy and MSHP were endorsed. An appropriation was made to subsidize publication for distribution to institutions.
A legislative report was made on proposals for The Board of Pharmacy, a Commission on Pharmacy Discipline and a new state Food, Drug and Cosmetic
Act.
12.
13.
14.
15.
16.
LT
The Maryland Pharmaceutical Foundation assumed financial responsibility for The Swain Model Phar- macy at the School of Pharmacy. Dr. Samuel Fox, President, is working on a solicitation campaign.
A report on The National Pharmacy Insurance Council by the MPhA representative was made on the universal Rx form, dual fee system, medication record cards and formulary, and pharmacy identifi- cation number.
A meeting with the State on the basis of computing “cost” under the Medicaid Program was held.
State prepaid programs and health centers associ- ated with hospitals was reported on.
Delegates to the APhA House of Delegates were approved: Anthony Padussis, Nathan Schwartz, Syd- ney Burgee, Mary Connelly and Nathan I. Gruz.
The need to delineate the role of MPhA in group practice and non-profit health organizations was pro- posed.
February 4, 1971
The President reported on two-day meeting of APhA Committee on Professional Relations, which includes a recommendation recognizing the use of supportive personnel (technicians). A task force on this has been set up by the School of Pharmacy.
A report was made on the NARD Legislative Con- ference in Washington.
MPhA is cooperating with Planned Parenthood.
. An appropriation was made for a gift to John
Crozier at his testimonial dinner.
Executive Director reported on Medical Assistance Advisory Committee meeting, which is working on reorganization. Other activities included: Inaugura- tion of Governor, legislative contacts; conference on survey on “cost of filling an Rx” and other third party payment plan matters; meeting with other health professions on legislation; MPhA Convention and trip; sustaining membership; Poison Preven- tion.
Plans for the 1971 Convention and reconvened ses- sions in Jamaica were presented.
Public Information Committee reported on Poison Prevention and Venereal Disease Education cam- paigns.
9
A new prepayment, “Prescription Drugs, Inc.” was
reviewed.
. A report was made on Medicaid, Jaffe Associates
and Paid Prescriptions plans. Legislative Committee report was approved.
Continued membership of MPhA as an affiliate of NARD was endorsed.
THE MARYLAND PHARMACIST
Information on
DRUG INTERACTION
important to every pharmacist
se DY Daniel A. Hussar, Ph.D.
More than a mere compilation of reported drug interactions, this booklet provides a fuller understanding of how and why drug interactions occur. Its purpose is to help you anticipate such situations and to aid you in your role as the physician’s advisor in the prevention and
management of drug interaction problems.
This booklet reflects Lederle’s continuing commitment to
support the efforts of pharmacy in gathering and
disseminating information regarding drug interaction.
Mr. Gale Smith,
Manager, Customer Relations LEDERLE LABORATORIES Pearl River, New York 10965
Pleasesend mea copy of DRUG INTERACTIONS — A REVIEW OF THE MECHANISMS BY WHICH THEY DEVELOP by Daniel A. Hussar, Ph.D.
NAME
ADDRESS —
CL) eee ee eee SA] ee mene 7 1
|
LEDERLE LABORATORIES A Division of American Cyanamid Company
Pearl River, New York 10965
382-1
LAMPA News
LAMPA Goes to the John A. Crozier
Testimonial Dinner
Thursday evening, February 18, 1971 was indeed a night to remember—not only for John and Nan Crozier, but for every one of the 428 who attended the testimonial dinner given in their honor at the Blue Crest North in
Pikesville, Maryland.
The guest list ran the gamut from fledgling manu- facturer’s representatives to the president of the Federal Wholesale Drug Association. Pharmacists, both active and retired, were very much in evidence. Represented were those in community service, in education, in government, and in publishing. The allied drug trades were also pres- ent. There were friendly competitors and close relatives attending along with fellow Calvert Drug Company em- ployees and the son of one of the founders of the com- pany. Naturally, LAMPA ladies were very much around —prettying up the occasion in their “mixi” fashions (““mixi’—meaning pants dresses, midis, maxis, peasant style and at-the-knee lengths ).
Since a testimonial dinner is almost synonymous with awards, John was presented with many interesting gifts. The Federal Wholesale Drug Association, of which John is the only person to have served two terms as presi- dent, gave a plaque appointing him an honorary director, for life, in that organization. The Governor of our State, through a representative, conferred a Certificate of Dis- tinguished Citizenship. The Mayor of Baltimore City also recognized the event by issuing a commemorative letter.
Diamond studded gold cuff links and tie tac were presented by the Maryland Pharmaceutical Association and a diamond studded, gold, past president’s pin was presented by the Travelers Auxiliary of the Maryland Pharmaceutical Association. The Baltimore Metropolitan Pharmaceutical Association honored John with a large crystal compote as a “token of our recognition of his ac- complishments and contributions to the profession of pharmacy.”
A framed scroll of appreciation was given by the Alumni Association of the University of Maryland School of Pharmacy. A light note was injected into the presen- tations by the Ladies Auxiliary of the Maryland Pharma- ceutical Association when they conferred honorary, life membership in their group. LAMPA also gave a host jacket, as well as providing the Guest Register and a Memento Book of the Testimonial. U.S. Savings Bonds in various denominations were presented by the Wedgewood
Club, the Arex Club and the Calvert Drug Company.
Unique, insofar as they came from competitors, were gifts from the Loewy Drug Company—a handsome plaque, and a silver bowl from the H. B. Gilpin Company. The Calvert Board of Directors gave John a beautiful plaque. A large framed portrait, a gift from all those attending, climaxed the evening’s presentation. Paramount Photo Supply, who took pictures of the evening's festivities, will present a photo album of the pictures at a later date.
Thorughout the evening, guests were reminiscing— each had their favorite anecdote—a kindness performed an unsolicited favor—a decision that went well. Words like dedication, judgement, friendship, work, patience
16
New Developments
In Drug Abuse ‘‘Shot Glass’”’ Pipes
Shot glass pipes are replacing hashish and water pipes, reports the Rotterdam, N.Y., Police Department. An ordinary shot glass is covered with a piece of alumi- num foil, and small holes are put into the foil with a toothpick. A larger hole is made in the foil at the rim of the glass, and the pipe is complete. A small amount of hashish is burned on the foil over the holes. The smoke is then drawn down into the glass and out the larger hole. After use, the foil is neatly thrown away, leaving no residue as evidence.
Glassine Envelopes
Glassine envelope production in sizes 144 x 14 and 134 x 1%4 inches has been discontinued by one of the largest manufacturers, as the result of Congressional hear- ings.
Parrot Food
Officers of the Portland Oregon Police Department had noticed over a period of months that youngsters seemed to be buying quite a bit of parrot food. Pur- chases from various pet stores in the area by two officers of the narcotics detail showed the presence of marihuana seeds, not sufficiently baked to prevent germination. The pet food suppliers were contacted and, needless to say, the number of parrot lovers took a drastic drop!
Narcotic Drug Law Arrests Increase According to the FBI’s 1969 “Uniform Crime Re-
ports,” representing voluntary statistical reporting from city and county police departments, total arrests in- creased 24.1% from 1960 to 1969, whereas narcotic drug law arrests increased 491.9% during this period. The age breakdown for the arrests is more startling. Tot arrests for persons under 18 increased 105.4% fro 1960 to 1969. During this same period, arrests for nar- cotic drug law violations in this age group increase
2,453.2%.
Further analysis reveals that narcotic drug law vi lations of males under 18 increased 2,281.1% while ar rests of females increased 3,468.0%. Narcotic drug la arrests for persons under 15 years of age showed an in- crease of 27.0%. :
were repeated many times. You cannot summarize 44 years of unselfish devotion quickly, or easily.
Some of the guests travelled long distances for the sole purpose of attending the Testimonial, but all wer of one mind—they wanted to and were happy to be a the John A. Crozier Testimonial.
—Ann Crane Communications Secretary
THE MARYLAND PHARMACIS
enlarge your service with enlargements
5x7’s and8x 10's are fine. But the bigger the enlargement, the bigger you make it. In profits. In customer satisfaction. Large prints are easy to sell. They’re in demand as wall portraits, gifts, for framing as wall decor... you name it. When it comes to big blow-ups, Berkey does it all. 5 x 7,
8x 10, 11 x 14 and larger. In color, up to 11 x 14. Black and white up to 16 x 20. We even make 11x 14 proofsheets | from ultra-miniatures. Berkey enlargements are better. because it’s a specialty with us — handled only by experts. Compare our color rendition and sparkle. 5 x 7’s and
8 x 10’s returned in a frame at no extra cost. You — and your customer will appreciate Berkey’s better quality and prompt service. Just drop the enlargement orders, regular and over-size into the Berkey bag. We’ll give them the Berkey treatment. Custom-care printing rigidly checked and double-checked by the ova quality inspectors in the business.
Berkey can do things for you that nobody else does, because nobody else can. And “one supplier, one bill” will simplify bookkeeping for you too. Call or write your nearest Berkey Laboratory now for the complete schedule of Berkey services and prices.
| ~] Berkey Film Processing ed of Washington, D.C. 3701 Mt. Vernon Avenue Alexandria, Virginia 22305 (703) 549-7500
W Berke Photo Inc.
SL.
Hospital Pharmacy Section
Nursing and Pharmacy — Towards Better Patient Care
by Mrs. Jean T. MacVicar, Director of Nursing, University Hospital, Baltimore
Presented at the Fifth Annual Hospital Phar- macy Seminar of the Maryland Society of Hos- pital Pharmacists at Ocean City, Maryland on June 13, 1970.
The knowledge explosion is bringing the health pro- fessionals to a time of interdependence. The public is concerned with rising hospital costs and is demanding improvement in health services. Students in the health professions want to be involved in service to the patient and want to practice what they are being taught.
There are three prescriptions offered by behavioral scientists which can be put into practice which will en- able us to move toward our goal of improved patient care —as well as improved utilization of our scarce and ex- pensive resources of knowledge—the pharmacist and the nurse.
The first one is “‘stretching”—not adding more in- significant detail but rather permitting the individual to stretch his intellect. I believe we still have stereotyped images to overcome—the pharmacist is one who puts a medication in a small bottle from a big one—the nurse takes the pill from the bottle and administers it without any thought. I wish I could say this was funny and not at all true—but I’m willing to admit as a nurse I’m sure this is practice—not a high level task for either member and certainly will not challenge or “stretch” the intel- lect. In order to change these stereotyped images we must strive to have students of both disciplines learn as stu- dents what goes into the educational experiences of each.
The second prescription is participation. If an indi- vidual is involved in decisions which affect his practice, he is more likely to be concerned with the results and we increase the probability he will follow through. If we wish to bring to bear upon the patient the best each has to offer, it is best accomplished by participative action rather than each member acting independently of the other. Discussion generates ideas. But—to be effective for the patient—the discussion should be at the operational level with the nurse and the pharmacist discussing a spe- cific patient. My philosophy as Director of Nursing and the philosophy of the Director of Pharmacy means noth- ing to the recipient of the health service—it is at the patient unit level where the objectives of the organiza- tion are met...
The patient benefits when those responsible for his care are interested and enthusiastic about their work .. . If those having direct contact with the client are en- couraged to participate the results should prove beneficial not only to the patient but also to employers who must find ways of retaining a valuable human resource.
The third prescription recommended by the behav- ioral scientists has to do with well defined objectives. Naturally, the objectives of a department must be met but the subordinate goal—patient care—gets lost some- where in the bureaucratic structure of many of our hos- pitals. We are not dealing with a product where the in- put—output can be neatly programmed. The variables we deal with are infinite—not only must the hierarchy of needs— ... be met but also the hierarchy of needs of the individuals responsible for providing that care—they are identical.
In conclusion—the objectives of any organization are measured at the extremity—in the Hospital the ex- tremity is the patient in the bed, in the Out-Patient-De- partment, or the Emergency Room. There are ways not yet explored, in addition to on-going attempts, by which we can introduce quality into the services we perform. It is the responsibility of the leaders to anticipate chang- ing needs—to be creative—to stimulate—and to influ- ence. To go back to Plato—that which is honored—will be cultivated—but—we cannot be passive—cannot wring our hands and decry the fact that the elusive “they” do not understand. “Together,” I believe we can make the necessary impact.
ASHP Staff Reorganized
The Headquarters staff of the American Society of Hospital Pharmacists has been reorganized, according to an announcement made recently by Joseph A. Oddis, Executive Director. The old staff structure consisted of seven eee reporting directly to the Executive Director. These departments have been consolidated into three Bureaus under the new organization. In addition, three specialized functions report directly to the Execu- tive Director.
The new staff structure consists of the Bureau of Administrative and Membership Services; the Bureau of Communication and Publication Services; and the Bureau of Professional and Scientific Services. Functions report- ing directly to the Executive Director are the Office of Controller, Office of Legal Counsel, and the Executive Assistant.
Staff reorganization became necessary because of the tremendous growth of the ASHP and its headquarters services. Since 1962, the year of the last staff re-organiza- tion, ASHP membership has increased from 3,200 to nearly 7,000; the Society’s budget has jumped from 250,000 dollars to 1.3 million dollars; the number of ASHP Affiliated Chapters has increased from 56 to 77;
and the headquarters staff has grown from 10 persons —
to 40 persons. Also reflecting this growth, the ASHP
THE MARYLAND PHARMACIST
.
urchased a six-story headquarters office building in eiasds: Maryland in April, 1970.
The American Society of Hospital Pharmacists is the national specialty society of pharmacists practicing in hospitals and related institutions.
ASHP Board of Directors Meet
Preparations Made for ASHP House of Delegates Meeting
The ASHP Board of Directors, at its January 28-29 meeting, voted to continue the Active Membership status of Immediate Past President Winston J. Durant through the 1971 Annual Meeting. Durant recently accepted an industrial position.
By unanimous vote, the Board of Directors renomi- nated Milton W. Skolaut for a three-year term as Treas- urer. Mr. Skolaut is former Chief of Pharmacy at NIH and a past president of the Maryland Society of Hos- pital Pharmacists.
Hospital Pharmacy Statistics
Based on licensure data for the calendar year Jan- uary 1, 1969 to December 31, 1969, the National Asso- ciation of Boards of Pharmacy has published the book- let, Licensure Statistics and Census of Pharmacy. The booklet includes figures on the total number of hospital pharmacies and hospital pharmacists; however, the accu- racy of these figures must be questioned since in four
states, ye bao, pharmacies are not registered by the board of pharmacy but by some other state agency.
The NABP booklet says that out of 55,719 pharma- cies in this country, 4,617 are hospital pharmacies; and that out of 106,801 registered pharmacists, 11,001 are hospital pharmacists. (Data from the 1970 Guide Issue of Hospitals indicate that there are over 5,600 hospitals with pharmacies attended by either a full-time or part- time pharmacist; or about 1,000 more than indicated in the NABP statistics.) NABP figures on the number of hospital pharmacists probably have greater accuracy since hospital pharmacists are listed by NABP even in those four states where hospital pharmacies are not registered by the state board of pharmacy.
How many hospital pharmacists really are there in this country? There are probably more than the 11,001 reported by NABP. ASHP has estimated the number to be 15,000, which is not unrealistic since American Drug- gist estimated the number to be 13,566 in 1968 and HEW’s Bureau of Health Professions Education and Manpower Training estimated the number to be 13,600 in 1969.
Dr. Blomster Elected ASP Vice President Dr. Ralph N. Blomster of the University of Mary-
land School of Pharmacy was recently elected Vice Presi- dent (President elect) of the American Society of Phar- macognosy.
The 400 member American Society of Pharma- cognosy will install Dr. Blomster at its annual meeting in Washington, D.C. in September.
a a ms em (wn (wn (me (me (mw (me (we (we me (ae (me (ee (ce (cm (we we (me (wm (ee (a (we (em (a (= (ee (ees (es (ea
Be Smart!
Think Smart!
PR LL A LL PL CL CL CL Ce PL me Py (Cf RY my Rene CL
Stock the One and Only— Original “SAFETY TIPS”
Always Sell Them !
i
Smart Users Ask For Them By Name 1 i
AMERICAN HYGIENIC CO. 1 111 S. Paca Street, Baltimore, Md. 21201 1 727-8328 4
Represented by H
IRV NORWITZ Phone 727-8328 H
i]
rs 19
MARCH 1971
THE MARYLAND PHARMACEUTICAL ASSOC. Playcation and ONLY 10
CMe RESERVATIONS
MAY 18 THRU MAY 23, 1971
MAY 18
MONTEGO BAY, JAMAICA
MAY 18 TO MAY 23
MAY 23
LEFT ... MAKE YOURS NOW!
Depart 9 A.M. from Friendship Airport in Baltimore via Eastern Airlines non-stop charter flight to your place in the sun. Relax in the gaiety of the party-like atmosphere, enjoying a leisurely Brunch — Free Open Bar — soaring over the ocean at nearly the speed of sound.
Arrive at the Montego Bay Airport. After clearing Customs, you will be whisked, with your luggage, to the HOLIDAY INN, the glamorous, new exciting tropical island resort. Here you will “live it up” in a breathtaking succession of six sun-splashed days and balmy starlit nights of sheer pleasure at Jamaica’s liveliest and loveliest resort hotel.
Glow in a sunshine world of complete vacation activities . .. revel in a magnificent pool, bask in the sun, plunge in the crystal-clear surf, sail, snorkel, water ski, skuba dive, deep sea fish . ... enjoy golf, play shuffle- board, explore the ¢harming Island, shop for exotic things in an international bazaar or “drive” your cares away on the hotel’s sporty putting green. Freeport prices on Perfumes, Linen, Cashmere Sweaters, Bone China and Porcelain, Watches, Crystal, Silver, Diamonds, Pearls, Cameras, Equipment.
When the sun goes down the magic of Jamaica nightlife takes over with gourmet dining, dancing to the Calypso beat of native drums or to rhythmic Latin and American music.
Just let your mood set the pace from “dawn to yawn” for an unforgettable vacation that dreams are made of.
In addition to the many, many resort activities available, we have included: Multi-course English breakfast each morning in the hotel.
Romantic candlelight dinner each evening in the elegant dining room, offering a wide selection of taste-tingling delights.
All good things must come to an end... and so must your delightful “playcation” in Jamaica. On checking out . . . before leaving you will be
responsible only for gratuities and personal charges.
Transportation will be provided from the hotel to the airport for your homeward journey via non-stop charter flight, enjoying a delightful Dinner and continuous complimentary bar en route.
You will alight from the plane relaxed and refreshed after six wonderful days in the sun enjoying the best that Jamaica has to offer.
FOR INFORMATION AND RESERVATIONS
CALL MPHA - 727-0746
or NATHAN
269-0212 or ALDER SIMON
747-3400 (Day or Nite)
SCHWARTZ, Chairman $ | PER 1-956-3300 4,2)o COUPLE
plus gratuities
~ SELSUN BLUE
the anti-dandruff shampoo
It’s elegant. It’s ethically promoted. And it keeps her hair in the clouds.
It isn’t often that a product combines the best of two pos- sible worlds-——the effectiveness of a professional product with the elegance of a cosmetic specialty.
It’s even rarer when that product is offered only through ethical drug channels. On both counts, Selsun Blue is an exception.
TM—Trademark.
It’s an elegant, effective product that physicians and pharmacists are highly recommending. And customers love the way Selsun Blue billows up into clouds of gentle, luxurious lather . . . leaves their hair sparkling clean . . . while helping to control dandruff symptoms.
We hope you're getting the =)
business that’s rightly-—and exclusively —yours. 102094
Maryland Board of Pharmacy News
Pharmacy Changes
The following are the pharmacy changes for the month of January:
New Pharmacies
Rosewood State Hospital Pharmacy, Norbert G. Las- sahn, Pharmacist, Owings Mills, Maryland 21117.
Thrifty-Wise, Arthur Solomon, Pres., 10335 Reist- erstown Road, Garrison Forest Shopping Center, Owings Mills, Maryland 21117.
Dart Drug Corporation, Maryland City, Herbert H. Haft, Pres., 3445 Fort Meade Road, Laurel, Maryland 20810 (A. A. Co.).
Peoples Service Drug Store, Inc., No. 244, W. E. Pannill, Pres., La Plata Shopping Center, La Plata, Mary- land 20646.
C and P Professional Pharmacy, Alvin Perkins, Pres., 8605 George Palmer Highway, Seat Pleasant, Maryland.
No Longer Operating As Pharmacies
Read’s, Inc., Arthur K. Solomon, Pres., 202 West Main Street, Salisbury, Maryland 21801.
Peoples Service Drug Store, Inc., No. 251, W. E. Pannill, Pres., 3401 Fort Meade Road, Laurel, Mary- land 20810.
Jefferson Pharmacy, Eugene Jacobs, 2491 East Jef- ferson Street, Baltimore, Maryland 21205.
Grosvenor Lane Nursing Home—Pharmacy, Leslie Berman, Pres., 5721 Grosvenor Lane, Bethesda, Mary- land 20014.
House in the Pines—Pharmacy, Roger C. Lipitz, Pres., 2525 West Belvedere Avenue, Baltimore, Mary- land 21215.
Change of Ownership, Address, Ete.
Burriss and Kemp, Joseph W. Loetell, Jr., Pres., 2200 Greenmount Avenue, Baltimore. Maryland 21218.
Federal Register Notice — Methadone
Methadone hydrochloride has been approved for use in suppressing the narcotic abstinence syndrome in the course of withdrawal therapy for narcotic dependence. Other approved indications include the belief cf moderate to severe pain and for the control of cough in those patients in whom antitussives with less abuse liability have proven indequate. .
According to FDA regulations, methodone is only approved for short-term detoxification, generally lasting 10 days or less. The use of methadone in long-term main- tenance programs for heroin addicts is still investigation- al and subject to the conditions published in the June 11. 1970 Federal Register.
22
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships )
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
ee SS eee
The United States of Mangini
Now, Mangini counts in 41 States! And we're counting with computers that deliver selective com- parisons, detailed cost factors and more customized information than ever before! Our experienced in- ventory teams are now covering more pharmacists in more areas across the country and doing it faster with the same, careful, guaranteed Mangini accu- racy. If your inventory service is not giving you the answers you need, you need Mangini. Write/call/wire for DESCRIPTIVE BROCHURE
MANGINI & ASSOCIATES, INC.
4850 W. Belmont Ave., Chicago, Ill. (312) 282-8181 = ape 11722 Studt St., St. Louis, Mo. 2760 W. Market St., Akron, Ohio 575 Savin Ave.,West Haven, Conn. 5501 Cherokee Ave., Alexandria, Va.
THE MARYLAND PHARMACIST
There’s a lot more going for you at LOEWY
a Shectro MEDICAL EQUIPMENT FRANCHISE
can make your store one of the most sought out sources for equipment and service in America
As the local Spectro Division in your area, we not only offer the unusual advantages
of one of America’s largest drug wholesaling operations, but those of the country’s most comprehensive medical equipment distributor, producer and servicing organization. As is being demonstrated right now in Spectro markets throughout the eastern seaboard, physical aids for the convalescent, the handicapped and the invalid can be the most significant
new profit source available to the pharmacy today. We are uniquely well endowed to provide you with professional administrative and technical direction, the widest
available range of product, application counsel and in-home servicing.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
DIVISION OF ww)
6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100 2% Shectvo Industries, Ine. A
tows?
ES
Wholesale Drug Companies Offer Service to Pharmacies
Medical Equipment Unlimited
This is the second in a series of articles describ- ing some of the services that the full-line, full- service drug wholesalers can offer to assist the pharmacist in establishing and maintauung a successful operation in the face of rising com- petition.
Medical Equipment Unlimited (MEU) operates as a division of Spectro Industries. The program, offered through Loewy Drug Company, provides the franchisee with complete training in all aspects of medical equip- ment. The prime purpose of the franchise is to establish outlets for the distribution of medical equipment for the home and institutional use.
Medical Equipment Unlimited furnishes the follow- ing services:
1. the franchisee is furnished with a fitting room equipped with an examination table and proper equip- ment necessary to adjust and fit orthopedic appli- ances.
2. a franchise agency sign.
3. the franchisee is given a complete course in home care treatment covering I.P.P.B. breathing machines, whirlpools, hospital beds, wheelchairs, traction, con- valescent supplies, and orthopedic appliances.
4. the personal training course covers all aspects of fitting cervical braces, sacro-lumbar belts, trusses, elastic stockings, leg braces and arch supports.
5. advertising in local newspapers and the availability of promotional materials to be used by the individual franchisee.
6. the franchisee is taught how to detail physicians, and how to operate a medical rental business.
~I
heavy equipment, such as a hospital bed, is delivered directly to the patient’s home.
For more information about the government ap- proved fitting school, or other aspects of the MEU plan, please contact the Loewy Drug Company.
Aleohol Abuse Institute Plan Advances
The House Commerce Committee approved a $300 million authorization to create a national institute on alcohol abuse within the U.S. Public Health Service. Health officials told the committee that an estimated 18 million Americans have an alcohol problem, and the problem costs United States industry about $4 billion annually,
(For a free copy of a full-color booklet on alcohol abuse—“The Alcoholic American’—write to the Mary- land Blue Shield Public Relations department, 7800 York Road, Baltimore, Maryland 21203).
24
Prince George’s-Montgomery County Pharmaceutical Association Meeting,
February 9, 1971 |
See ee ae en
Dr. David A. Blake, Chairman of the Department of Pharmacology, University of Maryland, School of Phar- macy, addressed the group on “Drug Interactions.” Left to right: MPhA President-Elect Nathan Schwartz; Dr. — Blake; Rudolph F. Winternitz, President and Martin Hauer, Vice-President and Program Chairman, Prince — George’s-Montgomery County Pharmaceutical Association. —
EE
Handbook of Non-Prescription Drugs
New, Revised Edition Now Available
The new, revised 1971 edition of the Handbook of Non-Prescription Drugs of the American Pharmaceutical Association is available for immediate order.
The new 202-page Handbook is 20 percent larger than the previous (1969) edition. Bound in a light tan hard cover, it contains 31 chapters, each devoted to a_ specific class of home remedies. It includes the formulas of more than 1,000 different brand-name products in al- most 1,200 dosage forms.
In addition to a cross-reference product index, there is an index of nearly 300 manufacturers, 76 pages con- taining tables and charts of products and a score of medical illustrations and scientific graphs.
The Handbook is available at $6.50 per copy from the Order Desk, American Pharmaceutical Association, 2215 Constitution Avenue, N.W., Washington, D.C. 20037. Orders under $10.00 must be accompanied by payment.
Bookoff and Greenfeld Lead Charities Campaign
Pharmacists Morris Bookoff and David D. Green- feld are Co-Chairmen of the Pharmacists’ Division of the 1971 Campaign of the Associated Jewish Charities and Welfare Fund. Assisting them on the Steering Com- mittee are: Jack Cohen, Samuel Lichter, Max Mendel- sohn, Irvin Norwitz, Earle Falck, Richard Plotkin, Frank Block, Sam Block, Ronald Lubman, David Pearlman, David Rombro, Israel Ruddie, Irwin Epstein, Robert — Kabik, Alvin Rosenthal, Kurt Sacki and Simon Solomon. :
THE MARYLAND PHARMACIST
_ _.. Reading iS Still the fas
to program the human
brain.
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
Ses
a
estW
test way
\apeanenn PIPES,
—_
shy
Maryland News Company is proud to be your area's prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
Washington Spotlight For
Pharmacists by APhA Legal Division
Determination of Standard of Care
The Michigan Supreme Court recently applied the national standard of ‘‘routine care’’ instead of the “‘local- ity rule” in a medical malpractice case.
An expert medical specialist offered testimony as to the routine, nationwide use by pediatricians of a standard procedure to diagnose and treat PKU. His testimony was held admissible in a suit involving the failure of a De- troit pediatrician to use such a procedure with the re- sultant deterioration of the condition in a stricken child. Such a procedure was not a common practice among De- troit area pediatricians at the time the suit arose.
The locality rule, widely used to establish standard of care, set the standard care at the level of care generally provided by physicians within a certain geographical area and excludes testimony by experts as to the standard of care in other areas.
The Michigan Supreme Court, however, ruled that the expert witness was qualified to testify concerning the standard of practice of pediatricians generally and ac- cordingly reinstated the jury’s verdict for the plaintiff child.
The court reasoned that where a person holds him- self out as a specialist, he is obligated to perform with that degree of skill and knowledge possessed by physi- cians who are similar specialists in the light of present day scientific knowledge. Public reliance upon the spe- cialists skills and the specialists knowledge are not lim- ited to the geographic area in which he practices. The court held that the standard of care for a_ specialist should be that of a reasonable specialist practicing medi- cine in light of present day scientific knowledge. Thus, geographical circumstances should control neither the standard of a specialist’s care, nor the competence of an expert’s testimony.
The move by several states away from the “locality rule” has implications for pharmacists as well, particu- larly with regard to the use of patient record systems. As these systems to detect drug interactions become more widely used, pharmacists who do not utilize these systems will run an increased risk of failing to meet the standard of care which may be required by a court such as the Michigan Supreme Court which looks beyond the stand- ard of care in the community. Thus, pharmacists who argue that they do not want to institute these patient record systems for fear of potential liability, may find themselves liable as a result of not having them.
A Guild is a Union
The National Labor Relations Board recently de- cided that a pharmacists “guild” is qualified to act as the collective bargaining representative of employed phar- macists. The employer had contended that the guild had a “conflict of interest” which barred it from being the representative. The employer based his argument on the guild’s past affiliation with a Barbers union which per-
26
mitted employer membership. The “guild” had also elected employers to various guild offices.
The NLRB pointed out that “generally, a potential conflict of interest disqualifies a labor organization when there is an innate or proximate danger that the interests of the employees will be subordinated to factors which are not germane to the employer-employee relationship.” The Board found, however, that no such danger existed in this case since the employer members had resigned, a slate of employee pharmacists officers had been elected and the Constitution and Bylaws amended to make regu- lar membership open only to employed pharmacists. The NLRB ordered an election to be conducted.
Members Resignation no Bar to Disciplinary Action
The U.S. Court of Appeals for the District of Co- lumbia recently held in a maritime case that a shipper may not avoid the consequences of its acts by resigning from its shipper’s conference before a decision to punish it has been reached. In this case, the member shipper resigned prior to the adoption of self-policing procedures by the conference. The offense, however, occurred prior
<p Zor? DATA, pp ANS ABOur WARMACEUTICAL rTk
ROLE IN THIRD PARTY PAYMENT PLANS
THE MARYLAND PHARMACIST
0
Mr. Pharmacist -
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue Baltimore, Maryland 21218
MARCH 1971
to the resignation. The shipper argued that the retroac- tive application of the procedures would amount to punishment for conduct that was previously not punish- able and make it answerable to a private penal system to which the shipper was not a party.
The court decided that a shipping conference’s effec- tiveness depends to a large extent upon its ability to po- lice its own members. To permit an individual shipper, by exercising an option of resignation, to escape con- ference action would negate completely the conference system’s effectiveness.
Applying this principle to disciplinary actions by professional associations, it is apparent that an association can proceed against a member who resigns after these proceedings have been instituted against him. The disci- plinary mechanism of a voluntary professional association would be totally ineffective if resignation could act as a bar to the completion of those actions which were com- menced against an individual while he was a member. This is especially true in light of due process considera- tions which require advance notification of the pending procedures to the accused member.
Current Good Manufacturing Practice Regulations
A proposed requirement, in the federal regulations, governing the good manufacturing practice for drugs, which would have required bioavailablity information, was deleted from the final regulations.
Various manufacturing groups had objected to this proposal on the basis that adequate methods do not exist
to make such testing practical and meaningful. It was also pointed out that although the development of such information for all drugs is necessary and desirable, this requirement has been deleted and will not be restored until appropriate methods for making and interpreting such determinations can be widely developed and _ veri-
fied.
National Baby Week—April 22-May 1
National Baby Week is an ideal opportunity for pharmacies to emphasize their “Baby Departments.” Items such as nursery ware, infant foods and related products can be featured. Display material and promo- tional aids are available from many manufacturers.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
Loyalty is a
love affair!
In Maryland you are first and foremost in our
hearts and mind, Why? Because Barre-National is the last broad-range pharmaceutical manufacturer owned by Marylanders.
We're “home folks” with a great sense of loyalty. And we love to promptly service your needs of OTC SPECIALTIES, TABLETS & CAPSULES, SUP- POSITORIES, WET PACK, DRY PACK, LIQUID
PHARMACEUTICALS, OINTMENTS, INJECT. ABLES, OPHTHALMIC SOLUTIONS. Give us a try.
BARRE - NATIONAL DRUG CO., INC.
4128 HAYWARD AVENUE @ BALTIMORE, MARYLAND 21215 ® PHONE: 542-5272
28
THE MARYLAND PHARMACIST
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
First name in ice cream
IC E G REAM for over a half-century
675-6000
Researchers Find Gases in Aerosol Sprays can be Dangerous
The gases used as propellants in aerosol sprays may affect the heart and lead to sudden death in certain cir- cumstances, researchers have found. They suggest that these findings may explain unexpected deaths among youths who turn on by inhaling these gases deliberately and among asthma patients who use brochiai sprays ex- cessively.
George J. Taylor, IV, and Dr. Williard S. Harris con- ducted this study at the University of Illinois Hospital in Chicago. Their research was supported in part by the NIH National Heart and Lung Institute.
In studies with laboratory animals, the researchers first exposed groups of mice to the propellant gases used in aerosol sprays. When they then asphyxiated these ani- mals markedly reducing available oxygen for less than a minute, they found that the mice’s sinus rate (the heart’s own pacemaker) slowed and that the mice quickly de- veloped atrioventricular block. Either or both of these re- actions slowed or stopped the heartbeat.
By contrast, in groups of control mice who were not exposed to the sprays but were asphyxiated in the same way for 4 minutes, their heartbeats increased in response to the lack of oxygen. The heart changes in the group of mice tested with the aerosol propellants were rapid, long-lasting and eventually lethal. When the researchers repeated these tests on rats and dogs, they noted similar results.
The researchers caution that their findings in ani- mals cannot be applied directly to humans without further study. They emphasize that the slowed heartbeat which was the most apparent effect of the gases in the laboratory animals may well be overshadowed in humans by other cardiac effects, such as fast or irregular con- tractions of the heart’s main pumping chambers (ventri- cle), or may combine with other cardiac effects to cause death. Because both turned on youths and asthma pa- tients who die suddenly do not get to hospitals in time for an electrocardiogram, the exact heart changes in these patients before death is not yet known.
The researchers add that millions of people use aerosol dispensers for cosmetic, household, and numerous other purposes, thus releasing propellant gases into the air they breathe. They suggest that people may vary in sensitivity to the harmful effects of these gases and that urgent studies are needed to determine the amount of propellant gases inhaled every day by people who use pressurized aerosol sprays.
Mr. Taylor and Dr. Harris published a report of this research in the Journal of the American Medical Association of October 5, 1970. They reported similar findings on the cardiac effects of glue-sniffing in mice in Science on November 20, 1970.
School of Pharmacy Expansion Dr. Wilson H. Elkins, President of the University of
Maryland, reported in his annual report on the need for expansion in the School of Pharmacy.
30
Obituaries...
Harry Greenberg
Harry Greenberg, 67, owner of Gardenville Phar- macy on Belair Road for over 30 years, died suddenly on February 14, 1971. Mr. Greenberg graduated from Balti- more City College in 1922 and from the University of Maryland School of Pharmacy in 1924. He was a mem- ber of the Maryland Pharmaceutical Association, the Baltimore Metropolitan Pharmaceutical Association, AZO Fraternity and Belair Road Merchants Association.
Mr. Greenberg was a 32nd degree Mason. He is sur- vived by his wife, Bertha, two sisters, and two brothers, one Albert G. who is also a pharmacist.
William Lester Brunnett
William L. Brunnett, 51, pharmacist’ at Leland Me- morial Hospital, Riverdale, died on February 13, 1971 at his home in Hyattsville. He was a graduate of the Uni- versity of Maryland School of Pharmacy Class of 1931.
Mr. Brunnett was an active member of the Maryland Pharmaceutical Association, serving at one time on its Executive Committee. He is survived by his wife, De]mar, two daughters, one sister and three grandchildren.
Arthur A. Musher
Arthur A. Musher, of Silver Spring, graduate of the University of Maryland School of Pharmacy Class of Sonat died recently. He had retired from People’s Drug
tores.
John A. Pelezar John A. Pelezar, of Connecticut, died recently. He had graduated from the University of Maryland School of Pharmacy in 1919.
John Henry Bradford
John Henry Bradford, 69, died on February 18, 1970. He graduated from the University of Maryland School of inne: in 1926. Mr. Bradford operated a pharmacy at Ashland and Milton Avenues for eight years. He is survived by his wife, Rita O'Connor Bradford who graduated from the University of Maryland School of — pean in 1929, one daughter and four grandchil- ren.
Sheldon S. Barke
Sheldon S. Barke, 35, died on February 12, 1971. He was with Read’s for seven years and then with Para- dise Pharmacy for five years. His father, Daniel S. Barke is a pharmacist with Drug Fair. He was a 1957 graduate of the University of Maryland School of Pharmacy.
He is also survived by his mother, Dorothy Sindler Barke; one brother and one sister.
THE MARYLAND PHARMACIST
smangitestenne
Thantis, the reliable throat lozenge.
The THANTIS DISPENSER, containing a roll of 25 individually foil-wrapped lozenges, is attractively packaged — 6 dispensers in a fold-up counter display. The packaging is right! The profit is good! The time to purchase Thantis is now!
a
(#740/171)
HYNSON, WESTCOTT & DUNNING, INC. Baltimore, Maryland 21201
Facts and Information
... your customers will want to find out all about Venereal Disease. They'll also want to know how you can help them prevent V.D. If you haven’t yet ordered your FREE supply of this informative 8- ‘page booklet . . . or if you require an additional quantity just mail in coupon. This pamphlet is contributed as a public service by: Youngs Drug Products Corporation—Manufactur- ers of “Trojan” quality brand prophylactics. _ Gentlemen: : [] Please send me —_., --_, copies of
50 100 150 “Plain Talk About Venereal Disease” in English.
[] Please send me___, .._., ___, copies of 50 100 150 “Plain Talk About Venereal Disease” in Spanish. Name. Ll Company Address City State. vig Fill in above or affix store label,
up Youngs Drug Products Corporation 865 Centennial Ave., Piscataway, N.J.08854
worn rr errr r nnn ace nn ncn ann nnn nanan anna ny a ef te ce ee a ae | it ee re a kn eo gn
the -° maryland
= pharmacis
wees
Photo by Paramount
John A. Crozier
Calvert Drug Executive Tendered Testimonial Dinner (See Page 10)
Volume 47 APRIL 1971 Number 4
Compliments of
oxell
\UAGH
Makers of NOXZEMA SKIN CREAMS NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
If it's for your family, which product would you dispense?
The choice would probably be Crystodigin® (digitoxin, Lilly).
Pharmacists know that quality is built into Lilly products... with exacting control procedures to provide uniform potency and, therefore, consistent therapeutic effectiveness.
Your professional judgment tells you... when it comes to your prescription patient’s health (and your reputation), you want to dispense the best.
& Og ae ole Be Rae Sees £6 $4 at i he dt
Naot toh ©
CRYSTODIGIN® (digitoxin, Lilly)
Description: Crystodigin is a crystalline- pure single cardiac glycoside obtained from Digitalis purpurea and is identical in phar- macologic action with whole-leaf digitalis. Crystodigin is noted for its uniform potency, complete absorption, and lack of gastro-in- testinal irritation. It permits accurate dosage adjustments to produce maximum therapeu- tic effect smoothly and dependably.
Indications: Heart failure, atrial flutter, atrial fibrillation, and supraventricular tachycardia.
Contraindications and Precautions: Crysto- digin should not be used in ventricular tachy- cardia.
Patients taking digitalis preparations must not be given the rapid digitalizing dose of Crystodigin or parenteral calcium.
Adverse Reactions: Overdosage causes side- effects, such as mental depression, anorexia, nausea, vomiting, premature beats, complete heart block, AV dissociation, ventricular tachycardia, ventricular fibrillation, restless- ness, yellow vision, mental confusion, dis- orientation, and delirium. [110570]
Lilly
Eli Lilly and Company
Indianapolis, Indiana 46206
For physicians and their patients
21 white tablets each containing ).5 mg. norgestrel with 0.05 mg. ethinyl estradiol and / pink inert tablets
‘To order, contact your Wyeth salesman or nearest branch.
® Wyeth Laboratories —_ Philadelphia, Pa.
The Maryland Pharmacist
NATHAN I. GRUZ, Editor 650 WEST LOMBARD STREET
~VoLuME 47
NORMAND A. PELISSIER, Assistant Editor BALTIMORE, MARYLAND 21201
ASSOCIATION
APRIL 1971 NUMBER 4
OFFICERS 1970-71
Honorary President MORRIS L. COOPER—Baltimore
President DONALD O. FEDDER—Dundalk President Elect NATHAN SCHWARTZ—Annapolis Vice President SYDNEY L. BURGEE, JR.—Baltimore Vice President BERNARD B. LACHMAN—Baltimore Vice President MELVIN J. SOLLOD—Adelphi Executive Director NATHAN I. GRUZ 650 W. Lombard Street, Baltimore 21201 Treasurer
MORRIS LINDENBAUM 5 Main Street, Reisterstown
Executive Committee Chairman I. EARL KERPELMAN-—Salisbury
District 1—Eastern Shore PHILIP D. LINDEMAN—Berlin JAMES W. TRUITT, JR.—Federalsburg
District 2—Central MORRIS BOOKOFF—Baltimore JOSEPH U. DORSCH—Baltimore
PAUL FREIMAN—Baltimore IRVIN KAMBNETZ—Baltimore JEROME MASK—Baltimore ANTHONY G. PADUSSIS—Baltimore DAVID I. SCOTT—Baltimore H. NELSON WARFIELD—Baltimore
District 3—Southern
PAUL R. BERGERON, II—Bethesda SAUL B. FRIEDMAN—Potomac EDWARD NUSSBAUM—Rockville DOMINIC J. VICINO—Mt. Rainier RICHARD D. PARKER—Silver Spring
District 4—Northern
ARNOLD L. AMASS—Taneytown ROBERT K. MOLER—Brunswick
District 5—Western
HARRY G. EISENTROUT, JR. Cumberland STEPHEN HOSPODAVIS—Cumberland
Committeemen at Large
JOHN R. McHUGH ROBERT E. SNYDER
Ex-Officio Members
FRANCIS S. BALASSONE WILLIAM J. KINNARD, JR.
Honorary Life Member of the Executive Committee
SIMON SOLOMON
MARYLAND BOARD OF PHARMACY Honorary President SIMON SOLOMON President NORMAN J. LEVIN—Pikesville
Secretary Fr. S. BALASSONE—Baltimore
FRANK BLOCK—Baltimore HOWARD L. GORDY—Salisbury MORRIS R. YAFFE—Potomac
TABLE OF CONTENTS
Editorial— Pi Pharmacists Can be Partners in Venereal Disease Prevention........ 6 Pharmacy. Caleridarge sa mee? ee ear een) ee eee te, 6 Maryland Board of ENATINACVENOWS Seo cc te oe en ee aes ee ee 8 ODM E ae CrOziere Testimonial eee eens eee pee 10 Maryland Pharmaceutical Association as Annual sConventions Program me.) 12 HOSDital ee Darnacyscectiong 7 eh em ete ey 14 MSHP Sixth Annual Hospital Pharmacy Seminar Program.................... 14 Spling Regionals Meatingeetin ce see ete hs) Ue de ha eek alu 5G 18 Federal Controlled Substances Act Of 1970 .ccccccccccccssesssssscossssecseseeeeeseececcccccee, 19 DTU A DUSG Wren eee ne nas RITE, carn Sey Meee Br! bln! gone,» 22 A Collection of Compounded Prescriptions Ye ab Pe Aller) eee. eee 26 LAMPARNGWSiE SUG operin Se oa ee he se Pkg. Wy 28 Obituaries eterna eel, emeree hom ee a ee ie 8 AN 30
INDEX TO ADVERTISERS
Page MING HCA Ueeists = INSirance:COq nse eon ee 27 gnenicangiyrienicaCOMmpan yarn. see ee ee Les 30 Borden: Hendlers) cosCrear mew, ci kee ee eas ea ae Re 29 Calverte DriigsCompanyeyinc sea eee ere le oe: ey Rye ee 29 TP neg Dregs louse NC a, wee ese enn or ee a ee Teel s 16 CelzveOnarmacouricalsr: Incr icone kn i ee ee ee te 32 PICU Vis eecrattyi1 COM Dany meee ne pet ree ee eR et 33 Ei Lilly,ano COM pan Verses 2 en eee ie oe ee) Se crt EEL ere 3 Loewys Drugs Compan yar tees Petre ete genie to ee ea ea 9 Manginigand s Associates ainCs, wee eee ene ey Se 21 Marviands News) Compan vane ee ee ene 25 Noxell’ Corporation Sire entree ren enn oe ee 2 ParAMOUNtEPHOtO SeLViCe mene Aa ee ee ee ee 13 Pension and Investment Association of America, INC... 24 Ax Lie hODings COMPANY mee. = ere eee gn ees Meee any eee Pee ee Gea 34 ROCHE SLADOTALOTI CG mera. 5 cotter cer se Recerca, eR chee al oa ee, 7 Deotuartawebb Advertising. Services 1.05 ee 30 WivethwLADOLafOricsaire sen oe os. anta eee ae ee es ee 4 MOuUngS VOTRE ErOguUCts eCOTDOration ier te ote a Po ee he ee 17
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical] Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
Editorial...
Pharmacists Can be Partners in Venereal Disease Prevention
“An epidemic is ravaging America—needlessly. The U.S. Public Health Service estimates there were almost 1.8 million new cases of venereal disease last year, well exceeding the medical definition of an epidemic. More Americans caught gonorrhea last year than caught the measles. And half of all new V.D. cases are in the 15 to 24 year old age group.’’*
In Maryland in 1970 there were more than 14,800 reported cases of gonorrhea and 440 reported cases of primary and secondary syphilis. These are said by authori- ties to be perhaps 10 to 20 % of the actual cases.
That is why V.D. is referred to as really pandemic, not just an epidemic.
“America’s teenagers are the chief viciims of the venereal disease epidemic now ravaging America. Young- sters in the 15 to 19 year age group have a rate of infec- tion for syphilis and gonorrhea more than twice that of all age groups combined. A U.S. youngster is infected with V.D. every two minutes.”’*
“Too many young people just don’t know what ve- nereal diseases are, how serious they can be, or how they can be prevented. In most cases, nobody bothers to tell them. Parents, schools, churches—any group in touch with young people—must face the important educational job of giving our young people the facts about V.D. The necessary information is readily available from physicians, clinics, and public health groups. And your local pharma- cist is the best source for medically recommended prod- ucts to control V.D.”*
Yes, the pharmacist is the most accessible source for factual information, for prescribed drugs for treat- ment and for products for prevention.
The Maryland Pharmaceutical Association is there- fore, launching an all-out Venereal Disease Awareness Campaign to bring these facts to the public’s attention. This effort will be initiated with the observance of ““V.D. Prevention Month” under MPhA sponsorship in June.
The key will be active personal involvement on the
part of pharmacists by:
1. Distributing “Plain Talk About Venereal Dis-
ease” pamphlets in their drug stores to customers.
i)
Actively displaying an official ““Venereal Disease” prevention sign.
aS Speaking wherever possible to local groups such
as Lions, Kiwanis, etc., on venereal disease, em-
phasizing knowledge, treatment, and prevention.
4. Marshalling the active interest and support of public officials, opinion leaders, the press, and general public. Scope of the program recognizes, too, that the ““Venereal Disease Awareness” ef- fort must be a never-ending responsibility of pharmacy, as a member of the public health team.
“Based on Youngs Drug Products Corporation advertise- ments published in the general press.
6
MPhA, with the important assistance and expertise of Youngs Drug Products Corporation, will work with governmental officials, health departments, clinics, youth groups, schools and colleges and the various public in- formation media (press, radio and TV).
The public and the profession of pharmacy are for- tunate that the Youngs Drug Products Corporation is devoting so much of their resources as well as the time and efforts of their management and field personnel to this campaign. Youngs’ personnel from both their head- quarters and the field are working and will continue to work in Maryland to make this program a success. Youngs is making thousands of pamphlets and counter cards available to pharmacies.
Youngs deserves a great deal of credit for their crea- tive approach to the leading public health problem of youth today. Youngs is to be congratulated for its cour- age in bringing V.D. to public awareness through its newspaper advertising which directs the public to obtain and use the tools of V.D. prevention—prophylactics — which are readily available in pharmacies.
V.D. is a health problem—a challenge to all the health professions, including pharmacy. But it is also a unique public health service opportunity for pharmacy.
Surely here is one campaign we can expect 100% pharmacist participation not only at this time, but as a continuing public education project in the months ahead.
—Nathan I. Gruz
PHARMACY CALENDAR
May 13—MSHP meeting, Colony 7 Motor Inn, Balti- more-Washington Pkwy, 6:00 P.M.
May 16-17—MPhA Annual Convention, Hunt Valley
Inn. May 18-23—Reconvened sessions—Jamaica Hilton
May 26—School of Pharmacy Alumni Association An- nual Meeting. Student Union Bldg. 8:00 P.M.
June—MPhA “V.D. Prevention Month”
June 2—School of Pharmacy Annual Alumni Banquet in Honor of Graduates.
June 5—School of Pharmacy Commencement Exercises.
June 11-13—6th Annual MSHP Hospital Pharmacy Sem- inar, Ocean City, Md.
September 7-12—3 1st International Congress of Pharma- ceutical Sciences of the FIP, Washington, D.C.
October 10-14—National Association of Retail Druggists Annual Convention, The Rivergate, New Orleans.
THE MARYLAND PHARMACIST
Roche is concerned with the professional needs of all practicing phar- macists along with the best health-care delivery. The needs of all pharma- cists start with a drug source that is fairly priced, equitably distributed and easily available.
Our pricing policy results from our commitment not only to develop new drugs but also to help the pharmacist better serve his community, his pro- fession and himself. That’s why pharmacists with broad firsthand pharmacy experience are in management positions at Roche. Programs, policies and services are conceived and implemented by pharmacists for pharmacists...to help you participate more fully in the ex- aberrant eae panding contribution of health sciences. Division of Hoffmann-La Roche Inc.
When it comes
Maryland Board of Pharmacy News
Pharmacy Changes
The following are the pharmacy changes for the month of February:
New Pharmacies None.
No Longer Operating As Pharmacies
Sussman’s Pharmacy, Samuel Wolfovitz, 3601 Park Heights Avenue, Baltimore, Maryland 21215.
Donnybrook Pharmacy, Maurice Karpa, President, 246 East Burke Avenue, Towson, Maryland 21204.
Hoffman’s Pharmacy, Sylvan Hoffman, 2658 Hunt- ington Avenue, Baltimore, Maryland.
Change of Ownership, Address, Ete.
Fullerton Pharmacy, Inc., Eugene Trief, President, 7542 Belair Road, Baltimore, Maryland 21222. Taneytown Pharmacy, Inc., Julian M. Friedman, President, 7 York Street, Taneytown, Maryland 21787. * * #& &
The following are the pharmacy changes for the month of March:
New Pharmacies
MEMCO Prescription Pharmacy, William H. Dyer, Jr., President, 6411 Riggs Road, Hyattsville, Maryland 20782.
Dart Drug Corporation, Downtown, Herbert H. Haft, President, 13625 Georgia Avenue, Silver Spring, Mary- land 20906.
Dart Drug Corporation, Cherry Hill, Herbert H. Haft, President, 6711 Annapolis Road, Landover Hills, Maryland 20784.
Drug Fair No. 134, Milton L. Elsberg, President, 5203 East Drive, Baltimore, Maryland 21227.
No Longer Operating As Pharmacies White Cross, D. M. Robinson, President, 116 East Baltimore Street, Baltimore, Maryland 21202. Hilton Court Pharmacy, Inc., Wesley N. Shelton, President, 3301 Liberty Heights Avenue, Baltimore, Maryland 21215.
Metro Drugs, No. 6, Leo Goldfeder, President, 4009 Main Street, Upper Marlboro, Maryland 20870.
Change Of Ownership, Address, Ete. Hertz Pharmacy, Inc., Hillel Aarons, President, 6309 Kenwood Avenue, Baltimore, Maryland 21237.
Libby’s Rexall Drug Store, I. Silen and A. Schwartz- man, 4901 Belair Road, Baltimore, Maryland 21206.
Samuel P. Jeppi, Inspector for the Maryland Board of Pharmacy, retired April 1 after 17 years of service. Newly appointed Inspectors for the Board are Alexander J. Ogrinz, Jr. and Jerome S. Wittig.
8
Notice—Board Exams The Maryland Board of Pharmacy will conduct an
examination for registration as Pharmacist at the School of Pharmacy, University of Maryland, 636 West Lom- bard Street, Baltimore, Maryland.
On Monday, Tuesday and Wednesday June 28, 29 and 30, 1971
The examination will begin at 8:00 a.m. each day. Applications must be in the hands of the Board by Fri- day, June 18, 1971.
ABBOTT BUILDS NEW FACILITY The Hospital Products Division of Abbott Labora-
tories announces that a new $6 million ampoule and vial manufacturing facility will be constructed adjacent to the intravenous solutions manufacturing facility in
Rocky Mount, North Carolina.
OFFER STRAIGHT, MEDICALLY
SOUND
GU) DANCE | y)
A SIGN OF PROFESSIONALISM
THE MARYLAND PHARMACIST
There’s a lot more going for you at LOEWy*
Ybeclw
COMPUTERIZED SERVICE
puts America’s most advanced warehouse facility behind your store
How much is it worth to you to know that the most advanced computerized distribution system in existence is in motion to process your every order
. instantly, efficiently, completely? That you needn’t ever stock more than a minimum ofa far greater variety of merchandise than you could ever show before... and without investment in excessive inventory? That your wholesaler is never likely to be out-of stock on any desirable item? That every invoice and statementis assured of up-to-the-minute accuracy? And that there is never a lapse of more than 60 minutes from receipt of your order to the time it is on the loading platform, ready to roll?
How much? You'll be able to measure its worth by the number of customers attracted to your store. Old customers and new, it’s the kind of service they aren’t likely to have known before.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call lV 5-8105 for order taking. (301) 485-8100 for the office.
em — Loewy Geet Sue je f ~@©——sCODRUG. COMPANY
DIVISION OF
Wi) si § Spectre Industrts, Inc. OS 40 ye
6801 Quad Avenue Baltimore, Md. 21206 Telephone: (301) 485-8100
Crozier Testimonial John A. Crozier
John A. Crozier was born in Mamaroneck, New York and there attended public school until moving to Phila- delphia where he transferred to Our Lady of Victory Parochial School. He continued formal education at Strayer’s Business College in Baltimore.
John met the lovely Miss Nancy Katherine Meyers, who on April 16, 1932 became Mrs. John A. Crozier. Mrs. Crozier was born in Timonium, Maryland at the present site of the Five Farms Club.
In 1928 he began his association with the Calvert Drug Company in the bookkeeping department. Three years later he was appointed Assistant General Manager and in 1938 became General Manager. In 1958 he was appointed Executive Vice President and General Manager, a position he held until the time of his retirement, De- cember 31, 1970. To many of his friends and associates he was known as “Mr. Calvert Drug Company.”
He gave unstintingly of his labor, talent and time, not only to the Calvert Drug Company, but also to vari- ous trade and pharmaceutical associations on the local, state and national levels. A grateful profession recognized his contributions and honored him with appointment to its highest offices. He is the only person ever to have served two terms (4 years) as president of the Federal Wholesale Drug Association of the United States and Canada. He is a Past President of the Travelers Aux- iliary of the Maryland Pharmaceutical Association and was elected Honorary President of the Baltimore Metro- politan Pharmaceutical Association in 1964.
To each of these he brought a high sense of purpose and unswerving dedication which earned him admiration and the respect of all his associates.
For almost half a century, John Crozier gave untir- ingly of his abilities and energies to the many-faceted drug and pharmaceutical field. It is therefore fitting that his friends honored him on the evening of February 18, 1971 with his Testimonial Dinner.
Photo by Paramount
Gordon Mouat, President of Calvert Drug Company, shown with plaque he presented to Mr. Crozier on behalf of Cal- vert Drug Company.
10
SR inst BE
Photo by Paramount
Mr. and Mrs. John A. Crozier
Photo by Paramount
Reverend James B. O’Hara, left, who gave the invocation, shown with John Crozier.
THE MARYLAND PHARMACIST
| Shown presenting awards to Mr. Crozier at the John A. Crozier Testimonial Dinner are: left to right—top row— Donald O. Fedder, President, Maryland Pharmaceutical As- | sociation; Irvin Kamenetz, President, Baltimore Metropoli- tan Pharmaceutical Association; William M. Burckart, Presi- dent, Ellicott Drug Company, Buffalo, N.Y. who was Toast- master for the evening shown here exhibiting a crystal bowl presented earlier. by BMPA president.
middle row: Dora Rockman, President, Ladies Auxiliary of the Maryland Pharmaceutical Association; William L. Nel-
APRIL 1971
Photo by Paramount
son, President, Traveler’s Auxiliary of the Maryland Phar- maceutical Association; Joseph J. Hugg, Executive Vice- President and General Manager of the Calvert Drug Com- pany, Inc.
bottom row: George C. Straayer, Executive Secretary, Fed- eral Wholesale Druggist’s Association; Joseph S. Kaufmann, legal counsel for the BMPA and MPhA, presenting Distin- guished Citizen Citation on behalf of Governor Marvin Mandel; Harry R. Wille, President, Alumni Association, Uni- versity of Maryland School of Pharmacy.
COME TOGETHER!
Maryland Pharmaceutical
89th Annual Convention In conjunction with TAMPA and LAMPA MAY 16 and 17, 1971 Hunt Valley Inn, Cockeysville, Maryland
Reconvened Sessions — Jamaica Hilton
Ocho Rios, Jamaica, W.I. May 18-23 via Eastern Airlines Charter
Condensed Schedule SATURDAY EVENING, MAY 15
Hospitality reception for early arrivals
SUNDAY, MAY 16 Golf available for Convention registrants 12:00 NOON—Registration desk opens 1:30 P.M.—First Business Session Call to Order—President Fedder Invocation Greetings from Affiliated and Recognized Associations Committee Reports Report of University of Maryland School of Pharmacy—Dr. William J. Kin- nard, Jr., Dean Report of Maryland Board of Pharmacy— Francis S$. Balassone, Secretary 2:00 P.M—LAMPA Hospitality Room 4:00 P.M.—Adjournment of First Session
6:30 P.M.—Limestone Valley Dinner Theatre, Beaver Dam Road, Cockeysville
Pre-dinner cocktails
MONDAY, MAY 17 9:00 A.M.—Second Business Session President’s Report—Donald O. Fedder Report of Executive Director—Nathan I. Gruz Report of Treasurer—Morris Lindenbaum Memorial Services Report of Legal Counsel—Joseph S. Kauf- man Organization of the MPhA House of Dele- gates
11:00 A.M.—LAMPA Business Meeting
12
12:00 Noon—LAMPA-TAMPA Luncheon — Speaker: Radio and TV Personality, Arnold Zenker 12:00 Noon—MPhA Luncheon—Guest Speaker 1:30 P.M.—Third Business Session Meeting of House of Delegates Old Business New Business Resolutions Nominations and Election of Officers Approval of List for appointment to Mary- land Board of Pharmacy 4:00 P.M.—Adjournment 6:30 P.M.—Presidential Reception — Courtesy Youngs Drug Products Corporation 7:30 P.M.—Annual Banquet Installation of Officers Dancing Prizes
TUESDAY, MAY 18 9:00 A.M.—Friendship International Airport — depart via Eastern Airlines for Jamaica and reconvened sessions. 12:30 P.M.—Arrive Montego Bay Continuing Educations Seminars—W ednes- day, Thursday and Friday mornings. Entertainment nightly.
SUNDAY, MAY 23 7:30 P.M.—Depart Montego Bay 10:30 P.M.—Arrive Friendship Internationai Airport
Photo by Paramount Photo Service
Stephen Overbeck, D.D.S. (left) was a guest of MPhA Public Relations Committee Chairman Charles Spigelmire (right) during Children’s Dental Health Week. Pharmacist Spigelmire broadcasts the program “Your Best Neighbor” Over Station WCAO every Sunday evening.
THE MARYLAND PHARMACIST
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue Baltimore, Maryland 21218
APRIL 1971 13
Hospital Pharmacy Section
Maryland Society of Hospital Pharmacists Meeting of March 11, 1971
The March 11th meeting was held at the North Arundel Hospital. The guest speaker for the evening was Dr. David N. Nurco, Commissioner, Maryland Drug Abuse Authority. Dr. Nurco’s topic was “Drug Abuse.” In his talk, Dr. Nurco explained some of the programs that are being conducted in the state in the area of drug addict rehabilitation and the problems that are encoun- tered with these programs.
Dr. Lamy, chairman of the Nominating Committee, submitted the list of nominees for office. Clarence Fort- ner reported on the Annual Seminar. The registration fee for those attending the seminar will be $20.00 this year. Howard Sherman reported for the Membership Com- mittee. A mailing was sent out to all 5th year students inviting them to join the Society. A follow-up mailing will be done on last year’s state-wide membership survey while a new state-wide membership survey will be con- ducted next fall.
June Shaw reported for the Program Committee. The April 8th meeting will be held at H. B. Gilpin and the May 13th meeting will be held at Schraft’s Colony 7 Motor Inn and will start with a cocktail hour at 6 P.M.
Robert Snyder mentioned that the society’s dele- gates to the Annual Convention in San Francisco will again vote in favor of adoption of the “Economic Status Program” of the ASHP. The following new members were approved: Donald W. Cathey, Philips Roxane Lab- oratories; John M. Motsko, Mercy Hospital; and Nor- man Yockelson, student-class of 1971.
Robert Snyder mentioned that all hospital pharma- cists were invited to attend a demonstration of the AIM- TWX information retrieval system on Thursday, March 25th from 1-3 P.M. at the Health Sciences Library. June Shaw reported on the Swain Pharmacy Seminar. Bob Snyder thanked the Roerig Company for sponsoring the meeting and thanked Dudley Demarest for hosting the meeting. The meeting adjourned at 10:45 P.M.
ASHP Announces 1971 Institutes
The following institutes conducted by the American Society of Hospital Pharmacists and cosponsored by the American Hospital Association and the American Phar- maceutical Association are announced for 197i.
Institute on Personnel Relations in Hospital Pharmacy, May 16-19, Atlanta, Georgia.
Institute on General Practice of Hospital Pharmacy, June 27-July 2, Williamsburg, Va.
Institute on Unit-Dose Drug Distribution Systems, July 25-28, St. Louis, Missouri.
Institute on General Practice of Hospital Pharmacy, Sept. 12-17, San Diego, Calif.
Institute on Drug Interactions and Clinical Communica- tions, Oct. 17-20, Key Biscayne, Fla.
For further information contact Department of Edu-
cation and Training, ASHP.
14
PROGRAM
Sixth Annual Hospital Pharmacy Seminar
Maryland Society of Hospital Pharmacists JUNE 11, 12, 13, 1971 OCEAN CITY, MD. TOPIC: “MEN — MACHINES — SERVICES”
9:00 A.M.— GREETINGS
Clarence L. Fortner, M.S., Chairman,
Head, Patient Care Pharmacy Services, Baltimore Cancer Research Center.
Clinical Instructor in Pharmacy, Univer- sity of Maryland.
Robert E. Snyder, President,
Director, Pharmacy Services, Maryland General Hospital.
Clinical Assistant Professor of Pharmacy, University of Maryland.
9:15 A.M.— MEN
“The Philosophy of Supportive Personnel in Pharmacy,”
Henry J. Derewicz, M.S.,
Director, Pharmacy Services, The Johns Hopkins Hospital.
Clinical Assistant Professor of Pharmacy, University of Maryland.
10:00 A.M.—*A Review of Existing Training Programs for Supportive Personnel in Pharmacy,” Louis P. Jeffrey, M.S., Director of Pharmacy Service, Rhode Island Hospital. Clinical Professor, University of Rhode Island, School of Pharmacy.
10:45 A.M.— COFFEE BREAK
11:00 A.M.—*Experiences with Supportive Personnel in a Health Care System,” Paul LeSage, Deputy Director of Pharmacy Services. U.S.P.H.S. Hospital, San Francisco, Cali-
fornia. LUNCHEON MACHINES
1:15 P.M.—Patrick Birmingham—Presiding,
Director of Pharmacy Services, Good Sa- maritan Hospital.
Clinical Instructor in Pharmacy, Univer- sity of Maryland.
“Computer Applications to the Health Care System,”
Cornelius P. McKelvey, MS.,
Instructor, University of Maryland, School of Pharmacy.
11:45 A.M?—
THE MARYLAND PHARMACIST
1:50 P.M.—“‘One Hospital’s Experience with the Brewer System,” Douglas R. Mowrey, Director of Pharmacy Services, The Wash-
ington Hospital Center.
2:25 P.M—*The Changing Health Care System,” Peter P. Lamy, Ph.D., Associate Professor and Director Institu- tional Pharmacy Programs, University of
Maryland, School of Pharmacy.
7:00 P.M—BANQUET ADDRESS “The Pharmacist on the Health Care Team,” John Collins Harvey, M.D., Executive Vice President and Medical Di- rector, Good Samaritan Hospital.
SERVICES SUNDAY 10:00 A.M.—Peter P. Lamy, Ph.D.—Presiding “Pharmacy Service in a Small Hospital,” R. David Anderson, M.S., Director of Pharmacy Service, Waynes- boro Community Hospital. President, American Society of Hospital Pharmacists.
10:45 A.M.—Presentation — The Maryland Society of Hospital Pharmacists Student Achieve- ment Award.
10:50 A.M.—‘‘Pharmacy Service in the Emergency Room,” Thomas E. Patrick, Chief Pharmacist, University of Maryland Hospital. Clinical Assistant Professor of Pharmacy, University of Maryland.
11:30 A.M.—Closing Remarks: Clarence L. Fortner, MS.
Prease Nore: All community pharmacists are invited to attend this weekend Seminar. Many of the topics would be of interest to those affiliated with nursing homes. For
information on registration, please contact Semfnar Chairman, Clarence Fortner at 338-1100, Ext. 243.
Actions of the American Society of Hospital Pharmacists House of Delegates
—Adopted Policy on Economic Status.
—Adopted a resolution to amend by-laws which will en- able streamlining of organizational structure by reduc- ing number of operating councils from six to four.
—Adopted a resolution to amend by-laws which will al- low for the election of Speaker of the House of Dele- gates by members of the House of Delegates upon nom- ination by a committee appointed by the President. The elected Speaker will preside over the House and repre- sent the House as a voting, ex-officio member of the
ASHP Board of Directors.
—Adopted a resolution authorizing the ASHP to study the feasibility of developing a Model Hospital Phar-
APRIL 1971
macy Practice Act for incorporating in the states’ Gen- eral Pharmacy Practice Acts. .
—Adopted a resolution to foster the discontinuance of drug sampling by pharmaceutical manufacturers, and to commend those manufacturers who have seen fit to discontinue drug sampling. Further to communicate
this position to individual pharmaceutical manufac- turers.
—Adopted a resolution to endorse and support the dis- pensing of out-patient medications in “child resistant” containers whenever applicable and to urge pharma- cists to promote drug usage safety.
The following resolutions were adopted with referral to the proper committee for further study.
1) Amendment of by-laws changing dues structure. 2) Directions to patients on prescriptions. 3) Supportive personnel.
Nominations for President-Elect: William Hotaling, III Wendell T. Hill, Jr.
Report on American Society of Hospital Pharmacists 28th ANNUAL MEETING MARCH 27 - APRIL 1, 1971 San Francisco, California
by Samuel Lichter
The Maryland Society of Hospital Pharmacists was well represented at the Annual Meeting of the American Society of Hospital Pharmacists. The members of the Maryland delegation participated in the House of Dele- gates and General sessions and benefited from the mu- tual exchange of ideas. As the Annual Meeting brought to an end another Society year, so it began another, to continue the expansion and development of the many worthwhile and meaningful Society activities. The reports of the various committees and councils of the A.S.H.P. were elaborate in their expression of the need for greater commitment and involvement of the Society and its mem- bers to the improvement of the delivery of health care services.
APhA President, William R. Whitten, noted, with optimism, at the first session of the A.S.H.P. House of Delegates, the advances in Pharmacy which have gradu- ally come to the foreground. President Whitten noted that the profession is experiencing a change in direction due to the attraction of a greater youth to the profession. One must also recognize the importance of the trend of increased service by community Pharmacy to hospital and other related institutions. He also emphasized that in spite of increased specialization of functions and re- sponsibilities, ““. . . we are all Pharmacists.”
A.S.H.P. Executive Director, Joseph A. Oddis, in his annual report, announced the purchase of a building to house the Society staff and its activities. Also an- nounced was the recent change in the Society’s organiza- tional structure to increase the efficiency of the enlarged staff needed to implement the growing budget necessi- tated by the ever expanding Society activities.
A.S.H.P. President Herbert S. Carlin foresees Hos- pital Pharmacy on the threshold of a new era: An era of new roles developed from without and from within— an era of specialization of function; of increased decen- tralization. The concept, or state-of-mind — “Clinical Pharmacy”—is being developed and expanded into com- munity based clinical programs, school-hospital joint programs, and hopefully the necessary change from in- ternship to externship programs. The necessity of attach- ing “clinical” to the practice of Pharmacy will be obvi- ated as pharmacist-patient relationship and involvement expands.
In addition to the management capabilities, techni- cal skills, and scientific knowledge required of the phar- macist in the clinical setting, there exists the need to effectively communicate his preparedness to the other members of the health professions and to the patient (consumer). The reports of the Society committees elab- orated upon what it has done and what it plans to accom- plish. The various General sessions of contributed papers expounded upon the many and varied attempts of indi- vidual practitioners to accomplish their objectives and attain their goals. A presentation by Kenneth N. Barker and Joseph G. Valentino, both of the United States Phar- macopeial Convention, suggested a political and legal foundation for Clinical Pharmacy Practice. Drug informa- tion systems, drug interaction reporting systems, fiscal management, third party payment programs, community health center involvement, intravenous solution therapy (hyperalimentation and incompatibilities) were among the topics of the papers presented.
Sister M. Gonzales was the recipient of the H.A.K. Whitney Lecture Award. R. David Anderson was in- stalled as president for 1971-72.
The Emergency Health Personnel Act of 1970 (PL 91-623)
MPhA given right to certify need for pharmacists
On December 31, 1970, President Nixon signed in- to law the Emergency Health Personnel Act of 1970. This bill provides for the assignment of Public Health Service personnel to areas where health manpower short- ages exist.
Under the bill, as reported to the floor of the House, among other requirements for assignment of PHS per- sonnel was a certification of need by a state or local medi- cal or dental society. Thus, medicine and dentistry would have been granted a veto power over the assignment of members of other health professions.
In cooperation with other associations representing the allied health professions, the American Pharmaceuti- cal Association, with the assistance of the Washington State Pharmaceutical Association, persuaded Congress- man Brock Adams of Washington to introduce an amend- ment on the floor to provide the professional association for each health care profession the authority to certify or not to certify need for assignment for members of their profession. The Adams amendment was adopted by the House and is incorporated in PL( 91-623). Conse- quently, under this Act, the Maryland Pharmaceutical Association will control the assignment of pharmacists in Maryland.
A Service of The Drug House, Inc.
LET OUR COMPUTER WORK FOR YOU With lee Or
TIP TOP is a computerized procedure by which you are automatically supplied with a monthly statement of purchases for each of your charge account
customers.
PLUS
An immediate monthly (and annual) breakdown of their pharmacy purchases
of deductible items for income tax purposes.
For information, call or write:
THE DRUG HOUSE, INC.
1011 West Butler Street Philadelphia, Pa. 19101 (215) 223-9000
1880 Princeton Avenue Trenton, New Jersey 08638
(609) 396-5586
3069 Newcastle Avenue Newcastle, Del. 17920 (302) 655-7401
THE MARYLAND PHARMACIST
Offer Guardian sensitivity
ae eee Se ime oe ee eS eer. Pa et eae Ee rea 3 £9 eh ‘
no X 9 Ric ns — ROLLED LATEX PROPHYLACTICS
...and they’ll never ask for just prophylactics again. They will be sold on the complete sensitivity afforded by
these premium prophylactics. They’ll stay sold because Trojan brand Guardians
are thin, pre-lubricated and sealed in foil. And you'll be happy because the extra profit in each Guardian makes it an ideal product for you to recommend.
Next time your customer comes in and asks for prophylactics, recommend Guardian, the Trojan brand premium lubricated product from Youngs, the
toyour customers first
| company tuned to today’s pharmacy
customers...for tomorrow’s profit.
Youngs Drug Products Corporation ™ 865 Centennial Ave., Piscataway, N.J. 08854
Spring Regional Meeting Maryland Pharmaceutical Association
The Spring Regional Meeting of the Maryland Phar- maceutical Association was held on March 24th, 1971 at the Colony Seven Motor Inn, Baltimore- Washington Parkway. The program was preceded by a luncheon at- tended by MPhA and LAMPA members. President Don- ald Fedder opened the afternoon session at this last gen- eral meeting to be held under the present Board struc- ture. The new House of Delegates structure will be in
effect for the Annual Meeting in May.
New Medical Care Prescription Forms
The first afternoon speaker was Mr. Harry Bass, Head of the Pharmacy Section, Division of Medical Serv- ices, Maryland Department of Health and Mental Hy- giene. Mr. Bass explained the new Medical Assistance prescription forms. The new forms (Form DHMH-235 for original prescriptions and Form DHMH-226 for refill prescriptions ) are three-part forms, designed to be proc- essed through a data recorder (imprinter). The first two copies remain with the pharmacist; the third copy (hard copy ) is submitted to: Purchased Care Services, State De- partment of Health and Mental Hygiene, 301 West Pres- ton Street, Baltimore, Maryland 21201. Al} pharmacies will be mailed complete instructions concerning the new forms.
Community pharmacies, who now have Blue Cross data recorders (imprinters) will not be required to pur- chase additional data recorders for the new forms. These pharmacies will be issued plates with their pharmacy name and Medical Assistance registration number which can be adapted to the Blue Cross data recorders. Other pharmacies will be provided with data recorders through
Photo by Paramount
Speakers at the Spring Regional Meeting of the Maryland Pharmaceutical Association. left to right: Harry Bass, Head, Pharmacy Section, Division of Medical Services, Maryland Dept. of Health and Mental Hygiene; Vincent J. Lozowicki, Staff Assistant for Compliance, Bureau of Narcotics and Dangerous Drugs (Region 4); Earl Vreeland, District Sales Director, Youngs Drug Products Corporation; Donald O. Fedder, President, Maryland Pharmaceutical Association.
18
the wholesaler of their choice. A $29.50 deposit will be re- quired which may be paid at the time of delivery or which may be deducted from reimbursement funds. Pharmacists are to fill in prescription blanks by hand until their new data recorders or plate attachments are received from the Medical Assistance Program.
Questions concerning the forms should be directed to Miss Jean Ingram or Mr. Frederick Hormes at 383- 2688. Mr. Bass can be reached at 383-2827.
VD Awareness Program
The second afternoon speaker was Mr. Earl Vreeland of the Youngs Drug Products Corporation. Mr. Vreeland presented the protocol for the upcoming VD Awareness Program. The month of June will be designated as VD Awareness Month. Paul Freiman, chairman of the MPhA Public Information Committee, will head up this pro- gram. Official VD Awareness signs and pamphlets en- titled “Plan Talk About Venereal Disease” will be dis- tributed to pharmacies. Speaking engagements are planned throughout the state stressing the three essen- tials—knowledge, treatment and prevention. Efforts will be made to marshall the opinion of community leaders.
Officials of the Youngs Drug Products Corporation are planning a press reception to kick off the campaign. The company will meet with MPhA staff and with state health officials. Advertisements will be placed in news- papers and there will be radio and television public serv- ice announcements. Official proclamations from the mayor and governor will be drawn up for their signatures. There will also be meetings with schools and colleges.
Mr. Vreeland mentioned that his company has played a major role in state legislation outlawing the sale of prophylactics through vending machines. ‘Twenty-two states now have such legislation. He also said that follow- up mailings will insure that the VD Awareness Program will continue throughout the year.
The third speaker on the program was Mr. Vincent J. Lozowicki, Staff Assistant for Compliance, Bureau of Narcotics and Dangerous Drugs. Mr. Lozowicki explained the Federal Controlled Substances Act of 1979.
Business Session
President Fedder briefly reviewed the topics on the agenda of the Annual APhA Meeting in San Francisco. Rudy Winternitz announced that the Installation of Of- ficers of the Prince Georges-Montgomery County Phar- maceutical Association would be held on April 17th at a dinner-dance and that all members were invited to at- tend. President-elect Nathan Schwartz announced that the registration fee for the annual MPhA Convention would be $5.00 for Sunday, May 16th and $10.00 for Monday, May 17th which includes lunch. A theater func- | tion on Sunday night will be $10.00. The convention will be held at the Hunt Valley Inn in Cockeysville.
The meeting adjourned at 4:30 P.M.
THE MARYLAND PHARMACIST
Comprehensive Drug Abuse Prevention and Control Act
The Controlled Substances Act essentially combines Federal controls over narcotics and stimulant and de- pressant drugs into one statute with the responsibility for enforcement placed in one Federal agency, the Bureau of Narcoties and Dangerous Drugs, U.S. Department of Jus-
tice (BNDD). The former designations of Class A, B, X and DACA
drugs are eliminated. In place of these, five schedules are employed to classify what are now designated ‘“‘con- trolled substances.”
Schedule I contains substances with a high potential for abuse that have no currently accepted medical use. Schedule II contains the former “Class A” narcotics and injectable methamphetamine. Schedule III consists of the former “Class B” narcotics and the majority of the DACA drugs, plus paregoric. Schedule IV contains drugs formerly classified as DACA drugs which have a lower abuse potential than those in Schedule III. A main dif- ference between Schedules HII and IV lies in the penal- ties for violation of the law, the penalties being greater if the violation involves a Schedule III drug. Schedule V consists of the former “Class X” products, both prescrip- tion and OTC items, with the exception of paregoric.
The commercial container of each controlled sub- stance will bear an identification symbol indicating the schedule in which the drug belongs. The symbol can ap- pear in either of two ways: a capital C followed by the roman numeral indicating the schedule number, or a capital C with the roman numeral inside of it.
The requirements of this new Federal Jaw and the regulations promulgated under it as they pertain to the practice of pharmacy, are summarized below. It must be kept in mind, that if the state law and Federal law differ, the more stringent law is applicable.
Pharmacy Registration
Around April 15, all pharmacies now registered with IRS (Narcotics Tax Stamp) or FDA (DACA Drugs) will
receive by mail a provisional registration application form.
Along with the application will be instructions for filling out the form. It is suggested that the instructions be care- fully reviewed before filling out the provisional applica- tion form. The registration fee is $5 which covers all con- trolled substances in Schedules II through V. A separate registration will be required for each pharmacy location. Individual pharmacists need not register unless engaged in independent research.
When the provisional registration application is re- ceived by pharmacies now registered with [RS and/or FDA, a new BNDD registration number will appear in Block No. 5 on the application form. Beginning May 1, this number must be used on all correspondence to BNDD as well as on all orders and any other documents of trans- fer.
Pharmacies registering for the first time after May 1 will request from the Bureau of Narcotics and Dangerous Drugs, P. O. Box 28083, Washington, D. C., cr from any BNDD Regional Office, a Registration Application for New Registrants. Complete instructions and return en- velopes will accompany the Registration Application for New Registrants.
APRIL 1971
Any change of address, location, business activity or name by existing registrants will be handled as a new registration under the system, including the payment of
the $5 fee.
Inventory Requirements
All pharmacies must make a complete and accurate record of all stocks of controlled substances on hand as of May 1. Thereafter, the registrant must repeat this in- ventory procedure every two years, either on the anni- versary of the original inventory or at the date of the registrant’s regular general physical inventory which is nearest to and not more than six months from the bien- nial date which would otherwise apply.
This inventory must be taken either as of the open- ing or the close of business on the inventory date and a notation as to the time entered on the inventory. It must include the kind and quantity of all controlled substances on hand, including strength and dosage form of the con- trolled substance. The inventory for Schedule II sub- stances must be recorded and filed separately from the inventory for Schedule III, IV and V substances.
For sealed containers, a bottle count is sufficient. For opened containers of Schedule II substances, a tablet, or capsule count is required. Schedule III, IV and V sub- stances either require a tablet or capsule count of opened bottles, or, if the bottle is graduated, an estimate of the contents is sufficient.
The inventory may be taken by tape recording or other electronic means but must be promptly reduced to a written form.
The inventory, upon completion, must be signed by the person responsible for taking it and must be main- tained for at least two years at the pharmacy. It should
not be sent to BNDD.
When new drugs are added to the list of controlled substances, each registrant will be required to make an initial inventory of all stocks of that particular product on hand.
General Recordkeeping Requirements
As of May 1, each pharmacy must maintain on a current basis complete and accurate records of all con- trolled substances received as well as all controlled sub- stances dispensed or transferred.
Invoices:
Invoices for all Schedule II substances must be main- tained separate from all other records. Invoices for con- trolled substances in Schedules III, IV and V may either be maintained separately, or may be maintained with in- voices for non-controlled substances. In the latter case, controlled substances in Schedules III through V must be red-lined, asterisked, or otherwise marked so as to make them readily distinguishable from the records of the non-controlled substances.
Prescriptions:
A pharmacy must file all Schedule II prescriptions separate from all other prescriptions. Prescriptions for controlled substances in Schedules III, IV and V may either be filed separately, or in the usual consecutively numbered file along with prescriptions for non-controlled substances. In the latter case, the prescriptions for con- trolled substances must be stamped in red ink with a letter “C” at least one inch in height on the lower right hand corner.
Dispensing of Schedule II Controlled Substances
Schedule IL controlled substances may normally be dispensed only pursuant to a valid written prescription. However, under certain emergency conditions, Schedule II substances may be dispensed pursuant to the oral au- thorization of a prescriber.
An “emergency situation” is one in which the pre- scriber determines:
“1. that immediate administration of the controlled substance is necessary for proper treatment of the intended ultimate user; and
“2. that no appropriate alternative treatment is avail- able, including administration of a drug which is not a controlled substance under Schedule II of the Act, and
3. that it is not reasonably possible for the prescrib- ing practitioner to provide a written prescription to be presented to the person dispensing the sub- stance, prior to the dispensing.”
In such an emergency situation, the pharmacist may dispense a Schedule II controlled substance on an oral prescription provided that:
1. If the prescribing physician is not known to the pharmacist, he must make a reasonable effort to determine the legitimacy of the authorization, such as a check in the phone book to verify the prescriber’s phone number, call-back, etc.;
2. The oral prescription must immediately be re- duced to writing, containing all the information normally contained in a written prescription, ab- sent the physician’s signature;
3. The quantity must be limited to the amount re- quired to treat the patient during the emergency period.
Thereafter, within 72 hours the prescriber must furnish the pharmacy with a written authorization for the emergency dispensing, which must be attached to the written notation previously made by the pharmacist and filed in the Schedule II prescription file. The burden of supplying the signed prescription is on the prescriber and the prescriber, not the dispenser, will be penalized if this requirement is not satisfied. However, the pharmacy must inform BNDD if the prescriber fails to deliver the signed authorization as required. The pharmacy’s failure to do so voids the original oral authorization, and makes the emergency dispensing unlawful.
Prescriptions for Schedule II substances may not be refilled. NOTE: In a change from prior practice, par- tial filling of Schedule II prescriptions will be permitted if the balance is supplied within 72 hours. In a partial filling situation, a notation must be made on the prescrip- tion form and the prescriber notified.
The prescription label for a Schedule IJ controlled
substance must contain: 1. Date of filling Name and address of the pharmacy Name and address of the patient Name and registration number of the practitioner
Ne wh
Directions for use and cautionary statements, if any
6. Warning on transfer to other than patient named on the prescription.
20
NOTE: The warning requirement is new. The ad- dress of the physician or the registery number of the pharmacy need no longer be placed on the label.
Dispensing of Schedule Ill & IV Controlled Substances
Controlled substances in Schedules II] and IV, whether narcotic or non-narcotic, may be dispensed pur- suant to either a written or oral prescription. The usual requirement that an oral prescription be promptly re- duced to writing and filed applies. As was the case for DACA drugs, a prescription for Schedule III and IV con- trolled substances may not be refilled more than six months after the date of issue nor more than five times regardless of the date. Upon each refilling, the pharma- cist must note on the reverse of the prescription the quantity of drug dispensed, if less than the amount pre- scribed, the date and the pharmacist’s initials.
After the expiration of a Schedule LI or IV _ pre- scription, additional quantities may be dispensed only on the basis of a new prescription.
Labeling requirements for Schedule III and IV sub-
stances are the same as those for Schedule II.
NOTE: Although former “Class B” narcotics are subject to more liberal dispensing rules under Federal law, the more restrictive requirements of state law will still be applicable in many states at least until state law is conformed to the new Federal law.
Dispensing of Schedule V Controlled Substances
Controlled substances in Schedule V may be dis- pensed only for a legitimate medical purpose, and for some no prescription is required. However, only a phar- macist may dispense an OTC Schedule V substance; a non-pharmacist employee, even under the direct super- vision of a pharmacist, may not. However, once the phar- macist has fulfilled his responsibility, for determining medical need, the actual sale transaction may be com- pleted by a non-pharmacist.
A purchaser must be at least 18 years of age and provide suitable identification. Not more than 240 cc. (8 oz.) of any substance containing opium, nor more than 120 cc. (4 oz.) of any other Schedule V substance may be sold without a prescription to the same purchaser in any 48 hour period.
A record book for OTC Schedule V substances must be maintained and must include the name and address of purchasers, the kind and quantity dispensed, the date of the transaction and the initials of the pharmacist.
NOTE: Paregoric, which could formerly be sold on an OTC basis under Federal law is now a Schedule III
substance requiring a prescription.
NOTE: All requirements pertaining to Schedule III and IV substances are applicable to Schedule V_ sub- stances dispensed pursuant to a prescription except that the refill limitations and label warning regarding trans- fer do not apply.
Warning Requirement
The dispensed container of all controlled substances in Schedules Il, III and IV must contain the following warning:
“CAUTION: Federal law prohibits the transfer of
this drug to any person other than the patient for whom it was prescribed.”
THE MARYLAND PHARMACIST
A strip-label or a pre-printed prescription label may be used to comply with this requirement.
Security for Storage of Controlled Substances All controlled substances listed in Schedule II shall
be stored in at least a securely locked, substantially con- structed cabinet.
Controlled substances listed in Schedule I1I, IV and V must either be stored in such a locked cabinet or dis- persed throughout non-controlled substances stock in such a manner as to obstruct the theft or diversion of the con- trolled substances. NOTE: Former ‘Class X” products, including OTC’s, are subject to this requirement.
Order Forms
Order forms provided at no cost by BNDD are re- quired to procure any controlled substance in Schedule II. Three books, each containing six forms, will normally be furnished per requisition.
Each form will be in triplicate. The pharmacy will submit the original and duplicate to the distributor and retain the triplicate separate from all other records for a two year period. The triplicate copy must then be used to record the number of containers for each ordered item re- ceived and the date or dates of receipt. The distributor will retain the original copy and forward the duplicate copy to the BNDD Regional Office. If the distributor can- not immediately fill a complete order, he may fill it in part and supply the balance by additional shipments with- in 60 days. No order form will be valid for more than 60 days after it is executed.
Theft or loss of order forms must be immediately
reported to BNDD.
NOTE: Existing IRS order forms will be valid until April 30, 1972. If these are used, the registrant’s BNDD number must be inserted in the block containing the old IRS number. If not used, these forms must be marked “VOID” and retained for a period of two years.
NOTE: An order form containing an item which is not a Schedule I or II controlled substance will be deemed to be improperly prepared and must be returned to the purchaser without providing any item on such form. Former “Class B” narcotics are in Schedule III, thus cannot be ordered on the official order form.
Transfer Between Pharmacies
In the event a pharmacy does not have a controlled substance required by a patient, and the patient has no alternative source of that drug reasonably available to him, the pharmacy may obtain it from a second phar- macy. In such a situation neither pharmacy need register as a distributor. Records of the transaction must be kept, however, and the amount transferred may not exceed that necessary for immediate dispensing. The transaction is recorded as a dispensing by the pharmacy providing the drug and as a receipt by the pharmacy receiving it. Each must retain a signed receipt of the transaction, which if it involves a Schedule II drug must be an official order form.
NOTE: Under previous law accommodation trans- fers of “Class A and B” narcotics between pharmacies were not allowed.
APRIL 1971
Returns to Suppliers and/or Manufacturers
A pharmacist may return a Schedule II substance to the supplier from whom he obtained it. An official order form for the quantity being returned must be obtained by the pharmacy from the supplier to whom the item is be- ing returned.
The regulations make no provision for the authorized return of controlled substances in Schedules III. IV or V. In light of the fact that Schedule I and II substances are returnable this is an apparent oversight. APhA will file appropriate comments with the Bureau to correct this deficiency.
Disposal of Controlled Substances
A pharmacist desiring to dispose of surplus or out- dated controlled substances may apply to the Regional Director of the Bureau for authority and instructions for such disposal.
The Director will grant authorization and direct disposition in one of the following manners:
1. By transfer to another registrant authorized to possess 2. By delivery to an agent of the Bureau
3. By destruction in the presence of an agent of the Bureau or other authorized person, or
4. By such other means as the Director may deter- mine.
The United States of Mangini
Now, Mangini counts in 41 States! And we're counting with computers that deliver selective com- parisons, detailed cost factors and more customized information than ever before! Our experienced in- ventory teams are now covering more pharmacists in more areas across the country and doing it faster with the same, careful, guaranteed Mangini accu- racy. If your inventory service is not giving you the answers you need, you need Mangini. Write/call/wire for DESCRIPTIVE BROCHURE
MANGINI & ASSOCIATES, INC. 4850 W. Belmont Ave., Chicago, III. (312) 282-8181
11722 Studt St., St. Louis, Mo. 2760 W. Market St., Akron, Ohio 575 Savin Ave.,West Haven, Conn. 5501 Cherokee Ave., Alexandria, Va.
21
Drug Abuse
Potency Unpredictable in Street Drug Sales
One of the major problems of street addicts is hav- ing confidence in their dope. There are very few drug users who haven’t gotten “burned’”’ at one time or an- other. Experience shows that samples submitted by gov- ernment agents to chemists for analysis are often not what they are purported to be. An illegal market means no regulation on quality or quantity of drugs. Unscrupu- lous dealers utilize this situation to pass off undesirable drugs or inflate their profit. Sometimes the dosage is cut with harmless lactose, but other times it may con- tain a lethal dose of speed, or one drug may be sold for another,
Dr. Frances Cheek of the New Jersey Neuropsychi- atric Institute has good rapport with young users. They
trust her and will give her samples to be analyzed, be- .
lieving that she will tell them the truth about the drug. A number of these samples were analyzed by Bureau of Narcotics and Dangerous Drugs chemists, and the results were summarized.
The 14 samples said to be LSD samples were indeed LSD, but of the 13 said to be mescaline, seven were LSD, four were STP, one aspirin, and one consisted of nothing identifiable. Of the two said to be psilocybin, one was LSD and the other unknown. The one MDA sample was MDA, while the two THC were actually phencyclidine. There was an average amount of 100 mcg of LSD in samples alleged to contain 250 meg.
The makers of street-purchased drugs are selling mescaline and psilocypin because there is a good market for these drugs, in part as a result of the LSD chromo- sone damage scare. However, the sellers are misbranding because no mescaline or psilocybin has been found in the actual samples. Many persons who would hesitate to use LSD or STP will take mescaline or psilocybin. If the STP is unknowingly combined with LSD by teenagers, prolonged confusional states may result. Or with the un- even quantities from pill to pill, an illicit user may take several to get a more pronounced reaction and may end up with an overdose. More publicity of facts such as these might be an effective curb on illicit drug use.
From BNDD Bulletin November/ December 1970.
New Anti-Drug Abuse Visuals are now Available to the Public
A 16 inch by 25 inch full color poster entitled “Wanted Dead or Alive . . . Marihuana” is available from the Preventive Programs Division of the Bureau of Narcotics and Dangerous Drugs, 1405 Eye Street, N.W.., Washington, D.C. 20537. The poster serves as an excel- lent aid to the layman in identifying marihuana in its various stages—from the plant to the pipe. It is ideal for public notice bulletin boards and internal employee in- formation centers. Single prints may be obtained free of charge; bulk copies may be obtained from the Superin- tendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402 at 20 cents each, 25% discount for 100 or more.
Also available is “Katy’s Coloring Book,” a delight- ful 20-page booklet created for pre-school and primary grade children. It teaches respect for drugs in an enter-
22
taining and positive way. Single copies are available from the Bureau address above, and bulk copies from the Gov- ernment Printing Office at 35 cents each.
Drug Arrests of City Youths up 174. per cent in Year
Arrests of youths under 18 years of age for nar- cotics violations increased 174 per cent in Baltimore City last year. A total of 103 juveniles—89 boys and 14 girls —were arrested for possession or sale of heroin and other opium derivatives. Four were under 14 years old, seven were 15, and thirty-one were 16.
Since last March, about 1,400 city policemen have been trained by federal narcotic agents at a series of 3- day workshops. They are now equipped with field-testing kits and as a result the traditional role of the depart- ment’s 22-man narcotics unit, a subsidiary of the larger
Vice Squad, has changed.
Addict Crimes Cut 80 Percent by Methadone
Criminal convictions of drug addicts drop more than 80 per cent after those addicts enter methadone treat- ment programs, but very few addicts become totally in- dependent of any form of drug. These are the major findings in a seven month study of 569 patients at Proj- ect Adapt, the city’s largest drug abuse center. The study is based on program records kept since Project Adapt opened in 1968, and on personal interviews with patients.
‘““We wanted to see exactly how much good we were doing,” said Rev. James Hodges, director of Project Adapt. “The study indicates very strongly that we can, in fact, treat large numbers of people and help them.” There are more than 700 addicts being treated at Adapt.
NABP and NPIC Agree to Use the Same Number to Code Pharmacies
Officials of the National Association of Boards of Pharmacy and the National Pharmacy Insurance Coun- cil have agreed to use the same identification code system for the nation’s pharmacies.
The six digit code number will indicate the street, city and state location of the pharmacy. Features such as size and type will be included in the master file. The program will be maintained by Fisher-Stevens, Inc., Clif- ton, New Jersey.
NPIC believes the unique pharmacy identification code will help reduce the cost of third-party administra- tion as well as equipment and will speed payment to pharmacists. Also, claim identification and adjustment will be greatly simplified.
NABP will make the code number available to state boards of pharmacy to utilize for licensure, thus assisting the states in their record-keeping procedures. — Further, it will act as a check to see that those facilities receiving legend, controlled or narcotic drugs are legally entitled to handle them.
THE MARYLAND PHARMACIST
;
Washington Spotlight For
Pharmacists by APhA Legal Division
Primary Duty Test to Determine Employees in an Executive Capacity
The Wage and Hour Division of the Department of Labor, recently clarified the “primary duty” test to de- termine whether an employee is in an executive capacity.
This is important in determining whether a person is exempt from the overtime requirement of the “Fair
Labor Standards Act.”
According to the clarification, a determination that
_ an employee has management as his primary duty must
be based on all the facts in a particular case. The regula- tion goes on to indicate that the amount of time spent in the performance of managerial duties, is a useful guide in such a determination. In the ordinary case, a good “rule of thumb” is that primary duty means the major part, or over 50 per cent of the employee’s time.
Time alone, however, is not the sole test, and in
_ those situations where less than 50 per cent of the em-
ployee’s time is spent in managerial duties, other factors may support the conclusion that management is the
primary duty. These factors include among others;
1. Relative importance of managerial duties as com- pared to other types of duties.
2. Frequency with which the employee exercises discretion.
3. Relative freedom from supervision.
4. Relationship between his salary and the wages paid other employees for the kind of non-exempt work performed by the supervisor.
New Law on Credit Cards
An amendment to the “Truth-in-Lending Act” passed by the 91st Congress near the end of its session, regulates issuance and use of credit cards. The new law was designed to remedy certain problems relating to credit cards, and supersede the trade regulation issued by the FTC last May, which banned the mailing of un-
solicited cards.
Beginning January 25, 1971, a cardholder may only be held responsible for the unauthorized use of his card by another up to a maximum of $50.00. The card issuer can recover this from the cardholder only if the issuer:
1. Gives notice of this potential liability.
2. Provides the cardholder with a self-addressed, prestamped notice which can be returned to the issuer in case a card is lost or stolen.
Once the cardholder has informed the issuer that a card is lost or stolen, no further charges can be made against him.
All cards issued after January 25, 1971, must pro- vide all required liability notices to the cardholder and some identification, such as a photograph showing the person authorized to use the card.
APRIL 1971
All credit cards, regardless of issue date must con- tain this identification by January 25, 1972.
The unsolicited issuance of credit cards is also banned by the law, except if the card is a renewal or substitute for an existing card.
Narcotic Paraphernalia Sales
A recently released report of the House Select Com- mittee on Crime, discusses heroin abuses and how these abuses are aided by manufacturers and retailers who sell various items used in the heroin trade in large quantities. These sales, for the most part, are legal but in most cases do contribute to the addiction problem.
The paraphernalia discussed, includes among others, hypodermic needles and syringes, empty gelatin capsules (especially No. 5’s), glassine envelopes and cutting agents such as dextrose, lactose, mannitol and guinine.
Pharmacists are advised to use the utmost discretion in making any large quantity sales of these products.
Federal legislation to limit such sales will no doubt be introduced during the next session of Congress. Vari- ous state legislatures will also consider this matter.
The State of Maryland has a statute regulating such sales, which went into effect in July of 1970. The Mary- land statute is aimed at the unlawful possession of such articles, but a regulation governing the sale of various paraphernalia by pharmacists has been promulgated. (See January, 1971 issue of this journal, p. 10). This regu- lation limits the sale of these articles by the pharmacist only in good faith to patients showing proper identifica- tion and an indication of need.
A record must be kept of these sales that contains the name and address of the purchaser, date of sale, item and quantity sold and signature of the pharmacist.
Maryland Blue Cross Prescription Program New Groups effective April 1, 1971:
Hochschild Kohn and Company—%$.50 deductible. Sheet Metal Workers Local No. 122—No deductible.
Retired employees and surviving spouses, and their de- pendents, as well as sponsored dependents of the United Auto Workers—$2.00 deductible.
This represents an increase of approximately 6,000 new members. The Maryland Blue Cross out-of hospital Prescription Drug Program now covers approximately
50,000 members.
Insulin Benefit:
Insulin is a covered item under the Prescription Pro- gram, even though no prescription is necessary for its purchase. If you dispense insulin, Blue Cross will pay you your reasonable charge to your regular customers less any deductible amount. NOTE: You may dispense a maximum of four (4) vials of insulin at one time and collect only one deductible.
23
Wholesale Drug Companies Offer Service to Pharmacists
This is the third of a series of articles describing some of the services that the full-line, full-service drug wholesalers can offer to assist the pharmacist in estab- lishing and maintaining a successful operation in the face of rising competition.
Sentry Drug Center Franchise Program
The Sentry Drug Center system is a program de- signed to allow aggressive pharmacists to own and man- age completely equipped modern drug centers that pro- vide quality products and dependable service at competi- tive prices. The Sentry Drug Center franchise offers the qualified pharmacist the advantages of ownership while minimizing all attendant problems and risks. Benefits that owners will have in their franchise are experience, consolidated management, drugstore marketing facilities, automated consolidated bookkeeping and billing, joint computerized inventory control and ordering procedures, joint merchandising, advertising and promotion, market- ing and traffic analysis, site selection, finance resources, and store design and fixtures.
Drug Center Features
A Sentry Drug Center is completely designed and programmed for volume business with the following fea- tures:
1. Complete professional prescription department.
2. Full line of proprietary and OTC merchandise and representative inventory of convalescent and home nursing aids.
3. Quality selection of health and beauty aids.
4. Scientific selection of high-turnover sundries and seasonal merchandise items.
High-profit camera and photo supply department. National brand box candy. Tobacco products and related items.
Self-service ice cream.
ep feoy C8) Ke (al
Greeting cards and gifts.
Shopping Center Sites
Sentry Drug Centers are designed primarily for the community-strip shopping center that ranges in size from 25,000 to 150,000 square feet. Each Sentry store is designed to occupy space from 3,000 to 10,000 square feet, depending upon site survey and feasibility studies of a specific market area. The program also offers the qualified pharmacy owner a AAA leasing facility in a certified site location.
Qualifications
Qualifications for a Sentry Drug Center franchisee include being a registered pharmacist and/or a qualified investor with a proven record of experience in retailing, references for credit and character and evidence of finan-
24
cial stability. Franchise and start-up costs under the Sen- try plan are about $130,000 with a cash requirement de- pending on store size, location and other variables of be-
tween $35,000 and $45,000.
Sentry estimates that a 3,000 square-foot store would have 36 per cent gross profit on an annual volume be- tween $300,000 and $600,000 with the total operating profit amounting to about 8.34 per cent.
Sentry Drug Centers, Inc. is a wholly owned subsid- iary of the Henry B. Gilpin Company .. . a full-line, full-service wholesale drug company, established in 1845. More information may be obtained from Sentry Drug Centers, Inc., 901 Southern Ave., S.E., Washington, D.C. 20032.
CHANGE OF ADDRESS
When you move—
Please inform this office four weeks in advance to avoid undelivered issues.
"The Maryland Pharmacist" is not forwarded by the Post Office when you move.
To insure delivery of "The Maryland Pharmacist" and all mail, kindly notify the office when you plan to move and state the effective date.
Thank you for your cooperation.
Nathan |. Gruz, Editor Maryland Pharmacist
650 West Lombard Street Baltimore, Maryland 21201
Associates of America, Inc. Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships)
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.J.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
Pension & Investment
THE MARYLAND PHARMACIST
b
IN
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- uage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
rain.
5
D
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
A Collection of
Compounded Prescriptions
by B. F. Allen*
Historically, one of the important professional serv- ices performed by a pharmacist is the compounding and formulation of even the simplest-appearing prescription written by a medical doctor. This is a function which the prescriptionist has executed exceedingly well, even during the last 25 years when the percentage of compounded pre- scriptions was less each year.
In 1964 it was estimated that 4 per cent of modern prescriptions required some compounding operation by the pharmacist. In 1965 a report indicated 3 per cent of prescriptions in America were compounded. The grand total of compounded prescriptions in 1968 was less than 1 per cent of all prescriptions dispensed.
Whenever prescription surveys are conducted, the ratio of compounded prescriptions seems to drop to a new all-time low. However, it is interesting to note that one busy Baltimore metropolitan pharmacist recently stated his average is about 2 per cent. A reason for this slightly higher than average percentage—several pharma- cies in his immediate area refuse to compound prescrip- tions.
Early in 1970 it was stated that in the United States there are about 190,000 physicians in private practice and together they originate in a year about 1,300,000,000 prescriptions, including refills. If only 0.5 per cent of modern prescriptions require some compounding opera- tion, the fact that 1.5 billion prescriptions (or more) may be filled in 1971 means the number requiring com- pounding will be in the millions.
A teacher, who is interested in compounding prac- tice, is often confronted by students, educators, pharma- cists, manufacturers’ representatives, as well as the pub- lic, with the statement that there is “no” compounding (and similar expressions) in the modern pharmacy.
For many years, discussions with students revealed that while some were aware of the problem and some- what concerned, others had no information that would indicate the situation exists. These, and other factors, led to a decision to embark on a simple study of the problem with the cooperation of students of the School of Phar- macy (the writer had these students for instructional purposes in several classes ).
The students were instructed to make a copy of the first prescription on the “current” file, requiring some form of compounding. This information was usually ob- tained in a pharmacy where the student was employed. The results of two studies were published in this Journal, June 1964 and March 1965.
Practicing pharmacists can make a valuable contri- bution to a teaching program involving current drug and other chemical material combinations in compounding. The busy practitioner often forgets that a student has not been exposed to the great variety of combinations of
*School of Pharmacy, University of Maryland
26
the past, and the student many times believes it is a first time up-to-date development.
This writer has, for a very long time, attempted to stimulate interest in compounded prescriptions among the students at the school. Every year students continue to bring in prescriptions of this type and later, after gradua- tion, often mail in some to the writer. One recent grad- uate sent a series of compounded prescriptions from Cali- fornia.
A young pharmacist soon finds in practice that many of the prescription formulas requiring compounding are mixtures and blends of unfamiliar or difficult to obtain raw materials or highly complex compounds. It often happens that two indviduals using the same ingredients in the same formula get different results. This may be due to slight deviations in the materials used or the technique.
The following are some of the more recent examples of prescription orders (and, at times, prescription prob- lems) supplied to the author by students and pharma- cists:
(1) Glycerin 4.0 Ether 8.0 Alcohol (50% ) QS 180.0 Para-Aminobenzoic Acid 150 (10) Rose Water Qs 100.0 Ammonium Chloride 5.0 (2) Ammonium Carbonate 5,0 Salicylic Acid 5.0 Hydrocyanic Acid Diluted 2.4 Olive Oil QS 100.0 Tolu Syrup 60.0 (3) Wild Cherry Syrup 60.0 Chrysarobin 25.0 Brown Mixture OS 240.0 Chloroform Qs 100.0 (11) (4) Benzoyl Peroxide 10.0 Ethyl Oxide 32,5 Ointment Base OSs 100.0 Alcohol 65.0 (12) Ethereal Oil 2 Salicylic Acid 5,0 (5) Lanolin 47.5 Hexachlorophene 0.5 Petrolatum 47.5 Cocoa Butter Lotion QS 100.0 (13) (6) Salicylic Acid 10.0 Olive Oil 70. Liquor Carbonis Detergens 20,0 Wintergreen Oil 14. Aquaphor Qs 100.0 Chloroform Liniment 14, (14) Neutracolor 0.03 Mineral Oil 33.0 Burow’s Solution 15 Strawberry Concentrate QS Titanium Oxide 1.0 Saccharin S Qualatum Qs 30.0 Preservative QS (15) Water Qs 100.0 Hydrocortisone 0.5 — (8) Mycostatin 2,000,000 units — Cudbear Tincture 3 drops Dermabase As Euresol 4, Water Qs 30.0 — Mercury Bichloride 0.1 (16) Rose Water 15,0 Salicylic Acid 2.0 Alcohol (70%) OS 240.0 Ammoniated Mercury 45 § (9) IE ACADY 3.0 Mercurie Chloride 0.13. Dermabase QS 60.0 Salicylic Acid 2.0 Euresol Procapillaris 4.0
The following chemicals or materials were also re- quested alone in the form of a prescription order: Bur- vundy pitch (to be used in the treatment of sores), cal- cined magnesia, camphoric acid (12 capsules requested each to contain 14 grain), fuming nitric acid (to be
} . THE MARYLAND PHARMACIST
dispensed in a glass stoppered bottle), methylcellulose (powder to be used as a bulk laxative), sodium thiosul- fate (25 per cent solution) and trichloroacetic acid (to be applied to warts).
Also, as examples, the following interesting formu- las were also prescribed:
(17) (18) Iodine Tincture 3 fl. oz, Methyltestosterone 1/10 Gr. KISS 3 fl. oz. Dextrose 9 Gm. Soft Soap 1 Ib. Mix into 10 equal powders, Pine Tar 1 pt. l-powder daily in % tsp. Water Qs 1 gal. eggyolk
(Liniment For Horse) (For Canary To Sing)
A pharmacist in the Baltimore metropolitan area also received a request for several pounds of glutamine to be used as a food supplement for cattle.
Students employed in a pharmacy and involved in the 1969-70 compounding course were instructed to make a copy of the first prescription on the “current” file requiring some form of compounding operation. A total of 26 prescriptions were received from interested students and an analysis of the formulas revealed that 66 different drugs or commercial preparations were pre- scribed by the physicians. A tally of the relative occurrence of items in these prescriptions is indicated in the paren-
theses: acacia (1), acetylsalicylic acid (1), Actifed-C (1), Alugel (1), amaranth solution(1), Amytal. (1), am- monium chloride (3), antipyrine (1), aromatic elixir (1), belladonna tincture (5), Benylin expectorant (1), bismuth subcarbonate (1), caffeine citrated (1), carbonis detergens liquor (2), carron oil (1), Cheracol (1), citric acid (1), cocaine hydrochloride (2), codeine phosphate (1), codeine sulfate (6), Continex syrup (1), Cordran cream (1), Creamalin (1), Demazin syrup (1), Emul- sion base (1), Gantrisin white liquid(1), glyeyrrhiza compound mixture (1), Hybephen elixir (1), Hycodan syrup (1), Hydryllin compound (1), hyosecyamus tine- ture (2), lanolin (2), magnesium carbonate (1), Metha- jade (1), Mylanta liquid (1), Orthoxicol (1), pepper- mint spirit (1), pepsin lactated elixir (1), petrolatum (2), phenacetin (2), Phenergan expectorant pediatric (1), phenobarbital (3), phenobarbital sodium (2), phe- nol (2), potassium citrate (2), potassium iodide saturated solution (1), Pyribenzamine expectorant with ephedrine (1), Robitussin (1), salicylic acid (1), Sedatole (1), Silvol (1), sodium bromide (1), sodium nitrate (1), sodium salicylate (1), sodium thiosulfate (1), sulfur pre- cipitated (1), Synalar cream (1), Taka-Diastase liquid (2), tannic acid (2), terpin hydrate with codeine elixir (1), tolu syrup (1), Trancopal (1), Triaminic syrup (1), Tylenol elixir (1), Valium (1), and wild cherry syrup (1).
TAILOR-MADE
Insurance Coverage
AMERICAN DRUGGISTS’ INSURANCE ...as the name im- plies, is specifically designed for the needs of the druggist. It’s an insurance company founded BY druggists FOR druggists, to assure especially prompt settlement of claims .. fire, theft, liability. And that’s exactly what we've been doing... settling such claims rapidly, without red tape ... since 1906. Any service with that many years of
experience HAS to be reliable. You can be certain of 100% security.
For full details on our complete coverage plan, contact your ADI agent NOW.
MAYER & STEINBERG Maryland State Agents 1101 N. CALVERT STREET BALTIMORE, MD. 21202 752-7311
DRUGGISTS’ INSURANCE CO. 700 American Building Cincinnati, Ohio 45202
APRIL 1971
27
LAMPA News
How do you describe a LAMPA “Show and Tell” program that featured approximately 46 antiques—many very valuable, some irreplaceable—all with interesting stories surrounding them? Ask any one of the members that attended the Spring Regional Meeting at the Colony 7 Motor Inn on esa 24, 1971.
Through our possessions, it was obvious our Lamp- ettes have interests as diversified as our dress sizes. Sev- eral pharmacists’ mates displayed treasured apothecary items, such as a rare, old quassia cup; a delicate, old, beautifully preserved scale; and an ancient Egyptian mortar and pestle. Cherished old silk, lace, and woolen bed linens and wearing apparel were shown. A century old newspaper, cook book and prayer missal, all in good condition and written in contemporary style, were briefly highlighted. A unique collection of old Tiffany and Kirk silver, for a lady’s boudoir and for travel, was beautiful to see and have explained. Rare stamps, an old car ornament, gold coins, icons and a copper B & B warmer (Bed and Bottle) were carefully displayed and discussed.
We had beautiful heirloom china and an irreplace- able Catholic relic of museum quality. Even the christen ing dress of a prominent member of our pharmacy coterie showed up. Jewelry—old, new, symbolic and precious, from far away places and of sentimental value evoked many ohs and ahs. Our world travelers were represented too, with colorful curios and interesting tales. An unusual plant (with free seeds available) and decorative rocks had a niche in our potpourri. We were so pleased with the treasures our 13 participating ladies brought, we in- vited the men attending the MPA meeting to browse too. The warmth and pleasure that prevailed during the Show was contagious.
A travel film extolling the food and fun on the island of Jamaica was also shown. The business meeting concerned itself primarily with preparations for our an- nual convention May 16 and 17, 1971 at the Hunt Valley Inn and the post-convention trip to Jamaica.
Each member left the meeting clutching a fresh potted geranium.
—Anne Crane, Communications Secretary
Photo by Paramount
Members of the Ladies Auxiliary at the MPhA Spring Re- gional Meeting, from left to right: Mrs. Charles S. Austin (Dorothy), treasurer; Mrs. Richard R. Crane (Ann), com- munications secretary; Mrs. Louis Rockman (Dora), presi- dent; Miss Mary DiGristine, recording secretary; Mrs. Man- uel Wagner (Sadie), membership treasurer; and Mrs. Frank Block (Eva), board member.
28
A.Z.O. News
Kappa Chapter of A.Z.O. Pharmaceutical Fraternity held a breakfast meeting on Sunday, February 21 at the Holiday Inn in Pikesville. The speaker was Mr. William Finnegan, Vice President, Paid Prescriptions. A joint
dinner meeting was held on Sunday, March 7 at Martin’s-
West and the speaker for that occasion was the Reverend Fred Hanna—well known in the Baltimore area for his work with youth.
District Wholesale Moves Into New Quarters
District Wholesale Drug Corp. division of Spectro Industries has moved into its new $1,500,000 distribu- tion facility in Prince George’s County, Md. Construc- tion was started last August. The 60,000 square feet office and warehouse is located at 7721 Polk Street, Landover, Md. 20785.
Local Testing Being Done on One-A-Month Birth Pill
About 250 Baltimore women are participating in tests of a once-a-month birth control pill at Baltimore City Hospitals. The women in the experimental research program include both private and welfare patients. Ac- cording to Dr. Frank Kaltreider, chief of obstetrics and gynecology at City Hospital, experience so far is too scant to be properly evaluated. However, he said that the once-a-month pill’s reliability appears to be on par with “every other type of oral contraceptive.”
“The active ingredients of the pill are similar to the oral contraceptives now on the market,” he added. “The major difference between the every day type and the once-a-month type is in its rate of absorption, re- lease and metabolic intake by the body.” Total dosage of effective ingredients is comparable and may be even slightly less than the total in the currently used pills.
31st International Congress of Pharmaceutical Sciences to be Held in U.S.
The 31st International Congress of Pharmaceutical Sciences of the International Pharmaceutical Foundation (FIP) will be held in Washington, D.C. from September 7 to 12, 1971. Founded in 1912, FIP is an international federation of national pharmaceutical associations which
represents pharmacy world-wide in its broadest sense.
Forty five national pharmaceutical associations from five continents are represented in FIP.
FIP scientific congresses have been heid regularly since the end of World War II. The 31st Congress, how-
ever, will be the first international meeting of pharmacy
to be held in the U.S. since the Fourth Pan-American
Congress of Pharmacy and Biochemistry, which met in
Washington fourteen years ago in 1957. The Congress will be hosted by the American Phar-
maceutical Association in cooperation with the APhA
Academy of Pharmaceutical Sciences. A contribution.
campaign under the chairmanship of Dr. Thomas J. Macek with a goal of $50,000. to help supplement the cost of hosting the Congress had reached one-third of its goal as of January, 1971. Contributions are being re- ceived from national and state pharmacy organizations as well as from the pharmaceutical industry.
THE MARYLAND PHARMACIST
(
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
First name in ice cream
ICE CRE A M for over a half-century
675-6000
* 1971 29
STENT SELL TE
Obituaries... ‘LEAT LAS RT NTL
Matthew Glenn
Matthew Glenn, 72, of Baltimore, died on March 5. He had reciprocated from New Jersey in 1926 and worked as a pharmacist in New Jersey and Maryland until his retirement in 1967. Mr. Glenn was a native of Ayr, Scot-
land. Arthur A. Musher
Arthur A. Musher, 57, of Silver Spring, died on March 19, 1970. He was a 1934 graduate of the Univer- sity of Maryland School of Pharmacy.
Zygmont W. Karwacki
Zygmont W. Karwacki, 80 died at Mercy Hospital on March 23, 1971 after a long illness. Mr. Karwacki was a 1914 graduate of the University of Maryland School of Pharmacy and proprietor of a pharmacy at Eastern Avenue and Ann Street for 41 years. He retired in 1958.
Emanuel Rosenthal
Emanuel Rosenthal, 70 died on March 26, 1971. He was a 1923 graduate of the University of Maryland School of Pharmacy and proprietor of a pharmacy at York Rd. and Rossiter Ave. for 38 years. He retired in 1964.
Officer Rank Sought for Inducted
Pharmacists
The American Pharmaceutical Association has recommended to a U.S. Senate committee an amendment to the Selective Service Law that would assure pharma- cists inducted into the service of commissioned officer rank.
The proposed amendment was contained in an APhA >
statement filed March 1 with the Senate Committee on Armed Services, which had been considering the Selec- tive Service Act. The APhA statement also discussed pharmacy student deferments.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
oe (eee LO OEE EEE EEE
Be Smart!
Think Smart!
IRV NORWITZ
30
Stock the One and Only— Original “SAFETY TIPS”
Always Sell Them Smart Users Ask For Them By Name
AMERICAN HYGIENIC CO.
111 S. Paca Street, Baltimore, Md. 21201
727-8328 Represented by
Phone 727-8328
THE MARYLAND PHARMACIST.
Reputation.:
it often depe n the compan - you keep.
imipramine hyd
Geigy ©
1000 tablets
Caution: Pacers! ! Sotstite depos without presets
CONVENTION TIME
MARYLAND PHARMACEUTICAL ASSOCIATION KELLY MEMORIAL BUILDING ° 650 W. LOMBARD STREET + BALTIMORE, MD. 21201
Telephone (301) 727-0746 NATHAN I. GRUZ, Executive Director
Convention Bulletin and Advance Registration Form
89th Annual Convention Maryland Pharmaceutical Association In conjunction with The Ladies and Travelers Auxiliaries Hunt Valley Inn, Shawan Road, Cockeysville, Maryland Sunday and Monday, May 16 and 17, 1971
A brand new convention facility - easily accessible to every area
of the state. This year - a different Annual Meeting format for MPhA's greater effectiveness and for our members' convenience.
The daytime program has been arranged to concentrate on the business of the MPhA and the issues in pharmacy. The evenings feature enter- tainment and above all, opportunities for good fellowship and social conviviality. Read the convention schedule on back of this page,
REGISTRATION FEES
Men Ladies
Sunday, May 16 $ 5.00 FREE Monday, May 17 $10.00* $10.00*
Total $15.00 $10.00
Per couple: $25.00* *This fee includes lunch and gratuities, with either the MPhA or the LAMPA-TAMPA group. No additional registration fee for family, children and guests of members. No one will be admitted to business sessions or functions who is not registered.
CHARGES FOR FUNCTIONS ONLY TO REGISTRANTS AND THEIR GUESTS
bee Sunday-— 1024540. LAMPAY TOUR wine ss siete eas no extra charge
2. Sunday- 6:00 P.M. Cocktails and Limestone Dinner Theatre........... $10.00 3. Monday- MPhA Luncheon..... Included in Monday Registration fee
4. Monday- LAMPA-TAMPA Luncheon with Arnold Zenker....Included in Monday
Registration fee 5. Monday- 6:30 P.M. Cocktail Hour and Installation Banquet and Dance... .b15,00
Urgent Notice: Register Early for complete Convention vackage as
there is only a limited capacity at the Limestone Dinner Theatre. Seats will be reserved on a "first come" basis. Mail your regis- tration and reservations.
Convention Registration Form Check registration fee and function fees desired (indicate number of persons)
Sunday Men@$ 5.00 Ladies FREE Monday _ Men@$10.00 Ladies@$10.00 Total Men@$15.00 Ladies@$10.00
Functions: Sunday - Limestone Dinner Theatre @ $10.00 Monday - Cocktail Hour, Banquet & Dance @$15.00
Complete Convention Package-registration fees and all functions: Men - $ 40.00, Ladies - $ 35.00 - $75.00 per couple.
Complete and detach this form and mail with check made out to MPhA
in enclosed envelopes. Enclose Hunt Valley Inn Room Reservations
Card for overnight accommodations. Include all names. Use reverse side. NAME ADDRESS
CITY STATE ZIP CODE
Computerized Inventory
and billing
Modern wholesaling demands modern accounting and inventory procedures. That’s why we at Gilpin con- tinually strive to up-date and streamline our operation to improve our services to you. Our computerized, systems enable us to serve your needs faster and more accurately from complete and up-to-date inven-; tories. It also makes possible additional data services like regular issuance of individual monthly reports on DACA drugs as well as other specialized reports. Our wide range of services can help you to realize the full potential of your pharmacy. Please let us Know which of these services fits your needs.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
THE HENRY B.
GILPIN
COMPANY
BALTIMORE + DOVER + NORFOLK * WASHINGTON
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
OTC ile Tee Ee ee |
Sirs:
! am interested in the following programs. Please have your
representative contact me in this regard.
Name
Name of Pharmacy.
CC ee enn OLS Cy Slate Zip
ap a a pay en
LUMAR
AH-OBINS
Donnagel’
its _ profit _ planting _ time!
Allbee winCh €€C with} s MULTIVITAMINS bach capsule contains: % Mi
hiamine } mon 15 ma 15007 :
f{ 10mg 834" 4
5 nig
50 mg
1 pantothenate 10 mg Ascorbic
acid (Vitamin C) 300 mg 1000
100 CAPSULES
§ AlibeewithC
MULTIVITAMINS
30 CAPSULES = AH 081NS sm
buy now for bigger summer and fall profits
_A.H. Robins announces money-saving deals on Alilbee® with C and Donnagel®. Allbee with C is the number one vitamin in its once class in drug store sales, and it also leads in drug store pur- ne eel chases with over 25% of the market. This isn’t surprising when you consider that it’s the B-complex with C most often pre- scribed by the medical and dental professions. Almost one million scripts are filled annually, and this doesn’t even lude professional recommendations or over-the- counter sales. More than one half of all Allbee with C oe sales are OTC. You purchase and sell far more Allbee withC. ~.. * isn’t it good business to also give it more facings and shelf space? ¥ The Spring Deals run from April 1-May 28. Your Robins representative will be around soon to discuss the deals and facings with you. With Allbee with C and Donnagel you’ve got Deal Power!
A. H. Robins Company, Richmond, Va. A-H[OBI NS Put your facings where your profits arel
eo a a i a a i
Rie ee Se A
Volume 47
St
maryland = oharmacist
Irvin Kamenetz, President of the Baltimore Metropolitan Pharmaceutical Association, receiving donations for the Camp Glyndon restoration project of the BMPA. The donators are Wm. Donald Schaefer, President
of the City Council of Baltimore City and Dr, Abraham Silver, Medical Director of Camp Glyndon.
MAY 1971
Number 5
Compliments of
oxell
CORPORATION
Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your reputation goes on the line every time you
fill a prescription—with patients and with physicians alike. You know that seemingly minor differences
in method of manufacture—the size of the particle, the excipient used, the character of the gelatin capsules, solubility, disintegration rate—all can make a crucial difference in therapeutic
effectiveness. Your professional judgment tells you... when it comes to your prescription patient's health (and your reputation), you want to
dispense the best.
Lilly ELI LILLY AND COMPANY
INDIANAPOLIS, INDIANA 46206
You wrap your » reputation
around the products
OU Clispense
No antacid can domore—
for your customers and you.
NET CONTEN
= duration of antacid effect, high acid-consuming capacity proven in over 4 years of laboratory and clinical testing
=» extensive promotion to physicians will generate continued sales
a 73¢ profit per bottle (based on sugg. ret. price)
Each teaspoonful (5 ml.) contains aluminum hydroxide, 720 mg., magnesium hydroxide, 350 mg. and calcium carbonate, 375 mg.
Contraindications: renal insufficiency, phosphate depletion.
Adverse Reactions: occasional laxation, nausea and, rarely, con- Stipation. Theoretically, hypophosphatemia, hypermagnesemia, hypercalcemia, milk alkali syndrome (with prolonged adminis- tration).
Usual Adult Dosage: 2 to 3 teaspoonfuls after meals and at bed- time, or as needed (40 to 60 ml. daily).
For complete product information, see your SK&F Representa- tive or contact SK&F.
Trademark
Ducon
ie antacid
SF Smith Kline & French Laboratories, Philadelphia
Duration through concentration
The Maryland Pharmacist
650 WEST LOMBARD STREET
NORMAND A. PELISSIER, Assistant Editor BALTIMORE, MARYLAND 21201
ASSOCIATION
VOLUME 47
MAY 1971 NuMBER 5
OFFICERS 1970-71 Honorary President MORRIS L. COOPER—Baltimore President DONALD O. FEDDER—Dundalk
President Elect NATHAN SCHWARTZ—Annapolis Vice President SYDNEY L. BURGEE, JR.—Baltimore Vice President BERNARD Eat LACHMAN—Baltimore
ce President MELVIN y. SOLLOD—A delphi Executive Director NATHAN I. GRUZ
NATHAN |. GRUZ, Editor
650 W. Lombard Street, Baltimore 21201
Treasurer
MORRIS LINDENBAUM 5 Main Street, Reisterstown
Executive Committee Chairman I. EARL KERPELMAN-—Salisbury
District 1—Eastern Shore PHILIP D. LINDEMAN—Berlin JAMES W. TRUITT, JR.—Federalsburg
District 2—Central
MORRIS BOOKOFF—Baltimore JOSEPH U. DORSCH—Baltimore PAUL FREIMAN—Baltimore IRVIN KAMBNETZ—Baltimore JEROME MASK—Baltimore ANTHONY G. PADUSSIS—Baltimore DAVID I. SCOTT—Baltimore H. NELSON WARFIELD—Baltimore
District 3—Southern PAUL R. BERGERON, II—Bethesda SAUL B. FRIEDMAN—Potomac EDWARD NUSSBAUM—Rockville DOMINIC J. VICINO—Mt. Rainier RICHARD D. PARKER—Silver Spring
District 4—Northern
ARNOLD L. AMASS—Taneytown ROBERT K. MOLER—Brunswick
District 5—Western HARRY G. EISENTROUT, JR. Cumberland STEPHEN HOSPODAVIS—Cumberland
Committeemen at Large
JOHN R. McHUGH ROBERT E. SNYDER
Ex-Officio Members
FRANCIS S. BALASSONE WILLIAM J. KINNARD, JR.
Honorary Life Member of the Executive Committee
SIMON SOLOMON
MARYLAND BOARD OF PHARMACY Honorary President SIMON SOLOMON President NORMAN J. LEVIN—Pikesville
Secretary Hen: BALASSONE Baltimore
FRANK BLOCK—Baltimore HOWARD L. GORDY—Salisbury MORRIS R. YAFFE—Potomac
TABLE OF CONTENTS
Page Editorial—The Emerging Patterns in Pharmacy Practices. 6 Maryland Board of Pharmacy NeWS cecececcccccccccsccoccoceccecececcseecoccccccccosecocscscecee. 8 Pharmacy Calendar #2... ene eee a le Oe 8 Baltimore Metropolitan Pharmaceutical ASSOCIatiON ooo.cccccccccccccscecsessecseesen 10 Washington County Pharmaceutical Association oo.....cccccccccccccccccececesecesesese. 10 Basterne shore Pharmaceutical society = 10 Prince Georges-Montgomery County Pharmaceutical Association.......... 10 The Student and the University—The Need for Responsibility DV. aw silitin eet ners ed tee Pi Dee a ee oe en 12 Hospitals Pharmacye section esse ee ee 16 King Cstsenya NOLManG eA SPelissiGrs — 1 oes oes, tare ore eee 16 Dangers in the Misuse of Drugs by David A. Blake, Ph.D...............000000.. 18 Wasninstons potent sore Pnarmacists see eee 26 ODIGUATICS ernment eee erence ecco e eaten ee ee mt eae eo ee sae 30 INDEX TO ADVERTISERS Page AMGMCANEIAVSIeniC COMPANY nin ae ee ee ee A 27 BerkeyvePiliteerOcessin gy ta. Weems Se cre Gury PFS aes TW eee Tens 25 Borden-Hendicrslees Crean tate es wee 8 ke es eid 2) es aie | 27 Calvert DIug: COMmpany.. Ince myeee es ences 5s UA een ae Vion a Oi 7 Pienr Veo. holt COMPANY seein meray a eat or a nt eke eae 32 TLYDSOL RW CSCOLL Pcs DUT Ea INC cet ee ety ee eee on Ghee eet OL Bg ral veandeCOmpanven cect) eee haces ee ee EE er 3 LOCW Ys DTUSR COMDED Vice, Gente ee ee Pesce Be a et ye 15 Manginisand s ASSOCIATES MING acres cstceosessde ee a tee 17 Marylarid News: Company ga. eee ret en Rn eter. |i gest 29
Noxell Corporation
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
Editorial Ones ©
The Emerging Patterns in Pharmacy Practice
During the past decade we have seen the following patterns in pharmacy service emerge:
First, we see a greater role for institutional phar- macy concomitant with the growth of the hospital as the source of an increasing percentage of the total services of the current health delivery “system”. This has come about for a variety of reasons, including population shifts, decline in availability of general practitioners and need for specialized equipment, facilities and personnel.
Second, there is the decline of the small independent neighborhood pharmacy, the relative growth of the “large independent” and explosive growth of chain (including discount and supermarket ) pharmacy. Nevertheless, many independents who have emphasized personalized relation- ships with their patrons have been able to retain their loyalty in the face of the most severe competitive chal- lenges. Where pharmacists have made it a cardinal rule to maintain person-person contact with patrons requiring prescription and health-related products, confidence and trust has been generated which is able to overcome to a considerable degree competitive appeals based solely on price.
Where pharmacists have personal contact with pa- trons who require prescription and other health products and maintain medication records for them, experience has shown that these pharmacists have established a solid pharmacist-patient relationship. Usually this includes the physician as well. Providing pharmaceutical services to nursing homes, extended care facilities, small hospitals and other health facilities is a great challenge to pharma- cists. Here the interested pharmacist must be sure he has become knowledgeable and expert in new developments in systems, procedures, equipment and automation so that he can provide the necessary services in an efficient and economical manner. This must be done in line with good professional practice and so that the needs for drug se- curity, proper storage, control of distribution and, above all, the needs of the patients are met.
This means that the opportunity for the innovative, flexible pharmacist applying new ideas in providing phar- maceutical services is present. It means, in many cases, new patterns in practice and in management. Group prac- tice by pharmacists may be the answer in some situa- tions. Participation in neighborhood health centers estab- lished by health professions, by governmental agencies or jointly by government and professions will be the answer for some.
Third, we see great change in what constitutes the “practice of pharmacy” both in the hospital and com- munity setting. That is, the concepts of pharmacist-pa- tient involvement and of “clinical pharmacy” are assum- ing greater significance in the providing of complete health care to both hospitalized and ambulatory patients. It is doubtful whether pharmacists will be able to escape the full professional and legal responsibilities for which their education and training qualify them.
6
This pertains especially to the pharmacist’s duties and responsibilities to patient and physician in maintain- ing patient drug histories and utilizing the data in re- gard to possible drug interaction, drug over-utilization, maintenance of the prescribed drug regimen and in gen- eral providing prescriber and patient with appropriate in- formation, guidance and counsel about drugs.
Why else have a five or six-year education to produce a pharmacist?
Fourth, there are great pressures both within and outside of pharmacy for pharmacists to assume an on- going function in drug product selection. This has long been the established practice in the closed system of in- stitutional practice. The APhA and others in pharmacy and many in labor, the consumer movement, legislators and others are nevertheless embarked on the road to change the status quo of “antisubstitution” laws in the face of legal restraints and strong opposition from indus- try and organized medicine.
Fifth, the proliferation of “third-party” patients health insurance plans which more and more are including drug programs, is having a critical professional and economic impact on pharmacy.
Sixth, there is the growing acceptance of the in- evitability of a national health insurance plan which will include a drug program. It seems very likely, however, that we will have for some time a variety of sources of health care available to the public: the private, solo prac- titioner, group practice, health centers, the medical or hos- pital center. How these services will be financed will per- haps be determined in the next two or three years.
Seventh, the kind of supportive personnel to be used in pharmacy, their role and status will have to be re- solved. Crucial professional and economic considerations are involved which deeply affect all pharmacists—com- munity, hospital independent, chain, proprietor, manager, and employee.
The profession of pharmacy through its professional organizations must address itself to all these issues.
The Maryland Pharmaceutical Association has estab- lished a mechanism through its House of Delegates for voice for all pharmacists in the State in developing poli- cies in the issues outlined above as well as any other issues. When pharmacists join and participate in the affiliated pharmaceutical organizations, they are entitled to maximum representation. The various recognized and related groups including students also have delegates.
The organizational structure in pharmacy now has the machinery for “participatory” democracy in Mary- land. Let us act to involve every pharmacist and the en- tire drug industry in our State so that we accelerate the professional and economic advancement of pharmacy. Professional growth for pharmacy will inevitably result in the maximum contribution of pharmacy to more effec- — tive health care for all for the benefit of both profession and society.
—Nathan I. Gruz
THE MARYLAND PHARMACIST
Changes in Controlled Substances Act
The regulations concerning the Controlled Sub- stances Act were printed in the April issue of The Mary- land Pharmacist. The Bureau of Narcotics and Dangerous Drugs now announces the following changes:
—Patients’ address and prescribers’ registry number will not be required on the prescription label.
—The transfer warning label will not be required until
June 15, 1971.
—Paregoric will be in Schedule III but OTC sales will be permitted (where permitted by state and local laws).
—Prescription labels for Schedule II, III, and IV sub- stances must contain: a) Prescription number b) Name and address of pharmacy c) Name of prescriber d) Name of patient e) Date of dispensing f ) Directions for use and cautionary statements, if any. g) Transfer warning (after June 15, 1971)
—Stocks of labels with the old IRS registry number im- printed thereon may be exhausted. —Prescription filing: a) one file for Schedule II and one file for all other pre- scriptions providing Schedule III, IV, and V_ pre-
scriptions be stamped in lower right hand corner with red “‘C” at least one inch in height. or
b) one file for all controlled substances providing Sched- ule III, IV, and V prescriptions stamped as above, plus one file for all other prescriptions.
or
c) one file for Schedule II prescriptions, one for Sched- ule III, IV, and V prescriptions and one file for all other prescriptions.
Biomedical information on iape
The National Library of Medicine will make avail- able on subscription, magnetic tapes containing data from the Library’s computer-based Medical Literature Analysis and Retrieval System (MEDLARS). The tapes contain citations to the biomedical journal articles which are indexed to provide the data base for NLM publica- tion and information services. Tapes will be made avail- able in only the following format: 14” IBM 7094, 800 BPI, seven-track.
Purchase agreements are available from: Dr. Joseph Leiter, Associate Director for Library Operations, Na- tional Library of Medicine, 8600 Rockville Pike, Bethes- da, Maryland 20014, ATTN: Tape Purchase Agreement.
Offering Independent
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, Wels
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
Pharmacies... |
MAY 1971
Maryland Board of Pharmacy News
Pharmacy Changes
The following are the pharmacy changes for the month of April:
New Pharmacies
Montgomery General Hospital—Pharmacy, Edward C. Wilson, President, 18101 Prince Philip Drive, Olney, Maryland 20832.
No Longer Operating As Pharmacies
Princess Anne Pharmacy, Benjamin McAllister, Jr., Main Street, Princess Anne, Maryland 21853.
Joppa Rexall Pharmacy, Leon Levin, 1220 East Jop- pa Road, Baltimore, Maryland 21234.
Change of Ownership, Address, Ete.
Marvin Oed, Inc., Marvin Oed, President, (Change from Rutkowski’s Pharmacy ), 743 South Conklin Street, Baltimore, Maryland 21224.
Kay Cee Drugs, Irving Goldberg, President, (Change of Ownership from Leo Goldfeder, President to Irving Goldberg, President and change of address from 4009 Main Street. Formerly Metro Drugs), Main Street, Upper Marlboro, Maryland 20870.
Korvettes—Pharmacy, Marshall Rose, President, 1955 East Joppa Road, Towson, Maryland 21204; Kor- vettes—Pharmacy, Marshall Rose, President, 11800 Rock- ville Road, Rockville, Maryland 20850; Korvettes—Phar- macy, Marshall Rose, President, Governor Plaza and Ritchie Highway, Glen Burnie, Maryland 21061; Kor- vettes—Pharmacy, Marshall Rose, President, 5407 Balti- more National Pike, Baltimore, Maryland 21229. (change of ownership from Murray Sussman to Marshall
Rose ).
__ Penn-Dol Pharmacy, Donald Schumer, President, (Change from Individual Ownership to Corporation), 1133 Pennsylvania Avenue, Baltimore, Maryland 21201.
Notice—Board Exams
The Maryland Board of Pharmacy will conduct an examination for registration as Pharmacist at the School of Pharmacy, University of Maryland, 636 West Lom- bard Street, Baltimore, Maryland.
On Monday, Tuesday and Wednesday June 28, 29 and 30, 1971 The examination will begin at 8:00 a.m. each day.
Applications must be in the hands of the Board by Fri- day, June 18, 1971.
8
Financial Statement 1970 Fiseal Year
The following statement was received following pub- lication in the March 1971 issue of the “Maryland Phar- macist” of the Annual Report of the Maryland Board of Pharmacy 1969-70.
FINANCES
All funds of the Board of Pharmacy are deposited to the credit of the Treasurer of the State of Maryland, and disbursement covering the expenses of the Board are paid . by voucher by the State Comptroller.
STATE BOARD OF PHARMACY FINANCIAL STATEMENT
1970 Fiseal Year
Balance forwarded—July 31, 1969 Receipts—July 1, 1969 - June 30, 1970 Expenditures July 1, 1969 - June 30, 1970 Salaries and Per Diem of Board Members $2,047
$ 8,740 12,659
Operation Expenditures 4,303 6,350 Balance—June 30, 1970 $15,049 Transferred to General Fund Surplus $15,049 Amount forwarded—July 1, 1970 $
Effective July 1, 1970, balance of funds ($6,309) for 1970 fiscal year together with $8,740 reserve was trans- ferred to General Fund surplus as the result of the Board becoming a General Fund operation in lieu of operating under Special Funds.
Respectfully submitted, F. S. Balassone
Secretary-Treasurer
PHARMACY CALENDAR
June 5—School of Pharmacy Commencement Exercises.
June 11-13—6th Annual MSHP Hospital Pharmacy Sem- inar, Ocean City, Md.
September 7-12—31st International Congress of Pharma- ceutical Sciences of the FIP, Washington, D.C.
October 10-14—National Association of Retail Druggists Annual Convention, The Rivergate, New Orleans.
October 16-21—National Wholesale Druggists’ Associa- tion Annual Meeting, Century Plaza Hotel, Los. Angeles.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
THE MARYLAND PHARMACIST
sandentpn tee tener DiI
In 1970, Roche Laboratories broke with pharmaceutical industry tradition by being the first company to discontinue mass, unsolicited sampling of professional products. The Roche aim is to ensure the greatest benefit to the patient while meeting the professional needs of the pharmacist and physician. All are served best by proper handling of drugs. Better control of all aspects of drug distribution ensures the highest standards of health care for the patient, physician and community.
This policy reflects Roche interest in the general problems of pharmacy management, as well as the pharmacist-doctor, pharmacist-patient and pharmacist-community relations. There are many of your colleagues at Roche—practical profes- sionals in various management positions— yho help make the policies and provide the services hat help you meet the challenge of pharmacy today.
ROCHE LABORATORIES Division of Hoffmann-La Roche Inc. Nutley, New Jersey 07110
Baltimore Metropolitan Pharmaceutical Association
Meeting of April 22, 1971
{r. Vincent J. Lozowicki, Staff Assistant for Com- puauce, Bureau of Narcotics and Dangerous Drugs, was the reatured speaker at the April 22 meeting of the Balti- more Metropolitan Pharmaceutical Association held at the Kelly Memorial Building. Mr. Lozowicki explained the Federal Controlled Substances Act of 1970 which went into effect May 1.
Camp Glyndon Project
BMPA President Irvin Kamenetz then introduced Milton Friedman, chairman for the BMPA Camp Glyn- don Fund Raising Drive. This recreational facility for diabetic children suffered an estimated $30,000 damage at the hands of vandals in mid-April. The diabetic chil- dren pay no fee for their two week stay at the summer camp. Estimated cost of operating the facility is $125,000 per year provided by funds from the Maryland Diabetic Association and private donations. Collection cans and window streamers have been distributed to all community pharmacies. Replacement cans may be obtained by con- tacting the BMPA office or from Milton Friedman or Charles Spigelmire.
The drive which opened on Monday, April 26 will run for one month. It will be publicized on radio and TV and in the newspapers. It is hoped that the camp may be in use this summer.
Washington County Pharmaceutical Association
The Washington County Pharmaceutical Association met on April 21, 1971. Guest speaker was Dr. William J. Kinnard, Dean of the University of Maryland School of Pharmacy. Dean Kinnard spoke on continuing education programs at the school of pharmacy. Accompanying the Dean was Henry Seidman, Director of Continuing Educa- tion.
The first in a series of continuing education pro- grams for the area was held at the Washington County Hospital on May 2, 1971. Twenty three pharmacists from the area attended. Samuel Weisbecker, president of the Washington County Pharmaceutical Association wel- comed the group. Speakers included Mr. Henry G. Seid- man, Dr. Peter P. Lamy who spoke on Cough and Cold Remedies, Dean William J. Kinnard who spoke on Gas- trointestinal Preparations, and Dr. Ralph F. Shangraw who spoke on Dermatological Preparations.
Eastern Shore Pharmaceutical Society
The Spring Meeting of the Eastern Shore Pharma- ceutical Society was held on Sunday, May 2 at the Easton Manor Motel, Easton, Maryland. Guest speaker was Charles Tregoe of the Maryland Board of Pharmacy. Mr. Tregoe discussed the Controlled Substances Act of 1970.
A Continuing Education Program on O-T-C products was presented by the University of Maryland School of Pharmacy on Sunday, April 25 at the Easton Manor Motel.
10
Prince Georges-Montgomery County Pharmaceutical Association
17th Annual Installation of Officers
The Prince Georges-Montgomery County Pharma- ceutical Association held their 17th Annual Installa- tion Dinner on Saturday, April 17 at the Burn Brae Dinner-Theatre Club in Burtonsville, Md. Toastmaster for the evening was Edward D. Nussbaum. Past-Presi- dent Rudolph F. Winternitz received the A.Z.O. Dou- ble Star Award for Meritorious Service to Pharmacy. The award was presented by Coleman Levin, Supreme Directorum, Alpha Zeta Omega Pharmaceutical Fra- ternity.
The new officers of the association are: Honorary President, Samuel Morris; President, Martin Hauer; Ist Vice President, Edward D. Nussbaum; 2nd Vice Presi- dent, S. Ben Friedman; 3rd Vice President, Gabriel E. Katz; Secretary, Paul Reznek; and Treasurer, Michael Leonard.
Joint Meeting With Montgomery County Medical Association
The Inter-Professional Relations Committee of the Prince Georges-Montgomery County Pharmaceutical As- sociation, chaired by Gerald Dechter, arranged a joint meeting with the Montgomery County Medical Associa- tion recently to inform members of both organizations about the new Federal Drug Control Regulations.
Photo by Paramount Photo Service
Martin Hauer, incoming President of the Prince Georges’- Montgomery County Pharmaceutical Association (right) be- ing presented with the President’s gavel by Ben Mulitz, Vice President of District Wholesale Drug.
THE MARYLAND PHARMACIST
ed
Wm. W. Gullett, Prince Georges County Executive, signing a proclamation for National Pharmacy Week in Prince Georges County. Looking on are Prince Georges-Montgomery County Pharmaceutical Association members Gerald Y. Dechter, Oliver Tibbs and Paul Reznek. A similar proclamation was signed in Montgomery County by Stanley Kramer, County Councilman.
The meeting which was held at the N.I.H. Audi- torium in Bethesda, was conducted by Norman Stein, member of the Inter-Professional Relations Committee. Mr. Vincent J. Lozowicki of the Bureau of Narcotics and Dangerous Drugs was the speaker. He explained the new regulations and later answered questions from the floor. Sharing the podium were Dr. Robert Angle, President of the Montgomery County Medical Association and Rudolph F. Winternitz, President of the Prince-Georges-Mont- gomery County Pharmaceutical Association.
Women Physicians
There are 21,404 women physicians in the United States out of a total of 306,907. This figure represents 6.7% of the total as compared to Russia’s 75%. By the end of this decade, it is expected that women will com- prise 15% of the physicians in the United States. In West Germany today, 35.8% of new doctor graduates are female. However in Spain the percentage of female physicians is lower than that of the United States.
DID YOU HIRE A NEW PHARMACIST LATELY? ... OPEN A NEW BRANCH? ... GET ELECTED TO OFFICE IN YOUR SERVICE CLUB OR SOCIAL OR- GANIZATION? . . . BECOME ASSOCIATED WITH ANOTHER PHARMACY?
WE WOULD LIKE TO KNOW—AND SO WOULD OUR READERS. WHY NOT DROP US A LINE AT THE MPhA OFFICE TODAY.
MAY 1971
Medical Care Study Shows Unexpected Results
A recent mailing to all prescribers in Maryland out- lines the results of a study done by the Division of Medi- cal Services on “Cost Analysis and General Prescribing Patterns in Maryland.” A survey was performed on 10,628 prescriptions. (The State handles approximately 10,000 prescriptions on an average day.) Only four drugs were considered for the survey. The drugs selected were Peni- cillin G Buffered Tablets, 400,000 Units: ‘Tetracycline Capsules 250 mg.; Chloral Hydrate Capsules 500 mg.; and Prednisone Tablets 5 mg. An “inexpensive brand” category was established based upon prices considered reasonable for generic products as follows:
The following prices are per 100 tablets:
(1) $5.00 or less for Tetracycline 250 mg. (2) $3.50 or less for Penicillin G 400,000 U. (3) $2.50 or less for Prednisone 5 mg.
(4) $2.00 or less for Chloral Hydrate 500 mg.
There were 266 prescriptions (2.50% ) of the 10,628 prescriptions surveyed which could be included in the study. Of the 266, 236 were written in generic terminol- ogy or for an inexpensive brand as outlined above (ge- neric 206, inexpensive brand 30). The preceding figures show that 89% of all prescriptions analyzed were written generically or for inexpensive brands by physicians prac- ticing throughout the State.
After applying identical analytical techniques to pharmaceutical compliance patterns it was found that pharmacists filled 234 or 88% of the prescriptions ana- lyzed at relatively low State expense as determined by the criteria for inexpensive brand.
One unexpected result of this survey was the dis- covery of a disparity between the number of prescriptions written for expensive brand drugs, but whose cost was included in the inexpensive brand category. This appears to have been due to lower costs being passed on to the State by hospital pharmacies due to their high volume purchases.
Costs for drugs under the Maryland Medical Care Program for the year ended June 30, 1969 were $5,843.- 000. For the year ended June 30, 1970 this cost was $9,408,000.
Shoplifting Detection Guide
One of the nation’s fastest rising crimes—shoplifting —is the subject for a new educational guide specifically designed for the retail businessman.
The Shoplifting Detection Guide, fully illustrated, contains the latest recommendations to expose shoplifters and avoid shoplifting losses. This guide may be imprinted with the business’ name at the top of each guide. A multiple choice quiz comes with each guide for distribu- tion to the business’ employees. The employee would study the guide and return the completed quiz to his de- partment head or immediate supervisor.
This new guide is available at quantity prices with or without imprinting or at $1.95 each through Guardian Publications. 915 N.E. 125th Street, North Miami, Florida 33161.
The Student and the University The Need for Responsibility
William J. Kinnard, Jr., Ph.D. Dean, University of Maryland, School of Pharmacy
Reprinted from the Bi-County Pharmacist
While each succeeding generation of students down through the ages has been influenced by major political, sociological, or technological factors, it would seem that the most recent generation has assimilated these factors and developed a philosophy of life that has been unan- ticipated by their elders.
The average student of today comes from a different background than his parents. Most have had less religi- ous training, many have been raised in the Spockian man- ner (permissiveness), and they certainly have a stronger high school education. They are children of television; learning more vocabulary from TV than from their par- ents and spending more time before the set than in school attendance.
Many sociologists feel that these students have been
manipulated by society and by their companions — a product of the constant competition in their lives, from the nursery school through college — competing to be
the best in their class, competing to get the best grades, competing to be accepted into college, ete. According to Dr. Bruno Bettelheim, a noted social scientist, this has caused a loneliness in a vast group of students—isolated by their competition.
When one analyzes the makeup of a student body composed of this new breed, a number of types of students can be delineated:
1. The “typical” student-student—In this the larg- est group, the student is primarily in school to obtain the education offered by the various course sequences in the University. He or she is usually goal oriented and out- side social and political problems rarely cause this stu- dent to be sidetracked from that goal.
2. The “‘concerned”’ student—The use of the word, concerned, doesn’t necessarily emphasize that these stu- dents are actually more concerned about socio-political problems than the previous group, but is used simply to note that they show significant outward signs of this concern through their participation in various types of demonstrations. Their career goal is interspersed with a desire to correct the faults of our society. Leadership in this group is not well structured and quite often they will follow a certain pathway when urged by available leaders, whoever they might be. These students are not violent by nature.
3. The activist student—These students are extreme- ly active in attempting to change the establishment, par- tially or totally. There are those in this group who are constructively working to correct obvious faults. There are others that are working only to cause the collapse of our society’s structure, at any cost. In this latter group we see many subgroups: the vocal leader, one who ignites a crowd and then disappears when physical action results; the destructive element, that uses acts of violence to de- stroy the status quo. Some of these radicals have now gone underground to surface only when disruption is to occur.
12
Some, according to one author, have remained emotion- ally fixated at the age of the temper tantrum.
The campus thus presents a mosaic of student-types that display varying degrees of activism toward intra- and extra-school problems. From this collage has erupted demonstrations on:
The war in Indo-China,
The tenure system,
The grading system,
The killing of students at Kent and Jackson State,
The draft,
ROTC on campus,
The trials of the Black Panthers,
The low wages of maintenance workers on campus, and
The polluted environment.
These causes, sometimes different, sometimes related, blend into a series of demonstrations whose causative reasons often tend to be blurred in the minds of those observing from outside their ranks.
What about the university during this student evolu- tion and revolution? It has generally remained unshaken in its traditional concepts of its role in the educational process, perhaps attempting a test of the theoretical phy- sics problem of the immovable object meeting the irresist- able force.
The university is called a community of scholars; one that is hopefully free from political influence through a set of controls developed over the years involving boards of regents at State universities, the tenure system, etc. It has rapidly enlarged in the last twenty years as it ab- sorbed ever increasing numbers of students and in doing so quite often has not sufficiently altered some of its poli- cies to meet this physical onslaught of student numbers, as well as the mental onslaught caused by the often un- expected demands of these students.
Let’s look at some of the problems pinpointed by stu- dent demands.
1. The ability of the college teacher—Often in the first years of college students only see graduate assistants or professors who are buffered from the individual student by the vast number of his classmates. The professor, who by virtue of his Ph.D., has been apparently divinely appointed to the role of teacher; since he has usually had no training in educational techniques. Quite often his teaching skills are completely inadequate. In the sciences and professions, the Ph.D. may even teach grudingly since it takes him away from his research. These need to be corrected by improving teaching methods, attracting better teachers, bringing educational techniques specialists
into our schools, and by utilizing new audio visual tech- |
niques. The tenure system for teachers was designed to en-
sure that an individual would be free from outside pres-
sures, political and otherwise, so that he might teach with a fair degree of academic freedom. This system does have its faults since it can follow the perpetuation of a bad teacher until his retirement, a disadvantage probably
THE MARYLAND PHARMACIST
kor physicians and their patients
ED +TUE «VION «-SUN «-SAT <—- FRI
O©O
DAY os ue on > 24 + 25 26 = 27 28
OVRAL-28
21 white tablets each containing
0.5 mg. norgestrel with 0.05 mg. Balt estradiol
and / pink inert tablets
To order, contact your Wyeth salesman
or nearest branch.
® Wyeth Laboratories Philadelphia, Pa.
outweighed by the need for academic freedom. The selec- tion of those teachers granted tenure, however, is very important for the forementioned reason. In drawing up the guidelines for the granting of tenure, one must define what a teacher should be. Is he one who is well liked by his class and relates to today’s problems? Can he be that and nothing more? I think not! For while he is effective today, he must be expanding his knowledge through re- search to prepare himself for a time 10-20 years from now when again he must pass the test of practicality and rele- vance.
2. Grading systems—Pass or fail and other systems are being suggested by the students involved in this spring’s crisis. But what about next year, do we have an- other crisis and a cry of the pass or fail system again? Our present method of evaluation is not satisfactory and we do need to re-examine our academic programs and see how we can best evaluate student progress. But to move to a pass-fail system totally is moving toward the homo- genization of our student talent. This is a disastrous shift away from the search for excellence. You might recognize this as occurring in many areas of our society. Even the new work in health care is producing a system that will reduce the excellence of health care available to some of our society in order to develop the broad based structure of health care that is needed to cover all of our people.
3. Student participation in policy determination in the university—The University has been remiss in not listening to the voice of the student, but the degree of involvement is debatable. As an example, the State of New York opened a new university at Old Westbury, L. I. four years ago. It was set up to be a program in partnership with the student body. A recent analysis of the effectiveness of this concept has led to serious doubts as to the practicality of this concept. As an example, the original students on the committee for building design are gone and the new students are demanding that the original plans be junked and redesigned along their thinking. Students must have an input into policy mak- ing, but on most committees their voice can’t be a ma- jority or equal one to the faculty and adminisiration. The university must go on, long after the departure of any student no matter how gifted he or she is.
What does the University need to do to help correct the present situation?
The university must maintain a firm, yet reasonable, guidance of the students, it cannot yield to immature requests because this will simply lead to additional de- mands. The university must find ways to educate these students who have a different definition of self. Part of this can be accomplished through better teaching meth- ods, by the recognition by a teacher that he should be just that. The students should be allowed to speak about university policy and learn the ways in which it is de- termined. Education must also find a way to break the vicious circle of competition in which students are thrust, perhaps a change in the grading system could be a way that the intense competition would be partially relieved.
What must the students do? The large group of students that are in the student-student category must be activated, perhaps even radicalized. They must become more aware of problems and seek ways to solve them. In doing so they must provide constructive leadership to other students as a more logical alternate to anarchistic leadership and rebellion.
14
In conclusion, I would like to quote from an edi- torial in the Diamondback, the University of Maryland student newspaper, “. . . the institution called a univer- sity is the best friend students have in society. Nowhere else is idealism the counterpart of reality. Nowhere else may an individual speak, dissent, and argue to any point as freely as within the university. To destroy the very structure upon which these freedoms are built is suicidal and ultimately destructive to all of society.”
This quotation needs to serve as a basic fact around which the student body, faculty, and administration can build a more responsive and responsible university.
NABP Holds School For Drug Law Officers
The National Association of Boards of Pharmacy held its Fifth School for Drug Law Officers in Washing- ton, D.C. May 16-20. The School was made possible through a grant from the National Pharmaceutical Coun- cil.
Over 40 drug law officers, including Board of Phar- macy inspectors, secretaries, etc. attended the five-day session.
COMMUNITY
PUBLIC PHARMACIST
Rb Sula by
A CITATION HE DESERVES
THE MARYLAND PHARMACIST
There’s alot more going for you at LOEwy
Sheclvc PERSONALIZED SERVICE PLUS
provides you with the flawless backing of 100% computerization— along with the special personal follow-through of people who care
Drug wholesaling divisions of Spectro were among the first in the industry to know the unprecedented advantages of fully computerized warehousing and delivery service. But as a retailing-oriented distributor, we know, too, that nothing can take the place of personalized understanding and service follow- through. That’s why every one of us at the management, sales and service levels is vitally concerned about any phase of service that is of special concern to you. This happy combination of automation and personalization adds up to a quality and completeness of service that just isn’t likely to be matched through any other source.
Got a special supply, financial or service problem? Why not give us a ring during any working hour any day of the week. That’s one way you'll really know what we mean by personalized service. See why more and more retailers throughout the eastern seaboard are saying right out loud...
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
: king. (301) 485-8100 for office and daytime order taking. After hours, 485-8105 for order taking. (301) we ae a a aes
LOEWY DRUG COMPANY ey: Spectro SIndustotes, Ine.
6801 Quad Avenue, Baltimore, Md. 21237 Tel.: (301) 485-8100
Hospital Pharmacy Section
Maryland Society of Hospital Pharmacists April Meeting
The April 8 meeting was held at the H. B. Gilpin Co. in Baltimore. Earl Maseth, FDA Consultant to the Bureau of Drugs, Division of Industry Services, presented a slide-talk entitled ““What is your QA on Sterile Dis- posable Medical Devices”? Mr. Maseth pointed out that as consumer demands for better sterile packaging in- crease, so must the manufacturer’s controls increase in order to keep the Quality Assurance Quotient (Q.A. Quotient ) constant.
Robert Snyder announced that a copy of the “Sug- gested Guidelines and Principles for Pharmaceutical Services in Hospitals” and the Pharmacy-Nursing Liaison Committee statement on drug dispensing and administra- tion would be mailed out soon to all members. The Guidelines will also be mailed out to the Administrator
of each hospital in Maryland.
The Professional Practices Committee of the Mary- land Hospital Association will meet on April 20 and Henry Derewicz, our representative to this committee, will discuss, among other topics, implementation of the Guide- lines, development of supportive personnel, and pharma- cist consultation in the design of new health facilities.
Robert Snyder, Mary Connelly, and Tom Patrick, who were our three delegates to the Annual Convention of the ASHP in San Francisco, reported on that meeting. Nominated for President-Elect of the ASHP are Wendell Hill and William Hotaling. R. David Anderson was in- stalled as President.
Clarence Fortner reported on the Annual Seminar scheduled for June 11, 12, and 13. Dr. Peter Lamy, Pro- gram Chairman for the Seminar, reviewed the list of speakers and topics. Howard Sherman reported on the membership committee. Eighty-five non-member hospital pharmacists received a follow-up mailing from last year’s membership survey.
June Shaw announced that she was completing de- tails on the May 13 combined Maryland-D.C. meeting. Robert Snyder announced that he and Dr. Ralph Shan- graw had participated in Careers Day at the Community College of Baltimore on April 7. A display was arranged and brochures were available to the 11th grade students.
The following were accepted for membership: J. Ed- mond Stickell, Eaton Laboratories; Darlene F. McMahon. Student-Class of °71; James TerBorg, Student-Class of °71; and Marina J. Young, Student-Class of 71.
President Snyder thanked the speaker, Karl Maseth and thanked the Henry B. Gilpin Company for sponsor- ing the meeting. The meeting adjourned at 10:00 P.M.
16
SKIN TESTS
by Normand A. Pelissier
Skin tests are most useful in allergies caused by contactants and inhalants, but are becoming increasingly important in diagnosing and in regulating treatment of various systemic diseases; e.g. systemic fungus infections. The wheal and flare are characteristic positive responses, appearing within 5 to 15 minutes in specific allergic dis- orders. The tuberculin type of response develops slowly over a period of 24 to 72 hours.
(1) SCRATCH TESTS are performed in rows on the patient’s back or forearm. The scratches should be about 1 cm. long and 2.5 cm. apart. The skin surface should be torn rather than cut, without drawing blood. An allergen then should be ap- plied to each scratch.
(2) For INTRADERMAL TESTS, a tuberculin sy- ringe is fitted with a short-bevel 26 or 27 guage needle. A separate syringe and needle must be used for each test substance. Not more than 0.02 ml. should be injected.
(3) INDIRECT SKIN TESTING (PASSIVE TRANS.- FER) may be done when direct skin testing is not feasible (as in dermographism, ichthyosis, eczema ). Blood (5 to 10 ml.) is drawn from the patient and centrifuged. Using the 7th cervical vertebra as a landmark, the back of a nonallergic adult is marked off in checkerboard fashion and 0.1 ml. of the allergic patient’s plasma introduced at each test site. These sensitized areas may be skin-tested with the suspected allergens 2 to 4 days later, the contralateral side of the back be- ing used as a control.
(4) For PATCH TESTS, the suspected material is placed on a paper, gauze, or linen patch, applied to the skin by means of adhesive or cellophane tape and allowed to remain in place for 24 to 48 hours unless the patch unduly irritates the skin, in which case it must be removed at once. Com- mercial patches may be used, but in any event the material is kept in a closed covered system up
to 48 hours to promote penetration and to allow —
time for the delayed reaction to develop. The area must not be bathed. A great number of varia- tions of techniques have been proposed but none achieve total uniformity or standardization. For example, reactions in summer regularly exceed those of winter.
Examples of Commonly Used Skin Tests
BLASTOMYCIN
For diagnosis of blastomycosis
BRUCELLERGEN
For diagnosis of brucellosis
THE MARYLAND PHARMACIST
| |
COCCIDIOIDIN
For diagnosis of coccidioidomycosis
DICK TEST
For susceptibility or immunity to scarlet fever
FREI ANTIGEN
Test for lymphogranuloma venereum
HISTAMINE CUTANEOUS TEST
For nonfunctioning sensory nerves of the skin
MANTOUX TEST (old tuberculin, human ) For diagnosis of tuberculosis
MUMPS SKIN TEST ANTIGEN
Test for hypersensitivity to mumps vaccine
SeHIGKSCKST Test for immunity to diphtheria
TOXOPLASMIN
For diagnosis of toxoplasmosis
TUBERCULIN TINE TEST
For diagnosis of tuberculosis
TUBERCULIN, PPD (1st, intermediate & 2nd strengths) For diagnosis of tuberculosis
TRICHINELLA EXTRACT
Aid in diagnosis of trichinosis
Ref: Shelley, Walter B. “The Patch Test’ JAMA 200:170
(June 5), 1967
The Merck Mannual, 11th Ed. MSD Laboratories, Rahway, N.J., 1966
MSHP Announces Election Results
Recently elected to office in the Maryland Society of Hospital Pharmacists are the following: President-Elect- Normand A. Pelissier, Secretary-Dolores A. Ichniowski, Treasurer-Thomas E. Patrick, Board of Directors-Samuel Lichter and June H. Shaw. Sydney L. Burgee, Jr. con-
tinues to serve as a member of the Board.
Incoming President Mary W. Connelly and all other officers will be installed at the Society’s Sixth Annual Hos- pital Pharmacy Seminar in Ocean City, Md. June 11, 12, and/13, 1971.
Tolfnaftate (Tinactin) Preparations Change Status April 1
Preparations of tolnaftate (Tinactin) will become exempt from prescription order only status effective April 1. Pharmacists are cautioned, however, that even after April 1 it would be a violation of the Food, Drug, and Cosmetic Act to dispense on an OTC basis any tolnaftate preparations which bear the “prescription-order-only” legend on their package labeling—since adequate direc- tions for use and certain warnings would not be present on the “prescription-order” labeled stock.
MAY 1971
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available)
HR-10. .
Plans (Sole Proprietor-Partnerships ) Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
The United States of Mangini
Now, Mangini counts in 41 States! And we're counting with computers that deliver selective com- parisons, detailed cost factors and more customized information than ever before! Our experienced in- ventory teams are now covering more pharmacists in more areas across the country and doing it faster with the same, careful, guaranteed Mangini accu- racy. If your inventory service is not giving you the answers you need, you need Mangini. Write/call/wire for DESCRIPTIVE BROCHURE
MANGINI & ASSOCIATES, INC. 4850 W. Belmont Ave., Chicago, III. (312) 282-8181
11722 Studt St., St. Louis, Mo. 2760 W. Market St., Akron, Ohio 575 Savin Ave.,West Haven, Conn. 5501 Cherokee Ave., Alexandria, Va.
Dangers in the Misuse of Drugs By David A. Blake, Ph.D.
Associate Professor of Pharmacology University of Maryland School of Pharmacy
Presented at Community-University Day, Au- gust 2, 1970, University of Maryland, College Park, Md.
The drug problem with youth today is at least par- tially the result of their exposure to adults who have per- petuated the idea that the stresses of daily life require chemical relief.
Unfortunately, drugs are potential poisons. They possess the capacity to cause serious and sometimes fatal damage, although deaths caused by properly used drugs
are rare.
Some of the toxic effects of drugs are grouped into dose-related effects. The greater the dose, the greater the effect. Too much anesthetic may prevent a patient from waking up; an overdose of morphine or heroin may stop breathing. Such dose-related deaths can usually be avoid- ed if the correct amount of active ingredient is measured in the tablet or capsule (incorrectly referred to as “pills” ) and proper dosage given.
Pharmacists and the drug industry usually produce drugs that have the proper potency. Mistakes are rare due to an extensive training of personnel, high standards and quality control procedures.
The problem that sometimes arises is that not all people require the same dose of a drug to cause the de- sired effect without producing dose-related toxicity. Hu- mans are not like light bulbs that require precisely 120 volts to operate properly. The proper dose of most drugs for each individual varies widely among the population and also changes in the same individual. Consequently, when a person takes the “‘proper dose,” it may be too little or too much for him because the dose was the “proper average.” If the dose were too much in the case of digi- talis, the heart might flutter and stop. Too much anti- coagulant would cause serious internal bleeding. Certain drugs are legally available only with a prescription from an authorized prescriber because of this dosage problem.
This does not mean that drugs available without a prescription (over-the-counter or OTC drugs) are not dangerous. It does mean that there is less risk with these drugs. However, OTC drugs can produce serious toxicity if used improperly. For example, aspirin can cause ulcera- tion of the gastrointestinal tract especially in persons prone to peptic ulcer. Many cold remedies contain drugs capable of causing very high blood pressure, especially in persons with hypertension. It is apparent that the per- son who chooses to self-medicate with OTC drugs should seek the advice of a physician or pharmacist, or at least take care to read the label and precautions before using the drug.
Another hazard of self-medication stems from the fact that many drugs can change the action of other drugs. For instance, aspirin can cause serious internal bleeding in the patient who is taking anticoagulants.
18
Some nasal decongestants can interfere with the action of insulin in diabetics.
Drugs can also affect diagnostic tests and then pre- vent physicians from correctly diagnosing a _patient’s condition. For example, certain cough syrups can react with the thyroid tests so that a person would appear to have an overactive thyroid gland. Many drugs can change the blood sugar concentration to mistakenly suggest a diabetic condition.
Drug users can avoid these problems by adhering to the following “do’s and don’ts.”
e@ Always take prescribed drugs according to the directions and always finish the prescription unless di- rected to the contrary. Many persons erroneously assume they can stop taking antibiotics when they feel better and usually suffer a relapse.
@ Never take someone else’s prescription nor offer yours to another person. Both the drug and the dosage were selected for you based on many factors which you might not recognize.
@ Consult a physician or pharmacist before self- medication, regardless of how trivial you consider the problem. Even drugs as innocuous as the antacids can cause problems,
@ Tell the physician or pharmacist your symptoms and what other drugs you are taking.
@ Promptly report any side effects you were not warned about. Most serious drug reactions are preceded by tell-tale symptoms warning you to stop taking the drug or take another one to counteract the effects.
@ Ask your pharmacist if he keeps a personal or family record of your drugs. If he does not, try to find one that does. This is the only way to learn of incorrect combinations if you have more than one physician.
@ If you have any questions regarding the medica- tion or its effects, don’t hesitate to question the physician or pharmacist. Many times your query will alert them to mistakes. They are human and also busy.
@ Don’t try to get more refills than your prescrip- tion designates. For many drugs the law limits the num- ber of refills to 6; otherwise, the prescriber must be con- sulted to insure that your situation is still being checked and that the drug will be discontinued when no longer necessary.
® Keep the phone number of your local Poison Con- trol Center handy in case of an emergency involving in- gestion or contamination with drugs or household prod- ucts.
@ Since many ingestions of drug overdoses and other poisons are first treated by inducing vomiting, keep a one ounce bottle of Syrup of Ipecac in your home in a safe place. This can be obtained without a prescription from
THE MARYLAND PHARMACIST
a pharmacist. The poison control office can instruct you when and how to use this drug.
@ Finally, teach your children the proper respect for drugs. Don’t tell them that aspirin is candy when they are infants and then expect them to change their attitudes when they are older.
These suggestions, however, still do not insure drug safety. As foreign chemicals to the body, drugs can be- come antigens and cause various allergic reactions from skin rash to fatal liver damage. There is no way to pre- _ dict in advance who will become sensitized to a particular drug, although persons who have asthma or other aller- gies are more prone to drug allergies. Exposure to just the dust of penicillin tablets has caused reactions in al- lergic individuals. Drug allergy is a non-dose related
effect.
Other non-dose related effects of drugs include birth defects, cancer, and genetic mutations. One may wonder why these effects are not seen during animal testing and why they can not be recognized after they are used in humans, Thalidomide does not produce birth defects in most animal species, but the human is exquisitely sensi- tive. It took four years to recognize this drug as the cause of 7000 grotesquely malformed babies in Europe.
There are drugs such as aspirin and antihistamines that produce birth defects in animals. These drugs may not, however, produce the same horrible action in hu- mans. The question cannot be answered except by specu- lation, since it would be unethical to test these drugs on pregnant women. It is probably, however, that some of the many pregnancies that end in miscarriage or birth defect are the result of drug exposure during pregnancy. The safest practice is for women of child-bearing poten- tial to abstain from drugs unless they are absolutely necessary. Birth defects are produced during the first and second month of pregnancy.
Cancer is still an enigma in medical science. Many causes have been suggested but few proven. Certain drugs or closely related chemicals can produce cancer in ani- mals. At least one expert has stated that anything given at a high enough dose over a long enough period of time can produce cancer. Cigarettes are a good example of this fact, yet it took billions of smoker-years to establish the relationship scientifically. Certainly this unknown aspect of oral contraceptives is one of the reasons for the recent concern of indiscriminant and prolonged use of them.
Mutations, which are produced by alterations of the chromosomes—those tiny DNA fragments that carry all of the information necessary for proper growth, function and reproduction—have been caused by some drugs under experimental conditions. Most of the anti-cancer drugs produce chromosomal changes but this is to be expected. Surprisingly, caffeine and even certain tranquilizers have been found to cause alterations of chromosomes.
Actually the main reason for the removal of cycla- mate from soft drinks was that a breakdown product had been shown to cause mutagenic effects, not because it had been shown to cause bladder cancer in rats. The lat- ter effect was cited as the reason, because of a law speci- fying that food additives cannot cause cancer in animals. There is no law concerning the mutagenic potential of
drugs.
MAY 1971
The non-dose related toxic effects of drugs shows that every drug ingestion is associated with some risk regard- less of the drug, the patient, or the circumstances. The question, “Do the expected benefits outweigh the poten- tial harm?”, must be answered by the physician, prior to writing a prescription, or a drug user, prior to self- medicating.
The increased use of drugs among the youth intro- duce other hazards. Most heroin addicts die of liver disease, infections caused by unsterile injections, or of an overdose. Many “‘speed mainliners” experience temporary or permanent insanity. Kids that use “downs” have died of overdoses (0.d.’s), especially if they were drinking.
Some “acid heads” go on bad trips they wish they had never taken. And there are numerous reports of kids who sniffed too much model airplane glue and were as- phixiated. Presumably these people don’t practice ra- tional drug use or they would have decided that the po- tential for harm exceeded their whimsical and somewhat naive quest for a high, trip or whatever other psychoactive experience they sought.
Although its toxic capabilities are still being studied, marijuana represents a most disturbing and increasing practice of society—that of self-medication with tran- quilizing and mood altering drugs. Alcohol and nicotine fall into the same category but neither produce the hal- lucinations and aberrent behavior that can be caused by marijuana and the more potent form of Cannabis known
as hashish.
Medical science knows little of addiction or drug dependence except that many drugs that have desirable effects on the brain will eventually cause a craving and compulsion to continued use. Unfortunately the desire stays after the drugs are gone. Neither the possibility of dependence after prolonged use of marijuana nor its comparison to alcohol matters as much as why members of society resort to this cerebral masturbation.
Society with all its problems cannot be blamed. In- stead, drug abusers need to ask themselves what human good is served by this self-excision. In times past, people resorted to religion, family, or nature for relief from anxiety. While these “outs” may seem “square” and “straight” today, they don’t produce physical toxicity. In fact, dependence on them can be satisfying and reward-
ing.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
Measles—Mumps—Rubella Combination Vaccine Approved
A new, three-in-one vaccine against measles, mumps and rubella has been approved for marketing in the U.S. by the National Institutes of Health. Merck Sharp & Dohme, Division of Merck & Co., Inc., said supplies of its new combination vaccine, which has the trademark ‘M-M-R’, are expected to be available for use by physi- cians this June.
Simultaneous with the action on the three-in-one vaccine was the licensing by the N.I.H. of a double vac- cine for use against measles and rubella, also issued to MSD. The company said plans are now being made for marketing the new double vaccine.
Licensing of the vaccines, which comes after more than three years of laboratory and clinical testing, has just been announced by the U.S. Department of Health, Education and Welfare. Federal regulations for the vac- cines were established by the Division of Biologics
Standards in N.I.H.
The vaccines come at a time when the nation has nearly reached the halfway mark in its goal to immunize 48 million youngsters against rubella, and also when health authorities are warning against the rising inci- dence of regular measles.
The combination vaccines prompt essentially the same antibody levels as each vaccine administered sepa- rately. The single vaccines induced almost 98 percent antibody response for measles, 96 percent or more for mumps and 96 percent for rubella. In clinical trials, re- actions to the triple and double vaccines, including fever, have not occurred more frequently than with the single vaccines given alone.
MSD said the triple vaccine is designed to protect children against measles, mumps and rubella with a single injection in order to make vaccination more con- venient for parents and physicians and to spare children the discomfort of two additional injections.
The combined vaccines were developed by Drs. Maurice R. Hilleman and Eugene B. Buynak and their associates at the Merck Sharp & Dohme Research Labora- tories. This same group also developed the world’s first separate measles, mumps and rubella live virus vaccines.
In August, 1970, the NIH Division of Biologics Standards licensed the company to manufacture a double vaccine against rubella and mumps, which has been available to physicians since that time.
Measles, mumps and rubella are acute contagious diseases caused by different viruses that are usually spread by young children. Although measles is usually a harmless disease, it can be a serious health problem. In the past, it has accounted for several hundred deaths in children each year, as well as thousands of cases of en- cephalitis, which sometimes caused permanent brain dam- age in those afflicted.
Mumps, like measles, is usually regarded as one of the minor illnesses of childhood, and, for mumps, this is generally true. But in some children and many adult males, the clinical course of the viral infection may be quite painful and distressing. On relatively rare occa- sions, complications may include impairment of the brain, the ears, the eyes, the heart and the reproductive organs.
20
Rubella is generally a mild disease in children, but the virus may cause birth defects when it strikes preg- nant women. As a result, public health officials have stressed the need for widespread immunization of chil- dren as a means of reducing the number of potential carriers of the disease thus avoiding the exposure of pregnant women to the virus.
The last major outbreak of rubella occurred in the U.S. in 1964-65 and left in its wake some 30,000 fetal deaths and 20,000 children born with birth defects.
In connection with plans for marketing of the three- in-one vaccine in June, the company pointed out that this vaccine is indicated for use in children between the age of one and puberty, and that it probably fits best in the routine immunization program for well babies start- ing at twelve months. This is the age previously recom- mended for the administration of live measles virus vac- cine alone.
As with rubella vaccine alone, the triple vaccine is contraindicated for use in pregnant women or in women who may become pregnant within three months after vaccination. The company’s directions note that because the vaccine contains live rubella virus, it should not be used for routine immunization of adolescent and adult women. The vaccine is contraindicated in persons in whom any of the component vaccines are contraindi- cated. There are no known contraindications unique to the triple vaccine.
Parke, Davis Mails ‘‘Dimpled” Capsules
Pharmacists all across the country are receiving free “dimpled” gelatin capsules from Parke, Davis & Company. The empty capsules, trademarked ‘“Pre-Fit,” are being distributed to the company’s customers at no additional cost.
The main characteristic of the capsules—two slight indentations or “dimples” in the cap—are designed to prevent premature separation during shipment of han- dling. According to Romeo B. Franceschini, director of Parke, Davis’ industrial products division, the “Pre-Fit” capsules will eventually replace the company’s present gelatin capsules.
Retirement Sometimes Premature
People who are young for their years should not be retired at age 65, Dr. Irving S. Wright, an expert in arterial diseases, strongly advises. Routine involuntary re- tirement represents great loss to companies that have spent years and large sums of money in training a man.
Dr. Wright describes “a biologically young person” as one who “still has the ability to conceive, initiate, adopt, activate, and operate new ideas, including those of others, no matter how radically new they may be.”
Physically, the physician describes him as standing straight, and moving quickly. “His face is full of life, he speaks well and interestingly, and he is still an able ad- ministrator who is much liked by the people in his de- partment.”
THE MARYLAND PHARMACIST
| Mr. Pharmacist --
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE 3024 Greenmount Avenue Baltimore, Maryland 21218
MAY 1971
Grace Period Established For BNDD Registration
Notice Received From
UNITED STATES DEPARTMENT OF JUSTICE, Bureau of Narcotics and Dangerous Drugs,
Washington, D.C. 20537.
Because of unexpected problems in registering by May 1, 1971, previously unregistered practitioners, indi- vidual practitioners, institutional practitioners, importers and exporters including import and export brokers, the Bureau of Narcotics and Dangerous Drugs has found it necessary to allow a grace period on the requirement of a BNDD registration number by the above-mentioned in- dividuals and institutions until our Registration Branch is able to catch up with the backlog of new applications. Individual practitioners would include, but not be lim- ited to, physicians, psychiatrists, podiatrists, osteopaths, naturopaths, dentists, veterinarians and researchers who are attempting to obtain personal research registrations. Institutional practitioners would include, but would not be limited to, hospitals, nursing homes, pharmacies, pub- lic and private laboratories, public and private university research projects, and industry research operations.
Under this policy pharmacists may continue to fill practitioner’s prescriptions without a registration number providing that:
(1) They have exercised their best professional judgement to ensure that the practitioner is au- thorized to practice in the particular State, and; (2) all such prescriptions contain the following state- ment: “Federal registration applied for on (Date),” Current dealings with the applicant practitioner would be indicative of his present qualifications.
Manufacturers and distributors may sell schedule III through V controlled substances to practitioners without registration numbers providing that they satisfy them- selves:
(1) of the authenticity of the purchaser, and; (2) that this individual or institution normally would have been authorized to purchase such substances under the Controlled Substances Act had time per- mitted processing of their application. The following statement must be placed on all such orders: ‘“‘Fed- eral registration applied for on (Date) .” Here also, current dealings with the applicant practitioner would be indicative of his present qualifications.
The industry and the professions are expected to ex- ercise caution and good judgement when supplying con- trolled substances or filling controlled substance prescrip- tions of a non-registered individual. If there is any doubt, they should contact BNDD Regional Offices before filling controlled substance prescriptions or orders. (31 Hopkins Place, Room 955, Baltimore, Md. 21201 Tel. 962-2224)
All intern and resident physicians authorized by State law to make an independent judgement as to whether a controlled substance prescription is warranted in a particular case involving out-patients or patients leaving the hospital, may do so using the hospital BNDD registration number until they become registered person-
22
ally. However, such interns and residents must apply for Federal registration immediately.
This policy will terminate no later than 90 days from May 1, 1971, unless specifically extended. Intern and resident use of the hospital’s registration number terminates upon their personal registration or completion of their training period, or after the expiration of 90 days from May 1, 1971, whichever comes first.
For further clarification contact your nearest BNDD office. Sincerely, John Finlator Acting Director
Cancer Immunization Theory
A renewed interest in the theory that cancer is caused by a virus and can be brought under control by immunization has emerged from the laboratory findings of one of the nation’s foremost cancer research specialists at the Bronx Veterans Administration Hospital.
Dr. Ludwik Gross, senior medical investigator and chief of the cancer research unit at the Bronx VA Hos- pital, has reported significant results in the immuniza- tion of guinea pigs against leukemia.
The results of his laboratory experiments are cur- rently featured in the Swiss scientific journal Acta Hae- matologica and demonstrates that transmitted small strains of leukemia implanted in guinea pigs appear to result in successful immunization.
Dr. Gross’s experiments began by demonstrating that leukemia can be transmitted to healthy guinea pigs.
“All inoculated animals,” he said, “develop leu- kemia and die from the spread of this disease.”
Dr. Gross observed, however, that when small doses of leukemia cell extracts are inoculated superficially into the upper layer of the skin, small intracutaneous leu- kemic cell infiltrates develop at the site of the inoculation and that these resulting tumors in certain animals “re- gress spontaneously without a trace.”
In experiments carried out recently in his labora- tory, Dr. Gross reported that 42 per cent of guinea pigs inoculated intracutaneously with small doses of leukemic cells recovered spontaneously from intradermal leukemic tumors. The great majority of animals that recovered from intracutaneous tumors were found to be solidly im- mune to reinjection of heavy doses of leukemic cells.
These laboratory observations, Dr. Gross was careful to stipulate, have no application at present to either the prevention or treatment of leukemia in man.
The Paris newspaper France-Soir, in commenting on Dr. Gross’s experiments, stated, however, that his findings in guinea pigs were of fundamental importance since it demonstrated for the first time that active, specific im- munity against leukemia can be obtained in laboratory animals.
Although an ultimate development of a preventive leukemic vaccine in man may be still far off, Dr. Gross’s observations open an encouraging and hopeful possibility in the fight against the dreaded and mysterious disease.
THE MARYLAND PHARMACIST
‘Display the Bidette duo for tullmonth feminine hygiene ~
oa — - Over the past two years more : : —-. trtsts—isi‘COsCONO than 3 million packages of . Bidette have been sold to women, who not only want Bidette Mist for odor pro-
at feminine hygiene tection during normal days
...but also want Bidette | _ deodorant mist” | 7 Towelette for difficult days
: : when they wish to cleanse
as well as deodorize.
This year our expanded national advertising campaign will be sending more women than ever before into your pharmacy looking for Bidette. Display the Bidette Duo prominently so your customers can find them...and you’ll find your profits growing.
Youngs Drug Products Corporation ™ 865 Centennial Ave., Piscataway, N.J. 08854
INTIMATE FEMININE HYGIEN
Deodo ran Mist
INTIMATE PEMININE HYGIENE
Joseph L. Garde
Joseph L. Garde, President of West Wholesale Drug Company and Spectro Industries, Inc., will be honored at the Sixty Third Annual Convention of the Drug Sales- men’s Association of Pennsylvania on Friday, June 11, 1971 at the Westover Gulf Club in Norristown, Pennsyl- vania.
Mr. Garde was presented the Tower of David award in 1969 and in 1970 he received an award from the United Jewish Appeai while also being named “Man of the Year” by the New York Division of Pharmaceutical
Trade.
SALMONELLOSIS
Salmonellosis is an acute infectious disease with a sudden onset of abdominal pain, diarrhea and frequent vomiting which may last several days. Fever is nearly always present. It can be spread by contaminated food, or by person to person contact. The most likely sources of food infection are poultry, eggs, egg products, salads, meat, meat products, powdered milk and the feces of in- fected persons or animals. Large outbreaks in nursing homes or other institutions are usually due to contami- nation of food during processing in the institution itself. Although usually mild in healthy adults, the effects of Salmonella infection may be severe at any age, and death may result in the older and younger victims.
Although the outbreak at Gould Convalesarium be- gan Monday, July 27, 1970, it did not come to the at- tention of the Baltimore City Health Department until Friday, July 31, 1970. For this reason, tracing the disease with any certainty by food epidemiologists of the City Health Department was difficult.
To prevent a recurrence of such Salmonellosis inci- dents in the future, a telegram has been dispatched to all institutions stressing the importance of reporting all future communicable disease outbreaks to the Baltimore City Health Department within 24 hours as required by law and pamphlets and other information on Salmonel-
24
losis have also been sent. In addition a letter will be sent regularly each year to all Baltimore institutions which will remind them of the communicable disease reporting law. Other regular mailings will also remind institution personnel that to prevent Salmonellosis, eggs and poultry must be cooked sufficiently, work surfaces where chicken has been cut up must be thoroughly disinfected between each use and that food handlers must wash their hands before handling food and particularly after visiting the bathroom. It is also required that food handiers, if they feel sick, should avoid all hand contact with food and should not work.
Computer Tells Nature of Lethal Drugs, Helps Doctors Decide Correct Treatment
During the past 15 months 45 patients who have entered Suburban Hospital in Bethesda suffering from potentially lethal doses of barbiturates or other drugs have survived because a computer determined the na- ture of the drugs. Because of this the physician was able to administer the correct treatment.
When a patient takes a sufficient amount of drugs that may kill, the emergency room physician must act swiftly. He must try to reduce the concentration of the drug in the body in order to save the patient’s life and also to prevent irreversible damage to the brain or other vital organs. But frequently the patient is unconscious and there may be no indication of the drug imbibed, and the amount.
Recently the NIH National Heart and Lung Insti- tute reported a technique that, usually within an hour, can determine which drug or drugs the patient has in- gested, and approximately how much he took. This sys- tem may also help to determine whether the drug is still mainly in the patient’s stomach or in his bloodstream.
Their method uses gas chromatography plus mass spectrometry to analyze a sample of the patient’s stomach contents and/or blood. The gas chromatograph rapidly separates drugs from one another and also from normal components of biological fluids. As the pure compounds emerge, one by one, from the column of the gas chromato- graph, they enter the second part of the instrument; the mass spectrometer. Here the compounds are bombarded by electrons to produce a complex signal, called the mass spectrum, that provides a very precise “fingerprint” of the drug in question.
The NHLI scientists have collected the mass spectra of 80 of the most toxic common drugs and stored them in a computer. The mass spectrum of the unknown drug is read by the computer which then searches through this list to find a drug with the same spectrum or finger- print. The result is that, within about one hour, the physician is told what he needs to know about the drug taken by his patient. Now he can begin treatment to re- move the drug from the patient’s system.
The identity of the drug determines the treatment. In some cases, the use of an artificial kidney may be necessary. In other cases, dialysis of the peritioneal sac — or intestinal wall may be the treatment. With some drugs, however, such serious surgical procedures are either un- necessary or ineffective and the patient must rely upon his own system for detoxification.
THE MARYLAND PHARMACIST
odd orders processed, naturally
The oddball customer who insists he wants a print cropped “just this way.”
The man who wants cut film developed, or some positive film strips. The guy who hands your clerk an unheard-of cartridge of film.
Welcome them. They all mean good business.
Just drop the oddball order into the Berkey bag. We'll process it with the
same professional skill, care, and dispatch we apply to all our D and P work. Berkey’s special facilities and broad experience gives us a distinct edge in processing every kind of film. From unfamiliar foreign films to Ultra-miniatures in color
and black-and-white, right up to 16 x 20 black-and-white blowups.
We're ready to service all your needs. Berkey does things for
you that no one else does . . . because no one else can.
Berkey
Film Processing
of Washington, D.C. 3701 Mt. Vernon Avenue Alexandria, Virginia 22305
4 Olvisiow oF 703) 549-7500 Berkey ay ( Photo he Lee
Washington Spotlight For
Pharmacists by APhA Legal Division
Pennsylvania Statute Prohibiting Price Advertising of Prescription Drugs held to be Unconstitutional
The Pennsylvania Supreme Court recently held that state’s statute prohibiting the advertising of prices for prescription drugs unconstitutional.
The case arose from the revocation of a pharma- cist’s license by the State Board of Pharmacy after the pharmacist had placed newspaper advertisements listing prices for certain prescription drugs. The pharmacist ap- pealed and received a six month suspension instead of the revocation. A further appeal to the Superior Court resulted in this suspension being affirmed. The pharma- cist then took the next step and appealed to the Supreme Court of Pennsylvania, which reversed the lower courts and dismissed the complaint.
In its decision, the State Board advanced three rea- sons for upholding this statute:
(1) to keep prescription drugs out of the public eye and thus reduce their use.
(2) the impaired ability of the pharmacist to per- form his “monitoring function” since price ad- vertising would lead to increased shopping for prescriptions.
(3) pharmacists would be encouraged to buy in larger quantity which could result in deterio-
rated drugs being dispensed.
The court rejected these arguments finding that the prohibition of drug price advertising does not bear a “substantial relation” to the reasons advanced for up- holding the statute.
The argument that the advertising of such drugs would increase usage was rejected since they are obtain- able only on prescription. The court reasoned that the advertising prohibition disregards completely the profes- sional and ethical integrity of the medical profession in prescribing remedies for patients, and that it actually suggests the probability of unethical conduct.
The court distinguished prohibitions on price adver- tising of eyeglasses having previously upheld such pro- hibitions. The court concluded there is greater public protection in the case of drugs, because while eyeglasses could be sold by a retailer on his own authority, the pharmacist is not allowed to deviate from the prescrip- tion given to him. The court concluded that while eye- glasses damaging to the patient could be sold by a re- tailer subjected to price competition this could not occur with drugs.
The court did not believe that the diminished ability of the pharmacist to perform the monitoring function was a sufficient reason to sustain the advertising prohibi- tion, since no evidence was introduced at the trial to indicate the extent to which it is being done in Pennsyl-
26
vania. The court went on to indicate that even in those states where this rationale has sustained prohibitions of | this type, the courts involved have referred to this prac- tice as being “infrequent” and “not completely effective.” The Pennsylvania court went on to state, “it is primarily the physician’s duty to be certain that he is not prescrib- ing drugs antagonistic to those being taken by his pa- | tient.” The court also rejected the argument that the pro-— hibition of price advertising would prevent the dispens- — ing of deteriorated drugs. The court pointed out that the state’s Drug, Devices and Cosmetic Act as well as the Pharmacy Act attack this problem directly.
The court thus concluded that, “we thus find that the prohibition in question bears no substantial relation to any of the objects which the Commonwealth .. . assert were sought to be obtained . . . we are drawn to the conclusion that the statute is unconstitutional . . .”’.
A common thread throughout the court’s decision is the apparent attitude that a pharmacist functions less as a responsible health care professional than as a mere “seller of drugs.” Unfortunately, this viewpoint might well have been reinforced by the very circumstances of the case which the court was considering. In any event, “professional”? arguments were not bolstered by sufficient evidence in the court’s view. The case illustrates dra- matically that in the public view professionalism may be based not on degrees or licenses but on performance.
FDA Warns Drug Manufacturers to get Agency’s Approval Before Marketing Drugs
The Food and Drug Administration recently issued a word of caution to drug manufacturers introducing new products without their approval. The Federal agency indicated that it is seriously concerned about the intro- duction into the market of new products without submis- sion and approval throughout the “New Drug” (NDA) procedures of the Food, Drug and Cosmetie Act. The agency indicated that this is being done either through a misunderstanding of the legal requirements or a deliber- ate effort to avoid the NDA procedures.
The statement pointed out the fact that anyone in- troducing a new product, or an old product for a new use, or a new combination of old ingredients, or any other product that is or may be a “New Drug” must sub- mit an (NDA) and obtain approval prior to marketing the preparation. It was also pointed out that if a manu- facturer or distributor decide unilaterally that any such product does not require pre-marketing approval, he must recognize that he risks criminal and civil regulatory ac- tion as well as possible recall of the product from the market. Ornex and Epitrate are two products currently involved in an FDA-manufacturer dispute over whether they are subject to the NDA requirements.
THE MARYLAND PHARMACIST
First name in ice cream
for over a half-century ICE CREAM
675-6000
Be Smart! Stock the One and Only— Original “SAFETY TIPS”
Think Smart! Always Sell Them : Smart Users Ask For Them By Name
AMERICAN HYGIENIC CO.
111 S. Paca Street, Baltimore, Md. 21201
727-8328 Represented by IRV NORWITZ Phone 727-8328
AAY 1971 27
Poison Prevention Packaging Act of 1970 The Poison Prevention Packaging Act of 1970, will
require safety closures for packages containing various household substances. Included in the definition of house- hold substances are: hazardous substances, economic poi- sons, prescription and non-prescription drugs. This _re- quirement will go into effect as soon as appropriate closures are developed.
The following are proposed performance standards for safety closures for containers of solid-type medica- tions, developed by the Joint Industry—U. S$. Food and Drug Administration Committee on Safety Closures:
1. The closure should be significantly more diffi- cult to open initially and repeatedly (for the number of openings customarily required for its size and contents) by children under five years of age than the ordinary screw cap or snap-off closure.
2. Nearly all normal adults should be able to open and to properly reseat the closure without undue diffi- culty.
3. Instructions for opening and closing in clear
and legible form should be provided.
4. The closure and the container should be of such material and such design that it would preserve the efficacy and quality of the medication under use condi- tions.
5. A closure may be designated as a child-resistant closure providing the tests have been done under the protocol conditions described below, and providing further that the closure shall successfully resist the attempts of at least 65% of the children to open the closures without demonstrations and at least a total of 50% with and with- out demonstrations. In addition, at least 90% of the adults 45 years of age and under shall be able to success- fully open and reclose the closure before demonstrations, and at least a total of 95% of them shall be able to open and to close the closures after demonstration.
New Trial Ordered in Pharmacy Malpractice Case
The Michigan Court of Appeals recently held that a pharmacist who negligently dispensed a mild tranqui- lizer when the prescription called for an oral contracep- tive, with the result that a child was born to the couple, is liable to that couple for damages. The case was re- turned to the trial court for a determination of the dam- ages,
The husband and wife had decided to limit the size of their family and consulted a physician who telephoned a prescription for an oral contraceptive to the pharma- cist. He supplied a mild tranquilizer by mistake. The wife took the tranquilizer on a daily basis, assuming it to be the contraceptive, subsequently became pregnant and delivered a healthy child.
The complaint alleged four items of damage: (1) wife’s lost wages; (2) medical and hospital expenses; (3) the pain and anxiety of pregnancy and childbirth; and (4) the economic costs of rearing this eighth child.
The original trial court adopted the pharmacist’s argument that the damage suffered by the husband and
28
wife were offset by the benefit of having a healthy child and refused to allow the question of damages to go to the jury.
The Court of Appeals reasoned that while the “bene- fit-rule” can be used in the determination of the total damages, it should not as a matter of law be concluded that the services and companionship of a child, in every case, have a greater dollar equivalent than the economic cost of his support.
The court also ruled that the failure of the parents to seek an abortion or place the child for adoption not be a consideration in the determination of the damages.
Methadone Programs
The Committee on Alcoholism and Drug Dependence of The American Medical Association and the Committee on Problems of Drug Dependence of the National Re- search Council has issued a joint statement on metha- done maintenance programs.
While these recommendations are directed to the physician, the same criteria are applicable to a pharma- cist considering participation in such a program.
Pharmacists are also reminded that the methadone maintenance treatment of narcotic addicts program re- quires the advance approval of the Food and Drug Ad- ministration. Such approval may only be obtained on the basis of a Notice of Claimed Investigational Exemption for a new drug justifying such a program.
The NRC/NAS-AMA recommendations are as fol-
lows:
1. Methadone maintenance programs should in- clude at least the following elements in order to constitute proper medical practice:
a. adequate facilities for the supervised collection of urine and for frequent and accurate urine testing for the presence of morphine and other drugs,
b. general medical and psychiatric services, c. hospital facilities as needed, d. adequate staff,
e. rigid controls of methods of dispensing methadone to prevent diversion to illicit sale or to possible intra- venous use.
2. Care should be exercised in the selection of pa- tients to prevent the possibility of causing the person who has not been dependent on heroin to become dependent on methadone.
3. There would be continued evaluation of the long- term effectiveness of methadone programs for persons who are stabilized on an inpatient or an ambulatory out- patient basis.
4. Where feasible, staff members of new methadone maintenance programs should be trained in this tech- nique in an established effective program.
5. Continuing research is essential particularly wit reference to:
a. the use of properly trained practicing physician as an extension of organized methadone maintenance pro- grams in the management of those patients whose need for allied services are minimal. These patients should re
THE MARYLAND PHARMACIST
Reading
iS Still the fast
to program the man
h brain
IN
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
est way
—————_——
4
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
main in contact with the methadone maintenance pro- gram for periodic evaluation, including urine testing. b. the role of methadone maintenance in the treat- ment of heroin dependent patients under age 18 years. c. the use of methadone maintenance in combina- tion with other approaches to the treatment of morphine type dependence.
Methadone maintenance is not feasible in the office practice of private physicians. The individual physician cannot provide all of the services for the various thera- peutic needs of the patient. The individual physician also is not in a position to assure control against redistribu- tion of the drug into illicit channels, to maintain con- trol of doses, or to establish the elements for proper eval- uation of the treatment. Practicing physicians, however, should cooperate with methadone maintenance programs in their communities and offer whatever services they may be capable of providing.
Pharmacists are advised not to provide methadone outside of an authorized program, or in conjunction with an individual physician who is not acting in accordance with the recommended guidelines.
Prescription Program Fee Increases Announced
The Department of the Army recently announced that the CHAMPUS prescription fee has been increased to $2.00. This marks the second increase in the CHAMP- US prescription fee since April 1, 1970 when the fee was increased from $1.75 to $1.85. Details of the CHAMPUS program were published in the August 1970 issue of The Maryland Pharmacist.
The Medimet prescription drug plan of the Metro- politan Life Insurance Co. announced an increase in the program’s prescription fee to $2.00 effective May 1.
Chain Store Report
Drug chain sales continue to make sharp inroads into sales of all drug and proprietary outlets according to the April 5 NACDS Executive Newsletter. Last year, chain sales advanced about 14 per cent, close to double the increase of the total group. Market penetration by chains exceeded 34 per cent in 1970 compared with 32 per cent in 1969.
In 1971, sales are forecast to maintain their upward momentum and total close to $5 billion, 15 per cent higher than last year. In 1970, a disappointing year for retail sales, drug chains were an outstanding performer. Their sales gain was larger than that of any other major type outlet.
Albert Lowental, of Read’s Ine. will retire April 30, 1971 after almost forty years of continuous service in- cluding many years as an Officer and Member of the Board of Directors. After retirement, Mr. Lowenthal will remain a Member of the Board of Directors of Read’s. Inc.
30
Pariser Named as Read’s Pharmacist of the Month
Joseph Pariser, Baltimore pharmacist with Read’: Drug Store, Parkville Shopping Center, was recently named Read’s Pharmacist of the Month. Mr. Pariser was chosen for this honor because of his prompt action taker to save the life of a woman patient at his pharmacy. The patient complained of indigestion and asked Mr. Parise for a suggestion to relieve her discomfort. Mr. Parise recognized she was having a heart attack and quickly summoned an ambulance. She was admitted to a hos pital beacuse of an acute attack of myocardial infractior and is now making normal progress.
Mr. Pariser is a 1963 graduate of the University o Maryland School of Pharmacy and has been with Read’ Drug Stores since 1962. He is a member of the Maryland Pharmaceutical Association and the Alpha Zeta Omega Pharmaceutical Fraternity.
Wholesale Drug Companies Offer
Service To Pharmacists
On Thursday, April 8, fire in the pharmacy at Va ley Forge Medical Center in Norristown, Pa. destroyed much of the usable stocks for the Center’s 72 patients By the time the fire was out, it was 3:35 p.m., the day before Good Friday. DRUG HOUSE representative Rich ard Caranfa helped the Center’s pharmacists take stock four members of the Hospital Sales Department tran scribed the 300-item replacement order, and warehous personnel stayed overtime to fill the order that night Caranfa personally delivered it to the hospital by 8:01 o'clock the following morning.
This is what service is all about.
Obituaries...
Warren Louis Johnson
Warren Louis Johnson, 51, pharmacist at the D.C General Hospital and member of the Maryland Pharm ceutical Association, died April 11. He was a graduate o the George Washington University School of Pharma and is survived by his wife, 3 children, 2 brothers an his mother. He had reciprocated to Maryland from D.C in 1950.
Frank J. Grau
Frank J. Grau,59, died suddenly on April 16 whil playing golf with friends. Mr. Grau graduated from th University of Maryland School of Pharmacy in 1934. was a former Grand Knight in the Little Flower Council ¢ the Knights of Columbus and a charter member of tha council. Until 1958, he operated the pharmacy founde¢ by his father, George P. Grau, in 1907. At the time 4 his death he was employed by the Read’s Drug chain.
THE MARYLAND PHARMACIS
MERCUROCHROME
HW&D BRAND OF MERBROMIN
Minor injuries requiring first-aid treatment occur frequently during the vacation season. Neglect of these injuries may cause infections which frequently can be prevented by prompt use of Mercurochrome. When Mercurochrome is the routine antiseptic, minor injuries are reported more promptly, because treatment is not painful.
Include Mercurochrome in your first-aid supplies!
Detailed literature available on request.
HYNSON, WESTCOTT & DUNNING, INC.
Baltimore, Maryland 21201 <p>
(mM-6)
Two giant product shows
each year
Gilpin offers continuing programs of merchandising ideas to its customers. The highlights of this plan include our January product show featuring summer goods, and our July-August presentation emphasizing fall and gift selec- tions. Dates for this year’s fall and gift merchandise show are as follows: For BALTIMORE-WASHINGTON-DOVER:
JULY 18th-25th—Gilpin Baltimore Division, 7401 Pulaski
Highway, Baltimore, Maryland. For the TIDEWATER RE-
GION: AUGUST 1st-8th—Gilpin Norfolk Division, 6435 Tidewater Drive, Norfolk, Virginia. Please mark down these dates. We know you'll want to attend. Contact your Gilpin representative or Division Sales Manager for more details
and to make your appointment.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now. A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department. A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales. A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation.
Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
THE HENRY B.
GLLPIN
COMPANY
BALTIMORE + DOVER + NORFOLK « WASHINGTON
Fosacien ees yD
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company 901 Southern Ave., Washington, D.C. 20032 (301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
a pr ey |
Sirs: | am interested in the following programs. Please have your J representative contact me in this regard. i
Nane. = SS j
Name of Pharmacy j Adis SS eee Phone j CE ote ie
ae
maryland [= ~oharmacist
NATHAN SCHWARTZ
President Maryland Pharmaceutical Association
1971-1972
(See Page 12)
Volume 47 JUNE 1971 Number 6
Compliments of
\oxell
CORPORATION
Makers of NOXZEMA SKIN CREAMS NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your prescription patients may not know the difference ... but you do.
As a pharmacist, you know that neither brand name nor generic drugs are any better than the demon- strated reliability of their manufacturers. The im- portant thing to you and your prescription patients is not what the product is called but how expertly it is made.
Four generations’ experience in producing fine pharmaceuticals is one of the many reasons you can have confidence in Lilly products.
Eli Lilly and Company * Indianapolis, Indiana 46206 EZ
100218
Open season on stuffy noses
Winter viruses, spring 50 keep both Privine allergies, dragging “summer —__ Nose Drops and Nasal Spray
colds,” or autumn in mind. And hay fever—it seems keep them in there’s always stock. They’re
something caus- ing stuffy noses. But whatever the reason—what- ever the season-— Privine makes it “open season” on
Sey noses. ba ustomers want fast
relief. And that’s what Privine is famous for.
fast acting. And fast selling. And Privine is OTC.
CIBA Pharmaceutical Company Summit, New Jersey 07901
® ®@ Privine hydrochloride (naphazoline
hydrochloride)
2/4646 C I B A
The Maryland Pharmacist
NORMAND A. PELISSIER, Assistant Editor
NATHAN I. GRUZ, Editor 650 WEST LOMBARD STREET
VoLUME 47
BALTIMORE, MARYLAND 21201
JUNE 1971
ASSOCIATION
NUMBER 6
OFFICERS 1971-1972
Honorary President H. NELSON WARFIELD—Pikesville
6 President NATHAN SCHWARTZ—Annapolis
President Elect BERNARD B. LACHMAN—Baltimore
Vice President JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore, Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore STEPHEN HOSPODAVIS (1972)
Cresaptown PHILIP D. LINDEMAN (1973)—Berlin ANTHONY G. PADUSSIS (1973)
Baltimore MELVIN J. SOLLOD (1974)—Adelphi SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore
EX-OFFICIO MEMBERS
FRANCIS S. BALASSONE—Baltimore WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON—Baltimore
President NORMAN J. LEVIN—Pikesville
Secretary
F. S. BALASSONE—Baltimore
Member FRANCK BLOCK—Baltimore
Member HOWARD L. GORDY—Salisbury
Member MORRIS R. YAF FE—Potomac
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association aah etesteles ere Stephen Hospodavis VicegRresidentaae eae James Ritchie Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association
PreSWent- Bre naeiea eae eee eds Irvin Kamenetz President, Elect. o3% cess + Joseph U. Dorsch TT EQSUT Chor ride nels ots Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille Secretary and Executive Director Nathan I. Gruz
Eastern Shore Pharmaceutical Society
Presidentaee certs teeeee Philip D. Lindeman First Vice President........ Gordon Harrison Second Vice President..... William P. Smith SClelaryamientieieeriee ne cate teers Carl R. June LTOGSUTET Raseeter ce esisteniactac es Thomas Payne Honorary President ........ James W. Truitt
Prince Georges-Montgomery County Pharmaceutical Association
Presidentins. 2 cath. wees Nas Martin Hauer First Vice President ...Edward D. Nussbaum Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz WQCRa MING Aacienrthonkn dancer Paul Reznek LTCQSUTCTEtiis cleetnele aa ee Michael Leonard Honorary President .......... Samuel Morris
Washington County Pharmaceutical Association Bresigentarrencs tc ctor Samuel E. Weisbecker Vicew Presidente Joseph Davies eenae Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter
TESILCT LM eee Darlene F. McMahon Vicew President es en stein ne David Snyder SECTELAT Ya ee os civ oie ss eeletie oe Margaret Karsch LT CASUT Chatieies clocicise Coe cere aote Harriet Lee
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association President MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE Communications Secretary MRS. RICHARD R. CRANE Treasurer
MRS. CHARLES S. AUSTIN
Membership Treasurer
MRS. MANUEL B. WAGNER
TAMPA — Traveler’s Auxiliary of The Maryland Pharmaceutical Association President WILLIAM L. NELSON First Vice President PAUL J. MAHONEY Second Vice President JOHN MATHENY Third Vice President ABRIAN BLOOM Secretary-Treasurer WILLIAM A. POKORNY Assistant Secretary-Treasurer C. WILSON SPILKER Honorary President HOWARD DICKSON
Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER
Secretary
DOLORES A. ICHNIOWSKI
Treasurer
THOMAS E. PATRICK
University of Maryland School of Pharmacy Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for
changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
TABLE OF CONTENTS
Page Editorial—A New Era For Pharmacy in Maryland.... 6
Annual Report of the Executive Director—
Nathan Le Griz Bececcteee cece eee ae eiscnccoeecnreteucceseucces 8 Pharmacy Calendars cee ce ceettetceersecntsactres acters cers 10 Nathan Schwartz installed as President of MPHA......12 AZO PNAarmaCeutiCalls HLALCITILLY mew esssse vereesterteeess asec: 12 TEA MIP Ate NCW eirreterrrrecte cee creotenadesccnee ehtnesscocesesevtenersceissserases 12 HOSpital S Pharmacy. SCCUION we sreressecerstentiee ster tescceceeeses cence: 14 Maryland Board of Pharmacy NewWS. ..............cc:cesseee 16
Prince Georges-Montgomery County Pharmaceutical mASSOCIAUON mes cetecessesceercnereccceteveness 18
Pharmacology in the Clinically Oriented Pharmacy Curriculum—by David A. Blake, Ph. D., H. Patrick Fletcher, Ph.D., and
\eUbb Ewen) Ay Mebetetshdeh dpe, TOD), cccccnsatcanonccoccontohon 20 The Economics of Third Party Prescription Plans by. Mavens Jee Myers i) PHD iaee uecrs cocsercrcretere aces stees 24
INDEX TO ADVERTISERS
Page AbbDOttmelabpOratOrleSmesessersecr- tetreeerestccete ne seneercreres ic AMericaneDIUSPISLS #1NSULANCEs © Ommrnccsstcescrsesess:tetrearses 27 Borden-Hendlermlces Creager tee tee ees 19 Calverte Drugs COMpPAany we LU Cimeesececcersrccete crersreceesestes sae te 19 Cibas Pharmaceutical COMpanViercs.eceseset eee 4 Geioys Pharmaceuticals: se LnG ameter sre ceertiner erro eae 29 Henry 95s Gilpiny COMpAany merc cener reece nereeceserree 31 Me hillye ands COMPAan Vier eececonitce canis ces tesesnesestes 3 LOeCWYy= DIugs COMPA Yurrcsrerecnssesceseetecceeces nates saceeastenetoeces es 15 Manginisand sASSOCIALCS sal Gamera eset nereceseteseteeseaeaeneneets 32 MarylanGseNe WSeCOLIDET Verner reenter eee 23 Noxell§ Corporation Gem reece eect ee eee 2 Paramount PHOtOP Service wiicceccc. sss iseeg ve -cenveieenaaes eee 21
Pension and Investment Associates of America, Inc...22
AS eee RODINS | COMPANY wewicerete etre cere eee 13 Roche; Laboratories geese ee ecco tee cee eee ee 17 D. Stuart Webb Advertising Services oo... cccccecceeeees 22 VOUNSSE DITO Ss Products sCorporationims eee 11
Editorial...
A New Era For Pharmacy In Maryland
The 89th Annual Meeting of the Maryland Pharma- ceutical Association which was held on May 16 and 17, 1971, at the Hunt Valley Inn in Baltimore with recon- vened sessions at the Jamaica Hilton, represented the end of an era in the history of pharmacy in Maryland and the beginning of what we hope will be a dynamic new phase.
At this meeting, the House of Delegates was inaugu- rated as the policy making and legislative body of the MPhA. The composition of the House reflects the varied facets of pharmacy in Maryland: all affiliated and recog- nized pharmaceutical associations, the School of Phar- macy, the APhA-MPhA Student Chapter, as well as the MPhA officers and Board of Trustees.
Obviously, a great responsibility rests upon the newly elected Speaker of the House, Sydney L. Burgee, Jr., to assure that the House of Delegates will function as the authentic voice of pharmacy in Maryland. During the coming months, he will be charged with leadership in developing the By-Laws, rules and procedures required to translate the skeleton structure into a vigorous mecha- nism capable of fulfilling its mission.
The beginning of this new era is a time to place aside any lingering antagonisms within our ranks. Now is the time—long past due—to mobilize everyone in every area of pharmacy into a unified, cooperative posture. Organizationally, our priorities are membership expan-
sion, adequate financial resources and effective com- —
munications.
Programmatically, our priorities include legislation, prescription prepayment plans, new health delivery sys- tems and their financing, employer-employee relations, peer review, pharmaceutical education, ( undergraduate, internship, preceptors and continuing), supportive per- sonnel and public health information. There are, of course, many other important areas one must be con- cerned with. The extent to which MPhA can involve it-
self in the many issues and problems facing us and the |
effectiveness of MPhA in these areas will depend upon its organizational strength. The nature and extent of this strength depends upon achieving close to 100% support from the pharmacists of Maryland. With the attainment of support of this magnitude we can then realistically ex- pect the resources and staff to address ourselves to the myriad of matters crying for our attention. Such a total
mobilization of our potential can come only with more—
of our present members making a minimal contribution of their time to their profession. We have been fortunate that a number of dedicated pharmacists have sacrificed some time and efforts to advance pharmacy for the mutual benefit of all in pharmacy and most importantly for the benefit of our patrons and patients.
With the streamlined structure of a Board of Trus- tees and a House of Delegates and with the energetic and dedicated leadership of incoming President Nathan Schwartz, we look forward to the era now unfolding.
It can be—it must be—the beginning of a new, vigorous spirit of subordinating personalities to the great
and noble goals of MPhA: representing and advancing:
pharmacy as a profession constantly working to assure better health for all. —Nathan I. Gruz
THE MARYLAND PHARMACIST
SELSUN BLUE
the anti-dandruff shampoo
It’s elegant. It’s ethically promoted. And it keeps her hair in the clouds.
It isn’t often that a product combines the best of two pos- sible worlds—-the effectiveness of a professional product with the elegance of a cosmetic = specialty. . It’s even rarer when that product is offered only through ethical drug channels. On both counts, Selsun Blue is an exception. : TM—Trademark.
It’s an elegant, effective product that physicians and pharmacists are highly recommending. And customers love the
way Selsun Blue billows up into clouds
of gentle, luxurious lather . . . leaves their hair sparkling clean . . . while
helping to control dandruff symptoms.
We hope you're getting the
business that’s rightly—-and cc) exclusively— yours. 102294
Maryland Pharmaceutical Association
89th Annual Convention
Report Of The Executive Director Nathan I. Gruz Hunt Valley Inn, May 17, 1971
Mr. President, Members and Guests,
This is my tenth annual report to the membership in my capacity as Executive Officer of the Maryland Pharmaceutical Association, the state professional society of pharmacists, as it approaches 9 decades of dedicated service to advance the health of the citizens of this state.
I am most appreciative of the support that sincere committed pharmacists and members of the allied drug industry have given to the Association and to me per- sonally. We must henceforth put aside all destructive, distracting divisiveness and concentrate on constructive use of our time, our energies and our resources. Let us henceforth utilize the best at our disposal, rather than search for the ideal—the perfect Moses to lead us out of the wilderness.
A great deal has happened in the past decade—revo- lutionary changes in our society—revolutionary changes, therefore, in pharmacy as well.
During the past decade we have seen the following patterns in pharmacy service emerge:
First, we see a greater role for institutional phar- macy concomitant with the growth of the hospital as the source of an increasing percentage of the total services of the current health delivery “system”. This has come about for a variety of reasons, including population shifts, decline in availability of general practitioners and need for specialized equipment, facilities and personnel.
Second, there is the decline of the small independent neighborhood pharmacy, the relative growth of the “large independent” and explosive growth of chain (including discount and supermarket ) pharmacy. Nevertheless, many independents whe have emphasized personalized relation- ships with their patrons have been able to retain their loyalty in the face of the most severe competitive chal- lenges. Where pharmacists have made it a cardinal rule to maintain person-person contact with patrons requiring prescription and health-related products, confidence and trust has been generated which is able to overcome to a considerable degree competitive appeals based solely on price.
Where pharmacists have personal contact with pa- trons who require prescription and other health products and maintain medication records for them, experience has shown that these pharmacists have established a solid pharmacist-patient relationship. Usually this includes the physician as well. Providing pharmaceutical services to nursing homes, extended care facilities, small hospitals
and other health facilities is a great challenge to pharma- cists and offers them rewarding professional opportuni- ties. Here the interested pharmacist must be sure he has
become knowledgeable and expert in new developments in
systems, procedures, equipment and automation so that
he can provide the necessary services in an efficient and economical manner. This must be done in line with good
professional practice and so that the needs for drug se- curity, proper storage, control of distribution and, above
all, the needs of the patients are met.
This means that the opportunity for the innovative,
flexible pharmacist applying new ideas in providing phar-—
maceutical services is present. It means, in many cases, —
new patterns in practice and in management. Group prac- tice by pharmacists may be the answer in some situa- tions. Participation in neighborhood health centers estab- lished by health professions, by governmental agencies or jointly by government and professions will be the answer for some.
Third, we see great change in what constitutes the “practice of pharmacy” both in the hospital and com- munity setting. That is, the concepts of pharmacist-pa- tient involvement and of “clinical pharmacy” are assum-
ing greater significance in the providing of complete |
health care to both hospitalized and ambulatory patients. It is doubtful whether pharmacists will be able to escape the full professional and legal responsibilities for which their education and training qualify them.
This pertains especially to the pharmacist’s duties and responsibilities to patient and physician in maintain- ing patient drug histories and utilizing the data in re- gard to possible drug interaction, drug over-utilization, maintenance of the prescribed drug regimen and in gen- eral providing prescriber and patient with appropriate in- formation, guidance and counsel about drugs.
Why else have a five or six-year education to produce
a pharmacist?
Fourth, there are great pressures both within and outside of pharmacy for pharmacists to assume an on- going function in drug product selection. This has long been the established practice in the closed system of in- stitutional practice. The APhA and others in pharmacy and many in labor, the consumer movement, legislators and others are nevertheless embarked on the road to change the status quo of “antisubstitution” laws in the face of legal restraints and strong opposition from indus- try and organized medicine.
I would strongly recommend that we take the steps necessary to enable Pharmacists in Maryland to choose the drug product to dispense pursuant to a prescription.
Fifth, the proliferation of “third-party” patients health insurance plans which more and more are including drug
THE MARYLAND PHARMACIST
programs, is having a critical professional and economic impact on pharmacy.
Sixth, there is the growing acceptance of the in- evitability of a national health insurance plan which will include a drug program. It seems very likely, however, that we will have for some time a variety of sources of health care available to the public: the private, solo prac- titioner, group practice, health centers, the medical or hos- pital center. How these services will be financed will per- haps be determined in the next two or three years.
Seventh, the kind of supportive personnel to be used in pharmacy, their role and status will have to be re- solved. Crucial professional and economic considerations are involved which deeply affect all pharmacists—com- munity, hospital independent, chain, proprietor, manager, and employee.
The profession of pharmacy through its professional organizations must thave the decisive voice in all these issues.
The Maryland Pharmaceutical Association has estab- lished a mechanism through its House of Delegates for voice for all pharmacists in the State in developing poli- cies in the issues outlined above as well as any other issues. When pharmacists join and participate in the affiliated pharmaceutical organizations, they are entitled to maximum representation. The various recognized and related groups including students also have delegates.
The organizational structure in pharmacy now has the machinery for “participatory”? democracy in Mary- land. Let us act to involve every pharmacist and the en- tire drug industry in our State so that we accelerate the professional and economic advancement of pharmacy. Professional growth for pharmacy will inevitably result ‘in the maximum contribution of pharmacy to more effec- tive health care for all for the benefit of both profession and society.
In order to attempt to meet these changes, we have made some progress, and we have had some successes. But we must admit there is much more remaining to be done.
What are some of these accomplishments?
The highlight of this past year—and indeed—of the MPhA’s history in the context of its contribution to the advancement of a unified organizational structure for pharmacy has been our affiliation with the American Pharmaceutical Association, our national professional society.
There are now 16 affiliated states, comprising more than 50% of the pharmacists of the nation. There are at present several more states involved in negotiations with
APhA.
We are proud, too, of the completion of the affilia- tion of all existing local pharmaceutical associations with MPhA—an important and essential attainment.
These two accomplishments are the result of long years of work by many devoted members of MPhA in overcoming many obstacles. I am gratified that these two goals which I set forth 10 years ago are a reality today, and I wish to thank the leaders of MPhA together with those of the Allegany-Garrett, BMPA, Eastern Shore, Prince Georges-Montgomery and Washington County Pharmaceutical Associations who have had the broad
\JUNE 1971
vision to recognize that strength and effectiveness must be based on a foundation of reciprocal relationships and coordinated efforts and were willing to lay aside local considerations for the mutual good of all of pharmacy in Maryland and in the nation.
Secondly, we have adopted the framework for a more effective organizational structure and a capability for greater participation by our constituents and allied groups through a Board of Trustees and a House of Dele- gates. This is now being implemented. There is much that has to be done in proper and complete implementa- tion, and this will be our objective during the coming year. It will take time to set up all the procedures re- quired for proper functioning.
Legislation, Medicaid, third-party payment plans, professional and economic seminars, public relations and information activities all are reported on at this Annual
Meeting.
In addition to our public health activities in the areas of Diabetes Detection and Poison Prevention, we are launching an extensive community wide campaign in Venereal Disease Education. All these projects serve to more strongly identify pharmacy with service to the health needs of the community.
In reference to legislation, the Pharmacy Law of Maryland, although far from completion or perfection, is the result of a tremendous amount of work by MPhA —hboth volunteer and staff. Some of the provisions are vital in maintaining a professional posture. We will have to be alert to sustain the integrity of the basic ele- ments of this vital legal mandate. At the same time, we will have to press vigorously forward on legislation re- quired to strengthen our professional disciplinary ma- chinery.
In implementing some of these changes, greater sup- port—not lip service—will have to be given to PHARM- PAC, the Pharmacists Political Action Committee, which is an independent group with objectives vital to all in
pharmacy.
We are concerned—and must be more involved—in the educational structure for educating pharmacists. Im- portant and long overdue progress is being made in bringing pharmaceutical education into the mainstream of emerging patterns of health care delivery systems. Hip, hip, hurrah for the progress in eliminating the fias- co called the “practical experience requirements” and its substitution by a professional type of supervised precep- tor system for pharmacy students.
This year progress was also made in the inclusion of our exhibit in the scientific section of the State Medical Society’s Annual Meeting. The theme of the pharma- cist’s contribution to better patient care through patient medication records is one which all of us must hope will be put into operation by all pharmacists as a recognized essential part of the practice of pharmacy.
A happy note, too, is the improvement in the publi- cation schedule of “The Maryland Pharmacist,” which is now almost current. However, it is recognized that com- munications need great improvement, and that must be advanced during the coming year.
In addition the Maryland Pharmacy Foundation has been activated with the goal of launching a campaign to complete the work associated with the Swain Model
9
Pharmacy and the Cole Museum. All in pharmacy will be contacted this year. Please give this your attention when you receive the brochure being prepared under the direction of Dr. Samuel Fox.
There is much to be done during the coming year and during the next five years in all the areas of vital concern to our members. We have professional, economic and management interests which we can only address ourselves to when certain prerequisites are met. These are:
1. By encompassing the great majority of the phar- macists of the state as members.
2. By operating on a budget which can realistically finance the required programs and the staff sufficient to implement these programs.
The leaders and the members of MPhA will have to develop and support the plans for enlarging our mem- bership and obtaining greater sustaining membership commitments, more advertising participation and more convention support.
In the critical area of membership solicitation, it may well be necessary to use a field representative. This has been the crucial factor in all the states experiencing dynamic membership growth.
If we are to make a radical breakthrough in the fields of prescription insurance plans, health planning,
legislation, Medicaid, public health, employer-employee relations, pharmacy management, proper communica- tions, etc. etc., we will have to have the numerical strength and the financial resources to do the job.
Will all of you help your new leaders and me to get the show on the road this year?
This is our challenge for 1971.
Your actions—not words—in the days and months ahead will be the test.
PHARMACY CALENDAR
September 7-12—31st International Congress of Pharma- ceutical Sciences of the FIP, Washington, D.C.
October 10-14—National Association of Retail Druggists Annual Convention, The Rivergate, New Orleans.
October 16-21—National Wholesale Druggists’ Associa- tion Annual Meeting, Century Plaza Hotel, Los Angeles.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
Photo by Paramount Photo Service
THE MARYLAND PHARMACEUTICAL ASSOCIATION RECENTLY INSTALLED THE
FOLLOWING OFFICERS: (left to right)
Donald O. Fedder, Chairman, Board of Trustees, Baltimore; Morris Lindenbaum, Treasurer, Reisterstown; H. Nelson Warfield, Honorary President, Pikesville; Nathan Schwartz, President, Annapolis; Bernard B. Lachman, President Elect, Baltimore; John R. McHugh, Vice President, Potomac; Nathan I. Gruz, Executive Director,
Baltimore.
THE MARYLAND PHARMACIST
| |
|
a Clean up..with>
wash-Up -
Your pharmacy can
make real profits by displaying Wash-Up pre-moistened,
towelettes in the proper place inside your | store. Wash-Up’s have | SO many uses that they make a great impulse buy... especially when you display them in your | party and picnic goods area. Be sure you don’t hide this premium
profit product:.. put it in the right place and you'll start to clean up...yourself.
vy
™ Rete Drug Products Corporation 865 Centennial Avenue Piscataway, New Jersey 08854
Bees ie
NATHAN SCHWARTZ
President Maryland Pharmaceutical Association
Nathan Schwartz, Annapolis pharmacist, was in- stalled as president of the Maryland Pharmaceutical As- sociation at its 89th Annual Meeting.
Mr. Schwartz, who was on the Maryland Pharma- ceutical Association Executive Committee, for four years, Convention Chairman and Chairman of the MPhA Medi- caid Committee, is a 1943 graduate of the University of Maryland School of Pharmacy. During World War II he served in the U. S. Maritime Service for almost three years. He is the proprietor of the South River Pharmacy in Edgewater. He holds membership in the American Pharmaceutical Association and the Baltimore Metropoli- tan Pharmaceutical Association.
He has been on the Board of Governors of Kneseth Israel Synagogue for over 16 years, serving as its young- est elected president in 1960 and 1961. He is currently Chairman of the Israel Bonds Committee for Annapolis. He is also a member of the South Anne Arundel Busi- nessmen’s Association.
Mr. Schwartz is married to the former Norma Lee Stein and they have two children: Steven, a junior at the Pennsylvania College of Optometry and Susan, a senior at the University of Maryland.
A.Z.O. Pharmaceutical Fraternity Kappa Chapter
New officers of the AZO Pharmaceutical Fraternity ae Chapter and the Ladies Auxiliary were installed on Sunday, June 6 at the Hunt Valley Inn in Cockeys- ville. They are as follows.
Directorum—Jerry Freedenberg
Graduate Sub-Directorum—Henry Leikach Undergraduate Sub-Directorum—Steve Bierer Excheque—Jerry Cohen
Recording Signare—Alan Stoff
Corresponding Signare—Steve Buchner Bellarum—Dennis Klein
Executive Unit: Paul Zucker, Steve Tompakov,
Kelvin Levitt, Henry Seidman, Sam Block, Morris Schenker.
Auxiliary Officers for 1971-1972 President—Vicki Buckner Vice President—Norma Samson Corresponding Secretary—Iris Bierer Treasurer—Rozzie Stoff
Three new members from the School of Pharmacy were welcomed into the fraternity. They are: James
Kessler, Barry Hecht, and Arnold Kaplan.
12
LAMPA News
CONVENTION TIDBITS
Breezewood
The rain drops kept falling on our heads—and con- sequently LAMPA’s tour of the garden and museum of the Alexander B. Griswold estate was called off. How-— ever, we have been given a “rain check” for a future date.
Art Exhibit
Our first art exhibit took place in the Noxell Suite of the new Hunt Valley Inn on Sunday, May 16, 1971. Eight local lady artists, including two LAMPETTES, Camilla Ogrinz and Arlene Padussis, exhibited. While the artists claimed amateur status, their work appeared to be quite professional. An interesting feature was the ex- planation each artist gave about her particular paintings, how they came about, problems surmounted and for whom they were painted.
Arnold Zenker
Just as he does on TV, Mr. Zenker charmed his live audience of LAMPA and TAMPA members. He told several very amusing stories of his experiences while in- terviewing guests. The serious side of his personality re- ceived equal time too, as he stressed the fact that times have changed and are continuing to change, even though each of us may prefer some particular facet of the past to remain the same. He was thought provoking, and his “show”? seemed to end much too soon. If you are curious as to the subject about which he receives most questions, during his personal appearances, check with a member that attended.
Annual Business Meeting
President Dora Rockman presided and judging from the yearly reports, we are doing well.
Our dues have been used to enhance attendance at our meetings through interesting programs and givea- ways. We earned that if a member attended the last three meetings (Fall, Spring and this Convention) she received almost double her annual dues, in gifts. Natural- ly, this does not include whatever information and pleas- ure she derived from attending. A shimmering, wiggly, metal gold fish, at the end of a chain, was LAMPA’s gift to members attending their 18th annual meeting.
LAMPA OFFICERS FOR 1971-72
President jet vatwtrcst rene eee Mrs. Louis M. Rockman Treasurer ®s/fa. cen Mrs. Charles S. Austin Membership Treasurer .............. Mrs. Manuel B. Wagner Recording Secretary ©2...c-ccr01rcces Miss Mary DiGristine Communications Secretary............ Mrs. Richard R. Crane
Executive Board Mrs. Frank Block Mrs. Kenneth L. Mills Mrs. Charles J. Neun Mrs. John G. Cornmesser Mrs. William A. Pokorny Mrs. Harry L. Schrader Mrs. George S. Stiffman Mrs. Anthony G. Padussis Mrs. Milton A. Friedman Mrs. Nathan Schwartz
Ann Crane / Communications Secretary —
THE MARYLAND PHARMACIST
|
Robitussin
(GLYCERYL GUAIACOLATE)
ee
»
. _Stockupon . the best sellers
_and put your
facings where your pr ofits are! facings they have earned. Your Robins Representative will be around to see you
*
&
(Deal runs July 1August 31)
i a aaa I Sai 1S
i
VSO enone ceeeseeste tie
@
summer deal starts July? “~ includes 4” and7™ sizes | \\\,
ao Again this summer you can stock up on Robitussin and oy} Robitussin-DM at special low deal prices. Last year, drug store sales of these two cough preparations increased 8%, while the market was up only 1%. These increases were recorded in chains and in small, medium, and large inde- pendents. Robitussin and Robitussin-DM alone now hold a big 10% share of this $100,000,000 market. They are also the most heavily prescribed cough syrups sold OTC with over 2 million scripts filled annually. In fact, Robitussin is the only OTC cough medicine among the 200 most prescribed drugs. In spite of all this Rx volume, some 71% of all Robitussin and Robitussin-DM business is OTC. Stock up heavy on these two leading cough preparations while they’re on deal by ordering more of the 4-ounce and a good supply of the 7-ounce size. And don’t overlook Robitussin®-PE. It’s moving up fast in scripts and OTC sales.
You know these products are going to move off the shelf, so give them the
soon. Buy ’em while it’s hot for extra fall and winter profits.
- A. H. Robins Company, aichnche: Va. 23220 A-H-[20 BINS
Hospital Pharmacy Section
Maryland Society Of Hospital Pharmacists Meeting of May 13 and May 27, 1971
Members of the Maryland Society of Hospital Phar- macists met at Schraft’s Colony Inn for a joint meeting with the D.C. Society of Hospital Pharmacists on May 13, 1971. The social hour and dinner were sponsored by the Organon Company.
Guest speaker for the evening was William J. Don- nelly, Jr., Chairman of the D. C. Bar Association’s Com- mittee on Medico-Legal Matters. His speech was entitled “Hospital Pharmacy and the Law.” A short D.C. Society
business session followed.
The Maryland Society of Hospital Pharmacists met on May 27, 1971 at Mercy Hospital in Baltimore to make final amendments and to approve the proposed re- vision of the Constitution and By-Laws. Present at the meeting was Mr. Jules Lichter, attorney, who has been actively involved in the Constitution and By-Laws re- vision.
Guidelines For Hospital Pharmacy Services Distributed
A booklet entitled “Suggested Principles and Guide- lines for Pharmaceutical Services in Hospitals” has re- cently been printed and distributed under the co-sponsor- ship of the Maryland Society of Hospital Pharmacists and the Maryland Pharmaceutical Association.
These comprehensive guidelines were developed in 1969 by the “Pharmacy Advisory Committee” appointed by the Council on Hospital Services for the Maryland- District of Columbia-Delaware Hospital Association fol- lowing the initial suggestion of Mr. Henry J. Derewicz, Director, Pharmacy Service, The Johns Hopkins Hos- pital, Baltimore, Maryland. The Committee was com- posed of representatives of the medical, nursing, phar- macy, and hospital association groups located in the Mary- land, District of Columbia, Delaware region. Morris Bookoff and Nathan I. Gruz represented MPhA and F. S. Balassone, the Maryland Board of Pharmacy. Since then, a substantial majority of these groups have indicated their endorsement of this manual.
The purposes of these guidelines are to:
1) Protect the safety and welfare of patients who re- ceive drugs while in the hospital;
2) Recognize the interdependence of the medical care team members in the hospital who participate in the acts associated with drug treatmtent or usage;
3) Guide individual hospitals in establishing their own specific policies and procedures for the safe use and distribution of pharmaceuticals within the institution.
An initial supply of the guidelines has been dis- tributed to each hospital in the state. Additional copies are available at $1.00 each by contacting Dolores A. Ichniowski, Secretary, Maryland Society of Hospital Phar- macists, 1212 Roundhill Rd., Baltimore, Md. 21218 or the MPhA office.
Antibiotic Booklet Available
A 25 page, pocket-size booklet describing dosages and choices of antibiotics and antibacterials for specific bacterial pathogens has been prepared by Dr. John H. Mulholland, Assistant Chief of Medicine at the Union Memorial Hospital in Baltimore in collaboration with Sydney L. Burgee, Jr., Director of Pharmacy and Cen- tral Supply, Howard Sherman, Staff Pharmacist, and Richard A. Wankel, Staff Pharmacist at the Union Me-
morial Hospital.
The booklet contains valuable information such as information on major untoward effects of the antibiotics and antibacterials, and a chart on modification of anti- biotic dosage in renal failure. Publication of the booklet was financed by Eli Lilly and Company.
Individual copies are available at no charge by send- ing a stamped, self-addressed, business size envelope to the Union Memorial Hospital Pharmacy, Calvert and 33rd Streets, Baltimore, Md. 21218.
Burroughs Wellcome gives $500,000 Grant to Hopkins
The Burroughs Wellcome Fund has announced a $500,000 endowment for a professorship in clinical phar- macology at the Johns Hopkins University School of
Medicine.
Dr. Pedro Cuatrecasas, the director of the Division of Pharmacology, was appointed to what is believed to be the first chair in clinical pharmacology ever endowed in this country. In accepting the chair, Dr. Milton Eisen- hower, the president of the university, noted that Hop- kins created the first full-time pharmacology department in this country almost 80 years ago. “We look forward to developments of even greater significance to medicine from this important development in clinical pharmacolo- gy,” he said.
Dr. Cuatrecasas, 34, came to the Hopkins last year from the National Institutes of Health. He was named Young Scientist of the Year last year by the Maryland Academy of Sciences. Burroughs Wellcome is a pharma- ceutical firm that has operations in both this country and Great Britain.
THE MARYLAND PHARMACIST
There’s a lot more going for you at LOEWY
a Shectc MEDICAL EQUIPMENT FRANCHISE
can make your store one of the most sought out sources for equipment and service in America
As the local Spectro Division in your area, we not only offer the unusual advantages
of one of America’s largest drug wholesaling operations, but those of the country’s most ‘comprehensive medical equipment distributor, producer and servicing organization. As is being demonstrated right now in Spectro markets throughout the eastern seaboard, physical aids for the convalescent, the handicapped and the invalid can be the most significant
new profit source available to the pharmacy today. We are uniquely well endowed to provide you with professional administrative and technical direction, the widest available range of product, application counsel and in-home servicing.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
AA DIVISION OF a ° 6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100 aS: Spectvo Industries, Ine.
Maryland Board of Pharmacy News
Pharmacy Changes
The following are the pharmacy changes for the month of May:
New Pharmacies Drug Fair No. 137, H. Lebowitz and M. Levinson, Pharmacists, 5270 Randolph Road, Rockville, Maryland 20853.
No Longer Operating As Pharmacies Vojik’s Pharmacy, Edward C. Vojik, 900 South Ellwood Avenue, Baltimore, Maryland 21224.
Change of Ownership, Address, Etc.
Westview Pharmacy, Pasadena, Alder Simon, Presi- dent (Change of name and ownership — Was Village Drugs, Inc.), 399 Fort Smallwood Road, Baltimore, Maryland 21122.
Final Regulations Published for Controlled Substances
Final regulations implementing the Controlled Sub- stances Act were published in the Federal Register on April 24. For those who desire a copy of the complete regulations, Volume 36, Number 80, pages 7776-7826, Saturday April 24, 1971, copies are available at 20c each, prepaid, from the Superintendent of Documents, United States Government Printing Office, Washington,
D.C. 20402.
Late clarifications, according to Carl Roberts, APhA Legal Division Director, include:
—Owners of multiple pharmacies may apply to BNDD for a permit to maintain central records, providing spe- cific conditions are met.
—If a date other than May 1 is elected for biennial in- ventories, BNDD must be so informed.
—A written prescription order for Schedule II con- trolled substances must contain the date of issue, name and address of the patient, signature, address and registration number of the prescriber. If the prescriber has applied for a number, he may (until July 29, (date) indicate—‘Federal registration applied for on (date) .”
—A pharmacy intern can make the determinations neces- sary for OTC dispensing of a Schedule V controlled substance, provided he is so authorized under applica- ble state and local laws.
—Any loss or theft of controlled substances when dis- covered must be reported to the nearest BNDD Re- gional Office immediately and Form 106 must be com- pleted.
16
Name of Drug Must Appear on Rx Labels
Senate Bill 110 will become effective on July 1, 1971. This bill will require that all prescriptions be labeled with the name and strength of the drug dispensed unless otherwise indicated by the physician.
Vaginal Spermicide — Not Pill — May Prove “‘Ideal’’ Contraceptive
In spite of the intensive search for a “perfect” con- traceptive that, by almost universal agreement would take the form of another pill, the ideal contraceptive of the future may well be a new type of vaginal spermicide that might perhaps need to be inserted only once a month, according to Dr. Irving Scheer, Director of Or- ganic Chemistry at Ortho Research Foundation.
That extraordinary possibility was raised at a sym- posium conducted in San Juan, Puerto Rico, recently by the American Chemical Society New York-New Jersey section. Dr. Scheer said that this new type of vaginal con- — traceptive “might readily outmode the pill and the I.U.D.— —and make prostaglandins a kind of back-up where un- wanted pregnancy did occur.”
ae CU
pees cf 0 (AN om a =) Grnancp = Ce Su
RP Yura pr ALWAYS TO KEEP SIGHT OF
THE MARYLAND PHARMACIST
ap yerneinseHegseed ‘stnteerehies eee TOE wnnessort esnonenectsnein ees
In 1970, Roche Laboratories broke with pharmaceutical industry tradition by being the first company to discontinue mass, unsolicited sampling of professional products. The Roche aim is to ensure the greatest benefit to the patient while meeting the professional needs
of the pharmacist and physician. All are served best by proper handling of drugs. Better control of all aspects of drug distribution ensures the highest standards of health care for the patient, physician and community.
This policy reflects Roche interest in the general problems of pharmacy management, as well as the pharmacist-doctor, pharmacist-patient and pharmacist-community relations. There are many of your colleagues at Roche—practical profes- sionals in various management positions— ho help make the policies and provide the services hat help you meet the challenge of pharmacy today.
ROCHE LABORATORIES Division of Hoffmann-La Roche Inc. Nutley, New Jersey 07110
Pharmacists Honored
Godfrey D. Kroopnick, a community pharmacist practicing at Brookfield Avenue and Whitelock Street for the past 40 years, was recently given an award as Out- standing Citizen of Reservoir Hill for the year 1970. The award was co-sponsored by the Parent-Teacher Associa- tion of School No. 61 and the Bureau of Recreation. The award was presented by Mr. John Graybill, Principal of School No. 61, on Sports Award Night at the John Eager Howard Community Hall. Chairman of the evening was Charles “Bull’? Robinson, ex-Colt football linesman, who is presently connected with the Bureau of Recreation in Baltimore City.
Mr. Kroopnick has been president of the Whitelock Business Men’s Association since 1963 and is secretary- treasurer of the Locke Chemical Co.
Pharmacist Godfrey D. Kroopnick, center, receiving award from Principal John Graybill of School No. 61. At right is ex-Colt football linesman Charles ‘Bull’ Robinson.
Jacob H. Greenfeld, former president of the Uni- versity of Maryland School of Pharmacy Alumni Asso- ciation, was honored at a banquet held on March 21 at the Rothstein Auditorium. The award was given for his 13 years of service as president of the Ner Tamid Con- gregation, Greenspring Valley Center. In 1964, Mr. Greenfeld received the Presidential Award of the Union of Orthodox Congregations of America, an award given to only 10 outstanding leaders of synagogues in the United States and Canada.
Leon Albin was general chairman of the banquet.
Nathan I. Gruz, Executive Director of the Mary- land Pharmaceutical Association and Baltimore Metro- politan Pharmaceutical Association and Editor of The Maryland Pharmacist, was elected President-elect of the National Council of State Pharmaceutical Association Executives at their annual meeting in San Francisco held at the end of March. He will be installed at the 1972
annual meeting in Houston, Texas.
Harold Holmes, a life-long resident of Baltimore and a pharmacist with Read’s Drug Stores since 1961 has been chosen as Read’s Pharmacist of the Month by the 88- year old drug chain. Mr. Holmes has been a store man- ager with the firm since 1962 and is a member of the Maryland Pharmaceutical Association, the Chi Delta Mu Fraternity and the NARD. He is a graduate of the How- ard University School of Pharmacy. :
Mr. Holmes was chosen for his professional interest in public health.
Dorothy Levi, staff pharmacist at Lutheran Hospital, is a member of the Steering Committee for Baltimore City Council President William Donald Schaefer’s candi- dacy for Mayor. Anyone interested in further informa- tion may contact Mrs. Levi at 484-9195.
ATTENTION: ALL MEMBERS
A small quantity of jewel-studded tie tacks and clips commemorating the 75th Annual Convention are avail- able to members. Obtain an attractive souvenir of the occasion . . . a sentimental remembrance for a friend or relative.
Supply is limited. Make your request by writing the MPhA office or by calling 727-0746 before August 1 1971;
Prince Georges-Montgomery County Pharmaceutical Association
The Executive Committee and Officers of the Prince Georges-Mont- gomery County Pharmaceutical Association assembled for this photo- graph at their recent Installation Dinner. From left to right: Michael} Leonard, treasurer; Samuel Morris, honorary president; Edward D.) Nussbaum, first vice president; Paul Reznek, secretary; S. Ben Friedman, second vice president; Rudolph Winternitz, Chairman oft Executive Committee; Martin Hauer, president; Simon Zvares ;)) Gabriel E. Katz, fourth vice president; Melvin D. Sollod; Paul Bergeron II; Edward Sandel; and Donald O. Fedder, past president of the Maryland Pharmaceutical Association. |
THE MARYLAND PHARMACIST
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
First name in ice cream for over a half-century
ICE CREAM
675-6000
Pharmacology in the Clinically Oriented Pharmacy Curriculum
by:
David A. Blake, Ph.D., Associate Professor and Chairman, Department of Pharmacology and Toxicology
H. Patrick Fletcher, Ph.D., Assistant Professor, Departments of Pharmacy and Pharmacology.
William J. Kinnard, Jr., Ph.D., Dean and Professor of Pharmacology. University of Maryland School of Pharmacy.
(Presented at the Fall Meeting, American So- ciety of Pharmacology and Experimentai Thera- peutics, Palo Alto, August, 1970.)
There is widespread national concern over the lack of proper health care, the accelerating cost of medical services and the inefficiency of the total health care sys- tem. Recently a television network aired a documentary entitled “Don’t Get Sick in America” which dramatically portrayed the seriousness of the problem. How can this complex problem be corrected? Many suggestions have been made but the one most commonly heard is—‘we need more doctors”! Actually the inadequacy of the num- ber of physicians has been known for some time, how- ever attempts to correct the situation by increasing the financial support of medical schools has mainly resulted in more research and an increased potential for the treat- ment of disease. But the overall deliverance of health care has not been greatly influenced. Rather, it is evident
that what must be done in this regard is to more effec- '
tively utilize the physician as a diagnostician by trans- ferring the non-diagnostic responsibilities to competent, highly-trained specialists.
With respect to the responsibility for drugs, there has been enthusiastic support for clinical pharmacolo- gists to specialize in this phase of health care. However, a large number of these “M.D., Ph.D.’s’’ have been ab- sorbed by research programs and a recent survey con- ducted by Dr. Edward Carr of the University of Michi- gan (Clin. Pharmacol. and Therap. 11: 455, 1970) shows that only a fraction of the Medical Schools are en- gaged in training medical students for this role. Some pharmacy schools have initiated revised academic pro- grams designed to produce highly-trained drug experts with clinical experience who will be able to provide direct assistance to the physician in his selection of therapeutic agents and the effective monitoring of drug response. This practitioner is being called a clinical pharmacist and is receiving from 5 to 7 years of education and train- ing and in some cases is being given a new degree—
Doctor of Pharmacy (Pharm. D.).
At the University of Maryland, we are in the 2nd year of a 3 year transition to a revised curriculum de- signed to produce B.S. level clinical pharmacists in 5 years. The program is divided into 3 phases: 2 years of general studies, 2 years of pharmaceutical sciences and 1 year of clinical education and training. The pharmacologi- cal aspects of drugs are presented in two courses: a 4th
20
year course in pharmacodynamics and a 5th year course in clinical pharmacology.
During the 4th year, the pharmacology course is close- ly integrated with courses in medicinal chemistry and biopharmaceutics. This latter course is greatly empha- sized and encompasses all of the factors which influence drug action. The purpose of this coordinated lecture series is to provide the student with a sophisticated understanding of drug action, variability in response to drugs and an appreciation for proper dosage formulation. Prototype drugs are studied in depth at the molecular, biochemical, cellular and whole animal level. Thus upon entering the Sth year clinical courses, the student is pre- pared to view medicinal therapeutics in the broader con- text of the patient, his disease and his therapy and their interactions.
Our first experience with this new program was dur ing the Spring Semester of 1969. The second semester of pharmacology laboratory was replaced by classroom evalu- ations of case histories which had been summarized from medical records. Groups of 3 students were assigned a case which represented a major disease category and asked to prepare 20 minute oral presentations on the disease, the drugs and the clinical course. The cases had been selected on a random basis and no attempt had been made to include only uncomplicated cases. Although a general invitation to attend these presentations had been made to all of the other schools and hospital services, only a few physicians were present but they played an active role in the discussions and offered criticisms where indicated.
It soon became apparent that much had been lost in the preparation of the summarized case histories and stu- dents complained of not having access to the patient, and his physicians and nurses. Nevertheless, students cited number of instances where questionable therapy, mistakes and dangerous practices had occurred. For ex- ample, a patient in cardiac failure had been overdigi- talized and was treated with antiemetics for 5 days before the digitalis dosage was reduced, even though a nurse had been consistantly recording an abnormally slow pulse and the lab results had showed hypokalemia. An- other patient experienced several uncomfortable days of postural hypotension because she was being given a double dose of guanethedine as the intern did not realize that Ismelin was the same drug. Another incident had occurred in the E.R. where an unconscious patient was given stat insulin in response to a high blood sugar report from the laboratory. Unfortunately the blood had been withdrawn from one arm while 5% glucose was being infused into the other.
Based on the results of this experimental course, the past year’s program (Spring, 1970) was changed so that students would have the opportunity of evaluating actual hospitalized cases. This was arranged by having a faculty member of our school (Dr. Fletcher) work on general medical wards in order to experience the same situations that would confront the students and thereby design a workable format. A series of lectures were given on a
THE MARYLAND PHARMACIST
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE 3024 Greenmount Avenue Baltimore, Maryland 21218
JUNE 1971
variety of important subjects such as: medical termi- nology, clinical chemistry, drug interactions, iatrogenic diseases, treatment of the emotionally ill patient, derma- tology and drug information. Where possible, experts from the clinics and laboratories provided these lectures which was greatly appreciated by the students.
Each student was assigned a patient who was cur- rently hospitalized and was asked to prepare a written and oral summary of the patient with emphasis on drug therapy. During the 12 hours on the ward allotted to the student, he was expected to observe the patient, take a drug history, attend ward rounds, and answer ques- tions posed by the physicians, nurses or the patient. The summaries were presented in small group conferences which were supervised by members of the pharmacology department.
A number of observations were made during this program; students were initially apprehensive but even- tually became enthusiastic about this unusual learning experience. One student devised a novel way of charting medication frequency and dosage which permits instan- taneous disclosure of current therapy, missed or wrong doses etc. Students were impressed at seeing drug ac- tion first hand such as: the dramatic improvement of parkinson’s disease with L-DOPA, iatrogenic Cushing’s syndrome from steroid therapy and the loss of hair caused by anticancer agents. Some students enjoyed interview- ing patients while others considered this an undesirable task and obtained little information.
During the coming year, the clinical orientation will be provided during both semesters and in the future will also include the summer. The didactic portion of the pro- gram will be expanded into a semester of clinical phar- macology which will be presented by physicians and pharmacologists. The organization of this course will be based on major disease categories and include a con- sideration of the pathology, comparative diagnosis and therapeutics. For example the subject of myocardial in- sufficiency will be covered by first describing the general process of atherosclerosis, myocardial ischemia, altera- tions in the ECG and the usual symptoms and com- plaints. Following this, a comparison of the clinical efficacy of the organic nitrate vasodilators, beta blockers, antihypercholesterolemic agents, anticoagulants and tran- quilizers will be made. This latter discussion will include a consideration of untoward effects, potential interactions of the drugs with each other and also with diagnostic tests.
The clinical experience will be lengthened and also extended into clinical specialties such as pediatrics, anes- thesia, intensive care etc. In fact, our pharmacy school is providing four “clinical pharmacists” to the hospital who will function full-time in the role expected of students. They will monitor patient charts, go on ward rounds, prepare drug histories and drug profiles, supply infor- mation to physicians and nurses, assist in drug adminis- tration, prepare intravenous fluid mixtures and determine blood levels of certain drugs for the rational selection of their dosage. Additionally, the clinical pharmacist will conduct a discharge interview with patients to instruct them on the proper use of their discharge drugs. These pharmacists will operate out of areas on the ward which are satellites of the main pharmacy where distributive drug services are handled.
Another related service which has been operating for the past year is a drug information center. This cen-
22
ter provides emergency and routine information on many aspects of drugs and is coordinated by clinical pharma- cists. It serves as a backup to the pharmacists with ward duty and has been a popular service.
In summary, when the role of the pharmacist is expanded to include clinical responsibility, curriculum changes are necessary to provide an adequate background of knowledge. Pharmacology must be extended from the traditional and somewhat simplistic laboratory situation of 1 drug and an isolated organ to the complex clinical situation of multiple drugs and a diseased patient who has psychological as well as medical needs. It is our con- viction that clinical pharmacists, who have a broad and sophisticated understanding of the fundamentals of drug action coupled with proper clinical orientation and ex- perience, can fill an ever-expanding need—that of a clini- cal drug specialist.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships)
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
LSS ee re
THE MARYLAND PHARMACIST
Reading
1S Still the fast
est way
to program the
brain.
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
human
Ss
ID
|
— f —a1E
——)
5
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
The Economics of Third Party
Prescription Plans by
Maven J. Myers, Associate Professor of Pharmacy Administration Philadelphia College of Pharmacy and Science
Presented to the Maryland Pharmaceutical Association at the Simon Solomon Pharmacy Economics Seminar,
Blue Crest North, Pikesville, Maryland November 19, 1970
According to the occupational historians, Carr- Saunders and Wilson, the physician in ancient Greek civilization usually was a slave attached to some rich man’s household. Somehow it is difficult for us to con- ceive of a physician or other professional, including a pharmacist, as a subservient person.
Rather, we conceive of the professional practitioner as a dominant, dictating force in his relationship with his clients or patients. The physician tells the patient he must get more exercise; usually he complies. The at- torney tells the client not to bother suing on a particular claim; usually the client accepts this advice. The phar- macist tells the patient to use caution if machinery must be operated while taking an antihistamine; usually the patient complies.
If we return to ancient Greece, we find that several of the other professions—such as accountants, architects, and engineers—were not free lance independent practi- tioners, but state-employed administrators. Again, it is difficult for one to grasp the concept of a professional practitioner being responsible to someone other than the patient or client. The physician’s primary duty is to con- trol the patient’s hypertension not to minimize the cost of a government health program; the pharmacist’s pri- mary duty is to dispense drug products from sources. he has confidence in, not to make sure that the welfare di- rector’s budget is met.
Is it possible that third party payment for prescrip- tions may cause a retrogression of the profession of phar- macy to the status of the professions in ancient Greece? Is it possible that the independent practice of pharmacy may become the dependent practice of pharmacy?
The Emergence of Associations
Returning to history, we find professions emerging with professional characteristics over a long period of time. One of the professional characteristics which emerged was the professional guilds which evolved into what we, in pharmacy, now generally refer to as phar- maceutical associations. These guilds satisfied several needs of the professions, primarily:
a chance to associate with professional peers for exchange and advancement of knowledge and
an organized pressure group which could work to achieve public acceptance of the high stand- ards of the profession and reward these high standards through the creation of legal mo- nopolies,
24
It is this latter purpose on which our attention should be focused. There are a number of reasons why the professions have been able to develop into what are referred to as “legal monopolies,” meaning, for example, only a registered pharmacist may practice pharmacy. Not the least of these reasons is embodied in the concept of a profession. Among other attributes, a profession must have a developed body of knowledge possession of which is necessary to effectively perform certain functions.
Because of this, it was only natural that society should want to protect itself from the performance of these functions by someone who failed to possess the requisite knowledge. Few of us, for example, would be willing to have our tonsils removed by the typical cab driver.
Thus, it was relatively easy for professions, par- ticularly those involving important functions (such as health services) to succeed in creating legal monopolies on the basis of the public interest.
A second, and very important contributing factor, may be referred to as a relative apathy on the part of the general population with regard to these claims for legal monopolies. While claims by the professions that these legal monopolies were in the public interest may have ~ effectively quieted some opposition, it is not likely that strong opposition existed. While pharmacists and their associations were vitally concerned with the passage of legislation creating their legal monopolies, the general public had little direct interest in this and, probably at the time, was unaware of the passage of this legislation.
As a historical note, Sonnedecker observes that there is an extremely close correlation in time between the founding of state pharmaceutical associations and the passage of state pharmacy laws, with the latter usually following by a few years, the former.
What thus came into existence in pharmacy and the other health professions were organized, legal mo- nopolies of health providers.
Provider Domination
Attempting to bargain with the organized provider was the unorganized consumer. One can immediately sense the disparity in bargaining power. The provider, backed by and guided by his organized monopoly versus the individual consumer who basically has but two choices:
1. Accept the service on the basis offered by the health professional
2. Do without the service.
This disparity likely is one of the root causes of our so-called health crisis. Our entire health care delivery system has evolved around what is convenient for the health care provider rather than what is best for the patient. Do fewer patients become ill on Sunday than any other day of the week? Probably not, but the avail-— ability of health care is substantially less on Sunday.
In the United States, one out of every fourteen dol- lars of our gross national product goes to pay for health
THE MARYLAND PHARMACIST
care. This is approximately $60 billion per year and is the highest figure both in terms of per capita spending and share of GNP of any nation in the world. Yet, it is tragic to observe that the United States ranks fifteenth among the nations of the world in infant mortality.
How can we explain these seemingly conflicting data of high spending but low health? The most probable ex- planation is that health care is not necessarily being pro- _vided to those who need it most, but, rather, to those _who can obtain it under the conditions providers impose on the system. Thus, providers tend to concentrate in the more affluent suburbs rather than in the ghetto; the person in a high income bracket is more likely to receive care than the person who cannot afford to pay the pro- vider; the person who becomes ill on a weekend usually cannot receive care through the normal channel, but must resort to treatment in hospital emergency rooms. In short, the providers of health care have been in the driver’s seat. They have decided to a considerable extent who gets treatment, what kind of treatment they get, and how much they will pay for the treatment.
The Emerging Organized Consumer
And now, for the economics. John Kenneth Gal- braith, variously known as a Harvard economist and a Kennedy Democrat, calls his theory, “countervailing power.” Basically what he suggests is that when a group gains control of one side of a market (such as the seller’s side), there will develop a countervailing or opposing power on the other side of the market. Thus, big labor became organized to deal on an equal basis with big busi- ness; farmer’s cooperatives organized to deal with the large food processors and most importantly, what we are seeing now are consumers organizing to deal with big health care providers.
We saw “consumer power” at work in 1965 when, after twenty-five years of success, the American Medical Association finally lost out to Medicare. We saw it in the Office of Economic Opportunity Health Centers which were established over the bitter opposition of certain health care providers. Legislators and politicians have be- gun to learn that consumers vote just as much as health care providers and there are more consumers than pro- viders.
We are seeing it in the growth of third party pay- ment programs for prescription care—Title XIX _ pro- grams, Blue Cross programs, programs sponsored by cer- tain union organizations, etc. The list is long and grow- ing. Predictions indicate that more than half of your prescription volume five years from now will be paid for through these third parties, rather than through an indi- vidual consumer’s direct payment.
Whereas in the past, the individaul consumer had no choice but to accept pharmaceutical services as we were willing to offer them, the organization which repre- sents several thousand consumers is not under such re- straints. If they dislike our existing system of delivering pharmaceutical services, they simply set up their own dispensary. If legislation interferes with their goals, they lobby, sometimes very effectively, for changes.
Basically, what is happening is that we no longer can, in isolation, control our own destiny without con- sidering the wants of the consuming public and being responsive to those wants. Our power is being offset by the countervailing power of the organized consumer.
JUNE 1971
But, you may say, “What power? Certainly the A.M.A. was and possibly is a strong power, but organized pharmacy has never had such strength and power that it could dictate to consumers.”
Unfortunately, you probably would be correct. Among all the major professions, pharmacy probably has the weakest, most poorly financed and most unsupported organizations.
Why do you think there are strong movements to unionize pharmacists, rather than to unionize dentists or physicians? Dentists and physicians can look to their pro- fessional associations and find strength and leadership for their professional careers. Pharmacists, unable to find this in many of our state professional associations, are turning to organizations which they know have strength and power—the unions.
Pharmacists looking to national associations of phar- macy-related people find they lack not only strength, but are more likely to be characterized by chaos, conflict and confusion. The continuing imbroglio over the “universal claim form” proposed by the National Pharmacy Insur- ance Council is an outstanding example of this, and I would like to dwell on it a little later.
Yet, we find consumer power or the consumer lobby as a countervailing power to pharmacy. The reason is simple to find. The countervailing consumer power arose not in specific opposition to pharmacy, but in opposition to the existing health care team.
Organizational Weakness
Pharmacy is a part of that health care team. This is the theme we have been hammering into the public’s mind. As members of the health care team, we are a part of the target of this countervailing power. But, perhaps more significantly, we are a most vulnerable target be- cause of our organizational weakness.
As one example, let us look at many of the govern- ment-financed Medical Assistance Programs. Many pro- viders receive usual and customary charges for the serv- ices they provide under these programs. It was just naturally assumed that the only way these providers would participate in the programs was on these payment terms. And how about pharmacists? Usual and customary might be nice, but the administrator figured he could enroll sufficient pharmacists with a 1/3 markup or a $1.50 fee, so he tried it and he was successful. Pharmacists com- plain bitterly at the same time they are taping up signs in their windows reading “We fill welfare prescriptions.” Round one for the consumer (in this case the taxpayer ) as far as pharmacy is concerned.
In round two we get the budget squeeze. Somehow someone underestimated the medical assistance budget (has anyone ever overestimated one? ). Cuts have to be made somewhere and the path of least resistance is to reduce the pharmacist’s reimbursement by 25c per pre- scription. Sure, he’s going to squawk; but not as loud nor as effectively as other providers.
Unless and until we are willing to give to our pro- fessional organizations the support they so desperately need in this time of rapid change, pharmacy will con- tinue to be the victim of the consumer movement when it could actually be its hero.
A second example of our impotence can be found in third party payment contracts negotiated under the
25
United Auto Workers and similar plans. Specifically, a very sore point is the extremely high deductible, usually $2.00, which is a part of these agreements.
A major selling point in these programs has been that over 20% of all prescriptions written by physicians are never filled because the patient doesn’t think she can afford the medication. While this statistic is questionable, its sales value appears sound.
Assuming this figure is valid, it would then seem to be the professional obligation of the pharmacist to utilize whatever reasonable forces he possesses to secure deducti- bles in contracts at a level which does not inhibit patients from obtaining prescribed drugs. If the average prescrip- tion charge of approximately $3.75 in the private market inhibited people from obtaining prescribed medication, how much has been accomplished by replacing this with a $2.00 deductible? Is it likely that many who can’t af- ford $3.75 will be able to afford $2.00?
Pharmacists don’t like the $2.00 deductible; pre- sumably patients would prefer a lower figure; but, the $2.00 deductible remains. Someone must favor it.
A deductible which is so high that it discourages utilization of prescription services is, at least in the short run, desirable from the point of view of the one who is footing the bill. It also is desirable from the point of view of the underwriter for two reasons.
First, it makes it easier to predict utilization. If a consumer without prescription insurance were suddenly told she could go out and get all the prescribed medica- tions she wanted ‘“‘free,”’ there is a fear that the consumer would attempt to take advantage of this and secure un- necessary supplies of drugs, thus significantly increasing the costs of the program. By having “$2.00” drugs rather than “free” drugs, this possible problem is reduced.
Second, it can be an extremely effective tool in re- straining pharmacists’ requests for increases in fees as costs increase with time. If some pharmacies in the area are discounting the $2.00 deductible by, for example, collecting only $1.00, the underwriter can point to this discounting and claim that the fees being paid are already higher than necessary since at least some pharmacies are capable of operating at $1.00 less than the fee offered.
This symptom represents two underlying basic prob- lems: 1. Our failure to establish the value of complete pharmaceutical services
2. Our willingness to accept anything as long as someone says, “That’s the way it has to be be- cause of antitrust.”
“Complete” Pharmaceutical Services
You and I know that the patient receiving prescrip- tions from the pharmacy employing the $1.00 discount on the deductible is not receiving complete pharmaceuti- cal services. Patient medication cards are not being main- tained, pharmacists are not taking the time to assure themselves that the patient completely understands the dosage regimen, the patient is not being warned about the concomitant use of OTC products which may affect drug action, etc.
Why doesn’t the patient demand this service and why isn’t she willing to pay an extra $1.00 per prescrip- tion for it? Why don’t the carriers insist on the provision of these services? The simple answer is that we have
26
never shown either the patient or the carrier (or some might add, the pharmacist) the value of complete phar- maceutical service. No one apparently has ever given them any reason to believe that there is a value associated with such service.
This must become a top priority of pharmacy if we are to have professional growth in the coming era of pre- payment. We must be able to establish, on a cost-benefit basis, the value of complete pharmaceutical services.
Antitrust
The second problem is that of antitrust. Pharmacy has been sensitive to the prospect of antitrust suits, espe- cially since the Northern California and related cases in the early sixties. Carriers are especially sensitive now in light of the recent decision in Virginia holding the im- position of a fixed fee by Blue Cross to be in violation of the antitrust laws. Pending appeal and the final outcome, most third party plans continue to employ the fixed fee approach.
What we have seen with the fixed fee is the concept of countervailing power become, in practice, the concept of overwhelming power. As the State Department would say, the balance of power has shifted.
In many cases today the pharmacist cannot eco- nomically refuse to participate in some of these pro- grams. One need only look to many areas of Michigan where the auto industry is the dominant employer. It is
economic suicide for a pharmacist not to participate in~
the U. A. W. program in these areas, just as it will be- come economic suicide for you as this type of coverage expands.
On the other hand, it may be professional suicide for us to participate. If these programs are not willing to reimburse pharmacists reasonably for providing complete pharmaceutical services, the pharmacist either will have to reduce his level of services or operate at a loss. Thus, the economic coercion of the third party becomes a coercion of professional standards.
There does exist one additional alternative; which makes a great deal of sense, but will require the
cooperative efforts of all pharmacists. At the direction of |
the American Pharmaceutical Association Board of Trus-
tees, Senator Hart has been requested to assist in amend- —
ing the antitrust laws to permit pharmacy associations to
negotiate fees in third party payment prescription pro-—
grams. In requesting this assistance, Dr. Apple noted,
“Clearly, there exists in this situation a monstrously inequitable imbalance of economic power. No single pharmacist or pharmacy is a match for any insurance company, employer or Blue Cross/Blue Shield plan—As a practi- cal matter, it is impossible for either a phar- macist or a sponsor to negotiate individual agreements with over 50,000 pharmacies for participation in such programs. This is not a ‘free market’ bargaining situation, but one in which pharmacists are captives, forced to par- ticipate at the threat of loss of a substantial por- tion of their practice. Moreover, failure to par- ticipate by a significant number of pharma- cists leaves them open to charges of ‘group boy- cott’ in violation of the antitrust laws.”
one
THE MARYLAND PHARMACIST
4 |
Clearly there is a need for a modification of the antitrust laws and their interpretation if pharmacy is to be free to concern itself with its professional advance- ment in the era of third party payment.
A final area which deserves comment in the current environment is the chaos, conflict, and confusion at the national level due to what appears to be a power strug- gle to determine what group represents “pharmacy” at _the national level.
While pharmacy in the past has been able to ad- vance with relatively weak organization and leadership, it has done so because there was very little organized opposition. In the present environment we are faced with potent countervailing powers.
The National Pharmacy Insurance Council was established on a representative basis to provide a unified voice for pharmacy in dealing with third party payment programs. Both the National Association of Chain Drug Stores and the National Association of Retail Druggists have been invited to participate in this organization, with seats on the Board of Governors. I feel we all should strongly urge these organizations to work with, not against, the National Pharmacy Insurance Council.
Pharmacy cannot afford the luxury of being divided internally during this rapid period of change.
Summary In summary:
1. The organized professions are now faced by or- ganized consumer groups who, in many cases, are dissatisfied with aspects of the current health care system
2. Because of the traditional weak and divided or- ganization in pharmacy, pharmacy becomes an easy target of these dissatisfied consumer groups and their representatives
3. Pharmacy must establish the value of the serv- ices it can provide if it is to be adequately reim- bursed for those services
4. Modification of the antitrust laws appears neces- sary if pharmacy is to have power equal to that of the third party groups
5. Pharmacy groups must work through a single organization, such as the National Pharmacy In- surance Council, if we are to fully utilize our influence as providers
6. Pharmacists must increase their support of the unified organizations which represent their inter- ests if these interests are to be advanced.
TAILOR-MADE
Insurance Caveraze
AMERICAN DRUGGISTS’ INSURANCE .., as the name im- plies, is specifically designed for the needs of the druggist. It’s an insurance company founded BY druggists FOR druggists, to assure especially prompt settlement of claims .. fire, theft, liability. And that’s exactly what we’ve been doing...settling such claims rapidly, without red tape ... since 1906. Any service with that many years of
experience HAS to be reliable. You can be certain of 100% security.
For full details on our complete coverage plan, contact your ADI agent NOW.
MAYER & STEINBERG Maryland State Agents 1101 N. CALVERT STREET BALTIMORE, MD. 21202 752-7311
AMERICAN
DRUGGISTS’ INSURANCE. CO.
700 American Building Cincinnati, Ohio 45202
| JUNE 1971
27
MPhA Sponsors Exhibit at Med Chi Meeting
The Maryland Pharmaceutical Association sponsored an exhibit on “Patient Drug Profiles” in the Scientific Exhibit Section at the Annual Meeting of the state medi- cal society (Medical and Chirurgical Faculty of Mary- land) held at the Baltimore Civic Center, May 12, 13, and 14, 1971.
The exhibit which received considerable interest from the physicians, was arranged by the Professional Relations Committee under the chairmanship of Sydney L. Burgee, Jr. and stressed the value of medication rec- ord systems in helping prevent drug interactions and in contributing to better patient care. Many physicians in attendance signed up for a booklet on drug interactions
to be mailed to them by MPhA.
The following pharmacists participated in manning the exhibit: Sydney L. Burgee, Jr., H. Nelson Warfield, Samuel J. Sheller, Charles E. Spigelmire, Donald O. Fed- der, James P. Cragg, Jr., Victor H. Morgenroth, Jr., Mel- vin Rubin, Joseph U. Dorsch, Paul Freiman, and Morris Bookoff.
PRODUCT ANNOUNCEMENTS
Vasodian (Isoxsuprine HC1, Mead Johnson) is now available in syrup form, one pint bottles, 10 mg. per tea- spoon, and a 10 mg. tablet unit dose blister pack.
Rifampin, a new drug indicated as an adjunctive in the treatment of pulmonary tuberculosis, was approved for release by the Food and Drug Administration on May 21. It will be marketed by Dow Chemical Co. as Rifadin and by Ciba as Rimactane. Rifadin (Dow) will be sup- plied as 300 mg. capsules in bottles of 30, 60, and 100. Rimactane (Ciba) also 300 mg. will be available in 100’s and 500’s. Cost is expected to be about 97 cents per cap- sule.
Pharmacy Student Exchange Program
The International Pharmaceutical Student’s Federa- tion Student Exchange program, sponsored in the United States by the Student American Pharmaceutical Associa- tion provides students with the unique opportunity of broadening their professional horizons by observing and working in pharmaceutical establishments in foreign countries.
Numerous applications have been received from U.S. pharmacy students wishing to take part in the Student Exchange Program. In order to complete an exchange, however, a host for a foreign student must be found in the United States for each U.S. student going abroad. Therefore priority is given to students who are successful in locating a host position in their own country.
Host pharmacists normally provide living expenses and/or pocket money although exchange students must pay travel expenses. In most countries it is not neces- sary to speak the native language. For further informa- tion contact Mr. J. Craig Hostetler, IPSF Liaison Secre- tary, Student American Pharmaceutical Association, 2215 Constitution Avenue, N.W., Washington, D.C. 20037.
28
L-Dopa Stimulates Secretion Of Human Growth Hormone
Scientists at Duke University have recently linked L-Dopa (levodihydroxyphenylalanine), the “miracle” drug used in treating Parkinson’s disease, with increased secretion of growth hormone in such patients.
Since its release by the Food and Drug Administra- tion in June, 1970, L-Dopa has been the focus of at- tempts to treat Parkinson’s disease. An amino acid which can penetrate the blood-brain barrier to reach the central nervous system, L-Dopa aids Parkinson patients by re- plenishing their depleted supply of dopamine. Although the drug is not effective or tolerated in all cases, regular doses of L-Dopa have produced promising results in a large percentage of patients. Many of these patients did not respond to other forms of treatment. .
In this study of 12 patients, Drs. A. E. Boyd III, Harold E. Lebovitz, and John B. Pfeiffer found that moderate doses of L-Dopa produced a rapid increase in the level of growth hormone in the blood. This level gradually returned to normal approximately two hours after the drug was administered.
The scientists found no appreciable difference in the growth hormone response of patients according to the size of the L-Dopa dosage. Nor was the response to growth hormone different in patients beginning L-Dopa therapy and those who had at least six months of contin- uing therapy, although patients having long-term ex- posure to L-Dopa took longer to reach the same level of — hormone production.
In an attempt to suppress the production of the growth hormone, the researchers administered glucose with L-Dopa. However, this also failed to alter the pat- tern of hormone secretion.
The mechanism by which L-Dopa activates growth — hormone secretion has not been determined, although the | researchers suggest several possible mechanisms. Further study of this response to L-Dopa is important because it | may help elucidate the normal mechanisms controlling © growth hormone secretion. Careful observations of pa- | tients in chronic L-Dopa therapy should be made for © possible consequences of long-term growth hormone stim- — ulation.
Noxell Sales Executive
Named To New Post
John James Meek of the Noxe!l Corporation has been promoted to National Field Sales Manager, having been Central Area Field Sales Manager, Chicago, sinve 1967. Before that he was Regional Manager, Cleveland.
A graduate of McKinley High School in Chicago, Mr. — Meek attended Northwestern University and the Univer- sity of Illinois, and has been living with his wife and three children in Mt. Prospect, Illinois. He will relocate to the Baltimore area shortly.
THE MARYLAND PHARMACIST
. Caution: © ‘ on Ms Sabsnat od Reeging re
Simple Test Developed to Detect Digitalis Reaction in Heart Patients
Researchers have developed a fast, simple diagnostic tool using saliva that can save lives by showing when a heart patient is suffering a toxic reaction to digitalis, an effective drug for heart patients that has been in use for nearly two hundred years in the management of heart failure and control of heart rhythm. Occasionally a heart patient, who has been taking digitalis, has an irregular heart beat. He could then be suffering heart symptoms because he needs more of the drug. However, the same signs also can indicate a toxic reaction to the drug itself, in which case the therapy must be changed.
Dr. Stephen Wotman and a team of researchers at Columbia-Presbyterian Medical Center in New York City have developed a fast, simple method using whole saliva that can diagnose digitalis toxicity. The NIH National Institute of Dental Research supported this study as a part of its extensive research program on salivary gland secretions.
Dr. Wotman discovered that the level of potassium in whole saliva rises significantly in cases of digitalis tox- icity and that simply measuring the potassium level in saliva can detect this. In a study of 47 patients, he found that the potassium level actually rises in all patients tak- ing digitalis but that the increase was significantly greater in patients with digitalis toxicity than in other patients on this drug.
Program Announced for FIP 31st International Congress
Internationally known scientists from Germany, Great Britain, Italy, Japan, and the USA will present papers at the main symposium of the 31st International Congress of Pharmaceutical Sciences to be held in Wash- ington, D.C., September 7-12, 1971.
The main symposium, to be held Wednesday-Thurs- day, September 8-9, will have as its theme * Optimizing Drug Activity.” The colloquia on “International Refer- ence Standards”’ will be held on Friday, September 10.
Correspondence relating to the Congress should be addressed to George B. Griffenhagen, Secretary, Organiz- ing Committee, 31st International Congress of Pharma- ceutical Sciences, c/o American Pharmaceutical Associa- tion, 2215 Constitution Avenue, N.W., Washington, D.C. 20037.
Adolescent Unit Started at University Hospital
With the appointment of Dr. Felix P. Ifeald as di- rector of the new division of adolescent medicine at the University of Maryland School of Medicine, this institu- tion has become the sixth in the United States to conduct training and research in adolescent medicine. Univer- sity Hospital’s new north hospital wing, now under con- struction, will devote its eighth floor to the specialty of adolescent medicine.
As Dr. Heald explains it, the teen-ager has been shuffled from ward to ward in medical centers. Some- times he is cared for by the department of pediatrics. Other times he is treated in adult wards. The whole idea of adolescent medicine is a young one. Dr. Heald says that there are already a number of pediatricians who limit their practices to the adolescent.
30
NIH Doubling Research On Oral Contraceptives
Spurred by a shortage of basic information about the effects of oral contraceptives, the Center for Population Research of the NIH National Institute of Child Health and Human Development plans to more than double its expenditures for research in evaluation of contraceptive methods.
Funds for methods evaluation research rose from $1.6 million for fiscal year 1970 to $3.5 million in fiscal year 1971. The evaluation program will emphasize in- vestigations of the pharmacological properties of various estrogen-progestogen combinations in varying doses, with the aim of improving the clinical safety and efficacy of these widely used drugs.
To administer the enlarged program, the Center has formed a new division, the Fertility Regulating Methods Evaluation Branch. The Branch will be under the direc- tion of Dr. John Schrogie, a clinical pharmacologist and former research division director of the Food and Drug Administration. The research program will explore doses, unique properties, and effects of oral contraceptive com- ponents, to determine whether equally effective or safer formulations can be developed. A secondary goal is to study the side effects of presently available formulations with as much precision as possible. Methodolgy for doing this has improved greatly since the oral contraceptives were introduced ten years ago.
Shifts in the Drug Industry
The 1967 Census of Business shows a continuing trend toward increased sales through a smaller number of retail outlets. Between 1963 and 1967, the retail drug industry also followed the trend toward fewer and larger outlets. Chain drug stores, between 1963 and 1967, in- creased their share of total drug sales from 26 per cent to over 33 per cent while the total number of chain out- lets increased only 2.5 points—from 8.4 per cent to 10.9 per cent. In sharp contrast to this trend, large indepen- dents increased in number by 41.4 per cent, while show- ing gains in sales volume similar to those of chains.
Study of Independent Drug Stores Completed
A perceptive study of “Independent Drug Stores” prepared by the Bank of America and released as part of its series entitled “Small Business Reporter” shows that initial inventory and fixture costs for a 3,000 square foot community pharmacy with a projected annual volume of
$150,000, fall within the range of $37,000 to $53,000.
Initial inventory and fixture investment for a super merchandising drug store of 7,000 to 12,000 square feet, is estimated between the range of $70,000 and $135,000. The number of independents in the U.S. has dropped from 46,550 to 38,000 in the last decade, the study notes, despite an overall growth in the retail drug market from $7 billion to $12 billion during the same time. Chains, with an increase in units from 9,000 to 15,000 in 10 years, have captured a large share of the retail drug market, according to the study.
THE MARYLAND PHARMACIST
Two giant product shows
each year
Gilpin offers continuing programs of merchandising ideas to its customers. The highlights of this plan include our January Product show featuring summer gvods, and our July-August presentation emphasizing fall and gift selec- tions. Dates for this year’s fall and gift merchandise show are as follows: For BALTIMORE-WASHINGTON-DOVER:
JULY 18th-25th—Gilpin Baltimore Division, 7401 Pulaski
Highway, Baltimore, Maryland. For the TIOEWATER RE-
GION: AUGUST 1st-8th—Gilpin Norfolk Division, 6435 Tidewater Drive, Norfolk, Virginia. Please mark down these dates. We know you'll want to attend. Contact your Gilpin representative or Division Sales Manager for more details
and to make your appointment.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
BALTIMORE + DOVER + NORFOLK * WASHINGTON
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company 901 Southern Ave., Washington, D.C. 20032 (301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
Sirs: | am interested in the following programs. Please have your
representative contact me in this regard. i
Name.
Name of Pharmacy.
AOd(6s6 ee ON ee
list the 150 manufacturers’ codes
explain the write-off throughout check the % called on open bottles
tell the expiration dates |
learn the recent packaging changes
~ name the discounts and amounts indicate the deals on major lines divulge the case discounts
now, take inventory.
Good. Now, that you've We'll not only keep you For further information, taken your inventory, run up-to-date. We'll keep you. write or ca// your nearest the figures through the several steps ahead of Mangini office. The computer and get your your competition. information is FREE and departmental and sectional For instance, our computer without obligation. breakdowns plus complete —qivision will have a new
HOI eC system within the next 60 a aoe days that will enable the a So if your present inventory busy pharmacist to meet _son o
service is not giving you the a// requirements on a single cio : fast, accurate meet eeeg form as third part Mangini & Associates, Inc. p Palsy 4850 W. Belmont Ave. Chicago, Ill. 60641
answers you need in your prescriptions, BNDD, (312) 282-8 anit gash iat é aoe : 11722 Studt St., St. Louis, Mo. 63141 ignly-competitive industry, family prescription files, 2760 W- Market St., Akron, Ohio 44313 ni 5 avin Ave., West Haven, Conn. 1 call Mangini. etc. 5501 Cherokee Ave., Alexandria, Va. 22312
the maryland
=" pharmacist
B. OLIVE COLE 1883-1971 (See page 8)
Volume 47 JULY SF L97,1
Number 7
Compliments of
oxell
CORPORATION
Makers of
NOXZEMA SKIN CREAMS
NOXZEMA SHAVE CREAMS
COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
> each prescription
a test of your professional
knowledge
Even the simplest-appearing prescription requires the exercise of your professional skill and judgment. Is it the
proper strength? Is the dosage within usual or accepted limits? Is it compatible with other medication your
il gh : aaa prescription patient may be taking:
This same judgment also tells you. . . when it comes to your prescription patient’s health (and your reputation ), you
want to dispense the finest-quality pharmaceuticals available.
There are no finer-quality products than those from Lilly.
100215
Eli Lilly and Company + Indianapolis, Indiana 46206 Lilly
S .
... your customers will want to find out all about Venereal Disease. They'll also want to know how you can help them prevent V.D. If you haven't yet ordered your FREE supply of this informative 8-
page booklet . . . or if you require an additional
quantity just mail in coupon.
This pamphlet is contributed as a public service by: Youngs Drug Products Corporation—Manufactur- ers of “Trojan” quality brand prophylactics. Gentlemen: ‘
{] Please send me + copies of
50 100 150 : “Plain Talk About Venereal Disease” in English
[] Please send me __, _..., ___, copies of — 80 100 150 “Plain Talk About Venereal Disease” in Spanish. Name Company Address
City State Zig Fill in above or affix store label.
up Youngs Drug Products Corporation 865 Centennial Ave., Piscataway, N.J.08854
5 | | | ! ! ! l | | | ' ! | ! ! | | | | | ! ' ! ' ' | | ! | ' | ! ' ! | | | ! | !
ail | | ! | ! ' ! | | | ! ! !
The Maryland Pharmacist
NATHAN I. GRUZ, Editor
650 WEST LOMBARD STREET
NORMAND A. PELISSIER, Assistant Editor BALTIMORE, MARYLAND 21201
ASSOCIATION
VOLUME 47
JULY 1971
NUMBER 7
OFFICERS 1971-1972
Honorary President
H. NELSON WARFIELD—Pikesville *
President NATHAN SCHWARTZ—Annapolis
President Elect BERNARD B. LACHMAN—Baltimore
Vice President JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore, Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore STEPHEN HOSPODAVIS (1972)
Cresaptown PHILIP D. LINDEMAN (1973)—Berlin ANTHONY G. PADUSSIS (1973)
Baltimore MELVIN J. SOLLOD (1974)—Adelphi SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore
EX-OFFICIO MEMBERS
FRANCIS S. BALASSONE—Baltimore WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON—Baltimore
President NORMAN J. LEVIN—Pikesville
Secretary
F. S. BALASSONE—Baltimore
Member FRANK BLOCK—Baltimore
Member HOWARD L. GORDY—Salisbury
Member MORRIS R. YAFFE—Potomac
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association HY coher ene Stephen Hospodavis ViceeL resident: poate ee James Ritchie Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association
Presideniva, \catectase ten cc} Irvin Kamenetz ETCSLCN te Le Chae en ter: Joseph U. Dorsch ETeasurergives sets co: Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille Secretary and Executive Director Nathan I. Gruz
Eastern Shore Pharmaceutical Society
Presidente. tte Gordon Harrison
First Vice President....... William P. Smith Second Vice President....... William Connor SECTELOTY Cae een aiscaisicetis ves Carl R. June LV COSUTOY Mees cs ss slsct ees kes Thomas Payne
Prince Georges-Montgomery County Pharmaceutical Association
Presulent: ie rete c ns Siam ae ok oats Martin Hauer First Vice President....Edward D. Nussbaum Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz WATMAUIEG AAAS DESEO oO CRAB OCE Paul Reznek eT CASUT-CT aca en Teenie Siete ates Michael Leonard Honorary President .......... Samuel Morris
Washington County Pharmaceutical Association Presid eniamrere ae Samuel E. Weisbecker Vicon Rresidentar caine ances Joseph Davies Ane eR ey cic Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter Sole ae ae peers ae Paul R. Webster Viceelresidentanane Geen Stephen B. Bierer SCCELAT Vann SAE cro ete het: Donna S. Levin Treasurer
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association President MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE Communications Secretary MRS. RICHARD R. CRANE Treasurer
MRS. CHARLES S. AUSTIN
Membership Treasurer
MRS. MANUEL B. WAGNER
TAMPA — Traveler’s Auxiliary of The Maryland Pharmaceutical Association President WILLIAM L. NELSON First Vice President PAUL J. MAHONEY Second Vice President JOHN MATHENY Third Vice President ABRIAN BLOOM Secretary-Treasurer WILLIAM A. POKORNY Assistant Secretary-Treasurer C. WILSON SPILKER Honorary President HOWARD DICKSON Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER Secretary DOLORES A. ICHNIOWSKI
Treasurer
THOMAS E. PATRICK
University of Maryland School of Pharmacy Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for
changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
TABLE OF CONTENTS
Page Editorial—Innovation in Health Care—
Wille Pharmacye Bees DIG me LOA Cierra teen 6 PHAaATMacys Calendar ccccset cee eae eee ees 7 Ins Memoriam——B® Oliver Colemrscerscesrsete tee eres 8 Maryland Board) of Pharmacy NEWS fees. 8
Installation Address—Nathan Schwartz, President....10
CONVeNGON BRGDOLUS Micmcsrccseeyoemtanees eentee ate dees eet meee eee cere 10 Metropolitan’ Gtild softs bharmacistSa= eee 14 CONVENTION EUS PtS menecese eee tee ee ee 15 HOSpItale Pharma Cy oCCllO lh meee eee eee ee 20
Prince Georges-Montgomery County Pharmaceutical leASsOclatio net te eee 24
Baltimore Metropolitan Pharmaceutical Association..26
Washington Spotlight for Pharmacists .................ccc0..: 29
INDEX TO ADVERTISERS
Page Borden-Hendlerulce Creamer oe eee eae 23 IBELKCy . Bile PLOGCESSIn meena eeeeeeeee ne eee 2a Calverte rule COMPan ya Ll) Chae eee en eee ae 23 Thea Drug RH OUSC LN Cae oe ere ee ee tf lnhsaumy 18%, (Enilvorbay (Cleyeoyeyswohye «ones. secassecrmosn nonrnenosasowneconaoe Zi HynsSonsawestcOtpeece Dinning Lica ea een eee ot lio Lally sand tCompanyacn. sce eee 3 MOYEN AY LDA DEE’ (CLOVEONOEN ONY geccconpscnesasssso.cpouncecoe oucrepannnrchreocsohonnte 32 Manginivand» Associates, Inc.99..0 4) a eee 9 Maryland News:.Company -2..5.5-500 72) ee 25 Noxell + Corporation iacpce ee ee ee 2 Paramount, Pooto. services: 4.1008 ee 19
Pension and Investment Associates of America, Inc...26
ALL tCODIN SO OLD ATI Vaan eee eee ee een eee 13 D. Stuart Webb Advertising Services ............................ 30 Youngs. Drus ProductsseCorporatione ee 4
Editorial...
Innovation in Health Care —
Will Pharmacy Be Able To Act?
Every gathering of two or more pharmacists in- evitably lends to a discussion of the changes in pharmacy and the many problems confronting the profession. There are always references to the impact of the third-party pay- ment prescription programs, hospital-affiliated health cen- ters, the interrelated growth of chain (and supermarket ) pharmacies with the decline in independent practice and so on, ad infinitum.
But perhaps the greatest impact upon pharmacy will come from “health maintenance organizations.” These are groups designed to develop innovative alternative sys- tems of organizing, delivering and financing health care.
Their aim is to utilize the private sector to the maxi- mum extent, using both governmental and nongovern- mental funds. An example is the Maryland Health Main- tenance Committee, Inc. Its statement of purpose says: “One approach that holds definite promise of strengthen- ing access to health services, cost containment, and as- surance of quality is prepaid group practice . . . Prepaid group practice can function in a variety of organizational — forms; however, there are certain basic concepts which constitute this delivery system: a prepaid plan with a broad scope of benefits, the group practice of medicine, integration of ambulatory, impatient, and other compre- hensive patient services, enrollment on a voluntary basis with choice of other systems available, and reimburse- ment by capitation.”
This committee seeks “‘to promote, assist, and pro- vide linkages for development of a network of geogra- phically distributed, autonomous, community-based health centers as a viable alternate system of health care delivery. The committee believes that uniform basic benefit pro- grams and compatible medical information and adminis- trative systems would enable individual group practice facilities to attract enrollment from the organized group market (i.e., labor unions, federal, state, and local goy- ernments and other employer groups) as well as benefici- aries of public programs (such as Medicaid and Medi- care). Both the purchasing groups and the prepaid group practice centers will be served by insurance carriers and other payer organizations who can offer the group prac- tice network benefit packages as a single, clearly defined option to conventional programs.”
Here we see a group made up of private and govern- ment agencies, professional societies, labor unions, health professionals and others interested in the delivery of health services joining together. With the recognition of the importance of this kind of an approach to the problems of medical care, the MPhA Board of Trustees has agreed to participate in the Maryland Health Mainte- nance Committee.
There are, of course, many other organizations in Maryland that are involved in health planning and in establishing new ways of providing for the health needs of the community. If pharmacy is to be a viable element
THE MARYLAND PHARMACIST
in the emerging new patterns for expanding accessibility to comprehensive health care, we obviously will have to be active participants in every effort involving health.
Are pharmacists prepared in attitude and orienta- tion for innovations? There is an urgent need for many pharmacists to be prepared to contribute to the work of these organizations. In addition, the Maryland Pharma- ceutical Association should be in a position to have suffi- cient staff available with special training and background to enable MPhA to provide the leadership and input into the many private, group and governmental programs which already exist and are now proliferating at an in- creasing rate.
Here is yet another critical challenge that must be faced by pharmacy—a challenge that can be met effective- ly only by a representative professional pharmaceutical society that is properly supported by those who have the most at stake—pharmacists!
Time is growing short. Let us hope a positive re- sponse will come in time.
—Nathan I. Gruz
DID YOU HIRE A NEW PHARMACIST LATELY? ... OPEN A NEW BRANCH? ... GET ELECTED TO OFFICE IN YOUR SERVICE CLUB OR SOCIAL OR- GANIZATION? . . . BECOME ASSOCIATED WITH ANOTHER PHARMACY?
WE WOULD LIKE TO KNOW—AND SO WOULD OUR READERS. WHY NOT DROP US A LINE AT THE MPhA OFFICE TODAY.
PHARMACY CALENDAR
September 7-12—31st International Congress of Pharma- ceutical Sciences of the FIP, Washington, D.C.
October 1-4—31st Annual Convention of the American College of Apothecaries, Hunt Valley Inn, Hunt Val- ley (Baltimore), Maryland.
October 10-14—National Association of Retail Druggists Annual Convention, The Rivergate, New Orleans.
October 16-21—National Wholesale Druggists’ Associa- tion Annual Meeting, Century Plaza Hotel, Los Angeles.
December 12-16—American Society of Hospital Phar- macists Sixth Annual Midyear Clinical Meeting, Washington, D.C.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
AMPHETAMINE REGULATIONS
Amphetamine and methamphetamine drugs, alone or in combination, have been reclassified from Schedule III to Schedule II drugs as of August 6, 1971. The change affects some 100 single entity and 300 combination prod- ucts. Full lists of these drugs appear in the july 17 issue of the APhA Newsletter.
MORE PHARMACIES CHOKE TO DEATH THAN STARVE TO DEATH
2.4 times $ 51,862- 25.9% 199,515-100.0% 124,785- 62.5% 74,730- 37.5% 25,481- 12.8%
6.7 times $ 19,434- 9.7%
Annual Turnover Ratio
Inventory Value
Sales (Weighted) 199,515-100.0%
Cost of Goods Sold 129,284- 64.8%
Gross Margin 70,231- 35.2% Employees’ Wages 20,890- 10.5%
Rent and Miscellaneous 20,589- 10.3%
Total Income (Proprietor’s Salary and Net Profit)
HERE'S WHAT INVENTORY TURNOVER MEANS TO PHARMACY OWNERS:
Lilly Digest statistics indicate that the turn- over ratio in pharmacies directly influ- ences the proprietor’s total income. The high turnover pharmacies generated over $6,700.00 more income than the pharma- cies with low turnover and their inventory investment was only 37% of that of the low turnover pharmacies.
27,222- 13.6%
$ 28,752- 14.4% 30.5% more income
Source: The Lilly Digest 1970 Eli Lilly and Company
$ 22,027- 11.1%
THE DRUG HOUSE, INC.—YOUR FULL-SERVICE WHOLESALER—CAN HELP YOU ACHIEVE TURNOVER RATIOS THAT PROMOTE OPTIMUM INCOME FOR THE PHARMACIST
See Your Drug House Salesman For Details
THE DRUG HOUSE, INC. PHILADELPHIA — TRENTON — WILMINGTON
JULY 1971 7
Jn Memoriam B. OLIVE COLE
Dr. B. Olive Cole, well known to more than two gen- erations of pharmacists as a unique personality in phar- maceutical education, died on June 5 at the Maryland General Hospital after an extended illness. She was an Honorary Member of the Maryland Pharmaceutical As- sociation and Baltimore Metropolitan Pharmaceutical As- sociation.
Doctor Cole, 87, was Professor Emeritus of Pharmacy Administration at the University of Maryland School of Pharmacy. Born in Mount Carmel, Baltimore County, Doctor Cole was the first woman to hold a full professor- ship at the School of Pharmacy, earning the distinction in 1948. She also is believed to be the first woman to hold a full professorship at any school of pharmacy in the United States. In 1948 and 1949 she was acting Dean of the School of Pharmacy and the first woman ever to hold that position.
She was graduated from the Baltimore Business Col- lege in 1903 and the University of Maryland School of Pharmacy in 1913. Ten years later she became the first woman graduate of the University’s School of Law, spe- cializing in the legal aspects of pharmacy. She also at- tended evening classes at the Johns Hopkins University where she pursued studies in English, history and eco- nomics.
From 1916 until 1920 she worked as a pharmacist in Washington after which she was appointed an Associ- ate Professor of Botany and Materia Medica at the Uni- versity of Maryland. She retired from the University in 1953.
Doctor Cole wrote a number of articles on the his- tory of pharmacy and also wrote histories of the Uni- versity of Maryland School of Pharmacy and the Mary- land Pharmaceutical Association. The latter was com- pleted in 1957.
Doctor Cole was a life member of the American Pharmaceutical Association. She was a charter member of Epsilon Chapter of Lambda Kappa Sigma Sorority.
She served as President of the Baltimore Branch of the American Pharmaceutical Association in 1935 and was Secretary of the Alumni Association of the University of Maryland School of Pharmacy from 1926 until 1953. She was also a charter member and Past President of the Quota Club International, the only woman member of the Baltimore Veteran Druggists Association and a charter member of the University of Maryland chapter of Rho Chi Society.
In 1966 in tribute to Doctor Cole the Maryland Pharmaceutical Association established the B. Olive Cole Pharmacy Museum in the Kelly Memorial Building. The museum contains antique apothecary equipment, most of it obtained from the collection of L. Manuel Hendler. A number of pieces also were collected by Doctor Cole and some of her former students.
In 1953 Doctor Cole received the Honored Alumnus Award of the University of Maryland School of Phar- macy.
Survivors include 11 nieces and two nephews.
BEES
8
Maryland Board
of Pharmacy News Pharmacy Changes
The following are the pharmacy changes for the month of June: New Pharmacies None.
No Longer Operating As Pharmacies
Read’s, Inc., Arthur K. Solomon, President, 5857 York Road, Baltimore, Maryland 21212.
Big Valu Family Pharmacy, James Cooke, Presi- dent, 100 Governor Ritchie Highway, Glen Burnie, Maryland 21061.
Allentown Drugs, Richard J. Schneider, President, 6325 Allentown Road, Camp Springs, Maryland 20031.
L and M Pharmacy, Inc., Frank F. Cwynar, Presi- dent, 703 Baltimore-Annapolis Boulevard, Glen Burnie, Maryland 21061.
Drennen’s Pharmacy, J. Holly Drennen, 8 South Main Street, Port Deposit, Maryland 21904.
Change of Ownership, Address, Ete.
Hancock Pharmacy, Adolph Baer, President, (Chang of ownership), 39 West Main Street, Hancock, Maryland 21750.
Pacifier Regulations
The first regulations in the nation governing the size, sale and distribution of pacifiers were adopted July 1 by the State of Maryland Department of Health and Mental Hygiene.
The regulations were approved after a public hearing conducted by John J. Appel, Jr., Chief Hearing Officer of the Department of Health and Mental Hygiene.
Appearing on behalf of the Department of Health and Mental Hygiene was Mrs. Beatrice Weitzel, Execu- tive Assistant to Dr. Solomon, who urged that for the protection of children who cannot help themselves, the regulations be adopted. Mrs. Weitzel also reported that the Maryland Pharmaceutical Association had requested that she announce the Association’s support for the regu- lations.
Francis S. Balassone, Chief of the Division of Drug Control, Environmental Health Services, whose agency will eventually be the regulation enforcement authority, also appeared. Mr. Balassone reported approval for the regulations from the Medical and Chirurgical Faculty of Maryland and the Maryland Nurses Association.
The standards for the pacifiers contain these re- quirements: the minimum width of guard must not be less than 42 mm (approximately one and three quarter inches), if made of collapsible soft plastic. If made of rigid plastic material, hard rubber or other non-breakable hard material, the guard must not be less than 38 mm (approximately one and a half inches). The handle must be hinged or collapsible.
Dr. Neil Solomon, Secretary of Health and Mental Hy- giene, had earlier stated that significant evidence has been produced to show that pacifiers below these dimen- sions pose a serious threat to children.
THE MARYLAND PHARMACIST
Mangini can tell you what you have.
Within 1%
Many pharmacists often esti- mate their inventory by relat- ing purchases to sales.
In today's competitive climate and with the cost of merchan- dise continuously rising, these estimated gross profit figures can be misleading. In fact, this can be extremely costly to the pharmacist who. un-
NA
Mangini & Associates, Inc.
4850 W. Belmont Ave. Chicago, III 60641/(312) 282-8181
aware of his shrinking inven- tory and gross profits, ts actually paying a higher in- come tax than he should.
So why guess? Call Mangini for fast, computerized inven- tory service that will tell you within 1% how your inventory realistically stacks up to your turnover, sales and profits!
WRITE FOR DETAILED INFORMATION. IT'S FREE!
11722 Studt St., St. Lows, Mo. 63141 2760 W. Market St., Akron, Ohio 44313 575 Savin Ave., West Haven, Conn. 06516 5501 Cherokee Ave., Alexandria, Va. 22312
INSTALLATION ADDRESS
Nathan Schwartz, President
Annual Banquet Mavyarlivcn bo tu Hunt Valley Inn, Cockeysville
An astute statesman once said that a speech to be immortal need not be eternal. Tonight my remarks will not fall into either category. Nor will I insult your intelli- gence by giving you the usual act about being humble for in reality, my friends, humble people neither aspire to nor ascend to the presidency of either the country, the senate, civic organizations or the Maryland Pharmaceuti- cal Association. A year from now after attempting to deal with the national and local issues facing our pro- fession, | may stand before you and say that [ am humble, but not tonight.
I take the helm of this organization at a time in our history when the improvement and availability of health care services occupies the attention of us all. Now comes a new era, new problems and new opportunities. The drug store has changed from a “ma and pa” store to a significantly large merchandising unit in one-stop shop- ping centers or, in some cases, large professional pharma- cies. Some people say that what has happened is a “‘split- ting with tradition” or “breaking with the establish- ment.” | say it is becoming part of the times. Some peo- ple say it’s revolutionary; I say it is evolutionary. How- ever, whatever one calls it, it inevitably means one thing —change! I think Margaret Mead’s definition of change says it all—‘No man will live in a world into which he was born — no man will die in a world in which he lived.” Change is inescapable; and if this premise is cor- rect as any successful person must surmise, then with the change will come challenge.
“Challenge!” is the key word in the year to come. What were acceptable practices in the past are fast being laid to rest, and in its place are failing ideas, methods and dealings which are making today’s business market fraught with danger, tingling with excitement and spec- tacular with innovation.
I call upon state, local and municipal governments to utilize some of the most brilliant, diligent, multi- talented and clear-thinking people in the state in capaci- ties for which they are so well suited. In the fields of drug abuse, planned parenthood, Medicaid. Medicare, third-party systems and venereal disease, pharmacy lead- ership should not have to remind government to include us in their programs. They should be coming to us.
We are afraid to blow our horns, to claim our vit- tues, to hold our heads high and say, “We are the great- est.” My challenge in the year ahead is to convince you to believe in yourselves. Pharmacy has become the “whip- ping boy” of many. We are beset by lawmakers, news media and political aspirants because we are splintered. It is of upmost importance that the chain operator, the chain pharmacist, the independent pharmacist and the hospital pharmacist realize that the problems of phar- macy affect all of us. We are entwined and interdepen- dent. We must combine knowledge, experience and opin-
10
Convention Reports...
Report of 1970-71 MPhA President Donald O. Fedder
With mixed feelings I stand before you this morn- ing to report to you on my year as president. As many of my predecessors have noted, the year has flown, and there remains so much yet to be done.
The year began for me as an active candidate for the House of Delegates, 2nd District of Baltimore Coun- ty. With the encouragement and support of many but without a political base, I entered the no man’s land of a political campaign and emerged some 13 weeks later a bit battered and bruised but none the less for wear. Both you and I learned much from this and from the cam- paign of Arnold Amass—the importance of strong, dis- ciplined political action and the need for commitment in terms of money and active participation. Incredibly, num- bers of people will vote for a candidate simply because they are asked to vote for him by a friend or neighbor.
We learned that politically friends are friends as long as there is need for support. When that need ceases, a cold, calculated, jaundiced eye is applied to that friend- ship, and changes are often made. We have learned the rules used to win. Whomever we support in the future will benefit from these lessons.
During this year I visited every local association with the exception of the Allegeny-Garrett Pharmaceuti- cal Association. I found the interest in what was happen- ing genuine and refreshing. Our most frequent complaint was the lack of communication existing between local and state associations.
I am happy to report that “The Maryland Pharma- cist” has been appearing with a degree of regularity. I would like to commend the Editor and particularly the Assistant Editor, Normand Pelissier, for their hard work. I would like to now see a qualitative improvement in our state journal. Such items as regular reports of the actions of the Board of Trustees, the officers and a frequent re- port of the activities and projects of the loval organiza- tions would be most welcome.
The most significant achievement in the past year has been the affiliation of our local and state organiza- tions with the American Pharmaceutical Association. Over the past four years we have made steady progress in solv- ing some of our organization’s problems. In the sixties we were constantly plagued by divisiveness between local and state associations. At times we went to the legislature divided. Frequently we wasted precious man-hours and resources, duplicating efforts or just “spinning wheels.”
ion and come up with new ideas to best benefit our entire profession.
I hope to justify your faith in me by doing all in my power to advance the cause of pharmacy. I ask all of you to work with me for the good of pharmacy, and in so doing we shall maintain our faith and our pride in our profession.
“Divided there is nothing we can accomplish — united there is nothing we cannot accomplish.”
THE MARYLAND PHARMACIST
ee ee ee Kad
Some groups became little more than fund raisers without goal or purpose.
This year pharmacy in Maryland has reached a de- gree of maturity. You have said, “Enough with wasted resources; enough with spinning wheels!’ Qne by one, every local organization has affiliated with the Maryland Pharmaceutical Association, and in April, I was quite proud to stand before the American Pharmaceutical As- - sociation Convention in San Francisco to accept the affili- ation certificate that you, in your maturity, overwhelm- ingly endorsed.
We now have established the conduit—the pipeline —through which ideas and policy decisions can flow. The rest is up to you. Action initiated locally can be swiftly directed through the state association to the APhA, de- veloping meaningful input and support from others, and action will result.
With the establishment of the House of Delegates we have another needed organizational improvement, one in which participatory democracy can be made workable. I must emphasize, however, there is no guarantee that this will assure you a role in shaping policy in this asso- ciation. The only way this role can be assumed is for you all to work, to participate, to investigate the facts of each issue and to be informed. Electing delegates is not enough; they must attend the meetings of the House! Yet attendance is meaningless without active participation in the development of ideas and in decision making.
You, the membership, must make a personal com- mitment to yourself and to your profession. Let your rep- resentatives know your problems and your suggestions for their solution. Only then can our organizational framework develop to the maturity that we all need and WENME G6 €
Yesterday, we had reports of the many committees of this association, and I will not repeat them today. As you can see, we had a busy year, with many accomplish- ments and some glaring failures. If I can leave you with any message today, it would be not to accept “progress” reports on face value. We must be ever wary of the very human tendency to accept the status quo and to allow mediocrity to go unchallenged so that progress is re- tarded. We have in us the power to excel! What is needed is the will to excel!
We the membership of MPhA must be constantly in pursuit of excellence in our leadership and in our goals.
Only then can we fulfill our mission—that of pro- viding strong, well-informed direction to promote public health and to assure progress of the profession of phar- macy.
Constitution and By-Laws Committee Melvin J. Sollod, Chairman
This year the changes in our Constitution and By- Laws will have the greatest effect on the structure of our organization since its inception. In the future we will have a new House of Delegates which will expand the number of people determining the policies of the organi- zation.
The new Board of Trustees will replace the Execu- tive Committee. This smaller group will be charged with carrying out the mandates of the House of Delegates. Mail balloting will insure participation by all members in the election of officers.
SLUNG GAA
A requirement for membership is that the new appli- cant be a member of the APhA. All local pharmaceutical associations are represented in the House of Delegates as are the Maryland Society of Hospital Pharmacists, Uni- versity of Maryland School of Pharmacy and students at the School of Pharmacy.
Medicaid Committee Nathan Schwartz, Chairman
When the Annual Convention was held in July 1970 in Atlantic City, a list of 10 proposals regarding Medicaid was drawn up, voted upon and approved by membership. These proposals were then submitted to the Department of Health and Mental Hygiene.
As of this date, one of these proposals has been ap- proved and implemented, the adoption of a_ three-part prescription form. Although the Department of Health included a request for an increase in the Medicaid pre- scription fee, the Budget Department deleted it. Our ef- forts to obtain more equitable compensation, a minimum base fee and a maximum prescription total have been un- successful.
We shall continue in our endeavors by requesting further discussions with other responsible personnel.
Simon Solomon Pharmacy Economics Seminar
Alder Simon, Chairman
‘he 1970 Simon Solomon Seminar was held from 9:30 a.m. to 4 p.m. on November 19, 1970, at the War- ren House Motor Inn in Baltimore.
The registration fee of $15 included morning coffee and buns and a prime rib luncheon. Guest speakers from Chicago, New York, Philadelphia and Baltimore were
featured.
The morning program was devoted to “Discounting” applicable to the retail pharmacy. Our panelists were Richard Schott, President of Merchants Buying Syndi- cate, the leading hard goods resident buying office in the United States, and Allen (Bud) Levis from Chicago, a supermarket consultant and analyst. Immediately follow- ing the discussion the chairman moderated questions di- rected to our panelists. Our luncheon speaker was Dr. Maven J. Myers, Associate Professor of Pharmacy Admin- istration, Philadelphia College of Pharmacy and Science, who spoke on “The Economics of Third Party Payment.” Following lunch, Dr. Dean Levitt, Head, Department of Pharmacy Administration and Associate Professor, Uni- versity of Maryland School of Pharmacy, spoke on “In- ventory Management” and then moderated a question- and-answer period. Our concluding speaker of the day was Raymond A. Gosselin who discussed, “Is There a Profit in Prescriptions?”
Those who attended the seminar acclaimed the day as well worth the time and the fee. A tremendous amount of information not normally available to the retail phar- macist was disseminated in a form applicable to the small- est store.
A total of 70 registrants were in attendance, and ex- penses exceeded income by $343.10.
Public Relations Committee Charles E. Spigelmire, Chairman
If we are to survive as a profession, we must unite all parts of our profession. Pharmacists must also realize that the needs of the public must be recognized. I can assure each and every one of you that no one is more cognizant of these situations than the members of your Public Relations Committee. This is why your Public Relations Committee attempts to instill in the minds of the consumers that the community pharmacist is truly their best neighbor.
We try to create an image that makes you feel proud to be a pharmacist and strive to develop an air of permanency and stability for pharmacy in the communi- ty. We have used radio, television, newspapers and pub- lic appearances to stress the role of pharmacy in public health and welfare. In a sincere effort to help your cus- tomers obtain a comprehensive and intelligent explana- tion of many health subjects your association is again offering you an opportunity to create complete and di- versified Health Information Centers in your stores. Through the efforts of our Executive Director, Nathan Gruz, we have been able to obtain a custom-made pamph- let rack which will hold about 20 different pamphlets. This rack may be obtained from your association for $15. Many pamphlets may be obtained from the State Depart- ment of Health free-of-charge. The success of the Health Information Center depends upon you. You must keep it filled with pamphlets. You must keep it neat and clean, and you must place it in a prominent spot in your store.
Your Public Relations Committee has organized health groups to participate in Poison Prevention Week. As a result the Maryland Pharmaceutical Association, the Baltimore Metropolitan Pharmaceutical Association, the Baltimore Safety Council, the Baltimore City Health De- partment and the Maryland Academy of Pediatrics have contributed time, ideas and advice to help you conduct one of the most successful Poison Prevention Weeks since the inception of this public safety activity.
Be kind to your feet, and they will be good to you. During Foot Health Week we presented Dr. Michael Sher- man, a prominent Baltimore podiatrist, on our radio pro- gram who discussed how important good foot care is.
During National Children’s Dental Health Week Dr. Stephen Overbeck explained the importance of beginning dental care at an early age. Doctor Overbeck also stated that materials needed for child dental care can be pur- chased in our community pharmacies.
Have you ever seen a small child suffering with tetanus? If you have, you would have been deeply im- pressed with our program on ‘Tetanus Prophylaxis.” On this program we presented Dr. Robert E. Marxiin who dis- cussed the disease—how to avoid it and how to treat it. He discussed the drugs and serums used in prevention which are available in drug prescription departments.
One of our most outstanding human interest pro- grams was the one on alcoholism. On this program we presented a member of the Baltimore Area Council on Alcoholism who explained the educational work being done by the Council in curbing alcoholism. Gf course. he informed listeners that prescription medication used in rehabilitation is available.
Our radio program during Pharmacy Week was de- veloped to inform listeners of the tremendous interest the pharmacist has in their safety and welfare. The edu-
12
cational background of the pharmacist, the work and ex- pense involved in opening a pharmacy and the laws and regulations governing the practice of pharmacy were de- scribed.
During Diabetes Detection Week your Public Rela- tions Committee cooperated with Dr. A. A. Silver, Chair- man of Diabetes Detection Week activities. Our weekly radio program was dedicated to this project. Recently we had Dr. A. A. Silver on our Best Neighbor Program to make an appeal for funds to help rebuild Camp Glyn- don for Diabetic Children. The destruction of this camp amounted to approximately $50,000. We have distributed over 500 Camp Glyndon donation containers to our phar- macists in an effort to raise money for this worthy cause.
For many Sundays during the past year at 10:30 p-m. our Association had the benefit of a 15-minute radio broadcast over radio station WCAO. On these programs we discussed many facets of pharmacy. Time and space do not permit me to describe each radio program pre- sented during the past year, but I can assure you that these programs will always say that the pharmacist is, has been and always will be the public’s best neighbor.
For their cooperation I would like to thank Mr. Byron Millenson, Manager of Radio Station WCAO; Mr. Charles Purcell, Public Service Director WCAO; and Miss Harriet Goldberg, Program Director at WCAO. Our achievement during the past year is the culmination of the cooperative efforts of many wonderful people. The magnificent spirit exhibited by this committee made the heavy burden seem light. The brilliant results obtained in our work were due to the untiring efforts of everyone who gave of their time and ability whenever they were called upon. For his ideas and encouragement I want to particularly commend our Executive Director, Nathan Gruz. For their kindness and cooperation I sincerely
thank Mrs. Martha Eckhoff and Miss Hazel Pfister.
Your Public Relations Committee can tell the people all of the many good things about pharmacy, not boast- fully but proudly, because pharmacy is a profession of which the whole world can justly be proud. People do not know unless we tell them. We can tell them by our ac- tions in serving them each day in our stores. We can tell them as we talk with them. There is no need to glorify pharmacy. The honest story is enough, but we must do the telling. If we do not, who will?
Swain Seminar Committee June H. Shaw, Chairman
The 11th Annual Robert L. Swain Seminar was held on Thursday, February 11, 1971 at the Good Samaritan Hospital under the joint sponsorship of the MPhA and the MSHP. The theme was “Pharmacy in the Seventies.”
The Committee hoped to offer understanding of the future trends of pharmacy and to create a forum for dia- logue for pharmacists in all areas of pharmacy. Only the future can measure our success.
The program was well received. The committee wishes to thank all the speakers as well as the drug companies for their contribution to its success.
As chairman, I would like to thank the members of my committee for their support and diligence, Miss
Pfister of the MPhA staff and the MPhA and MSHP for
the privilege of serving in this capacity.
THE MARYLAND PHARMACIST
AW ROBINS
Robitussin
(GLYCERYL GUAIACOLATE)
Robitussin
(GLYCERYL GU AIACOLATE)
i =S 4 >> summer deal starts July1* ~~ ~ includes 4" and 7™ sizes / | \\\.
aang
0 aoe Again this summer you can stock up on Robitussin and . pee “ - Robitussin-DM at special low deal prices. Last year, drug store : ; ae sales of these two cough preparations increased 8%, while the market was up only he 1%. These increases were recorded in chains and in small, medium, and large inde- oe pendents. Robitussin and Robitussin-DM alone now hold a big 10% share of this foe : $100,000,000 market. They are also the most heavily prescribed cough syrups sold wei f ; OTC with over 2 million scripts filled annually. In fact, Robitussin is the only OTC -— a Stock up on. » cough medicine among the 200 most prescribed drugs. In spite of all this Rx volume, * the best sellers some 71% of all Robitussin and Robitussin-DM business is OTC. Stock up heavy on : these two leading cough preparations while they’re on deal by ordering more of the _and put your - 4-ounce and a good supply of the 7-ounce size. And don’t overlook Robitussin®-PE.
, facings where It’s moving up fast in scripts and OTC sales.
ee = f You know these products are going to move off the shelf, so give them the your profits are: facings they have earned. Your Robins Representative will be around to see you
(Deal runs July 1—August 31) soon. Buy ’em while it’s hot for extra fall and winter profits.
ee . a A.H. Robins Company, Richmond, Va. 23220 AH-.OBINS
oe
#
Public Health Information Committee
Paul Freiman, Chairman
The function of this Committee is to involve the Maryland Pharmaceutical Association and its members in the various areas of public health in which the pro- fession of pharmacy can best serve the community. This Committee has worked toward the goal of making the public aware of the role of pharmacy in the health needs of the citizens of the state.
During Poison Prevention Week, March 21-27, 1971, labels were printed for distribution by our mem- bers to their patrons on which were printed the number of the Poison Control Center at the University of Mary- land School of Pharmacy. The public was informed through newspapers, TV and the radio broadcasts that these labels were available at their pharmacies.
Currently we are involved in a campaign on venereal disease. With the cooperation of the Youngs Drug Prod- ucts Corporation and the State Department of Health, V.D. Awareness Month will be launched in June. A press conference kicking off the campaign will be held to which representatives of the press, radio and TV will be invited. In attendance also will be representatives of the various health departments and a guest speaker to pro- vide the theme for the campaign which will be “Help eradicate V.D. through knowledge, prevention and edu- cation.”
During June the public will be asked to go to phar- macies where information on the prevention of V.D. will be available. All pharmacies will have pamphlets for dis- tribution on this problem as well as a list of clinics pro- viding treatment. During this month we hope to establish a speakers’ bureau of organized pharmacists and students who will discuss the problem and prevention of V.D. be- fore various civic and student groups. Again the pharma- cist’s role will be emphasized to make the public aware of our willingness and ability to serve wherever there is
a public health problem.
Metropolitan Guild of Pharmacists
New officers of the Metropolitan Guild of Pharmacists are:
President—John McKirgan
Vice President—Frank Frary
Secretary—Larry Jacobson
Treasurer—Edward Williams
Directors for District of Columbia—Robert Weiss, Paul Reznek and Harold Rosen
Directors for Maryland—Leonard Rosenberg, Michael Leonard and Robert Irby
Directors for Virginia—Lewis Bowles, Milton H. Hur- witz and Richard Dickenson
Tick-Borne Diseases
The City Health Department has recently issued a warning to residents of the danger of Rocky Mountain spotted fever, tularemia, tick-bite paralysis, and other tick-borne diseases. Ticks are most prevalent during late spring and summer and this is the time of highest risk for children and grown-ups who are spending more and more time out of doors.
According to Dr. David R. Berzon, public health veterinarian in the Baltimore City Health Department, not all ticks are dangerous but ticks infected with various diseases are found throughout much of the United States. So far this year the Maryland State Department of Health has received reports of 5 cases of Rocky Mountain spotted fever and 3 cases of tularemia in the state.
Ticks can usually be found in grassy, wooded and bushy areas in the city or suburbs. They transfer them- selves to people and animals passing through these areas. Although there is ordinarily little danger of infection un- less an infected tick has been attached several hours, Dr. Berzon warned that ticks should be treated with caution. These flat, blood sucking, spider-like animals should be removed as soon as they are felt or seen crawling on someone, before they have a chance to bite or become
attached to the body. To avoid being bitten by a tick the Health Depart-
ment makes the following recommendations:
1. Avoid areas of heavy vegetation where ticks thrive and breed.
2. Remove ticks from the person as soon as they are noticed. Use tweezers or a small piece of paper as protection for the fingers. Destroy ticks by burning or disposal in a flush toilet.
3. Children who have been playing out of doors should be inspected from head to toe before they go to bed. Special attention should be paid to the scalp and the back of the head. This goes for adults, too.
4. Pets should be inspected frequently and ticks re- moved and destroyed. Insecticides which keep ticks off pets for a week or more may also be obtained from vet- erinarians or pet departments of retail stores.
When attached to the body for any length of time, ticks become engorged with blood and expand in size. Should one attach itself to you or your child, don’t pull it off or the head may remain in the skin. Alcohol or ammonia applied to the rear of the tick will cause the tick to let go. Grasp the tick near its head and lift gently. A check should be made to be sure no mouth parts are left in the bite and an antiseptic should be applied to the bite area.
Chances are there will be no further developments. However, should a fever over 100 degrees occur within 3 to 10 days of a bite, tick-borne illness should be suspected and a physician seen at once.
THE MARYLAND PHARMACIST
Convention Highlights
President Nathan Schwartz receives gavel from outgoing President, Donald O. Fedder.
Attorney General Francis B. Burch delivered banquet ad- dress. President Schwartz (left) and Board of Trustees Chairman Fedder (right).
Toastmaster McHugh presents award to Morris L. Cooper, 1970-71 Honorary President.
Donald O. Fedder presented Past President’s plaque to Toastmaster John R. McHugh.
H. Nelson Warfield, selected as 1971-72 Honorary President, delivered invocation at annual banquet.
Photo by Paramount Photo Service
JULY 1971 15
MPhA and Local Association Dues Schedule
LOCAL ASSOCIATION DUES SCHEDULE — 1971 (Outside BMPA Area)
Allegany-Garrett County Pharmaceutical ASsOcicttion rssssussssnsseaseseseesneeunsesmsssssesnssares 510.00 Eastern shore: Pharmaceutical + SOC ty eeeccentecr cect te ercrreeeccetaceceert ciate sees eee onan ee oe 5.00 Prince Georges-Montgomery County Pharmaceutical octcccssuccceussseucsosrsesssonnsotneearesenseseanternes 15.00 Washington County, Pharmacenticale ASsociction! tcc ica caneccnees meee nae eens 10.00
All local pharmaceutical associations in Maryland are now affiliated with the Maryland Pharmaceutical Asso- ciation and their dues, therefore, must be included when joining the MPhA.
As Maryland Pharmaceutical Association is now affiliated with APhA (effective January 1, 1971), APhA dues must also be included for new members of MPhA.
Because of the extra services provided to MPhA by APhA as an affiliated state association, in addition to those granted all APhA members, we strongly urge all "“grandfathered’’ MPhA members (members as of Dec. 31, 1970) to also become members of APhA. APhA dues are $35.00.
Maryland Pharmaceutical Association—Baltimore Metropolitan Pharmaceutical Association JOINT DUES SCHEDULE—BALTIMORE METROPOLITAN AREA
Pharmacy Owner or Manager—(fee covers pharmacy and one pharmacist OF MAMCGEL) reseosssssssssssssesessssnsessnseseee $75.00* Pharmacist—other ‘than’ cove sari ccncecsetertstccqteten ces pa te tat css ee sSoese eit rleg eee ies ee ee 50.00* Affiliate—Non-pharmacist executive, other thar OWMer OF MANAGE reseessscsssnsssnsssnssssnsssnsestnssessssnscssnsssessssnssenessnsessenennnssiasesneees 50.00* Hospital Pharmacisi—MemberofsMiS; Hi. Piatra eee ee tr eee ee 25.00
Faculty; medical representative and adminisirative pharmacists) 0-2 ee 15.00** Retired pharmacist, graduate student, new registrants (for the first year), inactive and non-resident secs 15.00** Associate—Non-pharmacist employee or represe4nntcttiveennaacscssecmeresccseeesesseesesvnsoeseseetssonsessoseserssevnssscsessrresensesenasetanssenssceereeaseeansscetesaeneseres 15.00**
* includes $25.00 BMPA dues ** includes $ 5.00 BMPA dues
Build a strong profession — Every pharmacist a member of his STATE and LOCAL Association
Approving of their objectives, I hereby apply for membership
Name in full (Miss; Mrs.; Mr.; Dr.)
TT eee eee e errr rrr rrr rere rer rrr rere rere eee ree errr rrr eer er errr rere rrr rrr rrr irr rrr rire rrr rrr e errr rie errr rrrrirrirrrirrrri i rrrirrreer rier rr rrr rere
lalla tae TT ETP ee eee errr r errr rere r reer rere rere rere rr rrr rrr ree rr rrr reer reer rieee rere rerirrrrerrrrrrir rire reer eee
PP eee eee eee rrr Tree rere eee eee reer Terre rrr rrr rrr rr rrr rrr rrr rrr errr errr rrrr rire rrr rr rrr reer rere ere rir rir reer Tir rrr rr rrr rrrie eerie errr rrr
Member=7A.Ph.At soo ee eee INGALRD ace ee Local, etc. (name) *Fill in all blanks.
Or eree eer re rere reer errr e rr eere errr errr eer errr rere rere rere ee eee cere eee reer eee TTT ys
REFERENCE (Member’s name) Mail check with application.
NOTICE—This questionnaire is designed to provide information to enable the Association to serve you more effectively.
10.
iu he
12.
Please complete, detach and return to MPhA office.
Maryland Pharmaceutical Association 650 West Lombard Street Baltimore, Maryland 21201
BIOGRAPHICAL INFORMATION SHEET
Pharmacy/Firm/Institution Owner [] Employee (] Partner [] Officer [] Pharaneg eNO set eters: NG ee G ee If pharmacy, what hours open? .............::s0s000000 Te eee eect. or eee tent in ar vacant coves ates tee sheas dap onsen sce ceaeres
SCHOCUG MEIDCLVIC al Meee ttn tra Oe crs ee tees eay rece cre mace ieee feveeectnerstemte eeaeeerenuecess Full time Pet
Part time ([]
Emergency service ........ Delivery service
In your practice do you maintain patient medication records? Yes ........ Noga.
PSUSITESSMACULESS MRS rer rtt et rere eet ree tet cet oereennt crete ttc eitce ei tatisancdraconccessrs sees Lelephomne jaz yeiresetcs- eters sseccesspeere
Preferred mailing address: Home ...... Business ......
AAU CALLON mmo 1) SCHOOL OE erscicert teres ees renee eat tes eae heaters certs t ces ih oceeactedatsacésess AY CARMI ries Be ed oer terest College meer enter ert tess eee ee teces yctegen tes tredssacencaettsacisacsenstes NV CALM eye secrcsree sete ctnertetaer- coroners School of Pharmacy Other postgraduate education Professional seminars and continuing education ...... List on reverse side.
Previous positions held ...........ccccscsssessssssssececesesencsense tiesensnensesesssessnssesessnensessessssssssssserssenssesenenenenensneneeanensenscanensaenentes
Military experience oo... eeesssscsessssesessesssesesessenesesescsenscsssessseesessnsesenenseeeensnenesacsansecsnsnseccsesescescaaeasesasssnsessneseees
Professional organizations: APhA ...... Asn eee. AGAS.. NARD ...... MSHEP ......
Tet r OL Ce a irre ons ccec cia cecteaeccooutesovantielenrcevecssznconctecessenessensinesdeashectacensecssoncersbhcsaes
eee eee eee ee eee eee eee eH OSES HEHEHE SEES SES ESS EESH SEH EEE SES SEES OSTHS EES SSEEHEEH SHEE EOE » SBRBEISOCARIIUR OCD COO BORCOODCTNIOCODOORRUCDODOCOOCICTOOCT DOOD TO LCCC OOOO OOORUR CTC OGIO GOO EO Ne TR OI BT sialic Nae
Pee eee eee eee eee eH ees eE HEHE EEE H ESTES ESO EEHS EOE SES HOSS ES SEES HESHSESHSESEH SESE EHO OHES BINT RGCORCAROOLD CO OCORDOOO DO TTOORTISOOACUOUOF DRO RDOOU AME IOOCCONCLE OCOU OA RIOT RIO REMERON aN Sa Sad Pa = be
PoeeUeREPOEOEE CCC CTC eee eee eee eee H HEHEHE E OEE OEEOEEHHTEE ESE SES SES SESH SESHEE HOES EED whe saselvisins vis 6 5.0 bs cle vials celcw se 6.0'nle006.0]s6.0600 60600060 cececee cee ses e bese eneeTecsecsies 20 05S08©
If additional space is required for any item, please use reverse side or submit separate sheet.
13. Special interests: Political “Action 208. ah acs ee
Membership {promotion e000. ceee tenn eee ee Employee stelations=,.2.,th.csstecceacueetee tee reeneeee Continuing =education gene tn. ene ere nets Public relations %7./...), .<acgersse ace ee eee Schools of spharmacyyy, 22 MAg act niree nee Health: Centers’ 73). cacasat ete hose ene ee eee Lastitutional | Pharmacy ew secs eeesee rete Pharmacy practices \:.or,c./icceer apenas teeta! Publications sauce ee Convention, and imeectin gs gcc. yee rete erate Professional relations|] (seg wnavescceekreusdectar et eee Industry) relations Gera us aetna eee Legislation (250 Wate cn ete: CA en ere ee Third-party Rxaplansi x. 20. accr een eee ee ee Liaison with voluntary health agencies: (cancer, heart, €tG) 5 cecvy.ecnees sone crer aman ones satan esents eee ee 14." Suggested: topics for, meetings © 5, ...scccstesno-cescecesccstecccie coseesceseavetosssutiestatadteres codes ddr ces deee Olay Hee genat ere ed te te agente tee Professional. and scientific? semimars 62.235. cocliiscsasscecsudencovsvadendetedesouamenccacdactares. Cres taxcpa eines eetioer te eee aan ee Management. or economic, Seminars o205.0.15, 3. boots ues vs tousncane tanateestedate tee bolls on Gg hee aatE paca eee ee 15. MPhA convention: Preferred months (1) ................ Re ocak ores rere (32) Petree te Suggested: sitese(\1)).y. ee ee ee (Di) Sena ton andes eee tier ones (3) pti rieesaetens etecaeseereares
16. I would like to participate in a speakers’ bureau on:
Drug Abuse ...... Venereal Disease ...... Poison Prevention ...... Cost of Drugs ...... Pharmacy as a Career ...... Others © .ssisecered cock bevssveel Chssaoeledeyscescbesocutee cope ees oun eT a ee 17. Legislative and governmental contacts (patrons, friends, etc. ) i.e. ceseseseesdeacdetesdcsiotet tee
TEETER meee eee EHH EEE EEE EEE EH SESE EEEEEEEEEEEEEEE EE EEE ES EEEEES EEE EEE EEE EEEEH EEE EE HEHEHE EEEHEHEEEEHEEE EEE SEES HEHEHE EEHEEEEEEE EEE EEHEE ESHEETS ESSE HEH EEE EE EEE EE EEEEES SEES EE EEES!
MPhA MEMBERSHIP BENEFITS
Check below to receive information about plans.
Major Medical Plan |] 5. Retirement Investment Program Tax-free Disability-Income Replacement [] 6. Hospital Money Plan Plan || 7. Bad Debt Collection Service bel 83
Professional Liability Plan
Employment Register Family Life Insurance Plan
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4. Salesman inventory control
To get the complete story—call collect [301] 243-4439 PARAMOUNT PHOTO SERVICE
3024 Greenmount Avenue Baltimore, Maryland 21218
JULY 1971 19
Hospital Pharmacy Section
MARY W. CONNELLY President MARYLAND Society or HospitaAL PHARMACISTS
Mary W. Connelly, Chief Pharmacist at Mercy Hos- pital Baltimore, was installed as President of the Mary- land Society of Hospital Pharmacists at the Society’s Sixth Annual Hospital Pharmacy Seminar held at Ocean City, Maryland, June 11, 12, and 13, 1971.
Miss Connelly, who has been Chief Pharmacist at Mercy Hospital since 1968, is a 1951 graduate of the University of Maryland School of Pharmacy. She was Chief Pharmacist at Bon Secours Hospital in Baltimore from 1951 to 1957. From 1958 to 1968, she was associ- ated with the Eastpoint Medical Center.
Miss Connelly has been active in many pharmacy organizations among which include the American Phar- maceutical Association, American Society of Hospital Pharmacists, Maryland Pharmaceutical Association, D.C. Society of Hospital Pharmacists, National Catholic Phar- macists Guild and the Maryland Pharmaceutical Foun- dation,
She has served as Secretary of the Maryland Society of Hospital Pharmacists from 1956 to 1968, Secretary of the University of Maryland School of Pharmacy Alumni Association, 1970-1971, and is presently Secretary of the Lambda Kappa Sigma National Pharmaceutical Women’s Sorority. She also holds membership in the Democratic Club of Baltimore County.
20
Maryland Society of Hospital Pharmacists — Sixth Annual Hospital Pharmacy Seminar
The Maryland Society of Hospital Pharmacists held its Sixth Annual Hospital Pharmacy Seminar on July 11, 12, and 13, 1971 at the Carousel Motel in Ocean City, Maryland. Nearly 200 registrants and guests at- tended the three day seminar.
Included among the topics presented were: “The Philosophy of Supportive Personnel in Pharmacy” by Henry J. Derewicz, Director of Pharmacy Services at the Johns Hopkins Hospital; “Computer Applications to the Health Care System” by Cornelius P. McKelvey, Adjunct Instructor at the University of Maryland School of Phar- macy; “Pharmacy Services in a Small Hospital” by R. David Anderson, Director of Pharmacy Services at the Waynesboro Community Hospital, Waynesboro, Virginia and “Pharmacy Service in the Emergency Room” by Thomas E. Patrick, Chief Pharmacist at the University of Maryland Hospital.
Other speakers included Louis P. Jeffrey, Director of Pharmacy Service at the Rhode Island Hospital; Paul LeSage, Deputy Director of Pharmacy Services at the U.S.P.H.S. Hospital in San Francisco, Douglas R. Mow- ery, Director of Pharmacy Services at the Washington Hospital Center and Dr. Peter P. Lamy, Associate Profes- sor and Director of Institutional Pharmacy Programs at
the University of Maryland School of Pharmacy.
The Banquet Address, entitled “The Pharmacist on the Health Care Team,” was presented by Dr. John Col- lins Harvey, Medical Director of the Good Samaritan Hospital in Baltimore.
Among those receiving awards were Paul LeSage, recipient of the W. Arthur Purdum Award; Marsha Fruchtbaum, recipient of the M.S.H.P. Student Achieve- ment Award and Robert E. Snyder, recipient of the Geigy Achievement Award.
CHANGE OF ADDRESS
When you move—
Please inform this office four weeks in advance to avoid undelivered issues.
"The Maryland Pharmacist" is not forwarded by the Post Office when you move.
To insure delivery of "The Maryland Pharmacist" and all mail, kindly notify the office when you plan to move and state the effective date.
Thank you for your cooperation.
Nathan |. Gruz, Editor Maryland Pharmacist 650 West Lombard Street
THE MARYLAND PHARMACIST
A Professional Planning and
Remodeling Service
Should you upgrade your present location or select a new site in order to achieve your objectives for your business?
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
3. A complete sundries program providing sundries
departments and inventories designed specifically
for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
4 A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation.
5. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
THE HENRY B.
GILPIN
COMPANY BALTIMORE * DOVER + NORFOLK + WASHINGTON
Gilpin offers professional assistance in site selec- tion, floor design, fixturing and merchandising. Consult your Gilpin representative. He can help you build a better business.
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange
for Gilpin specialists to tailor the services which your particular interest or situation requires.
Sirs:
j ! am interested in the following programs. Please have your
representative contact me in this regard.
i
i Name
I Name of Pharmacy Ada¢s6 Phone. City. States 21
Ee a oa aa a ly
™l ; t i : I al
NEW EDITION AVAILABLE TO fale
PROFESSION INTRODUCTION
TO THE PRACTICE
OF PHARMACY
a guide for preceptors
and interns
Revised and re-edited by a joint committee of the National Association of Boards of Pharmacy and the Amer- ican Association of Colleges of Phar- macy in consultation with boards of pharmacy, colleges of pharmacy, state and national association leaders and pharmacists throughout the country.
This 60-page manual is the official NABP publication for internship eval- uation, standards and procedures. It is an essential in training programs:
e For pharmacy preceptors who are training students to qualify for licen- sure — what is expected and what to expect from the student.
e For students who are gaining ex- perience — what activities wil/ assure the full value from the internship period.
e For those interested in the general ethics and aesthetics of orienting fu- ture pharmacists to practice — com- munity and institutional.
INTRODUCTION TO THE PRACTICE OF PHARMACY
Mail to: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY 77 West Washington Street Chicago, Illinois 60602
Prices: Single Copies — $1.00 100 or more — $ .90 Please send copy(s) of the
PHARMACY PRECEPTOR’S GUIDE- A Manual for Internship Training.
NAME (Please print)
ADDRESS
Cltey,
STATE ) Payment Enclosed L) Bill Me
ALP
22
TNSEELESNIEW Seer
JOSEPH D. MANGINI, president of Mangini & Associates, Inc., inven- tory specialists with branches in five principal cities specializing in com- munity and hospital pharmacy inven- tories, was honored on June 6 by the Chicago-Joe Fox Lodge B’nai B’rith. Mr. Mangini was honored for his “outstanding support and contribu- tions” to the Jewish community in the Chicago area. He is a past president of the Illinois Pharmaceutical Travel-
ers and a member of the Chicago Drug Club since 1951.
VINCENT DE PAUL BURKHART has been appointed Assistant Chief Pharmacist at the University of Mary- land Hospital in Baltimore and Clini- cal Instructor on the staff of the Uni- versity of Maryland School of Phar- macy.
DR. RALPH SHANGRAW of the University of Maryland School of Pharmacy and ROBERT E. SNY- DER, past president of the Maryland Society of Hospital Pharmacists, par- ticipated in Careers Day at the Com- munity College of Baltimore. Mr. Snyder has recently been appointed by ASHP president R. David Anderson to serve a one year term on the ASHP Council on Organizational Affairs.
DOUGLAS J. GALLOW has been named Director of Market Research by NOXELL Corporation, Baltimore, Maryland.
VICTOR H. MORGENROTH, JR. will serve as Convention Chairman of the 31st Annual Convention of the American College of Apothecaries, October 1-4, 1971 at the Hunt Valley Inn, Hunt Valley (Baltimore), Md.
ABBOTT LABORATORIES has re- sumed full production of intravenous solutions at its Rocky Mount, N.C. plant. Abbott is reentering the market with a rubber-stopper closure and new equipment for administering intra- venous solutions developed under an agreement with Cutter Laboratories.
The TONI DIVISION of the Gil- lette Company is changing its name to The Gillette Company, Personal Care Division.
Copies of ‘‘Guidelines”’ Available
Copies of “Suggested Principles and Guidelines for Pharmaceutical Serv- ices in Hospitals” are available at no charge from the MPhA office. Since there is only a limited supply avail- able, please contact the office now.
Balassone Receives Harvey
Wiley Award
Francis S$. Balassone, Secretary of the Maryland Board of Pharmacy and Chief of Drug Control for the Mary- land Department of Health is the first pharmacist to receive the Harvey Wiley Award from the Association of Food and Drug Officials. He received the award for “outstanding contribu- tions” in administering state food and drug laws.
Product Announcements
Geigy Pharmaceuticals announces the introduction of Preludin Endurets 50 mg. (prolonged-action phenmetra- zine hydrochloride). This new dosage strength is intended to provide greater flexibility in individualizing weight- control programs.
Mead Johnson Laboratories an- nounces that a substantia! portion of
the Vi-Sol/Vi-Flor vitamin product -
lines have been reformulated to in- clude natural sweeteners in place of saccharin. Taste preference for the re- formulated products was expressed in extensive studies carried out using taste test panels.
Mead Johnson Laboratories is also introducing a new product, Sustacal, a nutritionally complete food recom- mended for nutritional support in a broad range of conditions that may include physically incapacitated pa- tients, patients with various types of paralysis, patients with appetite loss, and patients with food prejudices.
Important Notices
Pharmacists are urged to advise the Association office (727-0746) regard- ing all proposals or contracts regard-
ing prescription plans they may re-_ ceive. These plans are reviewed by the Association legal counsel before
being endorsed by the Association.
Please note that according to re-— cently passed Senate Bill No. 4, pre-
scriptions are not valid unless the phy- sician’s signature is legible to the phar- macist filling the prescription. This would not pose a problem when the physician has his name imprinted on the prescription blank but could be a factor where prescriptions originate from hospitals where the physician does not use his own personal blank.
THE MARYLAND PHARMACIST
r
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
First name in ice cream for over a half-century
ICE CREAM
675-6000
JULY 1971 23
Prince Georges-Montgomery County Pharmaceutical Association
Samuel Morris cited for outstanding work.
Rudolph F. Winternitz presented 1970-71 Order of the Double Star Award by Coleman Levin, National President, Alpha Zeta Omega Fraternity.
Herman Bloom, “official photographer” presented commen- dation certificate by Rudolph F. Winternitz.
Left to right: Samuel Morris, Honorary President; Paul President; S. B. Friedman, Second Vice President; Rudolph Reznek, Secretary; Gabriel E. Katz, Fourth Vice President; F. Winternitz, Chairman, Executive Committee; Michael Martin Hauer, President; Edward D. Nussbaum, First Vice Leonard, Treasurer.
Photo by Paramount Photo Service
24 THE MARYLAND PHARMACIST
_ _.. Readin iS Still the fastest wa
to program the.
brain
@
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
human ——
Pe
SK
te |
——| es
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
31st Annual Convention of the ACA to be held in Baltimore
The American College of Apothecaries invites all pharmacists and others associated with the profession to attend its 3lst Annual Convention at Hunt Valley Inn, Hunt Valley (Baltimore), October 1-4, 1971.
Guest speakers will include Mr. Henry J. Derewicz, Director of Pharmacy, Johns Hopkins Hospital, Balti- more; Dr. Ralph Shangaw, University of Maryland School of Pharmacy; Mr. Ralph Engel, Director, National Phar- macy Insurance Council, Washington, D.C.: Harry M. Robinson, M.D., Dermatologist, Baltimore; Mr. William Towle, Administrator, Columbia HMO and Henry Seidel, M.D., Medical Director, Columbia HMO, Columbia, Maryland; Samuel L. Fox, M.D., Ophthalmologist, Balti- more and Dr. William J. Kinnard, Jr., Dean, University of Maryland School of Pharmacy, Baltimore.
The program will include lectures and panel discus- sions on Dermatology and Ophthalmology, Private Third Party Prescription Programs, Generics and Pharmacy- Industry Relations.
Social and food functions will include an evening at the Limestone Valley Dinner-Theatre and a cruise on the Chesapeake Bay featuring a Maryland crab dinner on board.
Convention Chairman Victor H. Morgenroth, Jr., reminds pharmacy students that the registration fee will be waived and a special invitation is extended to them to attend any or all of the sessions.
Hotel and registration information are available from the ACA, 7758 Wisconsin Avenue, Suite 412 C, Washington, D.C. 20014.
Baltimore Metropolitan Pharmaceutical Association
The Baltimore Metropolitan Pharmaceutical Asso- ciation held a general meeting at the Kelly Memorial Building on Thursday, June 10, 1971 at 8:45 P.M. The evening's speaker was Benjamin L. Brown, Deputy State’s Attorney for Baltimore City. Mr. Brown’s topic was en- titled “Crime and the State’s Attorney’s Office: The Phar- macist’s Concern With Crime—From Shoplifting to Pre- scription Forgeries.”
Camp Glyndon collection cans were turned in at the meeting.
Obituary
JAMES A. MEMBERT
James A. Membert, 67, retired president of Wash- ington Wholesale Drug Exchange, died on June 8 after a long illness. A lifelong resident of the Washington area, he was a member of the Traveler’s Auxiliary of the Maryland Pharmaceutical Association for many years.
26
A Pharmacist Speaks
The following is based upon an open letter submitted for publication in the Prince Georges-Montgomery Coun- ty Pharmaceutical Association “Bi-County Pharmacist” by Simon Zvares, an MPhA member in Silver Spring:
Would you travel to the seashore and live in a room until you leave for home without enjoying the seashore? Would you go to the mountains just to stay in one room and not enjoy the outside view? NO! Yet you join the Maryland Pharmaceutical Association and do nothing to help your profession and yourself even though the two go together.
Why don’t you come to meetings, meet your col- leagues, but mainly why don’t you get involved? The best way is to serve on a committee. You can be a committee member even if you don’t have much spare time. Just spend a little time on the telephone as part of member- ship, of programming meetings, public relations, or even eight or nine other committees. You will get to know a nice group of your kind of people—fellow pharmacists.
Do you have a yen for politics? Then we really need you! Pharmacy is joining the politicians to prove to them that the pharmacist is a professional man. We meet hun- dreds of people in the community each day with more frequency and closed contact than a physician, lawyer or any other professional man. We really get the pulse of the community.
Participate in a committee and see how much better you will like being a pharmacist. Join in the committee work; feel like somebody, and you will find that you are somebody. Join with us to make a better way of life!
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships)
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
THE MARYLAND PHARMACIST —
fenlarge your service with enlargements
5 x7’s and 8 x 10’s are fine. But the bigger the enlargement, the bigger you make it. In profits. In customer satisfaction. Large prints are easy to sell. They’re in demand as wall portraits, gifts, for framing as wall decor... you name it. When it comes to big blow-ups, Berkey does it all. 5x7,
8x 10, 11 x 14 and larger. In color, up to 11 x 14. Black and white up to 16 x 20. We even make 11 x 14 proof sheets _ from ultra-miniatures. Berkey enlargements are better because it’s a specialty with us — handled only by experts. - Compare our color rendition and sparkle. 5x7’s and
8 x 10’s returned in a frame at no extra cost. You — and your customer will appreciate Berkey’ s better quality and prompt service. Just drop the enlargement orders, regular and over-size into the Berkey bag. We'll give them the Berkey treatment. Custom-care printing rigidly checked and double-checked by the tough quality inspectors in the business.
Berkey can do things for you that nobody else does, — because nobody else can. And ‘‘one supplier, one bill” will simplify bookkeeping for you too. Call or write your nearest Berkey Laboratory now for the complete schedule of Berkey services and prices. ©
[= Berkey Film Processing td of Washington, D.C. 3701 Mt. Vernon Avenue Alexandria, Virginia 22305 (703) 549-7500
percey ip
Photo Inc.
Contributions... 1971 Annual Convention
Sustaining Members
Calvert Drug Company
The Henry B. Gilpin Company Loewy Drug Company
Miller Drug Sundry Company Maryland News Company Borden-Hendler
Cash Contributions
Abbott Pharmaceutical Products Division Ayerst Laboratories
Burroughs Wellcome and Company, Inc. Ciba Pharmaceuticals
Geigy Pharmaceuticals
Eli Lilly and Company
Mead Johnson Laboratories
Merck Sharp and Dohme
Miles Laboratories, Inc.
Norwich Products
Parke, Davis and Company
Personal Products Company
Pfizer Pharmaceuticals
William P. Poythress and Company, Inc. A. H. Robins
Smith Kline and French Laboratories
E. R. Squibb and Sons, Inc.
The Upjohn Company
Youngs Drug Products Corporation
Merchandise
Alcon Laboratories, Inc.
Allen, Son and Company Colgate-Palmolive Company Ex-Lax, Inc.
Father John’s Medicine Company, Inc. Glenbrook Laboratories
The Gillette Company
Kaz, Ine.
Max Factor
The Mentholatum Company, Inc. Noxell Corporation
Organon, Inc.
Purepac Corporation
Resinol Chemical Company
Sea Breeze Laboratories, Inc.
MPhA Commends Manufacturers For New Starter Dose Policy
At its 89th Annual Convention Meeting, the Mary- land Pharmaceutical Association commended those phar- maceutical manufacturers that have eliminated traditional prescription drug sampling. These manufacturers initi- ated a controlled system for the introduction of new drugs in which physicians will prescribe prescription orders for their patients. This change produces greater distribution controls which are important in preventing diversion of drugs and the dangers of poisoning from samples discarded in trash receptacles. MPhA decided to investigate what legislative or regulatory steps might be needed in the interest of public health.
28
Postage Stamp for Pharmacy
The first known organized attempt to have a post- age stamp issued in honor of Pharmacy occurred in 1934 when a resolution was introduced at the annual meeting of the American Pharmaceutical Association in Wash- ington, D.C. Since that time there have been numerous other attempts by individuals and groups to achieve this goal. (For a history of these efforts, the reader is referred to the January, 1964 issue of JAPhA)
According to Henry Szancer in Drugs and Pharmacy on Stamps by George Griffenhagen (Topical Handbook No. 55, American Topical Association), 58 personalities connected with pharmacy, including William Sydney Porter (licensed pharmacist in N.C.), have been pictured on the stamps of 44 countries to date—none of these be- ing United States stamps.
Several major health professions have been recog- nized on U.S. stamps in the last 25 years. The American Medical Association was so honored in 1947; the Ameri- can Dental Association, in 1959; and the Nursing Pro- fession, in 1961.
Many believe today that the prospects of a Phar- macy stamp never looked brighter. The fact that Senator Robert Griffin has presented a statement to the U.S. Sen- ate and has written to the Postmaster General in support of a postage stamp in honor of Pharmacy is certainly en- couraging but a lot more support has to be demonstrated. The 91st Congress has seen 63 resolutions and joint reso- lutions calling for the issuance of 34 commemorative stamps. Of these, only five have brought forth the desired stamps and two of the five recognized major events that occurred that same year, namely the launching of Apollo 11 and the passing away of former president Dwight D. Eisenhower.
The Post Office generally issues about 15 commem- orative stamps per year. Of the approximately 600 com- memorative stamps issued to date, more than 500 have been issued in the last 30 years. The Post Ofiice receives from 250 to 300 proposals each year for stamps and presently has a backlog of requests for about 3000 dif-
ferent stamps.
The final decision as to what subjects are chosen for U.S. commemorative stamps is made by the Postmaster General with the assistance of his Citizen’s Stamp Ad- visory Committee which consists of approximately 12 members. To help them arrive at this decision, pharma- cists are urged to request that their congressmen contact. the Postmaster General in support of this stamp. In addi- tion, pharmacists should write directly or wire the Post- master General: The Honorable Winton M. Biount, Post- master General, Washington, D.C. 20260.
THE MARYLAND PHARMACIST
Washington Spotlight For Pharmacists by APhA Legal Division
NAS-NRC Drug Efficacy Evaluations Must
Be Disclosed in Drug Labeling And Advertising
New regulations of the Federal Food, Drug and Cosmetic Act will require the disclosure of the National Academy of Science—National Research Council evalua- tions for those claimed uses of a drug classified as other than “effective,” in the drug labeling and advertising.
The Food and Drug Administration has concluded that the NAS-NRC evaluations must be disclosed in labeling and other promotional material of a drug. The failure to disclose this material fact will result in the
drug being misbranded.
Thus, where the NAS-NRC has concluded that a drug is “ineffective,” “possibly effective,” “probably effec- tive,” or “ineffective as a final combination” for a par- ticular claimed use, all package labeling, promotional labeling and advertisements shall include, as part of the information for practitioners, an appropriate qualification of these claims.
This requirement was objected to by the various manufacturers associations, but supported by various groups including APhA. In overriding these objections, the Commissioner concluded that there is no reason why these judgments should not be shared with the medical profession in drug promotional material, and that such disclosures should lead to better patient care and to a better understanding by the physician of the drugs he prescribes.
Unlawful Narcotics Prescriptions
A Maryland physician was recently convicted of prescribing narcotics in a manner not authorized by the State Narcotic Drug Act. This conviction was sustained on appeal. The Appeal court held that his conduct fell so far short of minimum standards of diagnosis, treat- ment and care that it was a mere subterfuge.
A former drug addict, acting in cooperation with the police department, introduced a policeman posing as a drug addict to the physician. The policeman asked the physician for methadone and secobarbital. The physician, after asking only his name and address, wrote prescrip- tions for these drugs. The physcian indicated that he may have to take a urine test, “just to make it look good.” No test or other examination was ever made. The police- man obtained prescriptions for these items again upon the payment of $10.00. The physician did not inquire as to his condition, but only asked how many tablets were de- sired.
) Federal law also prohibits this type of activity. The regulations of the “Controlled Substances Act” require that a prescription for a controlled substance to be effec- tive must be issued for a legitimate medical purpose by a practitioner acting in the usual course of his profes- sional practice. An order purporting to be a prescription which is not issued in the usual course of professional
JULY 1971
treatment or authorized research is not a_ prescription within the meaning of the Act. A person who knowlingly dispenses a controlled substance pursuant to such a pre- scription is subject, along with the prescriber, to the penalties provided for the violation of this law.
A prescription is also invalid under the “Controlled Substances Act” if it is issued for the purpose of continu- ing a person’s dependence upon such drugs.
Pharmacists are reminded of their duty under both State and Federal law to determine the validity of a questionable prescription order.
THE DOOR TO CONSTRUCTIVE DISCUSSION
29
Physician Held Negligent for Disregarding Manufacturers Warning on Possible Effects and Dosage Recommendations
The Minnesota Supreme Court recently held a phy- sician negligent for his failure to heed the warnings on possible side effects and dosage recommendations of a drug manufacturer. The physician was held liable for his patient’s death as a result of the side effects of the drug, in a wrongful death suit brought by the woman’s heirs.
The patient was suffering from acute purulent otitis media. The patient did not respond to peniciilin therapy and a culture indicated chloramphenicol to be the most effective antibiotic in this situation.
The chloramphenicol produced improvement and the prescription was renewed several times. Three months later there was an exacerbation of the otitis and the pre- scription was renewed again. Three days later, after a hemoglobin test, it was again prescribed.
Six and one-half months later, the woman was ad- mitted to a hospital for hemorrhaging. The pathologist found severe anemia and bone marrow suppression. The woman died several weeks later of a gastro-intestinal hemorrhage due to aplastic anemia.
The suit was filed against the drug manufacturer and the physician. The suit claimed that the drug manu- facturer was negligent for placing the drug on the market without adequate warnings, and that the physician was negligent in prescribing the drug.
At the trial, the manufacturer introduced evidence showing that the proper warnings were disseminated. The physician testified that he was familiar with the warnings and the recommended dosage.
Several other physicians testified on the warnings and tests to detect the development of the side effects.
The trial court directed a verdict in fayor of both the manufacturer and the physician since it had not been shown that the failure to make the appropriate tests was the cause of death, or what the standard of the profession was in regard to the use of this drug.
On appeal, the court agreed that the drug company was not liable, but reversed the directed verdict for the physician. The court held that the deviation from the manufacturer’s warning and dosage recommendations re- quired him to explain the reasons for such deviation. The court also held that there was sufficient evidence to indi- cate that the physician may have been negligent in fail- ing to take periodic blood tests.
While a pharmacist was not involved in this suit, this case should serve as a reminder to all pharmacists to obtain the proper authorization before refiiling medica- tion for a patient. This is especially important in regard to those drugs which are known to produce severe side effects. A pharmacist who indiscriminately refills such medication could find himself party to a similar suit.
30
TOUR AND FROLIC IN EUROPE’S CITY OF REGAL TRADITION AND FAST TEMPO
For Members of The Maryland Pharmaceutical Association and Their
Immediate Families
SWINGING LONDON
November 7 to 14, 1971
All-inclusive cost—$389.00 per person (based on double occupancy )
Federal transportation tax—$3.00 per person
Supplemental cost for single room—$48.00
Reservations on this fabulous trip can only be con- firmed upon receipt of a deposit in the amount of $50.00 per person. All deposits and monies paid are refundable in full until September 25, 1971. After this date, refunds are subject to resale of reservation(s).
All Deposits Are To Be Made Payable and Seat To:
MATTERHORN TRAVEL SERVICE 1923 West Street Annapolis, Maryland 21401
For further information, please call 269-0123 (local Baltimore line ).
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
THE MARYLAND PHARMACIST
MERCUROCHROME
HW&D BRAND OF MERBROMIN
Minor injuries requiring first-aid treatment occur frequently during the vacation season. Neglect of these injuries may cause infections which frequently can be prevented by prompt use of Mercurochrome. When Mercurochrome is the routine antiseptic, minor injuries are reported more promptly, because treatment is not painful.
Include Mercurochrome in your first-aid supplies!
Detailed literature available on request.
HYNSON, WESTCOTT & DUNNING, INC.
Baltimore, Maryland 21201
(mM-6)
There’s a lot more
OE oe Sd esti
going for you at LOEWy?
COMPUTERIZED SERVICE
puts America’s most advanced warehouse facility behind your store
How much is it worth to you to know that the most advanced computerized distribution system in existence isin motion to process your every order
. instantly, efficiently, completely? That you needn’t ever stock more than a minimum ofa far greater variety of merchandise than you could ever show before... and without investment in excessive inventory? That your wholesaler is never likely to be out-of stock on any desirable item? That every invoice and statement is assured of up-to-the-minute accuracy? And that there is never a lapse of more than 60 minutes from receipt of your order to the time itis on the loading platform, ready to roll?
How much? You'll be able to measure its worth by the number of customers attracted to your store. Old customers and new, it’s the kind of service they aren't likely to have known before.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
DIVISION OF AT),
aes s(“2 GF ° or
6801 Quad Avenue Baltimore, Md. 21206 Telephone: (301) 485-8100
he
aryland ne harmacist
MPHA LAUNCHES ATTACK ON V.D. (See page 8)
Volume 47 AUGUST 1971 Number 8
Compliments of
oxell
CORPORATION
NOXZEMA SKIN CREAMS
Makers of
NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your prescription patients may not know the difference ... but you do.
As a pharmacist, you know that neither brand name nor generic drugs are any better than the demon- strated reliability of their manufacturers. The im- portant thing to you and your prescription patients is not what the product is called but how expertly it is made.
Four generations’ experience in producing fine pharmaceuticals is one of the many reasons you can have confidence in Lilly products.
Eli Lilly and Company « Indianapolis, Indiana 46206 EZ
100218
Offer Guardian sensitivity
ee Sse. ean
RD,
Sepich ED LATEX
PROPHYL ACT iC
WWE ROLL
-. ff Catia ensilive
Corti Dorsilite
..and they’ll never ask for just prophylactics again. They will be sold on the complete sensitivity afforded by these premium prophylactics. They'll stay sold because Trojan brand Guardians are thin, pre-lubricated and sealed in foil.
me yOur ( customers first
_ And you'll be happy because the extra
profit in each Guardian makes it an ideal product for you to recommend.
Next time your customer comes in and asks for prophylactics, recommend Guardian, the Trojan brand premium lubricated product from Youngs, the company tuned to today’s pharmacy customers...for tomorrow’s profit.
Youngs Drug Products Corporation ™ 865 Centennial Ave., Piscataway, N. J. 08854
The Maryland Pharmacist
NATHAN I. GRUZ, Editor
NORMAND A. PELISSIER, Assistant Editor
MARTHA ECKHOFF, Editorial Assistant ROSS P. CAMPBELL, News Correspondent
650 WEST LOMBARD STREET BALTIMORE, MARYLAND 21201
eH YY age
Sf Fs 4 &
8)
v
ASSOCIATION
VOLUME 47
AUGUST 1971
NUMBER 8
OFFICERS 1971-1972
Honorary President
H. NELSON WARFIELD—Pikesville s
President NATHAN SCHWARTZ-—Annapolis
President Elect BERNARD B. LACHMAN—Baltimore
Vice President JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore, Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore STEPHEN HOSPODAVIS (1972)
Cresaptown PHILIP D. LINDEMAN (1973)—Berlin ANTHONY G. PADUSSIS (1973)
Baltimore MELVIN J. SOLLOD (1974)—Adelphi SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore
EX-OFFICIO MEMBERS
FRANCIS S. BALASSONE—Baltimore WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON—Baltimore
President NORMAN J. LEVIN—Pikesville
Secretary
F. S. BALASSONE—Baltimore
Member FRANK BLOCK—Baltimore
Member HOWARD L. GORDY-—Salisbury
Member MORRIS R. YAFFE—Potomac
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association sf Sabare ele cieisieiare Stephen Hospodavis ViccmLrestd cr a nee James Ritchie Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association
BECSICCI Lata tines. tava x Irvin Kamenetz ROA VHWAS! ocho oone Joseph U. Dorsch IWS Gos ooeocnor Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille
Secretary and Executive Director
Nathan I. Gruz
Eastern Shore Pharmaceutical Society
LT EStCERT Rte a Cone oe. Gordon Harrison First Vice President....... William P. Smith Second Vice President....... William Connor SECT CLAny Me coiclacrs «icles is scc's Carl R. June U VEGSUTETMMes ca ches Gas tee ee Thomas Payne
Prince Georges-Montgomery County Pharmaceutical Association
Presiden tape ettesant corm: Martin Hauer First Vice President....Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz CCT ELOY amt reir a mteteniactats Paul Reznek LiT-C GSUT CLS te crete cone tee Michael Leonard Honorary President .......... Samuel Morris
Washington County Pharmaceutical Association Rresid en tmemetene vet Samuel E. Weisbecker Vices Presidentgaean nicotene: Joseph Davies aeictar Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter
Presidentoaoninnsee sacs cele Paul R. Webster Viceelresic citar eee Stephen B. Bierer SECHELOTY © Meron o Mens sicitepuain Donna S. Levin LT COSUT Ceears teat cle eto steiclere Dennis R. Reaver
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association President MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE Communications Secretary MRS. RICHARD R. CRANE Treasurer MRS. CHARLES S. AUSTIN Membership Treasurer
MRS. MANUEL B. WAGNER
TAMPA — Traveler’s Auxiliary of The Maryland Pharmaceutical Association President WILLIAM L. NELSON First Vice President PAUL J. MAHONEY Second Vice President JOHN MATHENY Third Vice President ABRIAN BLOOM Secretary-Treasurer WILLIAM A. POKORNY Assistant Secretary-Treasurer C. WILSON SPILKER Honorary President HOWARD DICKSON
Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER Secretary DOLORES A. ICHNIOWSKI
Treasurer
THOMAS E. PATRICK
University of Maryland School of Pharmacy Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
Change of address may be made by sending old nddress (us it appears on your journal) and new address with zip code number. Allow four weeks for
changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Baltt- more, Maryland, under the Act of March 8, 1879.
TABLE OF CONTENTS
Page Editorial—Pharmacy Services—How, Where andSBy WHOM 2, ee etcetera eee eee 6 Pharmacy, Calendarey. ices. ten en eee 7 VD BOUCatIONals Cam palgriiers, cnpeesnray cer eee rere 8 Maryland Board of Pharmacy News \.1cc...5.cc;cc.ccesecsssest=s 11 Proceedings of the 89th Annual Meeting of the Maryland Pharmaceutical Association ................ 12 Drug Abuse and the Maryland Drug Abuse AUtTHOLIGVAND Ve DAVICM VEIN ULL CO meets eee 20 Hospitalepharmacye sections eee 24 Classified 2AdS i203 aie oe Si eee ene 26 ODICUATICS e eeke, ree scere eset eres etesaoteae cong eecees aac cca enon ne RET 26 INDEX TO ADVERTISERS Page American Druggists’ Insurance CoO. 00.....cecccccecececeessceeees 7 Borden-Hendlers Ice | Creamiiwe see ee eee 21 BUrroughnsswellCOmes Co mesaee eee eee eee 28 CalvercuDrugeCompany,71ncy .c.saccic eee ee 21 Geigy [Pharmaceuticalsge 2 cc ee eee ee 23 Henrys DG) Ding COMPANY mete ee 13 Rlishillysands Company eos cnc eee ere 3 LoewyeDrug, Company 4.3 ee 27 ManginigandsASSOClates lll Cisse 1s: MarylandaNewssCOmpanyiae eee 25 Noxell. Corporation s.c.5.1cse- sea eee ee eee ee 2 Paramount: Photo Service gia. eee 17
Pension and Investment Associates of America, Inc...18
Roches Laboratories a ee ee eee 19
THE MARYLAND PHARMACIST
Editorial...
Pharmacy Services — How, Where and By Whom ?
The future of pharmacy may well be decided by the
nature of the answers to the following question:
How and where will the public receive their phar- maceutical services as we move well into the nineteen- seventies?
In addition we must also ask by whom?
Today, in mid-1971, pharmacy services are pro- vided primarily to ambulatory patients by community and hospital pharmacies and by some mai! order and “clinic” pharmacies.
The financing mechanism is still predominantly by dues payment by the patient. An increasingly significant share is being paid by third-party payment programs, either private such as Blue Cross or governmental such
as Medicaid.
The “How”
Observers agree that the majority of our population will be covered by some kind of national health insur- ance within a few short years. By this we mean that health care will be financed for the most part by a pro- gram of compulsory health insurance. This will, of course, be a form of third-party payment mechanism which could involve many kinds of medical practice. That is, the health care paid for could be provided by private solo practitioners, group or clinic physicians, hospitals or health centers. It could be based on fee for service or capitation.
The “Where”
The site where pharmaceutical services will be pro- vided as we proceed into the 1970’s may be crucial to the fate of pharmacy as a health vocation with a future as a free, independent profession. This matter will often be interlocked with the “How” pharmacy service will be financed and by whom.
What is emerging are governmentally fostered pro- grams for delivering comprehensive health care such as through comprehensive health centers. These are innova- tive systems involving existing elements of private, gov- ernmental, institutional, labor, insurance, individual and entrepreneural sectors of our society.
Pharmacy services may be provided by on-site phar- macies with or without “freedom of choice” for the patient. Or, where no pharmacy was established on-site, there would be freedom of choice for patient among ex- isting pharmacies in the community. |
Community pharmacies can provide the service from their existing locations; or if the decision-making authori- ties opt for on-site pharmacies, one or more pharmacies (acting cooperatively ) could provide the service.
Certainly community pharmacies as a class are in a stronger position to be selected to provide the pharma- ceutical service required (either on an in- or off-site
AUGUST 1971
basis) if a number of conditions prevail at the time of planning and decision.
These conditions include the relationship of the phar- macy management and pharmacists to the community, both rank and file and its leaders.
The reputation, deserved or not, of these pharmacists is a factor. The appearance, inside and outside, of the pharmacy weights heavily. Are non-health related cate- gories of products overwhelming the image cf the phar- macy? Does the pharmacy appear to be primarily a part of professional health service or does the space devoted and outside and inside signs project identification as food or liquor establishments? These are factors which rightly or wrongly have been brought out in hearings on this subject.
It is becoming more and more difficult for the pri- vate sector of pharmacy to ignore these considerations. Neglect of these factors in the past, and so often today, permits non-pharmacist firms and individuals as well as government, hospitals and so forth to leap into the oppor- tunities presented in the emerging patterns of health care.
Let us all concentrate on emphasizing our profes- sional capabilities so that we can preserve the maximum opportunities for pharmacists to contribute to better health for all through a free, independent profession.
—Nathan I. Gruz
PHARMACY CALENDAR
September 16—BMPA meeting, Kelly Memorial Build- ing, 8:30 p.m.
October 1-4—31st Annual Convention of the American College of Apothecaries, Hunt Valley Inn, Hunt Val- ley (Baltimore), Maryland.
October 3-9—National Pharmacy Week
October 10-14—National Association of Retail Druggists Annual Convention, The Rivergate, New Orleans.
October 16-21—National Wholesale Druggists’ Associa- tion Annual Meeting, Century Plaza Hotel, Los Angeles.
December 12-16—American Society of Hospital Phar- macists Sixth Annual Midyear Clinical Meeting,
Washington, D.C.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
More than 39 per cent of all traffic fatalities in 1970 were due to excessive speed. Speeding accounted for 17,- 700 persons killed and 988,000 injured.
TAILOR-MADE
Insurance Coveraze
AMERICAN DRUGGISTS’ INSURANCE ..,as the name im- plies, is specifically designed for the needs of the druggist. It’s an insurance company founded BY druggists FOR
druggists, to assure especially prompt settlement of claims .. fire, theft, liability. And that’s exactly what we've been doing...settling such claims rapidly, without red tape ... since 1906. Any service with that many years of experience HAS to be reliable. You can be certain of 100% security.
For full details on our complete coverage plan, contact your ADI agent NOW.
MAYER & STEINBERG Maryland State Agents 1101 N. CALVERT STREET BALTIMORE, MD. 21202 752-7311
<
AMERICAN
DRUGGISTS’ INSURANCE CO.
700 American Building Cincinnati, Ohio 45202
THE MARYLAND PHARMACIST
V.D. Awareness Begins...
The Maryland Pharmaceutical Association has launched a V.D. educational campaign. Paul Freiman, Chairman, MPhA Public Health Committee, is planning and directing the project which began with a press con- ference in June.
At the press conference held at the Kelly Memorial Building, officers of the Maryland Pharmaceutical Asso- ciation and local health officials stressed the significance of the soaring rate of venereal disease in Maryland. Rating ninth as a city, Baltimore is far above the national aver- age in incidence of V.D. while in Maryland, as a whole, 384 cases were reported for every 100,000 population in 1970—35% higher than the reported national average.
According to Nathan Schwartz, MPhA President, “Pharmacists . . . work under both personal and_pro- fessional obligations to dispense medications and other aides to public health in the manner prescribed by law.” As he further stated, “The role that pharmacy can fill and should fill is truly made up of equal parts of re- sponsibility and opportunity . . . which adds up,” he con- tinued, “to a combination of dispensing the means to as- sure better health and giving information and advice where (the pharmacist’s) special place on the public health team permits.”
“The pharmacists of Maryland,” stated Donald O. Fedder, Chairman of the Board of Trustees. “have re- solved to become very personally involved in a concerted effort to combat what has now become recognized as this nation’s ‘public disease enemy number one’.”
In a written proclamation read by William Donald Schaefer, President, Baltimore City Council, Mayor Thomas J. D’Alesandro, Jr.. urged “all public health agencies, health professionals and all other groups and individuals involved in health education, prevention and treatment as well as the general public to participate and cooperate in this greatly needed work.”
Education, prevention and treatment, cur speakers emphasized, are needed to stem the “epidemic” spread- ing through all levels of our society. In their speeches Messrs. Fedder and Schwartz continued to elaborate on the facts of venereal disease, its prevalence and the means by which pharmacy may assist in alleviating it. Questions from the floor stimulated the discussion among our phar- macists, health officials and news reporters. Cameras clicked, lights flashed and television cameras rolled, turn- ing the lower level conference room of the Kelly Me-
Have You Returned Your Biographical Information Sheet?
If you haven’t done so, please complete and return the biographical information sheet which appeared in the July 1971 issue of “The Maryland Pharma- cist.” Return of the questionnaire by each member will assist the Association in serving the profession more effectively.
Le |
8 THE MARYLAND PHARMACIST
morial Building into bustling activity during the hour and one-half cocktail-luncheon conference.
And the reporting was excellent as evidenced by “top spot’” coverage by WMAR TV on the evening news. “The Maryland Pharmaceutical Association’” was heard over radio, and newspaper writeups appeared in many paper throughout the state.
Subsequently, thousands of pamphlets entitled “Plain Talk About Venereal Disease,” published by Youngs Drug Products Corporation, were distributed from the MPhA office to pharmacies throughout the state as well as to individuals. Lists of V.D. clinics in Mary- land where individuals requesting treatment can be di- rected in a year-round effort to help eradicate the disease were distributed to pharmacies in the state. Pharmacists were encouraged to set-up counter V.D. prevention dis- plays. An MPhA speakers bureau with the cooperation of the students at the School of Pharmacy, University of Maryland, will bring speakers to civic, school and other community groups. For the benefit of private groups speeches have been made available to those requesting them.
Executive Director, Nathan I. Gruz, focused on the constructive roles that pharmacists can play because they have more contacts per week with the public than any other health professional. He spoke of the accessibility of all people to their pharmacists.
Dr. Howard J. Garber, Chief, Division of Communi- cable Diseases, State Department of Health, following his attendance at the conference moderated by Chairman Paul Freiman, wrote, “I would like to commend the Maryland Pharmaceutical Association’s efforts in making
the public aware of the V.D. problem in Maryland.”
Other representatives from the State Department of Health included Leland C. King and Thomas A. Sweeney, Public Health Advisors. From the Baltimore City Health Department were Dr. E. Walter Shervington, V.D. Clini- cal Director; Dr. Ralph E. Bennett, G.C. Coordinator, and John Supinski, Public Health Advisor. Dr. John A. Mullan, Chairman, Public Relations Committee, repre- sented the Medical and Chirurgical Faculty of Maryland and Dr. John Room, the Baltimore County Health De-
partment.
Assisting in the press conference arrangements were Youngs Drug Products Corporation staff, Messrs. Melvin Clark, Frank Hewens, Louis Rindone and Earl Vree- land; MPhA official photographer, Herman Bloom; TAMPA President, William L. Nelson; Co-chairman, MPhA Professional Relations Committee, H. Nelson War-. field; and BMPA President, Irving Kamenetz.
During 1970, 6,500 people were killed as a result: of driving off the roadway. Reasons for this type of acci- dent are tired motorists, unsafe cars, and those under the influence of alcohol. |
AUGUST 1971
Photos courtesy of Paramount
AUGUST
1971
aOR i neither
i "
THE MARYLAND PHARMACIST
MPhA’s PRESS CONFERENCE ON V.D.
TOP LEfT—Donald O. Fedder answers questions directed by health officials and newsmen. MIDDLE LEFT—Dr. Paul A. Mullan, second from left, hears of rising V.D. rate, pointed out by Donald O. Fedder, right. Nathan Schwartz, left, looks on. BOTTOM LEFT—wWilliam Donald Schaefer, second from left is presented Mayor's proclamation by Irvin Kamenetz, second from right. Standing on the left is Paul Freiman: on the right, Nathan I. Gruz. TOP RIGHT—Dr. Ralph E. Bennett, second from left, and Leland King, left, in conversation with Tom Ross (WBAL) and Nathan I. Gruz. MIDDLE RIGHT—Standing left to right: -aul Freiman, Thomas A. Sweeney, Dr. Howard J. Garber, Donald O. Fedder, and John Supinsky. CENTER—Dr. E. Walter Shervington di- rects question to speakers’ table. BOTTOM RIGHT—Mr. and Mrs. Irvin left, enjoy conversation of William Donald Schaefer, right,
Kamenetz, and Nathan Schwartz, second from right.
V.D. is an Epidemic in Maryland, in 1971
a quick glimpse of the trend, latest data ce)
(Cases per 100,000 population) | | | | | Maryland
1/2301 J hiy an a | Qo
| | | | | | | | 1960 ’61 "62 "63 "64 "65 "66 "67 "68 "69 1970
Venereal Disease Trend, In Order of Rate (Gonorrhea — cases per 100,000 population)
Baltimore City — 1,088.3 Dorchester — 916.9 WABABBABABEALEBAREAAAAAARARAREEEEEE' Talbot— 5228 PWWRABRRRARBARARARARRERE ET Wicomico— 469.9 PWBBABRRRRARBABARRRRERR™ MARYLAND— 347.3 ,WBBRRBRARRRRRERRER Twice as much vener- Anne Arundel — 281.1 BWA Bada daaaaaaeaa’ eal disease is reported as Woreste— 2743 RWWRRRRRRRREREE Ol other seortble com Caroline— 2649 PBBABARARRRARR bined. Somerset— 247.0 PRBRABRRRRRRRBA Harford— 194.8 PRWRBBaadastas Saint Mary’s— 192.8 BWaARBaAABaaaaae Kent— 151.4 JRBRRRRRRS Charles — 103.1 BWaaaa Queen Anne’s— 95.7 Wa Bay Cecil— 84.7 RWWA aN Montgomery — 84.7 AXANAAN Washington — 76.0 ~RRBAY Prince George’s — 67.2 BRAN Allegany— 43.8 BAYAWaN Howard— 36.2 ww
\.D.can be prevented
Prophylactic products, properly used, are the best ‘‘control device’’ against V.D.; effective against both Gonorrhea and Syphilis. Prophy- lactics, and free V.D. literature, from any
Baltimore County — 34.9 \\ Calvert— 31.0 pharmacy. & _ 26.5 . A : Ne Maryland Pharmaceutical Association rederick — 18.6 Garrett — 12.7 a
Maryland Board of Pharmacy News
Registrations Granted
| The following pharmacists recently became registered by the Maryland State Board of Pharmacy: Mary H. _ Brumback, Donald W. DeGroff, Stanley E. Gierhan, _ Michael R. Litton, Chester A. Schwer, Charles E. Thoma- son and James W. Wheatley.
The Board also announced 15 candidates who have _ previously passed the theoretical examination and recent- ly passed the practical examination will be granted regis- tration to practice within the state.
Included were: Donna K. Barr, Herman Bell, Jr.., Larry Bierley, Douglas Bjornson, Michael G. Buddie, Ted Cohen, William Harding, Tommy Hedge, Mike Mc- Cagh, E. D. McKeever, Jr., Donald Moor, Donald Phil- lips, Maurice Rumbarger, John Verhulst and Richard
Walsh.
Pharmacy Changes
The following are the pharmacy changes for the
month of July: New Pharmacies
Read’s, Inc., Ronald Sanford and Morris Feldman, Pharmacists, 711 West 40th Street, Baltimore, Maryland ei2ii.
University of Maryland Hospital Pharmacy, Thomas E. Patrick, Pharmacist, 22 South Greene Street, Balti- more, Maryland 21201.
No Longer Operating As Pharmacies
Pride Pharmacy, Samuel Adams, President, 2305 East Chase Street, Baltimore, Maryland 21213.
Gwynn Oak Pharmacy, Harold D. Mondell, 5500 Gwynn Oak Avenue, Baltimore, Maryland 21207.
Carney Pharmacy, William S. Karr, 9515 Harford Road, Baltimore, Maryland 21234.
Change of Ownership, Address, Ete. None.
CHANGE OF ADDRESS
When you move— Please inform this office four weeks in advance to avoid undelivered issues. "The Maryland Pharmacist'' is not forwarded by the Post Office when you move.
To insure delivery of ''The Maryland Pharmacist" and all mail, kindly notify the office when you plan to move and state the effective date.
Thank you for your cooperation. Nathan |. Gruz, Editor
Maryland Pharmacist 650 West Lombard Street
AUGUST 1971
BNDD Regulations Amended To Allow Unlicensed Interns and Residents to Prescribe Controlled Substances
On July 21, 1971, the Department of Justice pub- lished proposed new regulations in the Federal Register regarding BNDD registration of hospital interns and resi- dents.
According to an interpretation of these regulations by the Attorney General’s office of the State of Maryland, interns and residents who are not licensed in the State of Maryland may prescribe controlled substances under the registration of the hospital or other institution which is registered and by whom he is employed.
The individual practitioner must be acting only within the scope of his employment in the hospital or institution and such prescribing must be done in the usual course of his professional practice. Il'urthermore, the intern or resident must be authorized by the hospital or other institution to prescribe under the hospital regis- tration and the hospital or institution musi designate a specific internal code number for each intern or resident so authorized. The code number shall consist of numbers, letters, or a combination thereof and shall be a suffix to the institution’s BNDD registration number, preceded by a hyphen (e.g., APO123456-10 or APO123456-A12); and a current list of internal codes and the correspond- ing individual practitioner must be kept by the hospital or other institution and must be made available to the public upon request for the purpose of verifying the au- thority of the prescribing individual practitioner.
Prescriptions for controlled substances prescribed by an intern or resident during the usual course of his pro- fessional practice and bearing the individual practitioner’s assigned registration number for a hospital outpatient or discharged inpatient at the time of discharge may be filled by a community pharmacist.
BNDD Warning
The Bureau of Narcotics and Dangerous Drugs ad- vises all pharmacists that they may encounter patients with possible boric acid intoxication.
A potentially harmful mixture of cocaine and boric acid has been found in the illicit drug market in at least three cities. BNDD chemists have analyzed samples of the mixture obtained in New York and Chicago. U. S. Customs Service has also encountered samples of the mix- ture in San Antonio. The boric acid content runs as high as 50%. Based on use of cocaine by abusers this may result in an intake of up to 150 mg. of boric acid a day.
Almost 40 per cent of all highway deaths occur on weekends—56 per cent between 6 p.m. and 6 a.m. “Never on weekends” might be a driver motto worth observing.
THE MARYLAND PHARMACIST It
Proceedings of
the 89th Annual Meeting of the Maryland Pharmaceutical Association
Held At The Hunt Valley Inn, Cockeysville, Maryland, May 16 and 17, 1971
First Session, Sunday, May 16
The first session of the 89th Annual Convention of the Maryland Pharmaceutical Association was called to order at 2 p.m. by President Donald O. Fedder in the Maryland Room of the Hunt Valley Inn, Cockeysville, Maryland.
The invocation was delivered by H. Nelson Warfield, MPhA Executive Committee member and past Vice Presi- dent.
President Fedder then extended greetings and wel- comed all in attendance.
The following representatives of pharmaceutical as- sociations were called upon to bring greetings and messages from their respective groups:
Robert E. Snyder, President of the Maryland Society of Hospital Pharmacists; Paul Freiman, Vice President of the Baltimore Metropolitan Pharmaceutical Associa- tion; Stephen Hospodavis, President of the Allegany- Garrett Counties Pharmaceutical Association; Gordon M. Harrison, President of the Eastern Shore Pharmaceutical Society; Edward D. Nussbaum, First Vice President of the Prince Georges-Montgomery County Pharmaceutical Association; 5. Ben Friedman, Maryland Director, Metro- politan Guild of Pharmacists.
The following were recognized and introduced by President Fedder: Paul Reznek, Secretary, Prince- Georges-Montgomery County Pharmaceutical Association; F. S. Balassone, Secretary of the Maryland Board of Phar- macy and Chief, Division of Drug Control, Maryland State Department of Health and Mental Hygiene; Dr. William J. Kinnard, Jr., Dean, University of Maryland School of Pharmacy; Dr. C. Jelleff Carr, former Profes- sor of Pharmacology, now Adjunct Professor of Pharma- cology and Toxicology; Gerald Freedenberg, Directorum of Kappa Chapter, Alpha Zeta Omega Pharmaceutical Fraternity, and Simon Solomon, the first and only Hon- orary Life Member of the Executive Committee of the
MPhA.
Executive Director Nathan I. Gruz then read the following communications:
“Since its founding in 1883, the Maryland Pharma- ceutical Association has worked to advance the profession of pharmacy and the public health in Maryland. Your forthcoming annual meeting will provide the opportunity to build upon past accomplishments and to give new direc- tion to the profession of pharmacy in Maryland. We now are at a time when pharmacists can assume a greater role in the delivery of health care services ts the public than ever before. Pharmacists are looking to their state
12 THE MARYLAND PHARMACIST
and national professional societies to provide direction in assisting them to fulfill their full potential as health pro- fessionals.
“The issues discussed, positions taken and _ policies adopted at your annual meeting can shape the direction of pharmacy for years to come. As you make final prep- arations for your annual meeting, I extend you the best wishes of the officers and Trustees of the American Phar- maceutical Association for a most successful meeting and offer our pledge of continued cooperation.” (signed) William S. Apple, Ph.D., Executive Director, American
Pharmaceutical Association.
“We extend best wishes to your officers and mem- bers for a successful convention and assure you of our continued cooperation with your fine organization. Our mutual interests involve a number of legislative, pro- fessional and economic issues and objectives. The role of retail pharmacists in present and proposed health insur- ance programs must provide adequate compensation under — these programs and hopefully correction of discriminatory pricing policies relating to purchasing and distribution of drug store products. We are looking forward to your continued cooperation in developing constructive legisla- tive and educational programs concerning pharmacy par- ticipation in public health and welfare efforts. We can achieve many objectives by exerting unity of purpose. We © hope that many pharmacists will be with es when our — 73rd annual meeting convenes in New Orleans, Louisiana, October 10-14, 1971.” (signed) Williard B. Simmons, Executive Secretary, National Association of Retail Drug- gists.
Mr. Joseph S. Kaufman, MPhA Legal Counsel, re- viewed the past year’s activities from the legal and legis- lative viewpoints. He commented on emerging and antici- pated development for the coming year.
President Fedder then presented the following MPhA past presidents: George M. Schmidt (1957), Gordon A. Mouat (1959), Alexander J. Ogrinz, Jr. (1965), Morris R. Yaffe (1966), and I. Earl Kerpelman (1969).
Reports of committees were then delivered by com- mittee chairmen. The reports were published in the July issue of “The Maryland Pharmacist.”
Dr. William J. Kinnard, Jr., Dean, University of Maryland School of Pharmacy, delivered a report sum- marizing some of the current and projected activities of the School. He referred to a Task Force on Supportive Personnel and work to be done in the area of third-party payment programs.
There was discussion regarding implementing joint meetings of the MPhA-School of Pharmacy Committee and the School of Pharmacy.
F. S. Balassone presented the Annual Report of the Maryland Board of Pharmacy for 1970-71 which will be published in a later issue of the journal.
The Session adjourned at 4:00 p.m.
AUGUST 1971
An Experienced Pharmacy Orientated
Sales Force
Running a successful pharmacy takes a lot of effort and experience. That’s where the Henry B. Gilpin Co. can help you. Our expert sales force can assist you in both merchandising programs and store opera- tions. Within the Gilpin staff exists a depth of Knowledge in all phases of store operations. We are pre- pared to provide assistance and service wherever pharmacy is practiced.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
3] A complete sundries program providing sundries departments and inventories designed specifically
THE HENRY B.
GILPIN
COMPANY
BALTIMORE * DOVER * NORFOLK + WASHINGTON
Ta ae a |
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company 901 Southern Ave., Washington, D.C. 20032 (301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
ar Pre ree rere art |
Sirs: / am interested in the following programs. Please have your representative contact me in this regard.
Name of Pharmacy Address > Phone eS a eee Zip eee eget eS ee |
Name. j
Second Session, Monday, May 17
The second session of the 89th Annual Convention of the Maryland Pharmaceutical Association was called to order in the Maryland Room by President-elect Nathan
Schwartz at 10 a.m.
MEMORIAL SERVICES
Paul R. Bergeron began the services with the read- ing of the 23rd Psalm. Francis S. Ballassone followed
with the Necrology.
NECROLOGY
Sheldon S. Barke Vincent L. Blocher William L. Brunnett Irvin J. Cohen
Joseph L. Cohen Chester A. Duncan Webster K. Edwards Dominic Felicetti Marshall Fox
Albert C. Gakenheimer Earl A. Gates
Matthew Glenn
Frank J. Grau
Harry Greenberg Harold J. Hocking James E. Johnson Warren L. Johnson John J. Kairis Zygmont W. Karwacki George F. Kieffer
Morris Levin
Lester Levine Aaron M. Libowitz Joseph Lutsky James E. McMichael Frederick Minder Arthur A. Musher Frank M. Noll Joseph H. Pazel John A. Pelcher Clarence H. Pierson Wilkin M. Roddick Emanuel Rosenthal Nathan Rudo Arthur P. Shields, Sr. L. Rex Springer Harvey Todd William H. Webster Luther White Samuel Wolfovitz
Abraham A. Lemler
David I. Scott offered the memorial prayer.
Nathan Schwartz called upon Executive Director Nathan I. Gruz for his report which appeared in full in the June issue of ‘The Maryland Pharmacist.”
The report was accepted on motion of Sydney L. Burgee, Jr., seconded by Morris Bookoff.
The report of Treasurer Morris Lindenbaum was presented. It was accepted on motion of Henry Seidman, seconded by S. Ben Friedman.
The Speaker Pro Tem of the House of Delegates, Sydney L. Burgee, Jr., was called upon to organize the House of Delegates. The following were recognized as delegates from their respective organizations:
Affiliated Organizations:
1. Allegany-Garrett County Pharmaceutical Association
Harry G. Eisentrout, Jr. Stephen Hospodavis
James R. Ritchie Alternate: John H. Balch 9
2. Baltimore Metropolitan Pharmaceutical Association
(19)
Delegates: Alternates: Arnold Amass John Ayd Morris Bookoff Harry Bass
Mary Connelly Joseph U. Dorsch Gerald Freedenberg Paul Freiman Irvin Kamenetz
Frank Block Jerome Block James P. Crage Irving Galperin
Henry Glaeser
14 THE MARYLAND PHARMACIST
Alternates
Wilfred Gluckstern Dorothy Levi Norman J. Levin William I. Lottier, Jr. Richard Metz William Morgenstern David S. Pearlman Allan B. Shenker Morton Silverstein George Stiffman Charles W. Wagner
Maurice Weiner
Delegates
Bernard Lachman Harold Levin Ronald Lubman Jerome Mask
John Padousis Anthony G. Padussis Melvin Rubin David I. Scott Charles E. Spigelmire H. Nelson Warfield Harry R. Wille Stanley J. Yaffe
3. Eastern Shore Pharmaceutical Society (3)
Philip D. Lindeman James W. Truitt, Jr. Gordon M. Harrison Alternate: Donald R. Young
4. Prince Georges-Montgomery County Pharmaceutical Association (7) Paul Bergeron, II S. Ben Friedman John R. McHugh Louis N. Nobel
Edward D. Nussbaum
Richard D. Parker
Dominic J. Vicino
Alternates: Michael Leonard Morris R. Yaffe
5. Recognized Organizations
Maryland Society of Hospital Pharmacists (2)
Sydney L. Burgee, Jr. Robert E. Snyder Alternate: Normand A. Pelissier
University of Maryland School of Pharmacy (1) Henry G. Seidman
Officers and Board of Trustees (Executive Committee ) MPhA (not represented in other capacities ) President—Donald O. Fedder President elect—Nathan Schwartz Vice President—Melvin J. Sollod Executive Director—Nathan I. Gruz Treasurer—Morris Lindenbaum Immediate Past Presidents (3)
I. Earl Kerpelman Milton A. Friedman
Mr. Alder Simon took the floor to take issue on the manner that the BMPA selected delegates. BMPA Presi- dent Kamenetz announced that a special meeting of the BMPA Executive Committee would be held following adjournment of the Second Session to consider the matter.
Mr. S. Ben Friedman requested representation for the Metropolitan Guild of Pharmacists.
Speaker Pro-Tem Burgee ruled that the request be brought up for action at the first regular session of the House of Delegates to be convened after lunch.
The Second Session was adjourned at 11:30 a.m.
Third Session, Monday afternoon, May 17
President Fedder called the Third Session to order. President-elect Schwartz then presided, calling upon Pres- ident Fedder to deliver his Annual Report. President Fedder then called upon Speaker Pro Tem, Sydney L. Burgee, Jr., to convene the House of Delegates and con- duct the meeting.
A motion was made by S. Ben Friedman and see- onded to recognize the Metropolitan Guild of Pharma- cists as an officially recognized organization with delegate representation in the House. Mr. Freedenberg moved to
AUGUST 1971
Mangini can tell you what you have.
Within 1%
Many pharmacists often esti- mate their inventory by relat- Ing purchases to sales.
In today’s competitive climate and with the cost of merchan- dise continuously rising, these estimated gross profit figures can be misleading. In fact, this can be extremely costly to the pharmacist who, un-
a
Mangini & Associates, Inc.
4850 W. Belmont Ave. Chicago, III. 60641/(312) 282-8181
aware of his shrinking inven- tory and gross profits, is actually paying a higher in- come tax than he should.
So why guess? Call Mangini for fast, computerized inven- tory service that will tell you within 1% how your inventory realistically stacks up to your turnover, sales and profits!
WRITE FOR DETAILED INFORMATION. IT’S FREE!
11722 Studt St., St. Louis, Mo. 63141 2760 W. Market St., Akron, Ohio 44313 575 Savin Ave., West Haven, Conn. 06516 5501 Cherokee Ave., Alexandria, Va. 22312
table the motion and refer it to the Board of Trustees. Seconded and passed.
Sydney L. Burgee, Jr., was elected as speaker of the House of Delegates on nomination of Richard D. Parker.
S. Ben Friedman moved for nomination of John Mc- Hugh as Vice Speaker. Seconded by Mr. Sollod. Mr. Me- Hugh declined.
Richard D. Parker moved for nomination of S. Ben Friedman as Vice Speaker. He declined, nominating Henry G. Seidman, who was elected unanimously.
The BMPA Executive Committee having met, re- affirmed the list of delegates originally recommended and added Alder Simon and Robert Kabik to the list of alter- nate delegates.
President Fedder reviewed the action of the APhA House of Delegates at its 1971 Annual Meeting.
On motion of Mr. Schwartz the MPhA House of
Delegates was adjourned.
President Fedder then called the General Session to order again and called for New Business.
Mr. Sollod read the following proposed Amend- ment to the Constitution recommended by the Board of Trustees:
“Article VI ORGANIZATION (to read)
The functions of the ASSOCIATION shall be per- formed by the members through the agency of the Gen- eral Sessions, the House of Delegates, the Board of Trus- tees, and such other Subdivisions as may be authorized in the By-Laws.
Article VIT. Change ARTICLE VI. Quorum, to ARTICLE VII.”
There being no objection, the first reading of the Amendment was completed.
RESOLUTION
1. Mr. Vicino read a resolution supporting the recog- nition of “P.D.” (“Pharmacy Doctor’) for all pharma- cists.
2. He then read a resolution calling for national re- ciprocity in licensing pharmacists.
On motion of Mr. Freedenberg Mr. Vicino’s resolu- tions were referred to Professional Relations Committee for review.
3. Mr. Seidman stated that a resolution should be passed calling for educational programs to be included in the Business Sessions of the Convention and at the same site. The chair ruled that this would be referred to the Board of Trustees as a recommendation.
4. Mr. Bookoff moved that manufacturers be com- mended for adopting drug sampling policies of distribu- tion through pharmacies. He cited Smith, Kline and French and Roerig and recommended that other manu- facturers be urged to adopt similar policies. Seconded and passed.
5. Mr. Schwartz presented a request from Ciba to protest the FDA policy in combination drugs. On motion of Mr. Lachman it was referred to the Professional Rela- tions Committee.
6. Mr. Freiman moved that the routine distribution of drug samples directly to physicians be banned in the interest of public health. Motion was seconded and re- ferred to the Legislative Committee.
16 THE MARYLAND PHARMACIST
REPORT OF THE NOMINATING COMMITTEE
Chairman Kerpelman announced the following slate:
For President-elect Sydney L. Burgee, Jr.
For Vice President John R. McHugh
For Treasurer Morris Lindenbaum
Trustees: Eastern Shore (1) Gordon M. Harrison Central (BMPA (3) Morris Bookoff Joseph U. Dorsch Paul Freiman Southern (1) Richard D. Parker Western (1)
Stephen Hospodavis Samuel O. Weisbecker
Mr. Kerpelman stated that Mr. Burgee would not be a nominee as he was elected Speaker of the House of Delegates.
On motion of Mr. Freiman, Mr. Warfield was unani- mously elected Honorary President.
On motion of Mr. Bookoff, Mr. Lachman was unani- mously elected President-elect.
Mr. S. B. Friedman nominated Richard D. Parker for Vice President. In the vote Mr. McHugh was elected | Vice President.
On motion of Morris Yaffe, Mr. Lindenbaum was unanimously elected Treasurer.
Bernard B. Lachman
Philip D. Lindeman
Irvin Kamenetz Anthony Padussis Nelson Warfield
Dominic J. Vicino
The following action was taken on Trustees:
Mr. Bookoff was elected by unanimous ballot for a one-year term (1972).
Messrs. M. Rubin, I. Kamenetz and Melvin J. Sollod were then nominated from the floor. Messrs. Rubin and Kamenetz withdrew.
The following were then elected: Anthony G. Pa- dussis (1973) in contest with Mr. Vicino; Messrs. Paul Freiman (1974), Philip D. Lindeman (1973), Melvin J. Sollod (1974) and Stephen Hospodavis (1972) unani-
mously.
MARYLAND BOARD OF PHARMACY
For the vacancy of Howard L. Gordy in 1972 the Nominating Committee presented the following slate, one person to be selected by the Governor for appointment.
I. Earl Kerpelman
Philip D. Lindeman
James W. Truitt
On motion of Chester L. Price, seconded by Gerald Freedenberg, Irving I. Lottier was nominated from the floor.
The original slate was elected as the MPhA nomi- nees to the vacancy.
The General Membership then confirmed the action of the Executive Committee at its last meeting in unani- mously electing Simon Solomon as the First Honorary
Life Member of the Board of Trustees.
The final session of the 89th Annual Convention was adjourned at 4:14 p.m.
AUGUST 1971
Mr. Pharmacist -
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE 3024 Greenmount Avenue Baltimore, Maryland 21218
AUGUST 1971 THE MARYLAND PHARMACIST
Jamaica Welcomes MPhA for Holiday in the Sun
Via Eastern Airlines charter flight 139 MPhA mem- bers and their wives departed on the morning of May 18, 1971, from Friendship Airport to join other MPhA mem- bers for reconvened sessions at the Jamaicu Hilton in Ocho Rios, Jamaica.
As a result of the planning of Nathan Schwartz, Con- vention Chairman, and Alder Simon, Convention Co- chairman, everyone relaxed, enjoying luxurious atmos- phere, tropical sun and candlelight dinners.
During the day reconvened sessions included contin- uing education seminars. On Wednesday, Frederick A. Glass, M.D. spoke on “Dermatology for Pharmacists.” Morris Lasover, J.D., discussed “Professional Liability of Health Professionals” on Thursday, May 20. “Drugs in Dental Practice” was delivered by Irving Littman, D.D.S. on Friday.
A romantic highlight was the Saturday evening cocktail party sponsored by the Calvert Drag Company held on the hotel patio. Calypso rhythms beat in the dis- tance while the gentle Caribbean waters rippled just be- yond the wall of colorful native flowers surrounding the patio—a perfect setting for a memorable occasion.
After six funfilled days of golf, fishing, shopping and learning, everyone reluctantly returned to Baltimore, agreeing that the “Jamaica Trip” was unquestionably a success.
Reservations Still Being Accepted For London Trip
MPhA members and their immediate families will be visiting London from November 7 to 14, 1971. The group will depart from Friendship Airport in Baltimore on Sunday evening, November 7, via Air India’s Mahara- jah 707 Jet for a non-stop flight to London. Upon arrival Monday morning, local time, passengers will be met and transferred, with their baggage, to the beautiful Royal Garden Hotel, situated on the edge of Kensington Gar- dens adjacent to the Palace of Her Royal Highness, Princess Margaret. Here tour members will spend six unforgettable nights of sheer luxury.
In London the following will be included: Full multi-course English breakfast will be served each morn- ing at the hotel. A half-day tour of the oldest part of London, reliving history at the Tower of London where the magnificent Crown Jewels of England are on display. A half-day tour of the fashionable West End of London including Westminster Abbey and the Buckingham Pal- ace. A half-day excursion through the lovely countryside to stately Windsor Castle, built by William the Conqueror and royal residence for nearly 1,000 years.
Evening activities: The MPhA Hospitality Room will be open for pre-dinner complimentary cocktails be- fore beginning each night’s festivities. Dine sumptuously at such outstanding restaurants as_ the Mirabelle, the luxurious Caprice, Churchill’s-London’s smartest night spot and the fashionable Twenty-One Club, once the townhouse of Lord Chesterfield. A delightful evening at the theatre . . a ticket will be provided for an orchestra seat of your choice at any of London’s many hit shows.
18 THE MARYLAND PHARMACIST
Guest membership in the Victoria Sporting Club, one of Europe’s largest casinos, where you may “try your luck” at anything from craps to blackjack to chemin de fer.
Return flight and arrival in Baltimore via non-stop 707 Jet on Sunday, November 14.
All-inclusive cost—$389.00 per person (based on double occupancy). Federal transportation tax—$3.00 per person. Supplemental cost for single room—$48.00. Reservations on this fabulous trip can only be confirmed upon receipt of a deposit in the amount of $50.00 per person. All deposits and monies paid are refundable in full until September 25, 1971. After this date, refunds are subject to resale of reservation(s).
All deposits are to be made payable and sent to: Matterhorn Travel Service, 1923 West Street, Annapolis, Maryland 21401. For further information, please call 269-0123 (local Baltimore line).
Headquarters for
PHOTO-OFFSET PRINTING MAILING | PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans (Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships )
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
| Ss SS ene
AUGUST 1971
In 1970, Roche Laboratories broke with pharmaceutical industry tradition by being the
first company to discontinue mass, unsolicited sampling of professional products. The Roche aim is to ensure the greatest benefit to the patient while meeting the professional needs of the pharmacist and physician. All are served best by proper handling of drugs. Better control of all aspects of drug distribution ensures the highest standards of health care for the patient, physician and community.
This policy reflects Roche interest in the general problems of pharmacy
management, as well as
the pharmacist-doctor, pharmacist-patient and pharmacist-community relations. There are many of your colleagues at
Roche—practical profes-
sionals in various management positions—
hat help you meet the challenge of pharmacy today.
ROCHE LABORATORIES Division of Hoffmann-La Roche Inc. Nutley, New Jersey 07110
Drug Abuse and the Maryland Drug Abuse Authority
by Dr. David R. Nurco
Former Commissioner, Maryland Drug Abuse Authority
Presented to the Maryland Society of Hospital Pharmacists, North Arundel Hospital, March 1 he re
What Is Drug Abuse?
It is not possible to understand the meaning of the term “drug abuse” without first recognizing that using drugs is not necessarily the same thing as abusing them. Since all drugs are taken for their effect—which is some- times good and sometimes bad—it is necessary to know what drugs can do, taking into account that they can have side effects as well as direct effects.
What Are The Effects of Drugs?
The consequences of taking drugs are determined by a large number of interacting factors. Some of the ob- vious and important ones are the kind of drug used; the amount, manner, frequency, and duration of its usage; the person who uses it; and the total circumstances sur- rounding that person’s use of it, including his expecta- tions of what the drug will do. In other words, a person’s response or reaction to any drug is basically the result of an interaction between an ingested or injected chemical, and a physically and psychologically complex individual. It is this interaction that gives drugs their potential to affect mind as well as body.
The possibility always exists that any drug taken (with or without official medical approval) can have an unexpected undesirable side effect—that is, an abusive outcome. It would be difficult to find even one drug which is net potentially dangerous for some people, under some conditions, at some dose level. The opposite is also true: some individuals can sometimes tolerate without any negative consequences a drug that most people react
to badly. Who Takes Drugs, And Why?
The incalculable number of people who take drugs includes those who smoke cigarettes and other substances, drink alcoholic beverages, ingest diet pills, and take seda- tives at bedtime. It also includes individuals who sniff glue, smoke marijuana and hashish, take LSD, and in- ject heroin. Obviously a complete list of drug users and the kinds of drugs they use would be very long, and if it were fully descriptive, it would reflect great differences among both individuals and drugs.
But all drug users, regardless of the kind, amount, and frequency of the drug they use, share one important trait: they all take drugs because of some need. The na- ture and origin of their needs differ, of course, and in special circumstances such as medical emergencies, the drug-taking may be involuntary. In most cases, however, people freely choose to use a drug. This choice is made when someone buys an over-the-counter drug just as much as when an individual obtains and then smokes marijuana.
20 THE MARYLAND PHARMACIST
Etiology
Being informed requires, among other things, some understanding of why people get into trouble with drugs in the first place, and then—once they have a drug prob- lem—why they don’t simply stop taking drugs. These are matters that have already been studied at great length, and continue to be studied, because the issues are very complicated. | would like to review in detail only one of many concepts that are part of a theory of why people be- come and remain drug abusers. This is the concept of a “deviant subculture.”
Deviant Subculture First I would like to quote Albert Cohen, a sociolo-
gist who has offered a general explanation of why deviant —
individuals ultimately become involved in the develop- ment of deviant subculture.
Cohen begins by pointing out that most people ex- perience a great deal of frustration from the strain of what he calls “ambivalence relative to institutional expecta-
|
tions.”' Nevertheless, most people generally conform to— . . 4 these expectations because the consequences of conformity |
are defined as less costly than the consequences of devi- ance.
However, if the strain is great enough, some indi- viduals will transfer to a different reference group—one which provides legitimate sanction for their deviant in- clinations.
A third possible course for a potentially deviant in- dividual is for him to act out his deviance on a “go it
alone” basis. However, most persons reject this course, Cohen says, because it is the most costly of the three al-
ternatives.
Apparently, then, deviant individuals wil) not choose the first alternative because it is too conformist, or the third because it is too costly. That leaves the second: joining a group that sanctions deviance.
In choosing this course, the deviant may participate in the building and perpetuation of a membership group geared to the satisfaction of illicit desires. Other mem- bership groups of similar character may then interact
with his, so that together they create a network of parts |
that reinforce the whole. The totality becomes a mutually supportive subculture.
History
The reinforcing value that a deviant subculture has for a drug addict has been obvious for a very long time— we have extensive historical basis for making this and a number of other statements about drug-taking. Drugs have been around for many, many centuries.
Various kinds of records show that they have been used to relieve pain and change the emotions of man for thousands of years. This is documented in Assyrian medi-
1Albert K. Cohen, “The Study of Social Disorganization and Deviant Behavior,’ in Sociology Today: Problems and Prospects, Vol II, ed. by Robert K. Merton, Leonard Broom, and Leonard S. Cottrell, Jr. (New York and Evanston: Harper and Row, 1959), pp. 468-71.
AUGUST 1971
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply,
THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
ICE CREAM for over a half-century
675-6000
I I, rf Ii if [ i ji oy y AlN y / ep y/ | KO RDEN. First name in ice cream [ r f i
AUGUST 1971 THE MARYLAND PHARMACIST 21
cal tablets. Egyptian inscriptions, and numerous other sources from antiquity. However, most of the information about drugs that is pertinent to modern civilization dates from the nineteenth century. In the late 1800’s the Brit- ish issued a series of drug reports that are still a hallmark. One of these is a 3000-page study of marijuana use in India; it is a rich classic that I recommend highly.
During the same period—the late 1800’s—the Brit- ish convinced the Emperor of China that opium pro- duced in India and shipped by British merchants should be admitted for sale in China. By “convinced,” I mean that under threat from the British Navy, the Emperor complied. He did not want to, but when a British gun- boat in the harbor pointed its guns toward shore, he de- cided to open up China to traffic in opium.
There is real irony here, it seems to me, because this drug problem that was forced upon Oriental civilization quickly returned uninvited to Western civilization, and has been haunting us ever since. Orientals who came to America after having become addicted to opium in China, comprised one of three major groups who were using nar- cotics—chiefly opium and its derivatives—in this country by the turn of the century. (The other two were women who suffered from gynecological difficulties before ap- propriate medicines were developed, and Civil War vet- erans who became addicted to narcotics involuntarily as a result of medical treatment for severe wounds. )
Gradually, pharmaceutical chemistry added new syn- thetic drugs to the natural ones already known and used —for example, barbiturates were introduced into medi- cine in 1903, and then in the 1930’s amphetamines were discovered. The history of drug manufacture and drug- taking through the years is well known, and now we are becoming acquainted also with the facts surrounding the emergence of drug abuse as distinguished from drug use. It is clear that more and more people are continuing to seek escape from reality with the aid of opium, heroin, morphine, dilaudid, codeine, a whole series of hallucino- genic drugs, and tranquilizers.
Most of these drugs are subject to special laws and regulations, of course. The earliest ordinance that I know of in this country was passed in San Francisco in 1875. Michigan followed suit two years later, passing a law in 1877 that restricted drugs. A few years later Tennessee did the same.
In 1902 the Federal government passed its own legislation to prohibit giving drugs to any natives of the Philippines. In 1909 the United States and several other major nations participated in a conference in Shanghai to discuss international control of drugs. Another inter- national conference on this matter occurred at the Hague Convention of 1912, after which this country passed the Harrison Act. The Harrison Act outlawed the sale of all narcotics in the United States without a prescription. This law became the precursor of all subsequent Federal laws related to drugs.
At this time we have a solid structure of laws. state and Federal, for dealing with drug matters. In 1965 the Federal government passed the Drug Abuse Amendments to place further restrictions on stimulants and depressants. The Federal Controlled Substances Act of 1970 which went into effect on May 1, 1971 is similar to Maryland’s new omnibus drug law that went into effect on July Ist,
1970. Frequently Abused Drugs Both the Federal Drug Abuse Amendments of 1965
and certain provisions of Maryland’s omnibus law aim
22 THE MARYLAND PHARMACIST
specifically at amphetamines and barbiturates. Ampheta- mines are stimulant drugs, and are often called “pep pills’ —the pills that pep you up. Barbiturates, common- ly called “‘goof balls,” are depressant drugs—the pills that put you to sleep.
Narcotics are a different kind of drug: they are analgesics or pain relievers. Penalties for possessing and selling them for non-medical use are very strict. The
most frequently abused narcotics—all of which are ad-
dicting—are heroin, morphine, codeine, and synthetic drugs such as demerol, dilaudid, and methadone.
Heroin is the drug that most narcotic addicts prefer, with the exception of medical personnel: they prefer dem- erol because it is readily available to them. (“Them” means doctors, nurses, and ancillary medical personnel. )
Marihuana is not a narcotic; it is a hallucinogen- like drug which is similar to though not so potent as LSD. Only two of the components of marihuana are active: they are known as Delta 8 and Delta 9. Together they give marihuana one consistent level of strength, and the level is low. Marihuana comes from the plant Cannabis sativa, and so does hashish, which is much more concentrated and thus stronger than marihuana.
It is possible to form a concentrate of the two active components of the Cannabis sativa plant: Delta 8 and Delta 9, which I mentioned a moment ago. This con- centrate is called tetrahydrocannabinol, and it is much stronger than either marihuana or hashish. The activity
of tetrahydrocannabinol has been compared to that of —
LSD. So far no medical purpose has been found for tetra- hydrocannabinol, but there is some reason to believe that
further research will reveal it to be an effective anti-de- |
pressant drug. It may eventually become the preferred drug of addits who are now using heroin, so tetrahydro-
cannabinol is some thing we must be very concerned —
about.
LSD and marihuana are—or can be—habit-forming,
but they are not addicting drugs. By this I mean that they may be psychologically habit-forming or habituating, but not physically addicting.
The addicting drugs that I mentioned earlier (heroin, morphine, demerol, dilaudid, methadone, etc.) are some- times inhaled, but usually they are taken intravenously. Intravenous injection is what addicts call “mainlining.” For most addicts the initial injection is generally un- pleasant, and produces nausea and vomiting. However, this does not deter those who have a need to continue, and with repetition the unpleasant effects disappear and are re- placed by a feeling of euphoria together with a sensation called “flash.” “Flash’” has been compared to a sexual- like orgasm, followed by a feeling of having escaped wrom the worrisome aspects of reality. This “flash” gives the addict a promise of everything he has ever wanted in his life but never had, and without any work at all. Maryland Drug Abuse Authority
In closing I would like to say a few words about the Drug Abuse Authority, and its responsibility for providing services in four major areas. I would like to outline what is planned in each of the four: education, prevention, treatment, and evaluation and planning.
EDUCATION
Education about drug abuse will be undertaken in several different areas, with the schools receiving par- ticular attention. A detailed curriculum on drugs will be worked out in cooperation with the State Board of Education, and will then be taught in public and private
AUGUST 1971
por ks smal
Ns, Sha PRS Oe ei
ae
Reputation...»
often dapends
you keep.
Pe
Butazolidin
phenylbutazone »
ERO
Geigy ©
4000 tablets 7
Ss Sascha: Fesara) em : Ptitete dapece nee orate
elementary and secondary schools. This curriculum will make an honest presentation of facts about drugs, eXx- plaining objectively what drugs actually are; distin- guishing carefully the difference between their use and abuse; and teaching what is now known about the conse- quences to the individual of drug-taking.
This same kind of basic information about drugs needs to be communicated also at an adult level to the general public, and to particular segments of the public who deal extensively with young people—teachers and clergymen, for example, and of course parents. The Au- thority plans to reach this audience through informa- tional brochures and other materials written by its own staff to insure that their content is accurate and relevant to Marylanders.
PREVENTION
To help prevent drug abuse, the Authority will work toward early detection of the problem by protessional per- sons and others who are in a position to note potential drug abuse. This will be accomplished chiefly through four prevention centers that are planned. They will be called Coordinating and Counseling Centers, and they will serve and be located in Metropolitan Baltimore, Western Maryland, Southern Maryland and Metropolitan Wash- ington, and the Eastern Shore.
While these Centers will try to help all persons who seek assistance, they will aim especially at helping young persons and their families who need guidance in drug- related matters. They will make a particular effort to identify potential problems of drug abuse, emphasizing the importance of early detection.
Short-term counseling for individuals and families will be available at these Centers, but if long-term help with an on-going or potential drug-related problem seems indicated, staff members at the Centers will make ar- rangements for referral to appropriate helping agencies within the community.
Another activity of the Drug Abuse Authority aimed at prevention is the maintenance of a Drug Abuse Regis- ter to identify narcotic addicts, and determine whether they are using properly the programs designed to help them.
TREATMENT
The Drug Abuse Authority will create standards for treatment programs dealing with drug abuse. and licens- ing procedures for hospitals and other treatment centers.
Tt will assist in as many ways as it can, outpatient programs that are currently functioning under private auspices. All of these require continuing laboratory serv- ices to test whether patients are maintaining their thera- peutic regimens, and the Drug Abuse Authority will help meet the cost of this testing. Alternative methods of outpatient treatment need to be developed, and the Au- thority will help to explore promising new possibilities.
Services for drug abusers must be comprehensive, and the Authority’s activities in the area of treatment in- clude post-acute management and rehabilitation after im- mediate treatment needs have been met.
EV ALUATION
All programs dealing with drug problems will receive continuous evaluation by the Authority to insure that they carry out their intent, and to change their goals and methods when changes are required.
24 THE MARYLAND PHARMACIST
Hospital Pharmacy
Section
APhA, ASHP Elect National Officers _ APhA president-elect for 1972-1973 is Clifton J.
Latiolais, a practicing hospital pharmacist in Columbus, Ohio. Mr. Latiolais is director of pharmacy services at the Ohio State University Hospitals. He defeated Mary Louise Anderson, Wilmington, Delaware community pharmacist. Both nominees are former speakers of the APhA House of Delegates.
ASHP president-elect for 1972-1973 is Wendell T. Hill Jr., director of pharmacy services at Detroit General Hospital. Mr. Hill defeated William H. Hotaling, hos- pital pharmacist from Schenectady, New York. Mr. Hiill is also Associate Professor of Hospital Pharmacy at the College of Pharmacy, Wayne State University in Detroit.
New Collection of Drug Interaction Information Offered
An important new collection of drug interaction in- formation will soon be available to pharmacists, physi- cians, nurses and other health care practitioners. “Drug Interactions-1,” the first in a series of compilations of abstracts of articles dealing with the interactions of drugs, is being published by the American Society of Hospital Pharmacists. The abstracts included in “Drug Interactions-1’’ were originally printed in International Pharmaceutical Abstracts (IPA), a semimonthly journal published by ASHP that covers over 1,100 scientific and professional periodicals from throughout the world. All IPA abstracts since January 1970 have been on magnetic tape, and the “Drug Interactions-1” publication will be generated from this computer bank of abstracts.
“Drug Interactions-1” will include abstracts of the 300 articles on drug interactions covered by [PA from January 1970 to June 1971. The abstracts will be printed in the same format as in [PA and will contain the essen- tial qualities and sense of the original article. A maxi- mum of information in a minimum of words will be pro- vided. This compilation will be over 50 pages long and will be thoroughly indexed according to the names and the pharmacologic classes of drugs involved in the inter- actions reported. As an indication of the depth of index- ing, each abstract wil have an average of five subject index entries.
Commenting on “Drug Interactions-1,” [PA Edito Dwight R. Tousignaut said, “This new publication wil be a tremendous help to the practitioner or student who is concerned about keeping up with the flood of informa- tion on drug interactions. Drug interactions are being re- ported every day, not just in this country, but through- out the world. Since “Drug Interactions-1’ is derived fro IPA which covers the literature worldwide, much of th information presented here is probably not available any- where else as a single source.”
“Drug Interactions-1” will be available next month and may be purchased from ASHP for $5.00. Orders ar being accepted now and should be sent to: Drug Inter actions-1, c/o American Society of Hospital Pharmacists 4630 Montgomery Avenue, Washington, D.C. 20014
Payment must accompany all orders.
AUGUST 197
1S Still th to de brain."
Reading
efastest v way in ia
\
In an era of “information explosion,” how do you “pro-
gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
Pharmacy School Plans Continuing Education Courses
Based upon the interest and probable attendance in- dicated by return of a questionnaire mailed out to all of the State’s pharmacists, the Continuing Education Di- vision of the School of Pharmacy is planning to offer a two-semester course in Pharmacology and a series of one- day lecture programs this coming year.
According to Henry G. Seidman, Director of Con- tinuing Education Programs, the success of programs during the past two years and the widespread response to several questionnaires submitted to pharmacists through- out the State has prompted the Division to consider in- creasing its offerings to include additional subjects most requested by respondents.
Planned programs are:
(1) Pharmacologic Basis for Therapeutics: A 2-semester course, one night weekly from 7:00 to 9:30 p.m., begin- ning September 19, 1971 at the University of Maryland downtown campus. Estimated cost: $125.00.
(2) Management of the Maintenance Care Patient: A Sunday series of 4 programs at monthly intervals from 12:00 noon to 4:30 p.m., beginning January 23, 1972. Probable site: UMBC.
Tentative schedule:
January 23, 1972—The cardiac and diabetic patient.
February 27, 1972—The epileptic, asthmatic and emphysematous patient.
March 26, 1972—The patient with peptic ulcer, ileitis or colitis; the thyroid patient.
April 16, 1972—The pregnant and pediatric pa- tient; home nursing care in all these areas.
Estimated cost: Complete $30.00, individual session $10.
(3) A one-day program with lectures in the area of Antt- biotics and Biological and Clinical Chemistry (diagnostic agents, metabolic diseases) for presentation during Octo- ber or November, 1971.
For further information call 955-7589 or 955-7650.
CLASSIFIED ADS
As a service to MPhA members, we offer a free classified ad service. Maximum number of words permitted under this free service is 25.
In replying to “blind” ads, address Ad No....... : Maryland Pharmacist, 650 W. Lombard St., Bal- timore, Md. 21201.
Commercial classified ads (single issue inser- tion) will be carried at 15 cents a word, mini- mum charge per insertion, $5.00. PAYMENT TO ACCOMPANY ORDER.
Closing date for copy—15th of preceding month.
FOR SALE: Pharmacy in growing Gladstone, Oregon- Streeter fixtures, volume over 225,000, terms to qualified buyer. Richard M. Olson, Olson Drug, 920 7th St., Ore- gon City, Ore. 97045. Phone 656-1977.
26 THE MARYLAND PHARMACIST
Student APhA
APhA Executive Director Apple has named William F. McGhan, a 1970 Pharm.D. Degree recipient from the University of California at San Francisco, as the Execu- tive Secretary of the Student American Pharmaceutical Association, effective August 1, 1971.
Under APhA sponsorship, the Student American Pharmaceutical Association has been awarded a $36,225 National Institute of Mental Health contract to test the effectiveness of an interdisciplinary approach to drug edu- cation and to determine the feasibility of launching such a program on a nationwide basis.
Under terms of the one-year contract, Student APhA will identify sites for and assist in the organization and implementation of drug education programs carried out by interdisciplinary student teams and aimed at students in secondary and elementary schools.
In The News... SAMUEL LICHTER has been appointed Chief
Pharmacist at the Union Memorial Hospital in Baltimore. A 1960 graduate of the University of Maryland School of Pharmacy, Mr. Lichter has been with the Union Memorial since 1964. He is a past president of the Maryland So- ciety of Hospital Pharmacists. Sydney L. Burgee, Jr. will continue as Director of Pharmacy and Central Supply.
KARL WAGNER of Salisbury, Md. has been named Read’s Pharmacist of the Month for the professional com- petence he has shown in the interest of public health. Mr. Wagner recently assisted in giving first aid treatment to a victim of a shooting which occurred in the vicinity of the pharmacy where he is employed.
FREDERICK M. FRANKENFELD, 1967 graduate of the University of Maryland School of Pharmacy, has been named Manager, Drug Data Processing Systems and Services, American Society of Hospital Pharmacists Frankenfeld is currently completing a master’s degree thesis at the University of Lowa based on his research on formulary automation. He is a past recipient of eo MSHP Student Achievement Award and has been electe to the Rho Chi Society.
Obituaries
LAFAYETTE L. PIERPONT
Lafayette L. Pierpont, 86, died on June 6, 1971 a his home following a brief illness. Mr. Pierpont was a re tired wholesale drug salesman who at one iime worke for Loewy Drug in Baltimore.
RICHARD D. GIBBS
Richard D. Gibbs, 69, retired vice president and d rector of Peoples Drug Stores, died July 22 after a hea attack at his home in Fort Lauderdale, Florida.
Mr. Gibbs began his career with Peoples as a stock clerk in 1921. Three years later he became a registere
pharmacist and stayed with Peoples until his retireme Inv ep ag
AUGUST 197
There’s alot more going for you at LOEwy
Siecle PERSONALIZED SERVICE PLUS
provides you with the flawless backing of 100% computerization— along with the special personal follow-through of people who care
Drug wholesaling divisions of Spectro were among the first in the industry to know the unprecedented advantages of fully computerized warehousing and delivery service. But as a retailing-oriented distributor, we know, too, that nothing can take the place of personalized understanding and service follow- through. That’s why every one of us at the management, sales and service levels is vitally concerned about any phase of service that is of special concern to you. This happy combination of automation and personalization adds up to a quality and completeness of service that just isn’t likely to be matched through any other source.
Got a special supply, financial or service problem? Why not give us a ring during any working hour any day of the week. That’s one way you'll really know what we mean by personalized service. See why more and more retailers throughout the eastern seaboard are saying right out loud...
RUM DIVISION OF LOEWY DRUG COMPANY £52 Ysectoe Sndusloiis, Inc
6801 Quad Avenue, Baltimore, Md. 21237 Tel.: (301) 485-8100
All joking aside, Empirin Compound is one of your most profitable analgesics. And Empirin is making waves it’s never made before, so it really deserves a little more of your attention.
Now, there are more than two million opportunities a month for practically all physicians, all nurses and all dentists to see the new advertising for Empirin Compound.
And when these health professionals recommend Empirin, their patients won’t be looking for it in supermarkets—
EMPIRIN but in pharmacies.
Should you put EMPIRIN’ Compound next to your most profitable item?
So, look to your stock. In addition to good profits from > Empirin Compound, the extra traffic should help you move a e lot of other items as well. Display Empirin Compound for greater sales and profit.
When customers ask your professional advice: Recommend two Empirin tablets every three hours, for minor aches and pains, simple headache and toothache, and
to help relieve the discomfort
of colds.
Empirin Compound. Consistent relief.
Burroughs Wellcome Co. Research Triangle Park Wellcome / North Carolina 27709
item next to EMPIRIN Compound?
the >” maryland
=" pharmacist
National October 3-9. Pharmac 1971 We
ek -
Voluntary Disaster oe
See your pharmacist for the
National Pharmacy Week October 3-9, 1971
. : | ; BA luniamAZ SEPTEMBER 1971 Nambenko q
Compliments of
oxell
CORPORATION
N
Makers of NOXZEMA SKIN CREAMS NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your written assurance of quality
Each prescription you fill is an exercise of your pro- fessional judgment. The drug you dispense may be vital to your prescription patient’s health and well- being. Minor differences in dosage form, particle size, solubility, rate of absorption, or hardness of tab- let can make major differences in therapeutic effi- cacy. When the choice is yours, you want to dispense the best.
Lilly
Eli Lilly and Company « Indianapolis, Indiana 46206
In 1970, Roche Laboratories broke with pharmaceutical industry tradition by being the first company to discontinue mass, unsolicited sampling of professional products. The Roche aim is to ensure the greatest benefit to the patient while meeting the professional needs
of the pharmacist and physician. All are served best by proper handling of drugs. Better control of all aspects of drug distribution ensures the highest standards of health care for the patient, physician and community.
This policy reflects Roche interest in the general problems of pharmacy management, as well as the pharmacist-doctor, pharmacist-patient and pharmacist-community relations. There are many of your colleagues at Roche—practical profes- sionals in various management positions— sho help make the policies and provide the services hat help you meet the challenge of pharmacy today.
ROCHE LABORATORIES Division of Hoffmann-La Roche Inc. Nutley, New Jersey 07110
|
The Maryland Pharmacist
NATHAN I. GRUZ, Editor
NORMAND A. PELISSIER, Assistant Editor MARTHA ECKHOFF, Editorial Assistant ROSS P. CAMPBELL, News Correspondent
VOLUME 47
650 WEST LOMBARD STREET BALTIMORE, MARYLAND 21201
SEPTEMBER 1971
_s ASSOCIATION
NUMBER 9
OFFICERS 1971-1972
Honorary President
H. NELSON WARFIELD—Pikesville *
President NATHAN SCHWARTZ—Annapolis
President Elect BERNARD B. LACHMAN—Baltimore
Vice President JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore, Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore STEPHEN HOSPODAVIS (1972)
Cresaptown PHILIP D. LINDEMAN (1973)—Berlin ANTHONY G. PADUSSIS (1973)
Baltimore MELVIN J. SOLLOD (1974)—Adelphi SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore EX-OFFICIO MEMS8ERS
FRANCIS S. BALASSONE—Baltimore WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON—Baltimore
President
NORMAN J. LEVIN—Pikesville
Secretary
F. S. BALASSONE—Baltimore
Member FRANK BLOCK—Baltimore
Member HOWARD L. GORDY—Salisbury
Member MORRIS R. YAFFE—Potomac
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association
President Men eee re Stephen Hospodavis Vice-Presilent< a ee James Ritchie Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association
Bresigent@cc 8), 120), = yeeros Irvin Kamenetz Presidents Elect so). ee Joseph U. Dorsch LPCUSULEr ae eee oe ee Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille Secretary and Executive Director Nathan I. Gruz
Eastern Shore Pharmaceutical Society
President mete irs te Gordon Harrison First Vice President....... William P. Smith Second Vice President....... William Connor DECICLAFVA eae eaten ee, Carl R. June T FECSUr Grete. ce etn nk os os Thomas Payne
Prince Georges-Montgomery County Pharmaceutical Association
RIEStd ent teen rie ce ce eae Martin Hauer First Vice President....Edward D. Nussbaum Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz WECrOlary Mey cathe e ee ec Paul Reznek TT CGSURCh ae ce te ee eek oe Michael Leonard Honorary President .......... Samuel Morris
Washington County Pharmaceutical Association
Presiden tamercmtneca Samuel E. Weisbecker HiceeP resident meen ene Joseph Davies Secretary-Treasurer ...... Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter
President parca ot oe Paul R. Webster Vicew Presid cn tae een Stephen B. Bierer SCCTCLOTY tener eto. are Donna S. Levin Treastr erage: sclee cetee: Dennis R. Reaver
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association President MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE Communications Secretary MRS. RICHARD R. CRANE Treasurer MRS. CHARLES S. AUSTIN Membership Treasurer
MRS. MANUEL B. WAGNER
TAMPA — Traveler’s Auxiliary of The Maryland Pharmaceutical Association President PAUL J. MAHONEY First Vice President JOHN C. MATHENY Second Vice President ABRIAN E. BLOOM Third Vice President C. WILSON SPILKER Secretary-Treasurer WILLIAM A. POKORNY Assistant Secretary-Treasurer WILLIAM L. NELSON Honorary President JOSEPH GRUBB Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER Secretary
DOLORES A. ICHNIOWSKI
Treasurer
THOMAS E. PATRICK
University of Maryiand School of Pharmacy
Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
St. La aie aati ee Sess SSNSDSRSSNNSNNUSGISSSemeo=isst
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for
changeover.
The Maryland Pharmacist is published monthly by the Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Balti- more, Maryland, under the Act of March 8, 1879.
TABLE OF CONTENTS
Page
Editorial—Pharmacy and Public Health Education.... 6
Pharmacy, Calendartsec. ee ee 7 Summary of Minutes of Executive Committee
and Board of Trustees Meetings 00.........ccccccccccccceseeee 8 Washington Spotlight For Pharmacists ..........cccccccccc0. 12 Interactions of Drugs by Richard A. Wankel
ANOS YON Ye le ULe eC) 1 meee ene 14 Prince Georges-Montgomery County
Pharmaccutica meASSOCLAt]O lime etee eee 21 University of Maryland School of Pharmacy ............ 22 FOSspitalm Pharma Cys SCCLLO nee tee a enn 24 AZ.O] Pharmaceuticalerraternity ease nee eee 25 Obituaries tsctivie- enc) cok ee Re ee ee ee 26
INDEX TO ADVERTISERS
Page Berkey * Filmy 1Processin caec vent eee 23 Calvert Drug \ Company) ae eee 21 Henry, Bi Gupin Companys .e eee 28 Hynson Westcott: 62. Dunning... (nc... eee eee eee Dy EeligLillveanduCompaly sec. oe ee eee ee 3 Loew ys, Dries Company a. eee ee eee ils) Manginit and Associates, Inco as. ae eee Ath Maryland yNews:-Company. 050.5) ee 19 Noxell Corporation ineee. ee ee 2 Paramount) Photos Service chee ee ee ILA
Pension and Investment Associates of America,Inc... 7
AJA. 2 Robins! Company aac. ene ee ee 13 Roches Laboratoricsmre 2a ee 4 D. Stuart Webb Advertising Services ............................ 21 Youngs Drug Products Corporation ...0..0...022.-.............. 9
THE MARYLAND PHARMACIST
Editorial...
Pharmacy and Public Health Education
No other health profession has either ease of access to or the frequency of contact with the public that phar- macy has.
Through the years the Maryland Pharmaceutical Association has fostered the concept of the pharmacy be- ing the ready, convenient source of health information. For a number of years MPhA has had Health Informa- tion Racks available to its members as well as pamphlets on a wide variety of health subjects.
During the past 12 months MPhA has focused on the following public health areas among others:
—Drug abuse
—Diabetes detection —Children’s dental health —Poison prevention
—Drug interactions —Patient medication records —Venereal disease
As an example of the catalytic effects of MPhA leadership in a recent campaign, we would like to relate some of the results of just one of our programs.
In Maryland in spite of a raging venereal disease epidemic, efforts on both state and local levels to com- bat V.D. did not seem to achieve the sense of urgency the crisis deserved. In the spring of 1971 the MPhA Executive Committee, realizing the gravity of the situa- tion, decided to initiate a program to alert the public to the magnitude of the VD problem with the view of pub- lic health education in the prevention and treatment of
VED}
Under the chairmanship of Paul Freiman, a press conference was called which was attended by representa- tives of state and local health officials and medical so- ciety representatives as well as the media. The confer- ence was most successful in achieving its goals.
The result has been publicity in the press and on radio and TV, with favorable editorial comment. The Medical and Chirurgical Faculty of Maryland (state medical society) has decided to join with the MPhA in an educational campaign. The State Department of Health is establishing a Commission on V.D. and has asked for a representative from MPhA. A seminar for health professionals has been arranged by the State De- partment of Health and the Johns Hopkins University. The Baltimore City Health Department is also interested in working out a joint program with MPhA and Med Chi.
This year the theme of National Pharmacy Week has been designated appropriately “V.D. — Voluntary Dis- aster.”
Members will receive posters and additional informa- tional pamphlets to distribute to their patrons. News- papers, radio and TV announcements will direct the public to their pharmacies for information. A speakers’
SEPTEMBER 1971
program involving physicians, pharmacists and phar- macy and medical students will be available throughout the coming year to bring the message to young people.
During the coming months other activities of MPhA, both alone and with the medical society and_ health agencies, will be announced.
Pharmacists are uniquely qualified to “rap” with their patrons, young and old. Pharmacists are readily accessible in all the neighborhoods of our cities. in every town and in most hospitals. We look forward to more and more pharmacists participating in all the many pub- lic health programs in which MPhA is engaged. These are constructive projects which identify pharmacists with the public interest, creating an image in the public mind
which we trust will be justly deserved.
These are certainly the kinds of ongoing activities
that all health professionals—pharmacists included — commit themselves to when they embark on a career in
providing health care in their communities.
KERMIT D. WHITE
In June, a senseless tragedy occurred involving a dedicated community pharmacist, Kermit D. White, who lost his life in the line of duty at the hands of a desper- ate drug addict seeking to obtain drugs and money. He was a fine human being, a devoted husband and father. a friend to all the community and a worker on behalf
of young people.
We remember him as one who responded to the re- sponsibilities of his profession by participating in the MPhA committee working on the problems associated with neighborhood comprehensive health centers.
The Maryland and Baltimore Metropolitan Pharma- ceutical Associations mourn the death of Kermit White and extend sincere sympathy to his family. In order to perpetuate his memory, MPhA and BMPA have brought together representatives of the community as well as pharmacists to plan a suitable memorial tribute.
The initial meetings suggest the establishment of a community project, perhaps in the field of drug abuse, in service to the youth of West Baltimore where Kermit White practiced and where he sponsored youth activities.
We are sure that the entire city as well as all phar- macists will respond when called upon to contribute to the memorial for Kermit White.
Nathan I. Gruz
CHANGE OF ADDRESS
When you move— Please inform this office four weeks in advance to avoid undelivered issues.
"The Maryland Pharmacist" is not forwarded by the Post Office when you move.
To insure delivery of "The Maryland Pharmacist" and all mail, kindly notify the office when you plan to move and state the effective date.
Thank you for your cooperation.
Nathan I. Gruz, Editor Maryland Pharmacist 650 West Lombard Street
EPTEMBER 1971
PHARMACY CALENDAR
October 3-9—National Pharmacy Week October 7—MPhA Fall Regional Meeting, Playboy Club,
Baltimore.
October 10-14—National Association of Retail Druggists Annual Convention, The Rivergate, New Orleans.
October 16-21—National Wholesale Druggists’ Associa- tion Annual Meeting, Century Plaza Hotel, Los Angeles.
October 14—MSHP meeting at St. Joseph’s Hospital, October 21—( Thursday )—BMPA regular meeting. November 4—( Thursday )—TAMPA Ladies’ Night, Gar-
land Dinner Theatre, Columbia. 7:30 p.m.
November 11—MSHP meeting at the USPHS Hospital, 7:30 p.m.
November 18—( Thursday )—BMPA Annual Meeting.
December 12-16—American Society of Hospital Phar- macists Sixth Annual Midyear Clinical Meeting, Washington, D.C.
January 30, 1972—56th Annual Installation Banquet & Dance, Baltimore Metropolitan Pharmaceutical Asso- ciation, Blue Crest North.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10..
Plans (Sole Proprietor-Partnerships) Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
THE MARYLAND PHARMACIST 7
Summary of Minutes of Executive Committee and Board of Trustees Meetings
iy
March 4, 1971
Communications included letter from International Congress of Pharmaceutical Sciences requesting sup- port for meeting September 7-12, 1971, in Washing- ton, D.C. Letter from manufacturer regarding ad- vertising products changing from “available in gro- ceries” to “your favorite dealer.”
The President reported that Washington County Pharmaceutical Association had voted to affiliate with MPhA. The affiliation was endorsed. President attended Tri-Partite Committee meeting of School, Board of Pharmacy and MPhA to review changes in
curriculum and new preceptor programs.
The Executive Director reported on H.B. No. 569 which would establish a Board of Health Service Assistants. The bill was written with very broad implications which could affect Pharmacy and sup- ersede some of the functions of the Maryland Board of Pharmacy. Other activities included Swain Semi- nar, BMPA Executive Committee meeting, Crozier Testimonial Dinner, Maryland Society of Associa- tion Executives meeting; guest at AZO Breakfast Meeting featuring speaker from Paid Prescriptions, Inc.; meeting with William Donald Schaefer, Presi- dent of Baltimore City Council; Med-Chi Pharmacy
Liaison Committee meeting.
New Federal Controlled Substances Act discussed. Details to be presented at Spring Regional Meeting.
Effective date of the APhA “grandfather” provision for the local associations was put in line with their membership years, such as March 31, 1971 for Prince Georges-Montgomery County Pharmaceutical Association.
- Details for observance of Poison Prevention Week in-
cluding the printing and sale of labels with Poison Control Center telephone number were outlined.
The general format of the Convention and recon- vened sessions in Jamaica was reviewed. Report was made on the Spring Regional Meeting. Prince Georges-Montgomery County Pharmaceutical Asso- ciation will assist in the promotion.
Dean Kinnard reported on the new curriculum and preceptorship plan. A questionnaire will be sent out to all pharmacists regarding supportive personnel. A Task Force has been meeting on this issue. The entire Poison Information Center is to be moved with State Health Department approval, from the Baltimore City Hospitals to the School of Pharmacy.
A legislative report was made on Senate Bill No. 110 requiring placing name of drug on prescription label. Mr. Gruz testified for resolution regarding the role of advertising of proprietary drugs in drug abuse.
A report was heard on Prescription Drugs, Inc. Con- ferences have been held with some of the individuals involved. Paid Prescriptions contract discussed.
THE MARYLAND PHARMACIST
Lek
12.
13.
14.
Paul Reznek was appointed a delegate to the APhA House of Delegates in place of Mr. Burgee who could not attend.
The Board voted to participate in the Maryland Science Fair.
Procedure adopted for nomination by mail ballot. General membership and affiliated associations will be asked to recommend nominees for the various offices, with a biographical sketch and qualifications for the office submitted to the Nominating Commit- tee. There will be two nominees each for President- Elect; Vice-President and Treasurer. For the Board of Trustees there will be six pairs of candidates, the two opposing candidates being from the same area. Election Committee or Board of Canvassers to be composed of one member from each affiliated asso- ciation selected by each organization. Function will be to insure all ballots remain sealed until opened by the Board, counted and certified for eligibility to vote.
Senate Bill No. 415 to place exempt narcotics on prescription only discussed. MPhA position reaf- firmed for sale personally by the pharmacist in ac- cordance with the present federal and state law regu- lations.
Mareh 24, 1971
Communications included letter from APhA stating BNDD would mail inventory forms to all pharma- cies. Letter from Dean Kinnard regarding Executive Committee action on School support of Rho Chi dis- tribution of Poison Control Center labels. Letter from APhA to the Congress to place pharmacists under the same Selective Service provisions as other health professionals. Letter from Lt. Governor Lee acknowledging letter from President Fedder urging greater funding of the Drug Abuse Authority and stating this had now been done.
The President reported on his testifying before State Legislative Committee on a bill initiated by two pharmacists from Prince Georges-Montgomery County area to place exempt narcotics on prescrip- tion. He attended Open House at School of Phar- macy and taped radio program on Poison Preven- tion.
Executive Director reported on his attendance at legislative committee hearings, meeting with Pre- scription Drugs, Inc., meeting of Affiliated Mer- chant’s Association, and meetings on Medicaid Pro- gram and Venereal Disease Education Program. Also meetings on Poison Prevention and Convention plan- ning were attended.
The Membership Committee report indicates an in- crease in the non-owner-manager category of phar- macists but owner-manager category is behind. Mem- bership figures to date are 445 compared to 432
last year.
SEPTEMBER 1971
V.D. PREVENTION & CAMPAIGN REINFORCES PHARMACISTS’ EFFORTS
Youngs Drug Products Cor- poration, a leading producer of prophylactic products, has budgeted special funds for infor- mative V.D. awareness and prevention advertising; it is help- ing to organize V. D. control campaigns, currently in eleven states and cities; its executives have been making presentations to teenagers and adults in organi- zations, colleges, service clubs, ‘parents’ groups and schools.
More than 4 million copies in both Spanish and English of Youngs’ pocket-size pamphlet, “Plain Talk About Venereal Diseases,”
have been distributed from coast to coast. .
A major purpose of the Youngs program is to reinforce the role of pharmacists and their state associations as front-line fighters in the current battle against V.D. Company materials empha- size that pharmacists are the best sources for both prevention advice and prophylactic needs.
NEW V. D. PUBLICITY PROGRAM INVOLVES PHARMACISTS
As part of the many activities which make up its V. D. awareness and V.D. prevention program, Youngs Drug Products Corpora- tion has launched a national publicity program. The company maintains a steady flow of infor- mation about the venereal disease problem and its prevention to
all media—television, radio, news- papers and magazines. This has brought continuing editorial cov- erage on the magnitude of the V.D. problem and its control. The coverage highlights the pharma- cists’ key rolein V.D. control work.
YOUTH NEEDS V.D. INFORMATION
America’s young people badly need information about venereal disease, according to Melvin Clark, sales manager of Youngs Drug Products.
“Young people,” says Mr. Clark, “are the prime ‘V.D.-prone’ age group. And it seems evident that much of this may be because
they are not given the facts about V.D., particularly V.D. preven- tion. The average high school text on biology or hygiene contains dozens of pages of text about typhus, scurvy, beri-beri, bubonic plague, cholera, smallpox, even varicose veins. But most texts— we estimate about 98 percent— contain nothing, not even a sen- tence, about venereal disease.”
“Students and their teachers, however, want the facts, and we welcome their inquiries,”
says Clark.
NEW HIGH SCHOOL V.D. PROGRAM STARTED Venereal disease and its preven- tion were the subjects of a day-long session of New York City’s giant Bronx High School of Science recently. Youngs Drug Products Corporation served as invited-guest impresario.
Unique thus far in venereal disease “awareness” activity, the pro- grams started at 9:30a.m.ona school day and continued for six successive large classes.
Youngs’ program on V.D. was shown each group, witha question period following each discussion. The speaker advised that the pharmacist was an
prevention news
excellent source for both prevention advice and prophy- lactic needs.
LICENSE PLATE CARRIES V. D. MESSAGE
Dr. Warren A. Ketterer, Head, Venereal Disease Section, Califor- nia State Department of Public Health, carries his anti-V.D. message with him wherever he goes. His automobile has a very special license plate: “END V.D.”
i
The plate attracts considerable attention on the roads, and has received favorable press mention in California.
YOUNGS EXECUTIVE ON TV
CBS-TV Station KNXT, Los Angeles, recently granted free air time to a sales executive of Youngs Drug Products Corporation to broadcast a hard-hitting plea for greater accuracy in describing
the V.D. problem and for greater emphasis on V.D. prevention as the “prime dependable device in bringing V.D. under control.”
According to Youngs, its West Coast sales manager, Harold Halberstadt, was given this free time over KNXT to answer one of the station’s own broadcast editorials on the current epidemic scale V.D. increase.
John C. MacFarlane, president of Youngs, commented that KNXT’s offer of prime T’V time was “a gratifying example of the type of total community effort that can be mustered behind the all-out attack on the V.D. epidemic.”
Produced by Youngs Drug Products Corporation,
Manufacturers of Trojans Brand Quality Prophylactics, 865 Centennial Avenue, Piscataway, New Jersey 08854.
6.
Jt
~
Convention Committee chairman reported on status of Convention program. Original airplane for Ja- maica trip was sold out and arrangements were be- ing made for a larger plane.
Professional Relations Committee reported on forth- coming Med Chi exhibit on patient medication pro-
files.
A legislative report was made on Senate Bill 4 amendment requiring physician’s signature to be legible on prescriptions.
A motion was passed concerning approving appoint- ment of Executive Director and the consideration of employment of assistants.
Third-Party Payment Programs were reviewed along with activities of National Pharmacy Insurance Council. Motion passed on endorsement of policy whereby third-party payment programs would only be endorsed if dispensing of drugs is limited to pharmacists. “Paid Prescriptions” program for sam- ple distribution by means of prescriptions through pharmacies was endorsed.
May 16, 1971
Communications included letter from Irvin Rubin, Editor of Pharmacy Times requesting support for a commemorative postage stamp in honor of Phar- macy.
The President noted in his report that this would be the last Executive Committee meeting before re- organization and thanked all for their cooperation extended to him.
The Treasurer’s report indicated net income for the year of $24,704; expenditures, $17,621.10; $5,600 was temporarily transferred to the savings account.
Executive Director reported on his attendance at meeting of National Council of State Pharmaceutical Association Executives in connection with APhA convention. Work is proceeding under Dr. Samuel Fox on the campaign of the Maryland Pharmaceuti- cal Foundation. Also attended the installation affair of the Prince Georges-Montgomery County Pharma- ceutical Association. Major activities included: MPhA Convention planning and arrangements; in- quiries regarding the Controlled Dangerous Sub- stances Act (MPhA furnished rubber stamps and pads); APhA Annual Meeting—main topics: repeal of antisubstitution laws, ‘Pharmacy Doctor” degree, pharmacy recruitment; V.D., BMPA Camp Glyndon reconstruction project; “Suggested Guidelines for Pharmacy Practice” has been issued, published
jointly by MPhA and MSHP.
The Membership Committee reported total mem- bership to date at 586 versus 630 at the same time last year. Most of the new 1971 members are chain pharmacists.
The Public Health Information Committee outlined plans for V.D. Awareness Month in June. A press conference is scheduled in early June. The Speakers’ Bureau on V.D. is also being set up.
The Legislative Committee reported on the 197] legislative session and noted that Senate Bill 110 re- quiring labeling of ingredients on prescriptions was enacted.
THE MARYLAND PHARMACIST
LO:
WA.
The Third-party Payment Programs Committee re- ported on the increase for CHAMPUS prescription fees for Maryland from $1.85 to $2.00 and that the MEDI-MET program had increased its prescription fee to $2.00. There was discussion on some of the Union Prescription Prepayment Plans extending the maximum supply of drugs on a prescription to 90 days.
The motion to nominate Sydney Burgee as Speaker Pro-Tem of the House was passed.
The recommended budget of $44,500 was approved
after a review of income and disbursements.
The Nominating Committee recommended the fol- lowing names for filling the vacancy of Howard L. Gordy on the Board of Pharmacy for 1972: I. Earl Kerpelman, James W. Truitt, and Philip B. Linde- man. Simon Solomon was voted as an Honorary Life Member of the Board of Trustees.
June 10, 1971
The President asked committee chairmen to assume a more active role in the work of the Association and to delegate responsibilities.
The Treasurer’s report showed that income from dues for the first five months of 1971 was lower than the same period of 1970. The Annual Convention this year was more of a financial success than last year’s. Office expenses have been higher in 1971, attributed to the increased charges for mailing and printing.
The Executive Director asked for a moment of silence in memory of Dr. B. Olive Cole. Attendance was higher at the 1971 Annual Convention than in previous years. Other recent activities included the V.D. Awareness Campaign launched with a press conference that proved to be extremely effective. The exhibit at the Med Chi meeting was successful. About 50 pamphlets entitled “Drug Interactions” were mailed from the office as the result of requests from physicians who visited the exhibit. Director Gruz attended the meeting of the Maryland So- ciety of Association Executives and attended the Governor’s Commission on Aging meeting in prepa- ration for the White House Conference on Aging. Approval was granted for Director Gruz to attend the third year of a three-year course in organiza- tion management to be held in Philadelphia in early August.
The membership committee is currently meeting with the membership committee chairmen in the sub- groups. Because 30 pharmacies have closed last year. the membership figures in the owner-manager cate-
gory are behind.
It was suggested that educational programs be in- cluded in the next Convention.
The Prepaid Prescription Program Committee chair- man reported on the possible use of the standard form of the National Pharmacy Insurance Council. The need for legislation to allow negotiations by pharmaceutical associations was pointed out.
The matter of county Commissions on Aging list- ing pharmacies offering discounts was reported and was referred to legal counsel.
SEPTEMBER 197!
8.
oi.
12.
13.
14.
EPTEMBER 1971
MPhA policy concerning the use of unregistered personnel in prescription departments was discussed. A committee chairman was appointed to study and report on this.
zt committee was appointed to study and report on this.
The Legal Counsel reported on scheduled House Small Business Committee hearings on July 7, 8 and 9 on prepayment prescription plans. There was discussion regarding operation of pharmacies by corporations and nonpharmacists.
The following committee chairmen were approved: Prescription Insurance Plans: M. Bookoff
Finance: J. McHugh
Legislative: P. Freiman
Membership: M. Rubin
School of Pharmacy: D. Fedder
Public Relations: C. Spigelmire
Professional Relations: S. Hospodavis; N. Warfield Co-chairman
Public Health Information: P. Freiman Constitution and By-Laws: M. Sollod
Institutional Pharmacy: R. Snyder
?
Bowl of Hygeia Award: Charles E. Spigelmire was approved as the recipient of the Robin Bowl of Hygeia Award for 1972.
Discussion was held concerning joint committees between MPhA and MSHP. The matter will be dis- cussed with the new MSHP officers with a report to the Board of Trustees later.
Plans were reviewed for the London Trip November atone 197 1.
Brief discussion regarding increased representation on the Board for the Prince Georges-Montgomery area was held and the matter referred to the Consti- tution and By-Laws Committee.
July 8, 1971
Communications included a letter from Mr. Balas- sone regarding adoption of regulations on pacifiers, the first such regulation in the nation and a letter from the Maryland Diabetic Association requesting participation of MPhA in mobile testing program.
The Executive Director reported that Mr. Balassone has received the Wiley Award by the Association of Food and Drug officials of the U.S. and reported on attendance at the annual meeting in Washington of the National Coordinating Council on Drug Abuse Education as representative of state association exe- cutives. Mr. Gruz also attended the Maryland Health Careers meeting where health assistants legislation was discussed. He also reported on his correspon- dence to Governor Mandel regarding the inclusion of representatives of the MPhA on various govern- mental commissions. He noted that the Association is not endorsing the United Prescription Centers at the present time.
The membership committee reported a membership as of June 30 of 619 compared to 698 at the same time last year. The proprietor-manager category has
decreased by 58.
The Prescription Insurance Plans Committee pro- posed the possibility of developing a formulary in conjunction with Med Chi for use on Medicaid and other prescriptions. Request made for increase in
Medicaid Fee.
Dean Kinnard reported on the article in the Ameri- can Druggist on the preceptor program. The Reg- ional Medical Program is considering funding of a drug information center at the University which will be regional in scope and provide community service. The School will provide a two and one-half hour session at the 1972 annual Med Chi meeting on the new role of Pharmacy in drug interactions. The anticipated total of incoming students in the School is 65-68. Total incoming students must ex- ceed the previous class by 10% for the School to qualify for federal funds.
Mr. Kaufman, the legal counsel, reported a Chicago meeting indicated that although there may be a shortage of pharmacists in Maryland, there is a na- tional oversupply according to statistics.
The Metropolitan Guild of Pharmacists has requested representation in the House of Delegates. After con- siderable discussion, it was decided that the matter be brought up again for discussion at the next Board of Trustees meeting.
It was suggested that an appropriate memorial to Kermit White be established. Mr. White was fatally shot in a holdup attempt. A committee was ap- pointed to suggest an appropriate tribute to him.
MAKE IT A DAILY EXHIBIT
THE MARYLAND PHARMACIST 11
Washington Spotlight For
Pharmacists by APhA Legal Division
Security And The Controlled Substances Act
The security requirements for amphetamines, meth- amphetamines and their combinations are effective as of October 1, 1971.
The security controls for practitioners require that controlled substances in Schedules 1 and II shall be stored in a securely locked, substantially constructed cabinet. While pharmacies do not have Schedule I sub- stances under normal circumstances, they may have sub- stantial inventories of Schedule II substances, especially since the transfer of the amphetamine products.
Controlled substances in Schedule III, IV and V may either be stored in the same manner as Schedule II substances, or dispersed throughout the stock of non-con- trolled substances in such a manner as to obstruct the theft or diversion of the controlled substances.
Some pharmacies, may not at present have suffici- ent secure areas to store the Schedule II substances. The need to maintain excessive quantities of slow moving controlled substances is minimized under the Controlled Substances Act. The regulations allow for inter-pharmacy transfers of any controlled substance in an emergency situation, and a prescription for any controlled substance may be partially filled and the remainder dispensed with- in 72 hours for Schedule II substances and six months for Schedule III, IV or V substances. There are several ways in which pharmacies can maximize their present storage areas, and perhaps avoid the expenditure required to obtain more secure storage areas.
Dispense Schedule HI Narcotic Substances
The most obvious way to achieve this, is to remove the former “Class B” narcotics from the secure areas. Under prior law, these products were required to be kept under lock and key, along with the “Class A” narcotics. The former “Class B”’ narcotics, are now in Schedule III. thus, they may be removed from the special storage area and dispersed throughout the stock of the non-controlled substances. This should increase the storage area avail-
able for the Schedule II products.
Return Or Disposal Of Excessive Stocks
Another way to achieve greater storage space for these substances, is to reduce the inventory of Schedule II substances. This could be accomplished in part by re- turning or disposing of those Schedule II substances which are either no longer in demand, outdated, or too old to dispense. Many pharmacists, have been reluctant in the past to remove these old narcotic products from their inventory and continue to carry them, rather than go through the “red tape” necessary to dispose of them. It may well be that the time involved in preparing such
12 THE MARYLAND PHARMACIST
items for return or disposal, at this time, could result in appreciable savings. The disposal of these old stocks of narcotic drugs could, in some cases, result in enough of an increase in available security storage space to pre- clude further construction of such areas.
There are two major mechanisms by which a phar- macy may reduce its inventory of these substances.
Returns
The first method to consider, is the return of the substances to the manufacturer or supplier from whom they were obtained. The advantage in this method is the possibility that some credit may be issued to the phar- macy. A written record must be maintained for such re- turns of controlled substances which indicates:
a. the date of the transaction b. the name, form and quantity of the substance
name, address and registration number of the person making the distribution; and
d. the name, address and registration number of the supplier or manufacturer.
A return of a Schedule II substance, requires the use of the official order form. The manufacturer or sup- plier must provide the pharmacy with Copy 1, of the official order form for the pharmacy records.
Disposal
The second method of removing excess controlled substances from a pharmacy’s stock is disposal. The phar- macy will receive no credit using this method, but it is the only mechanism to dispose of those controlled sub- stances which can no longer be returned. To dispose of controlled substances by this method, a request is filed with the appropriate Regional Director of BNDD (use BND Form 41) in triplicate. The form is available from the BNDD Regional Offices. The Regional Director, upon authorizing the disposal, will instruct the pharmacist to dispose of the controlled substances in one of the follow- ing manners.
1. By delivery to an agent of the Bureau or to the nearest office of the Bureau.
2. By destruction in the presence of an agent of the Bureau or other authorized person; or
3. By such other means as the Regional Directo may determine to assure that the substance does not become available to unauthorized persons.
The time invested in returning or disposing of thes controlled substances which are no longer needed or us- able may help solve the security problem and save tim in the taking of future inventories required by the Con trolled Substances Act.
SEPTEMBER 197!
buy now for bigger fall and winter profits
A.H. Robins announces a special money-saving deal on Allbee with C.
_Here’s your chance to get the very best buy on the number one vit-
“ amin in its class in drug store sales. Last-year, Allbee with C led
‘in purchases with 25% of this big $20 million plus market. This in-
Li _.creased to a whopping 32% share during the fist part of 1971. Such
Put your facings ~ where your
profits arel (Deal runs Oct. 1—28)
an outstanding performance isn’t surprising when you consider that “it’s the B-complex. with C most often prescribed by the medical and dental professions. More than a million scripts were filled last year, and this didn’t even include professional recommendations or over- the-counter sales. Over oné»half of all Allbee with C sales are OTC! You purchase and sell far more Allbee with C. Isn’t it good busi- ness to also give it more facings’and shelf space? Your Robins rep- resentative will be around soon to discuss the deal and facings with you. You’ve got Deéal,Power with Allbee with C, and that means a better deal for you. ~~
A.H. he ’ ompany, Richmond, Va. A-HROBINS
Interactions of Drugs*
by Richard A. Wankel, Staff Pharmacist and Sydney L. Burgee, Jr., Director of Pharmacy and Central Supply, The Union Memorial Hospital, Baltimore, Maryland
Reprinted from Hospital Pharmacy, 5,10 (1970)
Patients can be seriously harmed through interac- tion of drugs, especially by those that are unsuspected by the physician. These can be unrecognized or misinter- preted. The compounded activity of two drugs that affect the same receptor, same organ, or same system are usual- ly expected, recognized, and understood. It is the more subtle, apparently unrelated, and poorly understood in- teractions that cause concern. Five pharmacological fac- tors affect the activity of systemically administered drugs. They are absorption, protein binding, metabolism ( de- toxication ), tissue distribution, and excretion. If a second agent changes one or more of these factors, the entire effect pattern of the original drug is altered. It has be- come obvious that such alterations of activity are not ab- stract laboratory principles, but real, serious clinical problems.
The principle of absorption
Proper absorption of weak acids and weak bases de- pends upon the pH of gastrointestinal fluids. Most or- ganic molecules are absorbed in the nonionized form, so that acidic interactants tend to increase absorption of weak acids and retard absorption of weak bases. Alkaline salts, such as antacids, have the opposite effect. Drugs that are weak acids and bases are listed in Table 1 Ab.
Table 1. Weak Bases and Acids A. Weak Bases B. Weak Acids
Anticholinergics Barbiturates Antihistamines Clofibrate Antimalarials Ethacrynic acid
Mefenamic acid
Nalidixie acid
Cardiac depressants Narcotic analgesics and
derivatives Nitrofurantoin Phenothiazines Phenylbutazone Sympathomimetics Salicylates Tricyclic antidepressants Sulfonamides Sulfonylureas Thiazides Thyroxine
Mono-amine oxidase inhibitors increase the action of sympathomimetics, narcotic analgesics and tricyclic anti- depressants that are destroyed by mono-amine oxidase.
Vegetable oils increase absorption of nonionized me- dicinal agents, while mineral oil has the opposite effect.
Intestinal absorbants, e.g., Kaopectate, nearly always inhibit availability of concurrently administered drugs.
Surfactants, e.g., Colace, generally enhance the ab- sorption of drugs, particularly those with poor lipid solu- bility.
*Author’s Note: This article is intended to be a guide, not a
compendium. It is not a complete list of all possible drug interactions; therefore, absence of a particular drug can- not be interpreted to mean that the agent would not cause an interaction.
14 THE MARYLAND PHARMACIST
Displacement from protein binding sites
Many drugs are bound to serum protein to a great extent. The bound portion is inactive but also protected from metabolic breakdown. An equilibrium exists be- tween the amount of free drug and the ameunt that is protein bound. If a second drug having a greater affinity for the protein binding sites is introduced, the first drug may be released in overwhelming amounts, resulting in effects of overdosage followed later by symptoms of drug absence as the unbound drug is metabolized or excreted.
Drugs in Table 2A displace drugs in Table 2B, there- fore increasing the action of the drugs in Table 2B; but there may also be interactions within each group of drugs. Coumarins may be considered as a middle point between the two groups of drugs; that is, able to be displaced by many drugs in Table 2A and able to displace many drugs in Table 2B.
Table 2. Drugs with Strong and Weak Affinity for Protein Binding Sites
A. Drugs With a Strong —_B. Drugs With A Weak
Affinity Affinity Phenylbutazone Coumarins Phenyramidol Alcohol Sulfonamides Sulfonylureas Diphenyhydantoin Methotrexate Clofibrate Steroid hormones Dextrothyroxine Penicillin Indomethacin Bilirubin Salicylates
Mefenamic Acid Chloral Hydrate
Coumarins
Tissue concentration and excretion
After absorption, some drugs remain primarily in the circulatory system. Others are distributed more or less equally with body water to all tissues. Still others are rapidly concentrated in particular tissues, such as adipose tissue, or at special organ receptor sites. As with protein binding, an agent that alters the usual distribution of a drug can change its effects.
Alcohol releases barbiturates from fat storage depots,
causing an increase in the concentration of barbiturates in the blood stream.
Cholinestrase inhibitors, when combined with tri- cyclic antidepressants, increase penetration of the blood- brain barrier and cause more pronounced effects from the psychotherapeutic agent.
Antihistamines potentiate the pressor effects of levarterenol, apparently by interfering with tissue uptake. — Drug-induced modification of renal or biliary activity can potentiate or diminish the effects of many agents. In addition to its effect on absorption, pH changes alter kid-
SEPTEMBER 1971
There’s alot more going for you at LOEwY
a Shiectro MEDICAL EQUIPMENT FRANCHISE
can make your store one of the most sought out sources for equipment and service in America
As the local Spectro Division in your area, we not only offer the unusual advantages
of one of America’s largest drug wholesaling operations, but those of the country’s most comprehensive medical equipment distributor, producer and servicing organization. As is being demonstrated right now in Spectro markets throughout the eastern seaboard, physical aids for the convalescent, the handicapped and the invalid can be the most significant
new profit source available to the pharmacy today. We are uniquely well endowed to provide you with professional administrative and technical direction, the widest available range of product, application counsel and in-home servicing.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
DIVISION OF we | | oe Spectre Industetes, Ine.
6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100
ney excretion patterns. Urinary acidifiers, for example aminonium chloride, inhibit excretion of weak acids (see Table 1A) and thereby potentiate their action. Conversely, the acidifiers enhance excretion of weak bases (see Table 1B) and decrease their action. Urinary alkalizers, for ex- ample sodium bicarbonate, produce the opposite effects in both groups mentioned.
At the end of the article are listed some categories of drugs (Appendix 1) and interactions (Appendix 2).
Medications can alter the metabolic rates of other agents by stimulating (Table 3) or inhibiting (Table 4) the metabolic enzymes of the liver microsomes, thereby speeding or slowing the detoxication of the other agent. Pharmacologic activity of the affected agent will increase if its metabolism is retarded and will decrease if its me- tabolism is accelerated.
Drugs that increase or decrease the action of other drugs may produce both desirable and/or undesirable re- sults. A popular example of a desirable drug interaction is the potentiation of narcotic analgesics, e.g., Demerol by antihistamines, e.g., Phenergan. When drug action is de- creased (for example the inactivation of tetracycline by antacids ) or increased (for example the CNS depressant potentiation of barbiturates by alcohol), serious conse- quences may result.
The potentiality of drug interaction does not pre- clude the use of more than one therapeutic agent con- currently. It does, however, require that the prescriber be well informed and observant, and that he adjust dos- age accordingly, if the patient is to benefit from the therapy.
Table 3. Enzyme Induction
Stimulator Enhanced Metabolism Phenobarbital and other Diphenylhydantoin, griseo- barbiturates fulvin, coumarins, digi- toxin, testosterone, bilirubin, cortisol Glutethimide Warfarin, dipyrone, glutethimide Phenylbutazone Aminopyrine, cortisol, coumarins Haloperidol Coumarin anticeagulants Meprobamate Meprobamate Ethanol Pentobarbital, tolbutamide Diphenylhydantoin Cortisol Nikethimide Bilirubin Table 4. Enzyme Inhibition Inhibitors Decreased Metabolism Coumarins —— Tolbutamide Phenylbutazone = Tolbutamide Phenothiamizines en Alcohol Desipramine ——— Amphetamines Phenyramidol == Coumarins, Diphenylhydan- toin, Tolbutamide Quinidine — Coumarins 16 THE MARYLAND
Appendix 1. Categories of drugs
Anticholinergics include: Atropine Belladonna Adiphenine (Trasentine ) Thiphenamil (Trocinate ) Trihexyphenidy! ( Artane ) Propantheline ( Pro-Banthine ) Dicyclomine ( Bentyl]) Mepenzolate (Cantil ) Procyclidine (Kemadrin )
Antihistamines include: Diphenhydramine (Benadry] ) Tripelennamine ( Pyribenzamine ) Promethazine ( Phenergan ) Carbinoxamine ( Clistin ) Chlorpheniramine (Chlor-Trimeton, Teldrin, etc.) Brompheniramine ( Dimetane ) Phenindamine (Thephorin ) Cyproheptadine ( Periactin )
Antimalarials include: Quinine
Chloroquine ( Aralen)
Cardiac depressants include: Procainamide ( Pronesty]) Propranolol (Inderal) Quinidine Lidocaine ( Xylocaine )
Cholinestrase inhibitors include: Edrophonium (Tensilon )
Neostigmine ( Prostigmin )
Coumarins include: Bishydroxycoumarin (Dicumarol ) Phenprocoumon (Liquamar ) Warfarin (Coumadin, Panwarfin)
Mono-amine oxidase inhibitors include: Isocarboxazid (Marplan ) Nialamide ( Niamid ) Phenelzine ( Nardil ) Tranyleypromine ( Parnate )
Narcotic analgesics and derivatives include: Morphine Dihydromorphinone ( Dilaudid) Levorphanol (Levo-Dromoran ) Codeine Methadone (Dolophine ) Meperidine (Demerol ) Proproxyphene (Darvon)
Pentazocine (Talwin )
Phenothiazines include: Pfobethazine (Phenergan ) Chlorpromazine (Thorazine ) Promazine (Sparine ) Prochlorperazine (Compazine ) Perphenazine (Trilafon ) Trifluoperazine (Stelazine ) Fluphenazine (Prolixin, Permitil) Thioridazine (Mellaril )
Sulfonamides include: Sulfadimethoxine (Madribon ) Sulfamethizole (Thiosulfil ) Sulfamethoxazole (Gantanol)
PHARMACIST SEPTEMBER 1971
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4, Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE 3024 Greenmount Avenue Baltimore, Maryland 21218
SEPTEMBER 1971 THE MARYLAND PHARMACIST
Sulfamethoxypyridazine (Kynex, Midicel ) Sulfisoxazole ( Gantrisin )
Sulfonylureas include: Tolbutamide (Orinase ) Chlorpropamide ( Diabinese ) Acetohexamide (Dymelor ) Tolazamide ( Tolinase )
Sympathomimetics include: Levarterenol ( Levophed ) Metaraminol ( Aramine ) Mephentermine ( Wyamine ) Methoxamine ( Vasoxy1) Ephedrine Pseudoephedrine (Sudafed ) Phenylephrine (Neo-Synephrine ) Dextro-Amphetamine (Dexedrine ) Methamphetamine (Desoxyn, Methedrine )
Tetracyclines include: Demethylchlortetracycline (Declomycin ) Oxytetracycline (Terramycin ) Tetracycline (Achromycin, Tetracyn, Tetrachel, Panmycin, Sumycin )
Thiazides include: Chlorothiazide ( Diuril ) Hydrochlorothiazide (Hydrodiuril, Esidrix, ete.) Benzthiazide (Exna) Bendroflumethiazide (Naturetin )
Tricyclic antidepressants include: Amitriptyline (Elavil ) Desipramine (Pertofrane, Norpramin ) Imipramine (Tofranil )
Appendix 2. Alphahetical list of some drugs and their interactions
A
Acetazolamide (Diamox )—increases action of Table 1B drugs; decreases action of Table 1A drugs
Alcohol—increases action of barbiturates, chloral hy- drate, glutethimide, narcotic analgesics; decreases ac- tion of sulfonylureas; action is increased by Table 2A drugs, phenothiazines, mono-amine oxidase inhibitors.
Aminosalicylic acid (Pamisyl)—action is increased by probenecid.
Ammonium chloride—increases action of Table 1A drugs; decreases action of Table 1B drugs
Antacids—increase action of Table 1B drugs; decrease action of Table 1A drugs, tetracyclines
Anticholinergics—increase action of Table 1B drugs; de- crease action of Table 1A drugs
Antihistamines—increase pressor effect of levarterenol; action is increased by Table 1B drugs; action is de- creased by Table 1A drugs
Antimalarials—action is increased by Table 1B drugs; action is decreased by Table 1A drugs
B
Barbiturates—action is increased by Table 1A drugs, alcohol, probenecid; action is decreased by Table 1B drugs; decrease action of coumarins, diphenlhydan-
C
Calcium chloride—increases action of Table 1A drugs; decreases action of Table 1B drugs
Cardiac depressants—action is increased by Table 1B drugs; action is decreased by Table 1A drugs
Chloral hydrate (Noctec, Somnos)—increases action of coumarins and diphenylhydantoin; action is increased by alcohol
Cholinestrase inhibitors—increase action of tricyclic anti- depressants
Clofibrate (Atromid-S )—increases action of Table 2B drugs; action is increased by Table 1A drugs and probenecid; action is decreased by Table iB drugs
Cortisone drugs—action is decreased by phenylbutazone, barbiturates, diphenylhydantoin
Coumarins—increase action of Table 2B drugs; action is increased by quinidine and methylphenidate; action is decreased by Table 2A drugs, griseofulvin, diazepam, barbiturates, chloral hydrate, glutethimide
Cyclamates—decrease action of lincomycin
D
Dextrothyroxine (Choloxin)—increases action of Table
2B drugs Diazepam (Valium )—decreases action of coumarins Digitalis drugs—toxicity increased by thiazides Digitoxin—( Crystodigin, Purodigin )—action is decreased by barbiturates
Diphenylhydantoin (Dilantin)—action is increased by phenyramidol, methylphenidate and probenecid; action
is decreased by barbiturates, chloral hydrate and —
glutethimide; increases action of Table 2B drugs; de- creases action of cortisone drugs
E
Ethacrynic acid (Edecrin )—action is increased by Table 1A drugs and probenecid; action is decreased by Table 1B drugs
G Gentamicin (Garamycin )—decreases action of neomycin Glutamic acid HCL (Acidulin)—increases action of Table 1A drugs; decreases action of Table 1B drugs Glutethimide (Doriden)—increases action of sulfony- lureas; decreases action of coumarins and diphenylhy- dantoin; action is increased by alcohol Griseofulvin, (Grifulvin Fulvicin)—decreases action of coumarins; action is decreased by barbiturates Guanethidine (Ismelin)—action is increased by pheno-
thiazines; action is decreased by tricyclic antidepres- sants
H
Hematinics—decrease action of tetracyclines
I
Indomethacin (Indocin )—increases action of Table 2B drugs L
Levarterenol (Levophed)—pressor action increased by antihistamines
Linomyecin (Lincocin )—action is decreased by cyclamates
M
Mefenamic acid (Ponstel )—action is increased by Table
toin, griseofulvin, digitoxin, corticosteroids, — testos- 1A drugs and probenecid; increases action of Table terone 2B drugs; action is decreased by Table 1B drugs 18 THE MARYLAND PHARMACIST SEPTEMBER 1971
ag Reading iS Still the fastest vi way
oram a mani...
eA
fo pro h brain a
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
<
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
Methotrexate—action is increased by Table 2A drugs
Methylphenidate ( Ritalin )—increases action of tricyclic antidepressants, coumarins, diphenylhydantoin, primi- done
Mineral oil—decreases absorption of fat soluble vitamins
Monoamide oxidase inhibitors—increase action of alco- hol, narcotic analgesics, sympathomimetics, tricyclic antidepressants
N Nalidixie acid (Neggram )—action is increased by Table 1A drugs and probenecid; decreases absorption of oral penicillin; action is decreased by Table 1B drugs Narcotic analgesics and derivatives—action is increased by Table IB drugs, mono-amine oxidase inhibitors, alcohol; action is decreased by Table IA drugs
Neomycin—decreases absorption of oral penicillin; action is decreased by gentamicin
Nitrofurantoin (Furadantin, Macrodantin )—action is in- creased by Table 1A drugs and probenecid; action is
decreased by Table 1B drugs Pp
Penicillin-oral absorption is decreased by nalidixic acid and neomycin; action is increased by Table 2A drugs and probenecid. Cerebrospinal fluid level is increased by probenecid
Phenothiazines—increase action of aleohol and guanethi- dine; action is increased by Table 1B drugs; action is decreased by Table 1A drugs
Phenylbutazone ( Butazolidin )—increases action of Table 2B drugs; decreases action of coumarins and cortisone drugs; action is increased by Table 1A drugs and probenecid; action is decreased by Table 1b drugs
Phenyramidol ( Analexin )—increases action of Table 2B drugs, diphenylhydantoin, sulfonylureas
Primidone (Mysoline )—action is increased by methy]- phenidate
Probenecid (Benemid)—increases action of Table 1B drugs, penicillin, diphenylhydantoin, para-aminosali- cylic acid; increases cerebrospinal level of penicillin
Q
Quinidine—increases action of coumarins
R
Reserpine (Serpasil)—action is decreased by tricyclic
antidepressants NS)
Salicylates—increase action of Table 2B druys; decrease action of coumarins; action is increased by Table 1A drugs and probenecid; action is decreased by Table 1B drugs
Sodium bicarbonate—increases action of Table 1B drugs; decreases action of Table 1A drugs
Steroid hormones—action is increased by Table 2A drugs
Sulfonamides—increase action of Table 2B drugs; action is increased by Table 1A drugs and probenecid; action is decreased by Table 1B drugs
Sulfonylureas—action is increased by Table 1A and 2A drugs, probenecid and glutethimide; action is decreased by alcohol
Sympathomimetics—action is increased by Table 1B drugs and mono-amine oxidase inhibitors; action is decreased
by Table 1A drugs
20 THE MARYLAND PHARMACIST
th
Testosterone—action is decreased by barbiturates
Tetracyclines—action is decreased by antacids and hema- tinics
Thiazides—increase toxicity of digitalis drugs; action is increased by Table 1A drugs and probenecid; action is decreased by Table 1B drugs
Thyroxine (Synthroid )—action is increased by Table 1A drugs and probenecid; action is decreased by Table 1B- drugs
Tricyclic antidepressants—action is increased by Table 16 drugs, mono-amine oxidase inhibitors, methylpheni- date, cholinestrase inhibitors; action is decreased by Table 1A drugs; decreases action of guanethidine and reserpine
V
Vitamins, fat soluble—absorption is decreased by mineral oil
References
1. Azarnoff, D. and Hurwitz, A.: Drug Interactions. Pharmacol. for Physicians 4:2, 1970.
2. Conney, A.: Drug metabolism and therapeutics. New Eng. J. Med. 280:653, 1969.
3. Conney, A.: Microsomal enzyme induction by drugs. Pharma- col. for Physicians 3:12, 1969.
4. Conney, A.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19:317, 1967.
5. Cucinell, S.; Conney, A.; Sansur, M. and Burns, J.: Drug interactions in man J]. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (dicumarol) and diphenylhydantoin - (dilantin). Clin. Pharmacol. Ther. 6:420, 1965.
6. Dinel, B. and Latiolais, C.: Drug Interaction-enzyme induc- tion. Hosp. Form. Manag. 2:35—39, 1967. {
7. Dunphy, T.: The pharmacist’s role in the prevention of ad- verse drug reactions. Am. J. Hosp. Pharm. 26:367, 1969.
8. Goldstein, A. and Aronow, L. and Kalman, S.: Principles of drug Action. Hoeber Medical Division, New York, Harper & Row, 1968.
9. Goodman, L. and Gilman, A.: The Pharmacological Basis of Therapeutics. 3rd Ed., New York, The Macmillan Co., 1965.
10. Hartshorn, E. A.: Drug interactions—How drugs interact. Drug Intell., 2:58—65, 1968.
11. Hunninghake, D. and Azarnoff, D.: Drug interactions with warfarin. Arch. Int. Med. 121:349, 1968:
12. Hussar, D.: Tabular compilation of drug interactions Am. J. Pharm. 141: 109, 1969.
13. MacDonald, M.; Robinson, D.; Sylwester, D. and Jaffe, J.: The effects of phenobarbital, chloral betaine, and glutethimide ad- ministration on warfarin plasma levels and hypoprothrombinemic re- sponses in man. Clin. Pharmacol. Ther. 10:80, 1969.
14. Myers, D.: Drug interaction. Tile and Till 56: 1, 1970.
15. Penna, R.: A screening procedure for drug interactions. J. Am. Pharm. Assn. NS10:66—67, 1970.
16. Stuart, D.: Drug metabolism. Part II Drug interactions. Pharmindex Oct. 1968.
17. Welch, R.: Harrison, A.: Conney, A.: Burns, J.: An ex- perimental model in dogs for studying interactions of drugs with bishydroxycoumarin. Clin Pharmacol. Ther. 10:817, 1969.
18. Zupko, A.: A practical guide to drug interactions. Resident and Staff Physician Mar., 1970. |
New Prescription Forms Must be Used After December 31
Pharmacies will be requested to discontinue use of MS-6A refill blanks after December 31, 1971. Also, pre- scribers will be asked to discontinue using the old MS-6 prescription form when ordering medication for Mary- land Medical Assistance patients.
After December 31, all prescriptions must be writ- ten on the new Prescription and Pharmacist’s Invoice
Form, DHMH-235 and refills on form DHMH-236.
SEPTEMBER 1971
Prince Georges-Montgomery County Pharmaceutical Association
The Prince Georges-Montgomery Pharmaceutical Association held a special meeting on Health Maintenance Organizations (H.M.O.) on Thursday, September 9, at the National Institutes of Health Clinical Center Audi- torium. Dr. Daniel Y. Patterson, Director, Office of Health Maintenance Organizations, H.E.W., discussed HMO’s with a question and answer period following. The meeting was arranged by Program Chairman, Edward D. Nussbaum.
Mangini can tell you what you have.
Headquarters for Within 1%
PHOTO-OFFSET PRINTING MAILING Many pharmacists often esti-
PRINTING ROBOTYPED LETTERS Paes ican call — MUlberry 59-3232, 33, 34 In today’s competitive climate
and with the cost of merchan-
D. STUART WEBB Gee eon RUGHEN Wieinduibese
estimated gross profit figures
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
Mangini & Associates, Inc.
4850 W. Belmont Ave. Chicago, Ill. 60641/(312) 282-8181
can be misleading. In fact. this can be extremely costly to the pharmacist who, un- aware of his shrinking inven- tory and gross profits. is actually paying a higher in- come tax than he should
So why guess? Call Mangini for fast, computerized inven- tory service that will tell you within 1% how your inventory realistically stacks up to your turnover, sales and profits!
WRITE FOR DETAILED INFORMATION. {iS FREE!
11722 Studt St, St. Louis, Mo 63141 2760 W. Market St, Akron, Ohio 44313 575 Savin Ave , West Haven, Conn 06516 5501 Cherokee Ave, Alexandria, Va. 22312
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
SEPTEMBER 1971 THE MARYLAND PHARMACIST
2|
University of Maryland School of Pharmacy
School of Pharmacy Alumni Association
The following officers were installed at the Alumni Banquet of the University of Maryland School of Phar- macy on June 2, 1971: President, Anthony G. Padussis; First Vice President, Ronald Sanford; Second Vice Presi- dent, Charles Tregoe; Executive Secretary, Dorothy S. Levi; Treasurer, H. Nelson Warfield.
Executive Committee members installed were: Harry R. Wille, Arnold Amass, Mary W. Connelly, Nicholas Lykos, Marvin Goldberg, Charles Sandler and David Serpick.
Appointments and Promotions at School of Pharmacy Announced
Dr. William J. Kinnard, dean of the University of Maryland School of Pharmacy, has announced the fol- lowing appointments and promotions for the academic year:
Appointed coordinator of the professional experience program and associate in the department of pharmacy: William J. Edmondson.
Appointed clinical associate, pharmacology and toxicology: Karen T. Collins.
Appointed adjunct professor, pharmacology and toxicology: Dr. C. Jelleff Carr; adjunct professor, micro- biology: Dr. Donald E. Shay.
Appointed adjunct associate professor, pharmacology and toxicology: Dr. Helmut F. Cascorbi.
Appointed adjunct assistant professor, pharmacy and medicinal chemistry: William J. Mader; adjunct assist- ant professor, pharmacy: Winifred Sewell.
Appointed clinical instructors (institutional pharma- cists): Adolph Biasini, Holy Cross Hospital; Richard J. Brodeur, Georgetown University Hospital; Mary W. Con- nelly, Mercy Hospital; Kent Johnson, U.S. Public Health Service Hospital, Baltimore; Douglas R. Mowrey, Wash- ington Hospital Center.
Appointed clinical instructors (community pharma- cists): Morton Abarbanel, Daniel S. Baker, Richard Bay- lis, Samuel Bialek, Jerome Block, Morris Bookoff, Gerald I. Cohen, John W. Conrad, Jr., James B. Culp, -Jra Joseph U. Dorsch, Donald B. Elliott, Jr., Donald O. Fed- der, Paul Freiman, Robert W. Henderson, Mare Lach- man, Ronald Lubman, Richard A. Metz, Martin B. Mintz, Victor H. Morgenroth, Jr., Anthony J. Padussis, Chester I. Price, Edward B. Roth, Melvin N. Rubin, Irving E. Swartz, John R. Thomas, Vito Tinelli.
Student APhA-MPhA Chapter Elects New Officers
The University of Maryland School of Pharmacy Student APhA-MPhA Chapter recently announced the
following election results:
President: Paul R. Webster
Vice President: Stephen B. Bierer Secretary: Donna S. Levin Treasurer: Dennis R. Reaver
All correspondence may be sent to them at the Uni- versity of Maryland School of Pharmacy, 636 W. Lom- bard Street, Baltimore, Maryland 21201.
Pictured at the School of Pharmacy Annual Alumni Banquet held on June 2 at Eudowood Gardens are: (1 to r) top left—Harry R. Wille, out-going president of the Alumni Association
presenting certificates commemorating 50 years of
Shannon, W. Chester Shoemaker, and Robert Wo
service in Pharmacy to Samuel Block, Donald oten; top right—Dr. C. T. Ichniowski presents
Honorary Alumni President’s Award to Robert Wooten; bottom left—Dr. Samuel L. Fox, Presi- dent of the Alumni Foundation, receives award from Dr. John C. Krantz; bottom center—Kenneth Walters, President of graduating class, addresses group; bottom right—Harry R. Wille turns over gavel to incoming president, Anthony G. Padussis as Dr. Frank Slama, former professor of Pharmacology and Mary W. Connelly, past secretary of the Alumni Association, stand by.
22 THE MARYLAND PHARMACIST
SEPTEMBER 1971
amiliar service or strange film
Are customers bringing in “strange” film brands lately? Have these mysterious “unknowns” been confusing your people?
They don’t have to. Big, small, foreign or domestic, just drop them into the Berkey bag and leave the rest to us. Who makes the film or where it comes from doesn’t matter. Whether it’s branded or unbranded, Berkey will process it. Our custom quality and custom service means satisfied customers for you.
Customers who come back. Again.and again,
Berkey can do things for you that nobody else does, because nobody else can.
Trust all your D and P work to Berkey. It’s good business. You uncomplicate life for
your staff. And with one bill from one supplier, your bookkeeper will love you.
toy Berkey Film Processing of Washington, D.C. 3701 Mt. Vernon Avenue
now's oF Ta Alexandria, Virginia 22305
Berke Photo nt Lind (703) 549-7500
Hospital Pharmacy Section
Maryland Society of Hospital Pharmacists Meeting of September 9, 1971
The September 9 meeting of the Maryland Society of Hospital Pharmacists was held at the Johns Hopkins Hospital in Baltimore. Guest speaker for the evening was Dr. Norman Fost, Assistant Professor of Pediatrics, Children’s Medical and Surgical Center, The Johns Hop- kins Hospital. His talk was entitled ““Drugs and the Pedi- atric Patient.’”’ Dr. Fost reviewed types of drugs that are contraindicated during pregnancy and described some of the problems that newborn can have with certain drugs.
The Squibb Past President’s Award was presented to Robert E. Snyder by F. Daniel Kammen, Hospital Di- vision Manager of E. R. Squibb & Co. The Society nom- inated Milton Skolaut and Dr. Peter P. Lamy as candi- dates for the 1972 Harvey A. K. Whitney Lecture Award. Clarence Fortner reported on the 1971 Hospital Phar- macy Seminar and announced that the 1972 seminar dates were tentatively set for June 9 through June 11 at the Carousel Motel in Ocean City, Maryland.
Other reports included those of Dr. Peter P. Lamy, Chairman of the Peer Review Committee; Samuel Lich- ter, representative to MPhA’s Medicaid Committee; and Charlotte B. Sholleck, representative to MPhA’s Legisla- tive Committee. Bernie Fisher and Samuel Lichter were recently appointed to the position of Chief Pharmacist at St. Agnes and Union Memorial Hospital respectively. A one-day joint seminar is planned for the Washington and Maryland Societies on October 23, 1971 at Friendship Airport Motel.
The President, Mary Connelly, thanked Henry Dere- wicz for hosting the meeting, Vincent dePaul Burkhart for arranging the meeting and E. R. Squibb and Co. for sponsoring the meeting. The meeting adjourned at 9:30 p-m.
ASHP’s Midyear Clinical Meeting Will Focus on Health Care Delivery
Hospital pharmacists will focus their attention on America’s health care delivery system when ASHP’s Sixth Annual Midyear Clinical Meeting convenes December 12- 16, 1971. The meeting will be held in Washington, D.C., a fitting location for discussing health care delivery, cur- rently one of the nation’s hottest political issues. In two general sessions, the ASHP Midyear Meeting will explore the pressures for change in the health care delivery sys- tem and will discuss possible responses to these pressures. Leaders from throughout the health care professions and the political arena are slated to appear on the program. The speakers will keep in mind the unique role pharma- cists play in health care and how this role may be ex- panded as new approaches to the delivery of health care evolve.
Following the format of the 1970 Midyear Meeting, the entire four-day program will consist of three general sessions, four contributed papers sessions, an exhibit pro- gram and eight clinic forums. The program will be de- void of the many conflicting activities of the Annual
24 THE MARYLAND PHARMACIST
Meeting, allowing registrants to devote their full atten tion to specific areas of study.
In addition to the two general sessions devoted te topics on health care delivery, a third session will be de: voted to current drug therapy. Specific topics covered in this session will be “drugs and the newborn,” “burn therapy,” and “drug treatment of leukemia.”
The contributed papers sessions are expected to cover a wide range of topics of interest to hospital pharmacists and community pharmacists providing service to small hospitals and nursing homes. Individuals wishing to pre: sent contributed papers must submit titles and abstracts (200-250 words) before September 1, 1971. The dead- line for completed manuscripts is November 1. Titles and abstracts should be submitted to Warren E. McCon- nell, Ph.D., Director, Education and Training, ASHP.
The clinic forums, held for the first time last year at the Anaheim Midyear Meeting, will be open discussion sessions on various topics in hospital pharmacy. Regis- trants will be permitted to move freely from one discus: sion group to another to allow maximum participation and to stimulate an uninhibited flow of ideas.
The exhibit program will add an important dimen- sion to this educational meeting. Registrants will have an opportunity to discuss with company representatives the latest developments in the hospital pharmacy field.
The Sixth Annual Midyear Clinical Meeting will be held in Washington’s famous Shoreham Hotel. The regis- tration fee is $45.00 for ASHP members and $55.00 for nonmembers. Residents in hospital pharmacy programs may register for $22.50 and undergraduate students for $10.00. One-day registration is $15.00 for members and $17.50 for nonmembers. A registration form and_ hotel reservation information may be obtained by writing to the Director of Education and Training, American So- ciety of Hospital Pharmacists, 4630 Montgomery Ave- nue, Washington, D.C. 20014.
ASHP, USP and FDA Cooperate In Defect Reporting Program
The American Society of Hospital Pharmacists, the United States Pharmacopeial Convention, and the Food and Drug Administration are cooperating in « pilot drug product defect reporting program. The program is de- signed to detect the various problems in pharmaceutical quality associated with the manufacturing and packaging of pharmaceuticals and to establish a central reporting system. |
In addition to coordinating the entire program, USP. will take the reported problems into account when it revises or devises drug standards. Copies of the reports will be forwarded to the Office of Scientific Coordinatio of the FDA and to the manufacturer or distributor in-. volved.
Drug product defects include the entire spectrum o defects which might be noted by a pharmacist when h receives or dispenses a drug product. A reportable defec could involve packaging, labeling, the immediate con-, tainer, closure, contents, or the drug itself.
SEPTEMBER 1971
A.Z.O. Pharmaceutical Fraternity Ae Chapter of the Alpha Zeta Omega Pharma-
ceutical Fraternity will host the organization’s Fall Re- ee Meeting on November 6 and 7 at the Hunt Valley nn.
The Registration and Hospitality Room will open at noon on Saturday and the Board meetings will start at 3:00 p.m. for both the Fraternity and Women’s Aux- iliary. Highlight of the Awards Night Banquet on Satur- day evening, will be the presentation of Honorary Mem- bership to Dr. William J. Kinnard, Jr., Dean of the Uni- versity of Maryland School of Pharmacy. The conven- tion winds up Sunday with a Brunch, national fraternity and auxiliary meetings, and a Farewell Dinner.
Gerald Freedenberg is President of Kappa Chapter this year, and Mrs. Steven Buckner is President of the Women’s Auxiliary.
Spectro Industries Reports Substantial Increase In Sales And Earnings
) Spectro Industries, Inc., the country’s fifth largest distributor of drugs, medical supplies and equipment, re- ported a substantial increase in sales and earnings for the first 12 week period ended June 23, 1971. Loewy Drug and District Wholesale are among its five distribu- tion centers.
Net earnings rose 80 percent to $172,693 or 11 cents a share from $95,962 or seven cents a share for the same period a year ago. Sales increased 18 percent to $16,704.- 269 from $14,176,450.
) pel es NARD Announces Program For New Orleans Convention
The 73rd Annual Convention and Drug Show of the National Association of Retail Druggists to be held in New Orleans, Louisiana, October 10-14, 1971 at the Rivergate Exhibition Center and Convention Hall will have as its central theme: “The Community’s first line of defense in providing effective health care for all citi- zens lies in the efficiency of the independent retail phar- macist.””
Among the distinguished speakers who will address the convention will be: Senator Hubert H. Humphrey (D-Minn.) and Representative Gerald R. Ford (R-Mich.),
‘Minority Leader, United States House of Representatives.
Three special panel presentations will be presented
during the Convention:
(1) “Controlled Substances Act of 1970.”
(2) “The Future of Third Party Prescription Payment and Community Pharmacists.”
(3) “Cosmetic Merchandising.”
A new film of interest to the entire field will be pre- sented by the Pharmaceutical Manufacturers Association. Special entertainment features will include a concert by Al Hirt, internationally known trumpet player; Pete Fountain, eminent jazz clarinetist; a night on the town and a parade of authentic Bourbon Street entertainment.
Post convention trips will include a seven-day Carib- bean cruise or an 8-day 7-night Mexican trip to Mexico
City and Acapulco.
SEPTEMBER 1971
Product Announcements
Ortho Diagnostics has introduced a diagnostic sys- tem for detecting the antigen associated with hepatitis. The new test called Hapindex Diagnostic Test will help curb this highly contagious liver disorder by identifying blood containing the antigen associated with hepatitis so that it will not be given in transfusion. Starting October 1, all blood banks inspected for American Association of Blood Banks accreditation must test for the hepatitis antigen.
The test is based on a phenomenon called counter- electrophoresis. When current is passed through blood samples containing the antigen associated with hepa- titis, a thin white band forms, indicating a positive test. The Hapindex System was developed jointly by scientists at the Ortho Research Foundation and Milli- pore Corporation.
Mor-tek U, a low-cost, compact kit used to identify the heroin user quickly and easily, has been developed by RPC Corporation. The contents of the kit are used with a urine specimen from the suspect. Morphine in the specimen, even in minute quantities, can be detected in minutes. For more information, contact RPC Corpora- tion, 1222 East Grand Avenue, El Segundo, Calif. 90245.
Lederle Laboratories announces the introduction of Flu-Immune X-31, a new bivalent influenza vaccine avail- able in 10ce vials.
Eaton Laboratories has recently marketed a new form of Chloraseptic. The new product is called Chlora- septic Aerosol Spray and is available in 1.5 oz. size.
USV Pharmaceutical announces the introduction of DBI-TD 100 mg. (timed-disintegration phenformin HC1) packaged in 100’s and 500’s.
In The News...
PAUL FREIMAN has been designated as MPhA representative to the newly formed Maryland State Ve- nereal Disease Commission established by the State of Maryland Department of Health and Mental Hygiene.
WILLIAM B. HENNESSY, past president of the APhA in 1969-70, has been named as the 1971 recipient of the J. Leon Lascoff Memorial Award presented by the American College of Apothecaries. The award will be presented during the 31st Annual ACA Convention at Hunt Valley, Maryland, October 1-4, 1971.
LINWOOD F. TICE, past president of the APhA in 1966-67 and Dean of the Philadelphia College of Pharmacy and Science, has been named recipient of the 1971 Remington Honor Medal of the American Pharma- ceutical Association. Presentation will be made on De-
cember 2, 1971, at the Remington Medal Dinner in the Statler Hilton Hotel, New York City.
BERNARD FISHER, pharmacist at St. Agnes Hos- pital was recently promoted to Chief Pharmacist at the
hospital.
THE MARYLAND PHARMACIST 25
Obituaries
KERMIT D. WHITE See Editorial, page 7
The following obituary is based on a presentation at the funeral service of Kermit D. White on July 6, 1971, following his death on July 2 as the result of gunshot wound:
Kermit Donald White, son of the late Lena and Peter White, was born on May 28, 1929, in Baltimore, Maryland. At an early age he was baptized at the Metro- politan Methodist Church. A devoted husband and father he believed in praying and would see that his children prayed each night before going to sleep.
After attending the Baltimore City Schools and graduating from Frederick Douglass High in 1947, he attended Morgan State College. His education was inter- rupted during this period while he served in the U.S. Air Force. Following honorable discharge he attended Howard University School of Pharmacy and was gradu- ated in 1963.
Well known as an affable pharmacist at Read’s Drug Store, North and Pennsylvania Avenue, he later became manager of Read’s Drug Store at Liberty Heights Avenue and Garrison Boulevard. His life’s aspiration was to own and operate a drug store, and in 1967 he opened the White’s Pharmacy at Edmondson Avenue and Wildwood Parkway.
He was a member of the Chi Delta Mu Fraternity and the American Pharmaceutical Association. He also sponsored the Edmondson Village Little League Baseball Team. His demise has affected the lives of many people, particularly those in the neighborhood of the drug store. He loved his customers who knew him as “Doc,” and he went beyond the call of duty to serve each and every one.
He is survived by a devoted wife, Sylvia; two sons and a step-son, Kermit and Wayne White and Gilbert Dolby; two aunts, Mrs. Beulah DePree of Baltimore and Mrs. Carolyn Jackson of Portsmouth, Virginia; a mother- in-law, Mrs. Bertha Williamson of Baltimore; and a host of relatives and friends.
BERNARD A. PETTIT
Bernard A. Pettit, 67, retired Washington pharma- cist, died on July 24 at Rogers Memorial Hospital, Wash- ington, D.C. Mr. Pettit was registered in Maryland by reciprocity in 1928.
HARVEY E. TODD
Harvey E. Todd, a 1914 graduate of the University of Maryland School of Pharmacy, died recently in An- derson, S.C.
VICTOR E. PASS
Victor E. Pass, 68, died on July 29 after a long ill- ness. He was a 1924 graduate of the University of Mary- land School of Pharmacy. Mr. Pass had operated the
26 THE MARYLAND PHARMACIST
Lead Paint Poisoning
The City Health Department now has reports of nine children who have become ill with lead paint poisoning so far this year. According to Mr. George W. Schucker, Assistant Commissioner for Sanitary Services, this toll will increase unless parents maintain close supervision of their teething-age children. In 1970 twenty children were reported to have lead poisoning and one child died.
A crippling and sometimes fatal illness, lead paint poisoning is caused when children eat peeling paint from walls or other objects either inside or outside the house. Nibbling on windowsills, painted plaster and furniture painted with a lead paint have also caused poisonings.
In addition to supervision of the child, Mr. Schucker offers the following advice:
1. Use lead free paint when painting indoor sur- faces, windowsills and furniture. The use of lead paint for interior painting of dwellings has been illegal since 1958. In addition, effective July 1, 1971 State Law pro- hibits the use of lead based paint on any exterior surface of a dwelling to which children may be exposed.
2. If you are a tenant and the owner is starting to paint be sure he uses lead free paint as required by law.
3. If there is peeling paint in the house scrape the surface until it is smooth and cannot be picked at by the child and eaten.
4. If you see your child eating paint take him to a physician or clinic without delay and be sure he has a blood test for lead. Early diagnosis and prompt treatment to remove lead from the body usually result in a good re- covery.
5. Symptoms of lead paint poisoning include abdom- inal pains, nausea and vomiting, persistent constipation, irritability, frequent headaches and convulsions. If you see any of these signs your child’s life may be in danger. Take him to a physician or hospital at once. Tell the doctor or nurse you suspect lead poisoning and ask for a blood test for lead.
Stadium Pharmacy, Wolf and Lanvale, for 40 years. He was a member of the Maryland Pharmaceutical Associa- tion, Baltimore Metropolitan Pharmaceutical Association,
and the Alpha Zeta Omega Fraternity.
IRVING M. MORRIS Irving M. Morris, 79, died on August 4. Mr. Mor-
ris was a pharmacist at the Union Memorial Hospital for many years until his retirement in 1961 as the result of an accident.
EDWARD A. MARKIN
Edward A. Markin, 58, a 1934 graduate of the Uni- versity of Maryland School of Pharmacy, died on August 13. His brother, Samuel Markin, is also a pharmacist.
PETER J. SLETTERDAHL Former NARD Journal Editor
Peter J. Sletterdahl, editor of the NARD Journal’ (1947-1965), died on August 25, in his home in Florida, after a long illness.
SEPTEMBER 1971
Thantis, the reliable throat lozenge.
The THANTIS DISPENSER, containing a roll of 25 individually foil-wrapped lozenges, is attractively packaged — 6 dispensers in a fold-up counter display. The packaging is right! The profit is good! The time to purchase Thantis is now!
(#740/171)
) HYNSON, WESTCOTT & DUNNING, INC. ee Baltimore, Maryland 21201
A comprehensive Convalescent
aids program
a
|
Medicare and other insurance programs have made it possible tor more people to buy and rent needed surgi- cal supplies and convalescent aids. Gilpin makes it easy and PROFITABLE for you to maintain a compre- hensive selection. Professional assistance is available to provide a program to meet your space and inventory
rojuirements. Call us today. Or mail the coupon:
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
THE HENRY B.
GILPIN
COMPANY
BALTIMORE + DOVER + NORFOLK + WASHINGTON
Wee ai.
L.
your ‘‘short-cut’’ to profitable plus business.
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange
for Gilpin specialists to tailor the services which your particular interest or situation requires.
ee errr tert me re tre mer eral |
Sirs:
| am interested in the following programs. Please have your
representative contact me in this regard.
Name
Name of Pharmacy
Addcs3 = enone City Slate eID
j : : i ] al
|
Volume 47
maryland
ASSOCIATION
=" pharmacist
Editorial—Third-Party Programs:
A Role for Pharmacists
Drug Storage and Stability
by Ralph F. Shangraw, Ph.D.
Controlled Drug Regulation Changes
OCTOBER 1971
Number 10
Compliments of
oxell
CORPORATION
Makers of NOXZEMA SKIN CREAMS NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
f it's for your family, which product
would you dispense?
The choice would probably be Crystodigin® (digitoxin, Lilly).
Pharmacists know that quality is built into Lilly products... with exacting control procedures to provide uniform potency and, therefore, consistent
therapeutic effectiveness.
Your professional judgment tells you... when it comes to your prescription patient’s health (and your reputation), you want to dispense the best.
Sete s.
Ce tn iad
ewer
Ned thts ©
Se pewme Ree ee URES RRS OS
oe
; - £ : a ee
g 4 ~
call i Bad
CRYSTODIGIN® (digitoxin, Lilly)
Indications: Heart failure, atrial flutter, atrial fibrillation, and supraventricular tachycardia.
Contraindications and Precautions: Crysto- digin should not be used in ventricular tachycardia.
Patients taking digitalis preparations must not be given the rapid digitalizing dose of Crystodigin or parenteral calcium.
Adverse Reactions: Overdosage causes side- effects, such as mental depression, anorexia, nausea, vomiting, premature beats, com- plete heart block, AV dissociation, ventricu- lar tachycardia, ventricular fibrillation, rest- lessness, yellow vision, mental confusion, disorientation, and delirium.
Administration and Dosage: Slow Digitaliza- tion—0.2 mg. twice daily for a period of four days, followed by maintenance dosage. Rapid Digitalization—Preferably 0.6 mg. in- itially, followed by 0.4 mg. and then 0.2 mg. at intervals of four to six hours. Mainte- nance Dosage—Ranges from 0.05 to 0.3 mg. daily, the most common dose being 0.15 mg. daily. [051972]
Lilly
100246
Eli Lilly and Company
Indianapolis, Indiana 46206
A computerized “Accounts Receivable” system.
Hand-prepared charge account statements are costly, time-consuming and liable to error.
Enhance your image as a professional pharmacy with a Gilpin computerized-accurate system that shows your customers their deductible medical expenses for the month and year to date, at the same time provid- ing yourself an up-to-date record of aging accounts. Call today or rush the coupon for full information.
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
THE HENRY B.
GILPIN
COMPANY
BALTIMORE + DOVER » NORFOLK * WASHINGTON
t I t d L.
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company
901 Southern Ave., Washington, D.C. 20032
(301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We’ arrange
for Gilpin specialists to tailor the services which your particular interest or situation requires.
Sirs: | am interested in the following programs. Please have your representative contact me in this regard.
Nene SS eae eee
Name of Pharmacy = sees Se ee
Addéss) = a Phones City. state= Zip
ai
The Maryland Pharmacist
NATHAN I. GRUZ, Editor
NORMAND A. PELISSIER, Assistant Editor MartHA Eckuorr, Editorial Assistant Ross P. CampsBeti, News Correspondent HERMAN J. BLoom, Photographer
650 WEST LOMBARD STREET BALTIMORE, MARYLAND 21201
- ASSOCIATION
VOLUME 47
OCTOBER 1971 NuMBER 10
OFFICERS 1971-1972
Honorary President
H. NELSON WARFIELD—Pikesville e
President NATHAN SCHWARTZ—Annapolis
President Elect BERNARD B. LACHMAN-—Baltimore
Vice President JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore. Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore STEPHEN HOSPODAVIS (1972)
Cresaptown PHILIP D. LINDEMAN (1973)—Berlin
ANTHONY G. PADUSSIS (1973) Baltimore
MELVIN J. SOLLOD (1974)—Adelphi
SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore
EX-OFFICIO MEMBERS - FRANCIS S. BALASSONE—Baltimore
WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON-—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON-—Baltimore
President NORMAN J. LEVIN—Pikesville
Secretary
F. S. BALASSONE—Baltimore
Member FRANK BLOCK—Baltimore
Member HOWARD L. GORDY—Salisbury
Member MORRIS R. YAFFE—Potomac
TABLE OF CONTENTS
6 Editorial—Third-Party Programs: A Role For Pharmacists 8 Maryland Board of Pharmacy 10 Baltimore Metropolitan Pharmaceutical Association 10 Pharmacy Calendar P27 MER AS News 14 Prince Georges-Montgomery Pharmaceutical Association 14 Metropolitan Guild of Pharmacists 16 Drug Storage and Stability by Ralph F. Shangraw, Ph.D. 22 University of Maryland School of Pharmacy 26 Obituaries 26 Pharmaceutical Directory
INDEX TO ADVERTISERS
24 American Druggists’ Insurance Co,
9 Calvert Drug Company, Inc.
11 Ciba Pharmaceutical Company 22 The Drug House, Inc. 23 Geigy Pharmaceuticals
4 Henry B. Gilpin Company
3 Eli Lilly and Company
17. Loewy Drug Company 22 Mangini and Associates, Inc.
19 Maryland News Company
7 Merck Chemical Division, Merck & Co., Inc. 14 Metropolitan Guild of Pharmacists
2 Noxell Corporation
13. Paramount Photo Service 24 Pension & Investment Associates of America 21 A. H. Robins Company
15 Roche Laboratories 25. Smith Kline & French Laboratories 20 D. Stuart Webb Advertising Services 27. Youngs Drug Products Corporation
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number, Allow four weeks for changeover. APhA members—please include APhA number,
The Maryland Pharmacist is published monthly by the Maryland Pharma- ceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post
Office at Baltimore, Maryland, under the Act of March 8, 1879.
Editorial...
Third-Party Programs: A Role For Pharmacists
One of the crucial factors that will determine the professional and economic future of pharmacy is how the profession will fare in third-party prescription programs.
At present governmental, union and other plans cover a minority of the population although Medicaid patients already comprise a large or a major part of the prescription practice of many pharmacies. But this situa- tion is, of course, only a slight portent of things to come.
Every day, it seems, brings news of additional third- party programs being established by employers, unions or under governmental auspices.
Whenever possible the Maryland Pharmaceutical Asso- ciation has sought to participate in the development and evaluation of third-party prescription programs. Many members have requested our guidance and have abided by our suggestions. On the other hand, many pharmacy proprietors have enrolled in programs without seeking or obtaining any information about a particular plan. It is hard to understand how an intelligent decision can be made without regard to the nature of the sponsors of a plan and its impact upon the practice of pharmacy. Often pharmacists will promptly sign up with a plan with poli- cies which are not in the best interest of either the pa- tient or pharmacist. Some of the plans are merely promo- tional or public relations gimmicks to advance the inter- ests of a sponsoring group, administrators or a particular group of pharmacy providers.
MPhA’s policy in the third-party payment field has been to assert the vital principle of “free choice of phar- macy’ and of quality of pharmaceutical service. We be- lieve that these factors are essential in the best interest of achieving accessibility to pharmaceutical services and the highest standards of professional health care.
MPhA is now embarking on a program of assuring, whenever legally and administratively feasible, the princi- ple of free choice and high standards of pharmacy service. Details will be mailed to members regarding a prescrip- tion insurance plan previously available to employees of a firm only from one pharmacy chain. All participating pharmacies will be thus able to submit their prescriptions for payment through the MPhA office. Several other plans are now being worked on by MPhA.
Pharmacists must be in a position to influence the policies of all third-party prescription programs. They must play a role in the decision-making process which affects their professional and economic futures.
Administrators of plans are only impressed and in- fluenced by presentations made by organized professional associations on behalf of providers of service. In turn the representative association must comprise a majority of the providers and must be equipped through adequate financial resources with staff to effectively achieve the objectives of the members.
MPhA will serve the needs of its members to the maximum of its resources. but a substantial expansion of
6 THE MARYLAND PHARMACIST
activities in the third-party area will necessitate the estab. lishment under pharmacy auspices of a separate nonprofit corporation as a pharmaceutical services foundation.
In the interim MPhA will meet with plan admin- istrators and will perform clearinghouse services so that the interests of patients, programs, sponsors and pharma- cists will be met.
Pharmacists can contribute to the success of these objectives by voluntarily accepting the discipline of an organized approach, by participating in the work of MPhA and assuming the obligations and responsibilities of the guidelines that will be promulgated by their representa- tives.
— Nathan I. Gruz
Current Literature of Interest
DRUG INTERACTIONS by Philip D. Hansten, Pharm. D., Assistant Professor of Clinical Pharmacy, Washington State University. June, 1971, Lea & Febiger, Washington Square, Philadelphia, Pa. 19106, $9.50.
ESSENTIALS OF TOXICOLOGY by Ted A. Loomis, Ph.D., M.D., Professor of Pharmacology, University of Washington School of Medicine, Seattle. January, 1968, Lea & Febiger, Washington Square, Philadelphia, Pa. 19106, $6.50.
PHARMACOLOGY AND THERAPEUTICS by Grollman and Grollman, 7th Edition, April, 1970, Lea & Febiger, Washington Square, Philadelphia, Pa. 19106, $19.50.
CLINICAL PHARMACY HANDBOOK by Hugh F. Kabat, Ph.D., Professor and Head of Dept. of Clinical Pharmacy, University of Minnesota College of Pharmacy. August, 1969, Lea & Febiger, Washington Square, Phila- delphia, Pa. 19106, $6.50.
PLANNING AND DESIGN OF HOSPITAL PHAR- MACY FACILITIES Reprint from the American Jour- nal of Hospital Pharmacy, June, 1971, Single copies (22 pages) $1.50. Payment must accompany order. Ameri- can Society of Hospital Pharmacists, 4630 Montgomery Avenue, Wachinores D.C. 20014.
FORMULARY DRUG LISTING SERVICE (FDLS) Subscription for an individualized, computer-produced formulary. Prerelease price $950.00. American Society of Hospital Pharmacists, 4630 Montgomery Avenue, Wash- ington, D.C. 20014.
Statistics suggest it is safer to ride in a truck than in a car. In 1970, over 54,000 passenger care were in- volved in fatal accidents compared to 12,400 commercial vehicles.
OCTOBER 197!
Maintain your professional image
Merck Prescription (hemicals
& Narcotics
Many prescriptions such as ointments, nose drops and
cough syrups, to mention a few, still require the know-how of a registered : pharmacist. Even a casual observer inany pharmacy is mightily impressed when he sees a prescription being compounded. There is an intan- gible value gained by watching : an expert at work. It instills even greater respect and confidence for the rofession and the man who has chosen it for his life’s work. The use of Merck Prescription Chemicals will not only enhance your professional ability, it will establish you as one who demands the highest quality in chemicals used for compounding.
CHEMICAL DIVISION, MERCK & CO., INC., Rahway, N. J.
Merck Chemicals are distributed by MERCK
Maryland Board of Pharmacy News
Board of Pharmacy Moves
The new location of the Maryland Board of Phar- macy is 610 North Howard Street as of September 24 WO ele
9
Pharmacy Changes
The following are the pharmacy changes for the month of August:
New Pharmacies
Drug Fair No. 141, D. Beer and J. Rhoades, Phar- macists, Patuxent Shopping Center, Crofton, Maryland 76 SE
The Treasury Drug Center, N. Moritz and J. Chave- rini, Pharmacists, 180 Shangrila Drive, North Lexington Park, Maryland 20653.
No Longer Operating as Pharmacies Rockville Drugs, Joel Shulman, President, 1069 Rockville Pike, Rockville. Maryland 20852.
Kay Cee Drugs, Irving Goldberg, President, Main Street, Upper Marlboro, Maryland 20870.
Carville’s Corner Pharmacy, Carville B. Hopkins, 3 Mile Oak, Annapolis, Maryland 21401.
Changes of Ownership, Address
Fallston Pharmacy, Chester L. Price, President
(Change of ownership ), 1916 Belair Road, Bel Air, Mary- land 21047.
Amphetamines in Schedule I
In accordance with Section 278 (c) and (d), Arti- cle 27 of the Annotated Code of Maryland, notice is hereby given to reschedule, update, and republish the substances in Section 279 (c) a. 1. of Article 27 (Sched- ule III Substances) of the Annotated Code of Maryland to Section 279 (b) of Article 27 (Schedule II Substances ) of the Annotated Code of Maryland.
The effect of this order is to place amphetamine, its salts, optical isomers, and salts of its optical isomers in Schedule II from Schedule III. Drugs in Schedule II may not be dispensed without the written prescription of a practitioner, except that in emergency situations the drug may be dispensed on oral prescription, reduced to writing promptly and filed and within 72 hours after authorizing the emergency oral prescription, the prescribing indi- vidual practitioner shall cause a written prescription for the emergency quantity prescribed to be delivered to the dispensing pharmacy.
This action is being taken in order for the Maryland Controlled Dangerous Substances Act to conform with the Federal Comprehensive Drug Abuse Prevention and Con-
trol Act of 1970 (Public Law 915513);
8 THE MARYLAND PHARMACIST
Registration of Interns, Resident and Foreign Physicians Under The Controlled Substances Act:
As a result of the new BNDD regulation, a pharma- cist may notice that the prescribing physicians registra- tion number contains more than the characteristic com- bination of two letters and seven numbers. Such a registra- tion number is representative of the optional, internal registration code now authorized for use by hospitals and other institutions who have elected to have their interns, residents and foreign-trained physicians use the institu- tion’s registration rather than have them register indi- vidually.
A practitioner will usually receive such prescrip- tions when a patient has come from a hospital emergency room or an out-patient clinic where an intern, resident or foreign-trained physician is authorized to practice.
Former Section 301.24 of the BNDD Rules and Reg- ulations provided a waiver of the regisration requirement for such an individual practitioner who was an agent or employee of a hospital or other institution which was registered to dispense controlled substances. When acting in the usual course of his employment, the individual practitioner could administer and dispense a controlled substance if permitted to do so in the jurisdiction in which they practiced. These individual practitioners were permitted to use the institutional practitioner’s registra- tion number for internal medication orders but were not authorized to issue prescriptions for out-patients unless they had registered with the Bureau.
It was recognized by the Bureau that on certain oc- casions, interns, residents and foreign-trained physicians would be required, during the regular course of their employment, to attend to patients and issue prescriptions for controlled substances to be compounded and dispensed on an out-patient basis.
Rather than require that all such individual practi- tioners personally register with the BNDD, the Bureau afforded the hospitals and other institutions an option to utilize an internal code based on the institution’s registra- tion number.
The hospital or institution must ascertain from the appropriate state agency whether or not the intern, resi- dent or foreign-trained physician is authorized or per- mitted to prescribe controlled substances. If the institu- tional practitioner then verifies that the individual prac- titioner is so permitted, he may dispense and_ prescribe controlled substances under the registration of the hos- pital or other institution, in lieu of being registered him- self, if these functions are performed within the scope of the individual practitioners employment and during the usual course of his professional practice.
The institutional practitioner authorizes the indi- vidual practitioner to dispense or prescribe under the hospital registration by designating a specific internal code number. This code number consists of numbers,
OCTOBER 1971.
letters or a combination thereof and will be a suffix to the institution BNDD registration number, preceded by a hyphen. For example, AP1234567-10, or AP1234567- Al2.
The hospital or institution must keep a current list of internal codes and corresponding practitioners. This list must be made available at all times to other regis- trants and law enforcement agencies upon request for the purpose of verifying the authority of the prescribing individual practitioner.
It should be noted that this registration procedure is optional and hence, a particular hospital or other in- stitution may not wish to adopt an internal code system. If such is the case, then the intern, resident or foreign- trained physician must register individually, if he is to issue out-patient prescriptions for controlled substances.
If an individual practitioner has registered with the Bureau and has received a registration number then he may not use the institution’s registration number.
BNDD Schedule Transfers
As of October 17, 1971, phenmetrazine ( Preludin) and methylphenidate (Ritalin) have been transferred from Schedule III to Schedule II of the Controlled Sub- stances Act. Additionally, the drug Naloxone Hydrochlo- ride (Endo) has been removed from Schedule IL and all regulatory controls of the Controlled Substances Act.
Rubber “C”’ stamps and red inked pads are still available from MPhA office at $1.00 for each item. Check should accompany order.
Effect of Physicians’ Curb on Prescribing of Amphetamines Noted
Physicians in many states are responding to the challenge to assume leadership in combating drug abuse. Many have already acted to curb the use of amphetamines and other stimulant drugs.
In Texas, James H. Sammons, M.D., president of the 11,000-member Texas Medical Association, asked physicians to limit their prescribing of amphetamines to specific, well-recognized medical indications. Earlier this year, nearly 600 physicians in Utah agreed not to pre- scribe amphetamines or similar drugs in the treatment of obesity.
The Utah Pharmaceutical Association reported an unusual effect of a joint effort by the Utah State Medical Association and the Utah Society of Internal Medicine to curb the use of amphetamines in treatment of obesity. According to the UPA, there has been a “precipitous” de- cline in the number of break-ins at pharmacies since word got around that the stores were stocking only mini- mum inventories of the drugs, in contrast to the thou- sands of doses they had on hand before.
Study Continues For Cure For Common Cold
A synthetic variation of ribonucleic acid (RNA) called Poly-I:C is being investigated for its possible role in the prevention of the common cold. The polynucleotide stimulates the production of interferon, a protein which prevents penetration by a virus into cells. By stimulating the cells with Poly-I:C to produce more interferon, the rest of the body would be defended from virus infection.
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply, THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
OCTOBER 1971
THE MARYLAND PHARMACIST 9
Baltimore Metropolitan Pharmaceutical Association
The Baltimore Metropolitan Pharmaceutical Associ- ation held a general meeting at the Kelly Memorial Building on September 16, 1971. The meeting was called to order at 9:00 p.m. by President Irvin Kamenetz.
Program Chairman Melvin Rubin introduced the first speaker, Victor Kardon of Ciba Laboratories, who spoke on “The Use of Rimactane in Antitubercular Ther- apy.’ Mr. Kardon pointed out that tuberculosis patients usually require six months to two years of continuous drug therapy and one of the most common problems is that patients discontinue taking their medication before they should. The standard drugs that have been in use- isoniazid, aminosalicylic acid, streptomycin-are bacterio- static agents. It is postulated that rifampin (Rimactane, Rifadin) is bactericidal at higher concentrations but this has yet to be proven. The advantages of rifampin over other anti-TB drugs is that it attacks the TB germ sooner. Results are shorter hospitalization and a more rapid re- turn to normal life. Rifampin is indicated to be taken with other anti-TB drugs such as isoniazid or ethambutol. Rifampin increases the anticoagulant requirements of the coumarins. Mr. Kardon then answered questions pre- sented to him from the audience.
The second part of the evening’s program dealt with the topic of “Drug Product Selection” and more specifically with repeal of the antisubstitution laws. Pre-
Among the speakers at the September 16 meeting of the BMPA were Dr. John S. Ruggiero, second from left, Director of Pharmacy Relations, Pharmaceutical Manu- facturers Association and James D. Hawkins, third from left, Assistant Executive Di- rector, American Pharmaceutical Association. Standing at left is Irvin Kamenetz, President of BMPA and at extreme right is Melvin Rubin, BMPA Program Chairman.
10 THE MARYLAND PHARMACIST
PHARMACY CALENDAR
November 11—MSHP meeting at the USPHS Hospital, 7:30 p.m.
November 18—( Thursday }—BMPA Annual Meeting.
December 12-16—American Society of Hospital Phar- macists Sixth Annual Midyear Clinical Meeting, Washington, D.C. |
January 30, 1972—56th Annual Installation Banquet & Dance, Baltimore Metropolitan Pharmaceutical Asso- ciation, Blue Crest North.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
May 7-9, 1972—Annual Convention, Maryland Phar- maceutical Association, Washington Motel and Country Club, Gaithersburg Maryland.
senting the American Pharmaceutical Association’s point of view on this subject was James D. Hawkins, Assistant Executive Director, American Pharmaceutical Associa- tion.
Presenting another point of view was Dr. John S. Ruggiero, Director of Pharmacy Relations, Pharmaceuti- cal Manufacturers Association.
An extensive question and answer period followed the presentations. :
The meeting was adjourned at 11:30 p-m.
aN
Photos by Paramount Photo Service
OCTOBER 1971
Open season ons uffy noses
Winter viruses, spring So keep both Privine allergies, dragging “summer — Nose Drops and Nasal Spray
colds,” or autumn in mind. And hay fever—it seems keep them in there’s always stock. They’re
something caus- ing stuffy noses. But whatever the reason—what- ever the season-— Privine makes it “open season” on
a noses. et ustomers want fast
relief. And that’s what Privine is famous for.
fast acting. And fast selling. And Privine is OTC.
CIBA Pharmaceutical Company Division of CIBA-GEIGY Corporation Summit, New Jersey 07901
ce) 8 Privine hydrochloride (naphazoline
hydrochloride) )
Ca 1 Baek
TAMPA News
The Traveler's Auxiliary of the Maryland Pharmaceutical Association held their annual installation dinner on September 16 at Bernie Lee’s Penn Hotel in Towson, Maryland. The eve- ning started with a social hour from 6:00 to 7:00 followed by a dinner at 7:00 p.m.
New officers installed for 1971-1972 are as follows: Joseph Grubb, Honor- ary President, Paul J. Mahoney, Presi- dent; John C. Matheny, First Vice President; Abrian E. Bloom, Second Vice President; C. Wilson Spilker, Third Vice President: John A. Cro- zier, Secretary-Treasurer Emeritus: William A. Pokorny, Secretary-Treas- urer; and William L. Nelson. Assist- ant Secretary-Treasurer.
Installed as members of the Board of Trustees were: William L. Nelson, Chairman; Herman J. Bloom; Joseph J. Huge; Kenneth L. Mills; Joseph Grubb; Albert J. Binko: Joseph A. Costanza; Francis J, Watkins; A. G. Leatherman; and J. William Gehring.
The committees for 1971-1972 con- sist of: Attendance, John H. Fagan, Chairman; Sherman FE. Levy; Earl V. Parr. Custodian, Robert ‘G. Rade- baugh, Chairman; Edgar G. Cumor: David H. Mervis. Welcome, C. Wilson Spilker, Chairman: Joseph A. Cos- tanza; J. Donald Brown. Luncheon, Paul J. Mahoney, Chairman: Natt Levy; Dick Brauer. Special Events, William L. Nelson. Chairman; Wil- liam A. Pokorny. Program, John C. Matheny, Chairman: Laurance A. Rorapaugh. Membership, Melvin M. Cernak, Chairman: E. Allan Turner; William R. Kolb, Jr. Maryland Phar- macist, Herman J. Bloom. Chairman: Joseph Grubb; Richard R. Crane. Pub- licity, Kenneth L. Mills. Chairman; Abrian E. Bloom: Edwin M. Kaber- nagel, Jr. Welfare, John G. Cornmes- ser, Chairman; Howard L. Dickson. Memorial Fund, Louis M. Rockman, Chairman; Ken Mills. Ways and Means, Joseph J. Hugg, Chairman: and Past Presidents.
Among other TAMPA activities held this year was a Crab Feast held on August 19 at Don Dever’s in Edge- wood, Md. The group has scheduled their annual T.A.M.P.A. Ladies Night for Thursday, November 4, at Garland Theatre in Columbia.
12
WUXILIARY® | ; _\*auxtary®
ORGANIZED (916 ORGANIZED 1916 *
Photos by Paramount Photo Service
Top (left to right)—William A. Pokorny, Secretary-Treasurer; Abrian E. Bloom, Second Vice President; John C. Matheny, First Vice President and Paul J. Mahoney, President; incoming officers at T.A.M.P.A. Installation Dinner on September 16. Bottom left (1 to r) William L. Nelson, Immediate Past Presi- dent turns over gavel to new president Paul J. Mahoney. Bottom right (1 to r) Howard Dickson, Immediate Past Honorary President, receives award from William A. Pokorny.
THE MARYLAND PHARMACIST CTOBER 1971
Mr. Pharmacist ~
YOU Are Number 1
In Photo Finishing when You are With
WHY? Because you get —
1. Quality — Assuring customer satisfaction 2. Service — True 24 hour delivery
3. Personalized consumer attention
4. Salesman inventory control
To get the complete story—call collect [301] 243-4439
PARAMOUNT PHOTO SERVICE 3024 Greenmount Avenue Baltimore, Maryland 21218
: : OCTOBER 1971 THE MARYLAND PHARMACIST 13
Prince Georges-Montgomery County Pharmaceutical Association
The Prince Georges-Montgomery County Pharma- ceutical Association will host the 1972 Maryland Phar- maceutical Association Annual Convention. The conven- tion site will be the Washingtonian in Gaithersburg, Maryland and will be held on Sunday, Monday and Tues- day, May 7, 8 and 9th, 1972.
The post convention trip to Acapulco will leave Baltimore on May 17 and return on May 22.
The Prince Georges-Montgomery County Pharma- ceutical Association held a general membership meeting on October 5 at the Hampshire Motor Inn, Langley Park,
Maryland.
The program began at 9:00 p.m. with a continuing education feature “Chemotherapy in Drug Abuse and Drug Addiction” from the St. Louis College of Pharmacy Library Cassette Series. At 10:00 p-m., Dr. Robert J. Taylor, Lecturer, School of Medicine and Dentistry, Uni- versity of Maryland, spoke on “Treatment and Rehabili- tation of Drug Addicts.’ Several former drug addicts also spoke on their experiences with drug addiction. A busi- ness session followed.
Photos by Paramount Photo Service
“Health Maintenance Organizations” was the topic of a Speech given by Dr. Daniel Y. Patterson, second from left, at the September 9 meeting of the Prince Georges-Mont- gomery County Pharmaceutical Association. Others in photo are: (1 to r) Martin Hauer, President; Paul Reznek, Secre- tary and Editor of the “Bi-County Pharmacist”; and Ed- ward D. Nussbaum, lst Vice President.
CHANGE OF ADDRESS
When you move—
Please inform this office four weeks in advance to avoid undelivered issues.
| “The Maryland Pharmacist" is not forwarded by the | Post Office when you move.
To insure delivery of The Maryland Pharmacist" and all mail, kindly notify the office when you plan to move and state the effective date. APhA members—please in- clude APhA number.
Thank you for your cooperation. | Nathan I. Gruz, Editor
| Maryland Pharmacist 650 West Lombard Street
14 THE MARYLAND
Metropolitan Guild of Pharmacists
by David Leise, Chairman of the Board
The Metropolitan Guild of Pharmacists is composed
solely of employee pharmacists and is governed by em-_
ployee pharmacists only. None of our officers receives pay- ment of any kind. We are an independent, voluntary or- ganization and are not affiliated with any other group. We are a guild and not a union and we are the only group locally which represents and protects the employee pharmacist exclusively.
Purpose
The Guild was formed for the purpose of improving the professional, economic and social status of all area pharmacists. Our main objective is to elevate the profes- sion of pharmacy. Guild members are encouraged to join other professional and civic organizations so as to im- prove and advance the status and respect of Pharmacy. To encourage membership in the APhA, the Guild pays half the dues for each member who wishes to join.
Our By-Laws state that a Guild member should re- fuse to practice pharmacy under conditions environmental or personal, which tend to interfere with or which would
compromise him into endorsing unethical conduct or
practices.
The Guild has been recognized by the Maryland —
Pharmaceutical Association and is represented in the House of Delegates of the Association.
Representing
EMPLOYED PHARMACISTS P.O. BOX NO. 2322 ROCKVILLE, MARYLAND 20852
PHARMACIST OCTOBER 1971
In 1970, Roche Laboratories broke with pharmaceutical industry tradition by being the first company to discontinue mass, unsolicited sampling of professional products. The Roche aim is to ensure the greatest
' benefit to the patient while meeting the professional needs
of the pharmacist and physician. All are served best by proper handling of drugs. Better control of all aspects of drug distribution ensures the highest standards of health care for the patient, physician and community.
This policy reflects Roche interest in the general problems of pharmacy management, as well as the pharmacist-doctor, pharmacist-patient and pharmacist-community relations. There are many of your colleagues at Roche—practical profes- sionals in various management positions— ho help make the policies and provide the services hat help you meet the challenge of pharmacy today.
ROCHE LABORATORIES Division of Hoffmann-La Roche Inc. Nutley, New Jersey 07110
Drug Storage and Stability
by Ralph F. Shangraw Professor and Chairman Department of Pharmacy University of Maryland, School of Pharmacy
If the curriculums of most schools of pharmacy were closely examined, it would become obvious that there are areas of knowledge which are currently being overlooked. These deficiencies are most often not inten- tional but reflect failure of faculties to reexamine course content in line with today’s technology and tomorrow’s practice of pharmacy.
An outstanding example of such an omission is drug packaging at both the manufacturing and dispens- ing level. All of us realize that a revolution in packaging has and continues to take place. The utilization of plas- tics for packaging of every conceivable type of product has reached proportions that are almost impossible to comprehend. Yet, few of us ever studied plastics in school. An excellent series of articles in the use of plastic in packaging was published in the January, February, and April — 1969 issues of Drug and Cosmetic Indus- try (1,2,3) and I highly recommend that you read them. Even though we are living in an age of plastics, many of us can still remember the sleeve type cardboard pill boxes which were common in the 30’s or the simple white envelopes with the name of the patient, doctor and direction. I am willing to bet that there are not a half a dozen schools of pharmacy that are not teaching students how to fold divided powder papers even though poly- ethylene pouches are readily available and represent a much more utilittarian package for powders and other bulk solids. On the other hand, I doubt that there are even a half a dozen schools of pharmacy which have strip or unit dose solid and liquid packaging equipment available for demonstration and teaching. How many schools of pharmacy give a course or even a few lectures in packaging technology? What chemistry course in a school of pharmacy discusses the chemistry of plastics and their properties?
If schools of pharmacy are still not teaching in these areas there is no reason to believe that pharmacists who have already graduated would be prepared to consult intelligently about such matters. Yet, these are subjects which pharmacists encounter every day.
I would like to review some of the things that you do know but might have forgotten as well as some new concepts relative to the stability and storage of drug products. Hopefully, at least one of the problems dis- cussed will hit home and you will be able to improve even if slightly, your professional practices in regard to these very important areas.
Lets take a look at drug stability first. Is there any part of your operation in which there is a danger in re- gards to the stability of the products which you are handling? What conditions influence the chemical sta- bility of a drug, i.e., increase the rate at which it might decompose? The two main considerations are:
1. Temperature 2. Moisture
16 THE MARYLAND PHARMACIST
In addition to these we may have chemicals which are subject to oxidation, or photolysis. For instance, the USP contains the names of over 300 drugs which spe- cifically require protection from light and when the NF is included the total list exceeds 500 (4). The Public Health Service adopted light resistance as a requirement for all prescription containers more than 17 years ago. In 1945, the then assistant FDA Commissioner Crawford issued the following statement:
“Where light protection is indicated for a USP preparation and that preparation is dispensed by a pharmacist in a container not assuring this protection, that prescription when sold in interstate commerce would be deemed mishan- dled under the Federal Food, Drug and Cos-
metic Act.”
It is fortunate for many pharmacists that most pre- scriptions are not dispensed in interstate commerce.
Fortunately, amber glass will afford the pharmacist with an easy method to comply with official regulations. According to Swartz et al., green glass will not give a product the same degree of protection (5).
Let us return, however, to the two most important considerations in drug stability—heat and moisture.
The speed of many chemical reactions increases about 2 to 3 times with each 10° rise in temperature. The storage of drugs at reduced temperature is simply a reflection of this basic chemical law. All drugs are chem- ically more stable at lower temperatures. This is true for two reasons. An increase in temperature increases the frequency with which two interacting molecules will col- lide and it increases the probability that they will collide with sufficient energy to undergo a reaction. When liquid products are frozen, rates of chemical reaction are re- duced dramatically approaching zero.
In spite of this, many drug storage areas in hos- pitals, extended care facilities or nursing homes, and for that matter, community pharmacies, are in areas of ex- cessive heat. The increased utilization of air conditioning has been extremely helpful in improving conditions of drug storage but surprisingly enough, drug storage areas are often the last part of a facility to be air conditioned.
In order to clear up misunderstandings as to storage conditions, new definitions of the terms used to designate storage temperatures will appear in NF XII and USP XVIII. In addition to narrowing the temperature ranges which apply to existing terms, two new terms have been introduced. They are Cool Place and Room Temperature.
The new definitions are: Cold Place—one having a temperature not exceed- ing 8°C (46°F) Refrigerator—a cold place in which the temperature
is held between 2° and 8°C. (36 and 46°F)
OCTOBER 1971
dastytes y :
There’s a lot more
going for you at LOEWY?
LOO1Nt
COMPUTERIZED SERVICE
puts America’s most advanced warehouse facility behind your store
How much is it worth to you to know that the most advanced computerized distribution system in existence is in motion to process your every order ...instantly, efficiently, completely ? That you needn't ever stock more than a minimum of a far greater variety of merchandise than you could ever show before... and without investment in excessive inventory? That your wholesaler is never likely to be out-of stock on any desirable item? That every invoice and statement is assured of up-to-the-minute accuracy? And that there is never a lapse of more than 60 minutes from receipt of your order to the time it is on the loading platform, ready to roll?
How much? You'll be able to measure its worth by the number of customers attracted to your store. Old customers and new, it’s the kind of service they aren’t likely to have known before.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
DIVISION OF
() ya 7 . foes Spectro Industries, Ine. 6801 Quad Avenue Baltimore, Md. 21206 Telephone: (301) 485-8100
Cool Place—a cool place is one having a tempera- ture between 8° and 15°C (46° and 59°F)
Room Temperature—room temperatures between Wsrands30 7G (59 and 86°F)
Excessive Heat—designates temperatures above 40°C
(104°F)
Storage areas near heating pipes, autoclave equip- ment or hot water lines may very well fall into the area of excessive heat.
When an official monograph does not list any spe- cific storage conditions, room temperature should be as- sumed,
Before going on to another subject, I would like to say a word about the second most important factor in drug stability and that is moisture. Very few chemical reactions take place in a completely dry state as it is extremely difficult for molecules to come together in a medium which does not allow for mobility. The basic cause of decomposition of many drugs is hydrolysis. Hy- drolysis can be prevented by keeping drugs completely dry or by adjusting the pH of a solution to a value where the rate of the chemical reaction is low. For instance, we know that aspirin when kept completely dry possesses a high degree of stability but when even small amounts of moisture are present, hydrolysis will occur (6). The acetylsalicylate acid dissolves in the water absorbed on the surface of the crystal and undergoes hydrolysis into acetic acid and salicylic acid. More aspirin then dissolves and the process continues.
The rate of degradation of procaine penicillin solu- tions was shown by Swindowsky to be due only to that portion in solution (7). Many drugs in solution have reasonable stability at an optimum pH bui decompose rapidly when that pH is changed.
For instance, procaine and tetracaine have almost identical rates of deterioration at room temperature (25°C) and pH 5.0. It would take 19 years for either compound to decompose 50% when in solution. At auto- clave temperatures (121°C) and the same pH it would take 36 hours. At autoclave temperatures and a pH of 6.8 it would take only 10 minutes (8).
Remember, anytime you change the pH of a liquid drug product there is a good chance you will change the stability of the drug—in many cases decreasing it.
It is extremely important that we not only avoid high temperature in drug storage but also moisture. The two best ways of insuring minimum damage to drugs is to (a) dispense in tightly closed containers and (b) avoid high humidity environments. For instance, in many homes and some nursing homes the medicine cabinet is in the bath room or washing area where relative humidi- ties are often 100%.
One indication that a drug is moisture sensitive is the presence of a dessicant package in the manufacturer’s bottle. It should be remembered that the moisture capaci- ty of these dessicants is limited and they soon become saturated when the bottle is opened regularly or left opened. The continued use of these dessicant packages without regeneration is worthless.
One of the major problems that has existed for many years is the one associated with the preparation of paren- teral products by the nurse just prior to administration. Although in many cases this involves a compounding funce- tion such as reconstitution of freeze dried preducts or in-
18 THE MARYLAND PHARMACIST
corporation of drugs with intravenous fluids, the nurse traditionally has been burdened with this responsibility. It is now becoming more and more customary for these functions to be carried out by pharmacists supplying the nurse with a dosage form ready to be administered. The pharmacist must take the responsibility for accurate prep- aration, complete labeling, and storage of the reconsti- tuted or combined drugs. He can also check to make sure that drugs which are pharmaceutically or therapeutically incompatible are not dispensed. Numerous lists of such incompatibilities have appeared in the literature (9).
As manufacturers have found out more and more about drug stability and the Food and Drug Administra- tion has set tighter restrictions on such products, there has been significant increase in the number of drug products with very limited stability after reconstitution. Some are stable for only a few hours, others for as long as a month or more without significant loss of potency. In many cases, this stability is dependent upon storage in a refrigerator or cool place after reconstitution.
Under no circumstances (except in an extreme emergency ) should drugs be administered beyond their indicated stability period as the therapeutic effectiveness is diminished and the decomposition of some drugs re- sults in the formation of chemical by-products which may cause untoward or toxic manifestations. It is the pharmacists’ responsibility to see that no such extreme emergency ever arises.
An excellent compilation of the stability of drugs after reconstitution appeared in the December 1967 issue of the American Journal of Hospital Pharmacy (10). In many cases the information in this compilation is much more complete than is supplied by the manufacturer and I heartily recommend that you have a copy in your pharmacy.
It should always be remembered that the stability data of a reconstituted product applies only when the stated diluent or vehicle is used. This applies to all type products such as oral suspensions, eye, ear, nose drops as well as to parenteral products. If another vehicle is used or the reconstituted product is further added to a standard IV solution, a whole new ball game arises and stability would have to be determined or ascertained from the manufacturer. It is mandatory that the expiration time (hours) or date (days) be placed on the label of each product. .
One approach that some hospital pharmacists have taken to increasing shelf-life after reconstitution is to quick-freeze the reconstituted liquid immediately on prep- aration and store the frozen product in a deep freeze. Stolar et al. (11), showed that sodium methicillin for injection can be reconstituted and stored at freezer tem- perature for prolonged periods of time without deteriora- ~ tion. Upon receipt of an order the pharmacist removes the vial from the freezer, permits the solution to thaw and dispenses the medication to the nursing unit. Small portable units for transferring frozen products from the community pharmacy to the nursing home are available or can be constructed. A number of precautions must be observed.
(1) The pharmacist must be sure that the product is stable when frozen. (Ampicillin is less stable in frozen dilute solutions than at room tem- perature. )
(2) Removal of a ce. of a very cold solution will give more drug than at room temperature due — to the increased density of the solution.
OCTOBER 1971
__ Reading iS Still the fast
to proer: poe
brain
@
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- ment.
uman
est way m the
Ng SPEEDS
=D
6 [0
Maryland News Company is proud to be your area's prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
(3) All products cannot be frozen due to physical changes which occur during the freezing proc- ess.
This latter point is important. We all know, for in- siance, that Milk of Magnesia should not be frozen but few people stop to think why? Remember when you freeze any material which is hydrated, the water freezes in a pure state and separates itself from the chemical to which it is attached. When the frozen product is thawed the water may or may not associate itself in the same manner as it was originally and this may lead to insolu- bility and precipitation.
The storage of insulin is particularly important as many types are sensitive to both freezing and to high temperatures. (12) Storage can be summarized as fol- lows:
(1) All insulin products except a vial in current use should be stored in a cool or cold place (2-15°C). They should not be frozen. Freezing does not affect potency but affects the physical form, preventing uniform redispersion. This is particularly true of the modified protein-insulin and lente preparations.
(2) The lente insulins, NPH insulin and protamine zine insulin all tend to coagulate at elevated temperatures. Exposure to temperatures above 79°F for a few days or 100°F for a few hours can produce a granular or clumped precipitate. Although potency may not be affected, the phy- sical change prevents withdrawal and adminis- tration of a uniform dose. Prolonged exposure to elevated temperatures will destroy potency.
(3) Normal room temperatures (68°-75°F) will not cause clinically significant lowering of activity of insulin during the use time of a single vial— up to a few weeks.
In regards to expiration dates on prescription prod- ucts, many of you may not be aware of the fact that the pharmaceutical industry is rapidly moving to the stage where all prescription drugs will have an expiration date.
For those products which would have unlimited sta- bility if stored at room temperature, an arbitrary expira- tion date such as five years will be set.
It is interesting to note that manufacturers were much more willing to set an expiration date on their products than to indicate the date of manufacture.
I realize that I have touched a number of different areas of drug storage and stability but hope that at least one of the points I have made will motivate you to im- prove your present drug storage procedures.
In closing, I would like to review a stability study on packaging of nitroglycerine which we recently com- pleted here at the University of Maryland School of Pharmacy (13). We have long been concerned with the preparation and stability of nitroglycerin tablets for sub- lingual use. Although pharmacists are generally aware of the fact that nitroglycerin tablets can lose their potency, they fail to translate this awareness into sound dispens- ing habits. The experiment was designed to show the sta- bility of hypodermic tablets of nitroglycerin when dis- pensed in a variety of containers including strip packag- ing at both room and elevated temperatures.
The nitroglycerin tablets were stable when packaged in glass regardless of whether a plastic snap cap or screw cap type closure was used.
20 THE MARYLAND PHARMACIST
Nitroglycerin tablets packaged in polystyrene vials showed almost identical rates of decomposition regardless of the type of cap employed. The stability was not suf- ficient to justify use of these types of containers.
Nitroglycerin tablets dispensed in a pill box showed rapid loss of potency even at room temperature.
The results of the strip packaging study were even more dramatic. Tablets were packaged using aluminum foil on one side and either (a) paper, (b) polyethylene, or (c) aluminum foil on top. The loss in potency in al systems was so rapid that accelerated aging passes through the paper layer completely. On the other hand, it dis- solves in the polyethylene and effectively partitions out of the tablet. In the case of the aluminum-aluminum strip package, the nitroglycerin apparently escapes through the thin layer of adhesive material on the surface of the foil which is present to enable the foil layers to seal to- gether. It is obvious that strip packaging of nitroglycerin in any of these systems would be disastrous. However, when I recently mentioned this to a pharmacist who is involved in one of the largest experimental unit dose studies in the country, he was frank to admit that they had been strip packaging nitroglycerin in this manner for over two years.
I would like to close with a simple question: How do you package nitroglycerin in your pharmacy or nurs- ing home?
BIBLIOGRAPHY
1. Varsano, Jacob, Drug and Cosm. Ind., 104, 88 (Jan. 1969).
2. Varsano, Jacob, ibid, 104, 72 (Feb. 1969).
3. Varsano, Jacob, ibid, 104, 98 (March 1969).
4. “These 305 Drugs Need Light Protection,’ Armstrong Cork Co., Lancaster, Pa.
5. Swartz, C. J., et al., J. Pharm. Sci., 50, 145-148 (1961).
6. Leeson, L. T. and Mattocks, A. M., J. Am. Pharm. Assoc., Sci. Ed., 47, 329, 1958.
7. Swintowsky, J. V., et al., ibid. 45, 34, 37 (1956).
8. Higuchi, T. et al., ibid, 39, 405 (1950).
9. Pelissier, N. A. and Burgee, S. L., Hosp. Pharm., 3, (1) 1968.
10. Latiolais, C. J. et al., Am. J. Hosp. Pharm., 24, 667 (1967).
11. Stolar, M. H., et al., ibid, 25, 32 (1968).
12. Shangraw, R. F. and Lamy, P. P., J. Am. Pharm. Assoc., NS9, 117 (1969).
13. Edelman, Barre A.; Contractor, Avinash M.; and Shangraw, Ralph F.; ibid., NS11, 30 (1971).
PHI DELTA CHI
Members interested in joining the alumni chapter of Phi Delta Chi Fraternity should contact Mr. William Ed- mondson, 955-7619, 955-7591: Mr. John Vakoutis, 661- 9088 or Mr. Ed Poklis, 477-4399.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
—_——
OCTOBER 1971
Si
Put your facings -« swhere your
profits arel (Deal runs Oct. 1—28)
buy now for bigger fall and winter profits A.H. Robins announces a special money-saving deal on Allbee with C. Here’s your chance to get the very best buy on the number one vit- min in its class in drug store sales. Last year, Allbee with C led _ (inpurchases with 25% of this big $20 million plus market. This in- ~ creased to a whopping 32% share during the fitst part of 1971. Such
_an outstanding performance isn’t surprising when you consider that ~~ it’s the B-complex with C most often prescribed by the medical and “dental professions. More than a million scripts were filled last year,
and this didn’t even include professional recommendations or over- the-counter sales. Over onehalf of all Allbee with C sales are OTC.
You purchase and sell far more Allbee with C. Isn’t it good busi- ness to also give it more facings’and shelf space? Your Robins rep- resentative will be around soon to discuss the deal and facings with you. You’ve got Déal,Power with Allbee with C, and that means a better deal for you. ~~
A.'H. Ro bing Company, Richmond, Va. A-H-[20 B | N )
Bi sinn bees
University of Maryland School of Pharmacy
Dr. David A. Knapp has joined the faculty of the School of Pharmacy as associate professor in the depart- ment of pharmacy administration. He will be responsible for teaching and research in the area of social sciences in pharmacy and will assist in the development of educa- tion and service programs including not only the School of Pharmacy but also other health profession schools and programs,
Nominations are now being received for the Honored Alumnus Award to be presented at the Annual Gradua- tion Banquet.
Names for nomination may be submitted to Harry R. Wille, 306 Marydell Road, Baltimore, Maryland 21229.
A. Z. O. News
Kappa Chapter of Baltimore will be the host chap- ter for the 1971 Fall Regional Meeting of the Alpha Zeta Omega Pharmaceutical Fraternity. Recent appointments on the national level include those of Paul Reznek, who has been appointed Legislative Representative for the fraternity and Gerald Freedenberg, Directorum of Kappa Chapter, has been appointed A.Z.O. Historian.
Mangini can tell you what you have.
Within 1%
Many pharmacists often esti- mate their inventory by relat- ing purchases to sales
In today’s competitive climate and with the cost of merchan- dise continuously rising, these estimated gross profit figures
Mangini & Associates, Inc. 4850 W. Belmont Ave. Chicago, III
6064 1/(312) 282-8181
can be misleading. In _ fact. this can be extremely costly to the pharmacist who, un- aware of his shrinking inven- tory and gross profits, is actually paying a higher in- come tax than he should.
So why guess? Call Mangini for fast, computerized inven- tory service that will tell you within 1% how your inventory realistically stacks up to your turnover, sales and profits!
WRITE FOR DETAILED INFORMATION. tiosEREES
11722 Studt St., St. Louis, Mo. 63141 2760 W. Market St., Akron, Ohio 44313 575 Savin Ave., West Haven, Conn. 06516 5501 Cherokee Ave, Alexandria, Va. 22312
WHEN YOU WANT Health and Beauty Products that offer:
Dependability Real Profits
Uniformity
Competitive Pricing
Outstanding Acceptance
YOU WANT DRUCO Quality Products!
YOU can display and recommend DRUCO Products with confidence. DRUCO — the Quality Line of Pharmacy Produets since 1898.
DRUCO consumer ads direct customers to your Pharmacy for
THE DRUG HOUSE, INC.
Philadelphia
Trenton
Wilmington
U. i Y DRUCO Products and all their Health Needs. 0
22 THE MARYLAND PHARMACIST
OCTOBER 1971
phenylbutazone
pres
Geigy «
1000 tablets i 2 ofan Tofranil imipramine hydro"
STATEMENT OF OWNERSHIP, MANAGEMENT AND CIRCULATION ‘Act of August 12, 1970; Section 3685), Title 39, United State Code) Title of Publication: MARYLAND PHARMACIST
Date of filing: October 1, 1971.
Frequency of issue: Monthly
4. Location of known office of publication: 306 N. Gay Street, Baltimore, Maryland 21202
5. Location of the headquarters or general business offices of the pub- lishers: 650 W. Lombard Street, Baltimore, Maryland 21201
6. Names and addresses of publisher, editor and managing editor: Publisher: Maryland Pharmaceutical Association, 650 W. Lombard St., Baltimore, Md. 21201
Editor: Nathan I. Gruz, 650 W. Lombard Street, Baltimore, Md. 21201 Managing Editor: Nathan I. Gruz, 650 W. Lombard Street, Baltimore, Md. 21201
7. Owner (If owned by a corporation, its names and address must be stated and also immediately thereunder the names and addresses of stockholders owning or holding 1 percent or more of total amount of stock. If not owned by a corporation, the names and addresses of the individual owners must be given. If owned by a partnership or other unincorporated firm, its name and address, as well as that of each individual must be given.) Maryland Pharmaceutical Association, 650 W. Lombard Street, Baltimore, Maryland 21201, (Non-Profit Corporation)
8. Known bondholders, mortgagees and other security holders owning or holding 1 percent or more of total amount of bonds, mortgages or other securities: None
9. For optional completion by publishers mailing at the regular rates (Sec- tion 132.121, Postal Service Manual
39 U. S. C. 3626 provides in pertinent part: ‘‘No person who would have been entitled to mail matter under former section 4359 of this title shall mail such matter at the rates provided under this subsection unless he files annually with the Postal Service a written request for permission to mail matter at such rates.’’
In accordance with the provisions of this statute, I hereby request permis- sion to mail the publication named in item 1 at the reduced postage rates
Che
presently authorized by 39 U. S. C. 3626. Nathan I. Gruz, Editor 11. Extent and nature of circulation AS Total= Now Copies) Printed) 72, soe ee sng Leos 1450+
B. Paid Circulation 1. Sales Through Dealers and Carriers, Street
Vendors and Counter Sales ....... eRe Soke eras None None 2. Mall “Subseriptlons vi ves cece eee eee ee eer eel ae 1250 1250 C.cotal Paid: Cireulation’ 77, kant re mls cope ee one aes 1250 1250 D. Free Distribution by Mail, Carrier or by Other Means 1. Samples, complimentary, and other free copies hee LOO 150 2. Copies Distributed to News Agents, but not sold....None None me, Lotal. Distribution © a. 3... Saye te, gets I, Latha ye 1400 1322 F. Office Use, Left-Over, Unaccounted, Spoiled After: PrintMeg i... <ea se eee ee De Roast ls TEU 138 G. Total Rete teed .. . 1450 1450
*Average No. Copies Each Issue During Preceding 12 months. +Single Issue Nearest to Filing Date I certify that the statements made by me above are correct and com-
plete. NATHAN I. GRUZ
TAILOR-MADE Insurance Coverage
AMERICAN DRUGGISTS’ INSURANCE ...as the name im- plies, is specifically designed for the needs of the druggist. It'S an insurance company founded BY druggists FOR druggists, to assure especially prompt settlement of claims .. fire, theft, liability. And that’s exactly what we’ve been doing... settling such claims rapidly, without red tape
... Since 1906. Any service with that many years of experience HAS to be reliable. You can be certain of 100% security.
For full details on our complete coverage plan, contact your ADI agent NOW.
MAYER & STEINBERG Maryland State Agents 1101 N. CALVERT STREET BALTIMORE, MD. 21202 752-7311
DRUGGISTS’ INSURANCE CO.
700 American Building Cincinnati, Ohio 45202
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships)
Mutual Funds
Prospectuses Available Upon Reyuest
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
Each teaspoonful (5 ml.) contains aluminum hydrox- ide, 720 mg., magnesium hydroxide, 350 mg., and calcium carbonate, 375 mg.
Contraindications: renal insufficiency, phosphate de- pletion.
Adverse Reactions: occasional laxation, nausea and, rarely, constipation. Theoretically, hypophosphatemia, hypermagnesemia, hypercalcemia, milk alkali syn- drome (with prolonged administration).
Usual Adult Dosage: 2 to 3 teaspoonfuls between meals and at bedtime, or as needed (40 to 60 ml. daily).
For complete product information, see your SK&F Representative or contact SK&F.
Ail antacids are not alike.
DUCON™: DUration through CONcentration
DUration means patients may be able to take ‘DUCON' less frequently.
CONceniration means ‘DUCON' has a high acid-consuming capacity.
And the taste of ‘DUCON'’ means antacids don't have to taste like chalk soup.
LAST BUT NOT LEAST: The 73¢ profit per bottle means
“DUCON is the most profitable item
in your antacid section.
*based on suggested retail price Trademark
Ducon antacid
SF smith Kline & French Laboratories, Phila., Pa. 19101
Obituaries
S. L. Anderson
S. L. Anderson, 59, died suddenly on September 20 in M.C.V. Hospital, Richmond, Virginia. He was a 1934 graduate of the University of Mary- land School of Pharmacy.
John A. Strevig
John A. Strevig, 82, a 1912 grad- uate of the University of Maryland School of Pharmacy, died on October 1. A past president of the Alumni Association, Mr. Strevig was a former hospital representative for Eli Lilly and Co. until his retirement in 1954. He was a member of the Baltimore Veteran Druggists Association.
Jacob H. Greenfeld
Jacob H. Greenfeld, 63, died on September 30, 1971 at Sinai Hospital. Mr. Greenfeld graduated from the University of Maryland School of Pharmacy in 1929. He was president for the past 13 years of the Ner Tamid Congregation, Greenspring Valley Synagogue and was active in raising money for development programs in Israel.
John F. Neutze
John F. Neutze, 55, owner of a Govans pharmacy for the past 20 years, died on September 16 at St. Joseph Hospital after being ill for several days. He was a 1937 graduate of the University of Maryland School of Pharmacy. In 1951, he and a part- ner opened the Combs and Neutze Pharmacy at 5925 York Road. He was a member of the Ancient Scottish Rite and Tuscan Lodge.
Mr. Neutze was also a member of the Maryland Pharmaceutical Associ- ation, served as vice president of the Baltimore Pharmaceutical Association, and was a member of the Wedgewood Club, and the National Association of Retail Druggists.
In The News... SAMUEL MORRIS, Publicity Chairman of the
Prince Georges-Montgomery County Pharmaceutical Asso- ciation, is now on the staff of the Easton Memorial Hos- pital. Dean WILLIAM J. KINNARD will be presented with an honorary membership in Kappa Chapter of AZO at AZO’s Fall Regional Con- vention. Also SAM BLOCK, MORRIS SCHENKER and
Pharmaceutical Fraternity
26
PHARMACEUTICAL DIRECTORY
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association
Rdalaciencte neko: Stephen Hospodavis Bicisto tate tye no ne James Ritchie
Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association
Presidentaeess «Cee ree Irvin Kamenetz Presidentellecta eee ren Joseph U. Dorsch LCOSUT erin wr coetaee Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille
Secretary and Executive Director
Nathan I. Gruz
Eastern Shore Pharmaceutical Society
President it haere ane Gordon Harrison First Vice President....... William P. Smith Second Vice President....... William Connor Secretary wage ota ee oe Carl R. June Theastrera tare es nea tee Thomas Payne
Prince Georges-Montgomery County Pharmaceutical Association
Presidentsc: sa oo ey ck vO Martin Hauer First Vice President....Edward D. Nussbaum Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz Secretary Ws f=) see a eee. Paul Reznek Treasurer’ {Ose ine Michael Leonard Honorary President .......... Samuel Morris
Washington County Pharmaceutical Association ear ee Samuel E. Weisbecker SOPHO SA iam Heb Baie Joseph Davies AS: Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter
Presidents ccc ce nee Paul R. Webster Vicew Presidente eee Stephen B. Bierer Secretaryer ne se eee Donna S. Levin Trédsurer tx kaudeue ee Dennis R. Reaver
NATHAN COHEN will receive pins acknowledging their 90 years of participation in Kappa Chapter. A very suc- cessful I.V. Additive Workshop, under the Direction of Dr. PETER P. LAMY, was recently conducted at the downtown Holiday Inn. Dr. SAMUEL FOX, U. of Md. School of Pharmacy graduate, has been appointed full Professor of Ophthalmology at the University of Mary- land School of Medicine.
THE MARYLAND PHARMACIST
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association
President MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE
Communications Secretary
MRS. RICHARD R. CRANE
Treasurer
MRS. CHARLES S. AUSTIN Membership Treasurer
MRS. MANUEL B. WAGNER i
TAMPA — Traveler’s Auxiliary of The ]
Maryland Pharmaceutical Association
President PAUL J. MAHONEY . First Vice President ; JOHN C. MATHENY |
Second Vice President ABRIAN E. BLOOM
Third Vice President C. WILSON SPILKER
Secretary-T reasurer
WILLIAM A. POKORNY | WILLIAM L. NELSON |
Assistant Secretary-Treasurer Honorary President JOSEPH GRUBB
Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER Secretary
DOLORES A. ICHNIOWSKI
Treasurer
THOMAS E. PATRICK
University of Maryiand School of Pharmacy
| | . f
Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
Metropolitan Guild of Pharmacists
President JOHN McKIRGAN Vice President FRANK FRARY Secretary LARRY JACOBSON Treasurer
EDWARD WILLIAMS
OCTOBER 1971
Youngs tells it as itis
Inmagazines, newspapers, in-store. promotions,
booklets, publicity and billboards.
Across the nation, through every promotional device we can use, we’re telling it as it is about the only positive V.D. preventative and male contraceptive product...the condom. Through mass media advertising and national public relations programs we’re making the community pharmacy the strongest weapon in the war on V.D.... and sending thousands of customers into pharmacies everywhere. We’re the only major manufacturer of prophylactics who recommends the pharmacist in every ad we run.
Advertising In 1969 Youngs ran the first prophylactic ad in a consumer publication. This year we will carry more than 485 million advertising impressions to people throughout the U.S. Also, millions of additional V.D. messages are being made by our buttons, matches and billboards.
Counter Displays
Across the nation, we’re telling it as it is about the only positive V.D. preventative and male contraceptive product...the condom. And...we’re making the pharmacy the strongest weapon in the war on V.D....and creating new prophylactic users for pharmacies everywhere.
7 V.D. Literature
| Plain Tatk ! about ; | Venereal Disease |
oer |
Over 4 million Youngs informative Plain Talk About V.D. booklets have been distributed in pharmacies, high schools and clinics. Many other important educational items such as Youngs’ “‘How to Use a Condom’”’ pamphlet have also been gaining widespread distribution.
Ne P25 Publicity Our continuing publicity program is attacking V.D. through radio, T.V., newspapers, magazines, telephone messages and seminars. It's done a tremendous job in educating young adults, teachers and parents on V.D. And—we’ve singled out the pharmacist as the best source for medically recommended products that aid in preventing V.D.
se Dn gat y
up Youngs Drug Products Corporation
Manufacturers of “Trojan” brand prophylactics—sold only in drugstores 865 Centennial Avenue, Piscataway, New Jersey 08854
The Maryland Pharmaceutical pga
Presents
MEXICAN FUN FEST
and Convention Round-Up in Acapulco
6 FANTASTIC DAYS! pre 5 FUN-FILLED NITES! 9 =~ - WEDNESDAY thru MONDAY, MAY 17 thru 09,1972
®Non-stop round trip jet flight via Eastern Airlines Deluxe Trip with OPEN FREE BAR and deluxe meal during flight.
@Deluxe twin bedded accommodation with private bath at the Super Deluxe PIERRE MARQUIS Hotel and Golf Club on Acapulco’s famous REVOLCADERO BEACH — 2 blocks long and one block wide, with the surf from the Pacific constantly rolling in.
® Transportation and transfers to and from hotel to airport and porterage. (Hotel only 5 minutes from airport).
®Full Course Breakfasts; Gourmet Dinners with dancing nitely from your ringside dinner table until the wee hours for FREE in the exotic Tabochin Dining Room.
@Cocktail Party plus Many Surprises!
®ALL Taxes and ie REG. *800°°
Gratuities Paid In Full S .00 ALL FOR ONLY... Oe Leave Friendship Airport, 8 A.M. PER Cou PLE!
Wednesday, May 17th — Arrive Plus $39.00 Tax and Gratuities
Acapulco 12:30 P.M.
(10:30 A.M. Their Time)
Leave Acapulco Airport, 4 P.M. Monday, May 22nd — Arrive
Baltimore 10:30 P.M. (Checkeut Time: 3 P.M.) * ; Educational Sessions Daily EARLY BUY PRICE!
Reservations on this fabulous trip can be confirmed only upon receipt of $50.00 deposit per couple. All monies refundable in full until April 17th, 1972, after which date refunds are subject to resale of the reservations.
CHECKS MADE PAYABLE AND MAILED TO:
MARYLAND PHARMACEUTICAL ASSOCIATION 650 W. LOMBARD ST., BALTO., MD. 21201- Phone 727-0746
Volume 47
the maryland
ASSOCIATION
=" pharmacist
Editorial—
Unity In Pharmacy: Necessity For Survival
MPhA Fall Regional Meeting
Third-Party Prescription Programs- Delight or Dilemma
by Morris Bookoff
NOVEMBER 1971
Number 11
Compliments of
oxell
CORPORATION
NOXZEMA SKIN CREAMS
Makers of
NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
Your reputation goes on the line every time you
fill a prescription—with patients and with physicians alike. You know that seemingly minor differences
in method of manufacture—the size of the particle, the excipient used, the character of the gelatin capsules, solubility, disintegration rate—all can make a crucial difference in therapeutic effectiveness. Your professional judgment tells you... when it comes to your prescription patient's health (and your reputation), you want to
dispense the best.
Lilly ELI LILLY AND COMPANY
INDIANAPOLIS, INDIANA 46206
You wrap your » reputation
around the
products you dispense
eh
lee «
Announcing an Important Price Reduction
The Leading Tablet Form of Erythromycin
Erythrocin — Stearate,250 Mil
(ERYTHROMYCIN STEARATE As0TT STEARATE TABLETS
250 mg. icivig
Caution: Federal (U.S.A.)
Nowcosts = = Siem 31.8% less S
New Low Price Takes Effect Immediately
Direct Price $14.99 per 100
Health Care World Wide
— es
The Maryland Pharmacist
NATHAN I. GRUZ, Editor
Normanp A. PE ttssier, Assistant Editor Martua Ecxkuorr, Editorial Assistant Ross P. CampsBet_, News Correspondent
650 WEST LOMBARD STREET BALTIMORE, MARYLAND 21201
HERMAN J. BLoom, Photographer ASSOCIATION VoLuME 47 NOVEMBER 1971 NumeBer 11 OFFICERS 1971-1972 Honorary President H. NELSON WARFIELD—Pikesville TABLE OF CONTENTS jad ialy 6 Editorial—Unity in Pharmacy: Necessity For Survival
NATHAN SCHWARTZ—Annapolis
President Elect BERNARD B. LACHMAN—Baltimore
Vice President
JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore, Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972) Cresaptown PHILIP D. LINDEMAN (1973*—Berlin ANTHONY G. PADUSSIS (1973) Baltimore MELVIN J. SOLLOD (1974)—Adelphi
| SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore
,
EX-OFFICIO MEMS5ERS
FRANCIS S. BALASSONE—Baltimore WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON—Baltimore
President NORMAN J. LEVIN—Pikesville
Secretary F. S. BALASSONE—Baltimore
Member FRANK BLOCK—Baltimore
Member HOWARD L. GORDY-—Salisbury
Member MORRIS R. YAFFE—Potomac
8 Washington Spotlight For Pharmacists
8 Maryland Board of Pharmacy
10 MPhA Fall Regional Meeting
10 Pharmacy Calendar
12 LA.M.P.A. News
129 2, Om News
12.) LAMP ASNews
12 Prince Georges‘-Montgomery Pharmaceutical Association
12 Eastern Shore Pharmaceutical Society
14 Hospital Pharmacy Section
16 Baltimore Metropolitan Pharmaceutical Association
18 Third-Party Prescription Programs—Delight or Dilemma by Morris Bookoff
21 University of Maryland School of Pharmacy
26 Obituaries
26 State Pharmaceutical Directory
INDEX TO ADVERTISERS
4 Abbott Laboratories 23 Berkey Film Processing
19 Calvert Drug Company, Inc.
20 Ciba Pharmaceutical Company
17. Henry B. Gilpin Company 27 Hynson, Westcott & Dunning, Inc.
7 Lederle Laboratories
3 Eli Lilly and Company
9 Loewy Drug Company
24 Mangini and Associates, Inc. 25 Maryland News Company 22 Metropolitan Guild of Pharmacists
2 Noxell Corporation
13. Paramount Photo Service 22 Pension & Investment Associates of America 15 Roche Laboratories 21 OD. Stuart Webb Advertising Services 11 Youngs Drug Products Corporation
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for changeover. APhA members—please include APhA number.
The Maryland Pharmacist is published monthly by the Maryland Pharma- ceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Baltimore, Maryland, under the Act of March ‘8, 1879.
Editorial...
Unity In Pharmacy: Necessity For Survival
The pharmaceutical literature and association meet- ings for many years have pointed to the lack of national organizational unity in the profession of pharmacy.
It is hard to believe that there is one pharmacist around who doesn’t recognize that the posture of antagon- ists that has prevailed between our two national groups— the American Pharmaceutical Association and the Na- tional Association of Retail Druggists—has not contrib- uted to the inability to achieve many of the goals and aspirations of the profession.
The following statement was not written in 1971. It is quoted from the first report of this editorialist as
Executive Secretary. The date of delivery was June 25, 1962:
“When we approach the national pharmaceutical scene, one dominant feature must be recognized. Over the years, many of the aspirations of pharma- cists to achieve their urgently needed professional and economic goals, as well as to secure a properly recognized role in shaping policies regarding the pro- vision of medicinal agents, has been the absence of a national front for pharmacy. For the defensive and offensive needs of the country, we have a Joint Chiefs of Staff under a Secretary of Defense. Phar- macy is engaged in a total war. The pharmaceutical situation also demands a unified command. As long as rivalry continues between our two national groups, we will continue to be divided and, therefore, to be defeated. Whatever courageous steps must be taken to achieve cooperation and harmony between our two essential national groups—the APhA and NARD —must be taken. No personality differences, no in- dividual ambitions, no organizational competitive- ness can any longer be allowed to stand in the way. Pharmacy resources of experienced and competent leadership, intelligent and dedicated members, and financial wherewithal are too valuable to be used, except in an integrated, unified manner. Our peril is too great, our enemies too strong, our forces too fragmented to permit continuation of this increas- ingly disastrous internecine warfare which stands in pharmacy’s path of progress.”
The state pharmaceutical associations represent in their totality more pharmacists than either the APhA or the NARD. We believe that it is the responsibility of the leadership of these state societies to demand that efforts for an integrated national organizational structure for pharmacy be initiated immediately. This is no time for half-way measures, such as an agreement for the execu- tive bodies of the two groups meeting twice during the coming year.
In addition, it is the duty of the pharmacists who are members of the APhA and of the NARD to advise these groups that they will counternance no delay. They should demand and expect to see concrete implementation of steps taken in good faith to proceed toward the ultimate goal of cementing the fragmented structure of pharmacy.
6 THE MARYLAND PHARMACIST
Every facet of the world of pharmacy has the right lo organize, to work and to fight for what is its own legiti- mate and what we hope is its enlightened self-interest. This goes for the pharmaceutical manufacturing industry, wholesalers, educators, licensing boards, hospitals and the allied health professions.
Pharmacists, too, have legitimate self-interests that are entitled to the benefits of the vigorous advocacy of a dynamic, enlightened, responsive national body. Phar- macists are providing their splintered national organiza- tions with more than $3,000,000 annually to represent them.
The APhA and the American Society of Hospital Pharmacists are to be commended for recognizing the need for an objective study of the current organizational structure of pharmacy with the view of de!e:mining what changes are required to cope with the challenges of today and tomorrow. They have agreed to proceed with this study and have invited the NARD to join them.
The American College of Apothecaries and the Na- tional Council of State Pharmaceutical Association Execu- tives have also exercised incentives in bringing about
face-to-face discussion between the APhA and NARD.
The patience of pharmacists is wearing thin. They expect a plan—a set of priorities—a program for their implementation and progress toward fulfillment during the coming 12 months.
The leadership of APhA and NARD bear grave re- sponsibilities for the resolution of this long-festering, com-
plex problem.
Certainly pharmacists will expect an accounting of the action of the executive bodies of the groups by the time of their annual meetings in April and October 1972.
— Nathan I. Gruz
CHANGE OF ADDRESS
When you move—
Please inform this office four weeks in advance to avoid undelivered issues.
“The Maryland Pharmacist" is not forwarded by the Post Office when you move.
To insure delivery of "The Maryland Pharmacist" and all
mail, kindly notify the office when you plan to move and state the effective date. APhA members—please in- clude APhA number.
Thank you for your cooperation.
Nathan I. Gruz, Editor Maryland Pharmacist 650 West Lombard Street
NOVEMBER 197!
. .
% yor
wo '
Developed by Lederle
Semisynthetic
MINOCIN
MINOCYCLINE HCI
Available: Bottles of 50, Blister Packs of 10 x 10
200,000 MD’s are getting the word on MINOCIN. Be ready to meet the Rx demand. Stock up.
LEDERLE LABORATORIES °¢ A Division of American Cyanamid Company, Pearl River, New York 10965
Washington Spotlight For
Pharmacists by APhA Legal Division
The Transfer of Controlled Substances By Pharmacies
A recent change in the Controlled Substances Act regulations allows a pharmacy to transfer a controlled substance to either another pharmacy or a_ prescriber, under certain conditions, without being registered as a distributor. These new regulations supersede the prior regulations which prohibited a pharmacy from_provid- ing a physician with stocks of controlled substances for his office use—unless the pharmacy was registered as a distributor, and the regulations which allowed inter- pharmacy transfers, only in “emergency situations” and only in the quantity needed for immediate dispensing.
The new regulation ($307.11) reflects the BNDD recognition that pharmacies and other dispensers per- form a vital and necessary service function by providing limited supplies of drugs, including controlled substances to other practitioners.
The Controlled Substances Act authorizes the Bu- reau to waive registration requirements for certain dis- tributors where it is consistent with public health and safety. The Bureau, has indicated by this recent change that the infrequent distribution of controlled substances by a practitioner, without registration as a distributor, is consistent with the public health and safety.
The new regulation is intended only to provide a mechanism for the accommodation transfers between pharmacies and the servicing of physicians, by supplying them with office supplies of controlled substances. It is not intended to allow large scale transfers between phar- macies nor to allow pharmacies or other practitioners to engage in wholesale distribution of these substances.
In line with the rationale of this section and the purposes for which it was formulated, a “five percent” limitation is imposed.
FIVE (5) PERCENT TEST
The total number of dosage units of all controlled substances distributed by a practitioner pursuant to this section ($307.11), may not exceed 5% of the total num- ber of dosage units of all controlled substances distributed and dispensed by the practitioner during a twelve month period. This figure is based on dosage units, not dollar volume.
If a pharmacist or other practitioner distributes in excess of this figure, he is considered to be engaged in a significant wholesaling business and must register addi- tionally, as a distributor.
RECORDKEEPING REQUIREMENTS
All distributions and receipts, under this section, must be recorded. The record should contain the name. address and registration number of each practitioner, the quantity, strength and dosage form of the controlled sub- stance involved, and the date of the transaction.
8 THE MARYLAND PHARMACIST
The Bureau will accept either of two systems for
the records distributions:
1. Invoices, order forms, or other documents evi- dencing the transfer may be stamped and filed in the same manner as prescriptions, provided it clearly states that it was a distribution and not a dispensing or prescription.
or
The documents may be filed separately from all other records.
i)
Records of receipts should be filed in the same manner as receipts of controlled substances from whole- salers or manufacturers.
RECORDS FOR SCHEDULE II CONTROLLED SUBSTANCES
Schedule II controlled substances may also be trans- ferred or distributed under this regulation. An official order form must be utilized for any distribution or re- ceipt of Schedule II drugs.
The records for Schedule II drugs distributed or
received under this regulation must be kept separate from the records for Schedule III, IV or V controlled sub-
stances, as required by the Act for all records.
Maryland Board of Pharmacy News
Pharmacy Changes
The following are the pharmacy changes for the month of September:
New Pharmacies
Larken Pharmacare, Inc., Kenneth S. Sumida, Presi- dent, 5202 Baltimore National Pike, Baltimore, Mary- land 21229.
Northwest Community Professional Pharmacy, Roger C. Lipitz, President, 3140 Oakford Avenue, Baltimore, Maryland 21215.
Plaza Drugs, Jonas Yousem, President, 2244 Hanson Road, Edgewood, Maryland 21040.
No Longer Operating as Pharmacies
Drug Fair No. 61, Milton L. Elsberg, President, 6891 George Palmer Highway, Seat Pleasant, Maryland 20027.
Changes of Ownership, Address
Crestlyn Pharmacy, Marvin Anshell (Change in ownership), 3840 Crestlyn Road, Baltimore, Maryland 21218.
Asbill Pharmacy, Alfred H. Alessi, President (Change of address), 42 West Chesapeake Avenue, Tow- son, Maryland 21204.
NOVEMBER 1971
ila tt a
There’s a lot more going for you at LOEwy
Sfectre PERSONALIZED SERVICE PLUS
provides you with the flawless backing of 100% computerization— along with the special personal follow-through of people who care
Drug wholesaling divisions of Spectro were among the first in the industry to know the unprecedented advantages of fully computerized warehousing and delivery service. But as a retailing-oriented distributor, we Know, too, that nothing can take the place of personalized understanding and service follow- through. That’s why every one of us at the management, sales and service levels is vitally concerned about any phase of service that is of special concern to you. This happy combination of automation and personalization adds up to a quality and completeness of service that just isn’t likely to be matched through any other source.
Got a special supply, financial or service problem? Why not give us a ring during any working hour any day of the week. That’s one way you'll really know what we mean by personalized service. See why more and more retailers throughout the eastern seaboard are saying right out loud...
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
- taking. (301) 485-8100 for office and daytime order taking. After hours, 485-8105 for order taking (301) aw So en
LOEWY DRUG COMPANY $52 Yrentr Sochotiin, Sa
6801 Quad Avenue, Baltimore, Md. 21237. Tel.: (301) 485-8100
MPhA Fall Regional Meeting
The Maryland Pharmaceutical Association held its Fall Regional Meeting in conjunction with TAMPA and LAMPA on Thursday, October 7, 1971 at the Baltimore Playboy Club. Luncheon and cocktails were served prior to the meeting.
The Squibb Past Presidents Award was presented to Donald O. Fedder by Gerald Bringenburg, District Man- ager for E. R. Squibb & Co. Charles E. Spigelmire, Bal- timore pharmacist, received the A. H. Robins “Bowl of Hygeia” award for outstanding community service by pharmacists from Roger L. Elgin, district manager in the Capitol Division of A. H. Robins Company. Mr. Spigel- mire is treasurer of the Baltimore Metropolitan Pharma- ceutical Association.
Samuel W. Kidder, Pharm. D., M.P.H., of the Com- munity Health Service, Division of Medical Care Stand- ards of the federal Department of Health, Education and Welfare was the guest speaker. The topic of discussion was “Health Maintenance Organizations.”
Sydney L. Burgee, Speaker of the House of Dele- gates, called the meeting of the House to order. A report from the Prescription Insurance Plans Committee was given by chairman Morris Bookoff. Mr. Bookoff reported that he was awaiting guidelines from the National Phar- macy Insurance Council before the association estab- lishes a pharmacy services foundation for handling third party area activities.
Other activities of this committee which were re- ported were: formulation of guidelines for pharmaceuti- cal services to the medically indigent, establishment of a pharmacy and therapeutics committee with the Maryland State Medical Society, development of a formulary, and processing of the Esskay Meat Company office and sales employees’ prescription insurance program which former- ly was available only through one drug chain in the Bal- timore area.
The committee is looking into other prescription in- surance plans such as the Teamsters Plan No. 355, Sen- ior Citizens Plan and the AFL-CIO Plan. It was pointed out that non-MPhA members will also be able to participate in any prescription insurance programs ad- ministered by MPhA.
Chairman of the Board of Trustees, Donald O. Fed- der, explained the Drug Product Selection issue and made a motion for endorsement of a proposal to amend State anti-substitution laws to permit pharmacists to dis- pense another brand than which the prescriber indicates on his prescription unless the prescriber also denotes the name of the manufacturer of the drug which he orders. After some discussion and an unsuccessful attempt to amend the motion, the motion was approved as presented.
The meeting was adjourned at 4:45 p.m.
10 THE MARYLAND PHARMACIST
Photo courtesy of Jerome L, Fine and Paramount Photo Service
Charles E. Spigelmire receives Bowl of Hygeia Award at MPhA Fall Regional. Roger L. Elgin, right, representative of A. H. Robins Company makes presentation.
APhA Asks Senator Humphrey To Help Gain Commissions
APhA has asked Senator Hubert H. Humphrey (D- Minn) to seek amendment of the Selective Service Act to assure commissions and pharmacy assignments in the military.
“It would seem that the time is right for such an amendment to the Selective Service Act,” APhA Execu- tive Director Apple wrote to Senator Humphrey. Dr. Apple reviewed APhA’s continuing efforts in the area and concluded: “There is ample justification for such a position in view of the contribution pharmacists could make to optimal health care in the military and in view of the long standing inequity which has existed whereby pharmacists are the only remaining major health pro- fessionals who are not granted the status and authority necessary for them to exercise their professional responsi- bilities while in the service of their country.”
PHARMACY CALENDAR
December 9—( Thursday )—Maryland Society of Hospital Pharmacists meeting at University Hospital, 7:30 p-m.
December 12-16—American Society of Hospital Phar- macists Sixth Annual Midyear Clinical Meeting, Washington, D.C.
January 30, 1972—56th Annual Installation Banquet & Dance, Baltimore Metropolitan Pharmaceutical Asso- ciation, Blue Crest North.
April 22-28, 1972—American Pharmaceutical Associa- tion Annual Meeting, Houston.
May 7-9, 1972—Annual Convention, Maryland Phar- maceutical Association, Washington Motel and Country Club, Gaithersburg Maryland.
May 17-22, 1972——Post-convention trip, Maryland Phar- maceutical Association, Pierre Marquis Hotel, Aca- pulco, Mexico.
NOVEMBER 1971
Display the Bidette duo for Tull month feminine hygiene
oe PEPLOAL OEE LAD LCL LR GLARED ED PE SELLOEOLO LR AAC CROLCIP CRED FEE EE
—mewintimate feminine hygiene deodorant mist
.
Size.
with
Purchase of
5 OZ. SIZE
.. INTIMATE FEMININE HYGIEN
Deodoran . Mist
INTIMATE FEMININE HYGIENE
deodora Mist
Over the past two years more than 3 million packages of Bidette have been sold to women, who not only want Bidette Mist for odor pro- tection during normal days ...but also want Bidette Towelette for difficult days when they wish to cleanse as well as deodorize.
This year our expanded national advertising campaign will be sending more women than ever before into your pharmacy looking for Bidette. Display the Bidette Duo prominently so your customers can find them...and you'll find your profits growing.
Youngs Drug Products Corporation ™ 865 Centennial Ave., Piscataway, N. J. 08854
LAMPA News
Ladies Auxiliary Maryland Pharmaceutical Association
The newly refurbished Playboy Club in Baltimore was the locale for LAMPA’s Fall Regional Meeting on Thursday, October 7, 1971. Over a hundred men and women enjoyed a delicious filet mignon lunch, served by the well-publicized “‘bunnies.”
After lunch, Donald Fedder, MPhA Board of Trus- tees Chairman, was awarded the Squibb Past President’s Award—a beautiful Delft Mortar and Pestle. Charles Spigelmire, Treasurer of the BMPA, received the 1972 Robins Bowl of Hygeia Award for community service— a handsome brass bowl, in silhouette, mounted on a wood- en plaque, and appropriately engraved.
During LAMPA’s business meeting, the revised Con- stitution was approved by a unanimous vote of the mem- bers present. President Dora Rockman announced that the MPhA would sponsor a trip to Acapulco, Mexico, May 17 thru 22, 1972, as part of the annual convention. All other reports reflected favorable news, both financial and social.
“Tools of the Apothecary” a presentation by Morris L. Cooper, curator of the MPhA Cole Pharmacy Museum, was another first for LAMPA. The Cooper Collection has been shown in Europe and South America, but has not had too much local exposure. The color slides, which were unusually clear, showed a large number of mortars and pestles, of varied sizes and shapes, in metal, wood and ceramic and ranging in age from the present to a rare 10th century Islamic antique. Elaborate show globes, as well as archaic drug chopping machines were shown. Also, the more familiar pill tile and tablet machines of 50 years ago. Several delicate and unusual scales; a cork reducer, as well as a cork retriever; and a quassia cup; all elicited spontaneous questions. Even a round, metal hot water bottle appeared on the scene.
Especially interesting was a collection of old com- pounds, the labels describing the many and diverse uses, brought forth chuckles. Suppository molds, for man or beast; a labeling machine, and a blood letting gadget, for relieving hypertension, were carefully explained.
At the conclusion of the slide showing, Mr. Cooper showed and explained several very old articles he had brought to the meeting, such as a banjo scale, used to weigh opium; an elaborate doctor’s kit; and silver pills. All the artifacts shown were of museum quality; many having been authenticated by officials of the Smithsonian Institute in Washington, D.C.
It is almost impossible to adequately summarize a collection so varied, but you leave with a distinct feeling that the collector is sincerely dedicated to his profession and enjoys seeking out and studying the treasures of the past—the foundation upon which some of today’s prog- ress is built.
—Ann Crane Communications Secretary
A. Z. O. News
An AZO Breakfast Meeting was held on Sunday, October 24 at the Quality Courts Motel on Reisterstown Road. The AZO Fall Regional Meeting was scheduled for November 6 and 7 at the Hunt Valley Inn, Baltimore.
12 THE MARYLAND PHARMACIST
TAMPA News
The Traveler’s Auxiliary of the Maryland Pharma- ceutical Association held a dinner meeting at Peerce’s.
Plantation in Dulaney Valley on October 7. The fea- tured speaker was Mr. Charles Keller of the Baltimore Sun, who showed slides of his recent trip behind the Iron Curtain,
The group held its very successful ‘Ladies’ Nite” on Thursday, November 4 at the Garland Dinner Theater in Columbia, Md. Members saw the hilarious play “A Very Uncomplicated Girl.”
Prince Georges—Montgomery County
The Prince Georges-Montgomery County Pharma-
ceutical Association held its 17th Annual Scholarship Fund Affair on Saturday, October 30, at the Washing- tonian Country Club in Gaithersburg, Maryland. Pro- ceeds from the affair will be used to provide scholarship assistance at the University of Maryland School of Phar- macy. The program was entitled “A Night at the Races” and included a buffet dinner and auction.
An executive committee meeting was held on Octo- ber 20 in Silver Spring.
Eastern Shore Pharmaceutical Society, Inc.
The Eastern Shore Pharmaceutical Society held its annual Fall Meeting on Sunday, October 17 at the Har- bor Vue Inn, St. Michaels, Maryland. The evening’s speaker was Mr. Richard J. Holt, Curator of the St. Michaels Museum.
Members of the group attended a meeting of the Delaware Pharmaceutical Association held at the Cen- tury Club in Milford, Delaware on October 20. A physi- cian from the Wilmington area spoke on “The Pharma- cist’s Role in Management of the Diabetic.” Also, a P.M.A. film was shown entitled “Mr. Galen Goes to Town.”
Have You Returned Your Biographical Information Sheet?
If you haven’t done so, please complete and return the biographical information sheet which appeared in the July 1971 issue of “The Maryland Pharma- cist.” Return of the questionnaire by each member will assist the Association in serving the profession more effectively. If you do not have your form, there are more available from the MPhA office.
|
NOVEMBER 1971
Paramount Photo Service
The Quality and Service Photofinisher
Is Pleased to Announce They’re Moving to Their New Laboratory To Serve You With The Most Modern and Latest Equipment.
Note our new address and telephone number:
PARAMOUNT PHOTO SERVICE
2920 Greenmount Avenue Baltimore, Maryland 21218
Telephone: Baltimore 366-1155 Washington Area [Local call] 484-4050
NOVEMBER 1971 THE MARYLAND PHARMACIST 13
Hospital Pharmacy Section
Maryland Society of Hospital Pharmacists Meeting of October 14, 1971
The Maryland Society of Hospital Pharmacists held its October 14 meeting at St. Joseph’s Hospital in Tow- son. The guest speaker was Sharon K. Chapman, Ph. D.. Assistant Professor, Pharmacology and Toxicology, Uni- versity of Maryland, School of Pharmacy. Her topic was entitled “Drug Therapy and the Cardiae Patient.”
New members admitted in the Society at the meet- ing were: David M. Arrington, pharmacy resident at the Johns Hopkins Hospital; Tuong Anh Bui Nguyen, phar- macy resident at Maryland General Hospital; Robert T. Wheeler, Jr., Ciba representative; and the following stu- dents: Brenda M. Brandon, Geoffrey J. C. Boyd, Linda Susan Craig, Michael A. Grover and Donna S. Levin.
Reports were heard from Clarence Fortner. the semi- nar committee chairman: Samuel Lichter, the seminar program chairman; Paul Burkhart, the monthly meetings program chairman; and Howard Sherman, the member- ship committee chairman.
Dr. Peter P. Lamy and Vincent dePaul Burkhart will present a paper entitled ‘Patient Education Using Audio-Visual Aids” at the annual meeting of the Asso- ciation for the Advancement of Science on December 26
in Philadelphia.
Mary Connelly announced that the Board of Di- rectors, at its meeting of September 22, had decided to institute a continuing education program which would recognize the society members’ attendance at society functions during the year by issuing credits. The Society approved a motion to adopt this continuing education pro- gram. The Board also met on October 13 with attorney Joseph S. Kaufman, legal counsel for the Maryland Phar- maceutical Association, in reference to legal implementa- tion of the “Guidelines for Pharmacy Services in Hos- pitals.” At a meeting of the Board held on October 14, some proposed changes in the medicaid prescription pro- gram were discussed.
All-American Hospital Pharmacy Seminar
An All-American Hospital Pharmacy Seminar was held on October 23, 1971 at the Friendship International Hotel in Baltimore. The seminar was attended by nearly 200 pharmacists from the District of Columbia and Mary- land areas. The seminar was presented by Eli Lilly and Company in cooperation with the District of Columbia Society of Hospital Pharmacists and the Maryland So- ciety of Hospital Pharmacists.
Mary Connelly, president of the Maryland Society of Hospital Pharmacists, gave the opening remarks. Loren
14 THE MARYLAND PHARMACIST
Platte of the Professional Relations Department of Eli — Lilly introduced the panelists.
The program included: “The Shape of Things to Come” — by Dr. Glen J. Sperandio, Professor and Head of the De- — partment of Clinical Pharmacy, Purdue University; “A Response to the Challenge” by John A. Oliver, Clinical Pharmacy Practitioner and Educator, San Diego, Cali- © fornia; “Drug Interactions” by Dr. Edward A. Harts- — horn, Director of Pharmacy Service, Evanston Hospital Association, Evanston, Illinois; ‘The Impact of Unit Dose on Drug Distribution” by Carl B. Burnside, Head, Tech- nical Services, Equipment Sales, Elanco Products Com- — pany, Indianapolis; and the dinner speech, “You Are the — Master of Your Future” was given by Martin S. Ulan, Vice President, Hackensack Hospital, Hackensack, New Jersey. .
ASHP Council Meets
The American Society of Hospital Pharmacists held a three day meeting of its Council on Organizational Affairs at ASHP headquarters on October 4, 5 and 6, 1971. The meeting which was attended by council mem- ber Robert E. Snyder of Baltimore consisted of a two day conference and a one day retreat on clinical problems at
which all ASHP councils participated.
One of the main objectives accomplished at the council meeting was a reorganization of the affiliated — state chapters arrangement.
American Medical Association Contracts
For ASHP’s Computer Drug Code
The American Medical Association has recognized the outstanding utility and versatility of the Drug Prod- ucts Information File (DPIF) in the recent signing of a two-year contract for its use. According to the terms of the contract, ASHP’s computer code of information on drug products will be employed in revising each chapter of AMA Drug Evaluations. With data on over 20,000 drug products and their packages, DPIF will provide in- formation on dosage forms, routes of administration, strengths, packages, etc., for incorporation into the AMA book.
The AMA utilizes an IBM 360/Model 50 computer at its headquarters in Chicago. About fifteen researchers, five systems analysts and fifteen programmers work on various AMA computer-related projects.
More than 40 hospitals in the United States, Canada and Israel now utilize ASHP’s Drug Products Information File in a wide range of computer systems including in- ventory control, patient billing, cost analysis, preparation of drug lists and abridged formularies, and maintenance of records on controlled drugs.
NOVEMBER 197!
In 1970, Roche Laboratories broke with pharmaceutical industry tradition by being the first company to discontinue mass, unsolicited sampling of professional products. The Roche aim is to ensure the greatest benefit to the patient while meeting the professional needs
of the pharmacist and physician. All are served best by proper handling of drugs. Better control of all aspects of drug distribution ensures the highest standards of health care for the patient, physician and community.
This policy reflects Roche interest in the general problems of pharmacy management, as well as the pharmacist-doctor, pharmacist-patient and pharmacist-community relations. There are many of your colleagues at Roche—practical profes- sionals in various management positions— ho help make the policies and provide the services
ROCHE LABORATORIES Division of Hoffmann-La Roche Inc. Nutley, New Jersey 07110
Baltimore Metropolitan Pharmaceutical Association
Baltimore Metropolitan Pharmaceutical Association Meeting of October 21, 1971
The Baltimore Metropolitan Pharmaceutical Asso- ciation held a general meeting at the Kelley Memorial Building in Baltimore on October 21, 1971 at 8:30 p.m.
The meeting began with a presentation on antibiotic therapy by Paul V. Niznik of the Eli Lilly Company. This was followed by a panel discussion on “Prescription Insurance Programs—New and Old” moderated by Mor- ris Bookoff, Maryland Delegate to the National Phar- macy Insurance Council. (Note: Mr. Bookoff’s presenta- tion is published on page 18 of this issue).
Other participating panelists were Stuart L. Ballti- more, Jr., Manager of Pharmacy Relations, Maryland Blue Cross and Robert E. Snyder, Pharmacy Consultant, Prescription Drugs, Inc. A business meeting followed.
Presentation Made to Camp Glyndon
Photo by Paramount Photo Service
Irvin Kamenetz, President, Baltimore Metropolitan Phar- maceutical Association, presents check to Dr. A. A. Silver (left), Medical Director, Camp Glyndon Camp for Dia- betic Children. More than $3300 was collected through pharmacies in the Baltimore area to help rebuild the vandalized facility.
16 THE MARYLAND PHARMACIST
BMPA Meeting
Founded
: : BN Photo by Paramount Photo Service Left to right: Melvin Rubin, Program Chairman; Paul V. Niznik, Eli Lilly Company; Stuart L. Baltimore, Jr., Manager of Pharmacy Relations, Blue Cross; Irvin Kamenetz, President, Baltimore Metro- politan Pharmaceutical Association; and Morris Bookoff, Moderator. Robert E. Snyder, Pharmacy Consultant to Prescription Drugs, Inc., and panelist, not photographed.
MPhA To Serve As Clearing House In Third-party Drug Program
The Maryland Pharmaceutical Association will serve as a clearinghouse for the prescription program for sales and office employees of the Esskay (Schluderberg-Kurdle Co., Inc.), a group representing about 400 families. The plan will be served through all pharmacies as a result of
efforts of the MPhA office.
MPhA is currently engaged in efforts to set up the machinery for an operation under pharmacy auspices to serve as a clearing house for all third-party drug pro- grams. This work is proceeding under Morris Bookoff, Chairman of MPhA’s Prescription Insurance Plans Com- mittee.
The objectives are to have pharmacy input into ev- ery aspect of third-party payment systems that affect the profession and develop a unified, disciplined posture vis- a-vis sponsors and administrators of these programs. Under consideration to implement these goals is the estab- lishment of a nonprofit corporation which will be com- posed of participating pharmacists.
NOVEMBER 1971
| ;
BR 7;
ed eeere o” 2 %%e 2” ,0%%e e
.s ° Pa eee Sits ees
COMPANY ! : d BALTIMORE + DOVER » NORFOLK +» WASHINGTON ww : ‘ ° t? AS. \ \ iD es
Vy
3 o phen eer a $ e @ e an taeians a i Dea Pe | t: 3 A wt : t emee x Geom. . §& :¢ 9 $ we fS2 AY FFE E PE ry $ : fins egy { me } fogs ENGEL NA cee 2
Third-Party Prescription Programs--Delight or Dilemma
by Morris Bootkoff, Maryland Delegate to the National Pharmacy Insurance Council
Based on presentations at the annual meeting of the American College of Apothecaries, Coc- keysville, Maryland held on October 3, 1971 and at the meeling of the Baltimore Metropoli- tan Pharmaceutical Association on October 21,
1971
Prior to 1968 third-party programs were of little magnitude, and in most states they were present only in the form of Medicaid or state welfare programs. Pharma- cists, of course, being noted for their philanthropy and public spirit mindfulness were asked, in most instances, to subsidize these programs through the payment of fees below prevailing rates, and in many states this situation still persists.
Since 1968, however, it’s been a new ball game. Here in Maryland, pharmacists, in addition to participat- ing in state programs, are also serving the “Blues,” union prescription plans, PAID, Prescription Drugs, Inc., Medi- Met and Champus. And _ those pharmacies near Wash- ington serve even more!
Unfortunately, when third-party programs became a fact, pharmacy was unprepared. Policy was dictated to us. \7e found ourselves faced with a different form, a dif- ferent fee and a different basis for computing cost with each developing program.
Initial forms were so poorly designed that the first task of the Maryland committee was to redesign them so that someone other than a Ph.D. in computer technology could complete one. With this accomplished, we sought to broaden the use of plastic I.D. cards and imprinters. Blue Cross cooperated by allowing pharmacies to use their imprinters for state Medicaid Rx’s. Of even greater importance is the work being done by the National Phar- macy Insurance Council in the development of a standard claim form and a single I.D. number for each pharmacy.
Fees . . . How are they determined? Oh! That formula is very simple. It was devised by a clever third- party administrator and goes like this: current state Medi- caid fees plus ten cents equals a happy pharmacist, de- lighted to make an extra dime . . . That’s his opinion! I guess this is where our philanthropy has finally caught up with us.
A recent survey of Rx fees for private patients in Maryland revealed an average fee of $2.25. However, the third-party fees average only $1.85. Are these third-party fees realistic when one considers the additional time in- volved in filling out forms and the delays in payment by these programs?
In the light of this, shouldn’t third-party fees be greater rather than less than regular fees? Take the problem of a different basis for computing cost of in- gredients. Why should someone in Detroit with no knowl- edge of pharmacy operations, make the decision that ac- quisition cost should be used to compute cost when nor-
18 THE MARYLAND PHARMACIST
mally we use wholesale cost. Let’s be realistic. What is acquisition cost? Is that the cost to the door or the cost to the Rx counter? For those who warehouse, is it the cost to the warehouse, or is it the cost to the store? It just doesn’t make sense to purchase drugs in quantity only to pass the savings on to General Motors, Chrysler, Ford, etc. Would they sell me my delivery vehicles at acquisi- tion cost plus a fee determined by me? Why is it that under the Noerr Doctrine, pharmaceutical associations may negotiate and discuss fees with federal, state and local governments; but we must petition the government to negotiate with other third parties? Isn’t it ironic that we cannot negotiate, but that those who are receiving the benefits of our services negotiate for these very benefits?
I refer to the N.A.R.D. bill—a proposed measure entitled the “Prepaid Prescription Negotiation Act.” It would permit negotiation of reimbursement and details of program operation. The interim guidelines proposed to the Federal Trade Commission and Justice Department would allow representative pharmacy groups to give third- party program administrators information on operational costs of retail pharmacies, costs incurred in dispensing prescription drugs and costs related to professional serv- ices performed by pharmacists. These guidelines, how- ever, will not permit any pharmacy group to enter into any binding agreements. Nor may the advisory groups engage in any boycott activity relating to a proposed or existing third-party program. In my opinion, this will accomplish very little.
In Maryland I have met informally with third-party administrators and sponsors on a one-to-one basis and, in fact, have done exactly what the guidelines suggest. Will the administrators or sponsors be any more recep- tive just because a committee of three or four is involved? I would like to think so, but I highly doubt it. Without some of the tools used by others who bargain collectively, I feel our efforts will be in vain.
Let me address myself to the area which concerns me the most, and | hope everyone here agrees. That is, the failure of these programs to establish guidelines as to what constitutes proper pharmacy service. I quote Dr. Donald Rucker, Senior Health Analyst, Social Security Administration, ‘The goal of a large third-party program (should be) to develop an objective basis for calculating the economic value of dispensing services.”' I say that the goal of a large third-party program should be to be certain that the recipients of service get proper pharmacy care—then, to worry about cost. Mr. Administrator, don’t force those pharmacies which have sought to improve the quality of pharmacy care to return to the dark ages. Don’t make us abandon the use of patient record cards and the ability to find drug interactions. Just two weeks ago my associate discovered a patient on Coumadin being given a prescription for Butazolidin. Should this patient now be
' American Druggist, August 9, 1971
NOVEMBER !971
among the dead because administrators who are totally ignorant of their impact determine that patient record ecards are a nonreimbursable service?
Many of us feel that prscription delivery is vital to proper pharmacy service. Just last week someone called and didn’t ask if we deliver but how soon we could de- liver since the patient was hemorrhaging. Should the patient bleed to death because administrators don’t recog- nize delivery as being important to good pharmacy care?
Again, let me quote Dr. Rucker, “Delivery is an- other matter which will have to be determined. Should this be included as a necessary operating cost?’ * Recent- ly, the state of Maryland budgeted $2,000,000 to provide for transportation of indigents to physicians and_hos- pitals yet no reimbursement is budgeted for pharmacists who provide delivery service.
Let me briefly mention some services not generally recognized by administrators:
(1) Compounding—Do third-party programs have adequate fees for compounding? Is it any wonder that some pharmacies refuse to fill these prescriptions, causing great inconvenience to the patients.
(2) Twenty-four hour emergency service — Shall those of us who provide this type of service discontinue at?
(3) Unit dose—With all the cry about the care of the aged, does our state recognize this method of pre- scription delivery system. Yes, but the payment is the same: no payment for packaging and no payment for
*F.D.C, Report, August 9, 1971
extra cost of dispensing. How archaic can a system be when it stifles improvement?
(4) Patient record cards—I just can’t over empha- size its importance. The responsibility of pharmacy to the public concerning drug and medication control and dis- semination of drug information demands an adequate pharmaceutical record system. A pharmaceutical record system serves as positive proof of the willingness of a pharmacist to accept additional responsibilities concern- ing patient health care.
(5) Continuing education—Shall those who strive to keep abreast of the times be treated as those who mere- ly go through the motions?
(6) Delivery And I’m sure you can add even more.
Obviously, the need is great to develop guidelines for pharmacy service and the establishment of dual or variable fees so that those pharmacies providing some of the vital services that I have mentioned are properly compensated.
It is relatively easy for us to overlook unjust fees when they represent such a small portion of our volume. But if current predictions on the growth of third-party programs are correct and certainly if a national health insurance bill is passed, this will not be the case. There- fore, Mr. Administrator, don’t let pharmacy be subject to criticism for failing to give proper care when our hands have been tied. Let us work together to establish guide- lines in order that we may have control of our future and so that we may give to the American public the type of pharmacy service to which it is entitled.
Offering Independent Pharmacies...
Top Discounts off of Traditional “list” prices ASTRO advertising-merchandising program CAL-SERV rack service
Full line service. The slow-moving as well as the fast-selling products.
Plus many other servies—all of which add up to making your best source of supply,
NOVEMBER 1971!
THE
CALVERT DRUG COMPANY, INC. 901 Curtain Avenue Baltimore, Maryland 21218
Phone 467-2780
THE MARYLAND PHARMACIST 19
You know the fellow up front — he’s your CIBA Representative. But what about the hundreds be- hind the scenes whom you never see? What con- nection do they have with you? You'd probably be surprised. No less than four CIBA departments are charged with servicing the pharmacist. For example:
Customer Service sees to it that your orders are processed within 24 hours. They also manage your account, credit your returns, resolve your com- plaints.
Do you ever come up against a difficult question from a doctor concerning the use of a CIBA prod- uct? If so, and you need help, write to Medical Com- munications. Several knowledgeable staff physi- cians stand ready to answer your inquiries promptly and thoroughly.
Or how about the problems you confront in your profession? Compatibility. Stability. Quality. Bio- availability. These are always of serious concern among pharmacists, especially when an unex- pected reaction occurs. If ever a CIBA product is
involved, Pharmacy Research usually has an ex- planation, for it is their responsibility to check and recheck all of our products during the develop- mental stage so that we can anticipate how our medications will react under almost any conditions.
Professional Relations serves as your personal liai- son with CIBA’s “home office.” It is this department that coordinates the policies and procedures that affect you. For instance, policies for return goods, disaster assistance, expiration dating, and product identification drug codes all originate in Profes- sional Relations. Members of this department also represent CIBA at many local and national meet- ings, so stop by and discuss anything that’s on your mind. They’re at your disposal.
There certainly is a lot more to CIBA than meets the eye — when you look a little deeper. 27 466s
CIBA Pharmaceutical Company Division of CIBA-GEIGY Corporation Summit, New Jersey 07901
Carbs
Ne, a
First Maryland Health Care
Corporation to Coordinate HMO’s
The First Maryland Health Care Corporation, a Baltimore non-profit organization affiliated with the City Health Department, has been funded with a $98,880 planning grant from the U.S. Office of Economic Oppor- tunity.
Incorporated early in the year, this new organization is now in the process of designing health maintenance organizations (HMOs) to offer prepaid family health care packages to potentially as many as 200,000 Balti- moreans in the northwest and west sections of the city. Over the next two years First Maryland anticipates an additional two to three million dollars in OEO funds to help pay for health services. When completely organized, this non-profit health agency will coordinate a network of consumers, interested physicians, medical groups, hos- pitals, neighborhood health centers and community health councils.
The First Maryland Health Care Corporation will be one of 11 model HMOs funded through OKO to carry President Nixon’s national health strategy to inner city residents. Dr. Robert M. Vidaver, former director of edu- cation in the Maryland State Department of Health and Mental Hygiene, is the agency’s first president. Health maintenance organizations are a new direction in health care. HMOs under First Maryland would provide total health care services from neighborhood centers for a single monthly premium. Subscribers and their partici- pating family members could have any number of doc- tors’ visits, consultations or days if general hospital care. Two HMOs are operating now in the First Maryland area: one is sponsored by the West Baltimore Communi- ty Corporation and the other by Provident Hospital.
City Health Department studies indicate large num- bers of Baltimoreans go without ordinary medical care simply because there are no physicians nearby. Fifteen of the city’s census tracts are without a single primary care physician. Many more are woefully understaffed. In search of solutions, Dr. John B. DeHoff, Deputy Commis- sioner of Health, was assigned the job of implementing a pilot Baltimore HMO having particular concern for inner city people. First Maryland, which is patterned after the academic health manpower organization, the Maryland Consortorium for the Health Sciences, grew out of this effort. Representatives of the Sinai, Provident, Lutheran and Bon Secours hospitals, the Provident OEO and West Baltimore neighborhood care centers, the Gar-Wyn Medi- cal Group, the Baltimore City Medical Society and the Northwest Community Organization have joined with City Health Department physicians Dr. James D. Carr, Dr. Jimmie L. Rhyne, and Dr. DeHoff in the corpora- tion. To be sure First Maryland’s consumers get the services they need, its guiding Board of Trustees includes one-half consumers, two-thirds of whom are poor people.
The First Maryland Health Care Corporation, like other health maintenance organizations, seeks to develop group practice alternatives to the time-honored solo prac- titioner, fee-for-service medicine. Rising costs, doctor shortages and crowded emergency rooms are adding im- petus to HMO formation, the more so since Mr. Nixon’s February “Health Message” endorsement.
NOVEMBER 1971
University of Maryland School of Pharmacy
William J. Kinnard, Jr., Ph.D., dean of the School of Pharmacy, University of Maryland at Baltimore, has announced new faculty appointments.
Laurence H. Hurley, Ph.D., has been appointed assistant professor of pharmacognosy. Herbert Kushner, M.D. has been appointed assistant professor of pharmacy. Dr. Kushner is presently assistant professor of medicine at the University of Maryland School of Medicine and will be responsible for coordinating the therapeutics course given to senior students in the School of Pharmacy. He will also serve as consultant in the clinical pharmacy program which is run by the School of Pharmacy and
the University of Maryland Hospital.
Also appointed to the clinical pharmacy staff, serv- ing jointly with the School of Pharmacy and the Univer- sity of Maryland Hospital, is Robert A. Kerr, Pharm. D. John F. Fader, Il has been appointed lecturer in_phar- macy administration. Mr. Robert J. Michocki and Mr. J. Kenneth Walters, both B.S. in pharmacy graduates from the University of Maryland in 1971, have been appointed associates in pharmacy, serving the School of Pharmacy and University Hospital in the area of clinical pharmacy. Mrs. Karen T. Collins has been appointed clinical asso- ciate in pharmacology and toxicology. Mrs. Collins has been poison control officer in the Poison Information Center located at the School of Pharmacy.
Mr. William J. Edmondson has been appointed co- ordinator of the professional experience program and associate in the department of pharmacy. Mr. Edmond- son, who will coordinate the school’s educational program with the clinical instructors in community and hospital pharmacy, will be teaching the pharmacy students dur- ing the professional part of their education.
Alabama Trains Preceptors
Effective August 1, 1971, all pharmacists who have been approved by the Alabama State Board of Pharmacy as preceptors must attend a training seminar for precep- tors at least once every two years. Such training seminar shall have prior approval of the board.
Headquarters for
PHOTO-OFFSET PRINTING MAILING PRINTING ROBOTYPED LETTERS
call — MUlberry 5-3232, 33, 34
D. STUART WEBB
Advertising Services, Inc. 306 N. GAY STREET Baltimore, Maryland 21202
THE MARYLAND PHARMACIST 21
J.T. Baker Signs Agreement With Hadassah
The J. T. Baker Chemical Company, division of Richardson-Merrell Inc., has signed a formal agreement with Hadassah for the rights to a cancer diagnostic test developed at the Hadassah Hebrew University Medical Center in Jerusalem. Announcement of the signing of the agreement was made by A. L. Baldock, President of J. T. Baker and Mrs. Max Schenk, President of Hadas- sah, the Women’s Zionist Organization of America. Mr. Baldock emphasized that development of this test for use in the United States will be prolonged and that it is not possible to predict what its commercial significance will be to Baker.
The evaluation program for this diagnostic test known as the T-globulin test, will be carried on jointly by the scientific staffs of J. T. Baker and Merrell-Na- tional Laboratories Division of Richardson-Merrell Inc. These chemical and pharmaceutical divisions of Richard- son-Merrell Inc. bring together a combination of the skills necessary to perfect the test.
The test, developed by Dr. Chloe Tal, an immunolo- gist at the Hadassah Hebrew University Medical Center in Jerusalem, shows promise for the early detection of cancer.
Joseph G. King Elected President of The American College of Apothecaries — College Adopts Single Resolution
At the 31st Annual Convention in Hunt Valley (Baltimore), Maryland, October 1-4, the following off- cers were elected and installed: Joseph G. King, Chatta- nooga, Tennessee, President; Casimir H. Srutwa, Scotts- dale, Arizona, President-Elect: Lynn H. Cook, Flint, Michigan, Vice President and Minter B. Ralston, Jr.., Weston, West Virginia, Treasurer. M. Donald Pritchard, Buffalo, New York is the new Chairman of the Board of
Directors.
For only the second time in its history, the ACA concerned itself with a single resolution. The resolution follows:
WHEREAS the hiking of minimum orders for di- rect purchasing to unrealistic levels is prejudicial to the best interests of the independent community pharmacist and is discriminatory to those Pharmacy practitioners who operate single pharmacies; and
WHEREAS unrealistically high minimum orders preclude the individual pharmacy owner from competing with the multiple pharmacy operator in today’s highly competitive market-place;
BE IT RESOLVED that the American College of Apothecaries in convention assembled urge Pharma- ceutical Manufacturers to review these policies in order that minimum direct orders may achieve a more realistic level.
22 THE MARYLAND PHARMACIST
Representing
EMPLOYED PHARMACISTS P.O. BOX NO. 2322 ROCKVILLE, MARYLAND 20852
Pension & Investment Associates of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships)
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
$$ —_—_ooOoOoOO LL eeeseSSSsSSseSs en
NOVEMBER 1971]
odd orders processed, naturally
The oddball customer who insists he wants a print cropped “just this way.”
The man who wants cut film developed, or some positive film strips. The guy who hands your clerk an unheard-of cartridge of film.
Welcome them. They all mean good business.
Just drop the oddball order into the Berkey bag. We'll process it with the
same professional skill, care, and dispatch we apply to all our D and P work. Berkey’s special facilities and broad experience gives us a distinct edge in processing every kind of film. From unfamiliar foreign films to Ultra-miniatures in color
and black-and-white, right up to 16 x 20 black-and-white blowups.
We’re ready to service all your needs. Berkey does things for
you that no one else does . . . because no one else can.
Berkey
Film Processing
of Washington, D.C. 3701 Mt. Vernon Avenue Alexandria, Virginia 22305
Balvision OF 703) 549-7500 Al ‘ need wg
PMA Announces New ‘Starter’ Research Grants
The Pharmaceutical Manufacturers Association Foundation announced a new program of “starter” re- search grants aimed at helping young college investiga- tors to develop their independent research capabilities.
Foundation President C. Joseph Stetler said the Foundation will make approximately 15 two-year grants of $5,000 a year. Research fields covered by the pro- gram are pharmacology, clinical pharmacology, and drug toxicology.
“The purpose of the Research Starter Grant Program is to provide financial support to young investigators who need initial funding,” Stetler said.
Funds generally will be unrestricted, except the grant cannot be used for salary support and no more than $500 can be used for travel.
Information describing the grant program has been mailed to colleges and universities throughout the coun- try. Grants will be made to the institution on behalf of the applicant.
Those holding academic rank through assistant pro- fessor and investigators at the doctoral level with equiva- lent positions are eligible to apply for starter grants, pro- vided their proposed research is neither directly nor in- directly subsidized to any significant degree by extramural support. Applicants will be judged on the merits of the proposed research and the degree of need by the investi- gator.
The deadline for awards beginning January 1, 1972, is January 1, 1972, is October 15, 1971.
Recipients will be selected by the Foundation’s Board of Directors, based on recommendations from its Scientific Advisory Committee.
Alabama Becomes 18th State To Affiliate With APhA
The Alabama Pharmaceutical Association became the 18th state pharmaceutical association to vote to affiliate with APhA since 1962 and the second to do so this year. Almost two out of every three pharmacists reside or practice in states affiliated with APhA.
Other states that have affiliated with APhA are: California, Delaware, Florida, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland, Michigan, New Jersey, Ohio, Pennsylvania, South Carolina, Texas. Virginia and Wisconsin.
APhA Is Clearinghouse For Wage-Price
Questions
In cooperation with the Office of Emergency Pre- paredness, APhA will serve as a clearinghouse for ques- tions from pharmacists regarding President Nixon’s 90- day wage and price freeze.
Under this arrangement, questions submitted to APhA by pharmacists and state pharmaceutical associa- tions will be compiled and submitted to OEP. Questions requiring policy determination will be submitted to the Cost of Living Council by OEP. OEP will respond to APhA in writing and answers will be disseminated to state pharmaceutical associations and published in the APhA Newsletter, as appropriate.
Mangini can tell you what you have.
Within 1%
Many pharmacists often esti- mate their inventory by relat- ing purchases to sales
In today’s competitive climate and with the cost of merchan- dise continuously rising, these estimated gross profit figures
Mangini & Associates, Inc.
4850 W. Belmont Ave. Chicago, III 60641/(312) 282-8181
ROFESS)\ONA A SERV us
can be misleading. In fact, this can be extremely costly to the pharmacist who, un- aware of his shrinking inven- tory and gross profits, ts actually paying a higher in- come tax than he should
So why guess? Call Mangini for fast, computerized inven- tory service that will tell you within 1% how your inventory realistically stacks up to your turnover, sales and profits!
WRITE FOR DETAILED INFORMATION. ihSaEREE!
11722 Studt St, St Louis, Mo 63141 2760 W. Market St, Akron, Ohio 44313 575 Savin Ave , West Haven, Conn. 06516 5501 Cherokee Ave . Alexandria, Va. 22312
FRIENDLY RELIABLE.
WINNING LOYAL CUSTOMERS
24 THE MARYLAND PHARMACIST
NOVEMBER 197!
a ee
———— ee eee ee
_ _.. Reading IS Still the fastest way
to program the man
h brai
)
\
In an era of “information explosion,” how do you “pro- gram” information to the human brain? Spoken lang- vage is far too slow. The average person speaks about 150 words per minute. Fast readers can read up to 1,500 words a minute—ten times the average rate for the spoken word. Perhaps this is why millions of people regularly purchase from pharmacies, magazines, paper- backs, comics and newspapers from insight and enjoy- iment.
Maryland News Company is proud to be your area’s prime source of fine reading material. We keep pace with consumers’ reading pleasure by constantly supply- ing your racks with current reading material that sells.
For every $100 invested in paperbacks and magazines, you can expect a return of $127 within thirty (30) days of the initial outlay. Unsold copies are returnable for full credit. For more information please call 233-4545.
MARYLAND NEWS COMPANY
1621 COLE STREET — BALTIMORE, MD. 21223 Telephone: 233-4545
Obituaries
Henry J. August
Henry J. August, 61, died sudden- ly on October 25 at Thurmont, Mary- land where, for the past 15 years, he had been proprietor of the only town pharmacy. He was a 1933 graduate of the University of Maryland School of Pharmacy and former proprietor of Medford Pharmacy on Eastern Ave- nue.
A member of the Maryland Phar- maceutical Association, Mr. August is survived by his widow Mary, son, Henry J., Jr., and two brothers and two sisters.
Joseph P. Marmor
Joseph P. Marmor, 70, died at the Veteran’s Administration Hospital at Perry Point, Md. on October 16. A former life member of the Maryland Pharmaceutical Association, Mr. Mar- mor was proprietor of the Modern Pharmacy in Frederick for 27 years until his retirement in 1965.
Samuel A. Romanoff
Samuel A. Romanoff, 74, former proprietor of Ruxton Pharmacy, died on October 13, 1971 at Fort Lauder- dale, Florida.
Grant Downs, Jr.
Grant Downs, Jr., 62, 1933 grad- uate of the University of Maryland,
School of Pharmacy died at Montgom- ery, Alabama on October 24, 1971.
Naney K. Crozier
Nancy K. Crozier, 71, died on Octo- ber 21, 1971 after a long illness. She was the wife of John A. Crozier, for- mer general manager of Calvert Drug Company. Mrs. Crozier was a member of the Ladies Auxiliary of the Mary- land Pharmaceutical Association.
STATE PHARMACEUTICAL DIRECTORY
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association
RANA sdeicnsadooodec Stephen Hospodavis VicesPrestdent pinata. tn aes James Ritchie Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association
Presid ent@ewcts dy foes cee Irvin Kamenetz President. Elects jesse Joseph U. Dorsch Tyeasirer cae. Come ee Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille
Secretary and Executive Director
Nathan I. Gruz
Eastern Shore Pharmaceutical Society
President’ at. 2 2 Po ee Gordon Harrison First Vice President....... William P. Smith Second Vice President....... William Connor SECTELATY Se rAL Bat yes eee ae Carl R. June Tfeasiiner2 a eke ee ees Thomas Payne
Prince Georges-Montgomery County Pharmaceutical Association
Presidente lng 6 ee Martin Hauer First Vice President....Edward D. Nussbaum Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz DSOCTCLOsY: buds Sean ee ee ie Paul Reznek
Ae oe ae A Michael Leonard
Honorary President .......... Samuel Morris
Treasurer
Washington County Pharmaceutical Association
eee ee Samuel E. Weisbecker
Vicer President eee eee Joseph Davies sats Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter
PG OIG McG Paul R. Webster Vices Presidenta eee Stephen B. Bierer SECTELETY Foe ieee Donna S. Levin Treastirers. hearers Dennis R. Reaver
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association President
MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE Communications Secretary MRS. RICHARD R. CRANE Treasurer MRS. CHARLES S. AUSTIN
Membership Treasurer MRS. MANUEL B. WAGNER
TAMPA — Traveler’s Auxiliary of The Maryland Pharmaceutical Association President PAUL J. MAHONEY First Vice President JOHN C. MATHENY Second Vice President ABRIAN E. BLOOM Third Vice President C. WILSON SPILKER Secretary-T reasurer WILLIAM A. POKORNY WILLIAM L. NELSON Assistant Secretary-Treasurer Honorary President JOSEPH GRUBB
Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER Secretary DOLORES A. ICHNIOWSKI Treasurer
THOMAS E. PATRICK
University of Marviand School of Pharmacy
Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
Metropolitan Guild of Pharmacists President
JOHN McKIRGAN Vice President FRANK FRARY Secretary LARRY JACOBSON Treasurer
EDWARD WILLIAMS
eee
Drug Strike Force Set for Baltimore A federal grant of $201,540. made by the Law En-
forcement Assistance Administration, has been received by the City of Baltimore for purposes of funding a spe- cial narcotics strike force that will operate out of the state’s attorney’s office. The strike force will be com- prised of seven prosecutors, seven investigators and four
26
torney.
THE MARYLAND PHARMACIST
administrative and clerical personnel and will be headed by Lt. Stephen Tabeling, a veteran detective in the police department, and Peter D. Ward, an assistant state’s at-
The strike force will aim at three basic targets: the source of narcotics, the drug pusher, and the basic net- work that supports narcotics and drug traffic.
NOVEMBER 197]
Thantis, the reliable throat lozenge.
The THANTIS DISPENSER, containing a roll of 25 individually foil-wrapped lozenges, is attractively packaged — 6 dispensers in a fold-up counter display. The packaging is right! The profit is good! The time to purchase Thantis is now!
(#740/171)
HYNSON, WESTCOTT & DUNNING, INC. Baltimore, Maryland 21201
The Maryland Pharmaceutical Association
Presents
_ MEXICAN FUN FEST
and Convention Round-Up in Acapulco
6 FANTASTIC DAYS! 5 FUN-FILLED NITES!
WEDNESDAY thru MONDAY, MAY 17 thru 22, 1972
®Non-stop round trip jet flight via Eastern Airlines Deluxe Trip with OPEN FREE BAR and deluxe meal during flight.
®Deluxe twin bedded accommodation with private Nal bath at the Super Deluxe PIERRE MARQUIS Hotel and Golf Club on Acapulco’s famous REVOLCADERO \Ni\ BEACH — 2 blocks long and one block wide, with NO i the surf from the Pacific constantly rolling in.
® Transportation and transfers to and from hotel to Q airport and porterage. (Hotel only 5 minutes from 1 airport).
ES! Course Breakfasts; Gourmet Dinners with
LAN dancing nitely from your ringside dinner table
v until the wee hours for FREE in the exotic Tabochin ~ Dining Room.
SOL ®Cocktail Party plus
Many Surprises!
1 @ALL Taxes and REG. *800°° OV ° Gratuities Paid In Full S .00 ALL FOR ONLY... BOe
Leave Friendship Airport, 8 A.M. PER COUPLE! Wednesday, May 17th — Arrive Plus $39.00 Tax and Gratuities Acapulco 12:30 P.M. oct Cette ae | (10:30 A.M. Their Time)
Leave Acapulco Airport, 4 P.M. Monday, May 22nd — Arrive Baltimore 10:30 P.M. (Checkeut Time: 3 P.M.) Educational Sessions Daily
* EARLY BUY PRICE!
Reservations on this fabulous trip can be confirmed only upon receipt of $50.00
deposit per couple. All monies refundable in full until April 17th, 1972, after which date refunds are subject to resale of the reservations.
CHECKS MADE PAYABLE AND MAILED TO:
MARYLAND PHARMACEUTICAL ASSOCIATION 650 W. LOMBARD ST., BALTO., MD. 21201 - Phone 727-0746
maryland
ASSOCIATION
= pharmacist
Editorial-A Revolutionary Decade: 1961-71
ls A Congress of American Pharmacy Needed?
Annual Report of the Maryland Board of Pharmacy
Summary of Minutes of MPhA Board of Trustees Meetings
EY olume. 47. DECEMBER 1971 Number 12
Compliments of
oxell
CORPORATION
NOXZEMA SKIN CREAMS
Makers of
NOXZEMA SHAVE CREAMS COVER GIRL PRODUCTS
and
THERA-BLEM
11050 York Road
Baltimore, Maryland 21203
NTNISININTNININININAAININNINININATNTSIAINININTSISIN NINININISTSTSININININININININY AINTSPSISINTNINTNAININTNTS INININININISISINININININTSINININT SINISINTSININISININT STS] NINTNTNINININ TSAI ST SINININININ] SISNISINININININIVIAAS SINTISINTININTISNININININNINININTNINAININTINININININIAINN] REBRERNANNERRERNSRARERARERRERERED DIDSDIDSDSISINN DDD RDINDISPDPDDPPDDAISDDD DI NAISRIAAINAANBSARERRANBSSRERBISNIINAING NSSISINISISRANISNISISINSINISISBININISINAANISISISSS SNEENSESNEERSERSSRSNSENESSENS RERARSRERNSERNRANEEERERNENENERN SN NSE SE SS RENNER ENNENENENSES NNRENSERSSESSSSEREBSERINRRRERIRBSRAERA
SEESESESSE SRE EERESERERSESESES
RRRRERERRRERERRRERRRRRRRRBRRE CRNAARBRERANINAEIRNSBISRBREERRARIRINBSBEEY NAAAAIRNENARAAININAABAIRAINAESIABRIAAIGGBRBI SNARE ARIRRININNINININNBABNB] AARBRRARBERRERAISSIRRIRARISSINGRISBERBY TREE RRIRERIRISRAERNANISBSSI NENENNEENSSSESREENSNERERESNAYS NINSISSISRISRIANIAINGISAISRSIRARERBSIRBSIRISESANI RSNNSRER SNS SESE SSNS SNS SSERISBRERERAGSEASSISEISSEBIAENESEA me RRRERERRARRRERARRERECRERARE
: mle ee Checks
i ae 809. were ai it soit be made.
When you fill a prescription with a Lilly product, you can rest assured
Lilly
Eli Lilly and Company Indianapolis, Indiana 46206
uar- tion
finer is available. For example, one Lilly product undergoes 808 excipients, stability, tablet compression, and decided difference in therapeutic efficacy.
g your professional judgment, consider the consistent, g anteed quality of Lilly products. When it comes to your prescrip
separate quality checks before reaching your pharmacy.
g Absolute control of ‘variables’ is essential. Even minor differences in
patient’s health (and your reputation), you want to dispense the best.
particle size, solubility, other factors can make a
In exercisin
nothin
x
“ January “7 Summer
Merchandise Shows
Gilpin offers continuing programs of merchandis- ing ideas. Highlights include our January mer- chandise shows featuring summer sundries. For Baltimore-Dover-Washington, Sunday, January 23, 1972 through Sunday, January 30, 1972 (continu- ous), at Gilpin’s Baltimore Branch, 7401 Pulaski
An experienced, pharmacy oriented sales force trained to assist you in merchandising and store operations. In addition to their own experience, these men are prepared to immediately draw upon a wealth of experience in every phase of store operations which exist within the Gilpin company now.
A comprehensive and up-to-date convalescent aids program. Professional assistance is available to design a program to meet your space and inventory requirements and train appropriate personnel in your store to make this a profitable department.
A complete sundries program providing sundries departments and inventories designed specifically for your store, with a built-in provision for economical and reliable restocking of your shelves. Along with this, we maintain expanding stocks of new promotional sundries and programs for increasing traffic and sales.
A professional planning and remodeling service within our organization which includes complete service in floor design, fixture and installation. Professional help in site selection, store development and in lease acquisition for desirable sites.
Computerized inventory and billing systems. This modern computerization also makes possible a wide range of additional data services including regular issuance of individual monthly reports of DACA drugs showing quantities and dates on which they were submitted.
BALTIMORE + DOVER + NORFOLK * WASHINGTON
Highway, Baltimore, Maryland; for Tidewater Re- gion, Sunday/Monday, January 30/31, 1972 and Sunday/Monday, February 6/7, 1972 at Gilpin’s Norfolk Branch, 6435 Tidewater Drive, Norfolk, Virginia. Please contact your Gilpin representative or sales manager for details or show appointment.
A financial service consultant to service you on request.
Professional Services Department. A professional services department which provides you with vital assistance in the form of direct services and/or consultation in areas including: Medicare, Medicaid, third party payment programs, pharmaceutical inventory control, federal and state regulations, and many other areas.
Two giant product shows each year: in January featuring summer goods; in July featuring selections of fall and gift merchandise and emphasizing promotional sundries.
An Accounts Receivable program. A computerized system that knows pharmacists. The program handles your charge accounts and gives your customers a monthly statement showing all their deductible medical expenses, both for the current month and for the year to date. It also provides a monthly report on the aging of your accounts in the summary.
Professional advertising and promotional assistance. Our specialists in this area now provide on-going advertising and promotional programs for many of our customers and are available to assist you in this increasingly important area of your operation. With complete stocks and complete lines of merchandise provided with it, we are well qualified to provide
the services required to nail down the profit dollars which you need and deserve from your business.
The Henry B. Gilpin Company 901 Southern Ave., Washington, D.C. 20032 (301) 630-4500
Check the area of your particular interest or need on the coupon below and mail it to us or phone us. We'll arrange for Gilpin specialists to tailor the services which your particular interest or situation requires.
| ERE Ea eS rae ete
Sirs: | am interested in the following programs. Please have your representative contact me in this regard.
Nine ee eee eee Name of Pharmacy > = eee Address SS eee Phone.
City State _—__ Zip
fa eee poems “noone eet hee
Weadeectn gitar ean
The Maryland Pharmacist
NATHAN I. GRUZ, Editor
NorMAnp A. PELIssiER, Assistant Editor Marrua Ecxuorr, Editorial Assistant Ross P. CAMPBELL, News Correspondent HERMAN J. BLtoom, Photographer
650 WEST LOMBARD STREET BALTIMORE, MARYLAND 21201
ASSOCIATION
VOLUME 47
DECEMBER 1971 NUMBER 12
OFFICERS 1971-1972
Honorary President
H. NELSON WARFIELD—Pikesville
* President NATHAN SCHWARTZ—Annapolis
President Elect BERNARD B. LACHMAN—Baltimore
Vice President
JOHN R. McHUGH—Potomac
Treasurer
MORRIS LINDENBAUM 5 Main St., Reisterstown, Md. 21136
Executive Director
NATHAN I. GRUZ 650 W. Lombard St., Baltimore, Md. 21201
TRUSTEES
DONALD O. FEDDER, Chairman—Dundalk MORRIS BOOKOFF (1972)—Baltimore PAUL FREIMAN (1974)—Baltimore
STEPHEN HOSPODAVIS (1972)
Cresaptown PHILIP D. LINDEMAN (1973‘—Berlin ANTHONY G. PADUSSIS (1973)
Baltimore MELVIN J. SOLLOD (1974)—Adelphi SYDNEY L. BURGEE, JR. Speaker of the House of Delegates Baltimore
EX-OFFICIO MEMBERS
FRANCIS S. BALASSONE—Baltimore WILLIAM J. KINNARD, JR.—Baltimore
HONORARY LIFE TRUSTEE SIMON SOLOMON—Baltimore
MARYLAND BOARD OF PHARMACY
Honorary President
SIMON SOLOMON—Baltimore
President NORMAN J. LEVIN—Pikesville
Secretary F. S. BALASSONE—Baltimore
Member FRANK BLOCK—Baltimore
Member HOWARD L. GORDY—Salisbury
Member MORRIS R. YAFFE—Potomac
TABLE OF CONTENTS
6 Editorial—A Revolutionary Decade: 1961-71. Is a Congress of American Pharmacy Needed?
8 Maryland Board of Pharmacy News
10 Summary of Minutes of Board of Trustees Meetings
12. Washington County Pharmaceutical Association
12. University of Maryland School of Pharmacy Alumni Association 16 Annual Report of the Maryland Board of Pharmacy
22 Baltimore Metropolitan Pharmaceutical Association
23 A.Z.O. News
24 Maryland Society of Hospital Pharmacists
26 Obituaries
26 State Pharmaceutical Directory
INDEX TO ADVERTISERS
21 American Druggists’ Insurance Co. 25 Calvert Drug Company, Inc.
13. Geigy Pharmaceuticals
Henry B. Gilpin Company
Eli Lilly and Company
Loewy Drug Company
NW f
Mangini and Associates, Inc.
11 Maryland News Company
25 Metropolitan Guild of Pharmacists
2 Noxell Corporation 27 Paramount Photo Service 25 Pension & Investment Associates of America
14-15 Smith Kline & French Laboratories
21 D. Stuart Webb Advertising Services
9 Youngs Drug Products Corporation
Change of address may be made by sending old address (as it appears on your journal) and new address with zip code number. Allow four weeks for changeover. APhA members—please include APhA number.
The Maryland Pharmacist is published monthly by the Maryland Pharma- ceutical Association, 650 W. Lombard Street, Baltimore, Md. 21201. Subscription price $5.00 a year. Entered as second class matter December 10, 1925, at the Post Office at Baltimore, Maryland, under the Act of March 8, 1879.
Editorial...
A REVOLUTIONARY DECADE: 1961-71
Is A Congress of American Pharmacy Needed?
The completion of a decade as the executive officer of the Maryland Pharmaceutical Association is the occa- sion to look at what has transpired. It has been a revolu- tionary decade for the world, for society, for our nation, for attitudes and practices in the area of health care. So why should we think pharmacy should stand still? Phar- macy like every aspect of society has also undergone radical change.
Upon assuming the executive and editorial posts with MPhA in November 1961, the major issues were maintenance of “Fair Trade,” effects of Kefauver hear- ings (“generic equivalents” and prices of drugs and _pre- scriptions ), APhA-NARD relations, “Medical care’ pro- grams (welfare and for the aged), entrance of food chains into pharmacy, discounting, the “professional fee” concept, outpatient hospital dispensing.
Some of these issues of 1961 have gone from the scene; some are still here but in a drastically changed form. But most important, we believe, is that the attitude of the profession has changed drastically.
Pharmacists today in greatly increasing numbers are reacting as more knowledgeable and sophisticated mem- bers of the health care professions. They are more mili- tant in their approach to the forces which obstruct their legitimate professional and economic aspirations as they seek to fulfill their essential roles in the delivery of health care.
Pharmacists seek to integrate their organizational structure in order to consolidate their limited manpower and financial resources. They recognize that a unified or- ganizational structure must be forged. Once a pharmacist would make a commitment to become part of his volun- lary professional representative democracy network, he would be able to enter it only through a single portal. It would be either all or none.
The form and substance of such a structure could be developed by convening a “Congress of American Phar- macy” with representation from every state.
Such a “C.A.P.”—Congress of American Pharmacy —made up of pharmacist representatives elected by the pharmacists of each state and including representatives of every facet of pharmacy practice and interest, could address itself to the resolution of the competitive and overlaping activities of APhA, NARD, ASHP and ACA. The agenda for American pharmacy can be laid down, the priorities spelled out and organizational roles delineated.
A difficult but not impossible task if pharmacists have but the wisdom and the will. In order for pharma- cists in Maryland to exert leverage, we must increase our voice in the APhA House of Delegates. The enrollment of every MPhA member as an APhA member will grant us the additional delegates. Affiliation with APhA also brings us new MPhA members.
6 THE MARYLAND PHARMACIST
In a decade—perhaps in a half-decade—we could thus mobilize all the elements of the profession of phar- macy into an instrument for maximum utilization of pharmacists as full-time health professionals.
— Nathan I. Gruz
MPhA Esskay Prescription Plan
MPhA is pleased to announce the completion of arrangements to serve as a clearinghouse for the Esskay Company’s Prescription Drug Program. Previously this program for the office and sales employees was limited to one pharmacy chain.
In line with the MPhA commitment to a policy of “free choice of pharmacy” in the prescription practice, all pharmacies will be eligible to participate by complet- ing and returning the required form available from
MPhA. Eligible employees of Esskay (Schluderberg-Kurdle
Company) will present an orange I.D. card which in- cludes the EXPIRATION DATE and deductible amount per prescription of $.50 to be collected by the pharmacist. Coverage includes husband, wife and their children.
All prescription claims will be submitted on the MPhA Rx form, which conforms to the National Phar- macy Insurance Council (NPIC) standard Rx form. The form fits standard imprinting machines. The professional fee or service charge is $1.95 per prescription. The whole- sale price of ingredients is used as a basis for this cost.
Insulin Benefit
Pharmacists may dispense a maximum of four (4) vials of insulin at one time and collect only one deducti- ble. Payment will be the reasonable charge to regular customers.
This MPhA service is a pilot program. In addition, work is progressing with several other prescription in- surance and third-party plans. Consideration is being given for the establishment of a nonprofit foundation under pharmacy auspices to provide for a full adminis- trative and processing capability.
CORRECTION
The editorial in the November 1971 issue, fourth paragraph from the end. should read as follows: “have also exercised initiatives in bringing about.”
DECEMBER 1971
There’s a lot more going for you at LOEWY
reathing Machines :
7 Shc 4 MEDICAL EQUIPMENT FRANCHISE
can make your store one of the most sought out sources for equipment and service in America
As the local Spectro Division in your area, we not only offer the unusual advantages
of one of America’s largest drug wholesaling operations, but those of the country’s most comprehensive medical equipment distributor, producer and servicing organization. As is being demonstrated right now in Spectro markets throughout the eastern seaboard, physical aids for the convalescent, the handicapped and the invalid can be the most significant
new profit source available to the pharmacy today. We are uniquely well endowed to provide you with professional administrative and technical direction, the widest available range of product, application counsel and in-home servicing.
FOR SERVICE AT ITS BEST... BETTER DEAL WITH LOEWY
Call any time, day or night. An automatic order taker will record your after-hours order.
Call IV 5-8105 for order taking. (301) 485-8100 for the office.
LOEWY DRUG COMPANY
th, DIVISION OF 28 Sheclso Industries, Ine.
6801 Quad Avenue, Baltimore, Md. 21206 Tel.: (301) 485-8100
DECEMBER 1971 THE MARYLAND PHARMACIST
Maryland Board of Pharmacy News
BOARD OF PHARMACY REVOKES LICENSES
At hearings held before the Maryland Board of Phar- macy on October 13, 1971, the licenses of Maurice A i Karpa and James W. Poindexter to practice pharmacy in the state of Maryland were revoked.
Mr. Karpa answered charges of having been con- victed of a crime involving the Controlled Dangerous Substances Act and of being guilty of grossly unprofes- sional conduct. Mr. Karpa had been tried in the Circuit Court of Baltimore County. He had been sentenced to pay a fine and to serve a term of six months in the Balti- more County Jail. Sentence was suspended on the condi- tion that Mr. Karpa discontinue the practice of pharmacy and that he not be in any manner interested in or em-
ployed in a pharmacy. He had operated the Donnybrook Pharmacy.
Mr. Poindexter, charged with having been con- victed of a crime by the Criminal Court of Baltimore City involving professional misconduct respecting the pharmacy or drug laws and having been convicted of a crime involving the State Uniform Narcotic Drug Act or the Federal Narcotic Laws, did not appear to testify. He had been convicted of the crimes of false pretense and conspiracy. On the basis of the evidence presented, his license to practice pharmacy in the state of Maryland was revoked. He formerly operated the Sav-On Pharmacy.
Pharmacy Changes
The following are the pharmacy changes for the month of October:
New Pharmacies
Dart Drug Corporation, Waldorf, Herbert H. Haft, President, Route 301, Waldorf, Maryland 20601.
MEMCO Prescription Pharmacy, Wayne H. Fisher. President, 12550 Rockville Pike, Rockville. Maryland 20850.
No Longer Operating As Pharmacies None
Change of Ownership, Address
GEM Pharmacy, Irving Wiggs, President ( Change of Corporate Officers), 3130 Branch Avenue. Suitland, Maryland 20023.
GEM Pharmacy, Irving Wiggs, President (Change of Corporate Officers), 5100 Nicholson, Kensington, Maryland 20795.
GEM Pharmacy, Irving Wiggs, President (Change of Corporate Officers), 6501 Baltimore National Pike, Baltimore, Maryland 21228.
GEM Pharmacy, Irving Wiggs, President (Change of Corporate Officers), 7930 Eastern Boulevard, Balti- more, Maryland 21224,
GEM Pharmacy, Irving Wiggs, President (Change of Corporate Officers), 2421 Chillum Road, Hyattsville, Maryland 20780.
8 THE MARYLAND PHARMACIST
The following are the pharmacy changes for the month of November:
New Pharmacies None
No Longer Operating As Pharmacy
Combs and Neutze Pharmacy, John F. Neutze, 5925 York Road, Baltimore, Maryland 21212.
Change of Ownership, Address
Thurmont Pharmacy, Gordon and Joyce Hair (Change of ownership), 12 East Main Street, Thurmont, Maryland 21788.
Macek’s Pharmacy, Bernard F. Macek, President (Change of name and ownership), 900 South Ellwood Avenue, Baltimore, Maryland 21224.
Finksburg Pharmacy, A. Neuburger and T. Suter (Change of ownership), Finksburg, Maryland 21048.
can be misleading. In fact. this can be extremely costly to the pharmacist who, un- aware of his shrinking inven- tory and gross profits. is actually paying a higher in- Many pharmacists often esti- come tax than he should. mate their inventory by relat- ing purchases to sales
Mangini can tell you what you have.
Within 1%
So why guess? Call Mangini for fast, computerized inven- In today’s competitive climate tory service that will tell you and with the cost of merchan- within 1% how your inventory dise continuously rising, these realistically stacks up to your estimated gross profit figures turnover, sales and profits!
WRITE FOR DETAILED INFORMATION. {T'S FREE!
11722 Studt St., St. Louis, Mo. 63141
es P 2760 W. Market St, Akron, Ohio 44313 Mangini & Associates, Inc. 575 Savin Ave., West Haven, Conn. 06516
4850 W. Belmont Ave. Chicago. Ill. 5501 Cherokee Ave . Alexandria, Va. 22312 60641/(312) 282-8181
DECEMBER 1971
_ Offer Guardian sensitivity to yYOUT customers first
ya Rich. VE ROLLED L
____“
oe ___
<*>
s és é Rich’
|
E ROLLED LATEX PROPHYLACTICS
ditto tesenienn coe HS
EDT,
{, CORLL |
be Bee ey LATEX eee
ATEX oe YLACTICS
..and they’ll never ask for just prophylactics again. They will be sold on the complete sensitivity afforded by these premium prophylactics. They’ll stay sold because Trojan brand Guardians are thin, pre-lubricated and sealed in foil. And you Il be happy because the extra profit in each Guardian makes it an ideal product for you to recommend.
Next time your customer comes in and asks for prophylactics, recommend Guardian, the Trojan brand premium lubricated product from Youngs, the company tuned to today’s pharmacy customers...for tomorrow’s profit.
up Youngs Drug Products Corporation
865 Centennial Ave., Piscataway, N.J. 08854
Summary of Minutes of Board of Trustees Meetings
Li)
~]
September 9, 1971
Communications included letter from Governor’s office in response to letters written by President Schwartz and Mr. Gruz regarding appointment of MPhA representatives to health commissions. The Governor has indicated that consideration will be given to MPhA recommendations. Letter regarding Kidney Foundation of Maryland (referred to Pro- fessional Relations Committee ). Letter involving Bal- timore City Health Department’s interest in the avail- ability of 24-hour pharmacy service in the inner city.
The President reported that he had participated in hearings in Annapolis regarding the use of suppor- tive personnel in pharmacies.
The Executive Director reported on his appearance before the zoning commission on behalf of Dr. John C. Krantz, Maryland Psychiatric Research Center, regarding the opening of Epoch House, a research center for drug abuse. The office has been receiving numerous inquiries related to the wage and _ price freeze. APhA is collating all questions and will sub- sequently provide the information to affiliated asso- ciations. Two meetings have been held regarding the Kermit White Memorial at which the establishment of a drug abuse program in Edmondson Village area was proposed. Other activities: meetings of the Board of Pharmacy and health centers and con- ferred with Attorney General’s office.
The Membership Committee report indicated a de- crease in owner category and an increase in non-
owner category. The 1972 campaign will begin in October.
The Public Health Information Committee report related that the MPhA V.D. Campaign resulted in meetings with Public Relations Committee of the state medical society. Dr. Howard J. Garber, Chief of Communicable Diseases, Maryland State Depart- ment of Health, advised MPhA of formation of a state commission on V.D. which will include Mr. Freiman as MPhA representative.
The Prescription Insurance Plans Committee report noted MPhA recommendations regarding Medical Assistance Program including recommendations for a prescription fee of $2.35 for FY 1973. Conference was held with Mr. Benjamin Jaffe of United Pre- scription Program regarding new prescription poli- cies. MPhA position was that “wholesale” should be used rather than “acquisition cost” and to limit number of abuse items to 30-day supply which would be taken up with state as well. The need for a staff employee to work on third-party plans was discussed.
The Legislative Committee reported it had reviewed resolutions for control of advertising of drugs on tele- vision, Other proposals included removal of geo- graphical limitations by Board of Pharmacy, use of supportive personnel, nursing home ownership of offsite pharmacies, freedom of choice of pharmacy in third-party programs, mailing of samples, registra-
THE MARYLAND PHARMACIST
103
1 x.
12.
13.
14.
ibsy
16.
tion of detail men, establishment by Board of Phar- macy and MPhA of a Commission on Pharmacy Dis- cipline and mandatory continuing education. Phar- maceutical services in nursing homes are to be sur- veyed. Opposition to a prefiled bill requiring phar- macists to place expiration date on label of prescrip- tions was approved.
The Convention Committee chairman reported that the postconvention trip for 1972 would leave Balti- more on May 17 to Acapulco, Mexico, returning on May 22. Arrangements are being made for approxi- mately 200 at the Pierre Marques Hotel. The 1972 Convention will be held at the Washingtonian on May 7, 8 and 9th.
Representatives of the Maryland Society of Hospital Pharmacists met with the Board regarding “Guide- lines for Pharmaceutical Services in Hospitals.’”’ The “Guidelines” will be redrafted in regulatory terms and condensed before submission to the Attorney General.
The Board of Trustees approved the Metropolitan Guild of Pharmacists as a “recognized organization” in the House of Delegates under Article V, Section 2.32 of the By-Laws.
The following new members were approved: Stephen Needel, Arnold Smolen, Charles Marsiglia, David R. Chason, Michael Cohen, Wayne Dyke of Baltimore; Milton Moskowitz, Laura Tepper, Ralph Sigman of Silver Spring; Robert W. Elliott, Ocean City; Charles D. Reynolds, Hyattsville; Darlene F. McMahon, Mt. Ranier; Joel Serin, Landover; Herbert Niefield. Rockville; Charles W. Kelly, Cambridge, Gary Boyer, Frederick; Edward B. Roth, Olney; Robert R. Hayward, Kensington.
The APhA Pledge Plan was approved as follows: First year, $10, second year, $15, third year, $20; and fourth year, $25 MPhA dues.
In response to the Maryland Comprehensive Health Planning Agency adopted motion to present to the Board of Pharmacy a proposal in cooperation with the School of Pharmacy and all facets of pharmacy for regulations on use of supportive personnel. There was discussion on the possibility of working out a formulary system with the state medical so- ciety and Board of Pharmacy utilizing statement on each prescription form.
Voted support for Senator Hart’s Bill “Regulation of Trade in Drugs” to prevent physicians from phar- macy ownership or ownership in drug repackaging companies.
Agreed to support position of D.C. Medical Society in regards to expelling of physicians prescribing methadone other than for detoxification purposes pro- vided the addicts are provided with adequate care.
October 7, 1971
Communications included new Controlled Danger- ous Substances Act received from Maryland Board of Pharmacy, offer of support for the 1972 Swain
DECEMBER 1971]
_ The only thing worse than beingill is being bored |
The cold and flu weather is on its way.
And most people can put up with the sneezing and
coughing.
But finding something to do ne all those hours in bed, that’s a real pain.
A person can only stand those game shows and soap operas for so long, before all they want to do is lay back with something good to read. “
Maybe a sports magazine, a hobby book, a paperback novel or a news magazine.
What medicine does for their body, reading does for their mind.
And at Maryland News ace gh we're proud to be
your area’s prime source of fine reading material.
We are constantly supplying your racks with the most current reading material to keep your customers reader interest at its highest.
The mathematics are quite simply: for an initial outlay of $100 you can expect a return of $127 within thirty days. And any unsold copies are returnable for full credit.
And when you have the very best reading material on sale in your pharmacy, people develop a habit of com- ing back.
So give us a call at 233-4545.
Maybe we're just what the doctor ordered.
. Maryland News Company -
~l
Seminar from MSHP, American Council of Pharma- ceutical Education concerning its revision of the ac- cereditation manual for schools and colleges of phar- macy in the United States and requesting comments, Maryland Diabetes Association again asking for MPhA participation during National Diabetes Week. Myr. Freiman will meet with representatives of MSHP and MPhA legal counsel Joseph S. Kaufman regard- ing adoption of “Suggested Principles and Guide- lines for Pharmaceutical Services in Hospitals’ as state regulation by the Board of Pharmacy. Morris Bookoff will represent MPhA at November 17 meet- ing of National Pharmacy Insurance Council in Washington.
The President commended Mr. Rubin for his efforts as Membership Committee Chairman in bringing in delinquent dues. Mr. Fedder will serve as chairman of the Nominating Committee for the coming year. The President attended the Washington County Pharmaceutical Association meeting in Hagerstown.
The Treasurer’s report indicated expenses for the year average about $4,000 per month. Mr. Gruz was commended for controlling office expenses. The Metropolitan Guild of Pharmacists will be paying one-half of the members APhA dues beginning in 1972;
The Executive Director reported on plans of the East Baltimore Community Corporation to establish onsite pharmacy. A meeting was held with represen- tatives from APhA regarding membership _pro- cedures. Maryland dues structure is lower than that of most other affiliated organizations. Attended the funeral of Eileen Brooks, Executive Secretary of the D.C. Pharmaceutical Association. Also meetings of the American College of Apothecaries and Washing- ton County Pharmaceutical Association.
Membership Committee. A total of 784 members was reported in September as compared with 781 in 1970. The need for adequate MPhA staffing for membership work and improved communications was pointed out.
Public Health Information Committee. “V.D. — Voluntary Disaster” is theme of National Pharmacy Week. Posters have been distributed to member pharmacies and press releases have been published by newspapers and. carried by television and radio stations. Mr. Freiman has been appointed to a Task Force on V.D. formed by the State Department of Health.
The Legislative Committee Chairman reported that proposed legislation preventing any third-party pro- gram from the interference with freedom of choice of pharmacy will be introduced. The sponsor of a bill requiring the expiration date to appear on Rx labels has withdrawn the bill. Revision of the label- ing law seems indicated to require “label” and “‘do not label” to appear on prescriptions.
The Professional Relations Committee Chairman re- ported on the meeting with the state medical society concerning drug product selection. There was discus- sion of a formulary system for Medicaid patients while maintaining physicians’ prerogatives of speci- fying manufacturer. The possibility of a combined
THE MARYLAND PHARMACIST
convention with the state medical society and the state dental association has been suggested.
9. The following applications for membership were ap- proved: Philip Bogash, Donald A. Schumer, Leon R. Catlett, Milton Watkowski, Stanton M. Rudo, Wil- liam Tabak, Sidney Sober, Harold W. Clinksdale, Sidney Litvin, Albert Lichtman, William Jackson, Angelo C. Tompros, Paul L. Goldstein, John R. Newcomb, Milton Hillmian, C. Herbert Wagner, Robert M. Plummer, Alvin Perkins.
10. The Nominating Committee was approved by the Board as follows: Donald O. Fedder, Chairman; I. Earl Kerpelman, Alder Simon, Rudolph Winternitz, Bernard B. Lachman, Stephen Hospodavis, H. Nel- son Warfield, Joseph U. Dorsch and Mary W. Con- nelly.
11. There was a detailed review of the status of MPhA activities concerning governmental and other third- party programs. Conferences were held with Medi- caid, Esskay, Senior Citizens groups, Maryland Com- mission on Aging, Benjamin Jaffe Associates and Maryland Health Maintenance Committee. Esskay has agreed to an MPhA plan to act as a clearing- house for third-party prescriptions. The School of Pharmacy has set up a task force on third-party programs. There was discussion on activating the ~ MPhA initiated Maryland Pharmaceutical Service Corporation for the handling of work involved with third-party payment plans.
Washington County Pharmaceutical Association
The Washington County Pharmaceutical Association held a meeting on November 17, 1971, in Hagerstown. Mr. Albert Metts, Executive Director of the Appalachian Regional Health Planning Council, was guest speaker for the evening. Mr. Metts discussed health planning for the future in Garrett, Allegany and Washington counties. He also spoke briefly on Health Maintenance Organiza- tions and their potential role in the Washington County area.
University of Maryland School of Pharmacy Alumni Association
Alumni are invited to submit nominations for the Honored Alumnus Award presented by the University of Maryland School of Pharmacy Alumni Association.
Nominations together with a brief statement of in- formation about the nominee should be submitted in writ- ing to Harry R. Wille, Chairman, Honored Alumnus Award Committee, 306 Marydell Road, Baltimore, Mary- land 21229.
The presentation will be made at the Alumni Asso- ciation Annual Banquet in honor of the graduating class
on May 31, 1972.
DECEMBER 1971]
“a
*, soy
pends on the company”
he Keep. : |
phenylbutazone
gaeine
Geigy . tie
5
a
NOW ONFIDENCE COSTS LESS
SK-AMPICILLIN™
brand ot AMPICILLIN TRIHYDRATE
SK-APAP™
brand of ACETAMINOPHEN
SK-BAMATE™
| brand ot MEPROBAMATE SK-ESTROGENS"
von ot ESTERIFIED ESTROGENS U.S.P.
SK-PENICILLIN VK"
brand ot POTASSIUM PHENOXYMETHYL PENICILLIN
SK-PETN"
brand of PENTAERYTHRITOL TETRANITRATE
SK-SOXAZOLE™
Trad 2mMark brand ot SULFISOXAZOLE L |
LINE SK-TETRACYCLINE™
brand of TETRACYCLINE HCL
yrTivinvdea
EE ——
NEW FROM SK&F: SK-LINE PHARMACEUTICALS
SK-AMPICILLIN™
brand of AMPICILLIN TRIHYDRATE Capsules: 250 mg., 500 mg. Chewable tablets: 125 mg. For oral suspension: 125 mg.,
250 mg./5 mi. Pediatric drops: 100 mg./ml.
brand of SODIUM AMPICILLIN Single dose vials: 500 mg.
SK-APAP ©
brand of ACETAMINOPHEN Tablets: 325 mg. Elixir: 120 mg./5 ml.
SK-BAMATE ~
brand of MEPROBAMATE Tablets: 200 mg., 400 mg.
SK-ESTROGENS ©
brand of ESTERIFIED ESTROGENS U.S.P. Tablets: 0.3 mg., 0.625 mg., 1.25 mg., 2.5 mg.
SK-PENIGILLIN VK
brand of POTASSIUM PHENOXYMETHYL PENICILLIN
Tablets: 250 mg., 500 m ™ For oral solution: 125 he 250 mg./5 mi. SK-LINE Dp ARMA e TI SK-PETN
brand of PENTAERYTHRITOL a line of basic
Stee ee pharmaceuticals SK-SOXAZOLE” of high quality brand of SULFISOXAZOLE at low prices.
Tablets: 500 mg.
~ SK-TETRACYCLINE®
brand of TETRACYCLINE HYDROCHLORIDE Capsules: 250 mg. SK-LINE™ PHARMACEUTICALS FOR QUALITY, ECONOMY, AVAILABILITY
brand of TETRACYCLINE exclusively from Syrup: 125 mg./5 mi. SMITH KLINE & FRENCH LABORATORIES, PHILADELPHIA, PA. 19101
Annual Report of the Maryland Board of Pharmacy
1970 1971
F. S. BALASSONE
Secretary-Treasurer
In compliance with the provisions as set forth in Section 258 of Article 43 of the Annotated Code of Mary- land, this report is submitted to the Honorable Marvin Mandel, Governor of Maryland, and to the Maryland Pharmaceutical Association. This is the sixty-eighth re- port to the Governor of the State and the fifty-eighth to the Association. The report covers the activities of the Maryland Board of Pharmacy for the fiscal year ending June 30, 1971. This report is also being submitted to the Secretary of the Department of Health and Mental Hygiene.
Personnel
During the year the Board held 13 meetings, five of which were held at the School of Pharmacy of the University of Maryland, for the purpose of conducting examinations for registration of pharmacists.
At its first meeting the Board reorganized and elected Mr. Norman J. Levin, President and Mr. F. S. Balas- sone, Secretary-Treasurer. The other members of the Board were: Messrs. Howard L. Gordy, Morris R. Yaffe and Frank Block.
At the annual meeting of the Maryland Pharma- ceutical Association held in Atlantic City, New Jersey on July 12-16, 1970, the Nominating Committee submitted the following names which were later submitted to the Governor as possible successors for Morris R. Yaffe whose term would expire on April 30, 1971:
Morris R. Yaffe William I. Lottier, Jr. Victor H. Morgenroth, Jr.
Governor Mandel reappointed Morris R. Yaffe a member of the Board for a term of five years, beginning May 1, 1971.
Examination
The Board will conduct two examinations for regis- tration of pharmacists during the fiscal year. They were held at the School of Pharmacy of the University of Maryland on November 2, 3 and 4, 1970 and will also be held on June 28, 29 and 30, 1971.
There were nineteen applicants for the full Board in November. Seventeen passed both the theoretical and practical portions of the examination and were subse- quently registered. Two failed the examination.
Having previously passed the theoretical portion of the examination, seventy-two candidates took the practi- cal examination in November. All of these candidates passed and were subsequently registered.
Six applicants took only the theoretical portion of the examination. All of these passed and will take the
16 THE MARYLAND PHARMACIST
practical examination upon completion of their practical experience.
Three applicants took only the practical portion of the examination, as they did not have the required ex- perience for reciprocity. These applicants passed and were subsequently licensed by reciprocity in Maryland.
There were eight applicants eligible to take the full Board in June. Seven passed both the theoretical and practical portions of the examination and were subse- quently registered. One failed the examination.
Having previously passed the theoretical portion of the examination, sixteen took the practical portion of the examination. All of these candidates passed and were sub- sequently registered.
Eighty-five applicants were eligible to take only the theoretical portion of the examination. Seventy-nine passed this portion of the examination and six failed the examination. Upon completion of their practical experi- ence, they will be eligible to take the practical portion of the examination.
Four applicants took only the practical portion of the examination, as they did not have the required ex- perience for reciprocity. All of these applicants passed and will subsequently be registered by reciprocity.
The Board has decided to use the Standard Examina- tion of the National Association of Boards of Pharmacy, and this examination was given for the first time in No- vember in the following subjects:
Chemistry Pharmacy Mathematics Pharmacology
The practical portion of the examination was prepared
by the Board.
For the June examination all portions including the practical portion of the Standard Examination of the Na- tional Association of Boards of Pharmacy will be given to all applicants.
Record of Examination Held
November 2, 3 and 4, 1970
Applicants Passed Withheld Failed oF 89 6 2 June 28, 29 and 30, 1971 Applicants Passed Withheld Failed 109 23 79 7 Total Number Examined for Registration as Pharmacists Applicants Passed Withheld Failed 206 112 85 9
DECEMBER 1971
__ The following table shows the number of pharma- cists who were registered by examination during the past
ten years:
YEAR 1961-1962 1962-1963 1963-1964 1964-1965 1965-1966 1966-1967 1967-1968 1968-1969 1969-1970 1970-1971
NUMBER OF PHARMACISTS
_ As in the past many pharmacists applied for re- ciprocal registration in Maryland in order to accept posi- tions with their employers who are opening stores in
Maryland.
Those applicants who did not meet our requirements concerning practical experience prior to or after registra- tion were advised that they must take our practical ex- amination in order to verify their qualifications.
In all cases an applicant for reciprocal registration must appear for a personal interview. The entire Board must act on whether or not to grant registration to such applicants, who must sign an agreement to comply with Maryland’s laws pertaining to drugs and pharmacy.
The following table shows those granted registration by reciprocity during the 1971 Fiscal Year:
Registered By Reciprocity
Certificate
Name Number Dated State William A. Koerner 7230 July 10,1970 New York Ellen McC. Suber 7231 July 10,1970 South Carolina Gerald S. Fine 7232 July 10,1970 Massachusetts Donald K. Fellows, Jr. 7233 July 10,1970 Louisiana Stuart N. Morris 7234 July 10,1970 Pennsylvania Bonnie E. Walt 7235 July 13,1970 Oregon Jack A. Chaverini 7236 Aug. 3, 1970 Pennsylvania Charles D. Conway 7237 Aug. 3, 1970 ‘Massachusetts Jerome B. Horwitz 7238 Aug. 3, 1970 Pennsylvania Aaron J. Kauffman 7239 Aug. 3, 1970 Pennsylvania Albert L. Moore 7240 Aug. 3, 1970 Oklahoma Arthur D. Schatz 7241 Aug. 3, 1970 Pennsylvania Joseph B. Summey 7242 Aug. 3, 1970 Georgia Joe Bill Dickerson 7243 Aug. 25, 1970 Georgia Elizabeth A. Ingrassia 7244 Aug. 25, 1970 Ohio Alan D. Levitt 7245 Aug. 25, 1970 New York James J. McKeever 7246 Aug. 25, 1970 Virginia Robert J. Preston 7247 Aug. 25, 1970 Michigan Morris L. Shapiro 7248 Aug. 25, 1970 Dist. of Columbia John G. Smith 7249 Aug. 25, 1970 Dist. of Columbia Oliver L. Thagard, II 7250 Aug. 25, 1970 Alabama James E. Gilghman 7251 Aug. 25, 1970 Missouri Haskell Bronstein 7257 Sept. 14, 1970 Massachusetts George M. Davenport, Jr. 7258 Sept. 14, 1970 Alabama Salvatore LaVerde 7259 Sept. 14, 1970 New Jersey Robert J. Ollins 7260 Sept. 14, 1970 New York Richard P. Stern 7261 Sept. 14, 1970 Pennsylvania Myron H. Winget, Jr. 7262 Sept. 14, 1970 Dist. of Columbia Albert H. Angel 7265 Sept. 30, 1970 Delaware Martin L. Jones, Jr. 7266 Sept. 30, 1970 Dist. of Columbia Sandra C. Woronow 7262 Sept. 30, 1970 New Jersey James C. Bradshaw, Jr. 7268 Oct. 20, 1970 Dist. of Columbia Barbara N. Dulichan 7269 Oct. 20, 1970 Dist. of Columbia Janet R. Waddell 7270 Oct. 20, 1970 Pennsylvania Donhue McD. Wilson 7271 Oct. 20, 1970 New York Nathan Zapolsky 7272 Oct. 20, 1970 New Jersey Steve C. Ippolito 7273 Oct. 23, 1970 Virginia James M. Deneen 7274 Oct. 30, 1970 [Illinois ; James F. Coover 7975 Nov. 12, 1970 Dist. of Columbia Robert F. Kaplan 7276 Nov. 12, 1970 Pennsylvania Frederick G. Marks 7277 Nov. 12, 1970 South Carolina
DECEMBER 1971
Certificate
Name Number Dated State Katherine Z. Petrone 7278 Nov. 12, 1970 New York Robert J. Roissier 7279 Nov. 12, 1970 Pennsylvania Charles H. Ziemianski 7280 Nov. 12, 1970 Pennsylvania Darnell Arnold 7281 Nov. 17, 1970 Texas Nathan Cooper 7282 -Nov. 17, 1970 Tennessee James David Ford 7283 Nov. 17, 1970 Tennessee Roger W. Mosley 7284 Nov. 17, 1970 Nevada Harvey B. Press 7285 Nov. 17, 1970 Dist. of Columbia Frederick M. Updike 7286 Nov. 17, 1970 Massachusetts Douglas A. Gregory 7331 Dec. 4, 1970 Oregon Hubert J. Malloy 7332 Dec. 4, 1970 Pennsylvania William G. Pigeon, III 7333 Dec. 4, 1970 Oregon Thomas E. Platek 7334 Dec. 4, 1970 New York Millard R. Robinson 7335 Dec. 4, 1970 Pennsylvania Darrell J. Bauer 7336 Dec. 7, 1970 Michigan Carl R. Grimes 7337 Dec. 7, 1970 Georgia Walter S. Szot 7338 Dec. 7, 1970 Massachusetts Daniel J. Lageman 7370 Jan. 19, 1971 Kentucky Albert H. Hurwitz 7373 Jan. 29, 1971 Pennsylvania Edith B. Kale 7374 Jan. 29, 1971 Dist. of Columbia Gary D. Leggett 7375 Jan. 29, 1971 Dist. of Columbia Simon L. Levin 7376 Jan. 29, 1971 Dist. of Columbia Kendal F. Melton 7377 Jan. 29, 1971 Tennessee Alan Schreiber 7378 Jan. 29, 1971 Illinois Maurice Cohen 7382 Feb. 17, 1971 Massachusetts Abraham R. Cooper 7383. Feb. 17, 1971 Dist. of Columbia David Vollmer 7384 Feb. 17, 1971 Pennsylvania Frederick L. Wendt 7385 Feb. 17, 1971 New York Melvin J. Wolfe 7386 Feb. 17, 1971 Pennsylvania Charles E. Kight 7389 Mar. 3, 1971 Pennsylvania Margaret F. Rumrill 7390 Mar. 3, 1971 South Carolina Thomas V. McKeever, Jr. 7394 Mar. 19, 1971 Virginia Richard C. Radwick 7395 Mar. 19, 1971 New York Philip Rubin 7398 April 16, 1971 Dist. of Columbia Johnnie Bingham, Jr. 7400 April 22, 1971 Dist. of Columbia Basil L. Giandonato, Jr. 7401 April 22, 1971 Pennsylvania Charles E. Hall 7402 April 22, 1971 Texas Helen O. Ross 7403 April 22, 1971 Dist. of Columbia John M. Torris 7404 April 22, 1971 Pennsylvania Eva A. Mead 7405 May 3, 1971 Puerto Rico Jerry L. Overbeck 7406 May 3, 1971 Texas Ray Howard Bragg 7407 May 13, 1971 Alabama Duncan Elliott Cameron 7409 May 13, 1971 Michigan James L. Goodson, Jr. 7410 June 1, 1971 Georgia Jimmie Wayne Bryant 7412 June 9, 1971 Virginia Irving Sacks 7413 June 10, 1971 Dist. of Columbia Leonardo S. John 7414 June 10, 1971 Dist. of Columbia Marie Theresa Luschas 7415 June 10, 1971 Pennsylvania Nicholas G. Sfakianos 7416 June 10, 1971 Pennsylvania Lawrence A. Trissel 7417 June 10, 1971 Indiana Paul David Chenoweth 7418 June 25. 1971 Virginia
The following table shows cists granted registration by reciprocity and the number who were certified to register by reciprocity in other states during the past ten years:
the number of pharma-
Certified for
Fiscal Year Reciprocity Registration in Other States 1961-1962 oD 20 1962-1963 54 18 1963-1964 46 23 1964-1965 63 20 1965-1966 44 25 1966-1967 61 AT 1967-1968 64 20 1968-1969 84 Pa 1969-1970 ne 40 1970-1971 92 26 Total 618 246
The table shows Maryland gained 372 pharmacists
by reciprocity during the past ten years.
THE MARYLAND PHARMACIST
17
Pharmacy Permits
Location 1969-1970 1970-1971 Counties: Allegany 22 21 Anne Arundel 53 54 Baltimore 144 148 Calvert I, 2 Caroline 5) 3 Carroll i) LZ Cecil 10 9 Charles 7 i Dorchester 3 4 Frederick 14 14 Garrett # S Harford mA 20 Howard 10 10 Kent 3 a Montgomery 86 ousy4 Prince George’s 98 98 Queen Anne’s 4 4 Saint Mary’s 4 4 Somerset oS 4 Talbot 9 8 Washington 16 16 Wicomico he 12 Worcester fl 6 County Totals 547 544 Baltimore City 238 223 State-wide Totals 785 767
The above figures include permits issued to hos- pitals in the counties as follows:
Allegany 2 Montgomery t Anne Arundel 2 Prince George’s 3 Baltimore 5 Talbot 1 Cecil 1 Washington 1 Frederick 1 Wicomico if Harford 1 oe Howard 1‘ Total 23
In Baltimore City, 14 hospitals received a permit to operate a pharmacy. Thus, a total of 37 hospitals have a licensed pharmacy. Five nursing homes have received a “limited” pharmacy permit, and one State Penal Institu- tion was also licensed.
From July 1, 1970 through June 30, 1971 permits have been issued to 23 new pharmacies. A total of 34 pharmacies have closed and have not, as yet, been re- opened as pharmacies.
The following table shows the number of pharma- cies opened, changes in ownership, and closed during the year:
Changes in Ownership Corporation, and/or
The following table shows the number of pharma- cies opened, changes in ownership, etc. and closed in the past ten years:
Fiscal Year Opened Changes Closed 1961-1962 34 31 15 1962-1963 39 45 22 1963-1964 20 38 20 1964-1965 ve 34 20 1965-1966 eal 46 44 1966-1967 41 Ae! 25 1967-1968 24 oh 35 1968-1969 34 19 a. 1969-1970 20 Pail 19 1970-1971] 24 28 40
Certificate of Registration Renewals
There are some who are still not aware of the bien- nial registration renewal which became effective in June 1961. The following shows the renewal periods, the num- ber of new renewals during the past year, and the total renewals to date:
Renewal During
Renewal Period Fiscal Year
Total Renewals
1961-1962 14 2,359 1963-1964 14 2,411 1965-1966 14 2,648 1967-1968 14 2,747 1969-1970 16 2,877 1971-1972 3,032 3,032
Manufacturer’s Permits
Permits to manufacture drugs, medicine, toilet arti- cles, dentifrices or cosmetics during 1971 were issued to 47 firms, 37 of which were “limited” permits. An appli- cant applying for a permit for a newly established com- pany is required to appear before the Board and to fur- nish all information the Board considers pertinent to the conducting of such operation.
Dangerous Drug Distributors’ Permit
The Board issued 130 permits to sell, distribute, give or in any way dispose of dangerous drugs during 1971. It is not necessary for a subsidiary or subsidiaries of a company to have a separate permit, as they are covered under the permit held by the parent company.
Legislation
There were many Bills introduced in the 1971 ses- sion of the legislature. However, the following Bills are of most interest to pharmacists and to the Board.
Senate Bill 729
Of particular importance to the Board is the passage of Senate Bill 729, sponsored by Senators Snyder and
tH Opened GS ace Schweinhaut. This Bill concerns itself with the qualifica-
Pate. ae tions for registration as a pharmacist and raising the 2 1 Pains ; : Aer ee
Bente Cas : 7 a6 fee for application for such registration. This Bill de-
agers he ne leted the reference that a person must have had 4 years 7 oe Eres . . 66
28 40 of experience and substitutes the language, “or has
ell 4 oe ; served an internship program regulated by the Board”
18 THE MARYLAND PHARMACIST DECEMBER 1971
and raises the fee from twenty-five dollars to “forty d l- lars.” This Bill passed, 3 aes chi
261. Who may be registered; proof of qualifications, fee.
Any person of good moral character, who has had four years’ actual experience in a pharmacy where phy- sicians’ prescriptions are daily compounded, OR HAS SERVED AN INTERNSHIP PROGRAM REGULATED BY THE BOARD and has attained the age of twenty- one years, who shall present satisfactory evidence to the Maryland Board of Pharmacy that he or she has had at least four years standard high school or college of phar- macy approved by the said Board OR accredited by the American Council on Pharmaceutical Education, as pub- lished in their official listing and who after examination by the said Board shall be by it deemed competent, shall be registered as a pharmacist and be given a certificate of such registration, provided, however, that (not more than three years may be deducted from the four years of actual drugstore experience aforesaid, for the actual time of attendance at a reputable school or college of phar- macy.) OR an internship program to be regulated by said Board be served. Such person shall make applica- tion to the secretary of said Board at least ten days be- fore any stated meeting of the Board and shall pay to the said Board a fee of forty (twenty-five) dollars.
No applicant for examination before the Board of Pharmacy having the other qualifications herein set forth shall be disapproved because he took his course of studies at a night school or college and nothing in this subtitle shall be held to abridge or abrogate the rights and _priv- ileges heretofore conferred by law upon any person now registered as assistant pharmacist in this State.
Any person enrolling as a student of pharmacy in any school or college of pharmacy in this State shall, not later than thirty days after so enrolling, file with the secretary of the Maryland Board of Pharmacy, an appli- cation for registration as a student of pharmacy in which _ said application he shall be required to furnish such in- formation as the Board may deem appropriate, and simul- taneously with the filing of said application, shall pay to the Board a fee of one dollar; all such students of phar- macy shall, at the beginning of any subsequent school or college year, submit to the said Board a sworn statement of any and all (actual drugstore experience acquired during the preceding vacation months) OR AN intern- ship experience acquired during the preceding year as requested by the Board.
Sec. 2. And be it further enacted, That this Act shall take effect July 1, 1971.
EXPLANATION: Italics indicate new matter added to exist- ing law. (Brackets) indicate matter stricken from existing law.
Senate Bill 110
Senate Bill 110 sponsored by Senator Abrams makes it mandatory that when a pharmacist sells or dispenses any medications on prescription issued by a physician or dentist, he shall affix to the contained in which the medi- cation is sold or dispensed, unless the prescriber indicates that he should not, a label showing the name and strength of the medication prescribed, in addition to all other in- formation required by law. This Bill passed. 254A.
Whenever a pharmacist sells or dispenses any medi- cations on prescription issued by a physician or a dentist, he shall affix to the container in which the medication is
DECEMBER 1971
sold or dispensed, unless the prescriber indicates that he should not, a label showing the name and strength of medication prescribed, in addition to all other informa- tion required by law. In listing the established or trade name, the label shall conform to the name used by the practitioner in his prescription. No person shall alter, deface, or remove any label so affixed so long as any of the original contents remain. Any person failing to ob- serve the provisions of this section is guilty of a misde- meanor, and upon conviction thereof, shall be fined fifty dollars ($50.00). Pharmacists violating this section shall be subject to disciplinary action by the Board of Phar- macy,
SECTION 2. And be it further enacted, That this Act shall take effect July 1, 1971.
EXPLANATION: Italics indicate new matter added to exist- ing law. (Brackets) indicate matter stricken from existing law.
Senate Bill 734
Senate Bill 734 was sponsored by Senator Snyder. This Bill sought to change the geographical residency requirement for members of the Maryland Board of Pharmacy and to change the salaries and expenses of members of the Board and to allow for the salaries to be fixed in the Annual State Budget. This Bill failed. It
was not reported out of Committee.
ale
The Governor, upon the recommendations of the Secretary of Health and Mental Hygiene, shall appoint five persons to be Commissioners of Pharmacy, said Com- missioners to constitute and be known as the Maryland Board of Pharmacy, which Board shall constitute part of the Department of Health and Mental Hygiene. Said Commissioners shall be skilled and competent pharma- cists, who have had at least five years’ active pharma- ceutical experience in compounding and dispensing phy- sicians’ prescriptions, and of whom at least four are actively engaged in the practice of pharmacy. None of said Commissioners shall be connected with any school of pharmacy either as teacher, instructor, or member of the board of trustees. (Two of said Commissioners shall be residents of the City of Baltimore, two residents of the counties of the State and the fifth a resident of either the City of Baltimore or the counties of the State.) The persons serving as Commissioners on June 1, 1947, shall continue to serve as such until the expiration of the term for which they have heretofore been appointed and their successors are duly appointed and qualified pursuant to the provisions of this section, and the Commissioners thereafter appointed shall serve as members of said Board for the term of five years. In the case of any vacancy or vacancies, whether from expiration of term, resignation, death or otherwise, the Governor, upon the recommenda- tion of the Secretary of Health and Mental Hygiene, shall appoint a successor from a list of pharmacists of three times the number of vancancies to be filled, said list to be submitted by the Maryland Pharmaceutical Associa- tion. The said Commissioners shall, after notification of their appointment each subscribe to the oath prescribed by the Constitution of the State of Maryland.
259.
(The salaries of said Board except the secretary- treasurer shall be $20.00 per day for each member, for each and every day upon which he is engaged upon the duties of the Board and all legitimate expenses incurred
THE MARYLAND PHARMACIST 19
in the discharge of his official duties. The secretary- treasurer of the said Board shall receive a salary to be fixed by the Board, and not to exceed one thousand dol- lars per annum; and all legitimate expenses incurred in the discharge of his official duties.) The members of the Board shall have the salaries fixed in the annual State budget, and shall receive such reasonable expenses as may be provided in the budget. All moneys collected under this subtitle shall be paid over the State Treasurer, and shall become general funds of the State. Such moneys shall thereafter be disbursed by the Comptroller only pursuant to an appropriation made in accordance with Sections 32 and 52 of Article 3 of the Constiution or pursuant to the provisions of Sections 1 through 15 in- clusive, of Article 15A of this Code, title “Budget and
Fiscal Planning,” as amended from time to time.
Sec. 2. And be it further enacted, That this Act shall take effect July 1, 1971.
EXPLANATION: Italics indicate new matter added to exist- ing law. (Brackets) indicate matter stricken from existing law.
Senate Bill 4
Senate Bill 4 was introduced by the President of the Senate. This Bill sought to bring up to date in con- formity with the Federal Law the Food, Drug and Cos- metic Law. The Bill expands the sections on adultera- tion and misbranding. It adds new sections on cosmetic, devices, embargo and new drugs. The Bill was also an administration bill and we were very fortunate to have the Legislative Staff of the Governor to assist us in ev- ery phase of the development of the new mini Food, Drug and Cosmetic Law. This Bill represents the first major overhaul of the initial food and drug law and is indeed a landmark in consumer protection as it relates to food, drugs and cosmetics. This Bill passed.
Senate Bill 793.
Senate Bill 793 was introduced by Senator Snyder and sought to amend the Controlled Dangerous Sub- stances Act which was passed during the 1970 legislative session of the General Assembly. The amendments were designed to bring the Maryland Law in conformity to the Federal Controlled Substances Act which became effective May 1, 1971. This Bill passed.
Senate Bill 415
Senate Bill 415 introduced by Senator Crawford sought to remove all codeine preparation now allowable for over the counter sale by the Controlled Dangerous Substances Act of 1970 and to relegate them to prescrip- tion use only. This Bill did not come out of Committee
A 9 hence did not pass.
Prescription Survey
The following table shows a survey of prescriptions
filled in 1970:
PRESCRIPTION SURVEY — 1970 Baltimore City
Average Number New Prescriptions Filled in
Average Price of Prescriptions in 93 out of 211 Pharmacies $3.54
Estimated New Prescriptions Filled iIngZUigeharmacies eaves: sete 3,117,947
Estimated Prescriptions Refilled
ine leeehanmnacies manic eee see 1,602,545 4,720,492
Counties Average Number New Prescriptions Filled in 150. 0m ole 16s Pharmacies: amie aaeeee ae: 18,981
Average Number Prescriptions Refilled in lS5s0utsor sol 6seharmaciesas seen 13,959 32,940
Average Price of Prescriptions
in 155 out of 516 Pharmacies $3.75
Estimated New Prescriptions Filled in SlOePharmaciesnaeee eee eee ee 9,794,196
Estimated Prescriptions Refilled ano 16% Pharmacies: ee ecketts oe aoe eee 7,202,844.
16,997,040 State Estimated New Prescriptions Filled in (2a Pharmaciteswaceeme cine ec clas eee 12,912,143
Estimated Prescriptions Refilled
ime(2i weharmacies wae ncerae ue cinerea 8,805,389 21,717,532
Cooperative Activities
The Board maintained membership in the National Association of Boards of Pharmacy. The annual meeting of the Association which was held in conjunction with the American Pharmaceutical Association was held in San Francisco, California on March 27 - April 2, 1971. The Board was represented by President Norman Levin, Secretary F. S. Balassone and Frank Block.
The Board also maintained membership in the Con- ference of Boards and Colleges of Pharmacy of the Na- tional Association of Boards of Pharmacy, District Num- ber Two, comprising the States of New York, New Jersey, Pennsylvania, Delaware, Maryland, the District of Co- lumbia, Virginia, and West Virginia. The annual meet- ing was held in Williamsburg, Virginia on October 22- 24, 1970. Secretary Balassone was the official delegate of the Board at the meeting.
Secretary-Treasurer, F. S. Balassone was the official delegate of the National Association of Boards of Phar- macy to the annual meeting of the Assiciation of Food and Drug Officials of the United States which will be held in Columbus, Ohio, June 20-25, 1971.
At the Wiley Award Banquet, Secretary F. S. Balas- sone was awarded and presented the Harvey W. Wiley Award “in recognition of outstanding service and devo- tion to duty in administering the Food and Drug Laws — of his State and the leadership, guidance and inspiration he has provided to his fellow workers throughout the na- tion.” This fitting tribute is indeed the highest attain- ment any person in this field could aspire to. Secretary Balassone was the first pharmacist ever to receive this award.
Secretary Balassone served as a member of the Awards Committee of the Central Atlantic States Asso- ciation of Food and Drug Officials of the United States and will attend the annual meeting in Philadelphia,
80 20UL Ole 2) Lb’ pharmacies aa eae ees 14,777 Pennsylvania on May 26-28, 1971. Average Number Prescriptions Refilled in : : : Ag ray A So outiot 2298Pharmacies see eee 7,995 PPI PL The Board maintained cooperative activities with eee the State Department of Health and Mental Hygiene, the 20 THE MARYLAND PHARMACIST DECEMBER 1971
School of Pharmacy - University of Maryland, the Mary- land Pharmaceutical Association, the Baltimore Metro- politan Pharmaceutical Association, Federal Bureau of Narcotics and Dangerous Drugs, Food and Drug Admin- istration, City, County and State Police.
Finances
All funds of the Board of Pharmacy are deposited to the credit of the Treasurer of the State of Maryland, and disbursement covering the expenses of the Board are paid by voucher by the State Comptroller.
Charge Accounts Increasing .. .
Collections Slowing Down . .
One of the excellent services the Maryland Pharma- ceutical Association sponsors is a low-cost but most effec- tive collection system. In these times of short profit, col- lection of receivables is important.
The U. S. Department of Commerce appraises the value of accounts receivable as follows:
Current Accounts — are worth 100c on the dollar
2 Months past due — are worth 90c on the dollar
6 Months past due — are worth 67c on the dollar
1-Year-old accounts — are worth 45c on the dollar
2-Year-old accounts — are worth 23c on the dollar 3-Year-old accounts — are worth 15e on the dollar 5-Year-old accounts — are worth le on the dollar
Every day an increasing number of our members are finding the help they need in collecting their DELIN- QUENT ACCOUNTS, including BAD CHECKS, NOTES, CONTRACTS, and JUDGMENTS, and in most cases for
less than half the usual collection fee.
Your total cost for this service is $1.00 per account plus 25% of the amount actually collected. Your Associa- tion will appreciate the opportunity of assisting you. Contact the MPhA office for full particulars.
D. STUART
WEBB
OFFSET PRINTING
PRINTING ADDRESSING
MAILING
wh
306 N. Gay St., Baltimore, Md. 21202
peuivery 689-3232
PERSONALIZED LETTERS
DUPLICATING
ADVERTISING NOVELTIES
TAILOR-MADE
Insurance Coveraze
AMERICAN DRUGGISTS’ INSURANCE ...as the name im- plies, is specifically designed for the needs of the druggist.
It’s an insurance company founded BY druggists FOR druggists, to assure especially prompt settlement of claims .. fire, theft, liability. And that’s exactly what we’ve been doing... settling such claims rapidly, without red tape ... since 1906. Any service with that many years of
experience HAS to be reliable. You can
be certain of 100% security. AMERICAN
DRUGGISTS’ INSURANCE CO.
700 American Building Cincinnati, Ohio 45202
For full details on our complete coverage plan, contact your ADI agent NOW.
MAYER & STEINBERG Maryland State Agents 1101 N. CALVERT STREET BALTIMORE, MD. 21202 752-7311
DECEMBER 1971 THE MARYLAND PHARMACIST 21
Baltimore Metropolitan Pharmaceutical Association
Report of Annual Meeting
The Baltimore Metropolitan Pharmaceutical Asso- ciation held its Annual Meeting on Tuesday, November 30, 1971 at the Kelly Memorial Building in Baltimore.
The meeting was called to order at 10:00 p.m. by President Irvin Kamenetz. The reports of the President, Treasurer, Charles E. Spigelmire, and Secretary, Nathan I. Gruz, were presented and accepted.
Report of Secretary and Executive Director Nathan I. Gruz
This month marks the tenth anniversary of my ten- ure as Secretary of the Baltimore Metropolitan Pharma- ceutical Association and my eleventh annual report.
Ten years ago the preservation of Fair Trade was the priority issue, followed by the fee schedule of the Medi- cal Care Program. Then Medical Care was the only third- party payment program we had to contend with. The fees were 50c and 70c, $1 and $2 for an average fee of 78e.
Today, third party prescription plans occupy a ma- jor portion of the time and effort of organized pharmacy. There are both positive and negative results to report.
As to Medicaid, MPhA recommended a fee of $2.35. The State Department of Health has requested a fee of $2 in next year’s fiscal budget. The outcome will depend upon the Department of Budget, the Governor and the Legislature.
We are working strenuously to establish freedom of choice of pharmacy in all programs. We were able to arrange for the participation by all pharmacies in the Ksskay prescription plan and work is in progress on other plans presently restricted to one pharmacy organization. Changes were also made in the AFL-CIO Council/Giant Pharmacy program, but the major accomplishment was in establishing the Association office as a clearinghouse for prescription prepayment programs. There are sey- eral other proposals under consideration including union plans and Model Cities.
A major public health information accumplishment was in the area of venereal disease. Pharmacy took the initiative in Baltimore and, in fact, the entire state. As a result the local and state health departments and the state medical society has been stimulated to address themselves anew to the V.D. problem. The State Depart- ment of Health has now appointed a Task Force on V.D. with Vice President Paul Freiman representing Phar- macy.
During the year, the Association participated in other public health and public relations activities which will be reported by Charles Spigelmire and Paul Freiman. These areas include Poison Prevention, Diabetes Detection, Med- ical Society exhibits and National Pharmacy Week.
We are proud to say that more cases of diabetes were detected in the screening program through Dreypaks
22 THE MARYLAND PHARMACIST
distributed by pharmacists than through tests in the armories.
At our initiative a committee of pharmacists and community representatives has been formed to establish a memorial to Kermit White. He was a dedicated phar- macist, operating a community pharmacy in a place of need and was ruthlessly shot in a holdup. We hope all will respond when called upon to make a memorial to him a reality.
Pharmacists are to be commended for the coopera- tion in helping to collect funds for restoration of Camp Glyndon. More than $3,200 was turned over as the re- sult of the hard work of Milton A. Friedman and Charles E. Spigelmire.
An important development is the new Professional Experience Program involving many of our members as preceptors. This is an important step in advancing phar- macy professionally and much credit is due our col- leagues, Dean Kinnard and Henry Seidman, in initiating the change.
This past year was the first under the MPhA affilia- tion agreement with APhA. This has involved working with computer printouts, and we hope this will result in greater efficiency when the records are properly inte- grated. Membership work has required a great deal of effort, but with Mel Rubin and Ron Lubman and their committee devoting themselves to this time-consuming activity, we are ending up with more members than in the year before.
We are receiving many more benefits now from APhA in the way of membership services, information, legal counsel and in certain administrative expenses.
Our major concern, and where I believe we must do a great deal more, is in the area of HMO’s—Health Maintenance Organizations—and health centers in gen- eral. We must make this priority one in the coming year, and I hope we can have a number of you working on this problem in various parts of the Baltimore Metro- politan area.
In closing, I wish to express my appreciation to the group of dedicated officers and committee chairmen with whom I have had the pleasure of working with during the past year. President Kamenetz, President elect Joe Dorsch, Chairman Tony Padussis, as well as the ones I referred to earlier in this report, are conscientious and devoted to pharmacy. They have been supported by many others, especially our hard-working Banquet Ticket Chair- man, George Stiffman.
There have been many frustrations, setbacks and destructive roadblocks, but nevertheless it has been grati- fying in many ways to have served the pharmacists of the Baltimore area and the entire state this past ten years. I was honored this year by election as President Elect of the National Council of State Pharmaceutical
DECEMBER 1971
Association Executives, | hope to make some constructive contributions to the profession of pharmacy nationally.
To the many sincere and devoted members who have
helped make it all worthwhile—Thank you.
Committee Reports
The Program Committee report was given by the Chairman, Melvin Rubin. Membership Committee Chair- man, Ronald Lubman, reported a membership total of 475 against 465 at the same time last year.
Public Relations Committee Chairman, Charles E. Spigelmire, presented his report.
_ Joseph U. Dorsch, Chairman of the 1971 Installa- tion Banquet Committee, presented his report.
Paul Freiman, Chairman of the 1972 Installation Banquet Committee, reported that all arrangements for the 1972 Banquet had been completed. The Banquet will be held on January 30, 1972 at the Blue Crest North in Pikesville.
Mr. Freiman, who is also Chairman of the Public Health Information Committee, reported on the increased recognition of Pharmacy in the area of Venereal Disease education. He was appointed to the State Department of
Health’s V.D. Task Force.
Election of Officers
The Nominating Committee report was presented. Charles E. Spigelmire moved that nominations be closed. The Officers and Executive Committee members were elected unanimously as per the slate presented by the Nominating Committee.
Honorary President—Philip Levin
President—Joseph U. Dorsch
President Elect—Paul Freiman
Vice Presidents—Ronald Lubman Melvin Rubin Henry G. Seidman
Secretary—Nathan I. Gruz
Treasurer—Charles E. Spigelmire
Executive Committee
Irvin Kamenetz, Chairman
Gerald Freedenberg Herman Glassband Harold Holmes Harry R. Wille Mark Levi Stanley J. Yaffe
The Nominating Committee submitted its list of nominees to the House of Delegates. Mark Levi nomi- nated I. Dennis Klein from the floor.
John Padousis Ralph T. Quarles
The following delegates and alternates received the largest number of votes and were declared elected.
Delegates (22)
I. Dennis Klein Mark Levi
Barry Levin Harold Levin Norman J. Levin Ronald Lubman
Jerome Mask
Mary W. Connelly Joseph U. Dorsch Gerald Freedenberg Herman Glassband Wilfred H. Gluckstern Robert Kabik
Irvin Kamenetz
DECEMBER 1971
John Padousis Ralph T. Quarles Melvin Rubin Alder Simon
Charles E. Spigelmire H. Nelson Warfield Harry R. Wille Stanley J. Yaffe
Alternates (22)
Sidney R. Klavens Richard Metz William Morgenstern David S. Pearlman Morton Pollack Stanley Protokowicz Allan B. Shenker Morton Silverstein George Stiffman Charles Wagner Maurice Weiner
Morton Abarbanel John Ayd
Harry Bass Frank Block Jerome Block James P. Cragg Irving Galperin Henry Glaeser Marvin Goldberg David D. Greenfeld Harold Holmes
Paul Freiman, MPhA Legislative Committee Chair- man, conducted a discussion of the MPhA proposal for drug product selection by pharmacists through amend- ment of the State “antisubstitution” laws.
The meeting adjourned at 11:30 p.m.
A.Z.O. News
Kappa Chapter Hosts Regional Convention
Kappa Chapter hosted the Fall Regional Convention of the Alpha Zeta Omega Pharmaceutical Fraternity held on November 5, 6 and 7 at the Hunt Valley Inn, Cockeys- ville, Maryland. The convention included business meet- ings and_ several social functions. National President Mitchell Ross presided. Gerald Freedenberg is the Presi- dent of Kappa Chapter.
The highlight of the meeting was the Awards Ban- quet held on November 6 at which Dr. William J. Kin- nard, Jr., Dean of the University of Maryland School of Pharmacy, was presented an honorary membership in the
A.Z.O. Fraternity.
Fifty-year service pins were presented to Samuel Block, Nathan Cohen and Morris Schenker. Receiving 25- year service pins were: Max Ansell, Morton Cohen, Al- bert Friedman, Irving Pruce, Stuart Shpritz, Paul Siegel. Samuel Robbins, Benjamin Scheinin, Morris Walman and Irvin Zerwitz.
The Spring Regional of A.Z.O. will be held in Louis- ville, Kentucky, and the National Convention, in Miami on July 23.
A.Z.O. Men in the News
Morris Walman has been appointed to the Maryland State Drug Abuse Administration. Gerald Freedenberg, Donald Schumer and Harry Bass have been appointed to the School of Pharmacy Task Force for Third-Party Pay- ments. Paul Freiman has been appointed to the Maryland
State V.D. Task Force.
Names In The News
MPhA member Ernest J. Gregg, proprietor of Gregg’s Pharmacy in Oakland, Maryland, is the current foreman of the grand jury in Garrett County.
THE MARYLAND PHARMACIST 23
Maryland Society of Hospital Pharmacists
On November 11, 1971, the Maryland Society of Hospital Pharmacists met at the Officers Club of the U.S. Public Health Service Hospital in Baltimore. President Mary Connelly introduced the speaker, Dr. Samuel L. Fox, Director of Ophthalmology and Chief of Ophthal- mology Services at South Baltimore General Hospital. Doctor Fox discussed ocular therapy, both present and future.
Following a question-and-answer period President Connelly called the business meeting to order. Samuel Lichter, Program Chairman for the Society’s Seventh Annual Hospital Pharmacy Seminar, reported that F. Regis Kenna, Director of University of Chicago Hospital and Clinics, and Paul Burkhart, Assistant Chief Pharma- cist, University of Maryland Hospital, have been added to the list of speakers. Harry Hamet, Financial Chair- man for the 1972 Seminar, reported on the status of re- quests for financial assistance.
Monthly meeting Program Chairman, Paul Burk- hart, announced that the December 9 meeting will be held at the University of Maryland Hospital. Dr. William S. Spicer, Associate Dean, Health Care Programs, Uni- versity of Maryland School of Medicine, will discuss “The Changing Health Care System.” A meeting will be held on January 13, 1972, at St. Agnes Hospital.
Dr. Peter P. Lamy, Chairman of the Peer Review Committee, gave his report. Various upcoming meeting announcements were made by President Connelly. Darryl Zellers will be a speaker at the Virginia Society of Hos- pital Pharmacists Seminar on November 13, 1972.
The Guidelines Committee, consisting of Chairman Robert E. Snyder, Henry J. Derewicz, Morris Bookoff, Wilfred H. Gluckstern, and Mary W. Connelly, ex-officio member, will meet with Attorney Joseph S. Kaufman, legal counsel for the Maryland Pharmaceutical Associa- tion.
Allan Jaskulski has been appointed to represent the Society on a Committee for Third-Party Prescription Pay- ments chaired by Dr. Dean E. Leavitt. A position has been created for a Society member to review M.S.H.P. meetings and other functions and assign credit hours for continuing education purposes.
Applicants Josehp P. Crisalli and Charles J. Mc- Teague, were approved for membership. President Con- nelly expressed appreciation to the evening’s host, Kent Johnson, Director of Pharmacy Service, U.S.P.H.S. Hos- pital, who introduced his three hospital pharmacy resi- dents to the group.
City Tuberculosis Cases on Decrease
For the first time since records were kept, the num- ber of cases of tuberculosis occurring in the City of Bal- timore is less than half the total for the whole state. This was noted in the Weekly Communicable Disease Report of the Maryland State Department of Health for the week ending August 26 in which the state total was given as 584 cases whereas the city figure was 290. It is encouraging to reflect that the City of Baltimore is mak- ing progress in the control of this disease which has for many years given the city an undesirable record.
24 THE MARYLAND PHARMACIST
Philatelic Recognition for Pharmacists Announced
The United States Postal Service announced that a postage stamp in tribute to the service role played by the nation’s pharmacists will be issued next year. The com- memorative stamp will be issued next year. The com- memorative stamp will be keyed to “Partners in Health.”
As the Postal Service points out, a stamp was issued honoring physicians in 1947, the centennial of the Amer- ican Medical Association; and a stamp was issued in 1959 saluting the centennial of the American Dental Associa- tion. Furthermore nurses had their stamp in 1961, and earlier this year America’s hospitals were commemorated with a postal card.
Design of the pharmacy stamp and date and place of issuance will be announced later, concluded the U. S. Postal Service.
APhA President Lloyd M. Parks has written the U. S. Postal Service commending this announcement, pointing out that the American Pharmaceutical Associa- tion has long been active in seeking a commemorative U.S. postage stamp honoring the profession of pharmacy. As early as 1934, APhA officially endorsed an effort to issue a commemorative postage stamp on the occasion of opening the American Institute of Pharmacy (headquar- ters of the American Pharmaceutical Association) in Washington, D.C.
In 1939 APhA supported organized efforts to com- memorate the 120th anniversary of the United States Pharmacopeia and in the late 1940’s, a concerted effort was made to commemorate the centennial anniversary of the American Pharmaceutical Association. In 1966, APhA proposed two deserving anniversaries for a com- memorative postage stamp (the 150th anniversary of the birth of William Proctor, Jr., the “father of American pharmacy”) or the 100th anniversary of the founding of the first (Maine) state pharmaceutical association.
Then, in 1969, APhA again proposed two equally suitable occasions for a commemorative postage stamp— the 150th anniversary of the United States Pharmacopeia (for 1970) or the 150th anniversary of the founding of the first pharmaceutical association in the U.S. which eventually became the first school of pharmacy — the Philadelphia College of Pharmacy and Science (for 1971). Motivated by the remarks made on the floor of Congress by Senator Robert P. Griffin (R-Mich) on April 26, 1971, APhA lent its full support to the most recent efforts initiated by Irving Rubin, editor of Phar- macy Times.
Dr. Parks offered the U.S. Postal Service the serv- ices of the American Pharmaceutical Association to assist in the design, and urged that the First Day of Issue be held during the 120th anniversary of the American Phar- maceutical Association’s Annual Meeting in Houston, Texas, April 22-28, 1972.
More Than 1200 Attend FIP Sessions
More than 1,200 pharmacists and pharmaceutical scientists from throughout the world gathered in Wash- ington, D.C. on September 7-12 to attend FIP’s 31st In- ternational Congress of Pharmaceutical Sciences. This was the first meeting of the International Pharmaceuti- cal Federation ever held in the United States.
DECEMBER 1971
Representing
EMPLOYED PHARMACISTS P.O. BOX NO. 2322 ROCKVILLE, MARYLAND 20852
Pension & Investment Associatcs of America, Inc.
Pension Consultants to
MARYLAND PHARMACEUTICAL ASSOCIATION
Individual Retirement Plans Corporate Pension Plans(Prototypes Available) HR-10.. Plans (Sole Proprietor-Partnerships )
Mutual Funds
Prospectuses Available Upon Request
For an immediate appointment with a P.I.A.A. rep- resentative, please contact P.I.A.A., 2000 Spruce Street, Trenton, New Jersey 08638, Phone: (609) 883-0696.
What is ASTRO?
* ASTRO — is a cooperative advertising PROGRAM available
to any or all Calvert members interested in merchandising
and presenting merchandise to the consumer in a discreet
intelligent, attractive, competitive manner.
Its success is lauded by its members.
For further information, contact your Calvert representative,
Wilson Spilker or Kenneth Mills. Phone 467-2780.
THE CALVERT DRUG COMPANY
*A subsidiary
DECEMBER 1971
THE MARYLAND PHARMACIST
Obituaries
Dr. Elvin E. Goffdiener
Dr. Elvin E. Goffdiener, 64, a 1926 graduate of the University of Mary- land School of Pharmacy who later be- came a radiologist, died on June 21 at Poughkeepsie, New York.
Raymond M. Morstein
Raymond M. Morstein, 61, a 1931 graduate of the University of Mary- land School of Pharmacy, died on November 15.
Raymond S. Porterfield
Raymond S. Porterfield, 74-year-old pharmacist, died on November 13. A brother, M. Perry Porterfield, is a practicing pharmacist in Hagerstown.
Harry C. Lewis
Harry C. Lewis, 82, 1911 graduate of the University of Maryland, School of Pharmacy, died on November 23 in Cumberland.
The Hart Bill
Senator Philip Hart reintroduced his bill in this year’s session “To regu- late trade in drug and devices by pro- hibiting the dispensing of drugs and devices by medical practitioners and their participation in profits from the dispensing of such products, except under certain circumstances and for other purposes.” In the new version there will be a prohibition of physi- cians ownership in HMO’s_ pharma- cies.
You are urged to write, wire or call Senators Charles McC. Mathias, Jr., and J. Glenn Beall, The U.S. Sen- ate, Washington, D.C. 20510, urging their support.
STATE PHARMACEUTICAL DIRECTORY
AFFILIATED ORGANIZATIONS
Allegany-Garrett County Pharmaceutical Association
President 20, ieee ere Stephen Hospodavis Vice. Presented tae meee James Ritchie Secretary-Treasurer....... Robert F. Tomsko
Baltimore Metropolitan Pharmaceutical Association She SomMaea sess Irvin Kamenetz BA ta oe Joseph U. Dorsch Sa I alae Charles E. Spigelmire
Vice Presidents— Paul Freiman, Harold P. Levin, Harry R. Wille
Secretary and Executive Director Nathan I. Gruz
Eastern Shore Pharmaceutical Society
PlOSIAEN Tee neers ee Gordon Harrison First Vice President....... William P. Smith Second Vice President....... William Connor SOCTetary nc ata ee Carl R. June Treasurer st, scene ae Thomas Payne
Prince Georges-Montgomery County Pharmaceutical Association
Presidente yy) Sto, ce ee Martin Hauer First Vice President....Edward D. Nussbaum
Second Vice President ..... S. Ben Friedman Third Vice President ...... Sidney Glashofer Fourth Vice President....... Gabriel E. Katz SCChELaT YN ETD eee ee Paul Reznek UTEGSUTERA. rein ae cee Michael Leonard Honorary President .......... Samuel Morris
Washington County Pharmaceutical Association
Ranincawear Samuel E. Weisbecker Vice, Presidentioe: . oe eee Joseph Davies Mitel a Frederick Fahrney
University of Maryland School of Pharmacy Student APhA-MPhA Chapter
Presidents de Hs aoe Paul R. Webster Vice President ¥ Acaigeren Stephen B. Bierer SeOCreltany: Rae facts eae as Donna S. Leyin TTedsUT er wns tome xd ote Dennis R. Reaver
MPhA AUXILIARIES
LAMPA — Ladies Auxiliary of The Maryland Pharmaceutical Association President MRS. LOUIS M. ROCKMAN Recording Secretary MISS MARY DiGRISTINE Communications Secretary MRS. RICHARD R. CRANE Treasurer MRS. CHARLES S. AUSTIN
Membership Treasurer
MRS. MANUEL B. WAGNER
TAMPA — Traveler’s Auxiliary of The Maryland Pharmaceutical Association President PAUL J. MAHONEY First Vice President JOHN C. MATHENY Second Vice President ABRIAN E. BLOOM Third Vice President C. WILSON SPILKER Secretary-Treasurer WILLIAM A. POKORNY WILLIAM L. NELSON Assistant Secretary-Treasurer Honorary President JOSEPH GRUBB
Secretary-Treasurer Emeritus
JOHN A. CROZIER
OTHER PHARMACY ORGANIZATIONS Maryland Society of Hospital Pharmacists President MARY W. CONNELLY President Elect NORMAND A. PELISSIER Secretary DOLORES A. ICHNIOWSKI Treasurer
THOMAS E. PATRICK
University of Marviand School of Pharmacy
Dean DR. WILLIAM J. KINNARD, JR. Assistant Dean DR. C. T. ICHNIOWSKI Delegate and Vice Speaker— MPhA House of Delegates HENRY G. SEIDMAN
Metropolitan Guild of Pharmacists
President JOHN McKIRGAN Vice President FRANK FRARY rs Secretary : LARRY JACOBSON Treasurer
EDWARD WILLIAMS
re ee MPhA—Acapulco, Mexico Trip Almost Sold Out
May 17-22, 1972
Act at once to make reservations: for the MPhA Convention Trip to Acapulco via Eastern Airlines Charter. A fabulous package at the luxurious Pierre Marques Hotel. Only $599 per couple plus $39.00 taxes and gratuities. Send deposit of $100 to MPhA, 650 W. Lombard Street, Baltimore, Maryland 21201.
PS
26
THE MARYLAND PHARMACIST
DECEMBER 1971]
Paramount Photo Service
The Quality and Service Photofinisher
Is Pleased to Announce They’re Moving to Their New Laboratory To Serve You With The Most Modern and Latest Equipment.
Note our new address and telephone number:
PARAMOUNT PHOTO SERVICE
2920 Greenmount Avenue Baltimore, Maryland 21218
Telephone: Baltimore 366-1155 Washington Area [Local call] 484-4050
Ya AAA SO
, DECEMBER 1971 THE MARYLAND PHARMACIST 27
NOW IS THE TIME TO MAIL IN YOUR RESERVATIONS
for the
S6TH ANNUAL
DINNER -DANCE INSTALLATION
of the
BALTIMORE METROPOLITAN PHARMACEUTICAL ASSOCIATION
SUNDAY, JANUARY 30, 1972 N
e Many valuable
e 6:00 P.M. BLUE CREST NORTH surprises Geesiausa’ 401 Reisterstown Road (Pikesville) « Music by Hors D’Oeuvres Morgan Baer Orchestra
e Featuring
e 7:00 P.M. Buddy Aaron
Dinner
TICKET INCLUDES e FREE VALET PARKING e FREE SET UPS and e FREE CHECKING SERVICE | ¢ BAR AFTER DINNER NO TIPPING
e Vienesset Table
TICKET ORDER FORM B.M.P.A. DINNER DANCE Phone 542-7933/727-6440 GEORGE STIFFMAN
Ticket Chairman 650 West Lombard St. 2120]
Please place my order for .......... Tickets at $17.50 each. Tables for ten (10) $175.00
Check enclosed'fom. 0a ae eee dollars
NAMES OF PERSONS IN PARTY:
Bhd ts Kispht he lore ad OR) ee Name
= =
ij | ti
4 4
ie ; ; ee ao | . a hs 5 iad | a Are Be ¥ “ i >
oe rea * are tet aera
ae BS At AE Rea ie ak te eee
mene SL * Sus
at ee ee Roe aed 5 Scere reo rene
Breas edie eho : FF ph ae
See AIOSN
OHA eee ey EEE HO aha hon cee onde
Racially ee Nt ME ti ek ae RN